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OW1.1
To catch a ride: packaging and delivery of retrotransposons
through extracellular vesicles
Kristina P. Friis1, Leonora Balaj1, Romy Verschoor1,
Rafael Contreras-Galindo2, Shilpa Prabhakar1, David M. Markovitz2
and Xandra O. Breakefield1
1Department of Neurology and Radiology and Program in Neuroscience,
Massachusetts General Hospital and Harvard Medical School, Boston, Maine,
USA; 2Department of Internal Medicine, University of Michigan, Ann Arbor,
Michigan, USA
Introduction: Retrotransposons are remnants of ancient viral infections
that infected the genome of our primate lineage through infection of
germ cells. Scattered throughout the genome, these elements are
capable of amplifying themselves as well as changing their position
through RNA intermediates. Interestingly, retrotransposon elements
are highly enriched in tumour extracellular vesicles (EVs) compared
with their cells of origin and have been shown to be transferred in vitro
from medulloblastoma cells to normal human umbilical vein en-
dothelial cells (Balaj et al., 2011). Furthermore, the production of
EVs seems to share resemblance with retroviral particle assembly,
thus making retroviral-like particles a component of the EV con-
tingent. Hence, we are now testing whether a high prevalence of the
retrotransposon-like elements known as human endogenous retro-
viruses (HERVs) in tumour cell lines leads to selective packaging and
transfer of exRNA through EVs. Methods: The assay is based on the
BOGOTA construct (Contreras-Galindo et al., 2015), which includes
parts of the HERV-K113 packaging signal, and is selected through a
neomycin reporter gene. We have screened several cell lines for
the presence of HERVs. Expression of neomycin is used to select for
cell recipients and the initial confirmation of integration of the
transferred retroviral element into the genome of the recipient.
Results: Preliminary studies indicate that the transfer of retroviral
elements is successful between different cell lines. The use of the
BOGOTA construct results in a selective packaging of the reporter
gene into EVs. The neomycin resistance encoding RNA is highly
enriched in the resulting EVs compared with their cells of origin.
Conclusion: The indication of retrotransposon transfer between
different cell lines supports future studies to determine the role of
retrotransposon transfer in tumorigenesis, and potentially as a means
of generating therapeutic vehicles utilizing viral packaging signals.
OW1.2
Milk-derived exosomes  a platform nanocarrier to enhance
anti-proliferative, anti-inflammatory and anti-cancer activities of
small drug molecules against multiple human cancers
Ramesh Gupta1, Farrukh Aqil1, Manicka Vadhanam1, Jeyaprakash
Jeyabalan1, Ashishkumar Agrawal1, Ashley Mudd1, Alhassan Kyakulaga1,
Divya Karukonda1, Wendy Spencer2 and Radha Munagala1
1University Of Louisville, Louisville, Kentucky, USA; 23P Biotechnologies,
Louisville, Kentucky, USA
Introduction: Exosomes are considered viable nano-transporters for
carrying a payload of both small and macromolecules. We recently
reported that bovine milk exosomes loaded with small molecules
are readily taken up by cells and show higher therapeutic response
than free agents against lung cancer. Using curcumin (CUR), bilberry
anthocyanidins (Anthos), withaferin A (WFA) and celastrol (CEL), we
now report that this concept applies to multiple cancers. Methods:
Human breast, lung, ovarian, pancreatic, prostate, cervical and colon
cancer cells were treated in vitro with CUR, WFA, CEL and/or Anthos,
as free agents or as exosomal (Exo) formulations. Inhibition of cancer
cell proliferation and inflammation were measured by multi-table
tournament assay and electrophoretic mobility shift assay, respec-
tively. The antitumour activities of Exo formulations given orally
were also determined against ovarian and lung tumour xenografts in
nude mice. Results: All test agents as Exo formulation showed 2- to
20-fold higher antiproliferative activity against the various cancer
cell lines versus free agents. A greater anti-inflammatory effect of
Exo-CUR was observed versus CUR in lung cancer cells challenged
with TNF-a. Oral delivery of Exo-WFA, Exo-Anthos and Exo-CEL
showed enhanced anti-cancer effects in nude mice carrying lung
and ovarian tumour xenografts versus the free agents. Tagging Exo-
WFA with a tumour-targeting ligand, folic acid further enhanced
the therapeutic activity against ovarian tumour. Exosomes alone
showed intrinsic activity of 2050% growth inhibition of all human
cancer cells tested in vitro; normal cells were not affected. Finally, no
systemic toxicity was observed following treatment of wild-type
mice with the exosomes. Conclusion: Our data suggest that milk
exosomes can serve as a nanocarrier platform to enhance activity of
therapeutics by increasing cellular uptake and bioavailability against
multiple cancers.
Financial support: From Duggan Endowment, Helmsley Trust Fund
and the USPHS grant R41-CA-189517.
OW1.3
Exosomes transfer chemotherapeutic drug resistance
between colorectal cancer cells
Stephanie Boukouris1, Suresh Mathivanan2, John Mariadason3 and
Michael Liem1
1La Trobe University, Melbourne, Australia; 2Olivia Newton-John Cancer
Research Institute, Heidelberg, Australia; 3Institute of Molecular Sciences,
La Trobe University, Melbourne, Australia
Introduction: Chemotherapy is currently the mainstay for advanced
colorectal cancer (CRC) with 5-fluorouracil (5-FU) being the most
commonly used chemotherapeutic drug. While some patients re-
spond to chemotherapy, some are inherently resistant for 5-FU.
Among the responding patients, some acquire resistance and there-
fore fail to further respond to treatment. In this study, we investigated
whether exosomes, a class of extracellular vesicles, can transfer
chemotherapeutic drug resistance between cells. Methods: Exosomes
were isolated by deferential centrifugation followed by ultracentri-
fugation from colorectal cancer cell conditioned media and charac-
terized by western blotting and electron microscopy. To identify
regulators of chemotherapeutic resistance, label-free quantitative
proteomics analysis was performed on both parental and 5-FU-
resistant colorectal cancer cells including the respective derived
exosomes. Fluorescence-activated cell sorting (FACS) cell cycle arrest,
clonogenic assay and western blotting were carried out on SW620
and HCT116 upon incubation with exosomes secreted by resistant
cells. Results: 5-FU-resistant CRC cells were established by continuous
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culture of parent cells with increasing concentrations of 5-FU.
Molecular biology and biochemical experiments confirmed the role
of epithelial-mesenchymal transition (EMT) in this acquired drug
resistance. Exosomes isolated from 5-FU-resistant cells were able to
transfer the resistant phenotype to parental and other wild-type CRC
cells as confirmed by cologenic and FACS apoptosis assays. Quanti-
tative proteomic analysis of exosomes released by resistant and
parental cells revealed the differential abundance of many proteins
implicated in EMT, including YBX1. Western blotting analysis con-
firmed the induction of EMT in the recipient cells upon incubation
with exosomes released by 5-FU-resistant cells. Summary: The results
established that exosomes can transfer resistance to 5-FU in colorectal
cancer cells therefore aiding in treatment failure.
OW1.4
Extracellular vesicles regulate gefitinib sensitivity in head
and neck cancer cells
Dorival Rodrigues-Junior1, D. P. Lau1, F. T. Chong1, H. S. Leong1,
D. S. Tan1, S. S. Tan2, S. K. Lim2, Andre Luis Vettore3 and N. G. Iyer1
1National Cancer Centre of Singapore, Singapore; 2Institute of Medical Biology,
Singapore; 3Federal University of Sao Paulo, Brazil
Tyrosine kinase inhibitors (TKIs) to epidermal growth factor receptor
(EGFR) (gefitinib) have shown limited efficacy in the treatment of head
and neck squamous cell carcinoma (HNSCC) patients despite pre-
clinical data showing addiction to these pathways. Notwithstanding,
a small subpopulation of patients has shown excellent response to
TKIs, which does not correlate with EGFR expression or amplification.
The objective of this study was to determine whether factors that
confer TKI sensitivity could be transferred via extracellular vesicles
(EVs). HNSCC cell lines Tm17 and Tm49, which were inherently
sensitive to gefitinib (wild type, WT), and their isogenic gefitinib-
resistant (GR) counterparts, generated through treatment with
sublethal doses of gefitinib, were used in this study. EV isolation
was based on binding properties: cholera toxin B chain (CTB) and
annexin V (AV), which, respectively, binds GM1 ganglioside and
phosphatidylserine. Both Tm17 GR and Tm49 GR were re-sensitized
to gefitinib when cultured in EV-enriched conditioned media from
Tm17 WT. Antibody arrays were performed to identify proteins in the
EVs of Tm17 WT and Tm17 GR. For CTB-EVs, 16 and 69 proteins were
overexpressed in WT and GR cells, respectively. For AV-EVs, 66 and
21 proteins were overexpressed in WT and GR cells, respectively,
with a further 18 proteins exclusively found in WT. Ingenuity Pathways
Knowledge Base analyses showed that differentially overexpressed
proteins in the EVs of sensitive cells were related to apoptosis,
cell death and inflammatory response (pB0.01). These data indicate
that WT HNSCC cells secrete EVs that have paracrine ability to re-
sensitize their resistant counterparts to gefitinib, providing a potential
treatment option of using EVs and improving clinical outcome for
these patients. Interestingly, we identified 18 proteins exclusively
present in EVs isolated from Tm17 WT that may contribute to the
development of tools for prediction and assessment of gefitinib
response.
OW1.5
Lipid and protein composition distinguishes stem cell EVs
from cancer cell EVs and affects efficiency of EV-mediated small
RNA cellular transfer
Reka Haraszti1, Andrew Coles2, Matthew Hassler2, Julia Alterman2,
John Leszyk2, Marie Didiot2, Scott Shaffer2, Hannah Rockwell3,
Michael Kiebish3, Neil Aronin2 and Anastasia Khvorova2
1RNA Therapeutics, University of Massachusetts Medical, Worcester, MA, USA;
2University of Massachusetts Medical School, Worcester, Massachusetts, USA;
3Berg Llc, Farmingham, Massachusetts, USA
Introduction: Extracellular vesicles (EVs) are implicated in the transfer
of endogenous small RNAs between cells and are being explored as a
formulation strategy for therapeutic RNA delivery. We hypothesize
that EV trafficking is dependent on lipid and protein composition,
which is defined by the source cell. Methods: Exosomes and micro-
vesicles (MVs) were purified from different source cell types via
differential ultracentrifugation. Lipidomic and proteomic profiles were
assessed by MS/MS(ALL) and liquid chromatography coupled to mass
spectrometry (LC-MS/MS), respectively. Purified vesicles were loaded
with hydrophobically modified siRNA (hsiRNA) and applied to primary
neurons in culture or directly infused into striata of mice. hsiRNA
distribution and mRNA silencing were quantified by PNA (peptide
nucleic acid)-hybridization and QuantiGene(r) assays, respectively.
Results: All cell types tested produced EVs with characteristic lipid
(1900 species identified) and protein (3500 proteins identified)
profiles. Most importantly, stem cell EVs significantly differed from
cancerous cell EVs with fibronectin, histone 3A, long-tailed glycolipids
and sphyngomyelins showing the largest difference. Furthermore,
MVs were more similar to their source cells than exosomes were
and displayed enrichment of certain mitochondrial and ER proteins
as well as ceramides, cholesterol esters and diacyl glycerols. Mean-
while, exosomes were depleted in these and rather enriched in
immune response and cell adhesion proteins as well as cardiolipins
and glycolipids. Cellular uptake and hsiRNA potency were enhanced
when formulated into EVs in a source cell-dependent manner. When
source cells were serum-starved before EV purification, up to 15-fold
enhancement in potency was observed. Conclusions: Functional as
well as proteomic and lipidomic studies confirmed that source cells
affect EV trafficking and composition. Serum-starved mesenchymal
stem cell exosomes were the most potent delivery vesicles for thera-
peutic hsiRNA.
OW1.6
Extracellular vesicle-mediated reversal of castrate-resistant
prostate cancer
Devasis Chatterjee1, Michael Del Tatto1, Joseph Renzulli2,
Justin Wang1 and Peter Quesenberry1
1Rhode Island Hospital, Providence, Rhode Island, USA; 2The Miriam Hospital,
Providence, Rhode Island, USA
Background: Castrate-resistant prostate cancer (CRPC) is the second
leading cause of cancer-related death in men in the developed world.
While androgen deprivation therapy is effective at the onset of
treatment, nearly all men develop castrate resistance. Several new
therapies, including enzalutamide (Enz)-based chemotherapy, have
improved outcomes for CRPC. We have shown extracellular vesicles
(EVs) isolated from non-malignant cells can inhibit the malignant
phenotype. We investigated the role of EVs isolated from human
mesenchymal stem cells (hMSC EVs) reversing the malignant pheno-
type and Enz resistance in prostate cancer (PCa). Methods: EVs
isolated from human mesenchymal stem cells were co-cultured with
Enz sensitive or resistant cells after which western blot analysis,
anchorage independent and tumour xenograft growth were assessed
and sensitivity to Enz was monitored via multi-table tournament
assay. Results: We used Enz sensitive (C4-2B) and resistant (C4-2BR)
PCa cells for our studies. hMSC EV treatment of C4-2BR cells restored
sensitivity to Enz via the transfer of Raf kinase inhibitor protein (RKIP).
RKIP inhibited STAT3 activation in C4-2BR cells. hMSC EV treatment
induced apoptosis, inhibited anchorage independent growth, cell
invasion and tumour xenograft formation. Conclusions: hMSC EVs can
reverse the malignant ‘‘education’’ of recipient cells and provide the
promising basis to investigate the therapeutic utility of hMSC EVs for
the treatment of CRPC.
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OW2.1
Advanced molecular tools for proteomic analyses and
characterization of microvesicles
Masood Kamali-Moghaddam1, Liza La˜F1, Di Wu2, Junhong Yan1,
Felipe Oliveira1, Qiujin Shen1 and Wik Lotta1
1Department of Immunology, Genetics and Pathology/Molecular Tools,
Uppsala University, Uppsala, Sweden; 2Department of Biochemistry and
Biophysics, Science for Life Laboratory, Solna, Sweden
Proteomic studies of extracellular microvesicles provide valuable
knowledge about their origin and functions. However, the small size,
low concentration and the heterogeneity are some of the features
limiting characterization of these microvesicles. We have developed
a large number of molecular tools such as different forms of proxi-
mity assays using two or more antibodies with conjugated DNA
strands for single- or multiplex measurement of proteins in solution
and in situ. Utilizing the multiplex proximity extension assay, we are
able to analyse microvesicles for their protein content in minute
amount of samples, and by applying a novel method, proximity
barcoding assay (PBA), we are also able to characterize proteomic
heterogeneity from individual microvesicles by targeting the surface
proteins. In PBA, distinct DNA oligonucleotides with different
protein-specific tags (ST) are conjugated to each of 24 different
antibodies, directed against their cognate potential protein targets
on the surface of microvesicle. Clusters of antibody-conjugated
oligonucleotides are brought in proximity when the antibodies bind
to the proteins on the surface of the same microvesicle, allowing
hybridization and extension on a DNA concatemer of identical copies
of a single-strand DNA molecule carrying a unique complex-ST. Thus,
clusters of DNA oligonucleotides on the same microvesicle will
incorporate the same complex-ST. The protein composition on
individual microvesicle will then be revealed via next-generation
sequencing by analysing the protein-ST and complex-ST from each
sequencing read. Here, we illustrate the application of PBA to
analyse thousands of individual microvesicles in each sample to
differentiate between microvesicles from different origins. We also
illustrate the application of the multiplex PEA for analyses of the
protein content of different microvesicles using different protein
panels. These methods can potentially be used to identify exosomes
as disease biomarkers.
OW2.2
Proteomics-driven design of endothelial stress-based protein
array for disease prognostics - applied to plasma and cerebrospinal
fluid
Kenneth Kastaniegaard1, Malene Møller Jørgensen2, Rikke Bæk2, Tobias
Sejrbaek3, C. Wiwie4, J. Baumbach4, Vladimir Zachar1, Torben Moos1,
Søren Nielsen1, John D. Nieland1, F. Cotton5, C. Guttmann6, Zsolt Illes3
and Allan Stensballe1
1Department of Health Science and Technology Aalborg University, Aalborg,
Denmark; 2Aalborg University Hospital, Aalborg, Denmark; 3Department of
Neurology, Odense University Hospital, Odense, Denmark; 4Institute of Clinical
Research, University of Southern Denmark, Denmark; 5Service de Radiologie,
Universite´ de Lyon, France; 6Center for Neurological Imaging, Bringham and
Women’s Hospital, USA
Introduction: Endothelial dysfunction is central to multiple auto-
immune diseases such as multiple sclerosis (MS). The stressed
endothelium may have a pro-inflammatory phenotype and can be
characterized by biomarkers derived from different molecular path-
ways. The ‘‘barcode’’ of protein profiles, lipid composition and
post-translational modifications (PTMs) from circulating classes of
microvesicles (MVs) are important features for EVs. Our aim was to
optimize the EV array, a well-functioning high-throughput method
for EV and exosome phenotyping, for rapid improved diagnosis and
prognosis of autoimmune diseases characterized by local endothelial
dysfunction. Methods: Crude MVs and exosomes of different biolo-
gical origins including endothelial cell lines (brain, lung), plasma and
cerebrospinal fluid from MS patients and synovial fluid from
rheumatoid arthritis patients were isolated using either ultracentri-
fugation or by immunoaffinity purification by custom-made immu-
nobeads. The endothelial cell lines were subjected to oxidative
stress, hypoxia or treatment with metabolism-modifying drugs.
Purified MVs were validated and characterized by particle size
determination and electron microscopy. The EV proteomes were
characterized using quantitative proteome analysis and functional
annotation. Results: Analysis of crude MVs and enriched exosomes by
label-free quantification enabled detection of the EV-subproteome
including surface-exposed proteins specific to treatment/disease.
Putative prognostic markers for endothelial stress were used as part
of the panel of the EV array, a sandwich ELISA type protein array
highly optimized for EV quantification in biofluids. The applicability
of the array and comparability of the quantitative data were
compared to similar data obtained by mesoscale (41 cytokines) or
quantitative mass spectrometry.
OW2.3
Proteomic analysis of extracellular vesicles isolated from airway
epithelial cells using ultrafiltration followed by size exclusion
chromatography
Birke J. Benedikter1,2, Freek G. Bouwman3, Emiel F. M. Wouters2,
Paul H. M. Savelkoul1,4, Gernot G. U. Rohde2, Edwin C. Mariman3 and
Frank R. M. Stassen1
1Department of Medical Microbiology, Maastricht University Medical Center,
Maastricht, The Netherlands; 2Department of Respiratory Medicine, Maastricht
University Medical Center; 3Department of Human Biology, Maastricht
University Medical Center; 4Department of Medical Microbiology & Infection
Control, VU University Medical Center, Amsterdam, The Netherlands
Background: Situated at the vast lung surface, the airway epithelium
is crucial for regulating pulmonary homeostasis. We and others have
found that airway epithelial cells (AEC) secrete extracellular vesicles
(AEC-EVs) under basal and pathological conditions. Getting insights
into the composition of these AEC-EVs will help unravel their
functions in lung homeostasis and pathology. Here, we characterized
the proteomic composition of basal AEC-EVs, which were concen-
trated using ultrafiltration (UF) and then purified by size exclusion
chromatography (SEC). Methods: Medium from BEAS-2B cells
(120 mL, conditioned for 24 h by 2.3x107 cells) was depleted of cell
debris and passed through a 0.22-mm filter. Next, it was concentrated
to 1 mL on a 10 kDa centrifuge filter and run over a sepharose CL-4B
column. Fractions were assessed for protein content (Bradford assay,
Silver staining) and EV content (CD63 CD81 bead-coupled flow
cytometry). Proteomic composition of the pooled EV fractions was
determined using mass spectrometry (nLC-MS/MS Q Exactive).
Overrepresentation analysis was performed using ConsensusPathDB.
Results: About 10 kDa UF concentrated the EVs with a recovery near
100%. The majority of EVs eluted in SEC fractions 611, while protein
only became detectable at fraction 12. Mass spectrometry of the EV
Wednesday May 4, 2016
4 Citation: Journal of Extracellular Vesicles 2016, 5: 31552 - http://dx.doi.org/10.3402/jev.v5.31552
fractions identified more than 500 different proteins, including 28
out of the 34 EV markers compiled by de Menezes-Neto et al. (JEV,
2015). Prominent pathways overrepresented in the AEC-EVs were
metabolism of proteins, translation, protein folding and proteasomal
degradation. Conclusion: UF followed by SEC efficiently separates
EVs from free protein, which is ideal for proteomic analysis.
The overrepresentation of pathways involved in protein metabolism
suggests that AEC-EVs may contribute to regulating cellular pro-
teostasis. Future research will focus on proteomic differences
between AEC-EVs released under normal and pathological condi-
tions, and their functional implications.
OW2.4
In-depth proteomics analysis of human breast milk-derived
extracellular vesicles reveals a novel functional proteome distinct
from other milk components
Martijn J. C. van Herwijnen1, Marijke I. Zonneveld1,2, Soenita Goerdayal3,
Esther N. M. Nolte-’t Hoen1, Johan Garssen2,4, Maarten Altelaar3,
Frank A. Redegeld2 and Marca H. M. Wauben1
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Introduction: Breast milk contains macromolecular components with
distinctive functions, whereby milk fat globules and casein micelles
provide nutrition, while whey contains molecules that stimulate the
infant’s immunity. Interestingly, the importance and function of
extracellular vesicles (EVs) in milk has not been addressed in detail.
This in part is due to the difficulty to purify EVs from other milk
components, and consequently, the molecular composition of hu-
man milk-derived EVs has not been fully elucidated. Methods: In this
study, an extensive liquid chromatography coupled to mass spectro-
metry (LC-MS/MS) proteomic analysis was performed on EVs isolated
via density-based separation from human breast milk of 7 individuals.
The proteome of milk-derived EVs was analysed using FunRich
and compared to the Vesiclepedia database, as well as to the whole
milk proteome, which was constructed from 38 previously published
milk proteomics studies. Results: A total of 1963 proteins were
identified in milk-derived EVs, including EV-associated proteins like
CD9, annexin A5 and flotillin-1. Overlap analysis revealed that 198
proteins were not yet listed in Vesiclepedia. Interestingly, these newly
identified proteins included common milk proteins, like oleoyl-ACP
hydrolase and parathyroid hormone-related protein. Next, the milk-
derived EV proteome was compared to the whole milk proteome.
Remarkably, 633 proteins identified in milk-derived EVs have not yet
been identified in milk to date. Interestingly, these novel proteins
included proteins involved in regulation of cell growth and control of
inflammatory signalling pathways. Conclusion: These data show that
milk-derived EVs harbour previously unidentified proteins that
have the capacity to support the infant’s developing gastrointestinal
tract and its immune system. In addition, this study provides an
expansion to the whole milk proteome, illustrating that milk-derived
EVs are a distinct macromolecular component with a unique
functional proteome.
OW2.5
Characterization of extracellular vesicles derived from hepatitis
B virus producing liver cells
Kwang Pyo Kim, Kyung-Cho Cho, Raju Bandu, Joon Won Lee and
Jae Hun Jung
Applied Chemistry, Kyung Hee University, Yongin, Korea
Infection of hepatitis B virus (HBV) is one of the major causes of
hepatocellular carcinoma (HCC) in the world. The extracellular vesicles
are expected to be involved in carcinogenesis, although their exact
oncogenic functions remain controversial. In this study, we character-
ized extracellular vesicles from hepatitis B virus (HBV)-infected liver
cell line (HepG2.2.15) and non-infected liver cell line (HepG2). The
extracellular vesicles were isolated using the method of centrifugation
with the sucrose cushion and density gradient solution. The western
blot results revealed that the isolated extracellular vesicles were
purely isolated without HBV, which have similar size as extracellular
vesicles. It is noteworthy that the transmission electron microscopy
(TEM) images and dynamic light scattering data showed that
the extracellular vesicles derived from HepG2.2.15 cell have more
size than the HepG2 cell-derived extracellular vesicles. Further, we
identified and quantified specific extracellular proteins from both
HepG2.2.15 and HepG2 cell lines by using Easy-nLC coupled Q-
exactive mass spectrometric analysis and Maxqaunt search tool. In
this study, a total of 1724 proteins were identified, and 364 proteins
were selected as dominant proteins in which 256 EV proteins were
significantly down-regulated and 108 EV proteins were up-regulated
in HepG2.2.15 when compared with HepG2. The biological functional
properties of the extracellular vesicles that are relevant to HBV-
infected cell, including their roles as actin cytoskeleton organization,
vesicle-mediated transport, generation of precursor metabolite and
energy and translation.
OW2.6
Apoptotic cell-derived extracellular vesicles  towards defining a
structure-function relationship
Ivana Milic1,2, Roberta Liccardo1,2, Allan Cameron1.2, Helen Griffiths1,2,
and Andrew Devitt1,2
1Aston Research Centre for Healthy Ageing and School of Life & Health
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Introduction: Apoptotic cell-derived extracellular vesicles (ACdEVs)
represent a vital link by which dying cells communicate their presence
to enable their removal, thereby modulating immune responses. This
process is of fundamental importance as failed clearance of dying cells
influences inflammation, cardiovascular diseases and cancer. While a
function of ACdEVs has been demonstrated, the molecular mediators
are ill defined. Our work seeks to undertake the first comprehensive
analysis of ACdEV molecular structure and function. A variety of cargo
may be loaded into EVs, with miRNA and proteins being the most
widely investigated. We aim to address fatty acid-derived lipid
mediators, for example, lipoxins, resolvins, protectins and maresins,
which have been identified as crucial mediators for the resolution
of inflammation. Methods: Peripheral blood mononuclear cells
(PBMCs) were isolated using lympoprep from defibrinated blood.
Anti-Fas-induced apoptosis was determined by flow cytometry with
annexin V and propidium iodide staining. ACdEVs were isolated by
ultracentrifugation. Size characterization and concentration of EVs
was determined using tunable resistive pulse sensing technology. The
molecular composition of ACdEVs was analysed by liquid chromato-
graphy online coupled to tandem mass spectrometry (LC-MS/MS)
operating in multiple reactions monitoring mode. Results: ACdEVs
released from apoptotic PBMCs fall within the exosome size range and
were demonstrated to be rich in pro-resolving lipid mediators. We
quantified docosahexaenoic acid-derived resolvins (RvD1, RvD2) and
maresin 1, eicosapentaenoic acid-derived RvE1, arachidonic acid-
derived lipoxins LXA4 and LXB4, including prostaglandins PGE2 and
PGD2, and leukotriene LTB4. The relative ratios of lipid mediators
between ACdEVs from early and late apoptotic PBMCs differed and
may underpin differential EV function. Summary: Our novel data
suggest that ACdEVs and lipid mediators may play an important role
in monocyte recruitment to sites of cell death and may provide new
strategies for the control of inflammation.
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The role of S-palmitoylation in the biogenesis of skeletal muscle-
derived extracellular vesicles and the structural organization of their
membrane
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Antonietta Notaro1, Ines Ferrara1, Alessandra d’Azzo3,
Vincenzo Martorana2, Mauro Manno2 and Antonella Bongiovanni1
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Introduction: Skeletal muscle (SkM) cells can release Alix-positive
exosomes directly from their sarcolemma, suggesting a new para-
digm for understanding how muscles communicate with adipose
tissue, the brain or tumours. Our goals, here, were to understand how
muscle cells generate these vesicles, to evaluate their heterogeneity
and membrane structure, and to determine what regulates them.
Methods: We have used an integrated biological/biophysical approach
to determine whether protein lipidation (i.e. S-palmitoylation)
affects the localization of extracellular vesicle (EV) modulator(s), EV
biogenesis, cargo selection or other processes by (i) evaluating
post-translational S-palmitoylation of EV proteins as well as their cell
membrane and EV protein levels and (ii) characterizing EV hetero-
geneity and membrane structure in dispersion using dynamic light
scattering (DLS), atomic force microscopy, small-angle X-ray scatter-
ing and small-angle neutron scattering. Results: By coupling these
data, we were able to determine that Alix is S-palmitoylated and
that palmitoylation inhibition altered its subcellular localization and
protein interaction. Furthermore, the biophysical analyses of SkM-
EVs showed that the structural organization of the lipid bilayer
of palmitoylated-inhibited exosomes is qualitatively different com-
pared to non-treated exosomes. Conclusion: We propose that S-
palmitoylation might regulate the proper function of Alix in SkM EV
biogenesis, support the interactions among the exosome-specific
regulators/biomarkers and maintain proper EV membrane structural
organization. Beside its biological relevance, our study sets the route
for a comprehensive structural characterization of EV, which is
expected to be crucial in EV-based therapies to be employed in the
tissue regeneration field, for example, to help in recovery from muscle
atrophy and/or injury.
Italian Ministry for Education, University, and Research in the
framework of the Flagship Project NanoMAX.
OW3.2
Unexpected cytosolic protein localization on the surface of
extracellular vesicles
Sarah Stewart, Florian Gessler, Stefano Pluchino and Kevin Moreau
University of Cambridge, Cambridge, United Kingdom
Extracellular vesicles (EVs) contain many specific proteins, both
cytosolic and membrane bound. The current model for extracellular
vesicle biogenesis dictates that the subcellular location of proteins
should be reflected in the EV architecture, where cytosolic proteins
are in the lumen and cell surface proteins are on the outside of EVs.
This is consistent with the conventional protein trafficking path-
way for cell surface localization, whereby proteins destined for the
plasma membrane (or secretion) must contain a signal sequence to
target them to the secretory pathway. It is clear that receptors
anchored in the membrane are retained in the correct orientation
and RNAs are in the lumen of EVs. However, there is limited data on
the packaging and location of other proteins commonly identified in
EVs. Annexin A2 is a cytosolic calcium-dependent membrane-
binding protein consistently identified in EVs. Using biochemical
approaches, we show that annexin A2 localizes to both the lumen
and the surface of EVs. Based on this result, we are now investigating
the function of annexin A2 on the surface of EVs. Additionally, we are
using mass spectrometry analysis to identify other proteins ex-
pressed on the surface of EVs. The presence of cytosolic proteins on
the surface of EVs raises questions about their trafficking and may
provide further insight into EV packaging and function. It is possible
that proteins are specifically packaged on the outer membrane of
EVs. In which case, EVs may provide a pathway for unconventional
protein trafficking to the cell surface. Understanding this unconven-
tional protein trafficking pathway is extremely important and will
uncover a novel fundamental cellular process.
OW3.3
Investigation of the molecular mechanism of cargo editing in human
PMN-derived EVs
Bala´zs Bartos, Attila Mocsai, David Szombath, Ma´rton A´kos Lorincz and
Erzsebet Ligeti
Department of Physiology, Semmelweis University, Budapest, Hungary
Introduction: In our previous studies, we demonstrated that the
neutrophilic granulocytes are able to produce different types of
extracellular vesicles (EVs) after different stimulation. EVs that were
generated after stimulation by opsonized particles have an inhibiting
effect on bacterial growth. The aim of this study was to investigate the
role of certain immune-receptors (FcR, C3R) and src tyrosine kinases in
the production of antibacterial EVs. Methods: We isolated polymorpho-
nuclear cells from peripheral blood of healthy donors. After different
biological stimulations, EVs were separated by two-step centrifuga-
tion and filtration. EVs were counted by EV-optimized flow cytometry.
EV protein amount was measured by Bradford assay, and granule
proteins were detected by western blotting. Antibacterial effect of
different EVs was analysed by bacterial survival test. Results: We found
that isolated stimulation of beta2 integrines or Fc receptors or pattern
recognition receptors increased the EV production. Combined stimu-
lation has additive effect on EV generation. In contrast to superoxide
production and phagocytosis, inhibiton of src kinases did not interfere
with EV production. However, cargo protein and biological function of
EVs depend on src kinases. Conclusion: EV production of neutrophils
can be increased and modified both through integrine and Fc receptor
stimulation, independent of the process of phagocytosis or super-
oxide production. Src kinases do not play a role in EV generation but
through EV quality control and cargo editing they do influence the
biological function of produced EVs.
OW3.4
YKT6 regulation of exosome release is mediated by microRNAs and
impacts prognosis in non-small-cell lung cancer
Marc Ruiz Martinez1, Sandra Santasusagna1, Alfons Navarro1,
Joan J. Castellano1, Jorge Moises2, Nuria Vin˜olas3, Carmen Mun˜oz1, Joan
Segui4, Ramon M. Marrades2, Josep Ramirez5, Hernando A. Del Portillo4,
Oriol Caritg1, Anna Cordeiro1, Laureano Molins6 and Mariano Monzo1
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Introduction: Non-small-cell lung cancer (NSCLC) has a dismal
prognosis, highlighting the need for new prognostic markers. The
role of exosomes and their regulatory genes in intercellular commu-
nication is a promising research area. YKT6 is involved in the control
of exosome release and has been linked to poor prognosis in breast
cancer but its role in NSCLC has not been studied. We aim to examine
the role of YKT6 in exosome release and to identify its regulating
microRNAs (miRNAs) in vitro, and to evaluate the prognostic impact
of YKT6 in NSCLC. Methods: After 48 h of YKT6 inhibition, exosomes
were isolated by ultracentrifugation, characterized by nanoparticle
tracking analysis and Cryo-TEM and quantified by western blot using
the exosomal marker TSG101. miRNAs targeting YKT6 were validated
by Renilla-Luciferase assay and western blot. In tumour and normal
tissue specimens from 98 surgically resected NSCLC patients, YKT6
expression levels were assessed and correlated with disease-free
survival (DFS) and overall survival (OS). Informed consent was
obtained in accordance with the Declaration of Helsinki, and Hospital
Clinic ethics comitee approved the study. Results: A549 cells with
YKT6 inhibition had an 80.9% reduction in exosome release (p0.01).
Renilla-Luciferase assay identified miR-134 and miR-135b as miRNAs
targeting YKT6. In A549 cells transfected with pre-miR-134 or pre-
miR-135b, YKT6 protein levels decreased by 51.45% (p0.01) and
45.53% (p0.02), respectively, while exosome release decreased by
43.92% (p0.03) and 53.43% (p0.008), respectively. In patient
samples, YKT6 expression was lower and miR-134 and miR-135b
expression was higher in tumour than in normal tissue. Patients with
lower YKT6 expression had longer DFS (p0.02) and OS (p0.01).
Conclusions: Our findings are a first step towards a greater under-
standing of the role of exosome release and their regulatory genes in
NSCLC and their potential role as new prognostic markers.
OW3.5
Scavenger receptor A blockade leads to tumour accumulation of
systemically administered extracellular vesicles bearing interleukin-15
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Introduction: We identified the scavenger receptor A family (SR-A) as
responsible for the rapid clearance by liver macrophages of
systemically delivered therapeutic extracellular vesicles (EVs). We
hypothesized that blocking SR-A would decrease liver uptake,
resulting in improved tissue distribution of therapeutic EV bearing
interleukin-15 (IL-15), which stimulate NK and T-cells, as an in vivo
anti-cancer therapy. Methods: HEK293 cells expressing heterodimeric
IL-15 (IL-15:IL-15Ra [hetIL-15]) were grown in a hollow-fiber bio-
reactor. EV-bearing hetIL-15 were purified from conditioned medium
by differential ultracentrifugation. EVs were stained with SytoGreen
RNAselect or DiR, and unincorporated dye removed by gel filtration.
Uptake of SytoGreen-stained EVs by cell lines and human primary
cells was monitored in vitro by flow cytometry in the presence of
specific scavenger receptor A and B blockers. Biodistribution of
DiR-stained EVs delivered into healthy and 4T1 (mouse breast cancer
cell line) tumour-bearing mice treated with dextran sulphate (SR-A
blocker) was monitored in vivo by fluorescence imaging. Results:
Dextran sulphate blocked EV uptake in the SR-A1 mouse macro-
phage RAW264.7 cell line and in human primary monocytes, but had
no effect in SR-A1() cell lines, such as 4T1. Combining selective SR-
AI and SR-BI blockers decreased EV uptake additively. A single
injection of dextran sulfate resulted in 50% reduction of EV liver
uptake together with an increase of free plasma EVs 2 h after
treatment. Finally, pretreatment with dextran sulfate of tumour-
bearing mice led to an increase, compared to untreated control mice,
of EV uptake by the tumour over 24 h. Summary/conclusion: SR-A is
responsible for EV clearance by the liver. Blocking this receptor
enhances EV pharmacokinetics and distribution to tissues, including
tumours. These effects could be improved by combination of several
SR inhibitors and the use of therapeutic EV bearing tissue-specific
targeting ligands.
OW3.6
Binding of EVs is regulated by CD44-hyaluronan interactions and
induce EMT-like changes in target cells
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Hyaluronan (HA) is the most abundant and essential polysaccharide
of the extracellular matrix for maintenance of normal tissues, but
it also creates a favourable microenvironment for growth of
tumour cells. HA is synthesized by specific plasma membrane-bound
enzymes, hyaluronan synthases (HASs). The HASs activate growth of
extremely long filopodia and shedding of HA-coated extracellular
vesicles (EVs). EVs are suggested to interact with their target cells by
utilizing receptors on the vesicular surface, such as CD44, which is the
most common receptor for HA. The aim of this work was to study
these interactions and their effects on target cells. The HA-coated EVs
secreted by GFP-HAS3 overexpressing cells were shown to carry GFP-
HAS3 (both as protein and mRNA) using techniques like immuno-
blotting and qPCR. Moreover, confocal microscopy and correlative
light and electron microscopy showed that GFP-HAS3 containing EVs
(i.e. HAS3-EVs) induced morphological changes and increased the
size of pericellular HA coat of the target cells. HA secretion of the
target cells to the culture medium was also increased as analysed by
ELISA-like assay. Furthermore, adding an excess of HA oligosacchar-
ides in the incubation medium to displace HA from the receptors,
Streptomyces hyaluronidase digestion to remove the HA coat or
treatment with CD44 blocking antibody regulated the vesicle binding
to the target cell, thereby showing that HACD44 interactions
are important for EVs binding to the target cells. HAS-induced EVs
act as carriers for HA on their surface and are potential vehicles in
preparing the premetastatic niches. Furthermore, CD44HA interac-
tions may act as universal mechanism facilitating cellular binding of
EVs. This may result in signals to modify the target cells functions like
paving way for benign cells to become metastatic. Moreover, HA-
induced EVs could be utilized as diagnostic tools and targets of
therapy.
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A protocol for isolation and proteomic characterization of distinct
extracellular vesicle subtypes by sequential centrifugal ultrafiltration
Rong Xu, David Greening and Richard Simpson
Department of Biochemistry and Genetics, La Trobe Institute for Molecular
Science, La Trobe University, Melbourne, Australia
Introduction: Extensive biochemical and biophysical validation with
heterogeneous EV mixtures, along with disparate isolation schemes
and annotations, has blurred the boundaries of defining EVs, raising
the query whether these vesicles represent discreet entities with
specialized functions or are they merely a size continuum of the same
entity. It is well recognized that cells secrete essentially two EV
subtypes that can be partially separated by differential centrifugation:
the larger size class (referred to as ‘‘shed microvesicles’’ or sMVs)
are heterogeneous (1001,500 nm), while the smaller size class
(’’exosomes‘‘) are relatively homogeneous in size (50150 nm). A key
issue hindering progress in understanding underlying mechanisms of
EV biogenesis and cargo selectivity has been the technical challenge
of isolating homogeneous EV subpopulations (exosomes and sMVs)
suitable for molecular analysis. Methods: In this study, we reveal a
novel method for the isolation, purification and characterization of
exosomes and sMVs. This method, based on sequential centrifugal
ultrafiltration (SCUF), affords unbiased isolation of EVs from condi-
tioned medium from a human colon cancer cell model. Results: For
both EV subtypes, this protocol details extensive purification, and
characterization based on dynamic-light scattering, cryo-electron
microscopy, quantitation, immunoblotting and comparative label-
free proteome profiling, in addition to fibroblast invasion. We reveal
TSG101, Alix/PDCD6IP and CD63, considered stereotypic protein
markers of exosomes, to be exclusively enriched only in exosomes,
while numerous proteins found exclusively in sMVs (KIF23, RACGAP1
and CSE1L/CAS) warrant further study as to their potential use as
discriminatory markers for sMVs. Summary/conclusion: This analytical
SCUF method developed is potentially scalable using tangential
flow filtration and provides a solid foundation for future in-depth
functional studies of EV subtypes from diverse cell types.
OPW1.2PF6.05
Label-free detection of extracellular vesicles in human breast milk
compared to infant formula
L. De Rond1,2, Edwin Van Der Pol1,2, Auguste Sturk2, Rienk Nieuwland2,
Frank Coumans1,2 and T.G. Van Leeuwen1
1Department of Biomedical Engineering and Physics, Academic Medical
Centre, Amsterdam, The Netherlands; 2Department of Clinical Chemistry,
Academic Medical Centre, Amsterdam, The Netherlands
Introduction: Extracellular vesicles (EVs) in human breast milk carry
immune relevant structures (J Immunol. 2007; 1;179(3)), and breast
milk has a beneficial long-term effect on infants’ health when
compared to infant formula. Therefore, we study the relation
between EV and infants’ health. For this study, the concentration
of EVs has to be determined. However, detection of EVs in breast
milk and infant formula is complicated by the abundance of
lipoprotein particles. We recently demonstrated that scatter signals
of a flow cytometer uniquely define the diameter (d) and refractive
index (RI) of particles below 500 nm. RI detection can discriminate
EVs (RI 1.371.42) from lipoproteins (RI 1.431.50). Therefore, we
determine the EV to lipoprotein ratio (EV:LP) of breast milk, cow milk
and (cow milk-derived) infant formula. Methods: Forward and side
scatter signals of particles between 200 and 500 nm are measured on
an A50-Micro (Apogee, UK). To validate the method, we compared
the measured d and RI to the specified d and RI for two silica and
three polystyrene bead populations. Breast milk (4 donors, 1120
weeks postpartum) was obtained with informed consent. The EV:LP
was derived from the RI distribution. Results: Validation with beads
showed that d and RI could be determined with a measurement
error between 1.5% and 9.5% for d and between 0.17% and 2.7% for
RI. The EV:LP of the breast milk samples was between 1.3 and 3.9,
which was much higher than the EV:LP of infant formula (0.22).
The EV:LP of infant formula was comparable to cow milk (0.34).
Conclusion: Calibrated measurement of the forward and side scatter
signals on a flow cytometer enables label-free determination of the
number of EVs and lipoproteins in milk. The average EV:LP of breast
milk is 9-fold higher than that of infant formula. The observed
difference indicates that EVs may contribute to human breast milk’s
beneficial effect on the infants’ health.
OPW1.3PF6.01
Characterization of EVs by flow cytometry
John Tigges, Camacho Virginia and Toxavidis Vasilis
Flow Cytometry Science Center, Center for Extracellular Vesicle Research,
Beth Israel Deaconess Medical Center, Boston, USA
Characterization of extracellular vesicles (EVs) is greatly impeded by
several factors: their size (below 100 nm), their overlapping size
distribution, particle polydispersity and an overall low refractive
index. Flow cytometry is an advantageous tool for the analysis and
characterization of EVs because of its robust statistical power and its
multiparametric capabilities. The goal of nanoscale analysis and
sorting, termed small particle flow cytometry (SPFC), is to accurately
represent the size distribution and scatter profiles of these vesicles.
The most challenging elements have been the lack of sufficient
forward scatter resolution and precision optics to delineate popula-
tions from background and instrument noise. Because conventional
flow cytometers are not equipped with necessary optical capacities
to reach this lower threshold, instruments that are used for SPFC
typically have specific adaptations. In the light of these enhance-
ments, there are a number of modifications to the conventional form
of analysis that should be considered. Here we describe a compre-
hensive methodology for the set up and standardization of EV
analysis using SPFC. Controls of different size ranges, fluorescent
intensities and materials are required to set up distribution curves.
These are then used for instrument optimization and as a reference
guide. Using these controls, FACS instruments can be primed for the
detection, analysis and sorting of specific EV populations. This allows
for cross platform comparison and the ability to monitor QC, QA. The
method here will describe the use of nanoparticles to optimize a
flow cytometer for small particle detection. It will also outline the
procedures necessary to recover EVs for downstream applications.
OPW1.4PW7.09
Comparative analysis of urine storage, exosomes/EV purification and
normalization methods for the selection of most appropriate solutions
for biomarker discovery, clinical diagnostics and biobanking
Natasa Zarovni1, Antonietta Corrado1, Giorgia Radano1, Elisa Lari1, Davide
Zocco1 and Riccardo Vago2
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Background: Non-invasive urine harvesting as well as its enrichment
with extracellular vesicles (EVs) from urinary-genital tract makes
it ideal for detection of diagnostic markers for a set of clinical
conditions. Unlike blood whose composition and volume is tightly
regulated, urine concentration varies with nutrition, hydration and
environmental factors. Biobanks usually comprise low volumes
and spot, rather than time normalized urine samples. Conservation
and purification impacts the detection of some analytes, including
EV subsets, and the normalization approach further introduces bias
in inter- and intra-individual/population comparisons. We have
evaluated (i) the stability of urine upon storage at room temperature
(RT), (ii) the appropriate method and minimal volume for recovery of
relevant EV proteins and RNAs and (iii) normalization method
including creatinine (CT) and protein measure and EV count.
Methodology: Ultracentifugation, precipitation, imuno/affinity cap-
ture and SEC column were used for EV isolation from healthy donor
urine that was either frozen or stored for 6 months at RT. EV proteins
and miRNAs were quantified by western blot, ELISA, FACS, qPCR,
while CT and protein levels, and EV number (nanoparticle tracking
analysis) were measured in row urine and in EV pellets. Results:
Tested long-term storage of urine at RT was equivalent or superior to
standard freezing protocol. Creatinine levels do not correlate with EV
content, while EV number and protein load have similar trends. The
correlation of latter with canonical EV proteins (CD9/CD63, Alix,
Tsg101) depended on the purification method. Relative abundances
of selected EV proteins/miRNAs are likely to give true information on
underlying condition/pathway. Imuno and affinity precipitation
methods provided most efficient and specific recovery of urine EV
molecules from as few as 1 mL of urine. Conclusions: We describe
realistic urine processing and normalization solutions for unbiased
readout of EV biomarker studies and realistic routine clinical
sampling and diagnostics.
OPW1.5PT3.15
Quick screening for microparticle content in platelet-rich plasma of
cardiovascular patients
Elisabeth Maurer-Spurej1 and Audrey Labrie2
1University of British Columbia, Department of Pathology and Laboratory
Medicine, Vancouver, BC, Canada; 2LightIntegra Technology Inc., Vancouver,
BC, Canada
Introduction: Cardiovascular disease is associated with elevated
plasma microparticle content (MPC). For routine clinical screening of
plasma samples, an inherently standardized test that requires minimal
sample preparation is desirable. Although dynamic light scattering
(DLS) cannot characterize particle origin or function, it enumerates
particles by size without need for calibration. ThromboLUX is a DLS
device specifically designed for quick screening of platelet-rich plasma
(PRP) and platelet concentrates. It detects particles in the size range of
20 nm to 20 mm (1001100 nm defined as microparticles). This study
tested the performance characteristics of the ThromboLUX micro-
particle assay and its utility to screen patients before and after
stenting. Methods: ThromboLUX microparticle assay precision was
determined over 20 days. For linearity, MPC between 4 and 57% was
tested with ThromboLUX and flow cytometry (N21). Following an
approved clinical protocol, PRP was obtained from sodium citrate
anticoagulated whole blood from fasting patients requiring percuta-
neous coronary intervention (PCI) (N17) and healthy subjects
(N8). Baseline samples before PCI were from the arterial sheath
and 1 day after PCI from peripheral venipuncture. PRP samples were
fixed and frozen until use. Results: Over 20 days ThromboLUX mea-
sured low, medium or high MPC in platelet concentrates at 4.491.8%,
19.592.6% and 53.895.8%, respectively. MPC was linear (CV11.8%)
and correlated highly with flow cytometry (r0.99). MPC in pre- and
post-PCI samples was significantly higher (32911% and 4099%) than
in healthy samples (1698%, p0.001) corresponding to MP concen-
trations of 3.892.2, 4.892.2 and 1.591.01012 MP/L, respectively.
Summary/conclusion: The ThromboLUX microparticle assay is repea-
table and linear without the need for platelet removal or dilution. In
combination with other parameters, elevated MPC (23% or 2.5
1012 MP/L) might be a diagnostic biomarker for cardiovascular disease.
OPW1.6PT4.10
Effect of ageing on pro-inflammatory micro-RNAs contained in
MSC-derived extracellular vesicles
Juan Antonio Fafian Labora1, Fons A. J. Van De Loo2, Onno J. Arntz2,
Pablo Ferna´ndez Pernas1, Miranda Bennink3 and Marı´a C. Arufe1
1Grupo de Terapia Celular y Medicina Regenerativa (TCMR-CHUAC), CIBER-
BBN/ISCIII, Departamento de Medicina, University of A Corun˜a, A Corun˜a,
Spain; 2Department of Rheumatology, Radboud University Medical Center,
Nijmegen, The Netherlands; 3Experimental Rheumatology, Radboud University
Medical Center, Nijmegen, The Netherlands
The promising role of mesenchymal stem cells (MSCs) in cell-based
therapies and tissue engineering appears to be limited due to a
decline of their regenerative potential with increasing donor age.
Recently, it has been reported that micro-RNAs play a role in ageing
and immunosenescence. miRNAs are also present in the extracellular
vesicles from MSCs and their composition may change during
ageing. It is believed that extracellular vesicle (EV)-based therapies
will reduce the risks and drawbacks associated with cell-based
therapies. For that we decided to analyse whether ageing affects
the miRNA profile in MSCs-derived exosomes. EVs from conditioned
medium of bone marrow MSCs obtained of Wistar rats at 4 ages
(newborn, young, pre-pubertal and old) using ultracentrifugation.
The size of EVs was characterized using nanoparticle tracking analysis
(NTA), electron microscopy and for exosome marker CD63 by flow
cytometry, and for the presence of micro-RNAs (miR-155, miR-146a,
miR-132 and miR-21) in MSC-derived EVs using a commercial kit.
We found that production of EVs by MSCs in old age group was
increased with ageing 25.691.2% but their expression of pro-
inflammatory miRs related to Toll-like receptor 4 decreased
93.393% as compared to the other age groups. Our extracellular
vesicles had a size of 160.3918.26 nm and their expression of CD63
was 0.490.1%. In MSC-derived EVs, the expression of miR-155, miR-
146a and miR-132, all known inhibitors of the TLR-4 signalling
pathway, decreased with age of the donor. MSC-derived EVs from the
pre-pubertal group had the highest level of miR-21, a known miRNA
that enhances the anti-inflammatory IL-10 cytokine production. We
conclude that ageing of rat donors affects the production of
extracellular vesicles by mesenchymal stem cells and also changed
their content of miRNAs. This an important finding as the age of the
donor may determine the therapeutic potential of MSC-derived EVs
to inhibit the innate immune response.
OPW1.7PF5.07
Extracellular vesicles released by induced pluripotent stem cells
modulate cellular function of recipient cardiac endothelial cells
Marta Adamiak1, Sylwia Bobis-Wozowicz1, Sylwia Kedracka-Krok2,
Slawomir Lasota1, Elzbieta Karnas1, Michal Sarna3, Zbigniew Madeja1 and
Ewa Zuba-Surma1
1Department of Cell Biology, Faculty of Biochemistry, Biophysics and
Biotechnology, Jagiellonian University, Krakow, Poland
Introduction: Stem cell-derived extracellular vesicles (EVs) have
recently gained attention as highly bioactive, acellular carriers in a
wide variety of biomedical applications. The molecular composition
and regenerative potential of EVs derived from murine-induced
pluripotent stem cells (miPSCs) have not been investigated. Thus, we
characterized RNA and protein content of miPSC-EVs and investi-
gated their effects on target cell behaviour. Methods: EVs were
purified by differential centrifugation of conditioned media collected
from the serum- and feeder-free culture of miPSCs. The morphology
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and size of EVs were characterized with atomic force microscopy and
nanoparticle tracking analysis. Western blot, high-sensitivity flow
cytometry, real-time RT-PCR and liquid chromatography coupled to
mass spectrometry (LC-MS/MS) analysis were used to characterize EV
content. Cardiac endothelial cells were exposed to miPSC-EVs in the
culture. Results: We established that miPSC-EVs are rich in mRNAs,
miRNAs and proteins carried by donor cells. In particular, miPSC-EVs
contained transcripts regulating pluripotency, self-renewal and
differentiation, including Oct4, Nanog and Rex1. Among 282 miRNAs
detected in iPS cells, 199 were simultaneously present in EVs.
Interestingly, 33 miRNAs were expressed exclusively in EVs, including
embryonic stem cell-specific miR-302a-5p. Endothelial cells treated
with miPSC-EVs exhibited greater migratory, proliferative and
angiogenic activity. Summary/conclusion: Our data show for the first
time that miPSC-derived EVs are natural nanocarriers capable of
transferring bioactive contents to mature cells affecting target
cell function as well as regenerative potential. We conclude that
miPSC-EV may represent a safe therapeutic alternative to whole
cell-based therapy for cardiovascular repair. In order to further
assess regenerative capacity of miPSC-EVs, we are currently studying
their effect for the repair of ischemic tissue injury in murine in
vivo model.
OPW1.8PT3.10
Pro-coagulant activity of platelet-derived extracellular vesicles
Carla Tripisciano1, Rene´ Weiss1, Tanja Eichhorn1 and Viktoria Weber1,2
1Christian Doppler Laboratory for Innovative Therapy Approaches in Sepsis,
Danube University Krems, Krems, Austria; 2Center for Biomedical Technology,
Danube University Krems, Krems, Austria
Introduction: The biological activity of human platelet-derived micro-
vesicles (MVs) was investigated with respect to their association
with tissue factor (TF) and their potential to initiate the clotting
cascade. We compared MVs from physiological platelets to MVs
from lipopolysaccharide (LPS)-stimulated monocytic THP-1 cells with
respect to amount and activity of TF. Methods: Platelet concentrates
from healthy volunteer donors were collected using the Trima Accel†
system (Version 5.0, Gambro BCT). After removal of platelets (1500 g,
15 min, RT), MVs were enriched by centrifugation (20000 g, 30 min,
48C) and characterized by flow cytometry (FC) and nanoparticle
tracking analysis (NTA). In FC, MVs were identified as annexin V-
positive events in the MV gate after calibration with fluorescent beads
(0.1, 0.3, 0.5, 0.9 mm). TF expression was evaluated by western blot
(clones: HTF-1 and TF9-10H10). The Technothrombin TGA kit
(Technoclone GmbH) and the Enzygnost TAT micro (DADE Behring)
were used to assess thrombin generation and formation of thrombin-
antithrombin complex. Results: The mean size of MVs was 173915 nm.
FC showed 7099.7% CD41 AV events in the MV gate. Both
platelets and platelet-derived MVs expressed TF to different extent
and supported the generation of thrombin in a dose-dependent
manner. Thrombin generation was strongly inhibited by pre-incubation
with annexin V and partially inhibited by anti-TF (HTF-1 clone, 10 mg/mL).
When compared to THP-1-derived MVs, MVs of platelet origin dif-
fered with respect to the lag phase rather than to the amount of
thrombin generated. Conclusion: Our findings support the pre-
sence of TF in platelet-derived MVs as well as its correlation to their
pro-coagulant activity. Differences between physiological platelet-
derived and LPS-stimulated THP-1-derived MV preparations suggest
that there are not only quantitative but also qualitative dissimilarities
between TF on physiological MVs and on MVs released during LPS-
stimulation.
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OPW2.1PW2.13
Induction of tolerogenic dendritic cells by nasopharyngeal
carcinoma-derived exosomes
Sarah Renaud
Centre national de la recherche scientifique, Lille, France
Background: A characteristic of the nasopharyngeal carcinoma (NPC)
micro-environment is the presence of immunosuppressive exosomes
released by tumour cells. Our team has recently shown that NPC-
derived exosomes, which carry galectine-9, favour the recruitment
and suppressive activity of human regulatory T cells (Treg), thus
contributing to NPC immune escape (Mrizak et al., JNCI, 2015). In this
study, our objective is now to evaluate whether these NPC-derived
exosomes could promote the emergence of tolerogenic immature
dendritic cells (tolDC) able to induce regulatory T cells from nave
CD4 T cells ultimately contributing to the tolerance of tumour
cells. Methods and results: We performed a complete phenotypical
and functional study comparing the effect of NPC and healthy
donor-derived exosomes on DC maturation. This study includes (i)
cell morphological analysis by photonic microscopy, (ii) transcrip-
tomic study by RT-qPCR, (iii) flow cytometric analysis of the expres-
sion of specific makers (phenotypic DC and co-stimulatory markers),
(iv) a preliminary DC functional study by western blotting (IDO)
and finally (v) a secretome analysis by ELISA (IL-10; TGF-b, TNF-a).
Taken together, our results strongly suggest that the presence
of NPC-derived exosomes favours the emergence of semi-mature
DCs seemingly tolerogenic. Conclusion: Despite the importance of
immature DCs as mediators of cancer immune escape, no other
studies have shown the impact of tumour exosomes on the
maturation of human DCs. Thus, these promising results should
open new prospects for antitumour immunotherapies based on the
inhibition of factors involved in the emergence and activation of
Treg.
OPW2.2PF3.01
Immunogenic and tolerogenic dendritic cells release extracellular
vesicles that differ in small noncoding RNA content
Tom Driedonks, Susanne Van Der Grein, Henrike Jekel, Tom Groot
Kormelink, Marca Wauben and Esther Nolte-’t Hoen
Department of Biochemistry and Cell Biology, Faculty of Veterinary Medicine,
Utrecht University, The Netherlands
Introduction: Depending on environmental cues, dendritic cells (DC)
differentiate into potent stimulators of T-cell-mediated adaptive
immune responses or into tolerogenic DC that downregulate
immune responses. We hypothesize that the molecular composition
of extracellular vesicles (EVs) released by tolerogenic and immu-
nogenic DC affects modulation of T-cell activation by these DC
subtypes. We previously reported that EVs from DCTcell co-cultures
are enriched in (fragments of) structural RNAs vault RNA, Y-RNA and
7SL-RNA, which may have the potential to regulate transcription and/
or translation processes. Methods: Murine bone marrow-derived DC
were rendered immunogenic by lipopolysaccharide (LPS) stimulation,
whereas tolerogenic DC were generated by 1a,25-dihydroxyvitamin
D3 (VitD3)-treatment. EVs were isolated from culture supernatant by
density gradient centrifugation. EV numbers were determined by
high-resolution flow cytometry. The small RNA content of the DC
subtypes and their corresponding EVs was compared for structural
RNAs and immune-relevant miRNAs by RT-qPCR using carefully
selected reference genes. Results: Immunogenic DC released more
EVs, which contained higher levels of endotoxin responsive miRNAs
(miR155a, miR146a and miR29a) than tolerogenic DC. The relative
differences in EV miRNA content reflected differences in cellular
miRNA levels in the DC subtypes. Strikingly, tolerogenic and immu-
nogenic EVs varied in 7SL-RNA, vault RNA and Y-RNA contents and
these RNAs were either enriched or underrepresented in EVs com-
pared to cellular levels. Conclusions: The EVs released by tolerogenic
and immunogenic DC vary in quantity and in (immune) regulatory
RNA content. Whereas levels of miRNAs in EVs reflected the cellular
levels, 7SL-/vault-/Y-RNAs were differentially incorporated into EVs.
These structural RNAs may therefore play a role in immune regulation
via EVs. Future studies will address whether and how the EV-RNA
released by these functionally different DC contributes to DCT-cell
communication.
OPW2.3PF3.02
Exosomes released by regulatory T cells modulates T cell
polarization
Sim Tung, Akansha Agarwal, Marilena Letizia, Giorgia Fanelli,
Robert Lechler, Giovanna Lombardi and Lesley Smyth
Division of Transplantation Immunology and Mucosal Biology, MRC Centre for
Transplantation, King’s College London, London, England, UK
Introduction: Regulatory T cells (Tregs) maintain immune tolerance
to self-antigens and prevent excessive pro-inflammatory actions of
T-effectors (Teffs) and antigen presenting cells (APCs) responses.
These cells inhibit in a variety of ways including the release of
extracellular vesicles (EVs) called exosomes. We have previously
shown that the immune modulatory role attributed to mouse Treg-
derived exosomes was the expression of the ectoenzyme CD73. To
date, whether human Tregs also use this mechanism has not been
investigated. Given our mouse data, we hypothesized that human
Tregs release exosomes that can prevent Teffs function. Methods:
Human CD4 CD25 T cells were isolated from blood and were
stimulated in the presence of rapamyacin using a protocol previously
shown to expand and stabilize Tregs. These cells inhibited Teffs
proliferation as expected. To isolate exosomes, Tregs were activated
using plate-bound anti-CD3/CD28 antibodies for 24 h. Culture
supernatant was collected, cells removed and supernatant passed
through a 0.22-um filter and either ultracentrifuged at 100,000 g
or was mixed with ExoQuick solution. EVs were characterized by
transmission electron microscopy, nanoparticle tracking analysis,
CD63 ELISA and flow cytometry. Functional assays were performed
by co-culturing exosomes with carboxyfluorescein succinimidyl
ester (CFSE)-stained Teffs stimulated using anti-CD3/CD28-coated
beads, and CFSE dilution and cytokine production were assessed
by flow cytometry. Results: Activated human Tregs release cup-
shaped EVs with a diameter size of approximately 50100 nm. They
were CD63 CD81 and also expressed molecules associated with
Tregs including CD25 and CD39. Excitingly, Treg exosomes were
immune suppressive. Teffs co-cultured with these EVs were less
responsive to activation and exhibited an anti-inflammatory cytokine
profile. Summary/conclusion: Our data highlight exosomes release
as a novel mechanism by which human Tregs modify immune
responses.
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OPW2.4PT3.11
Impact of leukocyte-derived procoagulant extracellular vesicles on
endothelial cells: significance in blood-mediated pancreatic islets graft
reaction
Ali El Habhab1, Malak Abbas2, Mohamad Kassem1, Guillaume Kreutter1,
Fatiha Zobairi1, Vale´rie Schini-Kerth2, Laurence Kessler1 and Florence Toti2
1UMR 7213, CNRS, Faculty of Pharmacy, University of Strasbourg, Illkirch,
France; 2EA 7293, Fe´de´ration de Medecine Translationnelle, Faculty of
Pharmacy, University of Strasbourg, Illkirch, France
Introduction: Microparticles (MPs) are procoagulant extracellular
vesicles that expose phosphatidylserine and are shed from the plasma
membrane. In blood flow, they are biomarkers of vascular disease
and act as inflammatory mediators. The active form of tissue factor
(TF), the cellular initiator of coagulation, exposed by MPs shed from
inflamed endothelium and activated leukocytes. During instant
blood-mediated inflammatory reaction (IBMIR), activated leukocytes
are recruited at the vicinity of transplanted islets. We aimed at
deciphering the impact of MPs from stimulated leukocytes on
endothelial senescence and inflammatory response. Methods: Porcine
coronary artery young P1 endothelial cells (ECs) were incubated
with leukocytes-derived MPs (130 nM) isolated from rat splenocytes
treated by lipopolysaccharide (5 mg/mL) or phorbol 12-myristate 13-
acetate (25 ng/mL)-A23187 ionophore (1 mM). Senescence-associated
b -galactosidase activity (SA-b-GALact) was assessed by C12FDG
probe, senescence markers, oxidative stress, local angiotensin system
proteins and TF by western blot, apoptosis by double propidium
iodide/annexin V (IP/AV) staining and caspase-3 protein expression.
Results: MPs induced a significant raise in SA-b-GALact in P1 ECs
(1895 vs. 5896 MFI, pB0.05) after 48 h associated with p53, p21, p16
(up to 3-fold) expression level. The 2-fold up-expression of NADPH
oxidase subunits (GP91, P47 and P22phox) and 3-fold down-expres-
sion of eNOS indicated MP-mediated oxidative stress. MPs prompted
procoagulant TF up-expression (up to 3-fold) and a secondary gen-
eration of MPs. AT1 and ACE expression (up to 1.5-fold) was increased.
No significant variation in IP/AV labelling (8% vs. 13%) nor caspase-3
activation was detected. Conclusion: Leukocyte-derived MPs induce
premature senescence and thrombogenicity in young primary ECs. Our
data suggest that MPs prompt premature endothelial ageing during
IBMIR and possibly contributing to poor islets survival.
OPW2.5PW5.13
Lupus nephritis was associated with a high increase in the urinary
amount of miR-146a via exosomes compared to microvesicles or
cellular pellet
Javier Perez-Hernandez, Maria Dolores Olivares, Maria J. Forner,
Josep Redon, Felipe J. Chaves and Raquel Cortes
Incliva Biomedical Research Institute, Valencia, Spain
Introduction: Previous studies have reported that microRNA-146a
is involved in renal inflammation and its cellular levels were related
with lupus nephritis (LN). Here we investigated the distribution
pattern of urinary miR-146a into exosomes (Exo) and microvesicles
(MVs) in a glomerular disease as LN and compared to levels in the
urinary sediment. Methods: We used urine of 33 patients with
systemic lupus erythematosus (SLE) (10 active, 10 inactive and 13
absence of LN) and 20 healthy controls. We quantified miR-146a by
RT-qPCR in urinary cellular pellet (uCP), microvesicles (MV, mean size
200 nm) and exosomes (Exo, mean size 60 nm). Vesicles were isolated
by differential ultracentrifugation, then pellets were treated with
dichlorodiphenyltrichloroethane (DDT) and RNase, and characterized
by electron microscopy and western blot. Results: To compare urinary
miR-146a levels inside the different types of vesicles analysed,
we obtained higher amounts of miR-146a into exosomes (20-fold
change, p0.005) compared to MVs in active LN patients. No
differences were found in the other groups (inactive or in absence
of LN). Furthermore, when comparing miR-146a levels in the uCP and
vesicles fractions among pathological groups with controls, we only
observed a significant increase in the active LN group (pB0.001),
being miR-146a in exosomes more augmented (86-fold change,
pB0.0001) than in MV (5-fold change, p0.009) and uCP (15-fold
change, p0.003). Summary/conclusion: Our results show a different
pattern of distribution of miR-146a in urine of lupus nephritis
patients. Therefore, in active disease state, the highest increase of
urinary miR-146a was found into exosomes when compared to MV
and uCP. Our findings suggest a potential selective cellular release of
miR-146a mainly packaged into exosomes to regulate inflammation
in an autoimmune disorder, such as LN.
OPW2.6PT3.01
Neutrophil-derived microvesicles could play a role in the early stages of
atherosclerosis
Ingrid Gomez1, Ben Ward1, Paul Hellewell2, Paul Evans1 and Victoria Ridger1
1Immunity, Infection and Cardiovascular Disease Department, University of
Sheffield, Sheffield, UK; 2Life Sciences, College of Brunel, Brunel, UK
Atherosclerosis is the most common cause of cardiovascular disease.
Despite their rare detection in plaques, depletion of neutrophils from
the circulation reduces plaque formation and monocyte recruitment
to the vessel wall. One possible mechanism for this is through the
release of microvesicles (MVs) that contain cargo such as microRNAs
(miRNAs). Hypothesis: Neutrophils influence atherosclerotic plaque
formation through the release of MVs. Aim: To determine the role of
neutrophil microvesicles in early atherogenesis. Methods and results:
To investigate plaque formation, mouse peripheral blood neutro-
phils were isolated and stimulated with fMLP in order to obtain MVs.
ApoE mice were fed a western diet for 6 weeks and injected twice
a week with phosphate-buffered saline (PBS) or neutrophil MVs.
Plaque formation was investigated using oil red O and was more
advanced in mice injected with MVs (% lesion area PBS0.4590.09,
MVs1.6490.38; p0.0118, n7). En face staining was performed
on aorta to quantify NF-kB. A significant increase was observed in the
atheroprone region from mice injected with MVs (mean fluorescence
intensity: PBS10395.793871.7, MVs41181.7916682.4; p
0.0335, n3). To investigate the role of miRNA, neutrophils isolated
from healthy human donors were stimulated with fMLP to obtain
MVs. Human coronary artery endothelial cells (HCAEC) were incu-
bated with MVs and miRNA extraction and RT-qPCR performed. miR-
155, which is known to be involved in NF-kB regulation, was
enhanced in HCAEC after incubation with MVs (2.2490.14-fold
increase, p0.0008). ICAM-1, VCAM-1 and MCP-1 were analysed by
qPCR and a significant increase in expression was observed in HCAEC
in response to MVs (fold increase: ICAM-12.2690.11, p0.0003;
VCAM-12.3090.26, p0.0073; MCP-12.9490.26, p0.0017;
n5). Conclusion: Neutrophil MVs enhance plaque formation by
activating the pro-inflammatory transcription factor NF-kB in en-
dothelial cells. The mechanism may involve transfer of mIR-155,
which is known to modulate NF-kB.
OPW2.7PW4.16
Novel therapeutic inhibitor cocktail suppresses extracellular vesicle-
mediated inflammation induced by micro-RNA in a humanized mouse
model of lupus
Nicholas Young, Giancarlo Valiente, Jeffrey Hampton, Holly Steigelman
and Wael Jarjour
The Ohio State University Wexner Medical Center, Columbus, Ohio, USA
Introduction: Systemic lupus erythematosus (SLE) is a prototypic
autoimmune disease affecting multiple organs. We have previously
shown that toll-like receptor (TLR)7 and TLR8 are significantly up-
regulated in peripheral blood mononuclear cells (PBMCs) of SLE
patients and activation of TLR8 stimulates extracellular vesicle (EV)
secretion. TLR7 and TLR8 bind to single-stranded RNA of viral origin
to stimulate innate inflammatory responses, but recent studies
have discovered that micro-RNAs (miRs) packaged and secreted in
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exosomes can also activate these receptors. Methods: To explore the
therapeutic potential of antagonizing TLR7 and TLR8 inflammatory
pathways induced by EV-derived miRs, PBMCs from active SLE
patients were injected into immunodeficient NOD-scid IL-2r (null)
mouse recipients to produce chimeras containing PBMCs from SLE
patients. Prior to injection, PBMCs were incubated with synthetically
produced liposomal EVs containing either a cocktail of locked nucleic
acid miR antagonists or a nonsense control. After 21 days, blood
was collected for both flow cytometry and cytokine analysis and
tissues were processed for histopathological examination by H&E and
immunohistochemistry. Results: Human T-cells (CD4 and CD8),
B-cells, monocytes and NK cells were all successfully recovered from
whole blood of chimeric mice at similar levels in both treatment
groups. However, levels of human IL-2, IL-6, IL-10 and TNF-a were
reduced with miR inhibition when compared to control treatment.
Although histopathological analysis revealed little to no inflammation
in the skin and ear, a robust response was detected in the small
intestine, liver and kidney, which was markedly reduced with miR
inhibition. Additionally, staining for human CD3 confirmed T-cell
presence in these infiltrates. Summary/conclusion: These results
establish a novel chimeric model to study the inhibition of EV-
encapsulated miRs that bind to TLR7 and TLR8 and to explore their
therapeutic efficacy in suppressing innate immunity in SLE.
OPW2.8PT7.08
Characterization of mycobacterial membrane vesicles
Vanessa Chang, James Dalton, Priscila Dauros Singorenko,
Cherie Blenkiron, Anthony Phillips, Siouxsie Wiles and Simon Swift
University of Auckland, New Zealand
Outer membrane vesicles released by Gram-negative bacteria have
well-documented roles in infection. Release of similar bodies from
acid fast bacteria is drawing attention. Mycobacterial membrane
vesicles (MMVs) range from 60 to 300 nm in size and contain
lipoproteins and polar lipids. To better understand MMV biology, we
analysed 3 mycobacterial species: Mycobacterium smegmatis (non-
pathogenic, fast grower), M. abscessus (pathogenic, fast grower) and
M. marinum (opportunistic pathogen, slow grower). M. marinum-
zebrafish model is proposed to be one of the best models to mimic
and study human tuberculosis. Mycobacteria were grown in Sauton’s
defined media, avoiding protein components like bovine serum
albumin (BSA) that interfere in downstream vesicle proteomics. MMV
composition, size, concentration and release with respect to cell
growth and viability were studied. We surveyed the macromolecular
contents of MMVs to quantify proteins and nucleic acids. Nanopar-
ticle tracking analysis technology was used to determine MMV size
and concentration. Vesicle sampling and live/dead staining at time
points along the mycobacterial growth curves were done to observe
release with respect to cell viability and growth phase. Electron
microscopy was used to image MMVs and their release. We isolated
MMVs with mean diameters between 80 and 250 nm and similar
protein banding patterns among replicates across all three myco-
bacterial species. DNA and RNA concentrations of 542 mg and
123 mg, respectively, were obtained from MMVs isolated from 14-
day mycobacterial culture in 1 L of Sauton’s media. MMVs were
produced throughout growth, with most produced at the transition
from exponential to stationary phase. Stationary phase MMVs from
M. abscessus were the largest and contained more DNA than RNA.
MMVs from M. smegmatis and M. marinum contained equivalent
levels of DNA and RNA. Live/dead staining demonstrated peak
vesicle release with culture viability 99%, supporting the notion
that release is an active process of living cells.
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OPW3.1PT5.05
Circulating RNAs as biomarkers in EpsteinBarr virus-associated
nasopharyngeal carcinoma
Octavia Ramayanti1, Sandra A.W.M Verkuijlen1, Lisa Beckers1,
Jordy Meijer1, Debora Martorelli2, Chantal Scheepbouwer3,
Michael Hackenberg4, Ruud H. Brakenhoff5, Marlinda Adham6,
Danijela Koppers-Lalic3, D. Michiel Pegtel1 and Jaap M. Middeldorp1
1Department of Pathology, VU University Medical Center, Amsterdam,
The Netherlands; 2Cancer Bio-Immunotherapy Unit, Cro Aviano, IRCCS,
National Cancer Institute, Aviano, Pordenone, Italy; 3Department of
Neurosurgery, VU University Medical Center, Amsterdam, The Netherlands;
4Genetics Department, University of Granada, Granada, Spain; 5Tumour
biology section, Department of OtolaryngologyHead and Neck Surgery, VU
University Medical Center, Amsterdam, The Netherlands; 6Ear and Throat
Department, Dr. Cipto Mangunkusumo Hospital, University of Indonesia,
Jakarta, Indonesia
Nasopharyngeal carcinoma (NPC) is an aggressive tumour associated
with Epstein-Barr virus (EBV), which has a poor prognosis when
detected late. Easy methods for detecting NPC at earlier stages are
highly needed. Host and viral miRNAs are perturbed in NPC, a fraction
of which are included in extracellular vesicles and/or in ribonucleo-
protein complexes that enter into the circulation. Measuring circulat-
ing miRNAs may provide a robust and direct insight of the oncogenic
process. Here we analysed whether host and viral circulating miRNA
fingerprints may reflect tumour burden and behaviour. Defined
circulating microRNAs were analysed from total serum and plasma
(NPC, non-NPC patients and healthy controls). Selected NPC sera and
plasma were fractionated by size-exclusion chromatography into
extracellular vesicle and lipoprotein fractions. Exosome-like vesicles
released from EBV-infected NPC were characterized by western blot
and transmission electron microscopy. Deep RNA sequencing (RNA-
seq) was done for NPC cell lines, exosomes and selected sera. EBV
DNA load was measured as well. Viral miRNA (mirBART7, 9, 13), host
miRNA (miR16, 21, 155) and small RNAs (EBER1 and vaultRNA) were
detected by stemloop reverse transcription-polymerase chain reac-
tion (RT-PCR). We detected viral miRNAs in NPC sera and plasma,
which levels seem to increase with TNM stage despite absence of
detectable EBV DNA in some. EBER1 RNA was absent in virtually all
NPC sera and plasma, despite high levels in NPC tissues. Cellular
miR155, which expression is induced by EBV-LMP1, was significantly
elevated in NPC when compared to controls. Fractionation from NPC
sera and plasma revealed that miR155 and vault RNA are selectively
enriched in extracellular vesicles, whereas viral miRNAs are more
randomly distributed. The pattern of tetraspanin (CD63, CD81)
protein expression is heterogeneous in NPC patients compared to
healthy controls. Further, RNAseq and RT-PCR analysis are being
performed to determine the diagnostic potential of circulating
miRNAs for NPC.
OPW3.2PF4.01
Gastric cancer cell-derived extracellular vesicles modulate E-cadherin
expression, invasion and migration of normal cells from the tumour
microenvironment
Joana Carvalho1,2*, Sara Rocha1,2*, Patrı´cia Oliveira1,2 and Carla
Oliveira1,2,3
1Expression Regulation in Cancer, Institute of Molecular Pathology and
Immunology, University of Porto (IPATIMUP), Portugal; 2Instituto de
Investigac¸a˜o e Inovac¸a˜o em Sau´de (i3S), Universidade do Porto, Portugal;
3Department Pathology and Oncology, Faculty of Medicine, University of
Porto, Portugal
*These authors equally contributed to this work
Tumours need to modify the surrounding tissue to grow and
disseminate. Extracellular vesicles (EVs) secreted by tumour cells
have emerged as main modulators of the tumour microenvironment;
however, the phenotypes induced in normal recipient cells remain
poorly known, as well as the underlying mechanisms. Our aim was to
identify and characterize the behavioural modifications that gastric
cancer cell-derived EVs (GC-EVs) promote in the adjacent normal
epithelia, which facilitate local dissemination of cancer cells. EVs
were isolated from 4 GC cell lines (GC-EVs), and their effects were
analysed in recipient normal epithelial (E) and mesenchymal (M)
states of the same cell line. GC-EVs were isolated by differential
ultracentrifugation and characterized by TEM, NTA and imaging
flow cytometry for the presence of exosomal markers (e.g. CD9).
Proliferation, migration and invasion abilities of E and M recipient
cells were assessed before and after treatment with GC-EVs, and
the expression of epithelial/mesenchymal markers was followed by
immunofluorescence. GC-EVs (50150 nm) expressed CD9, CD81 and
flotillin and were able to reduce E-cadherin expression and promote
invasiveness of E-recipient cells. The opposite effect was observed
in M-recipient cells, which regain E-cadherin expression and lose
invasion and migration ability. However, different GC-EVs induce
different levels of E-cadherin modulation and invasion ability. These
findings suggest that (1) GC-EVs do modulate the behaviour of
normal adjacent cells, (2) recipient cells respond differently to the
same EVs cargo depending on the recipient cells’ state and (3) each
cancer cell line secretes EVs with different efficiencies in inducing
phenotypic alterations in recipient cells. miRNA and proteomic
profiling of GC-EVs is ongoing to identify the EVs-factors likely
involved in the intracellular reprograming of normal recipient cells of
the tumour microenvironment.
OPW3.3PF2.09
D-type CpG oligonucleotide encapsulating and antigen-harbouring
exosomes improve therapy of tumours
Gozde Gucluler1, Tamer Kahraman1, Muzaffer Yildirim2 and
Ihsan Gursel1
1Bilkent University, Ankara, Turkey; 2Council of Forensic Medicine, Department
of Histopathology, Istanbul, Turkey
Introduction: Exosomes are membranous nanovesicles functioning
as natural conveyors of intracellular signalling. They are also known
to play important roles in immune modulation. CpG ODNs are
strong candidates for treatment of plethora of diseases including
cancer. Unfortunately, labile nature of synthetic ODNs hampered
their clinical performance. This study aims to investigate whether
exosomes could be harnessed as a delivery vehicle improving CpG
ODN adjuvant activity against cancer. Methods: D-type CpG ODN was
encapsulated into exosomes isolated from EG7 cell supernatants
known to stably express ovalbumin as the model cancer antigen.
Immunostimulatory activity of exosomal D-ODN on mouse spleno-
cytes was assessed by ELISA and flow cytometry for cytokine
induction and cell surface marker upregulation, respectively. C57/
Bl6 mice were immunized with EG7 exosomes harbouring D-ODN.
Anti-OVA IgG levels were assessed from mice sera. Next, immunized
mice were seeded with EG7 cells 2 months after booster immunization.
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Tumour development was followed. Results: Stimulation assays
revealed that D-ODN encapsulation into exosomes significantly
elevated IL6, IL12, IFNg and IFNa production in comparison to free
D-ODN. FACS analysis implicated that CD86 and MHC-II expressions
were 24-fold higher in cell treated with exosomal form rather than
free form of D-ODN. Th1-biased anti-OVA immune response was
established in mice treated with exosomal D-ODN as evidenced
by significantly higher anti-OVA IgG2a titres. More than 85% of
immunized mice with exosomal D-ODN cleared tumours following
EG7-thymoma induction, whereas all naive mice failed to control
tumour formation. Conclusion: Our data suggest that D-ODN encap-
sulation into exosomes harbouring tumour antigen is capable of
tumour clearance via improving innate immune activity as well as
cancer antigen-specific immunity in mice.
OPW3.5PW4.09
Repurposing glioblastoma exosomes as personalized multi-antigenic
antitumour vaccine
Sophie A. Dusoswa1,2, Sophie K. Horrevorts1, Jordi Berenguer De Felipe2,
Sjoerd T. Schetters1, Thomas Wu¨rdinger2, Yvette Van Kooyk1 and
Juan J. Garcia-Vallejo1
1Mcbi, Cca, Vu University Medical Center, Amsterdam, The Netherlands;
2Nrg, Cca, Vu University Medical Center, Amsterdam, The Netherlands
Introduction: Among multiple immune escape mechanisms operated
by glioblastoma (GBM) are glycosylation-dependent interactions with
Siglec and C-type lectin receptors on tumour-infiltrating immune
cells. Receptor triggering results in both cargo internalization and
signalling regulating the immunogenic/tolerogenic balance of the
cellular response. The composition of tumour-derived exosomes
(TEX) reflects plasma membrane and cytosol-derived proteins of the
parent cell and represents interesting candidates for antitumour
vaccination. However, literature reports potent immunosuppressive
characteristics of TEX that should be carefully considered. Our group
has shown glycosylation-dependent uptake and processing of
glycan-modified liposomes. The aim of this study is to investigate
whether repurposing of GBM TEX for vaccination can be achieved by
de novo glycosylation of their surface. Methods: Prior to their chemo-
enzymatic modification, TEX were carefully characterized by ELISA
and electron microscopy using a panel of human and plant lectins of
known specificity. Chemo-enzymatic modifications were aimed at
reducing Siglec ligands and enhancing DC-SIGN ligands. TEX uptake
and downstream routing was assessed by imaging flow cytometry
analysis. Results: GBM-derived TEX were 50-200 nm in size and
expressed high levels of CD63. The surface glycan profile of U251, U87
and GBM8-derived TEX was dominated by a-2,3 and a-2,6 sialic acid-
capped N-glycans, high mannose glycans and truncated Tn-bearing
O-glycans. These TEX appeared to have low affinity for DC-SIGN
and MGL. In contrast, glycan-modified TEX were efficiently taken up
by human dendritic cells and fused with the endosomal pathway.
Conclusion: GBM-derived exosomes exhibit glycans that are typically
associated with tolerogenic responses, indicating a possible role in
GBM immune escape. Repurposing through de novo glycan mod-
ification could provide a strategy for personalized, multi-antigenic,
anti-GBM vaccination.
OPW3.6PW4.06
Suppression of breast cancer metastasis by targeting cancer-derived
extracellular vesicles with antibodies
Nao Nishida1, Naoomi Tominaga1, Fumitaka Takeshita1, Hikaru Sonoda2
and Takahiro Ochiya1
1Division of Molecular and Cellular Medicine, National Cancer Center Research
Institute, Tokyo, Japan; 2Shionogi and Co., Ltd, Osaka, Japan
Introduction: Metastasis is the main cause of cancer mortality, but
it is still difficult to prevent metastasis. It has been recently reported
that cancer-derived extracellular vesicles (EVs) contribute to cancer
metastasis. Thus, therapeutic strategies targeting cancer-derived EVs
hold great promise due to the possibility of EVs to influence cancer
microenvironment towards metastasis. Here, we provide a novel
strategy of therapeutic antibody treatment targeting cancer-derived
EVs to inhibit metastasis of breast cancer in mouse model. Methods:
We prepared a mouse xenograft model for metastatic breast cancer
by transplanting human highly metastatic breast cancer cell line, MDA-
MB-231-D3H2LN to 6-week-old scid/scid female mice, orthotopically.
Forty-five micrograms of anti-human CD9 or anti-human CD63
antibody, which specifically recognize human CD9 or CD63
at the surface of EVs from MDA-MB-231-D3H2LN, was injected to
the mouse xenograft model intravenously, for 3 times with a 3-day
interval. The metastatic cancer cells were detected by in vivo
imaging system of bioluminescence from luciferase-expressing
cancer cells or immunohistochemistry. Phagocytotic assay of EVs
incubated with anti-CD9 or anti-CD63 antibody was performed
by mouse macrophage cell line, RAW264.7, to check opsonization
ability of the antibodies. Results: Administration with human
specific anti-CD9 or anti-CD63 antibodies significantly decreased
metastasis to lung, lymph nodes and thoracic cavities, although it
did not make obvious effect on the xenografted primary tumour size
or neovascular formation in tumour tissue. The EVs incubated with
the targeted antibodies were preferentially engulfed by macro-
phages in vitro, suggesting that cancer-derived EVs were eliminated
by phagocytosis to prevent metastasis in mouse model. Summary/
conclusion: Our results provide a novel therapeutic method to
prevent tumour metastasis by therapeutic antibody administration
targeting cancer-derived EVs.
OPW3.7PW1.11
The involvement of microvesicle miRNA in gestational vascular
complications
Annie Rebibo-Sabbah1, Ido Solt2, Adi Halberthal-Cohen2,
Benjamin Brenner1,3 and Anat Aharon1,3
1Department of Hematology and Bone Marrow Transplantation,
Rambam Health Care Campus, Haifa, Israel; 2Department of Obstetrics and
gynecology, Rambam Health Care Campus, Haifa, Israel; 3Bruce
Rappaport Faculty of Medicine, Technion- Israel Institute of Technology,
Haifa, Israel
Introduction: Gestational vascular complications (GVC) are a major
cause of maternal morbidity and foetal mortality. They are characterized
by vascular and placental dysfunction. The major aim of this study
was to explore the role of microvesicle (MV) miRNA of women with
gestational vascular complications and evaluate their effects on
endothelial cells (EC) and early-stage trophoblast (EST) cell function.
Methods: Plasma and placental samples were collected from healthy
pregnant (HP) women, women with GVC and pregnant women
treated with low molecular weight heparin (LMWH) after obtaining
informed consent. MV miRNAs were screened using NanoString
technology and further validated by RT-PCR. Effects of MV miRNA
derived from the study groups on EST and EC miRNA expression and
cell function were evaluated. Results: NanoString screening of
samples drawn from the same person demonstrated significant
differences in the profile of miRNA packed in MVs and those freely
circulating in plasma, including different expression levels in some of
them. Differences in expression clusters were also observed between
the study groups. RT-PCR findings showed that exposure of EC and
EST cells to the MVs of the study groups affected miRNA expression.
Changes were seen in different miRNAs known to be involved in the
MAPK signalling pathway, which is altered in GVC, as shown in our
previous study. Conclusion: MV content and effects on endothelial
and trophoblast cells vary depending on the physiological/patholo-
gical state of a pregnant woman. Our findings may point to a special
mechanism related to miRNA packaging in MVs and to the role of
the packed miRNAs upon their penetration to target cells. Further-
more, the current results support our previous findings showing
reduction in trophoblast invasion and increase in apoptosis under
the exposure to GVC-MVs, while MVs of LMWH-treated women
reversed these effects.
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Exosome DNA: a new promising liquid biopsy-based diagnostic tool for
personalized management of aggressive prostate cancer (PCa) patients
Chiara Foroni1, Natasa Zarovni2, Simona Bernardi3, Davide Zocco2,
Domenico Russo4, Francesca Valcamonico5 and Alfredo Berruti5
1CREA Lab - Oncology Unit, AO Spedali Civili of Brescia, Brescia, Italy;
2Exosomics Siena S.P.A., Siena, Italy; 3CREA Lab, Blood Diseases and Stem Cells
Transplantation Unit, Department of Clinical and Experimental Sciences,
University of Brescia, Ao Spedali Civili, Brescia, Italy; 4Blood Diseases and Stem
Cells Transplantation Unit, Department of Clinical and Experimental Sciences,
University of Brescia, Ao Spedali Civili of Brescia, Brescia, Italy; 5Oncology Unit,
Department of Surgery, Radiology, and Public Health, University of Brescia,
Spedali Civili of Brescia, Brescia, Italy
Introduction: Metastatic castration-resistant prostate cancer (mCRPC)
is associated with poor prognosis and response to hormonal or
conventional treatments. While novel drugs increase the therapeutic
options, they bring up elevated costs, over-treatment and side
effects. There is a pressing need to develop non-invasive tests for
stratification and surveillance of post- and in-therapy patients for
increased cost-efficiency of mCRPC treatments. Our aim was to
assess the comparative advantages of liquid biopsy methods based
on extracellular vesicle-associated DNA (EV-DNA) and cell-free DNA
(cfDNA) as an input for digital PCR (dPCR), a high sensitivity/accuracy
method for detection of the low abundant targets and promises to
improve the power of detecting AR gene status in biofluid samples.
Methods: Serum samples were collected following informed consent
from 10 mCRPC patients, progressing on systemic therapy, at 3 time
points of relapse. Total cfDNA and DNA extracted from immuno-
capture-enriched tumour-derived exosomes were analysed for AR
T878A point mutation by QuantStudio 3D dPCR test, calibrated using
positive controls (LNCaP and PC-3 cell line genomic DNAs). Results:
AR T878A mutation was detected in 3/10 patients. In one of AR
mutation positive patients, the mutation was detected at all time
points and using both cfDNA and EV-DNA samples, while in the
other two patients, AR mutation was detected at all time points
when EV-DNA was used, and only in later time points by using
cfDNA. An increment of AR T878A mutational events could be
appreciated in EV-DNA fraction comparing with cfDNA from the
same sample. Conclusion: Enrichment of AR somatic mutation in
tumour-associated exosomes suggests that tumour EV-DNA is more
appropriate than total cfDNA for specific and sensitive liquid biopsy
approaches. This small pilot study provides insights into the
potential of tumour exosomes as robust monitoring tool for the
clinical implementation of novel personalized strategies for PCa
patients.
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OW4.1
Glia-derived exosomes mediate neuroprotection and promote axonal
transport
Wen-Ping Kuo-Elsner, Dominik Fro¨hlich, Carsten Fru¨hbeis
and Eva-Maria Kra¨mer-Albers
Molecular Cell Biology, Johannes Gutenberg University Mainz, Mainz, Germany
Introduction: Oligodendrocytes myelinate central nervous system
axons and mediate maintenance of axonal integrity. We have shown
that neuronal electrical activity controls glial exosome release result-
ing in subsequent neuronal uptake and functional retrieval of
exosomal content. Functional assays revealed that glial exosomes
desensitize neurons towards cellular stress. Mouse mutants lacking
the oligodendrocyte-specific proteins PLP or CNP reveal a secondary
axonal degeneration due to absent glial support. To study the
potential role of exosomes in glial support, we analysed oligoden-
droglial exosome secretion in these mutants and their interaction
with target neurons. Furthermore, we investigated the influence of
exosomes derived from wild-type and mutant oligodendrocytes
on axonal transport. Methods: Mutant exosomes were isolated by
differential centrifugation and characterized by nanoparticle tracking
analysis, western blotting as well as by proteomics. Transfer of exosomes
to neurons was assessed by a Cre-reporter assay. The metabolic activity
of neurons treated with wild-type or mutant exosomes was measured
using the MTT assay. To study the influence of exosomes on axonal
transport, we performed time-lapse microscopy. Results: Analysis of
mutant-derived exosomes revealed that mutant oligodendrocytes
release less exosomes of an abnormal content. Furthermore, mutant
exosomes did not share the neuroprotective characteristics of wild-type
exosomes. Analysis of axonal transport demonstrated that wild-type
exosomes facilitate axonal transport by reducing the pausing time
and the number of static vesicles. In contrast, mutant-derived exosomes
did not promote axonal transport. Conclusion: Our results empha-
size that oligodendroglial exosomes exhibit a beneficial influence on
the neuronal metabolism and physiology. We propose that oligoden-
droglial exosomes facilitate axonal maintenance. Exosome-mediated
neuron-glia communication appears to represent a novel mechanism of
neuroprotection.
Supported by DFG.
OW4.2
Cerebrospinal fluid-derived extracellular vesicles as a novel source
of potential biomarkers for multiple sclerosis
Joanne Welton1, Sam Loveless2, Tim Stone3, Neil Robertson2 and
Aled Clayton4
1Biomedical Sciences, Cardiff Metropolitan University, Cardiff, UK; 2Institute of
Psychological Medicine and Clinical Neurology, Cardiff University; 3Central
Biotechnology Services, Cardiff University; 4Division of Cancer and Genetics,
School of Medicine, Cardiff University, Cardiff, UK
Introduction: Multiple sclerosis (MS) is one of the most common neu-
rological disorders in young adults, affecting over 100,000 people in
the United Kingdom. There are currently no reliable biomarkers to
aid in the diagnosis or monitoring of the disease. Here we developed
methods of isolation and proteomic analysis to examine the po-
tential of extracellular vesicles (EVs) as a novel source of biomarkers
for the relapsing remitting form of MS (RRMS). Methods: A method
was developed for EV isolation from cerebrospinal fluid (CSF), using
precipitation and size-exclusion chromatography (SEC). EV-enriched
fractions were selected based on their characteristics, including
elevated presence of tetraspanins CD9/81. EVs were isolated from
RRMS patient (n4) and control (n3) CSF. The EVs and paired CSF
were subsequently analysed using a novel aptamer-based protein
assay, providing semi-quantitative information for 1128 proteins.
Results: The isolation method removed 75% of contaminating pro-
tein in the EV-enriched fractions. These EV isolates were confirmed
compatible with the proteomics platform, despite the potential for
remaining precipitant. Around 350 and 580 proteins were identified
in CSF-derived EVs and CSF, respectively, of which 50 proteins were
significantly and exclusively enriched in RRMS-derived EVs. Some of
the RRMS-EV-enriched proteins were further evaluated, such as
KLKB1, and were found to be enriched in CSF EVs compared to CSF,
by western blot. Enrichment analysis of the 50 proteins (performed
via g:Profiler) revealed enriched biological themes visualized in
Cytoscape. Strongly interconnected terms included complement
and coagulation, vesicles and extracellular regions. Summary: This
study demonstrates that EVs can be isolated from the CSF of MS
patient and highlights the advantage of EV enrichment for identify-
ing novel disease-related proteins within CSF. This proof of concept
study has identified several candidate proteins for further evaluation
as biomarkers of MS.
OW4.3
Secondary release of exosomes from astrocytes contributes
to neural plasticity and improvement of functional recovery after
stroke in rats treated with IA administration of exosomes harvested
from miR-133b-enriched MSCs
Hongqi Xin
Henry Ford Health System, Detroit, USA
The exosomes from blank control vector transfected control me-
senchymal stem cells (MSCs) and from pre-miR-133b expressing
vector transfected miR-133b-enriched MSCs were harvested and
administered via intra-arterial (IA) injection to rats (31011 particles
per rats, n6 per group) subjected to 2 h of middle cerebral artery
occlusion (MCAo). All rats were sacrificed at 28 days post-MCAo.
Compared with phosphate-buffered saline treatment, both exosome
treatment groups exhibited significant improvement of functional
recovery (pB0.05 after day 14). Compared with control MSC
exosomes, treatment with miR-133b-enriched MSC exosomes sig-
nificantly increased functional improvement (pB0.05 after day 21)
and neurite remodelling and brain plasticity in the ischemic boundary
area (pB0.05). Quantification analysis showed that miR-133b-en-
riched MSC exosome treatment increased the presence of exosomes
in brain extracellular space (3.6890.58109 vs. 2.7190.34109,
particles/mg tissue, pB0.05). In vitro oxygen and glucose-deprived
(OGD) cultured astrocytes were incubated with exosomes harvested
from nave MSCs and miR-133b level modified MSCs. Compared with
that by nave MSC harvested exosome treatment, the exosome release
from OGD astrocytes was significantly enhanced (1.8890.33-fold,
pB0.05) by miR-133b-enriched MSC exosome treatment and sig-
nificantly decreased (0.3790.04-fold, pB0.01) by miR-133b down-
regulated MSC exosomes treatment. We also found that OGD
astrocytic exosomes harvested from miR-133b-enriched MSC exo-
some treated significantly increased neurite outgrowth and elonga-
tion compared with that from control MSC exosome treated. In
addition, the effect of astrocytic exosomes on neurite outgrowth and
elongation was dose-dependent. Although we do not exclude a
possible contribution from other parenchymal cells, our data suggest
that exosomes from miR-133b-enriched MSCs improve neural plasti-
city and functional recovery after stroke by increasing the exosome
release from astrocytes.
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Novel methods of polysaccharide-based EV isolation: a new
opportunity for EV-based diagnostics and therapeutics
Anirban Ghosh1, David Barnett1, Sebastien Fournier1, Nguyet Nguyen1,
Andrew Joy1, Ian C. Chute1, Rodney J. Ouellette1, M. Vicki Meli2 and
Biji Anish1
1Atlantic Cancer Research Institute, Moncton, Canada; 2Mount Allison
University, Moncton, Canada
Introduction: Circulating extracellular vesicles (EVs) have tremendous
potential for minimally invasive diagnostics and therapeutic applica-
tions. The interactions between the polysaccharides, polysaccharide-
proteins and polysaccharidelipids on the outer membrane surfaces
of cells and EVs are essential for their biological activities. These
biological interactions prompted us to hypothesize and test poly-
saccharide-based EV capture. Ultracentrifugation, ultrafiltration or
antibody-based EV isolation methods provide significantly less yield
compared to polymer-based EV precipitation. Currently available
polymer-based (polyethylene glycol or PEG and its derivatives) EV
isolation technologies are not compatible with therapeutic applica-
tions due to the presence of remaining polymers in the EV preparation.
Polysaccharides such as chitosan and hyaluronic acid are FDA
approved for multiple formulations, wound-healing and internal uses
in human medicine. Therefore, an EV-capture technology that uses
chitosan and/or hyaluronic acid strategically fits the demand for EV
isolation technologies that are applicable to therapeutic uses. Methods:
We used hyaluronic acid and chitosan to enrich EVs from cell culture-
conditioned media and human body fluids using a standard labora-
tory/clinical setup. We standardized low-speed centrifugation and
bead-conjugated batch purification methods of EV isolation using
these polysaccharides. Results: We validated the EVs captured with
hyaluronic acid and chitosan using electron microscopy, atomic force
microscopy, proteome-based cellular component ontology analysis,
nanoparticle tracking analysis and immunoblotting. Furthermore, our
results also indicate that both hyaluronic acid- and chitosan-captured
EVs are biologically active. Summary/conclusion: These polysacchar-
ide-based EV capture technologies open new opportunities to
develop subsequent manipulation methodologies to explore EV-
based therapeutics and provide new tools for diagnostics.
OW5.2
Prostate cancer diagnosis using extracellular vesicles isolated by
aqueous two-phase systems
Hyunwoo Shin1, Jaesung Park2, Hyejin Kang3 and Jongmin Kim1
1Mechanical Engineering, POSTECH, Pohang, Korea; 2Department of
Mechanical Engineering, School of Interdisciplinary Biosicence and
Bioengineering, POSTECH, Pohang, Republic of Korea; 3School of
Interdisciplinary Biosicence and Bioengineering, POSTECH, Pohang, Korea
Introduction: Prostate-specific antigen (PSA) is commonly used to
diagnose prostate cancer (PCa). However, PSA shows low specificity,
such that benign hyperplasic conditions can also be associated with
a PSA increase. To overcome this limitation of PSA, a new approach
that detects cancer extracellular vesicles (EVs) has been introduced.
However, diagnosis using EVs to date have been limited by ineffi-
cient process in isolating extracellular vesicles and lack of effective
purification strategies. We developed a simple strategy employing
aqueous two-phase system (ATPS) to isolate extracellular vesicles
from urine sample. In this study, we isolated EVs from urine with
efficiency of 100%; total processing time was ~35 min. After isolating
EVs from patients’ urine, we successfully distinguished benign
prostate hyperplasia (BPH) patients from PCa patients. Method: We
optimized the ATPS to get highest quality and quantity of EVs from
urine by controlling polymer concentration. Additionally, dextran
phase volume was minimized to obtain highly concentrated EVs.
After ATPS had been optimized, 20 BPH patients were recruited. Ten
millilitres of each patient’s urine was collected, and EVs were isolated
using the ATPS. The expression level of PCA3 (PCa mRNA marker)
and actin was measured using nested PCR and analysed by
comparing clinical data. Result: The ATPS isolation method optimized
by adjusting polymers concentration recovered ~100% of EVs from
the urine, whereas ultracentrifuged-pellet methods recovered only
B30% of total EVs. After isolating EVs from the patients’ urine by
ATPS, high quality and quantity of EVs can be obtained. We
measured an expression level of PCA3 of the EVs and normalized
the level using actin. Significant differences between benign and
PCa in PCA/ACTIN was identified. Conclusion: Using the proposed
method using ATPS, prostate cancer can be distinguishable from
benign prostrate hyperplasia successfully.
OW5.3
Flow cytometric detection and sorting of EVs: analysis and
characterization of background noise sources that may impact
EV fluorescence or scatter detection
Carley Ross1 and Jennifer Jones2
1Beckman Coulter Life Sciences, Fort Collins, Colorado, USA; 2National Cancer
Institute, National Institutes of Health, Bethesda, Maryland, USA
Introduction: Extracellular vesicle (EV) detection via flow cytometry in
fluorescence or scatter reaches the limits of current flow cytometry.
Measurements of Q and B using an LED pulser indicate scatter and
detection limits on the flow cytometer and are useful in under-
standing cytometer capabilities. However, understanding how
electronic and optical noise sources may individually contribute to
the system instrument noise pinpoints specific areas of instrument
improvement for better EV detection. With high-resolution electro-
nics at and below the photomultiplier (PMT) dynamic range for the
system, the noise background may be fully visualized, characterized
and reduced. This poster describes both optical and electronic noise
sources that may impact EV detection, characterization and sorting.
Methods: An MoFlo Astrios EQ (BEC) with a quantiFlash LED pulser
(APE) installed was used to study noise sources such as electronic
(ADC, Preamp and PMT) and optical (laser, stream, nozzle tip
distance, autofluorescence, nozzle tip sizes 25100 um and drop
drive frequency and amplitude). Results: Optical and electrical noise
determined the noise floor. The fluidic stream added 510% optical
noise in fluorescent channels. Larger nozzle tip sizes reduced drop
drive noise, whereas smaller nozzle tips reduced sort volume and
optical noise but require higher pressure. About 510% of the
optical noise is due to laser cross-talk. Conclusions: Characterization
and analysis of the sorter noise background provided insight into
instrument EV characterization capabilities. Improvements to drop
drive amplitude and frequency, laser selection and location and
nozzle tip will reduce the noise floor. Optimal EV detection, isolation
and characterization depend on measuring not only the Q value, but
also the B value and true noise floor of the flow cytometer.
# 2016 Beckman Coulter, Inc. All rights reserved.
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NGS analysis of EVs RNA in ageing and cancer
Hidetoshi Tahara, Megumi Okada, Naoki Sako, Shigeyuki Teranishi,
Yukie Nishiyama, Masaki Kinehara and Akira Shimamoto
Hiroshima University, Hiroshima, Japan
Extracellular vesicles (EVs) are 50100 nm in size and carry various
cargo, including microRNA and other small RNAs, released into the
extracellular environment and can be used for cell-to-cell commu-
nication in vivo. Recently, we found that the secretion of EVs in
senescent fibroblast cells is significantly higher than those in young
cells, and senescence-derived EVs inhibit cell proliferation, colony
formation and invasion of cancer cell lines. In contrast, EVs from
highly metastatic cancer cell lines significantly induce apoptosis in
senescent fibroblasts. To understand the function of these EVs from
young and senescence cells, we analysed EVs RNA by using a next-
generation sequencer (NGS), Ion PGM. Interestingly, microRNA
profiling of EVs is significantly altered between senescent cells and
young cells. Several significant tumour suppressive microRNAs,
which contained in senescence-derived EVs, significantly inhibit
tumour invasion and cell growth. We also analyse EVs RNA in cancer
cell lines and circulating small RNA in serum using NGS and found
specific microRNAs are altered in cancer. Most miRNAs are generated
as a family of related isomers that differ by a small number of bases
at the 5’ and the 3’ end of the miRNA, termed 5’ or 3’ isomiRs.
We also focus on the isomiRs difference in ageing and cancer.
Surprisingly, we found specific isomiRs between cancer patients and
healthy volunteer. We believe that these specific isomiRs are
powerful tools for identifying EVs from specific origin of cells.
OW6.2
BRAF inhibition regulates miR-211 expression in melanoma
extracellular vesicle subsets with functional consequences
Taral Lunavat1, Yong Song Gho2, Jonas Nilsson3, Andrew Francis Hill4,
Jan Lo¨tvall3, Roger Olofsson Bagge3, Cecilia La¨sser3, Robyn Sharples5,
Berglind Einarsdottir3 and Lesley Cheng4
1Krefting Research Centre, Department of Internal Medicine and Clinical
Nutrition, University of Gothenburg, Gothenburg, Sweden;
2Postech; 3University of Gothenburg, Sweden; 4La Trobe University, Melbourne,
Australia; 5University of Melbourne, Australia
Introduction: In melanoma, more than 50% of the tumours harbour
BRAFV600 mutations. Vemurafenib is a BRAF-V600 inhibitor used for
the treatment of late-stage melanoma. Here we determine the effects
of vemurafenib on melanoma cells and the RNA content in their
subsets of extracellular vesicles (EVs) including apoptotic bodies,
microvesicles and exosomes. Methods: EVs were isolated using
differential centrifugation, and ion torrent sequencing was used to
sequence small RNAs. Xenograft models were established by
transplanting patient tumour cells or cell lines into mice. Proteins
and miRNA from cells and EVs subsets were validated by using
western blot and quantitative PCR, respectively. Results: Vemurafenib
treatment of melanoma cells harbouring the BRAF mutation sig-
nificantly increases the RNA and protein cargo in the EV subsets.
The RNA profile also changes substantially in apoptotic bodies and
microvesicles, with significant alterations in the ribosomal RNA ratio.
With small RNA sequencing, we found that EVs from treated cells
harbour unique miRNAs. The significantly different miRNAs detected
were validated in vitro, confirming upregulation of miR-211 in cells as
well as in EVs subsets after vemurafenib treatment. Additionally, miR-
211 was significantly upregulated in tumours tissues harvested from
patient-derived xenografts as well as cell line-derived xenograft and
their respective vesicular subsets. Furthermore, treatment of BRAF WT
cells with treated exosomes showed significant post-transcriptional
downregulation of KCNMA and IGF2R genes that are known to play a
role in tumour growth and metastasis. Conclusions: Overall, BRAFi
induces miR-211 upregulation in melanoma cells and xenografts, and
in their subsets of EVs. Upregulation of miR-211 may be a biomarker
of response in patients carrying BRAF mutant melanoma. This study
also provides the framework for further investigations of miR-211
functions in melanoma cells and EVs as well as in cells receiving this
cargo.
OW6.3
Selective release of circular RNAs in platelet-derived extracellular
vesicles
Christian Preußer, Lee-Hsueh Hung, Silke Schreiner and Albrecht Bindereif
Institute of Biochemistry, Justus Liebig University Giessen, Germany
Introduction: Circular RNAs (circRNAs) are a new class of noncoding
RNAs present in all eukaryotes investigated so far. They are generated
by a special mode of alternative splicing from pre-mRNAs, whereby
single or multiple adjacent and spliced exons are released in circular
form. CircRNAs are cell-type specifically expressed, are unusually
stable and can be found in various body fluids such as blood and
saliva. Methods: We isolated extracellular vesicles from purified and
in vitro activated human platelets, using density-gradient centrifuga-
tion, followed by RNA-seq analysis and bioinformatic identification
of circRNAs; validation of platelet- and exosome-associated circRNAs
was based on semi-quantitative RT-PCR and northern blotting.
Results: Our analysis of circRNAs and the corresponding linear splice
isoforms revealed that  compared to other hematopoietic cell
types  circRNAs are particularly enriched in platelets. By activating
platelets and thereby inducing the generation of extracellular
vesicles, we also showed that platelet-specific circRNAs are packaged
and released within exosomes. Interestingly, we observed a selective
sorting of circular and linear RNA species into exosomes. Summary:
CircRNAs associated with exosomes are released from activated
platelets, representing yet another class of extracellular RNAs that
circulate in the body and may be involved in signalling pathways.
These findings will greatly help to extend the potential of circRNAs as
prognostic and diagnostic biomarkers since platelets are essential for
central physiological processes such as hemostasis, wound healing,
inflammation and cancer metastasis and play an important role in the
pathogenesis of cardiovascular disease.
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Adaptive Dynamic Artificial Poly-ligand Targeting (ADAPT): A Novel
Platform for Profiling Exosomes from Prostate Cancer Cells
Mark R. Miglarese, Tassilo Hornung, Stephen C. Logie, Aniket S. Bondre,
Jelena Zarkovic, Teresa T. Tinder, Varun Maher, Melissa N. Richards,
Heather A. O’Neill, and David B. Spetzler
Caris Life Sciences, Phoenix, AZ, USA
Introduction: Exosomes are small (40100 nm) vesicles secreted by
various cell types detected in a multitude of body fluids. Exosomes
have protein profiles characteristic of their cells of origin and play a
role in cell-to-cell communication making them attractive targets to
identify early disease stage biomarkers. Due to the heterogeneity of
cancer, it is unlikely to find a single cancer marker that will identify
the majority of individuals with a morphologically-defined cancer
type. We developed the highly multiplexed ADAPT platform to
capture systems-based biological signatures that may reflect the
molecular heterogeneity of various cancer types. Exosomes from
two prostate cancer cell lines, VCaP and LNCaP, were used to train
ssDNA libraries to discriminate them. Methods: A library of 1012
oligonucleotides (ODNs) was subjected to five rounds of positive and
negative selection against exosomes from VCaP and LNCaP prostate
cancer cell lines. From the remaining ~3105 sequences, ODNs that
were bound preferably to exosomes from VCaP cells were identified
by NGS. A subset of individual ODNs was resynthesized and binding
of co-precipitated ODNs to VCaP exosomes was verified by qPCR.
ODN-bound proteins were identified by affinity purification and LC-
MS/MS. Results: Cognate binding partners of ODNs bound to VCaP
exosomes were identified, including ESCRT endosomal sorting
proteins (CHMP1b/2a/4b, VPS28, Syntenin-1). Components of ESCRT
participate in exosomes biogenesis and are overexpressed in human
cancers. In addition, we found the chemokine I-TAC, which is
overexpressed in blood and tissue of men with advanced prostate
adenocarcinomas. Finally, we identified hnRNP-1, a cancer associated
splicing factor, and the cold shock proteins RNPL and A18 hnRNP.
Knock-down of these cold shock proteins has been shown to
enhance chemotherapeutic cell killing of prostate cells. Conclusions:
ADAPT is an unbiased profiling platform that identifies cancer
associated proteins expressed on exosomes. This platform can be
deployed against multiple cancer types and offers broad potential
applications in biomarker discovery.
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OW7.1
Hepatocytes-derived extracellular vesicles from metabolic syndrome
models influence adipocytes metabolism
Justyna Mleczko1, Juan Manuel Falcon Perez1 and Silvia Mora2
1CIC bioGUNE, Bizkaia, Spain; 2University of Liverpool, England
Introduction: Metabolic syndrome is a clinical condition affecting
up to 25% of all adults worldwide. It influences many cellular systems
including adipose tissue, hepatocytes and macrophages. Main char-
acteristics include impaired insulin signalling leading to abnormal
glucose and lipid metabolism and systemic inflammation. Up to date,
most cell types were described to secrete extracellular vesicles (EVs) and
their function was mostly associated with intercellular communication.
In the present work, EVs secreted by cellular models of metabolic
syndrome were characterized and their effect on 3T3-L1 adipocytes
metabolism was studied. Methods: EVs were isolated from hepatic
mouse cell lines and rat hepatocytes in normal, drug-induced liver injury
(DILI) and obesity-resembling conditions. The effect of these EVs on
metabolism of 3T3-L1 adipocytes was evaluated by adipokine array and
seahorse mitochondrial and glycolysis stress test. Results: EVs secreted
by hepatocytes are altered under DILI and obesity-resembling condi-
tions displaying significant differences in several EVs membrane markers
including CD81 and CD63. Furthermore, the different EVs have different
effects on the cytokine secretion ejected by adipocytes. Seahorse
assays also evidenced significant changes on the adipocyte metabolism
caused by hepatocytes-derived EVs under normal and damaging
conditions modifying the adipocyte capacity to handle mitochondrial
stress. Summary/conclusion: Our results suggest that hepatocytes in
metabolic syndrome conditions secrete EVs that influence adipocyte
metabolism. This intracellular communication mediated by EVs
could play a role in the development and progression of metabolic
syndrome.
OW7.2
Proteomic profiling of extracellular vesicles derived from adipocytes
reveals the presence of key metabolic proteins involved in
obesity-associated metabolic dysfunctions
Audrey Fleury*1, Maeva Durcin*1, Zuzana Krupova2, Sandrine Truchet3,
Ce´line Henry4, Martin Tro¨tzmu¨ller5, Harald Ko¨feler5, Guillaume Mabilleau6,
Ramaroson Andriantsitohaina1, Patrice Martin2 and Soazig Le Lay1
*Equally contributed
1Oxidative Stress and Metabolic Pathologies, INSERM U1063, University
d’Angers, Angers, France; 2Animal Genetics and Integrative Biology (GABI), LGS
Team, Inra UMR1313, Jouy en Josas, France; 3Animal Genetics and Integrative
Biology (GABI), GFP-GM Team, INRA UMR1313, Jouy en Josas, France; 4Papsso,
INRA UMR1319 MICALIS, Jouy en Josas, France; 5Core Facility For Mass
Spectrometry/Lipidomics, Center for Medical Research, Medical University of
Graz, Graz, Austria; 6Sciam, Angers University, Angers, France
Extracellular vesicles (EVs) are biological vectors that can modulate
the metabolism of target cells by their ability to convey signalling
proteins. Plasmatic EVs rate is significantly increased in cardiometa-
bolic diseases associated with obesity, suggesting their possible
participation in the development of metabolic dysfunctions. Few
data exist on adipocytes-derived EVs. The purpose of this study is to
qualitatively and quantitatively characterize EVs secreted by fat cells.
Adipocyte-derived EVs were isolated by differential centrifugations
of conditioned media collected from 24h-cultured 3T3-L1 adipocytes
in the absence of serum. Based on morphological and biochemical
properties as well as quantification of secreted EVs using nano-
particle tracking analysis, we distinguished two subpopulations of
adipocyte-derived EVs, namely, microparticles (MP) and exosomes,
with different mean size (285.3181 nm and 39.915 nm, respectively).
Proteomic study using high-resolution mass spectrometry analysis
(LC-MS/MS) revealed differential expression of proteins associated
with these EVs. Indeed, MP and exosomes exhibit specific protein
signatures allowing not only their sorting but also the prediction of
their subsequent function(s) with respect to metabolic responses in
recipient cells. By contrast, MP and exosomes present similar phos-
pholipid patterns with respect to quantitative mass-spectrometry
high-throughput lipidomic analysis. Our results demonstrate the
ability of adipocytes to secrete substantial quantities of EVs.
They also highlight the ability of adipocytes to produce the two
subpopulations of EVs that can be differentially sorted by their
protein contents known to regulate the glucidolipidic metabolism.
These adipocyte-derived EVs could therefore participate in metabolic
dysfunctions commonly associated with obesity.
This project was funded by a French grant (ANR MilkChEST n8ANR-
12-BSV6-0013-04), a grant from ‘‘Rgion Pays de la Loire’’ and by GIS
APIS-GENE.
OW7.3
Extracellular vesicles, extracellular vesicles-contained miRNAs and total
miRNAs as plasma-based biomarkers for metabolic syndrome
Sadhbh O’Neill1, Søren Gregersen2, Mette Larsen2, Kjeld Hermansen2 and
Lorraine O’Driscoll1
1School of Pharmacy and Pharmaceutical Sciences & Trinity Biomedical
Sciences Institute, Trinity College Dublin, Dublin, Ireland; 2Department of
Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus,
Denmark
Introduction: Metabolic syndrome (MetS) is the compounding of
several risk factors that increase the risk of cardiovascular disease,
type 2 diabetes and cancer. Reliable, minimally invasive biomarkers for
diagnosing MetS are needed. In an effort to identify biomarkers, we
investigated extracellular vesicles (EV), EV-contained miRNAs and total
miRNAs isolated from plasma of obese and MetS individuals. Methods:
EVs were isolated by filtration and ultracentrifugation and character-
ized by bicinchoninic acid assay, immunoblotting, nanoparticle
tracking analysis (NTA) and transmission electron microscopy (TEM).
RNA was extracted by TriReagent, and miRNAs were assessed using
miRNA panels and qPCR assays. Results: Evidence of successful EV
isolation included immunoblots showing CD81, PDC6I, with Grp-94
undetected. Also, NTA and TEM showed vesicles to be ~100 nm. The
amounts of EVs (mg/mL) was significantly (p0.004) increased in
MetS (250934) compared to obesity (136919). Total plasma miRNA
profiling identified miR-758-3p to be significantly (2.7590.44-fold,
p0.09) reduced in MetS (n19) compared to obesity (n19). This
was confirmed (23.291 fold, p0.03) by qPCR in an independent
cohort (n7 MetS, n7 obese). Considering EV-miRNAs, miR-758-3p
was undetectable in EVs from the same cohorts, suggesting that it is
not carried by EVs. Conversely, miRNA profiling of EV-RNA indicated
miR-15a-5p (22.790.5-fold, p0.01) and miR-100-5p (3.4290.4-fold,
p0.02) to be significantly increased in MetS (n12) compared to
obesity (n12). Summary/conclusion: This study shows, for the first
time, that EVs, EV-miRNAs and total miRNAs all have potential as
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minimally invasive biomarkers to decipher between obesity and those
who go on to develop full-blown MetS. Simply assessing ‘‘total
miRNAs’’ or ‘‘EV-carried miRNAs’’ may not be most beneficial, but a
combination of both maybe of most value. Further studies in larger
cohorts, including appropriate healthy controls, and co-analysing each
of these are now warranted.
OW7.4
Leukocyte microvesicle as fibrosis biomarkers in non-alcoholic fatty
liver disease
Joshua Welsh, Christopher Byrne, Nicola Englyst, Geraldine Clough and
Eleonora Scorletti
University of Southampton, England, UK
Introduction: Non-alcoholic fatty liver disease (NAFLD) is an increas-
ingly common, progressive inflammatory fibrotic liver condition, with
a variety of stages (steatosis, steatohepatitis (NASH), fibrosis and
cirrhosis). Better non-invasive liver fibrosis tests are required that
allow monitoring of fibrosis and testing of therapeutic interventions.
Microvesicles (MVs) are submicron vesicles released upon cell
activation or damage and may be useful for assessing the stage of
liver disease in NAFLD. The aim of this study was to determine
whether leucocyte MV production changes with severity of liver
fibrosis. Methods: Twenty-five adults with NAFLD diagnosed by liver
biopsy were recruited as part of a sub-study of the WELCOME Trial 1.
Liver fibrosis severity was graded 04 as part of Kleiner scoring of
NAFLD severity. Citrated plasma samples were centrifuged twice at
2000g and stored at 808C prior to analysis using flow cytometry.
Monocyte microvesicles (MMVs) between 200 and 1000 nm were
counted and categorized as the sum of CD14 and CD14CD16
events. An ANOVA with a post hoc least significance difference (LSD)
test for multiple comparisons was undertaken to test differences
between groups and associations. Results: Cohort characteristics
(meanSD): age49.4912.7 years, men13, type 2 diabetes n12,
Kleiner score6.02.5. Individuals with a fibrosis score of 0 (n5) were
shown to have significantly more MMVs than those with a score of
3 (n5, p0.009) and 4 (n4, p0.005), with a mean decrease in
the MMV number from no fibrosis of 61.4 and 67.8%, respectively.
Conclusion: MMV numbers may differentiate individuals with severe
fibrosis from those with little or no fibrosis in NAFLD, suggesting
further exploration of MMVs as NAFLD biomarkers is merited (1).
Acknowledgements: This study was supported by Diabetes UK
(BDA 09/0003937)
Reference
1. Scorletti, E. et al. Contemp Clin Trials 37, 30111 (2014).
OW7.5
High-density lipoprotein-like nanoparticles target SR-B1 and inhibit
melanoma cell-derived exosome uptake to block the pre-metastatic
niche
Michael Plebanek, Olga Volpert and C. Shad Thaxton
Northwestern University, Evanston, Illinois, USA
Introduction: Exosomes are natural nanovesicles produced by all
mammalian cells. They function as intercellular delivery vehicles,
to transport an array of molecular cargo. Exosomes are critical for
the pathogenesis of many diseases. In cancer, tumour exosomes
generate pro-metastatic microenvironments termed the ‘‘pre-
metastatic niche.’’ Exosome uptake depends on cholesterol-rich
membrane microdomains called lipid rafts and is blocked by non-
specific depletion of cholesterol in the plasma membranes. Our
laboratory has developed a synthetic nanoparticle mimetics of high-
density lipoprotein (HDL NP) that, like HDL, binds scavenger receptor
type B-1 (SR-B1), but, unlike HDL, they destabilize lipid rafts through
enhanced cholesterol efflux. We hypothesized that HDL NPs inhibit
exosome uptake and block the pre-metastatic niche. Methods:
Exosomes from A375 or B16F10 melanoma were labelled with
fluorescent lipophilic dyes. The ability of HDL NPs to block the
functions of melanoma exosomes was assessed in vitro and in vivo.
The methods included fluorescent microscopy and flow cytometry,
assessment of endothelial cell migration and quantifying mobiliza-
tion of the endothelial progenitors and myeloid-derived suppressor
cells in vivo. Results: We showed that HDL NPs inhibit uptake of
melanoma exosomes by tumour cells, endothelial cells and macro-
phages via SR-B1-dependent modulation of cholesterol flux and
disruption of lipid raft homeostasis. We also show that HDL NPs
prevent endothelial cell migration caused by melanoma exosomes in
vitro and block exosome-dependent mobilization of endothelial
progenitor and myeloid-derived cells from the bone marrow in vivo.
Summary/conclusions: Our study implicates SR-B1, as a critical
mediator of exosome uptake, and points to HDL NPs as a means
to inhibit exosome uptake. Importantly, because HDL NPs prevent
exosome-dependent pro-metastatic, they may be developed into
much needed therapy for metastasis.
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OW8.1
Immunomodulatory properties of large oncosomes from prostate
cancer cells
Dhong-Hyun Lee1, Valentina R. Minciacchi1, Umberto Foresta1,
Rebecca Porritt2, Maretti Ana2, Mandana Zandian1, Michael R. Freeman2,
Gislaine Martins2 and Dolores Di Vizio1
1Department of Surgery, Cedars Sinai Medical Center, Los Angeles, USA;
2Department of Medicine, Cedars Sinai Medical Center, Los Angeles, USA
Introduction: Metastasis is the leading cause of prostate cancer (PCa)-
related death in the United States. Immunotherapy confers survival
advantages for men with asymptomatic to minimally symptomatic
metastatic PCa, but not with symptomatic disease. Development of
new strategies will require a better understanding of the complex
cross-talk between PCa cells and the immune system. We recently
discovered cancer-specific extracellular vesicles (EVs) called large
oncosomes (LO), which may play an important role in the cross-talk.
LO contain tumour-derived macromolecules. MicroRNA 1227
(miR1227) emerged as enriched in EVs from tumorigenic but not from
benign cells. Methods: Ultracentrifugation for EV isolation; confocal
imaging to follow EV uptake; lentiviral overexpression of miR1227;
western blot; RT-qPCR. Results: miR1227 was predicted by multiple
algorithms to target the ring finger protein 125 (RNF125), an E3
ubiquitin protein ligase and a known inhibitor of the retinoic acid
inducible gene 1 (RIG-I). Overexpression of miR1227 in Jurkat cells
induced significant decrease in RNF125 mRNA and a modest increase
in RIG-I protein levels. We found that macrophages and dendritic cells
(DC) take up LO avidly. RNA125 mRNA levels were significantly
reduced in DC treated with LO from parental or miR1227 over-
expressing PC3 cells. In the same conditions, DC exhibited altered
mRNA levels of select cytokines downstream of the RIG-I pathway
(CCL5, IL6, IFNB1 and TNF). These results suggest that LO might inhibit
RNF125 that, in turn, can activate the RIG-I pathway, thus reprogram-
ming the immune system in favour of tumour progression. Conclusion:
Our study has identified a new molecular mechanism underlying
the modulation of the immune response to PC. This can potentially
contribute to the improvement of the current therapies as well as the
development of new immunotherapeutic strategies specifically tar-
geting pathways underlying impairment of the immune response to
PC and other types of cancer.
OW8.2
Characterization and functional evaluation of distinct exosome
subpopulations
E Willms1, HJ Johansson2, I Ma¨ger1,3, Y Lee1, KE Blomberg4, M Sadik5,
A Alaarg1, CI Smith4, J Lehtio¨2, S El Andaloussi1,4, MJ Wood1 and P Vader1,5
1Department of Physiology, Anatomy and Genetics, University of Oxford,
Oxford, United Kingdom; 2Cancer Proteomics Mass Spectrometry, Science for
Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet,
Stockholm, Sweden; 3Institute of Technology, University of Tartu, Tartu,
Estonia; 4Department of Laboratory Medicine, Karolinska Institutet, Stockholm,
Sweden; 5Department of Clinical Chemistry and Haematology, University
Medical Center Utrecht, Utrecht, The Netherlands
Cells release nano-sized membrane vesicles that are involved in
intercellular communication by transferring biological information
between cells. It is generally accepted that cells release at least three
types of extracellular vesicles (EVs): apoptotic bodies, microvesicles
and exosomes. While a wide range of putative biological functions
have been attributed to exosomes, they often are assumed to
represent a homogenous population of EVs. Here, we demonstrate
the existence of subpopulations of exosomes with defined molecular
compositions and biological properties. Exosomes isolated from
B16F10 melanoma cells consisted of two distinct subpopulations, as
demonstrated by both density gradient centrifugation and size
exclusion chromatography. Further characterization of the exosome
subpopulations, obtained after density gradient centrifugation,
revealed their distinct differences in biophysical properties, and their
proteomic and RNA signature. Exposure of H5V endothelial cells to
the exosome subpopulations induced differential changes in gene
expression. In conclusion, we demonstrate that cells release distinct
exosome subpopulations that differ in their composition, and more
importantly biological effects on recipient cells. Further dissection of
exosome heterogeneity will advance our understanding of exosomal
biology and function, and accelerate the development of exosome-
based diagnostics and therapeutics.
OW8.3
Extracellular vesicles regulate soluble secreted factors and epigenetic
profile of the tumour microenvironment
Michael Liem1, Suresh Mathivanan1 and Kalra Hina2
1La Trobe University, Melbourne, Australia; 2La Trobe Institute of Molecular
Sciences, Melbourne, Australia
Introduction: For a tumour to progress, a bidirectional crosstalk of the
cancer cells and its surrounding tissue is critical, and various soluble
factors released in the tumour microenvironment (TME) are known to
induce tumour growth. Extracellular vesicles (EVs) contain various
oncogenic proteins and RNAs, which can potentially regulate the TME.
We hypothesize that EVs derived from colorectal cancer (CRC) cells
promote cancer progression by reprogramming the cells in the TME by
altering the soluble secreted proteins and DNA methylation. Methods:
Quantitative proteomics analysis was carried out to identify the changes
in soluble secreted factors during exosomes treatment. In vitro scratch
assay was performed. Methylation profiling of cells in the tumour
microenvironment was performed using Infinium HumanMethyla-
tion450 BeadChip and targeted bisulfite sequencing. Result: In this study,
SILAC-based quantitative proteomic analysis highlighted the EV-based
transfer of various oncoproteins and histones from the cancer cells into
the recipient cells. A follow-up subcellular fractionation confirmed the
intercellular transfer of proteins into the recipient cell nucleus. EV-
mediated transfer of proteins regulated the soluble secreted proteome
of the recipient cells in the TME (fibroblast, pericytes, endothelial,
monocytes, NK and T cells). More importantly, the altered secreted
proteins induced more aggressiveness of cancer cells thereby aiding in
tumour progression. To further study the potential of EVs in educating
the TME, variety of cells in TME were treated with EV and analysed for
DNA methylation profile. Upon the uptake of cancer-derived EVs, the
recipient cells exhibited differential DNA methylation status of many
genes again aiding in tumour progression. Summary: The results confirm
that EVs can regulate the secretome and the DNA methylation profiles of
the recipient cells in favour of tumour progression.
OW8.4
Tumour-derived extracellular vesicles captured by mesenchymal
stromal cells induce an ERK1/2-dependent pro-tumorigenic
inflammatory reaction
Yves Declerck
Children’s Hospital Los Angeles-University of Southern California, USA
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The bone marrow (BM) is a microenvironment that promotes survival,
dormancy and therapeutic resistance in tumour cells. Central to this
function are mesenchymal stromal cells (MSC), precursor cells of
osteoblasts, chondrocytes and adipocytes that contribute to the BM
niche. Here, using neuroblastoma (NB) as a model of communication
between tumour cells and MSC, we demonstrate that tumour cells
release two populations of extracellular vesicles (EVs). One rich in
CMGA/chromogranin A, and a second, rich in proteins present in
exosomes such as HSP90 and HSP70, tetraspanin CD63/melanoma1
antigen, PDCD6IP/ALIX and SDCBP/syntenin and galectin-3 binding
protein (Gal-3BP), a sialoglycoprotein we had previously reported to
induce the expression of interleukin (IL)-6 in MSC. In contrast, these
EV contain few cytokines and chemokines. We then show that the
capture of these EV by MSC stimulates the production of several pro-
tumorigenic cytokines and chemokines like IL-6, CXCL8/IL-8, vascular
endothelial cell growth factor (VEGF), stromal-derived factor-1 (SDF1/
CXCL12) and monocyte-chemotactic protein-1 (MCP-1/CCL2) by
MSC. Exposure of MSC to NB-derived EV stimulates ERK1/2 and Akt
activation, and inhibition of ERK1/2 but not Akt prevents the
stimulation of IL-6 and IL-8 production by MSC. Thus, we describe
here a new mechanism by which EVs produced by NB cells educate
MSC towards a pro-tumorigenic role contributing to a favourable
microenvironment for NB cells in the BM.
OW8.5
Disruption of the LINC complex in cancer cells drives the genesis of
extracellular vesicles with nuclear content
Mariana Reis-Sobreiro1, Samantha Morley2, Kenneth Steadman1,
Jie-Fu Chen3, Sungyong You1, Edwin M. Posadas1, Dolores Di Vizio4 and
Michael R. Freeman5
1Cedars Sinai Medical Center, Los Angeles, CA, USA; 2Boston Children’s
Hospital, Boston, MA, USA; 3Samuel Oschin Comprehensive Cancer Institute,
Cedars Sinai Medical Center, Los Angeles, CA, USA; 4Department of Surgery,
Cedars-Sinai Medical Center, University of California, Los Angeles, CA, USA;
5Department of Surgery and Department of Biomedical Sciences, Cedars-Sinai
Medical Center, University of California, Los Angeles, CA, USA;
Introduction: Amoeboid tumour cells are phenotypically plastic,
move rapidly through extracellular matrixes, shed extracellular
vesicles (EVs) and have propensity to metastasize. For amoeboid
cells to squeeze into narrow spaces, nuclear deformations are critical,
as the nucleus is the largest and most rigid organelle. Protein
assemblies that link the cytoskeleton with the nucleoskeleton govern
nuclear shape and stiffness. Collectively, these structures are known
as the linker of nucleoskeleton and cytoskeleton (LINC) complex. We
tested whether alterations in the LINC complex are associated with
the amoeboid phenotype and shedding of EVs. Methods: Immuno-
precipitation-mass spectrometry (IP-MS), flow cytometry, differential
ultracentrifugation, iodixanol gradient, confocal 3D reconstruction,
life cell imaging, western blot and nanovelcro. Results: Loss of the
cytoskeletal regulator DIAPH3 drives the transition of cancer cells to
an amoeboid phenotype. We found that DIAPH3 directly interacts
with the LINC complex. DIAPH3 silencing in breast and prostate
cancer cells destabilizes the complex, promoting nuclear envelope
blebbing and shedding of non-apoptotic EVs with nuclear content.
LINC complex disruption through the silencing of emerin and lamin
A/C promotes increased migration, formation of nuclear envelope
blebs, increased shedding of non-apoptotic EVs and ROCK pathway
activation. Consistent with the idea that disruption of the LINC
complex is important in metastasis, lamin A/C is downregulated in
metastatic prostate cancer patients, and low levels of emerin are
associated with poor survival outcomes in breast cancer patients.
Furthermore, circulating tumour cells (CTCs) isolated from prostate
cancer patients express low emerin levels. Conclusions: Our study
provides new markers of lethal disease in prostate and breast cancer
and suggests that LINC complex disruption is a critical step for
metastatic spread. It also identifies a mechanism that promotes
inclusion of nuclear content into EVs.
OW8.6
Extracellular vesicles as a signalling system involved in kidney
morphogenesis and disease
Anatoliy Samoylenko, Mirja Krause, Khem Giri, Tuomas Nurmi,
Aleksandra Rak-Raszewska, Prateek Singh, Genevieve Bart,
Timo Pikkarainen and Seppo Vainio
Faculty of Biochemistry and Molecular Medicine, University of Oulu, Oulu,
Finland
Cells secrete different types of membrane-enclosed extracellular
vesicles (EVs), which are widely present in the body fluids and
incorporate mRNA, miRNA, proteins and signalling molecules. One
of the most studied groups of these vesicles are exosomes (EXs),
characterized by small size (30100 nm) and endosomal origin.
Increasing amounts of evidence suggest that EXs play an important
role in cell-to-cell communication. EXs secreted by kidney cells
control nephron function and are involved in kidney diseases and
cancers. In our study, EVs were purified from Renca renal carcinoma
and mK4 metanephric mesenchyme-derived cell culture media by
sequential and sucrose gradient ultracentrifugation and analysed by
electron microscopy (EM), confocal microscopy, nanoparticle track-
ing analysis (NTA) and western blotting using EV-specific markers.
Metanephric mesenchyme (MM) cells were isolated from E11.5 mice
embryos by micro-dissection and cultured as a monolayer. Morphol-
ogy, proliferation and viability of monolayer MM cells and mK4 cells
treated with EVs were assayed by immunofluorescent staining and
live cell imaging using IncuCyte ZOOM (Essen BioScience) and
Operetta (PerkinElmer). We found that conditioned media as well as
isolated EVs influence growth of MM and mK4 cells in culture. EM
and NTA showed hypoxia treatment (1% oxygen for 24 h) greatly
increased the EV count in collected culture media. Hypoxia also
changed protein content of Renca-derived exosomes, as identified
by liquid chromatographymass spectrometry. Thus, the in vitro cell
and organ culture models have proven to be useful tools in finding
out the roles of EV during inductive events and organogenesis.
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Integrated methodology for purification, detailed biophysical
characterization and phenotyping of extracellular vesicles from
biological fluids
Julien Muzard1, Anoop K. Pal2, Robert Vogel3 and Murray Broom3
1Nanobiochemistry, Izon Science Ltd, Oxford, UK; 22Nanobiochemistry, Izon
Science Ltd, Cambridge, MA, USA; 3Nanobiochemistry, Izon Science Ltd,
Christchurch, New Zealand
Extracellular vesicles (EVs) have been shown to play important role in
broad range of physiological and pathological processes. The size,
number, membrane composition and contents of EVs are highly
heterogeneous, dynamic and depend on the cellular source, state
and environmental conditions. Thus, understanding the biophysical
diversity in EV population is paramount for linking the impact of EV
properties to its biological role and function. Here, we outline an
integrated methodology that utilizes simple size exclusion chroma-
tography (SEC) based qEV columns for rapid EV purification from
variety of biological fluids (urine, serum, plasma, CSF, cell culture etc.)
followed by accurate, high-resolution particle-by-particle EV biophy-
sical characterization (size, size range, concentration and surface
charge) through qNano that utilizes Tunable Resistive Pulse Sensing
(TRPS) technology. The SEC columns provide a convenient, repro-
ducible and highly effective means of eliminating 99% of non-
vesicular protein from biological fluid samples. Moreover, the
integrated methodology has been further developed and utilized
for specific immuno-labelling and phenotyping of EV surface markers
(CD9, CD63 and CD142) from bio-fluids. Here, specific EVs are isolated
post SEC purification through antibody conjugated to magnetic
beads. The resulting EV-magnetic complex (immunoprecipitate) is
then directly analysed and the extent of aggregation monitored
through TRPS. Our results showed a proportional increase in size,
volume and surface charge of the EV-magnetic bead complexes over
a defined dose-range. Changes in physical properties indicated the
positive selection of specific sub-population, and these results were
confirmed with secondary endpoints. Tissue factor activity assay for
CD142 confirmed our findings. Thus, proposed methodology pro-
vides a simple, rapid, reliable and cost-efficient approach that has
tremendous utility for biophysical characterization and EV-based
diagnostics.
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OW9.1
TM9SF4 expression in tumour tissue and in circulating
exosomes: a novel diagnostic biomarker for gastrointestinal
tumours
Paolo Guazzi1, Sergejs Isaevis2, Natasa Zarovni3, Giorgia Radano3,
Antonietta Corrado3, Pietro Ferruzzi3, Antonio Chiesi3, Marcis Leja2 and
Francesco Lozupone4
1HansaBioMed, Tallinn, Estonia; 2Faculty of Medicine University of Latvia, Riga,
Latvia; 3Exosomics Siena, Italy; 4Istituto superiore di Sanita`
Background: The identification of novel biomarkers for the early
detection and monitoring of gastric (GC) and colorectal cancer (CRC) is
of paramount importance. TM9SF4 is a transmembrane protein highly
expressed in Golgi and endosomal membranes of cancer cells which
interacts with V-ATPase. The aim of this study was the evaluation of
TM9SF4 expression in GC and CRC patients and in GC and CRC deriving
exosomes, as potential new biomarker for early detection and monitor-
ing of GC and CRC. Methods: Tissue samples of 108 cancer patients were
analysed by Immunohistochemistry. Exosomal expression of TM9SF4
was assessed by western blot and ExoTEST analysis of blood plasma
deriving exosomes from a cohort of 162 cancer patients (80 with GC
and 82 with CRC) and 174 control subjects. Results: TM9SF4 was
significantly increased in both non-advanced and advanced GC and
CRC, compared to the control group and premalignant lesions, with a
sensitivity that is significantly higher than commonly used tumour
markers such as CEA and CA19-9. Furthermore, TM9SF4 expression is
also related with disease stage in both cancer types. The analysis of
TM9SF4 in tumour patients deriving exosomes and in exosomes
collected from healthy donors clearly suggested that TM9SF4 is an
exosome protein, strongly expressed in tumour cell and in cancer
patients’ plasma deriving exosomes, with a 2.5- and 2.7-fold increase,
respectively, for GC and CRC as compared to control group. Noteworthy,
a significant correlation between TM9SF4 expression in tissue samples
and in exosomes isolated from peripheral blood plasma of the same
patients has also been observed. Conclusions: TM9SF4 can be proposed
as a new, highly specific cancer biomarker exploitable for the disease
evaluation of gastrointestinal cancers patients. TM9SF4 bearing exo-
somes reflecting the pathological changes in CG and CRC patients are
applicable for the development of new and promising tool for a non-
invasive early diagnosis of GC and CRC.
OW9.2
Circulating tumour cells, tumour extracellular vesicles and serum
cytokeratins in castration-resistant prostate cancer
Afroditi Nanou1, Guus van Dalum1, Leonie Zeune1, Frank Coumans2,
Wendy Onstenk3, Stefan Sleijfer3, Mateus Crespo4,
Johann de Bono4 and Leon WMM Terstappen1
1Department of Medical Cell BioPhysics, MIRA Institute, University of Twente,
Enschede, The Netherlands; 2Department of Biomedical Engineering and
Physics, Academic Medical Center, University of Amsterdam, The Netherlands;
3Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam,
The Netherlands; 4Institute of Cancer Research, Royal Marsden Hospital,
London, UK
Introduction: Presence of circulating tumour cells (CTC) in castration-
resistant prostate cancer (CRPC) is associated with poor outcome
and may serve as a liquid biopsy and an intermediate surrogate
endpoint of treatment efficacy in CRPC. Herein, we investigated
the relation of CTC, tumour-derived extracellular vesicles (tdEV)
and serum cytokeratins (CK) with clinical outcome. Methods: CTC
and cytokeratin, EpCAM, CD45-tdEV smaller than 4 um were
determined with the CellSearch system in 7.5 mL of blood of 87 CRPC
patients and 16 healthy donors. The levels of circulating cytokeratin
18 (M65) and cleaved cytokeratin 18 (M30) were evaluated with ELISA
in the corresponding plasma samples. Results: The median number of
CTC and tdEV in 7.5 mL blood of 87 CRPC patients was 5 (IQR: 53.5)
and 275 (822.4), whereas the respective numbers of CTC and tdEV in
7.5 mL blood of 16 healthy donors were 0 (0) and 11 (11). The median
concentrations of M65 and M30 were 582 (349) and 268 (119) U/L in
the plasma of CRPC patients. The respective values in the plasma of
healthy donors were 158 (21) and 70 (22) U/L. CTC, tdEV, M30 and M65
values of patients were all significantly higher compared to the values
in healthy donors (Mann-Whitney U test, pB0.001). The presence
of]700 U/L of M65,]5 CTC and]500 tdEV in 7.5 mL blood of CRPC
patients predicted significantly shorter overall survival in the patient
cohort; M30 could not predict survival. Conclusion: CTC, tdEV and
circulating cytokeratin 18 (M65) are detected in significantly higher
amounts in blood of CRPC patients. Cut-off values for M65 and
tdEV were determined. Multivariate Cox regression showed that the
hazard ratios of M65 and tdEV in blood of patients are equivalent
to prostate-specific antigen and CTC and are potential markers to
predict the outcome of CRPC patients. The cut-off values presented
for each biomarker will be validated in another set of CRPC patients to
determine their potential clinical utility.
OW9.3
Detection and functional implications of tumour-derived microvesicles
in cancer patients
Kerstin Menck1, Annalen Bleckmann1, Astrid Wachter1,
Bianca Hennies1, Tobias Pukrop1, Dirk Wenzel2, Florian Klemm1 and
Claudia Binder1
1University Medical Center Go¨ttingen, Germany; 2Max Planck Institute for
Biophysical Chemistry, Go¨ttingen, Germany;
Introduction: Plasma membrane-derived microvesicles (MVs) are
known as important mediators of intercellular communication.
Especially in cancer, many in vitro studies already showed that
tumour cells use MVs to create a favourable tumour niche that
promotes tumour progression. However, in vivo studies on tumour-
derived MVs (T-MVs) are still missing due to the lack of suitable
markers. Previously, we had described the protein EMMPRIN/CD147
as a novel marker for T-MVs and demonstrated an increase of
EMMPRIN MVs in the blood of a small number of breast cancer
patients. Now, we aimed to evaluate which markers can be used to
detect T-MVs in peripheral blood of a large cohort of patients with
different tumour entities and whether T-MVs are associated with
tumour progression in vivo. Methods: MVs were isolated by differential
ultracentrifugation from peripheral blood of 274 cancer and 103
control patients. All samples were collected upon informed consent
with approval from the local ethics committee. Results: We demon-
strate a significant increase in the number of MV positive for the
tumour markers EMMPRIN, MUC1 and EpCAM in the blood of cancer
versus control patients. Flow cytometry revealed a population of
EMMPRIN/MUC1 double positive MVs that was significantly elevated
in cancer patients and almost undetectable in control patients.
In vitro, MVs from cancer patients increased cancer cell invasion,
which was antagonized by blocking peptides directed against the
highly glycosylated form of EMMPRIN. In contrast, MV from control
patients had no such effect on tumour invasion. Interestingly,
stimulation of human macrophages with cancer patient-derived
MVs induced expression of WNT5A and VEGF, two proteins known
to promote tumour invasion and angiogenesis. Conclusion: T-MVs can
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be detected in the blood of cancer patients by conventional flow
cytometry with a combination of different markers. Apart from being
potentially useful biomarkers, they also seem to play a role in cancer
progression in vivo.
OW9.4
Identification of Del-1 on circulating exosomes as a liquid biopsy to
detect early breast cancer
Eun Ju Im and Moon-Chang Baek
Department of Molecular Medicine, School of Medicine, Kyungpook National
University, Daegu, Republic of Korea
Introduction: Emerging evidence suggests that cancer cell-derived
exosomes containing proteins linked to the disease pathogenesis
may provide early biomarkers for various cancers. Here we report on
Del-1 protein on circulating exosome (cirExo) as an early diagnostic
biomarker for breast cancer (BC). Methods: To understand the
mechanism of BC metastasis and identify early biomarkers of this
cancer, we studied exosomes secreted from BC cells. We focused on
the Del-1 protein based on the fact that this protein is highly
expressed in MDA-MB-231 exosomes. Enzyme-linked immunosorbent
assays (ELISAs) were used to measure Del-1 in plasma samples from
healthy controls, patients with BC, BC patients after surgical resection,
patients with benign breast tumours and patients with non-cancerous
diseases, in two cohorts. Results: These exosomes are sufficient for
enhancement of BC cells invasion, which is most likely mediated via
the integrin-FAK signalling cascade in cancer cells and for acceleration
of lung metastasis at the initial stage of cancer mouse models.
However, these effects are significantly suppressed when Del-1 is
inactivated, providing evidence for a critical role of Del-1 in develop-
ment of cancer. Consistently, in human patients with BC, the levels of
Del-1 on cirExo are significantly elevated at the early stage of breast
cancer, including ductal carcinoma in situ (DCIS), but return to normal
levels after removal of the tumour, as determined by a developed
ELISA with96% high sensitivity and specificity using 1 mL of plasma.
Summary/conclusion: Taken together, these results identify an exo-
somes-mediated mechanism of invasion and an early diagnostic
biomarker for BC using Del-1 protein on circulating exosomes.
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PW1.01
New insights into sortilin regulation in lung cancer
Cornelia Wilson, Triantafyllos Liloglou and Amelia Acha-Sagredo
University of Liverpool, England, UK
Lung cancer is the leading cause of cancer death worldwide killing
over 1.2 million people each year with non-small-cell lung cancer
(NSCLC) being the most common form (7585% lung cancer patients).
This is mainly due to the lack of early screening and efficient tools for
early diagnosis of the disease. Exosomes are small membrane-bound
microvesicles (or extracellular vesicles) released from most eukaryotic
cells, containing a plethora of nucleic acids and proteins that are
thought to facilitate microenvironment communication and control.
In cancer, the number and content of exosomes changes affecting the
microenvironment and inducing immune suppression, angiogenesis
and pre-metastatic niche formation. Microenvironment communica-
tion through neurotrophin signalling could lead to the progression of
cancer, while an imbalance in expression of neurotrophin receptors
such as sortilin is strongly linked to different types of cancer. Sortilin is
a member of the Vps10 family, having a multifaceted role both as a co-
receptor and as a trafficking molecule in the trans-Golgi network
(TGN). Sortilin can form a novel complex with TrkB and EGFR (TES
complex), found in exosomes that are released from NSCLC cells
conveying a microenvironmental control upon endothelial cells. We
hypothesize that an imbalance of sortilin’s role in protein trafficking
and exosome biogenesis may contribute to cancer progression.
We demonstrate that sortilin exists as two variants, sharing high
homology with each other, the variant 1 is well described in the
literature while the identity and function of variant 2 is still
unknown. We show that the expression of the two sortilin variants
is deregulated in early stages of lung cancer. Hence, the deregulation
of sortilin expression in NSCLC could provide the first insights
of its function in exosomes as an early diagnostic and prognostic
marker.
PW1.02
Biogenesis of exosomes derived from macrophages exposed to
Mycobacterium avium subsp. paratuberculosis is altered in relation to
infection dosage and time of exposure
Matt Johansen, Kumudika De Silva, Karren Plain, Richard Whittington and
Auriol Purdie
The University of Sydney, Australia
Introduction: Johne’s disease is a chronic granulomatous enteritis
caused by Mycobacterium avium subspecies paratuberculosis (MAP),
primarily affecting a variety of agriculturally significant ruminant
species such as sheep, cattle, deer and goats. The pathogenesis of
paratuberculosis resembles other chronic mycobacterial diseases.
While the importance of exosomes and the role they play in the
development of tuberculosis are documented, their role in para-
tuberculosis is unknown. The aim of this study was to investigate the
biogenesis of exosomes released from MAP-exposed murine macro-
phages associated with changes in the infection dosage and length of
exposure in vitro. Methods: Exosomes were studied using nanoparticle
tracking analysis, flow cytometry and transmission electron micro-
scopy. Mass spectrometry analysis was used to identify proteomic
constituents of exosomes. Results: The infection dose influenced the
concentration of exosomes produced at 24 h post-exposure. An
increasing bacterial load resulted in a linear increase in exosomes
produced. Examination of a series of increasing durations of bacterial
exposure revealed that the production of exosomes was associated
with specific timepoints post-exposure. Furthermore, the crucial
timepoints identified for the production of exosomes changed
significantly in relation to the bacterial load and the exosome isolation
method used. While protein quantification is typically used to
estimate the abundance of exosomes, it was found there was no
correlation between protein concentration and exosome particle
concentration. Mass spectrometry analysis identified a number of
MAP-specific proteins within exosomes that changed in relation to
infectious dosage and length of time post-exposure. Summary/
conclusion: This study demonstrates that the infection dosage and
time post-exposure have significant impacts on the production and
composition of exosomes from MAP-exposed macrophages.
PW1.03
Extracellular vesicles in pharmaceutical bioprocess  comparison of
two cell lines
Apolonija Bedina-Zavec1, Matjazˇ Brinc2, Veronika Kralj Iglicˇ3,
Monika Svetina2, Marjetka Podobnik1 and Gregor Andreluh1
1National Institute of Chemistry, Ljubljana, Slovenia;
2Sandoz Biopharmaceuticals-Lek Pharmaceuticals D.D., Ljubljana, Slovenia;
3Biomedical Research Group, University of Ljubljana, Slovenia
Introduction: Recognition of the role of extracellular vesicles (EVs) in a
variety of diseases mostly stimulates their investigation for clinical
purposes. In this work, we present EVs from a different point of view,
as a tool for the bioprocess monitoring. EVs are rapidly released by
cells during cell activation and cell stress; therefore, the amount
of released MVs could be used for the identification of cell state and
cell condition during the bioprocess. However, the release of EVs
depends on cell type also. We have compared the vesiculation of
two different cell lines during pharmaceutical bioprocess. Methods:
We have used two different cell lines, both derived from a Chinese
hamster ovary (CHO) cell line. EVs were quantified by flow cytometry.
EVs were measured in samples from the bioreactor after cells were
centrifuged off. Results: The absolute amount of EVs in the bioreactor
increased highly during the bioprocess for both cell lines; besides,
the amount of EVs in comparison to cells increased obviously during
the bioprocess. During the early stages of the bioprocess, the
amount of EVs with regard to cells increased only slightly, but
the amount of EVs in comparison to cells increased significantly at
the end of the bioprocess because of the increase in cell dying. The
amount of dead cells continuously increased during the biopro-
cesses of both cell lines. The amount of EVs continuously increased
with one of the cell lines; however, the release of EVs of the cell line
with higher proportion of dead cells throughout the bioprocess was
highly dynamic, and enormous amount of EVs were released on the
bioprocess days 9 and 12. Conclusions: The amount of EVs increased
during the bioprocesses of both cell lines and indicates deteriorating
conditions in bioreactor. However, while the release of EVs conti-
nuously increased during the bioprocess of one of the cell lines, the
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other cell line with decreased viability showed dynamic and hostile
reaction of the cell vesiculation.
PW1.04
Inhibitors of microvesicle release with the potential to enhance
effectivity of cancer chemotherapy
Uchini Kosgodage1, Lange Sigrun2,3 and Jameel Inal1
1Cellular and Molecular Immunology Research Centre, School of Human
Sciences, London Metropolitan University, London, UK; 2University of
Westminster, UK; 3University College London School of Pharmacy, London, UK
Introduction: Microvesicle (MV) release from tumour cells plays an
important role in cancer drug resistance. It is essential that chemo-
therapeutic drugs are retained within target cells for increased
effectiveness in inducing apoptosis. Microvesiculation influences drug
retention so minimizing drug efflux is important. Based on MV
biogenesis pathways, a range of potential inhibitors were tested.
Methods: The NanoSight LM10 was used to analyse MV release from
PC3 human prostate cancer cells. Cells were maintained in serum-
free RPMI 1640. Washed cells were seeded in triplicate at 3.8105
cells/well initially treated with 300 mM BzATP for 1 h, and further 1 h
with relevant concentrations of MV-inhibitors. MV count, annexin V
staining and cell viability were assessed. Results: The numbers of
MVs released were compared to control (BzATP alone). Up to 60%
clear inhibition of MV release was shown with all reagents used.
The maximum MV inhibition was with 500 mM ethylene glycol
tetraacetic acid (EGTA) and 10 mM bisindolymaleimide I, resulting
in 48 and 34%, respectively. Cell viability was 80% in all cases
except for panthethine, which only resulted in 25%. Annexin V
staining confirmed the vesicles identified were indeed MVs. Summary/
conclusion: EGTA and bisindolymaleimide I are potent inhibitors of MV
release. Both novel and classic reagents described may be used
individually or in combination. This could be similar to calpeptin
and chloramidine, which enabled prostate cancer cells to sensitize to
docetaxel treatment previously. This study extends the range of
inhibitors that can be utilized to enhance novel combinatory
treatment options.
PW1.05
Extracellular vesicles derived from SW480 cancer colon
cells are internalized by human primary monocytes but not by
lymphocytes
Beate Vestad1,2, Lilly Alice Skaaraas1, Alicia Llorente3,
Kari Bente Foss Haug1,2 and Reidun Øvstebø1,2
1The Blood Cell Research Group, Department of Medical Biochemistry, Oslo
University Hospital, Ulleva˚l, Norway; 2Regional Research Network on
Extracellular Vesicles, South-Eastern Regional Health Authority; 3Department of
Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital,
The Norwegian Radium Hospital, Oslo, Norway
Introduction: Extracellular vesicles (EVs) carry a range of nucleic acids,
proteins and metabolites and play an important role in cell-to-cell
communication. Cells have been shown to internalize EVs by a
variety of endocytic pathways that may depend on specific proteins
found on the surface of both the vesicle and the target cell.
Importantly, EV uptake seems to influence the phenotypic status of
cells. Aim: To investigate the endocytic pathways of extracellular
vesicles in human primary monocytes and lymphocytes. Methods:
Elutriation-purified, cryopreserved human monocytes and lympho-
cytes were thawed and incubated (150,000 cells per well in 96-well
plates) with and without the actin polymerization inhibitor cytocha-
lasin D (110 mg/mL) or with the PI3K-inhibitors LY294002 (5500 mM)
or Wortmannin (1100 mM) for 30 min at 378C. Cells were further
incubated with approx. 1109 PKH67-labelled SW480 EVs per well
(based on particle concentrations obtained by a NanoSight NS500
instrument) for 4 h. Subsequently, the cells were trypsinized
(0.25% trypsin/ethylenediaminetetraacetic acid) for 5 min, washed
3 times with phosphate-buffered saline and further analysed by flow
cytometry (BD Accuri C6) to determine the degree of EV internaliza-
tion (reported as mean fluorescence intensity, MFI), as well as by
fluorescence microscopy (Nikon Eclipse Ti). Results: PKH67-labelled
SW480 EVs were internalized by human primary monocytes, but not
by lymphocytes, as observed by both flow cytometry and fluores-
cence microscopy. The internalization of EVs in monocytes was
inhibited to 1570% of control by the 3 compounds cytochalasin D,
LY294002 and Wortmannin, in a dose-dependent manner, as shown
by MFI measurements. Conclusions: Our findings show that SW480
EVs are internalized by human primary monocytes, but not by
lymphocytes, thus suggesting that cells have different requirements
for internalizing EVs. In addition, our results suggest that EVs are
internalized by an actin- and PI3K-dependent endocytic pathway in
primary monocytes.
PW1.06
Preferential uptake of circulating extracellular vesicles by
lung-marginated Ly6C-high monocytes during systemic
inflammation
Kieran O’Dea, Soni Sanooj, Sneh Shah, Kate Tatham and Masao Takata
Section of Anaesthetics, Pain Medicine and Intensive Care, Faculty of Medicine,
Imperial College London, Chelsea and Westminster Hospital, London, United
Kingdom
Introduction: Under normal conditions, circulating extracellular vesi-
cles (EVs) are taken up in the liver and to a lesser extent in the
lungs and spleen (1,2); however, the profile of EV clearance during
inflammatory conditions has not been described. During subclinical
endotoxaemia, lung uptake of circulating microbial particles is
increased due to enhanced ‘‘margination’’ of monocytes and
neutrophils within the pulmonary microcirculation (3). Here we
hypothesize that lung capture of EVs would increase during systemic
inflammation, with implications for their vascular activity and
function. Methods: EVs were prepared by ATP stimulation of
J774A.1 macrophages and differential centrifugation. EVs labelled
with the fluorescent membrane-intercalating dye, DiD, were injected
intravenously (i.v.) into untreated or low-dose lipopolysaccharide
(LPS) (20 ng, i.v. 2 h) pre-treated C57BL/6 mice. After 1 h, single-cell
suspensions were prepared from excised lungs, liver and spleen for
flow cytometric analysis of cell-associated DiD-fluorescence as a
measure of EV uptake. Results: In untreated mice, EV uptake was
primarily in the liver by Kupffer cells and endothelial cells, while EV
uptake in the lungs was low and mainly by monocytes. Systemic LPS
pre-treatment enhanced Ly6C-high monocyte subset margination to
the lungs and liver and resulted in substantial increases (3-fold) in
their EV uptake. EV uptake remained low in lung Ly6C-low mono-
cytes, neutrophils and endothelial cells, while uptake in the liver by
Kupffer and endothelial cells was substantially reduced. DiD-fluores-
cence in the spleen was negligible in both groups. In additional
experiments using ex vivo isolated buffer-perfused lungs from LPS-
treated mice, EV uptake was also limited to Ly6C-high monocytes.
Conclusion: These findings indicate that EV-cell interactions within
the vasculature are dynamic, with inflammation resulting in a sig-
nificant redistribution of uptake from the hepatic to the pulmonary
microcirculation.
PW1.07
Nogo/RTN4 as an extracellular vesicle-associated ligand
Mea Holm1, Danielle Van Rossum1, Oliver Weinmann1, Inge Hermann2
and Martin Schwab1
1ETH Zu¨rich and University of Zu¨rich, Switzerland; 2Empa Swiss Federal Federal
Institute for Materials Science and Technology, St. Gallen, Switzerland
Nogo-A (RTN4A) is a200 kDa member of the reticulon (RTN) protein
family identified in the late 1980s as a myelin-associated inhibitor
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of axonal regeneration after central nervous system (CNS) injury. It
consists of a C-terminal trans-membrane reticulon homology domain
(RHD) and an almost 1000 amino acid-long soluble N-terminus
unique to Nogo-A with the exception of the first 170 amino acids,
which are also present in a splice variant, Nogo-B. The current view of
Nogo signalling is that plasma membrane-bound full-length Nogo
initiates signalling cascades through binding to receptors on cells in
direct contact with the Nogo expressing cell. However, the presence
of Nogo sequences in body fluids such as the cerebrospinal fluid (CSF)
has been anecdotally reported and recently found in a proteomic study
(Chiasserini et al., 2014). As the presence of functionally active Nogo in
the CSF and other body fluids would have major implications, for
example, for the administration of anti-Nogo-A antibodies as the-
rapies, we sought to investigate whether either full-length or cleaved
fragments of Nogo are released into the supernatant of cultured neuron-
like cells. We found that full-length Nogo-A, full-length Nogo-B, as well as
cleaved fragments, which include the shared N-terminus of Nogo-A/-B,
are found in the culture supernatant of N2a neuroblastoma cells.
Both the full-length proteins and the cleaved fragments were associated
with extracellular vesicles rather than free in solution. Broad spectrum
inhibition of metalloproteases with the compound GM6001 almost
completely eliminated the N-terminal fragments, indicating that Nogo-A/
B is cleaved by metalloproteases. Furthermore, preliminary data
indicate that full-length Nogo-A is also found in extracellular vesicles
from the CSF of adult rats. Further studies will assess the functional
relevance of vesicle-bound Nogo-A and evaluate the significance
of the proteolytic processing of Nogo-A/B in the context of Nogo
signalling.
PW1.08
Thiol-based labelling of prostate-derived exosomes for analysis of
cellular uptake and intracellular traffic
Hope Roberts-Dalton1, Aled Clayton2, Jason Webber2, Arwyn Jones1,
Peter Watson3, Edel Brown1 and James Van Gemeren1,2
1School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff,
Wales, UK; 2Division of Cancer and Genetics, School of Medicine, Cardiff
University, Cardiff, Wales, UK; 3School of Biosciences, Cardiff University, Cardiff,
Wales, UK
Introduction: A major goal in drug delivery is transportation of
macromolecular therapeutics to the insides of cells. These include
nucleotides, proteins and peptides, which are normally cell imperme-
able requiring vectors for intracellular delivery. More effective delivery
vectors than those currently available are needed to meet the
challenge of overcoming diseases such as cancer. Exosomes could
be viewed as natural vectors capable of delivering signal mediators
and macromolecular cargo and could be manipulated as vectors
for therapeutic applications. How exosomes deliver cargo, however, is
not fully understood. Exosome cell uptake is typically studied
following labelling with fluorescent lipids such as Paul Karl Horan
(PKH) dyes that could modify their structure and function. Our aims
were to develop new exosome labelling methods and high-content
endocytosis assays to assess their internalization and intracellular
traffic. Methods: Here we describe a novel thiol-based conjugation
method for the attachment of Alexa-488 to well characterized
prostate cancer (Du145) exosomes. The involvement of different
endocytic pathways in cell uptake was investigated using siRNA
targeting specific endocytic proteins and pharmacological inhibitors
of endocytosis, together with live cell confocal microscopy. Uptake
was analysed in fibroblasts and HeLa cells. Results: Alexa488-exo-
somes retained their function (to differentiate fibroblasts to myofi-
broblasts) and were effectively internalized into fibroblasts and HeLa
cells as motile punctate cytoplasmic structures. siRNA and inhibitor
studies in HeLa cells highlighted actin-dependent macropinocytosis
as a major pathway mediating cell uptake suggesting that exosomes
may be activating their own internalization. Conclusions: The use of
this novel labelling technique and endocytosis assays will help
characterize how exosomes gain intracellular access to mediate their
effects and allow for further assessment of their potential as drug
delivery vectors.
PW1.09
New molecular approaches to quantitatively assess exosome uptake
by specific target cells
Alessandra Ciullo1, Elisabetta Cervio1, Chiara Foglieni2, Paolo Paganetti2,
Giovanni Camici3, Tiziano Moccetti1, Giuseppe Vassalli1 and Lucio Barile1
1Cellular and Molecular Cardiology Laboratory, Cardiocentro Ticino Foundation
at Swiss Institute for Regenerative Medicine, Taverne-Torricella, Switzerland;
2Laboratory of Biomedical Neuroscience, Swiss Institute for Regenerative
Medicine, Taverne-Torricella, Switzerland; 3Clinic for Cardiology, University
of Zurich, Schlieren, Switzerland
Introduction: Exosomes (Exo) deliver specifically their cargo from the
donor to recipient cells. Thus, approaches for the application of Exo as
tool for a cell-specific delivery of signalling molecules need to be
tested in in vitro and in vivo models. Here we describe experimental
design for the assessment and the quantification of Exo uptake
by target cells. Methods: C. elegans species specific Cel-miR-39 was
overexpressed in human cardiac progenitor cells (CPC) or human
dermal fibroblasts (DF) as control. Exo containing Cel-miR-39 (Exo-
Cel39) were isolated, and the amount of the miRNAs has been
quantified by real-time polymerase chain reaction (RT-PCR). Cardio-
myocytes (CM) were incubated with Exo-Cel39 for 5 h. After
incubation, total CM RNA was isolated and Cel-miR-39 quantified.
As second approach, we used the ‘‘fluorescent complementation
technology.’’ With this technique, CPC-producing Exo were trans-
fected with a small green fluorescent protein (GFP) fragment fused
with Exo-specific marker (Exo-smGFP). The large GFP fragment is
expressed by CM as target cells. Following the uptake of Exo by CM,
the small and large GFP fragments spontaneously associate, resulting
in GFP folding and formation of the fluorophore. Results: we found
that CPC and DF similarly sort Cel-miR-39 into Exo even if
cell transfection efficiency was different. Five hours after incubation,
Cel-miR-39 expression levels were significantly higher in CM incu-
bated with Exo-Cel39 from CPC then DF (3.810594.3103 vs.
4.110391.9103 folds increase, pB0.05, in CPC vs. DF). Constructs
carrying the GFP fragment fused with Exo-specific marker have been
obtained and they are currently undergoing validation in vitro in rat
CM. Conclusions: Using a specific and quantitative method, we were able
to demonstrate that Exo have specific uptake by target cells. Particularly
Exo derived from CPC have higher tropism to CM when compared to
DF-derived Exo. Thus, CPC-derived Exo can be thought as a potential
tool for a specific delivery of functional molecules in the heart.
PW1.10
Cell-non-autonomous neurogenesis by convective exosomal transport
of microRNA
Dong Soo Lee1, Do Won Hwang1, Hyun Jeong Oh1, Seok Chung2 and
Yoojin Shin Shin3
1Department of Molecular Medicine and Biopharmaceutical Sciences,
Seoul National University, Seoul, South Korea; 2Department of Mechanical
Engineering, Korea University, Seoul, South Korea; 3Department of Mechanical
Engineering, MIT, Boston, USA
Various biological processes are regulated by cell-non-autonomous
function, which is crucial for the change of physiological cellular
behaviour. However, it is unclear whether exosome-mediated cell-
non-autonomous fashion contributes to regulation of neurogenesis.
Here, we found a new mode of cell-non-autonomous miRNA/
exosome-mediated differentiation of neural progenitor cells and
visualized exosomes carrying the neurogenic miRNA from leading
to neighbouring cells. MiR-193a facilitated neuronal differentiation in
Ngn1-induced F11 cells. In addition to 2D co-culture and transwell
culture setting, time-lapse live-cell confocal imaging using micro-
fluidic assay visualized the convective transport of exosomes from
differentiated to undifferentiated F11 cells. Individual exosomes
containing miR-193a from differentiated donor F11 cells reached
the recipient cells and were taken up by undifferentiated F11 cells to
lead them to neuronal differentiation. These findings indicate that
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exosomes of neural progenitors and neurogenic miRNA within these
exosomes propagate cell-non-autonomous differentiation to neigh-
bouring progenitors, to delineate the roles of extracellular vesicles
mediating neurogenesis of population of homologous progenitor
cells.
PW1.11
The involvement of microvesicle miRNA in gestational vascular
complications
Annie Rebibo-Sabbah1, Ido Solt2, Adi Halberthal-Cohen2,
Benjamin Brenner1,3 and Anat Aharon1,3
1 Department of Hematology and Bone Marrow Transplantation, Rambam
Health Care Campus, Haifa, Israel; 2Department of Obstetrics and gynecology,
Rambam Health Care Campus, Haifa, Israel; 3Bruce Rappaport Faculty of
Medicine, Technion- Israel Institute of Technology, Haifa, Israel
Please see OPW3.7
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Endometrial extracellular vesicles are important for maternal-embryo
communications
Hong Nguyen1, Kirstin Elgass2, Richard Simpson3, Lois Salamonsen1 and
David Greening3
1Centre for Reproductive Health, Hudson Institute of Medical Research,
Clayton, Australia; 2Monash Micro Imaging, Monash University, Hudson
Institute of Medical Research, Clayton, Australia; 3Department of Biochemistry
and Genetics, La Trobe Institute for Molecular Science, La Trobe University,
Melbourne, Australia
Successful pregnancy can only be achieved when communications
between the endometrium and the embryo occur synergistically
during the receptive phase of the menstrual cycle. Endometrial
extracellular vesicles (eEVs) released into the uterine microenviron-
ment are proposed to play an essential role in this process. In this
study, we investigated eEVs molecular content cargo and examined
their functions. eEVs were isolated, purified and characterized from
ECC1-derived serum-free conditioned media using differential ultra-
centrifugations, cryo-electron microscopy and western blot analyses
and subjected to molecular profiling. We have shown that eEVs
contained distinct subset of miRNAs compared to their parental cells
and their protein cargo profiles are hormonally regulated. Mass
spectrometry of highly purified eEVs found 258 and 131 proteins
responsive to oestrogen and progesterone, respectively. Live cell
imaging showed an accumulation of fluorescently labelled eEVs in
HTR8 trophoblast cells and enhanced their adhesive response (24%,
pB0.001) by 1.5 h and maintained throughout the 4 h of real-time
cell analysis recording using XCELLigence. SytoRNA-Green was used
to selectively label the RNA content of eEVs and were localized to the
mitochondria compartment of trophoblast cells, suggesting their
role in energy production during implantation. This study demon-
strated that molecular content cargo packaged within endometrial
EVs are selective and are important modulator of maternal-embryo
communications. This data set provides new evidence that eEVs
could be used as biomarker of endometrial receptivity and improve
pregnancy outcomes.
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Identifying RNA and protein cargo that is responsible for EV-mediated
transfer of malignant properties in vivo
Sander Steenbeek, Anoek Zomera and Jacco Van Rheenen
Hubrecht Institute, Utrecht, The Netherlands
Introduction: Tumour cells release a wide variety of extracellular
vesicles (EVs), including multivesicular body (MVB)-derived exo-
somes, limiting plasma membrane-derived microvesicles, and apop-
totic bodies. EVs contain proteins, lipids and diverse RNA species that
reflect the cell of origin and which can be functionally transferred to
recipient cells. A growing number of studies show that uptake of EVs
can change the gene expression and behaviour of recipient cells,
thereby influencing tumour progression and metastasis. Methods:
Here, to study functional EV exchange between less malignant and
more malignant mouse melanoma cells in vivo, we use the Cre-LoxP
reporter method (1, 2) to differentiate between cells that have and
have not taken up EVs from a predefined cell population. Results and
conclusion: Using intravital imaging, we show that less malignant
tumour cells that have taken up EVs from more malignant tumour
cells have a higher migration speed compared to less malignant
tumour cells that have not taken up these malignant EVs. This shows
that EVs can phenocopy maligant behaviour from more malignant to
less malignant tumour cells. Current experiments focus on identify-
ing the vesicular RNAs and proteins that are responsible for the
transfer of this malignant phenotype.
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PW2.02
Developing high-throughput tools to evaluate exosome-induced
motility in breast cancer cells
Ainsley Underhill, Mikhael Bashkurov, Liang Zhang, Jacob Belman and
Jeffrey Wrana
Lunenfeld-Tanenbaum Research Institute, Toronto, Canada
Stimulating cellular motility is a key step in promoting metastasis,
which causes cancer cells to migrate from the initial tumour to a
distal site. One method of triggering cellular motility is through
interactions with exosomes released from cancer-associated fibro-
blasts (CAFs) found in the tumour microenvironment. These exo-
somes interact with breast cancer cells, modifying the CAF-exosomes
through the addition of Wnt11. This allows the CAF-exosomes to
activate non-canonical Wnt signalling within the cancer cells, leading
to increased cellular motility and metastasis in vivo. Further research
has determined that the motility is achieved through planar cell
polarity pathways. Although the phenotype is extensively character-
ized, the exact mechanisms involved are unknown. I am developing
a high-throughput methodology, which will allow me to screen for
essential proteomic components of this exosome-induced motility in
the cancer cells. Utilizing MATLAB, I have developed a script that can
track cells over an imaging series and determine their individual
velocity. Expressing H2B-Clover in the cancer cell line, MDA-MB-231,
the programme can detect individual nuclei and produce continuous
tracks between each captured image of nuclei. Optimization of
the plating and imaging conditions produced a 2-fold dynamic
range. Analysis shows the programme can successfully differentiate
between conditions containing CAF-exosomes and controls when
compared to manual tracking. Additionally, the script could detect
differences in cellular motility when the MDA-MB-231 cells were
treated with siRNA against key motility proteins, SMURF2, WNT11
and PK1, when compared to the knockdown of GAPDH. Currently,
I am treating the motility-stimulated MDA-MB-231 cells against a
kinase inhibitor library to further evaluate the script as well as
develop my final screening methodology.
PW2.03
Autologous tumour-derived extracellular vesicles affect
tumour cells
Rafal Szatanek, Monika Baj-Krzyworzeka, Kazimierz Weglarczyk,
Bozenna Mytar, Jarek Baran and Maciej Siedlar
Department of Clinical Immunology and Transplantology, Jagiellonian
University Medical College, Krakow, Poland
Background: Tumour cells release extracellular vesicles (tumour-
derived microvesicles or TMV) and this ability was shown to protect
them from immunological surveillance; however, no reports are
available on the effects that TMV may exert on the tumour cells
themselves. Methods: TMV from the supernatants of three gastric
cancer cell lines (GC1401, 1415 and 1436) were isolated by differential
centrifugation. For size analyses, nanoparticle tracking analysis (NTA)
was used. Impact of autologous TMV on tumour cells was assessed by
PCR arrays and western blotting. Results: The mean size of GC1401,
GC1415 and GC1436 TMV were 120.2, 186.3 and 101.4 nm, respec-
tively. The mode size for the GC cell lines were as follows: 19.6, 40.2
and 15.2 nm. The size distribution range for GC1401 TMV was
13237.2 nm, GC1415 TMV: 40364.6 nm and GC1436 TMV:
10.2169.2 nm. The following genes were overexpressed in the
respective GC tumour cells after stimulation with autologous TMV:
GC1401  IL-18, SRC, HRAS, BRMSI, RORB and MMP13; GC1415 
TCF20, TIMP3, METAP2, MDM2 and TSHR; GC1436  TIMP2, MET,
CXCR2, CXCR4 and TGFB1. The following genes were underex-
pressed in the respective GC tumour cells after stimulation with
autologous TMV: GC1401 MET; GC1415 - VEGFA, TP53, CHD4, MMP2,
CCL7 and TRAIL; GC1436 - NME1, CD44, PNN and NME4. Conclusion:
The NTA analyses revealed that mean and the modal size values
of TMV from all of the three GC cell lines were similar. The modal
value, however, suggests that the predominant TMV population is
composed of exosomes (as defined by size criterion). The PCR
array analyses showed that autologous TMV stimulate tumour
cells to produce mRNA transcirpts of genes whose protein products
may aid further tumour growth, angiogenesis and metastasis.
These results suggest that besides the impact that the released
TMV exert on the tumour microenvironment (i.e. extracellular
matrix and infiltrating leukocytes), they also affect the tumour cells
themselves in a manner that promotes a more aggressive tumour
progression.
PW2.04
Selective packaging of certain microRNAs into tumour microvesicles
impacts tumour cell as well as adjacent stroma via TGFBR1
Chris Dickman, Kevin Bennewith and Cathie Garnis
University of British Columbia, Vancouver, Canada
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Microvesicles are small, secreted vesicles that have previously been
reported to play a role in specific extracellular exclusion of several
molecular factors, including microRNAs (miRNAs). Emerging data
suggest that packaging of miRNAs into microvesicles is a selective
process targeting specific miRNAs, rather than an indiscriminant
process. It follows then that miRNAs selectively excluded or retained
by cancer cells may play key roles in malignant processes. We have
identified selective exosomal packaging of multiple miRNAs in a
panel of oral dysplasia and oral squamous cell carcinoma cell lines.
Inhibition of exosome export protein Rab27A increased intracellular
expression of these miRNA candidates and prevented their packa-
ging into microvesicles. Increased intracellular expression of miR-
142-3p specifically was found to target TGFBR1, causing a decrease
in its expression and a reduction of malignant features. Conversely,
increased exosomal release of miR-142-3p from cancer cells was
found to activate TGFBR1 and promote growth in endothelial cells,
supporting a possible cell signalling role for this miRNA in promoting
malignancy. In vivo analysis demonstrated that tumours overexpres-
sing miR-142-3p  and subsequently releasing more miR-142-3p
via microvesicles  exhibited decreased tumour growth. However,
increases in angiogenesis caused tumours to be more vascular as
well as less hypoxic and necrotic. Untangling the complex role of
selective exome-mediated miRNA release in these model systems
will enhance our understanding of oral cancer biology, potentially
leading to identification of new druggable cell processes.
PW2.05
A model to study the role of extracellular vesicles in the interaction
between ovarian tumour cells and the peritoneum
Linda Rikkert1, Anita Bo¨ing1, Frank Coumans1, Koen Van De Vijver2,
Jan Stap1, Gemma Kenter2, Rienk Nieuwland1 and Christianne Lok2
1Academic Medical Center, Amsterdam, The Netherlands; 2Netherlands Cancer
Institute, Amsterdam, The Netherlands
Introduction: In advanced stages of epithelial ovarian cancer, small
clusters of tumour cells spread through the abdominal cavity and
adhere to the peritoneal surface. The underlying molecular mechan-
isms of this interaction are poorly understood. Since tumour-derived
vesicles are abundantly present in the ascites, these vesicles may play a
role in the adhesion of tumour cells to the peritoneum. A model
to study the role of extracellular vesicles (EVs) in this interaction,
however, does not exist. Therefore, we developed an in vitro model to
image EVs and study their role in tumour cell interaction with the
peritoneum. Methods: In the developed model, two fluid-containing
compartments are separated by a specimen of abdominal peritoneum
of ovarian cancer patients. The interaction between tumour cells and
the peritoneum was studied using human ovarian cancer cells (SKOV-
3). Cells were labelled with a fluorescent dye (PKH67) and added to the
model. Adhesion of tumour cells was imaged by fluorescence
microscopy, and trans-peritoneal passage of tumour cells was
monitored by flow cytometry. Results: In our model, we were able to
mount the peritoneum specimen onto gauze. Morphology and
immunohistochemistry confirmed that the peritoneum specimen
was still vital after 5 days. With fluorescent microscopy, tumour cell
adhesion to the peritoneum tissue was shown. Trans-peritoneal
passage of tumour cells could not be detected by flow cytometry.
Conclusions: The developed system enables studies on the interaction
between ovarian tumour cells and peritoneum. The next step will
be high resolution microscopy of the interaction between tumour
cells, EVs and the peritoneum. Additionally, concentration measure-
ments of EVs in supernatant may confirm involvement of EVs in this
interaction. In the future, this model can also be applied to other studies.
PW2.06
Exosomes enriched in stemness/metastatic-related mRNAs promote
oncogenic potential in breast cancer: specific prognostic exosome
signature
Marta Rodrı´guez1, Alberto Herrera1, Mercedes Herrera1, Cristina Pen˜a1,
Beatriz Gil-Caldero´n1, Fe´lix Bonilla2 and Vanesa Garcı´a3
1Instituto de Investigacio´n Sanitaria Puerta de Hierro-Majadahonda,
Madrid, Spain; 2Centro de Estudios Biosanitarios, Madrid, Spain;
3Molecular Oncology, Instituto de Investigacio´n Sanitaria San Carlos,
Madrid, Spain
Introduction: Tumour-derived exosomes are a significant mechanism
of intercellular communication, affecting tumour-related pathways,
such as angiogenesis, drug resistance and immune response. This
study analysed the release of exosomes from breast tumour cells with
different capacities of stemness/metastasis based on CXCR4 expres-
sion and evaluated their involvement in the capacity to generate
oncogenic features in recipient cells. Methods: Oncogenic effects
of breast cancer cells-derived exosomes were evaluated in in vitro
and in vivo models. Exosome cargo in mRNAs involved in stem cell
differentiation and metastasis were analysed by specific quantitative
PCR arrays. Finally, stemness- and metastatic-related mRNA most
differentially detected in exosomes were analysed in plasma of breast
cancer patients assessing its capacity as a prognosis marker. Results:
In vitro, exosomes released from CXCR4-tumour cells modify stem-
ness markers and proliferation, migration and invasion capacities of
neighbouring cells. Accordingly, inoculation of CXCR4-cells-derived
exosomes in immunocompromised mice mediated primary tumour
growth and metastatic potential. Exosomes isolated from CXCR4
cells and stem-like cells were highly enriched in stemness- and
metastatic-related mRNAs and showed high homology between
them. Furthermore, comparative analysis of mRNAs contained in
exosomes isolated from patients revealed a gene signature of mRNAs
highly enriched in exosomes of patients with worse prognosis.
Summary/conclusion: Our data support the view that exosomes
released by CXCR4-cancer cells that exhibit stem-like properties are
capable of transferring these oncogenic features to recipient cells. In
addition, our results show the involvement of ‘‘stemness and
metastatic signature’’ mRNA in exosomes from plasma in breast
cancer patient survival.
PW2.07
Malignant extracellular vesicles derived from ovarian cancer
cells promote peritoneal metastasis by the breakdown of
peritoneum
Akira Yokoi1, Yusuke Yamamoto1, Tomoyasu Kato2, Fumitaka Kikkawa3,
Hiroaki Kajiyama3, Yusuke Yoshioka1 and Takahiro Ochiya1
1Division of Molecular and Cellular Medicine, National Cancer Center Research
Institute, Tokyo, Japan; 2Department of Gynecology, National Cancer Center
Hospital, Tokyo, Japan; 2Department of Obstetrics and Gynecology, Nagoya
University Graduate School of Medicine, Nagoya
Introduction: Ovarian cancer is the most lethal gynecological malig-
nancy, and the lethality is mainly attributable to the frequency of
peritoneal metastasis. However, the molecular mechanisms of dis-
semination and implantation in the peritoneal cavity remain unclear.
Methods: The mice model of peritoneal metastasis was orthotopically
established by injecting the A2780 ovarian cancer cell line. To assess
the metastatic effect of extracellular vesicles (EVs) derived from
ES2 high-metastatic ovarian cancer cell line, the EVs was injected
intraperitoneally. To investigate the effect of EVs from cancer cells to
mesothelial cells, which are main components of peritoneal mem-
brane, 2 types of mesothelial cells (Met5A cells and HMPC cells) were
used. Results: It was clearly demonstrated that EVs derived from ES2
cells promote peritoneal metastasis in vivo. On the other hand, there
was no significant change in primary tumours. Next, it was found that
the mesothelial cells, which were treated with the EVs from ES2 cells,
were broken in vitro and in vivo because the EVs induced apoptosis.
From microarray gene expression analysis in mesothelial cells, which
were treated with various types EVs, a lot of genes significantly
changed. The gene, which is known as the metastasis-associated
gene, was validated by RT-qPCR at high reproducibility. Interestingly,
the gene mRNA also packaged in the EVs from ES2 cells. The gene is
confirmed as a prognostic factor for ovarian cancer patients by
referring to open access database. In addition, the EVs that contain
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the gene mRNA also exist in the EVs derived from ovarian
cancer patients’ ascites, and furthermore, the EVs also induced
apoptosis in vitro. Summary/conclusion: These results indicated the
existence of the malignant EVs, which promote peritoneal metastasis
by the breakdown of peritoneum and which contain the specific gene
mRNA. Furthermore, this fact will lead to elucidation for novel
mechanisms of peritoneal metastasis involved in EVs from cancer
cells.
PW2.08
Live imaging of exosomal chemokine receptor release
Maarten Bebelman1, Martine Smit1 and Michiel Pegtel2
1Vrije Universiteit Amsterdam, The Netherlands; 2Vrije Universiteit Medical
Center Amsterdam, The Netherlands
Introduction: Chemokine receptors play a key role in the trafficking of
immune cells, but are also involved in the progression of a large number
of human cancers. By activating oncogenic signalling pathways, these
receptors can contribute to tumour growth, angiogenesis and metas-
tasis. Recently, we observed the presence of chemokine receptors on
membrane vesicles of chemokine receptor-expressing cells. However,
the nature of these vesicles was not clear. Methods: We developed pH-
sensitive fluorescent chemokine receptor mutants that enable live-cell
imaging of the fusion of receptor-containing endosomes with the
plasma membrane. Moreover, we used stimulated emission depletion
(STED) super resolution microscopy to visualize the membrane vesicles
containing the chemokine receptor. Results: In this study, we showed
the colocalization of intracellular chemokine receptors with the late
endosomal/multivesicular body marker CD63. Furthermore, we ob-
served the fusion of acidic endosomal compartments containing pH-
sensitive receptor mutants with the plasma membrane. Moreover,
super resolution microscopy revealed that the receptor mutants were
released on membrane vesicles with a size corresponding to what has
previously been reported for exosomes. Summary/conclusion: In this
study, we provide evidence that chemokine receptors are released via
exosomes that are generated in acidic endosomal compartments,
presumably multivesicular bodies. The pH-sensitive fluorescent recep-
tor mutants can be used in future studies to elucidate the mechanism
behind the exosomal release of chemokine receptors.
PW2.09
Towards exosome-based cancer therapy: rejuvenation of exosomes
derived from normal bone marrow stromal cells
Tomohiro Umezu1, Satoshi Imanishi2, Kenko Azuma2, Chiaki Kobayashi1,
Kazuma Ohyashiki1 and Junko Ohyashiki2
1Department of Hematology, Tokyo Medical University, Tokyo, Japan; 2Institute
of Molecular Science, Tokyo Medical University, Tokyo, Japan
Introduction: Multiple myeloma (MM) is a refractory hematologic
malignancy. Because MM is a disease of the elderly, stem cell trans-
plantation is rarely used to treat it. Novel therapies for MM need to be
developed. The bone marrow stromal cell (BMSC) is one of the most
promising sources of cell therapy. However, the biological properties of
BMSCs, such as ageing, are largely unknown. Recently, exosomes
derived from normal BMSCs have been found to be efficacious for
treatment of graft versus host disease. Therefore, we investigated the
biological properties of BMSC-derived exosomes to establish exosome-
based therapy by engineering the incorporation of therapeutic miRNA.
Methods: Human BMSCs obtained from bone marrow of young healthy
donors (yBMSCs; age of donors: 1921 years) and elderly healthy donors
(eBMSCs; age of donors: 6872 years) were purchased from Lonza. The
exosomes were isolated from conditioned medium of BMSCs using
Exoquick-TC (SBI). Exosomal miRNA profiling was performed using a
TaqMan miRNA array (ABI). The candidate miRNA mimics were directly
introduced into exosomes by Exo-fect (SBI). Nude mice were subcuta-
neously injected with 400 mL Matrigel containing a hypoxia-resistant
myeloma cell line (HR-MM cells) established in our laboratory with BMSC-
derived exosomes. Results: Nanoparticle-tracking assays revealed that
there were no significant differences in the size and amount of exosomes
among yBMSCs and eBMSCs. The yBMSC exosomes significantly
reduced the endothelial cells in Matrigel. We compared exosomal
miRNA profiles of yBMSCs and eBMSCs. Four miRNAs were obtained as
specific miRNAs of yBMSC exosomes. The engineered exosomes
transfected with two miRNA mimics significantly inhibited HR-MM-
induced angiogenesis in Matrigel plug. Conclusion: Our results sug-
gest that BMSC exosomes are able to transfer miRNAs, which have
the ability to inhibit angiogenesis and progression of MM. The present
study explores the therapeutic potential of exosome-derived BMSCs
in MM.
PW2.10
MicroRNA-containing exosomes derived from human gallbladder
cancer cell inhibit HUVEC tube formation
Yohei Yamamoto, Aki Nishijima and Yasufumi Omori
Akita University Graduate School of Medicine, Akita, Japan
Introduction: Exosomes are small vesicles (40100 nm in diameter)
secreted by most of cells. They contain a variety of molecules including
microRNAs (miRNAs) and are suggested to participate in intercellular
communication. Recently, tumour-derived exosomal miRNAs were
shown to be involved in tumour microenvironment, tumour angiogen-
esis, metastasis and tumour immunity. We isolated human gallbladder
cancer cell-derived exosomes and characterized their function. Methods:
Exosomes are isolated from culture media of human gallbladder cancer
cell lines NOZ and G-415 by means of ultracentrifugation. Extracted
RNAs from the exosome fraction were applied to miRNA array analysis.
We further examined whether the tumour-derived exosomes contain-
ing miRNAs affect angiogenesis by employing human umbilical vein
endothelial cell (HUVEC) culture systems. Results and summary: miRNA
array analysis revealed enrichment of miR125b, miR-320, miR-494 and
miR-638 in exosomes. These miRNAs are reported as an inhibitor of
angiogenesis. Supplemented the tumour-derived exosomes into the
medium, HUVEC declined its tube formation on Matrigel, but did not
change its proliferation. The results suggest that gallbladder cancer cell-
derived exosomes may inhibit tumour angiogenesis, through transmis-
sion of these miRNAs into endothelia.
PW2.11
Jagged1 extracellular vesicles influence endothelial cell behaviour
by downregulating VEGFR2
Evan Tan1, Harry Asada2 and Ruowen Ge1
1National University of Singapore, Department of Biological Sciences,
Singapore; 2Massachusetts Institute of Technology, Department of Mechanical
Engineering, Cambridge, Massachusetts, USA
Notch signalling is an evolutionary conserved pathway that is
essential in development. Jagged1(Jag1), a Notch ligand, is over-
expressed in several cancers. It promotes tumour cell survival,
proliferation and metastasis. It also influences angiogenesis by
controlling endothelial cell differentiation. Dll4, another Notch ligand,
was previously shown to be packaged into extracellular vesicles,
bypassing its canonical contact-dependent signalling, to influence
Notch signalling. Together, these observations suggest the possibility
that tumour-derived Jag1 could be packaged into extracellular
vesicles, whereby it could influence cells in the tumour microenviron-
ment. Here, we aim to study the effect of Jag1 extracellular vesicles on
angiogenesis. In order to study the effect of Jag1 extracellular vesicles
(Jag1-EVs) on endothelial cells, we purified Jag1-EVs from Jag1-
overexpressing HEK293T cells. We found that Jag1-EVs are inter-
nalized by endothelial cells. Jag1-EVs induce a downregulation of
VEGFR2 in endothelial cells, thereby inhibiting endothelial cell
proliferation, migration and sprouting. Although these phenotypes
are consistent with Notch activation, Jag1-EVs did not stimulate Notch
signalling directly. This suggests that Jag1 might function differently
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when packaged into EVs. Our findings show a novel paracrine
function of Jag1-EVs on angiogenesis and prompts further studies
into extracellular vesicle-mediated signalling.
PW2.12
Role of osteosarcoma-derived exosomes in tumour angiogenesis
in vitro
Francesca Perut1, Laura Roncuzzi1, Elena Torreggiani1, Nicoletta Zini2 and
Nicola Baldini3
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Introduction: Osteosarcoma (OS) is the most common primary
malignant bone tumour in childhood and adolescence and is
characterized by a high metastatic potential. Angiogenesis is a
pivotal process during OS development, as it is involved in cancer
cells growth, invasion and metastasis (1). Angiogenesis involves a
number of different players among which exosomes have been
recently proposed as efficient cargoes of pro-angiogenic mediators
(2,3). In cancer other than sarcoma, acidity of tumour microenviron-
ment, developed by the peculiar metabolism of tumour cells, has
been associated with an increased exosome release and uptake (4).
In this study, we investigated the role of OS-derived exosomes on
tumour angiogenesis in vitro and the influence of cancer-induced
extracellular acidic pH in this process. Methods: Exosomes were
isolated by differential centrifugation of culture media from 143B OS
cells grown at different pH (6.5 or 7.4). Successful isolation was
confirmed by transmission electron microscopy. To test the effect of
exosomes on angiogenesis, human umbilical vein endothelial cells
(HUVEC) were stimulated with exosomes, and cell proliferation,
migration and tubule-like structure formation were analysed. Results:
Exosomes isolated by OS cells displayed the expected size range
(30100 nm). The release of exosomes by OS cells was significantly
increased at acidic compared to neutral pH (p0.009). HUVEC
proliferation and migration was not significantly affected by the
treatment with OS-derived exosomes. Exosomes derived from OS
cells at pH 6.5 induced a higher tubulogenesis when compared to
OS-derived exosomes at pH 7.4. Conclusions: Our findings suggest
that OS-derived exosomes may be involved in tumour angiogenesis
and that acidic tumour microenvironment may increase this process.
Acknowledgement: AIRC IG 15608.
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Induction of tolerogenic dendritic cells by nasopharyngeal carcinoma-
derived exosomes
Sarah Renaud
Centre national de la recherche scientifique, Lille, France
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Breast cancer cell migration is induced by exosomes via surface
interaction and through the activation of FAK signalling
Anastasia Malek, Roman Samsonov and Irina Kovalenko
N.N.Petrov Institute of Oncology, Saint-Petersburg, Russia
Introduction: Tumour metastasis accounts for the vast majority of
cancer-related deaths. Metastatic dissemination of cancer is
mediated by concordant activation of matrix degradation and cell
movement. There are a number of different mechanisms by which
exosomes have been shown to modulate pericellular proteolysis
(Sevenich L. et al., 2014). Exosome-induced pathways regulating
cancer cell movement are less studied. Internalization of exosomes
was shown to be associated with cancer cell spreading (Koumangoye R
et al., 2011). However surface interaction of exosomes and target
cells may play an important role as well and may produce a rapid
effect. We observed fast activation of breast cancer cell movement
by exosomes and hypothesized that this effect is mediated by
surface interaction. The study was aimed to evaluate molecular
mechanism of this phenomenon. Methods: We used MDA-MB-231
breast cancer cell line. Exosomes were concentrated by ultracen-
trifugation and analysed by western blotting, NTA and RAMAN
spectroscopy and treated with trypsin to alter a molecular composi-
tion of their surface. Results: Incubation of cells with concentrated
exosomes induced their random movement (2D) and FBS-directed
migration (3D) in vitro. Breast cancer cells with over-expressed focal
adhesion kinase (FAK) were more sensitive to stimulation by
exosomes, whereas cells with FAK stably knocked down were almost
resistant to stimulatory effect. Treatment of exosomes with trypsin
resulted in considerable decrease of their motility induction activity.
Incubation of ‘‘nude’’ exosomes with fibronectin restored their
activity. Further analysis revealed difference of hydrodynamic radius,
surface composition and fibronectin content between the native and
trypsin-treated (‘‘nude’’) exosomes. Summary: Surface interaction of
exosomes and target cells is enough to stimulate cell movement.
Fibronectin attached on exosome surface may induce migration of
cancer cell via activation of FAK pathway.
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Clinical and functional aspects of HLA-G-positive extracellular vesicles
in breast cancer
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The non-classical human leukocyte antigen G (HLA-G) molecule and
its soluble forms exert multiple immune suppressive functions in
malignancy and in stem cells contributing to immune escape
mechanisms. Soluble HLA-G (sHLA-G) can be released as free sHLA-
G molecules or via extracellular vesicles (EVs). Extracellular vesicles
are secreted vesicles representing important elements for intercel-
lular signal transduction often being operative in tumour immune
evasion. Our study on EVs harbouring sHLA-G (sHLA-G EVs) derived
from blood plasma of locally advanced, neoadjuvant chemotherapy-
treated breast cancer (BC) patients (N190) revealed (i) elevated
sHLAG EV levels in BC patients compared to healthy controls, (ii) an
association between high sHLA-G EV levels and disease progression
and (iii) the occurrence of stem cell-like circulating tumour cells. For
this reason, we investigated the uptake of sHLA-G pos EVs by
peripheral blood cells (PBLs), with respect to HLA-G-specific recep-
tors ILT2 and ILT4 expression. HLA-G pos EVs were isolated from
gynaecological, malignant ascites fluids by non-blocking HLA-G
antibody after differential ultracentrifugation and PKH67 staining.
The uptake was visualized using AMNIS Image Stream technology.
HLA-G-bearing EVs were taken up by ILT2 and/or ILT4pos monocytes
and B-cells in an accumulating fashion, whereas some ILT2pos and
ILT2neg T cells seized HLA-G pos EVs up in a punctual manner.
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Cytokine array analysis showed that HLA-G pos EVs contained
a higher proportion of VEGF, uPAR, TRAIL receptors and others,
which are mostly involved in tumour proliferation, metastases and
angiogenesis than in contrast HLA-G neg EV, which displayed
elevated levels of pro-inflammatory, chemotactically and cell adhe-
sion factors, such as Fas ligand, E-selectin, PECAM and various
chemokines. In conclusion, sHLA-G EV are of prognostic relevance
in BC, are taken up by ILT2pos and some ILT2neg PBLs and contain
mediators known to promote tumour spread in gynaecological
tumour entities.
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An improved method to isolate milk-derived extracellular vesicles to
study the impact of a null allele at the CSN1S1 locus on their secretion,
size distribution and molecular content
Zuzana Krupova1,2, Christine Pe´choux3, Ce´line Henry4, Pierre Defrenaix1
and Patrice Martin2
1EXCILONE, Elancourt, France; 2GABI-LGS, INRA, AgroParisTech, Universite´;
3GABI, INRA, AgroParisTech, Universite´ Paris-Saclay, MET core facility,
Jouy-en-Josas, France; 4INRA UMR1319 MICALIS, PAPPSO, Jouy-en-Josas,
France
Mammary epithelial cells secrete huge quantities of proteins, lipids
and other milk components such as minerals and lactose. The
biosynthetic pathways responsible for the secretion of the main milk
components are known in general outline but less is known about
extracellular vesicles (EVs), recently identified in milk. Milk-derived
extracellular vesicles (MEVs) contain proteins and RNA, which
could be transferred to neighbouring cells and are recognized as
mediators of intercellular communication. Goats homozygous for a
null allele (naturally occurring KO) at the CSN1S1 locus encoding as1-
casein display a chronic endoplasmic reticulum (ER) stress due to
an accumulation of the other caseins in this compartment, thus
triggering a general MEC dysfunction with a strong impact on milk
composition. The objective of this study is to precisely assess the
impact of as1-casein deficit on MEVs and to perform a comparative
analysis of proteins, lipids and RNA content of MEVs from goats with
extreme genotypes at the CSN1S1 locus. Since in our hands
commercially available kits for the isolation of MEVs result in the
co-precipitation of contaminants with EVs, we developed a method
based on an improved conventional density gradient ultracentrifu-
gation to purify MEVs free of contamination by other milk
components, at sufficient concentrations to subsequently perform
a full characterization. The quality of MEVs prepared according to the
different implemented methods was analysed morphologically by
transmission electron microscopy. The specific ‘‘exosome’’ protein
markers (CD63, CD81, HSP70) were detected by western blot and
the size distribution was measured by dynamic light scattering or
tunable resistive pulse sensing. After validation, their proteome was
acquired by liquid chromatography coupled to mass spectrometry
(LC-MS/MS) approach and nucleic acid content (mRNA and miRNA)
by next-generation sequencing methods. Several differences distin-
guish goats of extreme genotypes at the CSN1S1 locus.
This project was funded by the French National Research Agency
(MilkChEST, ANR-12-BSV6-0013-04) and by GIS APIS-GENE.
PW3.03
CD9-positive EVs isolated from size exclusion chromatography-
precleared plasma from patients and healthy individuals reveal
microRNA patterns
Kari Bente Foss Haug1,2, Tine Hiorth Schøyen1,2, Beate Vestad1,2,
Bente Kierulf2,3, Peter Kierulf1,2, Ketil Winther Pedersen2,3,
Axl Neurauter2,3, Elin H. Kure2,4 and Reidun Øvstebø1,2
1The Blood Cell Research Group, Department of Medical Biochemistry,
Oslo University Hospital, Ulleva˚l, Oslo, Norway; 2Regional Research Network
on Extracellular Vesicles, South-Eastern Norway Regional Health Authority;
3Thermo Fisher Scientific, Life Sciences Solutions, Waltham, MA, USA;
4Translational Studies on Solid Tumors, Institute for Cancer Research,
Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway
Introduction: Size exclusion chromatography (SEC)-preclearing of
plasma has been shown to reduce interfering components and
thereby facilitate downstream characterization of extracellular vesi-
cles (EVs) (1,2). Our overall aim is to capture specific EVs in plasma
from patients and healthy individuals, by combining SEC-preclearing
and magnetic bead-based isolation, for profiling and comparing
molecular patterns, here presenting an introductory microRNA
(miR) study. Methods: Plasma (ethylenediaminetetraacetic acid or
EDTA, 0.5 mL) from fasting colorectal cancer (CRC) patients and
healthy individuals (n3) was precleared by SEC (Sepharose CL-2B,
GE Healthcare) in homemade 10 mL columns. Fractions (30, 0.5 mL)
were eluted and joint fractions (8-10), harbouring the majority of EVs,
concentrated 2:1 and used directly or for isolation of CD9-positive EVs
(DynabeadsTM, Thermo Fisher Scientific). RNA was isolated (miRNeasy
Serum/Plasma, Qiagen) and selected miRs (miR-29a, miR-92a, miR-
223) quantified by RT-qPCR (Viia7, TaqMan, Thermo Fisher Scientific).
miR levels from CD9-positive EVs or directly from joint SEC-fractions
were compared between patients and healthy individuals. Unfractio-
nated plasmas represented the total amount of circulating miRs.
Spike-in control for normalizing was ath-miR-159a (1 nM). Results:
CD9-positive EVs, joint SEC fractions and unfractionated plasmas
contained detectable levels of miR-29a, miR-92a and miR-223 for all
samples. CRC patients showed higher amount of selected miRs
compared to healthy individuals. miR-223 from CD9-positive EVs
showed the highest level (14-fold) in patients compared to healthy
individuals. Relative increase of mir-92a was 7-fold in CD9-positive
EVs compared to unfractionated plasma levels and 3-fold com-
pared to joint SEC fractions. Conclusions: This combined protocol of
SEC-preclearing and bead-based capture of EVs allows for isolation of
specific EVs and downstream quantification of miRs. Comparing miR
levels derived from specific plasma EVs to unfractionated plasma may
enable characterization of disease-specific sources of miRs.
PW3.04
Influence of Anticoagulation on Microvesicle Release in Stored Whole
Blood
Birgit Fendl, Rene´ Weiss and Viktoria Weber
Christian Doppler Laboratory for Innovative Therapy Approaches in Sepsis,
Danube University Krems, Austria
Aim: We aimed to characterize microvesicles (MVs) released in whole
blood with respect to their cellular origin and their interaction
with blood cells. We further assed the influence of storage and
anticoagulation on vesicle generation. Methods: Freshly drawn whole
blood was anticoagulated with ethylenediaminetetraacetic acid
(EDTA), sodium citrate or heparin. Time-dependent release of MVs
with and without gentle rolling was studied at 48C, 218C and 378C.
Flow cytometric analysis was performed using Gallios Flow Cytometer
(Beckman Coulter) after calibration with fluorescent beads (Megamix
PLUS FSC, Biocytex, France; 0.1, 0.3, 0.5 and 0.9 mm). MVs were
identified as lactadherin-positive events in the MV gate. Antibodies
against cell-specific markers for monocytes (CD45CD14), ery-
throcytes (CD235a) and platelets (CD41) were used to identify
the cellular origin of MVs. Results: MV release was dependent on
anticoagulation: EDTA contained the lowest, citrate a medium and
heparin the highest concentration (34829404 vs. 66999651 MV/mL
for EDTA; 22989383 vs. 2387894317 MV/mL for citrate; 630692256
vs. 3964693350 MV/mL for heparin after rolling for 3 h at 378C). In
EDTA, blood erythrocyte-derived MVs were predominant (55%) and
stayed constant during incubation. Platelet-derived MVs were mainly
generated in citrate (69%) and heparin (66%) blood during storage.
Heparin blood showed the fastest kinetics of MV generation. MV
concentration increased with increasing temperature, and this
increase was substantially higher for samples that were rolled during
storage. MVs adhered to blood cells, in particular to monocytes. MV-
monocyte aggregates increased significantly during storage, with
96% of all monocytes carrying MVs in heparin after 3 h. Conclusion:
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MV generation in whole blood depends on the anticoagulation used.
EDTA shows low sensitivity to preanalytical factors, while both
rolling and temperature influence MV generation in citrate and heparin
blood.
PW3.05
Enabling metabolomics-based biomarker discovery studies using
molecular phenotyping of exosome like vesicles
Tatiana Altadill
Vall d’Hebron Institute of Research (VHIR), Barcelona, Spain
Biomarker detection and characterization from complex biological
matrices, especially for markers that are low in abundance remains
a challenge. Exosomes represent an information-rich matrix to
discern novel disease mechanisms that are thought to contribute
to pathologies such as dementia and cancer. Although proteomics
and transcriptomic studies have been reported using exosomes-like
vesicles (ELVs) from different sources, exosomal metabolome char-
acterization and its modulation in health and disease remains to be
elucidated. Here we describe methodologies for small molecule
profiling of ELVs from human plasma and cell culture media. Our
results demonstrate that ELVs represent an untapped source for
metabolic and lipidomic biomarker discovery. Finally, we present
an experimental pipeline that can be broadly applied for identifica-
tion of low abundance biomarkers and characterization in clinical
samples.
PW3.06
Advances in EV isolation from human plasma using the Vn96 synthetic
peptide
Remi Richard1, Rodney J. Ouellette1, Ian C. Chute1, Andrew Joy1,
David Barnett1, Anirban Ghosh1, Scott Lewis2, Annie-Pier Beauregard1,
Melissa Daigle1, Stephen M. Lewis1 and Sebastien Fournier1
1Reasearch, Atlantic Cancer Research Institute, Moncton, Canada; 2Antibody
Division, New England Peptide, Gardner, USA
Introduction: Given the growing evidence that extracellular vesicles
(EVs) may be a clinically relevant biomarker source, there is a
great demand for simple and efficient EV isolation from biofluids,
especially blood. The complexity of this biological material makes it a
particularly challenging sample with which to work and many are
still struggling to separate its constituents. We have improved our
signature Vn96 synthetic peptide isolation method for optimal use in
plasma. Methods: Plasma samples were collected from healthy
volunteers and patients (consenting and ethics approved). EVs from
1 mL of human plasma were then isolated by using either the Vn96
synthetic peptide in the presence of the new PlasME buffer or the
Vn96 peptide in the presence of phosphate-buffered saline (PBS). EV
isolation was completed using a 1-h incubation time with Vn96. The
presence of canonical EV markers was assessed by western blotting.
Total RNA was extracted and yields were measured by NanoDrop
and Agilent TapeStation. EV-DNA was also extracted and analysed
for the KRAS mutation. Results: Western blot analyses revealed the
presence of EV markers. The use of PlasME buffer in combination
with the Vn96 peptide showed greater abundance of these EV
markers compared to the PBS counterpart. From 1 mL of plasma,
RNA yields for EVs isolated with Vn96 in the presence of PlasME
buffer range from 20 to 25 ng when analysed with TapeStation, and
as high as 140 to 240 ng when measured by NanoDrop. DNA was
extracted from EVs and the KRAS mutation was detected by poly-
merase chain reaction from diseased samples. Summary/conclusion:
Here we report a novel, alternative time-saving method of EV
isolation that provides high RNA yields and DNA mutation detection.
The Vn96 peptide in combination with PlasME buffer considerably
improves the effectiveness of EV isolation and simplifies the isolation
process in plasma. The efficient capture of EVs from blood with Vn96
provides a tremendous opportunity to develop clinically important
liquid biopsy tools.
PW3.07
Getting insight of uterine fluid-derived extracellular vesicles
Elisa Giacomini1, Ana Maria Sanchez1, Paola Vigano`1, Paolo Giardina2,
Enrico Papaleo2, Paola Scaruffi3 and Riccardo Vago4
1Reproductive Sciences Laboratory, Division of Genetics and Cell Biology,
Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele Scientific
Institute, Milan, Italy; 2Centro Di Scienze Della Natalita`, Obstetrics and
Gynecology Unit, Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele
Scientific Institute, Milan, Italy; 3U.O.S. Physiopathology of Human
Reproduction, Istituto di Ricovero e Cura a Carattere Scientifico, Aziendia
Ospedaliera Universitaria San Martino-IST, Genova, Italy; 4Urological Research
Institute, Istituto di Ricovero e Cura a Carattere Scientifico, Ospedale San
Raffaele and Universita` Vita-Salute San Raffaele, Milan, Italy
Introduction: Uterine fluid content is worthy of investigation for both
a diagnostic and a prognostic standpoint in terms of its potential
role as a ‘‘liquid’’ biopsy. Uterine fluid contains a number of proteins
differentially regulated between proliferative and secretory phases,
between midsecretory samples from fertile and infertile women and
between prereceptive and receptive endometrium. Characterization
of extracellular vesicles (EVs) from uterine fluid may be an indicator
of endometrial status with the advantage of containing higher
levels of locally secreted proteins. In our pilot study, an explorative
analysis of molecular content of uterine fluid-derived EVs was
performed. Methods: Uterine fluid samples have been collected from
reproductive age patients undergoing diagnostic hysteroscopy.
Uterine fluids (23 mL) were aspirated by an IVF transfer catheter
and subjected to differential ultracentrifugation to isolate EVs.
The nature of the EVs was demonstrated using transmission electron
microscopy and western blot analysis. Total RNA from EVs was
analysed by 2100 Bioanalyzer. Amplification of the mRNAs correlated
with endometrial pathophysiology was done. Mitochondrial MT-7S
D-loop region and RNAse P gene were specifically amplified. Results:
Our explorative analysis confirms that uterine fluid is extremely rich
in EVs. EVs in uterine fluid contain large amounts of heterogeneous
RNA species that could be used to study levels of expression of
genes known in endometrial pathophysiology. The PCR amplifica-
tions indicate the presence of COX2 and WNT4 transcripts and of
CYP19 transcript traces. gDNA and mtDNA were detectable in all the
samples tested. Conclusion: The state of the art in this research area
tends to support the possibility to isolate consistent amount of
EV-derived biological material from few microliters of uterine fluid.
This aspect together with the potential value of uterine fluid as
predictor of endometrial normal functions and dysfunctions repre-
sents the focus of this study.
PW3.08
Characterization of residual urinary extracellular vesicles in
ultracentrifugation supernatants
Luca Musante1, Dorota Tataruch1, Harry Holthofer1, Michael Henry1,
Paula Meleady1 and Dontscho Kerjaschki2
1Dublin City University, Dublin, Ireland; 2Medical University of Vienna, Vienna,
Austria
Background: Urinary extracellular vesicles (UEVs) appear as ideal
source of biomarkers for kidney and urogenital diseases. The majority
of protocols designed for their isolation are based on differential
centrifugation steps. Independent of the method, however, vesicles
may still be present in the supernatant in considerable quantities.
Method: Here we used an isolation protocol for UEVs, which uses
hydrostatic filtration dialysis (HFD) as first pre-enrichment step,
followed by differential centrifugation. Transmission electron micro-
scopy (TEM), mass spectrometry (MS), western blot (WB) and tunable
resistive pulse sensing (TRPS) were used to characterize UEVs left in
the final ultracentrifugation supernatant waste. These residual EVs
were subjected to RNA extraction, quantification, electrophoresis
profiling and TEM. Results: TEM showed the presence of a variety of
small size vesicles while protein identification by mass spectrometry
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fully matched with the protein list available in the Vesiclepedia
repository. Screening and relative quantification for specific vesicle
markers showed that the waste still contained 51% of TSG101,
36% of ALIX, 97% of CD9, 38% of CD63 and 6.1% of CD81 positivity,
respectively, of the signal recorded for the ultracentrifugation
pellet (‘‘catch’’). TRPS quantification of the particles before and after
ultracentrifugation showed that 26% of vesicles are left in the waste.
Finally, extraction of the small RNA (snRNA) species from vesicles
revealed that an equal amount of snRNA is present in both catch and
waste with a closely similar electrophoresis profile. Conclusion: Here
we show, for the first time, the full characterization of exosomes
and other small size urinary vesicles that are normally discarded in
the final supernatant of the differential centrifugation protocol.
These results unequivocally call for re-evaluation of the efficiency and
loss of potentially valuable material with the presently used isolation
workflows.
PW3.09
Different extracting methods affected the quantity and quality
of exosomes and exo-RNA from cell culture medium and
serum
Lei Zheng1,2, Yueting Tang1, Yiyao Huang1, Weiqi Li2, Xiaohui Yan1,
Qian Wang1, Wen Wang2
1Department of Laboratory Medicine, Nanfang hospital, Southern Medical
University, Guangzhou, China; 2School of Engineering and Materials Sciences,
Queen Mary University of London, London, UK
Background: Exosomes are cell-derived vesicles and abundant in
biological fluids, RNA in which could be served as potential diagnostic
biomarkers in precision medicine. To promote clinical application
of exoRNA, many isolation methods in existence should be com-
pared to obtain exoRNA with high quality and concentration.
Methods: Exosome in cell culture medium (CCM) or serum isolated
by ultracentrifugation (Ultra), ExoQuick, Total Exosome Isolation
Reagent (TEI) and hydrostatic filtration dialysis system (HFD) was
compared by NanoSight and protein analysis. ExoRNA extracted by
Trizol-LS, SeraMir, Total Exosome RNA Isolation (TER), HiPure Liquid
RNA/miRNA Kit (HLR), miReasy and exoRNeasy were assessed by
Bioanalyzer 2100, NanoDrop, Qubit, qPCR and high-throughput
sequencing. Results: TEI showed the highest extraction efficiency
and ExoQuick presented the most homogeneous size distribution.
HFD revealed minimal loss and protein contaminants meanwhile. For
CCM, combinations of ExoQuick and SeraMir, and for serum, ExoQuick
and HLR and TEI and TER methods have more stable and higher
extraction efficiency of exoRNA. Filtration, ultrafiltration, freezing and
thawing may reduce the recovery of exosome. High yield and narrow
size distribution pattern of small RNA presented in exoRNA isolated by
Ultra and SeraMir, TEI and TER and ExoQuick and HLR from CCM, and
exoRNeasy from serum. In RNA profile analysis, variation of RNA
fragments size, small RNA constituent ratio, miRNA contents and
amount can result from methodological variability. Profile of exoRNA
isolated by kits (ExoQuick and TEI) methods was more similar.
Discussion: Different isolation methods may account for the con-
centration, purity and size discrepancies of exosome or exoRNA,
so the same isolation methods should be used in one research.
Considering advantages and disadvantages of each method, the most
appropriate one should be flexibility to choose according to research
design.
PW3.10
Comparison and miRNA profiling of extracellular vesicles isolated from
human urine with five different methods compatible with clinical
settings
Felix Royo1, Elnaz Atabakhsh2, Michael Tackett2, Izzuddin Diwan2 and
Juan Manuel Falcon Perez1
1CIC Biogune, Bizkaia, Spain; 2Abcam, Cambridge, United Kingdom
Introduction: Urine sample analysis is irreplaceable as a non-invasive
method for disease diagnosis and follow-up. However, handling of
samples in clinical environment is troublesome, due to the require-
ment of ultracentrifuges and availability of space to storage samples
of large volumes. In recent years, various methods of urinary
extracellular vesicles (uEVs) enrichment using low volumes of urine
and unsophisticated equipment have been developed, with variable
success. Methods: We have characterized the cargo de uEVs obtained
by 5 different methods of isolation. Protein markers were detected by
western blot, and miRNA profiling was performed by a commercial
service platform. The isolation methods compared include differential
ultracentrifugation, lectin-based purification and three commercial
kits based on EV agglutination. The study was approved by the ethical
committee under the reference P-CBG-CBBA-1410. Results: The
analysis of selected gene transcripts and protein markers of uEVs
revealed that each method isolates a different mixture of uEV protein
markers. In addition, the isolated uEVs contain miRNA within a panel
of miRNA commercialized for liver damage studies, opening a door
to miRNA profiling in urine as a source of biomarkers of miRNAs.
Summary/conclusion: The isolation of uEVs is feasible from small
volumes of urine and avoiding ultracentrifugation, making easier the
analysis in a clinical facility. However, caution should be taken in the
selection of the enrichment method since they have a differential
affinity for protein uEVs markers. Interestingly, we also detect in urine
miRNA belonging to a commercial panel of reference for liver
diseases, suggesting that urine is indeed a source of biomarkers for
liver diseases.
PW3.11
Detection of microRNA in plasma extracellular vesicles
Eriomina Shahaj1, Veronica Huber1, Viviana Vallacchi1, Valentina Bollati2,
Licia Rivoltini1 and Monica Rodolfo1
1Department of Experimental Oncology and Molecular Medicine,
Fondazione IRCCS Istituto Nazionale dei Tumori; 2Molecular Epidemiology
and Environmental Epigenetics Laboratory, Department of Clinical
Sciences and Community Health, Universita` Degli Studi Di Milan, Milan,
Italy
Introduction: Circulating extracellular vesicles (EVs) act as mediators of
immune suppression and tumour progression in cancer. EVs contain
miRNA, potent regulators of immune functions that are dysregulated
in tumour cells. Plasma EVs offer non-invasive access to molecules
conditioning tumour immunity that can be explored to gain
prognostic information. We compared different protocols of isolation,
RNA extraction and miRNA detection in plasma EVs from melanoma
patients. Methods: EVs were isolated from 250/500 mL of plasma of
melanoma patients and healthy donors (HD) by using ExoQuick or
differential ultracentrifugation (UC). The isolated EVs were characterized
for size by NanoSight and electronmicroscopy, and for exosome
markers by western blot. RNA was extracted, quantified and tested
for a set of miRNA selected in previous studies (miR146, miR155,
miR125, miR100) by two different qPCR approaches using Taqman
technology. Normalization of results by endogenous or exogenous
spike-in RNA was considered. Results: EVs isolated by ExoQuick and
UC were similar in size and markers. The RNA yield was not always
measurable by fluorimetric analysis (1ng). miRNAs were detectable in
EVs isolated by both methods. The Taqman technique including
specific RT and preamplification showed a higher sensitivity com-
pared to universal RT technique (Advanced Assays). For quantitative
analysis, the exogenous synthetic RNA (ath-miR159a) was used to
monitor the efficiency of RNA extraction and normalize the expres-
sion levels of tested miRNA. miRNA expression was then tested in EV
samples from melanoma patients in comparison to HD (n40) by the
set protocol. Conclusions: The EVs isolated from plasma of melanoma
patients and HD showed different miRNA content: the number of
samples resulting positive for the expression of each miRNA was
higher in EVs of patients compared to HD, and a significantly higher
expression level of miR146 was detected in patients’ EVs.
Supported by AIRC grant 12162 to LR and fellowship to ES.
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ExRNA virtual biorepository
Rocco Lucero1, Sai Lakshmi Subramanian1, Matthew Roth1,
Aleksandar Milosavljevic1, Bob Carter2, Fred Hochberg2, Ryan Kim2,
Johnny Akers2, Douglas Galasko3, Matt Huentelman4, Kendall Jensen4,
Rebecca Reiman4, Jorge Arango5, Yashar Kalani5, Julie Saugstad6,
Theresa Lusardi7, Betty Lind8 and Joseph Quinn8
1Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA;
2Neurosurgery, UC San Diego, San Diego, CA, USA; 3Neurosciences, UC San
Diego, San Diego, CA, USA; 4Neurogenomics, Translational Genomics Research
Institute, Phoenix, AZ, USA; 5Neurosurgery, Barrow Neurological Institute,
Phoenix, AZ, USA; 6Anesthesiology and Perioperative Medicine, Oregon Health
and Science University, Portland, OR, USA; 7RS Dow Neurobiology Laboratories,
Legacy Research Institute, Portland, OR, USA; 8Neurology, OHSU School of
Medicine, Portland, OR, USA
The exRNA virtual biorepository (EVB), developed by the Resource
Sharing Working Group and the Data Management and Resource
Repository (DMRR) of the exRNA Communication (ERC) Consortium,
facilitates tracking and sharing of biofluids and their genetic
preparations. The shared EVB is key to discovery and validation of
biomarkers of diagnosis, prognosis, stratification and toxicity while
providing normative and experimental controls for specificity
assessments. The first ‘‘use case’’ for the EVB involves the evaluation
of cerebrospinal fluid (CSF) for the diagnosis of primary tumours of
brain (UCSD); subarachnoid hemorrhage (TGen); Alzheimer’s and
Parkinson’s diseases (OHSU) and extracellular vesicle (EV) profiles of
normal CSF. Each institution possesses a ‘‘node’’ within the system.
EVB, built on the existing GenboreeKB framework, offers distributed
and extensible infrastructure maintained at the DMRR at Baylor
College of Medicine. The central repository hub is the ‘‘repo services
broker’’ of web services for data query, annotation, sample request
and tracking. The hub provides an EVB portal to browse and
generate summaries of stored specimens. Convenient web interfaces
simplify entry of specimen metadata. Genboree REST APIs provide
extensibility and enable controlled data sharing across physically
distributed nodes using Linked Data technologies. Clinical information,
encoded using ontologies and controlled ‘‘pull-down’’ vocabularies,
includes specimen source and handlers, diagnostic categories, speci-
men quantities, preparative standard operating procedures and EV
quantitative and qualitative data. The EVB will devise specimen tracking
request policies, voting rules and prioritization rules for sample
requests. The EVB as a model for collaborative EV studies will be
expanded to hepatobiliary diseases and oropharyngeal fluids as the
next series of ‘‘use cases.’’
PW3.13
A highly multiplexed real-time PCR demonstrated with quantitative
profiling of miRNAs and DNAs from extracellular vesicles
Sang Kyung Kim
Korea Institute of Science and Technology, Seoul, Korea
We have previously reported that quasi-liquid particles for real-time
polymerase chain reaction (RT-PCR) enabled multiplex quantification
of miRNAs in 10 mL of sample. Each particle contained specific primers
for a miRNA and marked with a specific pattern. Since extracelluar
vesicles are very tricky to collect and analyse in traditional ways,
multiplex detection of tens of genetic targets is critical to catch
holistic view of the sample (1). The particle-based qPCR was improved
in stability and reliability. Ten particles of individual primers were
mixed in master mix and simply analysed according to the general
work flow of RT-PCR. Single strike of the assay provided quantitative
information of the ten target miRNAs. The reliability of the multiplex
assay was validated through comparison with single-plex assays. The
multiplicity of the assay is 20 target at a time in the present platform.
Extracellular vesicles contain other interesting genetic targets such as
DNAs and RNAs. PIN with carbon nano-tubes store a pair of specific
primers, resulting in very effective amplification of the target gene.
Thus, as in miRNAs, DNAs were independently amplified in each
particle and signified their quantity in parallel. To demonstrate the
highly multiplexed assay, sequences of 6 anti-microbial resistant
bacteria were targeted in each particle of PIN. Specificity of the assay
with PIN particles is better than that of the conventional solution-
phase qPCR, suppressing non-specific random dimers. Since plasma
or urine often carries extracellular vesicles of pathogens containing
their unique genetic fingerprints, extracellular vesicle (EV) is one of
non-invasive samples for facile diagnosis. However, EVs from body
fluids are challenging specimens for diagnosis due to their very
limited volume. The present multiplex RT-PCR could analyse the EVs
diagnosing bacterial infection in a rule-in manner, with only one
action of qPCR.
Reference
1. Kim, S.K., ISEV2015, ABSSUB-281.
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Urinary extracellular vesicles: RNA isolation shows gender-related
yield profiles
Dorota Tataruch-Weinert1, Luca Musante1 and Harry Holthofer2
1Dublin City University, Dublin, Ireland; 2Clinical Research Center, University
Hospital Freiburg, Freiburg im Breisgau, Germany
Urinary extracellular vesicles (UEVs) carry an abundance of proteins
and nucleic acid species characteristic for their cells of origin along
the kidney and urogenital tract. Thus, many lines of evidence
highlight urine as an ideal biofluid to discover early biomarkers for
kidney damage as well as for systemic diseases. Although urine is an
easy to obtain biofluid, efficient enrichment of vesicles, sufficient RNA
yields and quality issues remain unresolved. Accordingly, clear
guidelines to reach optimized quality and quantity of RNA together
with improved methods for urine collection itself and UEV isolation
in particular are required. Recently, we have established a method
for UEV enrichment based on hydrostatic filtration dialysis (HFD).
This method concentrates and standardizes the physicochemical
properties of samples and allows to process large volume of urine
to provide sufficient amounts of urinary EV RNA. Using HFD for EV
enrichment, we assessed the quality and quantity of RNA yield
extracted with multiple approaches to identify the vesicle RNA
profiles. The results showed that the yield and RNA quality are
remarkably dependent on the competing extraction methods in
the market. The individual RNA profiles from HFD isolated EVs were
then obtained. Although enrichment of 4080 nucleotide fractions
remained similar for both genders, surprising differences were
repeatedly revealed in the fraction of higher than 80 nucleotides.
Notably, enrichment of this fraction occurs only in samples from
females. Our results show that careful attention should be paid
on selection of RNA isolation method but also on urine collection
and the UEV enrichment procedure itself. All these aspects have
considerable impact on quality of RNA yield. Use of HFD to UEV
enrichment allowed us to establish the characteristic RNA profiles
that demonstrate small but significant differences related to the
gender of the donor.
PW3.15
Influence of menstrual cycle and retroviral infection on cervicovaginal
extracellular vesicles in primates
Dillon Muth, Kathleen Mulka, Zezhou Zhao, Kelly Metcalf-Pate,
Bonita Powell, Lauren Ostrenga and Kenneth W. Witwer
The Johns Hopkins University, Baltimore, Maryland, USA
Introduction: Extracellular vesicles (EVs) have been found in every
body fluid examined, but little is known about their abundance, cargo
or function in cervicovaginal secretions (CVS). Previous work in our lab
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demonstrated decreased particle concentrations in CVS of a rhesus
macaque with endometriosis compared with secretions of reproduc-
tively normal rhesus and pigtailed macaques. For reliable interpreta-
tion of these data, more information is needed on the influence of
factors, including the menstrual cycle (MC). In this study, we aimed to
characterize changes in particle count and RNA expression changes in
EVs during MC in simian immunodeficiency virus (SIV)-infected and
uninfected rhesus macaques. Methods: Cervicovaginal lavage (CVL)
and blood collection were performed weekly for 5 weeks. Nanopar-
ticle tracking analysis (NTA) was performed on whole CVL and EV
fractions enriched by stepped centrifugation. Plasma was analysed
for levels of oestradiol and progesterone to correlate particle counts
with phase of MC. Total RNA was obtained from fractions using an
optimized method for biofluids RNA extraction. miRNAs were profiled
with a medium-throughput stem-loop/hydrolysis probe qPCR plat-
form and confirmed by individual qPCR assays. Results: NTA showed
an increase in EV concentration in the week following the progester-
one peak in uninfected macaques. SIV-infected macaques did not
show any significant changes in hormone levels across the 5-week
period, suggesting MC irregularities. Similar findings for HIV have
been sporadically reported in human, but are unreported in the
nonhuman primate literature. Conclusions: Our preliminary results
suggest that MC may affect EV concentration in CVS and should be
taken into account in future studies. Additional studies of cervicova-
ginal EV and their RNA cargo are merited to characterize the potential
role of EV and specific small RNAs as markers for any manifestation of
reproductive tract disease.
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siRNA delivery by exosome-mimetic nanovesicles  implications for
targeting c-Myc in cancer
Su Chul Jang1, Taral Lunavat1, Lisa Nilsson2, Gabriella Repiska1,3,
Cecilia La¨sser1, Jonas Nilsson2, Jan Lo¨tvall1, Hyun Taek Park4 and
Yong Song Gho1,4
1Krefting Research Centre, Department of Internal Medicine and Clinical
Nutrition, University of Gothenburg, Gothenburg, Sweden; 2Department of
Surgery, Sahlgrenska Cancer Center, Institute of Clinical Sciences, University of
Gothenburg, Gothenburg, Sweden; 3Institute of Physiology, Comenius
University in Bratislava, Faculty of Medicine, Bratislava, Slovakia; 4Department
of Life Sciences, POSTECH, Pohang, Republic of Korea
Introduction: To develop RNA-based therapeutics, it is crucial to
develop delivery vehicles that help the siRNA reach the cell cytoplasm.
Naturally released vesicles, for example, exosomes, have been pro-
posed as possible RNAi carriers, but the yield of exosomes is relatively
small. We have previously generated exosome-mimetic nanovesicles
(NVs) by serial extrusions of cells through nano-sized filters, which
increases yield 100-times versus exosomes. Here, we hypothesize that
NVs can function as efficient siRNA delivery systems. Methods: We here
take two approaches to load siRNA into NVs. Firstly, we overexpress
shRNA against human c-Myc to generate an NV carrying this siRNA.
Secondly, we produced an NV from the cell and loaded these vesicles
with a siRNA against green fluorescent protein (GFP) by electropora-
tion. We examined whether these siRNA-loaded NVs can be taken
up by recipient cells and whether a targeted gene knock-down can be
achieved. Results: The siRNA was efficiently loaded into NVs both
by endogenous expression of shRNA and by exogenous loading by
electroporation. The c-Myc siRNA containing NVs were taken up by
mouse lymphoma cells, downregulated their human c-Myc expression
and finally induced cell death. In addition, siRNA against GFP were
delivered to GFP expressing cells and reduced GFP expression.
Conclusions: NVs have several advantages as delivery vehicles of RNAi
molecules, including high yield during production compared to
exosomes. This study provides two platforms for delivering siRNA by
NVs, which possibly can be applied to different types of diseases.
PW4.02
Comparing the loading efficiency of exosomal protein chimeras
Giulia Corso1, C. I. Edvard Smith1, Oscar P. B. Wiklander1, Joel Z. Nordin1,
Matthew Wood2, Justin Hean2, Imre Mager2,3, Samir El Andaloussi2,1 and
Yi Xin Fiona Lee1
1Laboratory Medicine, Karolinska Institutet, Solna, Sweden; 2Department
of Physiology, Anatomy and Genetics, Oxford University, Oxford,
United Kingdom; 3Institute of Technology, University of Tartu, Tartu, Estonia
Introduction: Due to the innate ability of extracellular vesicles (EVs)
to deliver biological cargos and mediate changes in target cells,
there is growing interest in developing bioengineered EVs as new
therapeutic tools. However, one of the major obstacles in pursuing
this interest is the lack of knowledge about mechanisms/factors that
control the loading of proteins into EVs. Here, we use a green
fluorescent protein (GFP) reporter system to screen the efficacy and
specificity of different EV proteins for loading molecules into EVs.
Methods: We selected a panel of both membrane and cytosolic
proteins, which were highly ranked on our EV proteomics data set
across 17 cell types. Each of these proteins was then fused with
enhanced green fluorescent protein as a read-out. The chimeric
proteins were overexpressed in HEK293T cells and EVs were purified
using ultracentrifugation, including a phosphate-buffered saline
wash. Samples were characterized by nanoparticle tracking analysis
(NTA), western blot (WB), fluorometry and electron microscopy.
Results: We observed heterogeneous loading of different chimeric
products: vesicular loading of proteins seems to be more efficient
when coupling to membranous as opposed to luminal proteins.
Any of the overexpressed proteins do not seem to significantly
change the size of isolated EVs. Moreover, we observed that using
NTA in fluorescence mode is less sensitive than WB for the analysis of
EV protein loading. Summary/conclusion: In this study, we compare
the loading efficiency of different EV chimeric proteins, using
different methods. Although specific sorting mechanisms still need
to be elucidated, we believe that our work will help developing new
strategies for loading compounds into EVs, towards therapeutic
applications.
PW4.03
Effect of exosome isolation methods on their yield, physicochemical
and pharmacokinetic properties
Takuma Yamashita, Yuki Takahashi, Makiya Nishikawa and
Yoshinobu Takakura
Kyoto University Graduate School of Pharmaceutical Sciences, Kyoto, Japan
Introduction: Exosomes, which are expected to be used for therapeu-
tics and drug delivery, can be collected by several methods. Isolation
methods of exosomes may affect exosome yield and properties
of exosomes such as physicochemical, pharmacokinetic and pharma-
ceutical properties. In this study, we compared the yield and
these properties of exosomes collected by three typical methods.
Methods: We collected exosomes from the culture medium of murine
melanoma B16BL6 cells by simple ultracentrifugation (pelleting
method), ultracentrifugation with an iodixanol cushion (cushion
method) and ultracentrifugation with an iodixanol density gradient
(gradient method). Exosome yield was evaluated by measuring the
protein amount and particle number of the collected exosomes. Size
distribution was analysed by transmission electron microscopy (TEM)
and tunable resistive pulse sensing (TRPS). Clearance of intravenously
injected exosomes from blood circulation was examined by using
exosomes labelled with Gaussia luciferase. Recovery rate after sterile
filtration using a 0.2-mm filter was evaluated by western blotting
analysis of an exosome marker protein, Alix, and by measuring
luciferase activity of labelled exosomes. Results: There was no
significant difference in the exosome yield among the three methods.
TEM and TRPS showed that the exosomes collected by the gradient
method were the most dispersed. Irrespective of the collection
methods, exosomes immediately disappeared from the blood circula-
tion after intravenous injection into mice. Recovery rate after filtration
was about 80% for the exosomes collected by the gradient method
and about 40% for those collected by the other methods. Summary:
The three ultracentrifugation-based methods collected almost same
amount of exosomes. The exosomes collected by the gradient method
were the most dispersed and suitable to sterile filtration, whereas no
differences were observed in blood clearance after intravenous injection.
PW4.04
Extracellular vesicles as biological theranostic nano-vectors for tumour
therapy: comparison of production and purification methods
Max Piffoux, Amanda Silva, Zoran Marinkovic, Jean-Baptiste Lugagne,
Pascal Hersen, Claire Wilhelm and Florence Gazeau
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Introduction: Extracellular vesicles (EVs) are subcellular entities
released by cells in a constitutive manner or in response to stress.
We compared different production and loading methods for the
design magnetic drug-loaded EVs as theranostic nano-vectors for
tumour therapy. Methods: EVs were produced from human umbilical
vein endothelial cells (HUVEC) previously loaded with a drug
(mTHPC photosensitizer) and iron oxide nanoparticles. We compared
3 production methods: exosome preparation, serum deprivation
protocol and a mechanical method (a new microfluidic set-up using
shear stress in microchannels). We investigated the effect of the
vesiculation method on the secreting cell, either on its morphology,
cell state (living, necrotic, apoptotic), debris production or on its
loading. Ultracentrifugation and magnetic sorting purification meth-
ods were investigated. We compared the samples using powerful
image-based tools, as ImageStreamX flow cytometer and nanopar-
ticle tracking analysis (NTA) to determine the number of vesicles,
purity, size, nanoparticle and drug loading, and annexin V labelling.
Results: Regarding the effect of the vesiculation method on parent
cell, we demonstrated that the microfluidic method significantly
affected the cell viability, morphology and debris formation com-
pared to other methods. Although classical exosome preparation
seemed apparently an efficient method according to NTA yield,
the purity (p/mg) was very low probably due to serum protein
contaminants. Microfludic chip and serum deprivation enabled EV
production at similar high yield and loading. Serum starvation
enabled the production of the purest EVs, while microfluidics
enabled EV production at high speed. Ultracentrifugation was more
efficient for EV purification than magnetic sorting, but magnetically
sorted EVs displayed higher magnetic load. EVs were able to transfer
their cargo to cells and to induce phototoxicity. Conclusion: This
study sets the basis for future investigations in the field of EVs as
theranostic vectors.
PW4.05
Recombinant phosphatidylserine-binding proteins for targeting
of extracellular vesicles to tumour cells: a plug-and-play
approach
Sander Kooijmans, Jerney Gitz-Francois, Pieter Vader and
Raymond Schiffelers
University Medical Center Utrecht, The Netherlands
Introduction: Extracellular vesicles (EVs) are increasingly being recog-
nized as candidate drug delivery systems. However, manipulation of
targeting properties of EVs can be challenging and time-consuming.
As a novel approach to confer tumour targeting properties to isolated
EVs, we generated recombinant fusion proteins of nanobodies
against the epidermal growth factor receptor (EGFR) fused to
phosphatidylserine (PS)-binding domains of lactadherin (C1C2). Here,
we evaluated the effects of these proteins on EV tumour cell targeting.
Methods: C1C2-nanobody fusion proteins were expressed in HEK293
cells and purified. Binding to PS and EGFR was tested in proteinlipid
overlay assays and ELISAs. EVs isolated from red blood cells (RBCs) and
Neuro2A cells were mixed with C1C2-nanobodies and analysed by
western blotting, electron microscopy and nanoparticle tracking
analysis. EGFR-dependent binding and uptake of C1C2-nanobody-
decorated EVs by tumour cells were determined using flow cytometry.
Results: C1C2-nanobody fusion proteins were obtained with near-
complete purity as determined by SDS-PAGE. Proteins specifically
bound PS and showed no affinity for other common EV membrane
lipids. Furthermore, C1C2 fused to anti-EGFR nanobodies (EGa1-C1C2)
bound EGFR with high affinity, as opposed to C1C2 fused to non-
targeting control nanobodies (R2-C1C2). Both proteins readily self-
associated with membranes of isolated RBC and Neuro2A EVs without
affecting EV size and integrity. EV-bound R2-C1C2 did not influence
EV-cell interactions, while EV-bound EGa1-C1C2 dose-dependently
enhanced specific binding and uptake of EVs by EGFR-overexpressing
tumour cells. Conclusions: We developed a novel strategy to efficiently
and universally confer tumour targeting properties to PS-exposing
EVs after their isolation without affecting EV characteristics, circum-
venting the need to modify EV-secreting cells. This strategy may also
be employed to decorate EVs with other moieties, including imaging
probes or therapeutic proteins.
PW4.06
Suppression of breast cancer metastasis by targeting cancer-derived
extracellular vesicles with antibodies
Nao Nishida1, Naoomi Tominaga1, Fumitaka Takeshita1, Hikaru Sonoda2
and Takahiro Ochiya1
1Division of Molecular and Cellular Medicine, National Cancer Center Research
Institute, Tokyo, Japan; 2Shionogi & Co., Ltd, Osaka, Japan
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PW4.07
Exosomal doxorubicin demonstrates improved tumour cell potency,
but reduced cardiotoxicity compared to other doxorubicin
formulations
Christina Schindler1, Andrea Longatti1, Lesley Jenkinson1,
Laura Fitzpatrick1, Amy Pointon2, Carl Matthews1, Andie Collinson1,
Tristan Vaughan1 and Natalie Tigue1
1Medimmune, Gaithersburg, Maryland; 2Astrazeneca, London, United Kingdom
Introduction: The cytotoxic small molecule drug doxorubicin is
frequently used in chemotherapy. As cardiotoxicity of the free drug
has been reported, liposome-formulated doxorubicin with reduced
cardiotoxicity is currently more often used in the clinic. Additionally,
exosomes loaded with small molecule drugs, for example, doxorubi-
cin, are promising new therapeutic agents as they are well tolerated
by the immune system and can be targeted to specific cell types using
surface motifs. However, the potency and cardiotoxicity of exosomal
doxorubicin has not yet been determined and compared to the
marketed pharmaceutical forms. Methods: Exosomes were loaded
with doxorubicin (exo-Dox) by electroporation. After removal of the
non-incorporated drug, doxorubicin loading was determined by the
drug’s fluorescence. Uptake of exo-Dox into HEK293 cells was
analysed by FACS and microscopy and compared to free doxorubicin
and liposomal formulations. Furthermore, toxicity of exo-Dox and
other formulations of doxorubicin was tested in various cell lines and
human cardiomyocytes (hiPS-CM or hESC-CM) in cell viability assays as
well as assays testing the function of cardiomyocytes such ATP
depletion, calcium mobilization and beat rate. Results: We were able to
demonstrate that exo-doxorubicin is taken up into HEK293 more
efficiently compared to other doxorubicin formulations. Furthermore,
Exo-Dox showed a higher toxicity than free doxorubicin and
liposomal doxorubicin in all cell lines tested. Most importantly,
cardiotoxicity was dramatically reduced compared to the pharma-
ceutical forms currently used in the clinic. Summary: We show that
exosomal doxorubicin is efficiently taken up into cells, and exo-Dox is
more potent compared to other doxorubicin forms, but shows
reduced cardiotoxicity. These data provide compelling evidence that
the delivery of therapeutics via exosomes could offer advantages over
existing options.
PW4.09
Repurposing glioblastoma exosomes as personalized multi-antigenic
antitumour vaccine
Sophie A. Dusoswa1,2, Sophie K. Horrevorts1, Jordi Berenguer De Felipe2,
Sjoerd T. Schetters1, Thomas Wu¨rdinger2, Yvette Van Kooyk1 and
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Exosome-based cancer immunotherapy is independent of exosomal
MHCI
Stefanie Hiltbrunner1, Pia Larssen1, Maria Eldh1, Maria-Jose Martinez
Bravo1, Arnika K. Wagner2, Mikael Karlsson2 and Susanne Gabrielsson1
1Immunology and Allergy Unit, Department of Medicine Solna, Karolinska
Institute, and Karolinska University Hospital, Stockholm; 2Department of
Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm
Peptide-loaded exosomes are promising cancer treatment vehicles;
however, low T-cell responses in human clinical trials indicate a need to
further understand exosome-induced immunity. We previously demon-
strated that antigen-loaded exosomes carry whole protein antigens and
require B cells for inducing antigen-specific T cells. Therefore, we
investigated the importance of exosomal major histocompatibility
complex (MHC) I for the induction of antigen-specific T-cell responses
and tumour protection. We show that ovalbumin-loaded dendritic cell-
derived exosomes from MHCI-/- and allogeneic mice induce antigen-
specific T cells to the same extent as syngeneic exosomes. Furthermore,
lack of or mismatched MHC on exosomes induces tumour infiltrating T
cells and increases overall survival similarly as syngeneic exosomes in a
B16 melanoma. In conclusion, T-cell responses are independent of
exosomal MHC/peptide complexes if whole antigen is present. This
demonstrates the potential of using unpersonalized exosomes, which
greatly increase the feasibility of exosome-based vaccines or therapeu-
tic approaches.
PW4.11
Inhibition of in vitro and in vivo chronic myeloid leukaemia cell growth
by IL3R-targeted exosomes
Stefania Raimondo1, Daniele Bellavia2, Giovanna Calabrese3,
Stefano Forte3, Agostina Patinella4, Marta Cristaldi4, Lorenzo Memeo3,
Gianluca Giavaresi2, Giacomo De Leo1 and Riccardo Alessandro4
1Department of Biopathology and Biomedical Biotechnologies, School of
Medicine, University of Palermo, Palermo, Italy; 2Laboratorio di Ingegneria
Tissutale  Piattaforme Innovative per l’Ingegneria Tissutale, Istituto
Ortopedico Rizzoli, Bologna, Italy; 3Istituto Oncologico del Mediterraneo,
Universita` degli Studi di Palermo, Viagrande (CT), Italy; 4Dipartimento di
Biopatologia e Biotecnologie Mediche, sezione di Biologia e Genetica,
Universita` degli Studi di Palermo, Palermo, Italy
Introduction: Chronic myeloid leukemia (CML) is a myeloproliferative
disorder characterized by the expression of the constitutive tyrosine
kinase BCR-ABL. The prognosis of CML patients has been improved
by imatinib, a selective inhibitor of BCR-ABL. Despite this remarkable
progress, acquired resistance may occur; thus, there is an urgent
need to develop alternative strategies to overcome drug resistance.
Exosomes have a specific cell tropism, according to the molecules
expressed on their surface, which can be used to target them to
specific cells. Moreover, exosomes can be loaded with a variety of
molecules (drugs or siRNA), serving for the delivery of therapeutic
agents. Methods: We use IL-3 receptor subunits, overexpressed on
CML blasts compared with normal hematopoietic cells, as receptor
target in our cancer drug delivery system. HEK293T cells have been
engineered to express the exosome protein Lamp2b, fused to a
fragment of IL-3. Transfected or un-transfected cells were treated
with imatinib in order to load the drug in exosomes. Furthermore,
we transfected cells with Bcr-Abl siRNA and we assayed the ability to
load exosomes and to inhibit imatinib-resistant CML cells. Results:
The therapeutic potential of exosome-mediated imatinib delivery
was demonstrated by the reduction of cell growth concomitant to
the inhibition of BCR-ABL phosphorylation. We found that engi-
neered exosomes, carrying Bcr-Abl siRNA were able to specifically
target imatinib-sensitive and resistant CML cells. Furthermore, by
using a CML xenograft model, we showed a significant decrease of
tumour growth in mice treated with IL3-expressing exosomes loaded
with imatinib or siRNA. We found that engineered exosomes exert
their function by reaching tumour site. Conclusion: In conclusion, we
demonstrated that IL3-engineered exosomes specifically target CML
cells thus delivering imatinib and/or siRNA for Bcr-Abl. While focused
on CML, results from this study could have an impact on other types
of tumours.
PW4.12
Induction of potent antitumour immune response by development of
CpG DNA-conjugated tumour cell-derived exosomes
Masaki Morishita1, Yuki Takahashi2, Makiya Nishikawa2 and
Yoshinobu Takakura2
1Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan;
2Kyoto University Graduate School of Pharmaceutical Sciences, Kyoto, Japan
Introduction: Since tumour cell-derived exosomes contain tumour
antigens, their application to cancer vaccine is expected. To induce
potent antitumour immune response, we developed immunostimu-
latory CpG DNA-conjugated tumour cell-derived exosomes (CpG-exo)
by using streptavidin (SAV)biotin interaction. Methods: Exosomes
were collected from mouse melanoma B16BL6 cells transfected with a
plasmid encoding a fusion protein of SAV and lactadherin (LA). CpG-
exo were obtained by mixing SAV-LA-modified exosomes (SAV-exo)
with biotinylated CpG DNA. Conjugation was confirmed by fluores-
cent microscopic observation of CpG-exo prepared with fluorescein
isothiocyanate-labelled CpG DNA and PKH26-labelled SAV-exo.
Mouse dendritic DC2.4 cells were treated with CpG-exo, and the
levels of TNF-a were determined by ELISA. Antigen presentation
capacity was evaluated by measuring the levels of IL-2 released from
BUSA14, a mouse T-cell hybridoma specific for melanoma antigen
gp100, after co-culture with DC2.4 cells treated with CpG-exo. Mice
were intradermally immunized 3 times with CpG-exo with 3-day
intervals and subcutaneously inoculated with B16BL6 cells 7 days after
the last immunization. Separately, mice with established B16BL6
tumour were intratumourally injected with CpG-exo 3 times with 3-
day intervals. Tumour volume and survival of mice were evaluated.
Results: Fluorescent microscopy showed colocalization of biotinylated
CpG DNA and SAV-exo, indicating the successful preparation of CpG-
exo. Addition of CpG-exo produced a large amount of TNF-a from
DC2.4 cells and increased antigen presentation. In both the pre-
ventive and therapeutic models, CpG-exo efficiently retarded the
B16BL6 tumour growth compared to co-administration of the
unmodified B16BL6 exosomes and CpG DNA. Summary: CpG-exo
were prepared by SAVbiotin interaction and showed high immu-
nostimulatory activity as well as tumour antigen-specific immune
response in vitro. Moreover, CpG-exo were the most effective in
inhibiting tumour growth in tumour mouse models.
PW4.13
Recombinant exosomes carrying CD40L and herpesviral proteins
redirect antiviral immune responses towards malignant B-CLL cells:
an immunotherapeutic approach
Kathrin Ga¨rtner1, Manja Luckner2 and Reinhard Zeidler1
1Department of Gene Vectors, Helmholtz Zentrum Mu¨nchen, Mu¨nchen,
Germany; 2Department of Biology I, Ludwig-Maximilians-Universita¨t Mu¨nchen,
Martinsried, Germany
Introduction: Chronic lymphocytic leukemia (CLL) continues to be an
incurable disease that is mainly characterized by accumulation of
malignant B cells that possess a poor antigen-presenting ability.
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However, this dysfunction can be restored by CD40 stimulation with
its ligand, CD40L. Our works aim at the generation of recombinant
exosomes in order to transfer functional CD40L together with
immunodominant EpsteinBarr virus (EBV) and cytomegalovirus
(CMV) proteins to B-CLL cells, redirecting the strong preexisting
herpesviral immunity to these cells. Methods: Recombinant exosomes
were generated in HEK293 cells overexpressing the proteins of
interest and isolated from conditioned media by serial centrifugation
and density gradient fractionation. Purified exosomes were character-
ized by western blot, electron microscopy and nanoparticle tracking
analysis. Interaction of exosomes and B-CLL cells was visualized by
flow cytometry and fluorescent microscopy. The immunostimulating
effects of the exosomes were studied in T-cell assays using virus-
specific T-cell clones as well as autologous peripheral blood T cells
derived from CLL patients. Results: Our experiments showed that
CD40L, the EBV protein gp350 and the CMV protein pp65 are
efficiently packed into HEK293-derived exosomes and remain func-
tional. Gp350 conferred a B-cell tropism, while exosomal CD40L
increased the antigen-presenting capacity by inducing the expression
of costimulatory surface molecules not only in directly bound B-CLL
cells but also in bystander cells. B-CLL cells treated with CD40L+/
gp350+/pp65+ exosomes induced increased IFNg secretion in virus-
specific T-cell clones and subsequently became targets for autologous
cytolytic T cells. Summary/conclusion: We have shown that recombi-
nant exosomes are efficient tools for the transfer of functional
proteins to specific target cells and can trigger virus- and tumour-
specific immune responses. This might facilitate new strategies for
treatment of B-cell malignancies, such as CLL.
PW4.14
Meningococcal outer membrane vesicles as vaccine platform
candidate
Matthias Gerritzen, Merijn L.M. Salverda, Arno Van Der Ark,
Peter Van Der Ley and Michiel Stork
Intravacc, Bilthoven, The Netherlands
Outer membrane vesicles (OMVs) have great potential as vaccine
candidates. OMVs have been successfully used to elicit immune
responses against the bacteria from which they are derived.
However, OMVs are a complex product especially when compared
to conventional subunit vaccines making the development of robust
production processes demanding. By expressing heterologous anti-
gens on the OMVs, a vesicle is created, which acts as a carrier
platform that retains its intrinsic adjuvant properties. The expression
of one or more proteins in this carrier platform is not expected
to actively change the production process. We used a Neisseria
meningitidis strain (MenB) expressing the borrelial outer surface
protein (OspA). OspA has been bioengineered to the outside of the
outer membrane by combining the protein to a meningococcal
surface-exposed lipoprotein. We have tested the production of
platform OMVs in our production process for neisserial OMVs.
Production of both spontaneous and detergent-free extracted OspA
OMVs showed to be highly similar to neisserial vesicle production.
These preliminary results show a glimpse of the potential of using
heterologous expressed lipoproteins on OMVs in the development
of a vaccine platform.
PW4.15
Role of degS and nlpI in outer membrane vesicle production and
cell-to-cell interactions in Actinobacillus pleuropneumoniae
Fabio Antenucci1, Janine Bosse´2, Gry Persson1, Zofia Magnowska1,
Paul Langford2 and Anders Miki Bojesen1
1University of Copenhagen, Copenhagen, Denmark; 2Imperial College, London,
United Kingdom
Introduction: Actinobacillus pleuropneumoniae (App) is a Gram-
negative bacterium, which infects pigs as its sole host and reservoir.
The most widely used vaccines (bacterins) confer protection against
one or a limited number of App serotypes and do not prevent
colonization. Thus, it is highly desirable to develop an alternative
vaccine that confers broad protection against App in a serotype-
independent manner. To achieve this goal, our approach is focused
on the production, analysis and utilization of App outer membrane
vesicles (OMVs) as vehicles to deliver a selection of conserved
antigens to the host immune system. Methods: Deletion of degS
and/or nlpI has been demonstrated to increase OMV secretion in
numerous bacteria. Both genes were knocked out (separately) in App
serovar 8 (MIDG2331) and OMV secretion levels were compared to
that of the wild type (WT) by transmission electron microscopy (TEM)
and oCelloscope analysis. Antigenicity of OMVs was determined by
immunological assays using convalescent porcine serum. Results: TEM
analysis showed that both degS and nlpI mutants secrete an
increased amount of OMVs compared to the WT parental strain. The
nlpI mutant produced OMVs much more variable in terms of
morphology and size than the WT, thus confirming the role exerted
by the nlpI gene in outer-membrane biogenesis and integrity.
Furthermore, unlike the WT, degS and nlpI mutants did not aggregate
during growth, suggesting a role of degS and nlpI genes in App cell-
to-cell interactions that could possibly affect resistance or coloniza-
tion, that is, mechanisms typically associated with aggregation.
Finally, all the OMVs showed almost identical antigenic profiles when
probed with immune serum, suggesting conservation of antigens in
the OMVs of both mutants. Conclusion: In conclusion, these data
support the use of App OMVs as a reliable scaffold to carry and
present App antigens to the porcine immune system.
PW4.16
Novel therapeutic inhibitor cocktail suppresses extracellular vesicle-
mediated inflammation induced by micro-RNA in a humanized mouse
model of lupus
Nicholas Young, Giancarlo Valiente, Jeffrey Hampton, Holly Steigelman
and Wael Jarjour
The Ohio State University Wexner Medical Center, Columbus, Ohio, USA
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Redox state of exofacial molecules on leukocyte-derived EVs in
inflammation
Katalin Szabo´-Taylor, Eszter A´gnes To´th, Anna Balogh, Kinga Godo´,
Krisztina Pa´lo´czi, Andrea Ne´meth, E´va Pa´llinger, Gyo¨rgy Nagy,
Xabier Osteikoetxea, Barbara So´dar, Krisztina V. Vukman and Edit I Buza´s
Department of Genetics, Cell- and Immunobiology, Semmelweis University,
Budapest, Hungary
Introduction: Exofacial thiols and redox molecules are abundantly
present on all cells and they participate in inflammation, cellular
activation and extracellular vesicle (EV) biogenesis. Until now,
exofacial thiols and redox active surface molecules have not been
investigated in EV biology. In this work, we analysed both cellular
and vesicular exofacial thiol levels and a redox molecule, peroxir-
edoxin 1 (Prdx1), in healthy and inflammatory conditions. Methods:
Peripheral blood samples were taken from rheumatoid arthritis (RA)
patients (n=43) and healthy subjects (n=42) in ACD-A and EDTA
tubes for studies on EVs and peripheral blood mononuclear cells
(PBMCs), respectively. Platelet-free plasma samples were snap-frozen
and stored at 808C until analysis. A new flow cytometric (FCM)
assay was developed to measure exofacial thiols on CD81+, CD9+,
annexin V+ and CD41+ EVs. Exofacial thiols were also measured on
PBMCs using FCM. EV-, blood plasma- and cell-associated Prdx1 were
investigated by FCM and western blotting. After in vitro inducement
of oxidative stress in human monocytes, using lipopolysaccharide
and tumour necrosis factor (confirmed by dihydrocalcein staining),
Prdx1 and surface thiols were measured on cells and EVs. Results: The
level of exofacial thiols was elevated on monocytes of RA patients
(pB0.05) as compared to controls, while the surface thiols on
plasma EVs did not differ. In vitro activated monocytes had an
increase in surface thiol levels (pB0.05). In contrast, the released EVs
had decreased levels of surface thiols (pB0.05). We demonstrated
the presence of exofacial Prdx1 on cell lines and primary monocytes
by FCM and western blotting. We detected Prdx1 on the surface of
plasma EVs. Prdx1+ EVs were present in an elevated number in RA
patients’ plasma compared to healthy subjects (pB0.05). Conclusion:
We propose that the EV-mediated release of membrane segments
with reduced exofacial thiol levels and the increase in the number of
Prdx1+ EVs may serve as the cells’ antioxidant defence system.
Funded: OTKA-PD104369
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Mesenchymal stem cell-derived microvesicles exposed to normoxic and
hypoxic culture conditions are involved in macrophage polarization
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Mesenchymal stem cells (MSCs) are considered effective therapeutic
agents inducing the functional improvement in the repair of injured
tissues, not only through direct engraftment and differentiation,
but mainly through their paracrine activity. Increasing evidences show
that besides the secretion of trophic factors, the release of extra-
cellular microvesicles (MV) constitutes an alternative paracrine
mechanism adopted by MSCs. In this study, we aim to carry out a
detailed characterization of MVs released by human adipose tissue-
derived MSCs, to study their possible involvement in macrophage
polarization from a pro-inflammatory (M1) to a pro-resolving (M2)
phenotype. The MV-isolation method is based on repeated ultracen-
trifugation steps of the MSC-conditioned medium exposed to both
normoxic and hypoxic conditions (MV-normo and MV-hypo, respec-
tively), followed by characterization of the resulting pellet enriched in
MV through electron microscopy, flow cytometry and western blot for
the expression of the proteins typically enriched in MVs. Size- and
Trucount beads were used in the flow cytometric analysis to define
the proper size and number of isolated MVs. In addition, culturing
bone marrow-derived macrophages with MV-normo and MV-hypo
previously stained with the fluorescent lypophilic dye PKH67 resulted
in the uptake of MVs by macrophages. The flow cytometric analysis
showed that when macrophages were cultured in standard medium,
they did not express the typical M2 markers, such the mannose
receptor CD206. Interestingly, the percentage of CD206-expressing
macrophages significantly increased after the cell treatment with MVs
cultured in both normoxic and hypoxic conditions, and this increase
was even greatest in hypoxic conditions. We can conclude that the
presence of MSCs-derived MVs induced and enhanced macrophage
polarization towards an M2 pro-resolving profile.
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Distinguishing PMN-derived activated EVs from apoptotic vesicles
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Introduction: Neutrophils (polymorphonuclear neutrophils or PMN)
produce extracellular vesicles (EVs) in resting and also in many,
differentially activated states. In some cases, the amount and
biological properties of PMN-derived EVs show antibacterial activity.
This capacity is reduced if the activation is partial. In order to assess
the importance of cell activation in the production of antibacterial
EVs, in this study we characterize the EVs produced during
spontaneous death of the neutrophils and test their antibacterial
effect. Methods: PMNs were prepared from the blood of healthy
volunteers and were held in Dulbecco’s modified eagle’s medium in
cell culture incubator for 3 days. EVs were separated by two steps,
centrifugation and filtration. The separated EVs were counted and
analysed with EV-optimized flow cytometry. The characteristics of
EVs were analysed with dynamic light scattering, fluorescent- and
electron microscopy, and with lipid and protein quantity assay. The
antibacterial effect of the EVs was tested in bacterium survival assay.
Results: During the 3 days incubation of PMN, the number of
produced EV was increased parallel with PMN count decrease. The
flow cytometric appearance, the annexin V and CD11b positivity, and
the lipid/protein ratio of apoptotic EV were similar to antibacterial
EVs, whereas the protein content and electron microscopic appear-
ance differed significantly. Unlike EVs produced after PMN activation,
the apoptotic EVs were ineffective in bacterium survival assay.
Conclusion: The apoptotic EVs of neutrophils have a right side out
vesicular nature, which is similar in size and appearance to the
antibacterial EVs, but apoptotic vesicles do not have antibacterial
effect. These results highlight the difference between distinct vesicle
populations and support the specific formation of antibacterial EVs.
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Investigating the apoptotic cell-derived extracellular vesicles with
ICAM3 on apoptotic cell clearance
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Introduction: Apoptotic cell clearance is a vital mechanism that
prevents dying cells from undergoing necrosis, which may lead to
inflammatory and autoimmune disorders. Apoptotic cell-derived
extracellular vesicles (ACdEV) are shed during apoptosis by loss of
plasma membrane, aiding apoptotic cell removal by acting as
‘‘find me’’ signals to attract phagocytes. Apoptotic cell binding by
phagocytes is achieved by various ligands on the apoptotic cell and
counter receptors on the phagocytes, which together form a
phagocytic synapse. One interesting apoptotic cell-associated ligand
is ICAM-3, a highly glycosylated member of the immunoglobulin
super family IgSF that is expressed on human leukocytes. On viable
cells, it participates in initiating immune responses, while on
apoptotic cells, it participates in the clearance of the apoptotic cells
by attracting phagocytes and mediating tethering and binding of AC
to phagocytes. However, the precise mechanism of ICAM-3 action is
unknown. We aim to characterize the role of ICAM-3 and EVs in the
clearance of apoptotic cells and attempt to identify the mechanisms
that underlie their function in apoptotic cell clearance. Methods:
Human B cells were induced to apoptosis by UV, and EVs were isolated
by two-stage centrifugations. The ability of ICAM3 on ACdEV to
promote phagocyte recruitment between AC and macrophages
(MØ) was assessed by horizontal and vertical chemotaxis assays and
by an in vivo mouse tumour model.The anti-inflammatory effects of
ACdEV on lipopolysaccharide-induced inflammation was assessed.
Results: Our results show that ICAM3 on EVs has chemoattractive
potential for phagocytes and suggest ACdEV may exert anti-
inflammatory effects. Our in vivo assays demonstrate that the
anti-ICAM3 mAb MA4 prevent MØ migration towards the AC.
Summary: ICAM3 on ACdEV promotes migration of MØ both in
vitro and in vivo. Additionally, ACdEV may exert additional anti-
inflammatory effects.
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DNA on the extracellular vesicle surface
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Introduction: Cell-free DNA in body fluids has been suggested to
have biomarker potential and can harbour disease-specific genetic
mutations including oncogenes. However, cell-free extracellular
DNA and its relative location with respect to the extracellular vesi-
cle (EV) membrane is unclear. Methods: EVs from mast cells
(HMC1.2) were isolated by differential ultracentrifugation. Isolated
EVs were subjected to DNase-I treatment prior to being floated
on an optiprep gradient. The zeta potential and particle number
of the floated EVs were determined using nanoparticle tracking
technology (Zeta viewer). Functional analysis of uptake was
performed on human mesenchymal stem cells (hMSC). Results:
DNase treatment of non-lysed EVs reduces the concentration of
nucleic acids in EV isolates. DNase treatment also increases the
zeta-potential and particle numbers. Additionally, cytoplasmic DNA
traces (DAPI) were found in recipient hMSC after EVs treatment.
Conclusion: We here show that EV-associated DNA at least partly can
be present on the surface of EVs, which may contribute to EV
aggregation. We hypothesize that EV surface DNA may assist their
uptake.
PW5.06
Exosomes mediate crosstalk between the cell populations that
contribute to DMD progression
Silvia Consalvi, Pier Lorenzo Puri, Valentina Saccone, Martina Sandona` and
Luca Tucciarone
Farmacologia epigenetica, IRCCS Fondazione Santa Lucia, Rome, Italy
Introduction: Muscle regeneration is dependent by a complex inter-
play of different cell types in the muscle stem cell niche. In particular,
a population of interstitial fibro-adipogenic progenitors (FAPs) and
muscle stem cells (MuSCs) establish a complex network of interac-
tions to coordinate muscle regeneration in mdx mice  mouse model
of Duchenne muscular dystrophy (DMD). Recent findings demon-
strated that treatment of mdx with histone deacetylase inhibitors
(HDACi) increases the ability of FAPs to support MuSCs-mediated
muscle regeneration at early stages of disease. We are investigating
the role of exosomes released by FAPs as mediators of this functional
interaction. Methods: FAPs are isolated from untreated (control, CTR)
or trichostatin A (TSA)-treated mdx mice by FACS as Sca1-positive
cells. Exosomes are isolated from muscles and from FAPs using a
specific exosome isolation kit. Exosomes biogenesis was blocked
using GW4869 exo-budding inhibitor. Taqman miRNA microarray was
used to analyse miRNA contents in exosomes released by FAPs CTR
and TSA. Results: FAPs released exosomes improve MuSCs differentia-
tion. This effect is further increased by the treatment with TSA.
Inhibition of exosomes biogenesis in FAPs strongly reduces their ability
to support MuSCs differentiation. Transplantation of exosomes from
FAPs in injured muscles increases muscle regeneration and recovery.
Analysis of exosome content by miRNA-microarray shows a huge
increase of myogenic miRs (myomiRs) in exosomes of FAPs exposed to
TSA. Conclusions: Our results suggest that exosomes mediate the ability
of FAPs in supporting MuSCs differentiation. HDACi increase this
activity enhancing the myomiR content in exosomes. All these findings
suggest that exosomes could act as therapeutic agents promoting
muscle regeneration in injured or dystrophic muscles.
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Central role of the beta2 integrin Mac1 (CD18) in activated
EV-generation in murine neutrophilic granulocytes
Erzsebet Ligeti, Akos Lorincz, Attila Mocsai and
David Szombath
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Introduction: In earlier studies, we demonstrated that human neu-
trophilic granulocytes (polymorphonuclear neutrophils, or PMN) were
able to produce extracellular vesicles (EVs) that impaired bacterial
growth. Production of antibacterial EVs occurred only upon stimula-
tion of PMN with opsonized particles. In the present investigation, we
applied genetically modified animals to identify the receptors that
initiate the generation of activated EVs and to decide whether
phagocytosis is required for generation of activated EVs. Methods:
PMN were isolated from the bone marrow of wild-type mice or from
mice deficient in major surface integrins (CD18, CD11a, CD11b), or Fc
receptor signalling (FcR-g chain, DAP12) or all the Src kinases (Hck, Fgr,
Lin triple KO). Stimulation of PMN was carried out with opsonized
yeast. Extracellular vesicles were separated by two-step centrifugation
(2,000g followed by 33,000g). The separated vesicles were
counted and analysed with EV optimized flow cytometry. Phagocytosis
of opsonized bacteria was determined by flow cytometry. Results:
Generation of activated EVs was seriously impaired in cells lacking either
chain (CD18 or CD11b) of the ß2 integrin Mac1, but it was not signi-
ficantly influenced in the absence of CD11a (LFA), FcR signalling or Src
kinases. Both in wild type and in most mutant animals PMN phagocy-
tosis changed in parallel to EV generation, but in Src triple KO animals
we observed a clear divergence: EV generation did not require Src
kinase activity, whereas phagocytosis did. Conclusion: The ß2 integrin
Mac1 plays a central role in the generation of activated EVs in
murine neutrophils, whereas the role of Fc receptors seems to be
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moderate. However, phagocytosis is not a prerequisite of activated
EV formation.
Funding: Hungarian Research Fund (OTKA 108382)
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Immuno-modulatory role of exosomes in tuberculosis
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Introduction: Tuberculosis (TB) ranks as a leading cause of death
worldwide (WHO, 2015). Immuno-pathology of TB is characterized
with increased T-regulatory cells and suppressed immunity. But the
role of exosomes in modulating the function of Tregs in TB remains to
be studied. Loss of T-cell polyfunctionality to oligofunctionality has
been observed among TB patients. Here, we studied the role of
exosomes in the immune regulation of poly-functional T cells.
Materials and methods: Exosomes were purified by differential
centrifugation followed by ultracentrifugation at 110,000g. The
pelleted exosomes were washed with phosphate-buffered saline and
stored. Further, exosomes were analysed by NanoSight, stained for
surface markers and acquired in FACS Calibur, and the data were
analysed using FloJo software. The impact of exosomes isolated from
plasma of TB patients was studied in in vitro peripheral blood
mononuclear cell culture. The change in effector T-cell function was
monitored by flow cytometry. Results: We had isolated exosomes
from plasma of TB patients and identified their cellular source by
cell-specific surface markers. Exosomes derived from T cells showed
CD3+CD4/CD8; monocyte- and B-cell-derived exosomes contained
CD14 and CD19, respectively. Monocyte-derived exosomes from TB
patients were significantly increased, whereas T-cell- and B-cell-derived
exosomes were similar as compared to healthy controls. Next, the effect
of TB-patient-derived exosomes was studied in terms of effector
functions of T cells. Our preliminary results suggest an increase in
polyfunctional T cells (IFNg+ TNFa+). Conclusion: Our preliminary study
indicates that monocyte-derived exosomes are the most abundant in
plasma of TB patients suggesting their role in modulation of immune
functions. This was demonstrated by increased frequency of effector
T-cells producing IFNg+TNFa, suggesting a role of exosomes in con-
trolling immune response. Further studies are in progress to define their
diagnostic and immune-modulatory potential.
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Microparticles derived from cultured macrophages and
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Inflammatory antigen presenting cells (APC, dendritic cells and
macrophages) are characteristic for patients with affective disorders
and can be enriched from Ficoll-isolated mononuclear cells by 34
weeks of in vitro culture. Flow cytometry, electron microscopy,
western blots and cytokine quantification were applied to characterize
the cell type and the inflammatory response in blood and cerebrosp-
inal fluid (CSF). These analyses demonstrate that the enriched APC can
be classified into either dendritic cells (iDCs), M1 or M2 macrophages.
All cell isolates display high macropinocytotic activity and in addition
form prominent autophagous vacuoles. The M1 type occurred more
often in affective disorders than in schizophrenics. M1 cells expressed
the ATP-sensitive P2X7 ion channel. ATP stimulation of the P2X7 ion
channel caused the release of plasma membrane vesicles and
microparticles (MPs). MPs enriched from blood-derived APC cultures
and from native CSF were subjected to protein chemical as well as
miRNA analysis. All MP preparations were ß-actin positive and in part
stained for the autophagy marker LC3-II. When compared to the
cultured APC-target cells, the microparticles were stronger positive for
arginase 1, CD95, S100 and CD178, whereas CD36 and the TNF-R type I
(CD120a) were decreased. miRNA analysis revealed inflammatory
signatures in the majority of affective disorders. These results indicate
that microparticles may transport protein and miRNA species to target
tissues. The current protocol proved to be valid to simultaneously
study MP generation in vitro using cultured APC and to isolate and
characterize MP from the CSF. Electron microscopical examinations
support the distinction of microparticles from exosomes.
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The miRNAs are selectively enriched in retinal pigment epithelium cell-
derived microparticles and mediate oxidative stress-induced retinal
cells dysfunction
Pierre Hardy, Chun Yang and Carmen Gagnon
University of Montreal, Quebec, Canada
Purpose: A normally functioning retinal pigment epithelium (RPE) is
indispensable for vision. The cumulative oxidative injury induces RPE
membrane microparticles (RMPs) production and RPE cell degenera-
tion. This study was designed to investigate how RMPs participate in
the retinal cells dysfunction and to investigate the role of RMPs
containing miRNAs in the oxidative stress-induced RPE degeneration.
Methods: RMPs were isolated from ARPE-19 cells under oxidative
stress. The size distribution of RMPs in culture supernatants was
determined using a NanoSight Tracking Analysis System. RMPs-
treated RPE cells were subjected to cell viability assay, cellular
senescent, apoptotic assay and FACS cell cycle analysis. RNAs were
isolated from RMPs and subjected to miRNAs sequencing analysis.
The miRNA (let-7f) mimic was transfected into RPE cells and cell
viability was determined and compared with miRNA control. Results:
Oxidative stress induced extracellular microvesicles (EVs) production
from RPE cells. These EVs had a size distribution with diameters of
50 to over 600 nm including both exosomes and ectosomes. In addi-
tion, the majority of EVs are ectosomes which presented in RMPs. RMPs
significantly reduced RPE cell viability. RMPs at low dose (5 mg/mL)
significantly induced RPE cell-cycle arrest at G0/G1 phase; RMPs-
treated cells exhibited higher senescence-associated ß-galactosidase
activity, whereas RMPs at concentrations over 20 mg/mL induced cell
apoptosis. The miRNA sequencing revealed that miRNAs are selectively
enriched in RMPs in which members of hsa-let-7 family are the most
abundant ones. Enforced expression of let-7f dose-dependently re-
duced cell proliferation and induced cell senescence of RPE cells.
Conclusions: We demonstrated for the first time that RMPs-containing
let-7f causes RPE cell degeneration, which suggest RMPs may function
as mediators to exacerbate the oxidative damages to RPE cells and let-7
may be the key active components of RMPs.
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Identification and proteomic profiling of extracellular vesicles in
peritoneal dialysis fluid
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1Systems Biology Centre, Chulalongkorn University, Bangkok, Thailand;
2Chulalongkorn University, Bangkok, Thailand
Introduction: Dialysis treatment for chronic kidney disease has
increased markedly worldwide. Increased understanding of perito-
neal dialysis pathophysiology, peritoneal dialysate composition and
biomarkers for patient management is needed. Obtaining samples
directly from the peritoneum is invasive. Extracellular vesicles may
be a useful approach to analyse changes to the peritoneum, yet
there are no known reports of their presence or composition in
peritoneal dialysate. Methods: We used a differential centrifugation
technique to concentrate vesicle-associated proteins from relatively
dilute peritoneal fluid, reducing abundant extravesicular proteins.
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The presence and number of vesicles was demonstrated using trans-
mission electron microscopy, nanoparticle tracking analysis (NTA),
and dynamic light scattering (DLS). Finally using a high-throughput
tandem mass spectrometry approach, we investigated proteins of
potential interest. Proteins commonly used as identifying proteins
for apoptotic bodies, ectosomes and exosomes were ranked.
Results: The average particle size using NTA and DLS was 210 nm
(47820 nm) and 280 nm (561100 nm), respectively. Forty-three
protein markers were identified which are used to identify different
types of vesicles in extracellular fluids, consistent with the size
range as being representative of a heterogeneous population of
vesicle types. In total, 1142 proteins were identified, including many
proteins with known roles in peritoneal pathophysiology, and other
transmembrane proteins. Proteins of interest for disease character-
ization included proteins of epithelial to mesenchymal transition,
and the TGF pathway. Other peptides of interest included markers of
ultrafiltration ability (aquaporin-1), peritonitis (C-reactive protein,
acute phase protein). Conclusion: We characterized extracellular
vesicles in peritoneal dialysis fluid, and showed as proof of concept
that this approach enriches for potential proteins of interest.
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The senescence-associated secretory phenotype (SASP) is one hall-
mark of senescent cells, whereby pro-inflammatory factors are
secreted and alter the tissue microenvironment. Recently, miRNAs
packaged into extracellular vesicles (EVs) have been found as part of
SASP (miR-SASP). Here, we report the identification of EV-miRNAs as
part of the human dermal skin fibroblasts SASP. For this purpose,
stress-induced premature senescence was triggered by repeated low
doses of H2O2 in cells of 3 donors and EVs of senescent and control
cells were harvested by ultracentrifugation for miRNomics and
functional biological studies. We identified differentially secreted
miRNAs by qPCR arrays and correlated their extracellular and
intracellular abundance. Based on that, we have confirmed selected
prominent, highly secreted miRNAs including miR-23a, miR-29a and
miR-31 to be more abundant in EVs of senescent cells. Furthermore,
by nanoparticle tracking analysis we observed that senescent
fibroblasts secrete more vesicles than controls. In order to test if EV-
miRNAs might be part of a paracrine crosstalk between dermal
fibroblasts and epidermal keratinocytes, we confirmed uptake of cel-
miR-39 enclosed in fibroblast-derived EVs by keratinocytes in mono-
layers and in full thickness skin equivalents. To summarize, our data
indicate that extravesicular miRNAs of senescent fibroblasts are
bonafide members of the SASP and that they contribute to the
communication between fibroblasts and keratinocytes in 2D and 3D
model human skin models.
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Lupus nephritis was associated with a high increase in the urinary
amount of miR-146a via exosomes compared to microvesicles or
cellular pellet
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Introduction: Glass wool (GW) is a man-made mineral fiber that is
widely used as thermic, acoustic and flame retardant insulation of
buildings, vehicles and high-tech products. Exposure to GW has been
linked to interstitial lung diseases (ILD). However, sensitive markers
for the early detection of GW-induced pulmonary damage are still
lacking. Extracellular vesicles (EVs) are released by cells upon various
stressors and are involved in intercellular communication. Hence, we
hypothesized that GW induces lung epithelial cells EVs release and
elicit an inflammatory response in immune cells. Methods: Bronchial
epithelial (BEAS-2B) cells were exposed to several concentrations
(10100 mg/mL) of commercially available GW (Isover(r)) for 48 h and
cell viability was assessed. EVs in the cell supernatant and after
isolation were quantified by flow cytometry and further character-
ized by transmission electron microscopy (TEM) and tunable resistive
pulse sensing (TRPS). EVs-mediated production of interleukin (IL)-8
was determined over 48 h in human macrophage-like (THP-1) cells.
Results: Whereas 48 h GW exposures did not affect bronchial
epithelial cells’ viability (8099% of unexposed cells), 100 mg/mL
GW resulted in a 6.5-fold increase in EVs in the cell supernatant
compared to unexposed cells. TEM revealed membrane-surrounded
vesicles whose mode diameters (GW: 10996 nm (78629 nm),
control: 11598 nm (77578 nm)) did not differ between the
exposure conditions. Flow cytometry confirmed the presence of
the exosomal proteins CD63 and CD81. EVs from GW exposed but
not from unexposed cells stimulated the production of IL-8 in
macrophage-like cells. Summary/conclusion: GW-induced release of
EVs from bronchial epithelial cells prior to a reduction in cell viability
suggests EVs as biomarkers of early cytotoxicity. Moreover, the EV-
induced inflammatory response in immune cells may contribute to the
early onset of pulmonary inflammation upon GW exposure.
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MicroRNA cargo of extracellular vesicles from alcohol-exposed
monocytes signals naı¨ve monocytes to differentiate into M2
macrophages
Banishree Saha1, Fatemeh Momen-Heravi2, Karen Kodys2
and Gyongyi Szabo2
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Introduction: Extracellular vesicles (EVs) released by immune cells can
regulate immune responses via transmission of biological signals.
Recently, we demonstrated that alcohol-treated hepatocytes crosstalk
with immune cells via exosomes containing miRNAs. Here we
hypothesized that alcohol-exposed monocytes (MØ) can commu-
nicate with naı¨ve MØ via EVs. Methods: THP-1 cells or human MØ were
exposed to alcohol (25100 mM) and EVs were assessed in the
supernatants with NanoSight or isolated for microRNA profiling. M1
and M2 MØ markers were assessed by FACS. Results: We found that
alcohol affects monocyte EV secretion and contents, which signals
naı¨ve monocytes to differentiate into macrophages. We observed
increased number of EVs, mostly exosomes, secreted by primary
human monocytes and THP-1 monocytic cells in the presence of
alcohol in a concentration- and time-dependent manner. EVs derived
from alcohol-treated monocytes stimulated naı¨ve monocytes to
polarize into M2-macrophages as indicated by increased surface
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expression of CD68 (macrophage marker), M2 markers [CD206
(mannose receptor), CD163 (scavenger receptor)], secretion of IL-10
and TGFß, and increased phagocytic activity. miRNA profiling of the
EVs derived from alcohol-treated THP-1 monocytes revealed high
expression of the M2 polarizing miRNA, miR-27a. Treatment of naı¨ve
monocytes with control EVs overexpressing miR-27a reproduced the
effect of EVs from alcohol-treated monocytes on naı¨ve monocytes and
induced M2 polarization, suggesting that the effect of alcohol EVs was
mediated by miR-27a. We found that miR-27a modulated the process
of phagocytosis by targeting CD206 expression on monocytes.
Importantly, circulating EVs from plasma of alcoholic hepatitis
patients had increased numbers of EVs that contained high levels of
miR-27a compared to healthy controls. Summary/conclusion: Alcohol-
EVs mediate their effects via miR-27a on monocytes and induce
macrophage polarization.
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Hypoxia and TNFa co-treatment affects the number and size of
adipocyte-derived EVs
Rebecca M. Wadey1, D. Aled Reess1, Katherine D. Connolly1 and
Philip E. James2
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Adipocytes release extracellular vesicles (EVs) (1). In addition, adipo-
cytes in obesity are subject to an extracellular milieu that is both
hypoxic and inflammatory (2). As such, this study questioned whether
a hypoxic and inflammatory environment influences the release of
adipocyte EVs. Mature 3T3-L1 adipocytes were incubated for 24 h in
one of four conditions: ‘‘control’’ (serum-free medium (SFM), 95% air/
5% CO2), ‘‘TNFa’’ (SFM supplemented with 30 ng/mL TNFa, 95% air/5%
CO2), ‘‘hypoxia’’ (SFM, 1% O2), or ‘‘TNFa and hypoxia’’ (SFM supple-
mented with 30 ng/mL TNFa, 1% O2). EVs were isolated from media by
ultracentrifugation (500g for 5 min15,000g for 15min100,000g
for 60 min). EVs were quantified using nanoparticle tracking analysis
and results expressed as mode size and mean yield of EVs/viable cell
(assessed using trypan blue). Data were analysed using one-way
ANOVA and post-hoc Tukey testing, and differences deemed sig-
nificant when pB0.05 (N=3, n=9). No differences in cell viability were
identified (5090.96%, 5191.3%, 5291.1% and 5391.2% (mean9
SD)). Compared to control (21289131 (mean9SD)), TNFa (31979
386; pB0.05), hypoxia (40739444; pB0.001) and TNFa & hypoxia
combined (51579331; pB0.001), increased the EVs/viable cell yield.
TNFa & hypoxia combined yielded more EVs than that of TNFa
(pB0.001) and hypoxia (pB0.05) alone. Compared to control
(18891.4 nm (mode9SD)), TNFa (17592.5 nm; pB0.01), hypoxia
(17395.3 nm; pB0.01) and TNFa & hypoxia combined (16091.5 nm;
pB0.001), decreased EV size. TNFa & hypoxia combined yielded
smaller EVs than that of TNFa (pB0.01) and hypoxia (pB0.01) alone.
TNFa and hypoxia affect the release and size profile of adipocyte EVs,
and when combined, their affect is enhanced. Future studies aim to
determine the functional relevance of this observation within the field
of obesity, and given its strong association (3), cardiovascular disease.
References
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Denmark; 2Department of Health Science and Technology, Aalborg University,
Aalborg, Denmark; 3Department of Neurology, Odense University Hospital,
Odense, Denmark; 4Department of Mathematics and Computer Science,
University of Southern Denmark, Odense, Denmark; 5Service de Radiologie,
Universite´ de Lyon, Lyon, France; 6Center for Neurological Imaging, Bringham
and Women’s Hospital, Boston, USA; 7Institute of Clinical Research, University
of Southern Denmark, Odense, Denmark
Introduction: Multiple sclerosis (MS) is an inflammatory demyelinat-
ing disease of the central nervous system (CNS). Disruption of the
bloodbrain barrier (BBB) plays a major role in disease activity and
damage of the BBB may be initiated by systemic or CNS inflamma-
tion and contribute to escalation of pro-inflammatory responses
within the CNS. We hypothesized that damage of the BBB is reflected
in the appearance of endothelium-derived extracellular vesicles (EVs)
in the plasma and correlate with soluble biomarkers of endothelial
stress and regulators of systemic inflammation. Methods: Five
patients with untreated MS were followed by weekly blood sampling
for 7 weeks. Plasma samples were analysed for 41 soluble biomarkers
by Mesoscale V-PLEX, whereas EVs were analysed by the EV array.
The array was customized by known EV markers and endothelial
stress-induced EV markers as determined by quantitative proteomics
to include 33 different antibodies against EV markers involved
in inflammation and endothelial stress. For detection of EVs, a
cocktail of antibodies against CD9, CD63 and CD81 was used. Results:
In this study, the plasma contents of EVs was compared to soluble
biomarkers indicating systemic inflammation and endothelial stress.
Each patient revealed an individual phenotype of plasma EVs, which
changed over time. Pearson correlations between the EV pheno-
types, and soluble biomarkers were made. Hierarchical clustering of
biomarkers and patients, and time-series clustering were generated.
Summary/conclusion: Further data analysis has been performed in
order to conclude whether any of the EV markers correlates with the
soluble biomarkers and their changes over time.
PW5.18
Inflammation- and thrombin-induced endothelium-derived
microvesicles and modulation of endothelial barrier function
in human brain microvasculature
Larry Hunter, Muthuvel Jayachandran and Virginia Miller
Mayo Clinic, Rochester, Minnesota
Introduction: Mechanisms contributing to changes in the blood
brain barrier associated with brain pathologies are incompletely
understood. We investigated the phenotype of microvesicles (MVs)
released from cultured human brain microvascular endothelial cells
(HBMECs) stimulated with proinflammatory, prothrombotic or oxida-
tive stress agents, and changes in endothelial barrier function
associated with their release. Methods: Male donor HBMECs were
cultured to higher than 95% confluency, then treated for 24 h with
medium alone (control) or with medium plus either tumour necrosis
factor (TNFa, 20 ng/mL), thrombin (THR, 2 U/mL), angiotensin II
(AngII, 10 nM) or hydrogen peroxide (H2O2, 0.8 mM). MVs released
into the medium were isolated by centrifugation and labelled with
annexin V in combination with an antibody against either PECAM-1,
ICAM-1, E-selectin, integrin aV or MCAM and then analysed by
digital flow cytometer. HBMECS were also cultured on microporous
supports and then treated for 24 h with the above-described agents;
then paracellular permeability was quantified by measurement of
FITC-dextran passage across each cell monolayer during a 90-min
period. Results: Total MVs released (MVs/mL) with TNFa, (615.8913.9),
THR (113.894.8) and H2O2 (152.8923.5) were significantly greater
(pB0.05) compared to control (82.295.4). Each treatment released
a distinct array of MV subtypes. Permeability (% control) was in-
creased by 199.5%, 234.1%, 126.8% and 588.3% for TNFa, THR, AngII
and H2O2, respectively. Also, control MVs pre-labelled with the
fluorescent dye PKH67 were endocytosed into HBMECs within 60
min and trafficked to punctate peri-nuclear structures, identified by
confocal microscopy. Conclusions: Molecules associated with inflam-
mation, thrombosis and oxidative stress increase both paracellular
permeability and MV shedding from HBMECs in vitro. Pre-labelled
MVs are rapidly endocytosed supporting a contribution to modulat-
ing dysfunction of microvascular endothelium.
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Peptide-mediated ‘‘miniprep’’ isolation of extracellular vesicles for
high-throughput proteomics: method evaluation and application in
colon cancer
Connie Jimenez1, Sander R. Piersma2, Egbert F. Smit2, Nicole Van Grieken2,
Robin Beekhof2, Henk M. W. Verheul2, Remond J. A. Fijneman3,
Gerrit Meijer3, Thang V Pham2, Inge De Reus2, Tim Schelfhorst1,
Logan Bishop-Currey1, Meike De Wit2 and Jaco C. Knol2
1VU University Medical Center-Cancer Center, Amsterdam, The Netherlands;
2VU University Medical Center, Amsterdam, The Netherlands; 3The Netherlands
Cancer Institute, Amsterdam, The Netherlands
Introduction: Extracellular vesicles (EVs) are released into body fluids
and their cargo represents a rich source for disease biomarkers.
However, standard ultracentrifugation methods for EV isolation (abbr.
UC-EV) are laborious, time-consuming and require high inputs.
Recently, a novel HSP-targeted isolation method, which can be
performed at small scale, was described (Ghosh et al., PLoS ONE
9:e110443). Using cancer secretome and biofluid samples, the authors
showed enrichment of exosome markers with their method (abbr.
HSP-EV) but a detailed description of the captured HSP-EV versus
UC-EV proteomes and application to small tumour proximal fluid
samples is lacking. Methods: Here we used label-free proteomics of
replicate EV isolations from HT-29 cancer cell-conditioned medium to
compare EV fractions captured using either HSP-EV or UC-EV.
Subsequently, we applied the HSP-EV method to profile EVs released
from fresh human colorectal (CRC) tumours (n=17) and colon
adenoma tissue (n=4) as well as patient-matched normal colon tissue
(n=21). Results: Despite a 30-fold different input scale (UC-EV: 60 mL
vs. HSP-EV: 2 mL), both methods yielded comparable numbers of
identified proteins (3115 vs. 3085), with reproducible identifications
(72.5% vs. 75.5%) and spectral count-based quantification (average CV
31% vs. 27%). EVs obtained by either method contained established EV
markers and proteins linked to vesicle-related gene ontologies. In the
EV fraction of CRC tissue secretomes, 6390 proteins were identi-
fied, of which 471 proteins were at least 5-fold more abundant in CRC
EVs than in normal tissue EVs. Gene ontology analysis revealed en-
richment of nuclear proteins involved in DNA damage response, chro-
mosome organization and RNA processing in CRC EVs. Conclusion: The
HSP-EV method provides an advantageous, simple and rapid approach
for EV isolation from small amounts of biological samples, enabling
high-throughput analysis in a biomarker discovery setting.
PW6.02
Simple and effective isolation of exosomes by polyethylene glycol from
cell culture supernatant for in-depth proteome profiling
Zhigang Sui
Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian,
China
Exosomes are secreted nanovesicles shed by most types of cells.
Recently, increasing interest has been focused on these small
membrane vesicles (30150 nm) containing functional biomolecules
(i.e. proteins, lipids, RNA and DNA) that can be horizontally
transferred to recipient cells and play critical role in intercellular
communications. In the past few years, many different approaches to
obtain exosomes with high quality are available. However, the current
isolation techniques are to some extent not convenient and often
require expensive kits or specialized equipment. Herein, we intro-
duced a very simple, polyethylene glycol (PEG)-based approach,
which could permit a fast and effective isolation of exosomes from
cell culture supernatant. The size and morphology of isolated
exosome aggregates were visualized by high-resolution electron
microscopes. All exosomes had a spherical shape with a diameter of
about 100200 nm and coated with silk-like PEG films, implying the
mechanism of PEG-based precipitation may be attribute to the
enhancement of sedimentation coefficient of these wrapped exo-
somes. The size distribution of isolated exosomes was also presented
by nanoparticle tracking analysis (NTA) and showed a narrow peak
with a maximum at 100 nm. After combining with tandem mass
spectrometry, 4932 protein groups encoded by 4478 genes were
successfully characterized from 30 mL of HeLa cell culture super-
natant, including numerous exosome proteins which could overlap
95% of the top 100 exosome proteins recorded in ExoCarta, as well as
a series of low-abundance cytokines and biomarkers. Furthermore, we
found a higher ratio of neo-cleavage sites in exosome samples
compared with cellular proteins, revealing significant roles of exosome
in accumulation and transport of protein degradation intermediates.
PW6.03
Simplified method for proteome analysis of platelet-induced
membrane vesicles
Joanna Kasprzyk1, Wojciech Piekoszewski1 and Ewa Stepien2
1Faculty of Chemistry, Jagiellonian University, Krako´w, Poland; 2Jagiellonian
University, Krako´w, Poland
Background: Activated platelets release two classes of membrane
vesicles: most dominant microvesicles produced by surface shedding,
which are larger ranging in size from 200 to 500 nm, and much smaller
exosomes derived from exocytosis process (less than 200 nm). They
are supposed to have important role in haemostasis and thrombus
formation. Aim: Developing a method to assess the protein content of
platelet organelles and microvesicles. Methods: Generation of platelet
derived vesicles (PDVs)  platelets were washed from platelet-rich plasma
(PRP) collected from healthy donors. PDVs were induced by thrombin
activation (1IU). Activated platelets and released PDVs were subjected
with analysis. Nano-LC-MALDI-TOF-MS/MS analysis was performed using
nano-liquid chromatography method. Tryptic peptides were separated
with the reverse phase column. Peptide identifications were performed
using BioTools together with the MASCOT server for searching against
the Swiss-Prot human database. The precision tolerance was 100 ppm for
peptide masses and 0.7 Da for fragment ion masses. Individual peptide
matches with score above 28 were considered statistically significant.
Results: In total, 412 proteins were identified in PDVs and 450 proteins
in activated platelets. Among them 307 proteins were identified in
both types of samples. PDVs contained exosome- and microvesicle-
specific sets of markers, for example, glycoproteins, transmembrane
and adhesive proteins as well as transcription machinery proteins.
Conclusions: In this study, we applied a new approach to the analysis
of microvesicles based on bottom-up proteomic analysis. All preparation
steps were carried in solution instead of gel.
Acknowledgements: This study was funded by the NCN grant (2012/
07B/NZ5/02510). The research was carried out with the equipment
purchased thanks to the financial support of the European Regional
Development Fund in the framework of the Polish Innovation Eco-
nomy Operational Program (contract no. POIG.02.01.00-12-023/08).
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PW6.04
Lipid profiling of normal and tumourigenic cell-derived extracellular
vesicles reveals differences in composition
Joshua Brzozowski1,2, Helen Jankowski1,2, Belinda Goldie2,3,
Benjamin Munro1,4, Danielle Bond1,4, Christopher Scarlett1,4,
Kathryn Skelding1,2 and Judith Weidenhofer1,2
1Cancer Research Program, Hunter Medical Research Institute, NSW,
Australia; 2School of Biomedical Sciences and Pharmacy, The University of
Newcastle, NSW, Australia; 3Institute for Integrated Cell-Material
Sciences (iCeMS), Kyoto University, Kyoto, Japan; 4School of
Environmental and Life Sciences, The University of Newcastle,
NSW, Australia
Introduction: Extracellular vesicles (EVs) are important for cell-cell
communication via the transfer of protein, nucleic acid and lipid cargo.
It has been extensively reported that tumour-derived EVs transport a
cargo of oncogenic material, including functional oncogenes and
oncoproteins that aid in the malignant transformation of target cells.
Whilst the precise mechanisms controlling which cells receive this
cargo are still unknown, it is proposed that the lipid composition will
play a key role and that tumour-derived EV lipid profile will facilitate
cargo delivery to a greater distribution of cells. Methods: EVs from the
RWPE1 cell line, an immortalized normal prostate line, and the WPE1-
NB26 cell line, a chemically modified and tumourigenic derivative of
the RWPE1 line, were collected using an ultrafiltration procedure.
Lipids were extracted using chloroform:methanol (2:1), freeze dried
and resuspended in LCMS loading buffer and detected by LCMS.
Quantification of 265 lipid metabolites, including phospholipids (PC,
PE, PI, PS), ceramides, sphingolipids (SM), cholesterol esters (CE) and
di- and tri-acyl-glycerides (DG, TG), was conducted in a lipid-targeted
approach to identify differences in EVs from normal and tumourigenic
prostate cells. Results: All 265 lipid metabolites targeted were
detected in EVs from at least one sample. Differences were identified
using a Student’s t-test with Benjamini-Hochberg (BH) correction after
the data was median normalized and log transformed. Of the 265
metabolites detected, 71 WPE1-NB26 EV metabolites including
various CE, PC, PE and SM species were significantly different from
RWPE1 metabolites based on the BH-adjusted p-value (pB0.05).
Summary/Conclusion: These results indicate that there is a selective
and identifiable difference in lipid metabolites between EVs derived
from normal and tumourigenic cells. Future studies will look at
whether these differences in metabolites enhance the uptake of these
EVs by surrounding cells.
PW6.06
Proteomics of subpopulations of extracellular vesicles: clues of
subcellular origin
Aleksander Cvjetkovic, Cecilia La¨sser and Jan Lo¨tvall
University of Gothenburg, Sweden
Introduction: Extracellular vesicles (EVs) can be separated on density
gradients from other components such as soluble proteins, but may
also be utilized to spatially separate different subpopulations of EVs
with different density. We herein present a proteomics analysis
of two vesicle subsets with slightly different density, derived from the
human mast cell line HMC1. Methods: Vesicles from human mast cells,
HMC1, were isolated with differential ultracentrifugation followed by
bottom-loaded separation on an iodixanol gradient. After separation with
ultracentrifugation, 1 mL fractions were collected and analysed based on
their contents. Two visually distinct fractions, found above and below
22% iodixanol, were further analysed with mass spectrometry and
evaluated based on their proteomic contents. Results: There is a wide
distribution of materials throughout the gradient after separation but a
clear accumulation of markers of EVs in the low-density fractions.
Proteomics data suggest that two subpopulations of EVs not only differ
slightly in density but also in protein content. Although sharing common
markers for EVs, GO term analysis suggests that the slightly higher
density band is enriched in organellar components, while the lower
density band harbours more components characteristic of the plasma
membrane. Conclusion: We here present proteomics analysis of
two EV bands separated slightly by iodixanol density gradient, support-
ing the presence of several types of EVs with different origin, one
possibly from the plasma membrane and the other from intracellular
organelles.
PW6.07
Proteomic analysis of Mycobacterium tuberculosis membrane vesicles
Alemayehu Godana Birhanu1, Solomon Yimer2, Tahira Riaz2
and Tone Tønjum1,2,
1University of Oslo, Norway; 2Oslo University Hospital, Norway
Introduction: A deeply rooted phylogenetic lineage of Mycobacterium
tuberculosis termed lineage 7 was recently discovered. In order to
explain its recent evolution, we performed vesicle isolation and whole
cell proteomics analysis of 30 lineage 7 strains. We defined the intra-
lineage proteome variation and identified unique characteristics
associated with this lineage, focusing on proteins involved in DNA
repair, recombination and replication (3R genes). Methods: M.
tuberculosis lineage 7 strains were cultured in minimal media (MM)
at 378C. Membrane vesicles were purified using density gradient
ultra-centrifugation. The purified membrane vesicles and cellular
pellets were loaded on Bis-Tris Protein Gels (412%) for in-gel
digestion and cleaned up using c-18 zip-tip columns before injecting
in to the mass spectrometer. MS analysis was performed by the Q-
Exactive mass spectrometry (Thermo Fischer, Waltham, MA, USA) to
achieve high-resolution protein identification and quantification.
MaxQuant software was used to define the amounts of the various
peptides present, while post-translational modifications (PTMs)
were identified by Proteome Discoverer and manual inspection.
Results: Next-generation mass spectrometry revealed that there is
enriched packaging of virulence-associated mycobacterial proteins in
its vesicles. The proteomic constituent of membrane vesicles changed
through different growth phases of the bacteria. Furthermore,
some of the proteins identified in the vesicles were reported to be
highly immunogenic. Summary/conclusion: This study generated
novel knowledge regarding the proteomic profile of M. tuberculosis
membrane vesicles and their surface-exposed antigens. Further
in silico and in vitro/in vivo experiments will reveal the potential
of M. tuberculosis vaccine and drug target discovery and potential.
PW6.08
Proteomic analysis of human reticulocyte-derived
exosomes
Mı´riam Dı´az-Varela1, Ana Ga´mez-Valero2, Joan Seguı´-Barber2,
Carmen Ferna´ndez-Becerra2, Hernando A. Del Portillo3 and
Armando De Menezes-Neto2
1Barcelona Institute for Global Health (ISGlobal) - Hospital Clı´nic - Universitat
de Barcelona, Barcelona, Spain; 2Barcelona Institute For Global Health,
Barcelona, Spain; 3Icrea At Barcelona Institute For Global Health, Barcelona,
Spain
Introduction: Reticulocyte-derived exosomes (rex) are nanovesicles
of endocytic origin released during the maturation of reticulocytes
to erythrocytes, thus playing a role in erythropoiesis. Remarkably,
Plasmodium vivax, the most widespread human malaria parasite has
a unique tropism for reticulocytes. Using a rodent malaria model, it
was shown that rex from infections contain parasite proteins capable
of inducing protective immune responses (Martin-Jaular et al., 2011
PloS One). Therefore, rex can be explored as a new vaccine against
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reticulocyte-prone malarial parasites. Most of the studies on rex,
however, have been performed in non-human species. Here, we
present the first proteomic analysis of human rex. Methods: rex were
isolated from cultures of human cord blood using two different
culture conditions: absence and presence of exosome-depleted
serum, and two different isolation techniques: size-exclusion chro-
matography (SEC) and ultracentrifugation. Human rex preparations
were finally subjected to liquid chromatography followed by mass
spectrometry. Only proteins identified with 2 or more peptides were
considered for analyses. Results: Proteomic analyses revealed a total
of 197 proteins, 53 of which were found in common in human rex
purified by SEC of serum-supplemented reticulocyte cultures. Many
of these proteins were also identified in rex preparations obtained by
different methodologies, reinforcing this consistent core proteome.
Moreover, GO analysis confirmed that these proteins have an
exosomal origin, as many terms related to extracellular vesicles
and exosomes were overrepresented. Of interest, we observed a core
of proteins conserved in rex isolated from humans, rats and mice.
Conclusion: To our knowledge, these results provide the first report
about the proteomic profile of human rex, enabling further studies
on their role in erythropoiesis and their exploration as a vaccine and
platform against vivax malaria.
Funded by AGAUR and MINECO.
PW6.09
Proteomics profiling of mouse pluripotent stem cells and their
extracellular vesicles
Yi Xin Fiona Lee1, Imre Mager2,3, Samir El Andaloussi2,4, Matthew Wood2,
Janne Lehtio¨5 and Henrik Johansson5
1Karolinska Institutet, Stockholm, Sweden; 2Department of Physiology,
Anatomy and Genetics, University of Oxford, Oxford, United Kingdom;
3Institute of Technology, University of Tartu, Tartu, Estonia; 4Department of
Oncology-Pathology, Karolinska Institutet, Solna, Sweden; 5Karolinska
Institutet, Stockholm, Sweden
Introduction: Increasing evidence indicates that paracrine factors and
secretory elements such as extracellular vesicles (EVs) contribute
positively in mesenchymal stem cell-based therapy. Recently, it has
been reported how the delivery of mRNAs and miRNAs via EVs
derived from pluripotent stem cells can aid in cardiovascular disease
treatment. Here, we report on our study comparing the proteomic
profiles of EVs from different pluripotent stem cells and discuss how
these data could help in unravelling their biological functions and
lead to the development of other therapeutic applications of stem
cellderived EVs. Methods: Conditioned media was collected from
mouse embryonic (ES) and induced pluripotent stem (iPS) cells
grown on gelatin-coated plates. EVs were purified by size-exclusion
liquid chromatography (LC) and characterized initially with nano-
particle tracking analysis (NTA) and western blotting. Subsequently,
we applied nano-liquid chromatography (LC)-mass spectrometry
(MS)/MS proteomics analysis of both ES and iPS cell lysates and their
respective EVs. Results: Physically, EVs isolated from both ES and iPS
cells have similar size distribution profiles. Interestingly, proteomic
profiles were more similar among cells and among EVs, regardless of
their cell type. Contrary to previous reports, we failed to detect the
presence of pluripotency-associated transcription factors in the EVs.
Further gene ontology (GO) analysis showed some selective enrich-
ment of different molecular components between ES and iPS EVs.
Summary/conclusions: Due to safety concerns in stem cell replace-
ment therapies, there is a gradual shift to develop and characterize
alternative cell-free modalities, such as EVs. Here, we demonstrate
that stem cellderived EVs express a distinct profile of selected
luminal and membrane proteins as compared to their cellular origins.
Importantly, this information would be useful for the future
development of customized stem cell-derived EVs for treatment of
various diseases.
PW6.10
Cell confluence affects the proteome of extracellular vesicles from oral
cancer cells
Adriana Paes Leme, Flavia Winck, Romenia Domingues, Sami Yokoo and
Bianca Pauletti
Laborato´rio Nacional de Biocieˆncias, Sa˜o Paulo, Brazil
Tumorigenic cells produce and release extracellular vesicles (EVs)
which can exert different functions on cell-to-cell communication
carrying several types of molecules to recipient cells. However, how
the high cell confluence, hence high cell-to-cell contact interferes in
the protein repertoire of EVs has not been completely elucidated.
In the present study, we used shotgun proteomics approach to
compare the effects of cell confluence on the protein repertoire of
EVs from oral squamous cell carcinoma. We identified differences
between the proteome of EVs isolated from cells cultured until 50
and 80% confluence. The proteomics analysis revealed that proteins
related to cell adhesion and cell cytoskeleton organization mechan-
isms are overrepresented in the EVs. Biological pathway analysis
indicated that EVs from cells at 80% confluence are enriched in
proteins related to vesicle fusion and metastatic potential. Functional
assays demonstrated that EVs from cells cultured until 80%
confluence enhanced cell migration and Erk expression in recipient
tumorigenic cells, thus suggesting a possible role of cell confluence,
hence cell-to-cell contact in triggering alterations on the content of
EVs and confirming the role of EVs in modulating cancer-related
biological pathways.
PW6.11
Targeted proteomic analysis for biomarker discovery of
colorectal cancer metastasis from plasma extracellular
vesicles
Takashi Shiromizu1, Naomi Ohnishi2, Risa Fujii2,
Mimiko Ishida3, Nagayama Satoshi4, Takeshi Tomonaga1 and
Koji Ueda2
1National Institutes of Biomedical Innovation, Health and Nutrition, Osaka,
Japan; 2Project for Realization of Personalized Cancer Medicine, Genome
Center, Japanese Foundation for Cancer Research, Tokyo; 3Laboratory of
Proteome Research, National Institutes of Biomedical Innovation, Health and
Nutrition, Osaka, Japan; 4Department of Gastroenterological Surgery, Cancer
Institute Hospital, Japanese Foundation For Cancer Research, Tokyo, Japan
Introduction: Liver metastasis is the predominant prognostic factor of
colorectal cancer (CRC). However, effective biomarkers or therapeutic
targets were not yet established. Recent studies indicate that cancer-
derived extracellular vesicles (EVs) could contribute to cancer
progression and metastasis. In this study, we aimed for a biomarker
discovery from membrane fraction of clinical specimen tissues and
plasma EVs by using target proteomic method. Methods: Membrane
fraction proteins were extracted from 12 pairs of CRC primary and
liver metastatic tissues. Quantitative proteomic analysis of mem-
brane fraction proteins was performed by the isobaric tandem mass
tag (TMT)-labelling method. Differentially expressed proteins be-
tween primary and metastatic tissues were verified by the selected
reaction monitoring (SRM) assay, which is a high-throughput and
high-resolution quantitative proteomic approach. EVs fractions were
prepared from plasma samples using a differential centrifugation
protocol. For detection and verification of the biomarker candidates
in plasma EVs, 120 plasma (40 of each metastatic, non-metastatic
and healthy sample) were prepared and subjected to SRM analysis.
Result and conclusion: A total of 4967 proteins were identified by
quantitative proteomic analysis and 342 proteins were differentially
expressed between primary and metastatic tissues. Among these
biomarker candidates, several dozens of proteins were detected
in plasma EVs by SRM analysis and some proteins were found to
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be potential biomarkers for colorectal cancer metastasis. These
results suggest that target proteomics was an effective method for
biomarker discovery in plasma EVs.
PW6.12
Proteomic characterization of circulating extracellular vesicles in
multiple myeloma
Shona Pedersen1,2, Marie Sigrid Lund1, Ole Østergaard3,
Gunna Christiansen4, Thøger Nielsen1,2, Søren R. Kristensen1,2 and
Niels H. H. Heegaard3,5
1Department of Clinical Biochemistry, Aalborg University Hospital, Aalborg,
Denmark; 2Department of Clinical Medicine, Aalborg University, Denmark;
3Department of Autoimmunology and Biomarkers, Statens Serum Institute,
Copenhagen, Denmark; 4Department of Biomedicine, Aarhus University,
Aarhus; 5Department of Clinical Biochemistry and Pharmacology, Odense
University Hospital, Odense, Denmark
Multiple myeloma (MM) is the second most common hematological
malignancy. Extracellular vesicles (EVs) are thought to be involved in
the increased procoagulant tendency in patients with MM, contribut-
ing to increased risk of venous thrombosis. The aim of this study is to
effectively isolate EVs from the plasma of MM patients and healthy
volunteers and use high sensitivity label free liquid chromatography
coupled to mass spectrometry (LC-MS/MS) for extensive profiling of
proteome differences in the pathological processes associated with
MM. EVs were isolated and purified from platelet-poor plasma from
5 healthy volunteers and 5 MM patients (approved by the local ethics
committee) by repeated 18,900g centrifugation followed by 4
consecutive washing cycles in PBS-citrate. The prepared EV samples
were then analysed by nanoparticle tracking analysis (NTA) for particle
concentration, Bradford protein assay (BCA) for protein concentration
and EV purity, western blotting (WB) for determination of vesicle-
associated proteins, transmission electron microscopy (TEM) for EV
morphology and quantitative proteome analysis by LC-MS/MS
followed by functional annotation of the identified proteins. BCA
quantification of the prepared EVs fractions showed reduced levels of
plasma proteins, indicating increased sample purity. WB and TEM
confirmed presence of EVs in fractions, and NTA data revealed
adequate yields of particles for LC-MS/MS analysis. LC-MS/MS un-
covers specific differences in the proteome of MM-EVs compared with
EVs from healthy controls, displaying biological and molecular
functional variation between proteins in EV samples from MM and
healthy plasma.Our results accentuate that by reducing plasma
proteins while still perceiving an acceptable yield of EVs is paramount
for LC-MS/MS analysis of EV containing samples and that proteome
profiling could possibly enable the identification of candidate
biomarkers for diagnosis, disease progression and treatment in MM
patients.
PW6.13
Erythrocyte cells and HRV16-infected HeLa cells derived microvesicles
protease profiling
Roberta Freezor, Gary McLean and Sheelagh Heugh
Faculty of life Sciences and Computing (FLSC), Cellular and Molecular
Immunology Research Centre (CMIRC), London Metropolitan University,
London, UK
Proteases determine the fate, localization and activity of many
proteins by the hydrolysis of the unique peptide bond. Therefore,
they play a key role in various physiological processes including
division, differentiation, migration, ageing and death of cells. This
suggests they may alter the contents of microvesicles (MVs) by
proteolytic processing and assist in MV-mediated cellcell commu-
nication. In this study, a detection panel of 34 proteases including
ADAMs, cathepsins, kallikreins and matrix metalloproteinases (MMPs)
was used and its presence observed in erythrocyte cells(e) and
HRV16-infected HeLa cells(HRV16iH) derived MVs. This contributes to
ongoing research into the characterization and functions of MVs.
eMVs and HRV16iHMVs were isolated through the ultracentrifugation
method: 200 relative centrifugal force (rcf) for 5 mins to pellet
cells, 4000 rcf for 1 h to remove large molecules and 25,000 rcf for
90 mins to concentrate samples. Subsequently, all samples were
prepared and experiment procedures were followed as directed by
R&D Systems Proteome Profiler(tm) Human Protease Array Kit
protocol. The location of controls and capture antibodies identifica-
tion were detected by the mean spot pixel density, created using
ImajeJ software. Cathepsins (A, B, D, V and X/Z/P) and MMPs (8 and 13)
were observed in all samples 300 mean pixels, whereas ADAM8,
ADAMTS13, cathepsins (E, S and X/Z/P), DPPIV, kallikreins (7 and 10),
MMPs (2,3 and 12), presenilin and PC9 were strongly expressed
on eMVs ranging 250 mean pixels with a significant expression of
MM9 550 mean pixels. In comparison, ADAM9, ADAMTS1 and
MMP10 nephilysinC were highly expressed on HRV16iHMVs. This
study has identified the presence of key molecules in MV biology.
This is a particularly exciting prospect, given that metalloproteinases
are intensively involved in MV biology. However, this concept needs
further investigation and understanding of the link between MVs and
proteases. This will help unravel their complex biological functions in
human diseases and may open new perspectives on MV activities.
PW6.14
Proteomic analysis of redox signalling in extracellular vesicles
Lakshmi Krishnamoorthy and Christopher Chang
University of California at Berkeley, California, USA
Introduction: Cancer cells produce copious amounts of reactive
oxygen species (ROS) owing to their high metabolic activity and
increased signal transduction, but increased levels of ROS can
generate aberrant oxidative stress and trigger damage events. As
such, the survival, migration and proliferation of cancer cells are
influenced by the delicate balance between pro- and antioxidant
molecules. At the molecular level, reversible oxidation of cysteine
residues is one of the key mechanisms involved in modulating the
effects of ROS, but redox signalling of proteins within extracellular
vesicles (EVs) remains insufficiently understood. Methods: The reactive
cysteines in a proteome can be identified using various reactivity-
based protein profiling reagents in conjunction with chemical pull-
down and enrichment followed by tandem mass spectrometry, thus
allowing for proteomic profiling of cell lysates and EVs from normal
mammary epithelial cells and breast cancer cells. Results: Character-
ization of EVs has revealed a number of modified cysteine residues in
vesicles, thereby establishing that rich redox reactivity exists within
these extracellular vesicles. In addition, we are also assaying these EVs
for specific ROS-generation and antioxidant machinery to better
understand the contributions of EVs to redox signalling and stress
pathways in cancer cells. Summary/conclusions: This targeted chemical
biology approach for the analysis of EV proteomics will enable us to
dissect the roles of ROS and their effects on protein function in
extracellular vesicles during cancer progression.
PW6.15
Phospholipid profiles of red blood cells and their extracellular vesicles
are not significantly changed during storage of red cell concentrates
Erja Kerkela¨1, Eva Laure´n1, Feven Tigistu-Sahle2, Sami Valkonen2,
Maarit Takatalo2, Pia Siljander2, Reijo Ka¨kela¨2 and Saara Laitinen1
1Finnish Red Cross Blood Service, Helsinki, Finland; 2University of Helsinki,
Finland
During storage, red blood cells (RBCs) undergo physical and chemical
changes affecting their quality and function, leading to accumulation
of cell waste in red cell concentrates. These changes are referred
to as ‘‘storage lesion.’’ The RBC membrane is heavily affected by
storage as RBCs lose 20% of their membrane via vesiculation.
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The clinical relevance of the storage lesion, or vesiculation in relation
to the quality and safety of RBC concentrates, is still unclear. However,
the accumulating extracellular vesicles (EVs) might serve as potential
markers of RBC quality, and EVs may also be immunogenic. Our aim
was to identify the phospholipid composition of RBCs and EVs during
storage. Our hypothesis was that certain lipid classes or species might
accumulate in EVs. Additionally, the immunological effects of EVs
were studied. Red cell concentrates (n = 6), stored in standard blood
banking conditions (35 days), were sampled weekly. RBCs were
pelleted and resulting supernatant was ultracentrifuged to obtain
EVs. Mass spectrometric analysis of phospholipids, nanoparticle
tracking analysis, western blot and electron microscopy were per-
formed. The immunological effects of EVs and supernatants were
studied with in vitro assay. The most abundant phospholipid classes
in RBCs were phosphatidylcholine (PC), phosphatidylethanolamine
and sphingomyelin, which together constituted the majority of all
phospholipids, followed by phosphatidylserine and small amounts of
lysoPC and ceramides, as previously described. According to pre-
liminary analysis, phospholipid profiles did not significantly change
during storage in RBCs or EVs and no accumulation of certain lipids
could be detected in EVs, even during prolonged storage, although EV
amount increased considerably. The lipid profile of EVs resembled
that of RBCs. Preliminary data indicate that especially red cell
concentrate supernatant, but less the EVs, induced the proliferation
of T cells indicating pro-inflammatory characteristics.
PW6.16
Extracellular vesicles from tumour cells display specific glycosignatures
Julia Costa1,2, Patricia Gomes-Alves1,2, Joana Gomes1, Sofia Carvalho1,2,
Cristina Peixoto1,2, Paula Alves1,2, Peter Altevogt3 and Markus Glatzel4
1ITQB-UNL, Oeiras, Portugal, 2iBET, Instituto de Biologia Experimental e
Tecnolo´gica, Oeiras, Portugal, 3Department of Dermatology, Venereology and
Allergology, University Medical Center Mannheim, Ruprecht-Karl University of
Heidelberg, Mannheim, Germany; 4University Medical Center Hamburg-
Eppendorf, Hamburg, Germany
Introduction: Extracellular vesicles (EVs) present specific lipid and
protein compositions. More recently, evidence has also shown that
EVs have specific glycosylation profiles and are enriched in distinct
glycoproteins. Methods: In this work, EVs have been purified from
supernatants of tumour cells (ovarian carcinoma OVM, SKOV3,
glioma Tu-2449, H4 cells) in culture. Supernatants were centrifuged
at 500g, 10,000g and 100,000g. EVs (100,000g pellet) were
analysed by immunoblotting with antibodies anti-Tsg101, Alix,
CD63, CD9, flotillin-2 and galectin-3-binding protein. EVs were
analysed by nanoparticle tracking analysis. Total membranes (MBs)
were obtained by cell sonication followed by ultracentrifugation
at 100,000g. EVs were analysed by lectin blotting with a panel of
lectins (including Maackia amurensis and Sambucus nigra lectins for
sialylated glycans; Phaseolus vulgaris erythroagglutinin for bisecting
GlcNAc; Gomes et al., 2015). N-Glycan profiles were established
by HPAEC-PAD and MALDI-TOF MS (Escrevente et al., 2013). Results:
The 100,000xg pellet was enriched in EVs as evaluated from the
detection of specific markers. Furthermore, the collected EVs had
diameters compatible with those described in the literature. The
glycoprotein galectin-3-binding protein was strongly enriched in EVs
relatively to MBs, and it contained sialylated complex N-glycans.
Lectin blotting with a panel of lectins showed that EVs had specific
glycosignatures relatively to MBs. Furthermore, characteristic glycan
structures have been identified in the tumour cells. Conclusion:
EVs have characteristic glycosignatures, which could result from
specific sorting mechanisms of glycoproteins into EVs. The identified
glycosignatures could provide with novel cancer markers.
References
1. Escrevente et al. (2013). PLOS One 8, e78631.
2. Gomes et al. (2015). Biomolecules 5, 174161.
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Minimizing the loss of exosomes during their storage at 48C
Elena Khomyakova1, Evgeniy Evtushenko2, Mikhail Livshits3,
Vassili Lazarev1, Dmitry Bagrov2, Edward Generozov1and
Vadim Govorun1
1Federal Research and Clinical Center of Physical-Chemical Medicine, Moscow,
Russia; 2Lomonosov Moscow State University, Moscow, Russia; 3Engelhardt
Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia
Introduction: Extensive studies and wide applications of exosomes in
clinical diagnostics require the standardization of not only isolation,
but also storage conditions. However, at present there is no strictly
established protocol for exosomes storage. It is a rather common
practice to store the exosomes at 48C for a couple of days to avoid
freeze-thaw cycle. In this work, we analyse the influence of buffer
composition and tube surface pre-treatment on kinetics of exosomes
loss during the storage at 48C. Methods: Exosomes from HT29 cell
culture supernatant were purified by differential centrifugation,
aliquoted and kept at 808C. Further, the aliquots were conse-
quently unfrozen, dissolved in different storage buffers, placed into
the tubes with different surface treatment and kept at 48C. The
kinetics of exosomes concentration decay was followed with Nano-
Sight LM10 HSBF instrument. TEM was used to determine the
morphology of the particles. Results: NTA data show that the
concentration of exosomes stored in PBS essentially decreases during
12 h of the storage. However, if exosomes are stored in HT29
supernatant, no essential decrease of their concentration is observed.
One of the explanations may be absorption of the exosomes on the
tube wall. According to theoretical estimation, a standard 2 mL
polypropylene tube could adsorb up to 1010 particles/mL. Higher
stability of exosomes stored in cell culture supernatant may be due to
the fast blockage of tube walls by proteins, thus preventing the
adsorption of exosomes. We also demonstrate that pre-treatment of
tube surface can minimize the exosomes loss during storage.
Summary/conclusion: Exosomes may absorb to the tube wall during
storage at 48C. Storage of non-pelleted exosomes or use of pre-
treated tubes can reduce the exosomes loss. The work was partly
performed at User Facilities Center of MSU.
Support was provided by Ministry of Education and Science of the
Russian Federation (grant No. 14.607.21.0068, Sep 23, 2014).
PW7.02
A protocol for isolation and proteomic characterization of distinct
extracellular vesicle subtypes by sequential centrifugal
ultrafiltration
Rong Xu, David Greening and Richard Simpson
Department of Biochemistry and Genetics, La Trobe Institute for Molecular
Science, La Trobe University, Melbourne, Victoria, Australia
Please see OPW1.1
PW7.03
An ultracentrifugation-based protocol for exosome isolation in diffuse
large B-cell lymphoma
Vildan Caner, Sevil Zencir, Sibel Hacioglu, Gulseren Bagci, Ismail Sari,
Ikbal Cansu Baris, Emre Tepeli, Nilay Sen Turk and Gokhan Ozan Cetin
Pamukkale University, Denizli, Turkey
Introduction: Non-Hodgkin’s lymphoma (NHL) is the eighth most
common cancer in women and the seventh most common cancer
in men in Turkey. Most NHL is derived from B cells and the most
common type is diffuse large B-cell lymphoma (DLBCL). The studies on
exosomes in DLBCL are still very limited. The aim of this study was to
characterize the exosomes in the patients with DLBCL compared to
healthy controls. Methods: Eleven patients with DLBCL (4 with
germinal centre B-cell phenotype and 7 with non-germinal centre B-
cell phenotype) and 13 age- and sex-matched healthy controls were
included in the study. Blood samples were drawn from the right
antecubital vein using a large (21-gauge) needle and processed
within 30 min. Briefly, two-step centrifugation was used to obtain the
platelet-free plasma samples. After a 0.2 mm filtration, the samples
were ultracentrifuged at 110,000g for 2 h and 100,000g for 1 h to
pellet exosomes. The exosomes were characterized by electron
microscopy, specific markers commonly used for exosome detection
and protein quantity. Results: All exosome samples showed typical
morphology and expressed exosomal markers such as CD63, CD81
and TSG101, however at different levels. Total protein content was also
higher in the cancer patient exosomes compared to the controls.
Summary/conclusion: Our results showed that the centrifugation-
based procedures assessed in this study are able to isolate high-
quality, analysable exosomes in DLBCL patients. We suppose that it
would be important to describe the strategies for the isolation of high-
quality exosomes from blood samples of DLBCL patients before
focusing on further experiments.
PW7.04
Methodological comparison of CSF extracellular vesicle
extraction as a novel source of biomarkers in amyotrophic
lateral sclerosis
Elizabeth Gray1, Alexander Thompson1, Imre Mager2, Kevin Talbot1,
Samir Andaloussi2,3, Matthew Wood2 and Martin Turner1
1Nuffield Department of Clinical Neurosciences, University of Oxford,
Oxford, UK; 2Department of Physiology, Anatomy and
Genetics, University of Oxford, Oxford, UK; 3Department of Laboratory
Medicine, Karolinska Institutet, Stockholm, Sweden
Introduction: Biomarkers sensitive to disease activity are needed to
advance therapeutic development for the adult fatal neurodegenerative
disorder amyotrophic lateral sclerosis (ALS). Cerebrospinal fluid (CSF) EVs
may reflect core pathogenic processes with promise for biomarker
discovery, though extraction and analysis have been limited by variable,
often poor yield with insufficient exclusion of contaminating protein. The
aim of this study was to optimize the extraction of EVs from the CSF of
ALS patients for subsequent proteomic characterization. Methods: EVs
were purified from CSF either by ultracentrifugation (UC) or ultrafiltration/
liquid chromatography (UF-LC). Purified EVs were quantified and char-
acterized using transmission electron microscopy (TEM), nanoparticle
tracking analysis (NTA) and western blotting for known exosomal markers
(ALIX and CD9). Results: Both methods produced purified EVs. NTA
revealed more particles of the expected size distribution and improved
protein exclusion following UF-LC, compared to UC. Details of compara-
tive morphology and marker expression are presented. Conclusions: UF-
LC is a more potent method to advance the goal of neurochemical
biomarker development in ALS and central nervous system disorders
more widely.
Acknowledgements: This work was funded by the Medical Re-
search Council and Motor Neurone Disease Association UK Lady
Edith Wolfson Fellowship and Oxford University John Fell Fund
(both MRT).
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PW7.05
Comparison of a fast column-based EV isolation method with
ultracentrifugation and size-exclusion chromatography
Maija Puhka1, Maarit Takatalo2,3, Sami Valkonen2,3, Olli Veikkola1,
Manuel Aledo-Ferra´ndez2,3, Marjo Yliperttula3,4, Olli Kallioniemi1,
Taija Af Ha¨llstro¨m1 and Pia Siljander2
1Institute for Molecular Medicine Finland (FIMM), Helsinki Urological Biobank,
Helsinki, Finland; 2EV-group, Biochemistry and Biotechnology, Faculty of
Biological and Environmental Sciences, Helsinki, Finland; 3Division of
Pharmaceutical Biosciences, Faculty of Pharmacy; University of Helsinki,
Helsinki, Finland; 4Departement of Pharmaceutical and Pharmacological
Sciences, University of Padova, Padova, Italy
Introduction: The methods used for extracellular vesicle (EV) isolation
are often tedious or have other limitations with respect to sample
volume, aggregation, yield or purity. Therefore, EV research will
benefit from the introduction of new, more simple and efficient EV
isolation methods. Our aim was to compare a new column-based
method to differential centrifugation and size-exclusion chromato-
graphy using plasma as the source material of EVs. Methods: The
endpoint parameters were purity, yield, quality and integrity of EVs
analysed by nanoparticle tracking analysis (NTA), electron micro-
scopy (EM), flow cytometry, western blotting (WB) and RNA analysis.
Results: The most notable differences between the column method
and other methods were observed in EM and light scattering-based
methods. Negative staining protocol for column-derived EVs showed
black aggregates in addition to regular EVs that were the only
population observed with other methods. The elution buffer of the
column method alone showed considerable number of particles
using either NTA or flow cytometry that were not detected in other
buffers used as diluent. However, the purity of the EV sample was
acceptable and the yield comparable or better than with the other
methods. Conclusions: The EM and the two light scattering methods
suggested the presence of larger particles in the column-derived
EV preparations perhaps due to the elution buffer, which may
complicate some downstream analysis.
PW7.06
Comparison of exoEasy Maxi kit (Qiagen) with size-exclusion
chromatography qEV columns (Izon Science) for isolation of
extracellular vesicles from human plasma
Ruzena Stranska1, Jens Wouters2, Katarzyna Bloch2, Robert Snoeck1 and
Graciela Andrei1
1Rega Institute, Laboratory of Virology and Chemotherapy, KU Leuven, Leuven,
Belgium; 2Department of Oncology, KU Leuven, Leuven, Belgium
Introduction: Identification of extracellular vesicle (EV)-associated
biomarkers is crucially dependent on isolation methods that yield
pure EVs without contaminating plasma proteins and lipoproteins
and that are reproducible, efficient and easy to perform. Size-
exclusion chromatography (SEC) has increasingly become a method
of choice for isolation of uncontaminated EVs from plasma. More
recently, Qiagen introduced a new membrane affinity spin column
method for the isolation of highly pure EVs from biofluids named
exoEasy Maxi Kit. We have compared the exoEasy Maxi kit (Qiagen)
with the SEC using qEV columns (Izon Sciences) for the isolation of
EVs from 2 mL of human plasma. Methods: EV-rich SEC fraction pools
or exoEasy Maxi Kit eluates were concentrated, and the yield, size
distribution and purity of EVs were determined by NTA, EM and
western blot analysis. RNA was extracted by miRNeasy Micro Kit
(Qiagen), and yield and size range were analysed using Agilent
Bioanalyzer. Results: EM analysis confirmed enrichment of vesicles in
SEC early fractions, which sharply contrasted with rare occurrence of
vesicles in exoEasy Maxi kit eluates. NanoSight data showed smaller
particle peak size of EVs isolated by SEC (127 nm) compared to
exoEasy Maxi kit (196 nm). Particles per microgram protein ratio were
significantly higher for SEC suggesting a protein contamination in
exoEasy Maxi kit preps. Correspondingly, enrichment of exosomal
markers (syntenin, flotillin-1, CD9) was higher in SEC preps with a
significant albumin contamination in exoEasy Maxi kit preps. The
Bioanalyzer profile of isolated RNA indicated the presence of small
RNAs without rRNA in both methods. ExoEasy Maxi kit RNA yield
was higher. Conclusion: qEV columns (Izon Science) outperform the
exoEasy Maxi kit (Qiagen) for the isolation of highly pure EVs for
biomarker research.
PW7.07
Comparison of isolation methods for EVs from fresh and frozen serum
and plasma samples
Verena Bo¨rger1, Sheila Lo´pez-Cobo2, Crista Ochsenfarth3, Aikaterini
Krikoni1, Michel Bremer1, Luis Felipe Santos Manvailer1, Ioana Cosgarea4,
Sabine Schramm1, Monika Collenburg1, Ulrich Frey3, Annette Paschen4,
Peter A. Horn1, Vera Rebmann1 and Bernd Giebel1
1Institute for Transfusion Medicine, University Hospital Essen, Essen, Germany;
2Department of Immunology and Oncology, Centro Nacional de Biotecnologı´a,
Agencia Estatal Consejo Superior de Investigaciones Cientı´ficas, CNB-CSIC,
Madrid, Spain; 3Department of Anesthesiology and Intensive Care Medicine,
University Hospital Essen, Essen, Germany; 4Department of Dermatology,
University Hospital Essen, Essen, Germany
Extracellular vesicles (EVs), such as exosomes and microvesicles, are
increasingly considered as signalling organelles in intercellular
signalling as well as biomarkers in a variety of different diseases.
Despite extensive studies on their functional properties, no gold
standard to isolate them from cell culture supernatants or body fluids,
respectively, has been defined so far. Here, we compared several
commercial and non-commercial methods to harvest EVs from plasma
and serum samples. In detail, we compared 4 procedures based
on ultracentrifugation, 3 on size-exclusion chromatography and 3 on
polymer-based precipitation. To this end, freshly taken and frozen
serum and plasma samples from 5 healthy volunteers were taken;
cells, organelles and cell debris were eliminated via differential
centrifugation (300g; 2000g and 10,000g). Aliquots of 500 mL
of each serum and plasma sample were used for EV enrichment with
each of the given methods. All obtained EV samples were analysed by
nanoparticle tracking analysis (NTA; Zetaview(r) from Particle Metrix)
to determine particle concentrations and average size distributions.
In addition, protein concentrations were determined using the
Pierce(tm) BCA Protein Assay Kit. In our ongoing work, we currently
analyse the presence of defined EV markers, that is, CD9, CD81 and
TSG101. So far, we detected severe differences in the EV and protein
yield between the different methods; the average size distribution
was comparable within all fractions. After obtaining the western blot
data, we can finally compare and analyse the data. The obtained
results will provide new insight on EV isolation methods for small
serum or plasma samples, for example, to perform liquid biopsy
analyses on patient-specific materials.
PW7.08
Impact of SEC, PEG and PROSPR isolation methods on Extracellular
Vesicles: A Comparative Study
Ana Ga´mez-Valero1,2, Laura Carreras1, Marta Monguio´-Tortajada1,
Marcel’la Franquesa1, Katrin Beyer2 and Francesc E. Borra´s1,3
1Remar-Ivecat Group, Health Science Research Institute Germans
Trias I Pujol, Can Ruti Campus, Badalona, Spain; 2Department of
Pathology, Hospital Universitari and Health Sciences Research Institute
Germans Trias i Pujol, Universitat Auto`noma de Barcelona, Spain;
3Nephrology Service, Germans Trias i Pujol University Hospital,
Badalona, Spain
Introduction: One of the major challenges in the extracellular vesicles
(EVs) field is to find a consensus method for EVs isolation. Historically,
ultracentrifugation has been the most widely used method though
new methodologies are emerging. Lately, a cold acetone-based
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protein precipitation method, PRotein Organic Solvent PRecipitation
(PROSPR), has been reported. Here, we have compared PROSPR,
PEG precipitation and size-exclusion chromatography (SEC) evaluat-
ing the workflow time, total protein content, nanoparticle tracking
analysis (NTA), flow cytometry for EV markers and small RNA
extraction. Methods: EVs from urine and serum samples were isolated
by SEC, PEG and PROSPR. Protein content of purified fractions was
measured by the BCA protein assay and NanoDrop analysis. Purified
EVs were characterized by NTA and flow cytometry. Small RNAs were
extracted from serum-derived EVs obtained from each method.
Results: EVs were successfully purified by the 3 methods. Total
protein content in the EV preparations using both precipitation
methods was higher than using SEC. When characterized by NTA and
flow cytometry, PROSPR and PEG preparations also showed higher
EV concentration by NTA compared to SEC, but EV markers (CD9,
CD63 and CD81) were uniquely detected by flow cytometry when
purified by SEC. Small RNAs were positively extracted from all
3 isolation methods, being the RNA yield higher using PEG and
PROSPR precipitating agents. Conclusions: Although precipitation
strategies result in higher protein and RNA contents, SEC removes
the overabundant soluble proteins and contaminants as reflected by
BCA, NanoDrop and NTA analysis. Higher concentration of small RNA
in PEG and PROSPR may be related to non-EV contaminants.
Moreover, only SEC allowed the detection of EV markers, suggesting
a putative interference of these precipitation agents in the structure
and/or composition of the vesicles that should be taken into account
depending on their forthcoming application.
PW7.09
Comparative analysis of urine storage, exosomes/EV purification and
normalization methods for the selection of most appropriate solutions
for biomarker discovery, clinical diagnostics and biobanking
Natasa Zarovni1, Antonietta Corrado1, Giorgia Radano1, Elisa Lari1,
Davide Zocco1 and Riccardo Vago2
1Exosomics Siena Spa, Siena, Italy; 2Urological Research Institute, Istituto di
ricovero e cura a carattere scientifico Ospedale San Raffaele, Milan, Italy
Please see OPW1.4
PW7.10
Isolating exosomes from cell culture supernatant: a comparison of
commonly used protocols
Sebastian Borosch, Sandra Kraemer, Eva Dahmen, Mareike Hoß,
Christian Beckers, Christian Stoppe and Andreas Goetzenich
University Hospital RWTH Aachen, Aachen, Germany
Introduction: Numerous exosome isolation methods are described
including different ultracentrifugation (UC) protocols, size-exclusion
chromatography (SEC) and commercial kits based on precipitation,
immunoaffinity or membrane affinity capture. The most common
protocol is differential (ultra)centrifugation, but even this method
differs between publications, regarding pre-centrifugation treat-
ments, speed, duration and washing. Therefore, we wanted to
compare different UC-protocols among each other as well as the
two most efficient UC protocols with SEC and two commercial kits.
Methods: Cardiac cells were grown in medium (1% exosome-depleted
FCS) for 48 h. Six different UC-protocols were compared:9sucrose
cushion, filtration before or after UC and also different washing steps.
UC was carried out at 118,000g for 90 min. Additionally, supernatants
were concentrated and exosomes were isolated via SEC or the
commercial kits ExoEasy and Exospin. Exosomes from all methods
were characterized by tunable resistive pulse sensing (TRPS) and
electron microscopy. Purity was assessed by protein to particle ratio
and the exosomal cargo was analysed by western blot. Results:
Different isolation methods, even the 6 UC protocols, lead to different
exosomal subsets with varying marker expression. The comparison
between UC, SEC, ExoEasy and Exospin showed that ExoEasy
resulted in the highest yield but also the lowest purity. UC showed
fewer impurities but also resulted in less yield and was very time
consuming. SEC produced the purest exosomes with the smallest
yield. Conclusion: Isolation of exosomes with different UC protocols
leads to different exosomal subpopulations, which should be
carefully considered. Without the use of a sucrose cushion, the
exosomes had high amounts of impurities. The kits resulted in a
high exosome yield but also co-isolated contaminating proteins. Thus,
SEC showed the most promising balance between yield, purity and
effort.
PW7.11
Isolation of extracellular vesicles from plasma using magnetic
nanoparticles functionalized with annexin-A5
Romain Linares1, Yan Boucaud1, Stephane Mornet2, Laurent Adumeau2,
Ce´line Gounou1 and Alain Brisson1
1University of Bordeaux, CNRS UMR-CBMN, Pessac, France; 2CNRS UPR-ICMCB,
Pessac, France
Introduction: Extracellular vesicles (EVs) are recognized to display
various physio-pathological properties. Given their heterogeneity in
origin, composition and function, it is critical to develop reliable
methods for isolating EVs. Commonly used methods, like SEC or
centrifugation, are non-specific and can lead to sample modifications
(1). On the other hand, immuno-magnetic isolation is specific and
has proven its efficiency to purify cells or EVs (2). We will report on
the synthesis of 60 nm magnetic nanoparticles (MNps) and their
conjugation with annexin-A5 (Anx5). Anx5-MNps were used to
isolate phosphatidylserine (PS) exposing membranes, namely, lysed
red blood cells (RBC) or PS-positive EVs from platelet-free plasma
(PFP). Electron microscopy (EM) was used for imaging lysed RBCs and
EVs, and flow cytometry (FCM) allowed us to quantify the efficiency
of the magnetic isolation. Methods: The binding of Anx5-MNps to PS-
exposing membranes was measured by direct counting of MNps
bound to lysed RBCs, by EM. The efficiency of magnetic isolation was
determined by FCM after labelling lysed RBC and PFP EVs with Anx5-
Cy5. Results: First, we used lysed RBCs as a model system to study, by
EM, the influence of the incubation time and the concentrations of
Anx5-MNps and lysed RBC on the binding of Anx5-MNps. Then, we
investigated the relationship between the number of Anx5-MNps
bound per lysed RBC and the efficiency of magnetic isolation,
by FCM. Third, based on these results, the isolation of PS-positive EVs
from PFP was studied. Reproducible conditions of total extraction
were obtained. Summary/conclusion: An optimized method was
developed for isolating PS-positive EVs, using Anx5-MNps. This
approach is currently applied to the isolation of erythrocyte- or
platelet-derived EVs. Future work will focus on the composition
analysis of isolated EVs by mass spectrometry.
References
1. Linares et al., J. Extracellular Vesicles 2015,4: 29509.
2. Arakelyan A et al., Nanomedicine: NBM 2015; 11:489498.
PW7.12
Improved large-scale EV production using a two-compartment
bioreactor
Heikki Saari, Mari Palviainen, Maarit Neuvonen, Marjo Yliperttula and
Pia Siljander5
University of Helsinki, Finland
Introduction: Large-scale production of extracellular vesicles
(EVs) requires extensive volumes of traditional 2D cell cultures,
which consume media, laboratory equipment and working time. In
this work, we examined the possibility to use of a two-compartment
bioreactor in order to make EV production more efficient.
Methods: PC-3 prostate cancer cells (ATCC, USA) were grown both
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in T-175 cell culture flasks and in a Celline AD 1000 bioreactor
(Integra). Cell culture medium for 2D culture was supplemented with
FBS depleted from EVs by ultracentrifugation. The bioreactor
medium was supplemented with additional glucose (4.5 g/L), and
only the medium in the medium compartment (750 mL), separated
by a 10 kDa cut-off membrane, was supplemented with untreated
FBS. The cell conditioned medium (CM) was harvested three times
per week from the 2D cultures and once per week from the
bioreactor cell compartment. The EVs were collected by differential
centrifugation into 20kg and 110kg pellets and analysed
by electron microscopy, western blotting, nanoparticle tracking
analysis (NTA) and Apogee flow cytometry. Results: The PC-3 cells
in the bioreactor produced approximately 121012 EVs collected
in the 20k pellet and 241012 in the 110k pellet from 15 mL of
CM, while a single 2D cell culture flask produced approximately
121010 and 811109 EVs, respectively, from 25 mL of CM over
7 days. No FBS-derived particles penetrated the 10 kDa mem-
brane into the cell compartment as analysed by NTA. Detailed
characterization of the differently produced EVs is currently in
progress. Conclusions: Bioreactors have the potential to improve EV
production in virtually every aspect. The structure of the bio-
reactor allows a high concentration cell culture in a 3D matrix,
improving the EV yield, reducing the workload and bringing the
culture closer to in vivo conditions. To best utilize them, the
produced EVs need careful comparison with the EVs produced in
standard 2D cultures.
PW7.13
Rapid detection and enrichment of tumour-derived exosomes using
targeted high-density lipoprotein-like gold nanoparticles
Nicholas Angeloni1, Kaylin Mcmahon1, Suchitra Swaminathan1,
Iman Osman2, Olga Volpert1 and C. Shad Thaxton1
1Northwestern University, Evanston, Illinois, USA; 2New York University,
New York, USA
Introduction: Exosomes produced by tumour cells (TEx) contain a
wealth of information about their parent cell and could be excellent
serum biomarkers for early-stage cancer or occult metastasis.
However, existing protocols for exosome isolation are costly, labor-
ious and lack the ability to differentiate between TEx and host
exosomes. New detection methods would more fully reveal the
diagnostic potential of TEx. Scavenger receptor type B1 (SR-B1)
is present on TEx from multiple cancer cells. Because SR-B1 is a
high-affinity receptor for high-density lipoprotein (HDL), we used a
synthetic HDL-like gold nanoparticle (HDL NP) for targeting TEx-
associated SR-B1 to detect and enrich TEx with high specificity from
tissue culture media and patient sera. Methods: HDL NPs were labelled
with a fluorophore and incubated with TEx from a variety of sources:
(1) conditioned media from tumour cells, (2) TEx-spiked serum of
healthy individuals and (3) sera obtained from melanoma patients.
Samples were then stained with CD81-specific antibody. CD81-
positive TEx labelled with the fluorescent particle(s) were visualized
and quantified by flow cytometry. Low-speed centrifugation (16,000 g
for 1 h) was used to isolate TEx associated with gold particles for
western blot analysis. Human sample collection was covered by
Northwestern University and New York University Institutional
Review Board protocols, and informed consent was obtained from
all patients. Results and summary/conclusion: Fluorescent HDL NPs
bind a significant population of TEx as visualized by flow cytometry.
The HDL NP-bound TEx population scaled proportionally with
increasing amounts of TEx added to the sample. Precipitation of gold
particles efficiently retrieved TEx, as was evidenced by western blot for
CD81 and SR-B1. The yields of SR-B1 positive TEx from the sera of
healthy individuals were low, while significant amounts were found
in the sera from melanoma patients. In conclusion, we have developed
a new HDL NP technology, which enables rapid TEx detection using
small sample volumes. This technology should increase TEx utility
as a biomarker, particularly for hard-to-detect cancers or occult
metastasis by facilitating fast, easy and specific TEx retrieval for
molecular analysis.
PW7.14
Isolation and purification of extracellular nanostructures from
Novosphingobium sp. PP1Y: a novel example of Outer Membrane
Vesicles?
Federica De Lise1, Francesca Mensitieri1, Giulia Rusciano1,
Antonio Molinaro1, Fabrizio Dal piaz2, Anna Di Cosmo1, Antonio Sasso1,
Alberto Di Donato1 and Viviana Izzo2
1University of Naples Federico II, Napoli, Italy; 2University of Salerno, Baronissi,
Italy
Outer membrane vesicles (OMVs) are nanoscale proteoliposomes
of 20200 nm diameter, derived from the surface of some Gram and
Gram+ bacteria as part of their growth cycle. OMVs have several roles;
they can reduce levels of toxic compounds, remove stress pro-
ducts from the cell such as misfolded proteins, and have a role
in biofilm formation (Adam K et al. Annu Rev Microbiol. 2010; 64: 163
84). The biotechnological use of OMVs, for example as drug delivery
systems, is limited by the presence in their outer membrane of the
immunogenic LPS produced by Gram bacteria. As a consequence,
much interest is currently devoted to vesiculating strains lacking
LPS. In this context, an appealing source of OMVs can be found
among Sphingomonadales, an order of Gram- bacteria lacking LPS. A
marine microorganism belonging to this order, Novosphingobium sp.
PP1Y, was isolated in the harbour of Pozzuoli and microbiologically
characterized. This bacterium is able to grow in a very polluted en-
vironment and to use polycyclic aromatic hydrocarbon as a source
of carbon (Notomista E. et al. Microb Ecol. 61(3) (2011) 582594).
We have successfully isolated extracellular nanostructures from
Novosphingobium sp. PP1Y for which different growth conditions
were tested. AFM analysis showed the production of circular
nanostructures when PP1Y was grown in minimal medium supple-
mented with 0.4% glutamate. These were purified from the exhausted
growth media following ultrafiltration and ultracentrifugation proce-
dures; AFM and DLS analyses indicated for these structures a circular
morphology with a diameter of ca. 200 nm, and a rough uniformity in
both size and conformation. These preliminary results boost a more
detailed characterization of these nanoparticles to identify both the
proteomic and lipidomic profile. In addition, the complete annotation
of Novosphingobium sp. PP1Y genome (D’Argenio V. et al. BMC
Genomics (2014) 15, 384397) is an advantage and gives the
possibility to further engineer surface proteins of PP1Y OMVs.
PW7.15
Large-scale production of extracellular vesicles in a hollow fibre
bioreactor
George Pavlakis1 John Ludlow2, Dionysios C. Watson3 and
John Cadwell4
1National Cancer Institute, Rockville, Maryland, USA; 2Zen-Bio, Durham,
North Carolina, USA; 3Human Retrovirus Section, National Cancer Institute,
National Institutes of Health, Bethesda, Maryland, USA; 4FiberCell Systems Inc.,
Frederick, Maryland, USA
Introduction: Production of extracellular vesicles (EVs) such as
exosomes for clinical applications remains a challenge. Current
methods can utilize large numbers of flasks and serum starvation
in a batch mode process. Hollow fibre bioreactors are perhaps ideal
for producing large quantities of EV at 100X higher concentrations
than conventional protocols. They support the culture of large
numbers of cells at high densities, 12108 cells/mL. Cells are
bound to a porous support with a 20 kDa MWCO so cell passaging is
not required and EV cannot cross the fibre in either direction.
Methods: 5108 adipose-derived adult MSC were cultured in a
hollow fibre bioreactor for 8 weeks. Cells did not expand (monitored
by glucose uptake rate) nor did they differentiate (by multiple
immunocytochemistry assays) over this time. 40 mL of conditioned
medium from the extra-capillary space was harvested weekly.
An HEK293 culture expressing heterodimeric interleukin-15 was
similarly maintained in hollow fibre culture for over 4 months, with
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3 harvests of 20 mL per week. Results: 4.21012 EV particles with
total protein of 27.73 mg in 720 mL were harvested from the adult
adipose-derived MSC culture. The HEK293 bioreactor culture yielded
approximately 11012 EV/mL compared to about 1109 EV/mL in
flask culture. CD63 and Alix were greatly enriched from the
bioreactor compared to flask culture. Additionally, EV/protein was
10-fold higher in harvests from the bioreactor suggesting higher
purity as well. Purified HEK293 cell EV retained their IL-15 bioactivity.
Summary/conclusion: Hollow fibre bioreactors have demonstrated
potential for the production of EV using cGMP compliant materials
and methods with a number of significant advantages compared to
flask-based protocols including higher concentrations, large capa-
city, time and space efficiency, and perhaps EV quality. Current
technology can produce gram quantities of EV, with potential use for
clinical applications.
PW7.16
Development of an automated microfluidic platform for the isolation
of extracellular vesicles
Chihchen Chen1,2, Hsing-Yu Lin1, Hung-Lin Cheng2, Wen-Hsin Chang1,
Yi-Hsing Hsiao2 and Gwo-Bin Lee1,2
1Department of Power Mechanical Engineering, National Tsing Hua University,
Hsinchu, Taiwan; 2Institute of Nanoengineering and Microsystems,National
Tsing Hua University, Hsinchu, Taiwan
Isolation of extracellular vesicles (EVs), often a tedious process,
can greatly affect the clinical importance of EVs. We are developing
an automated microfluidic platform that is capable of isolating E
Vs without user’s attention. The platform consists of pneumatic
valves and pumps for the transport and controlled gentle mixing of
solutions, respectively. EVs were captured by the specific antibody
coated on magnetic beads and then concentrated by a magnet.
Total RNAs were extracted and their concentrations were quantified
to assess the capture efficiency of the proposed method. The
capture yield increased by 1.8 times when the duration of mixing
was extended from 20 min to 22 h. Parameters affecting the
mixing EVs with magnetic beads are currently under optimization
to increase the capture yield.
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Identification of novel biomarkers by comprehensive proteomics in
urinary exosomes for prostate cancer detection
Mireia Olivan1, Ine´s De Torres2, Eduard Sabido´3, Juan Morote1,4,
Andreas Doll1, Michiel Pegtel5, Melania Montes1, Jaume Revento´s6,7,
Iolanda Garcia-Grau1, Cristina Chiva3, Marina Rigau1 and
Tamara Sequeiros1
1Biomedical Research Group in Urology, Vall Hebron Research Institut and
Universitat Auto´noma de Barcelona, Barcelona, Spain; 2Department of
Pathology, Vall d‘Hebron University Hospital, Barcelona, Spain; 3Proteomics
Unit, Centre de Regulacio´ Geno`mica (CRG), Barcelona, Spain; 4Department of
Urology, Vall d’Hebron University Hospital, Barcelona, Spain; 5Department of
Pathology, VU University Medical Center, Cancer Center Amsterdam,
Amsterdam, The Netherlands; 6Department of Basic Science, International
University of Catalonia, Barcelona, Spain; 7IDIBELL- Bellvitge Biomedical
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Background: Rapid and reliable diagnosis of prostate cancer (PCa) is
highly desirable. Sensitivity and failure rate of current methods for
diagnosis limit the success to early detect this type of cancer and,
consequently, advanced disease is often encountered. Furthermore,
the identification of PCa biomarkers that can classify patients into
high- and low-risk groups of disease progression and therefore help
in the treatment decision-making is a major area of ongoing research.
Objectives: In this study, we aimed to identify protein biomarkers in
urinary exosomes for early non-invasive detection and stratification of
PCa. Methods: Protein biomarker candidates for PCa were initially
identified from a discovery phase done in urinary exosomes from
urine obtained after digital rectal examination. Specifically, label-free
liquid chromatography coupled to mass spectrometry (LC-MS/MS)
protein quantitation was performed on 24 samples: 8 benign samples,
8 low-risk PCa samples and 8 high-risk PCa samples (Gleason 7).
Proteins significantly changing in abundance were selected for further
selected reaction monitoring (SRM) validation in 53 urinary exosomes
samples from PCa patients and 54 from benign counterparts. Results
and discussion: We identified 1673 proteins including PSA, PSMA and
ACPP and selected a panel of 64 candidates for validation by SRM.
Ultimately, we identified a profile of 2 novel urinary exosome-
associated protein biomarkers after the comparison between benign
and PCa patients and a promising profile of 5 proteins able to signi-
ficantly distinguish between high (Gleason =7 (4 + 3)) and low (Gleason
=7 (3 + 4)) risk patients. The presence of the candidates was confirmed
in urinary exosomes of PCa and benign prostate pathologies patients
by western blot and analysed in TMA PCa samples. In summary, our
proteomic studies identified a list of markers which are very good
candidates for evaluation of their clinical utility in future studies, in
order to reduce PCa-related over-diagnosis and over-treatment.
PW8.02
Identification of prostate cancer protein biomarkers by proteomics of
urinary extracellular vesicles
Irene Bijnsdorp1, Aarzo Kardar1,2, Tim Schelfhorst2, Thang Pham2,
Jaco Knol2, Sander Piersma2, Andre Vis1, Albert Geldof1,
Jeroen Van Moorselaar1 and Connie Jimenez2
1VU Department of Urology, Vu University Medical Center, Amsterdam,
The Netherlands; 2Department of Medical Oncology, Oncoproteomics
Laboratory, Vu University Medical Center, Amsterdam, The Netherlands
Background: Prostate cancer (PCa) is the most common cancer in
males. Extracellular vesicles (EVs) secreted by PCa cells can be found
in urine. The cargo of urine-EVs therefore represents an attractive
source for biomarkers to detect PCa in a minimally invasive manner.
Here we report on candidate PCa biomarker discovery using EV
isolation via ultracentrifugation. Yet for clinical application, isolation
should be easy and fast. Therefore, we investigated a novel EV-
isolation method that captures EVs using heat shock protein (HSP)-
binding peptides that aggregate HSP-decorated EVs (Ghosh, 2014).
Approach: In this study, we determined which proteins were related
to PCa using label-free proteomics in urine EVs (ultracentrifugation)
from 3 control, 3 indolent and 3 aggressive PCa patients. Further-
more, the protein profile in HSP-isolated EVs was compared in urine
samples of 2 control and 2 PCa patients by proteomics. Results:
In urine EVs, 3000 proteins were identified. Hierarchical cluster
analysis separated aggressive from indolent and control patients.
Candidate proteins (259) were selected based on significance
(pB0.05) and fold change (2). These proteins were functionally
related to translation and cell migration. Known PCa-markers were
differentially expressed, including PSA, PSMA, integrins, and CDH1.
In addition, several non-reported candidates were identified. The
overlap between the identified proteins isolated by HSP-kit and
ultracentrifugation across all 4 patients was large (86%), with a
correlation of R = 0.80. EV fractions obtained by both methods were
linked to established EV markers. In a preliminary exploration of
biomarker potential, unsupervised hierarchical cluster analysis of the
entire protein profile separated the control from the PCa-patients.
Conclusion: Urine EV proteins are attractive as source for biomarkers.
Furthermore, urinary EV isolation by HSP-binding peptides offers
new opportunities in the identification and application of PCa
biomarkers.
PW8.04
The potential of urinary exosomal miRNAs as biomarkers for prostate
cancer
Samuel Brennan1, Aled Clayton2, Paul Cozzi3 and Rosetta Martiniello-Wilks4
1University of Technology, Sydney; 2Division of Cancer and Genetics, School of
Medicine, Cardiff University, Cardiff, UK; 3Faculty of Medicine, University of
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Introduction: Prostate cancer is currently the most diagnosed cancer
of Australian men, and the incidence is likely to keep increasing
given our ageing population. Compounding this issue is the fact that
the available tests are either discouragingly invasive or lacking in
specificity/sensitivity and offer no prognostic information. To over-
come these issues, we have been profiling the RNA content of
exosomes isolated from human urine and assessing their utility as
diagnostic/prognostic markers. Methods: Human urine was collected
with consent from healthy, age-matched volunteers and prostate
cancer patients. The patient urine was collected both before and
after radical prostatectomy. Exosomes were then isolated from the
urine samples using ultrafiltration, followed by ultracentrifugation.
To ensure that exosome samples were of sufficient purity, NanoSight
and DELFIA Europium assays were performed to determine particle
size/concentration and to probe for exosomal markers. RNA was
then extracted from the exosomes and analysed using Bioanalyzer
Pico chips to ensure that only high-quality RNA was used for further
analysis. Finally, the RNA samples were profiled using Taqman-based
OpenArray technology. Results: All exosome samples isolated from
urine contained particles of expected size with minimal contamina-
tion, and the markers CD9 and TSG101 were abundant in all samples,
while AGO2 could not be detected. The Bioanalyzer confirmed
previous results showing that exosome samples contained mostly
small RNAs. The OpenArray results revealed 24 highly upregulated
exosomal miRNAs, and 4 of these marker candidates became
massively reduced in patient urine post radical prostatectomy.
Conclusion: Urine exosomal RNA shows great promise as a source
of diagnostic/prognostic markers for prostate cancer. Furthermore,
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the non-invasive method of isolating urine is likely to fill a significant
gap in the clinical care of prostate cancer.
PW8.05
A novel urinary EV-based prostate cancer assay that correctly predicts
cancer grade as identified in the biopsy sample
Remi Richard1, Marie-Eve Gingras1, Marc Savoie2, Guy Breault2,
Sebastien Fournier1, Melissa Daigle1, Michelle Davey1, Anirban Ghosh1
and Rodney J. Ouellette1
1Atlantic Cancer Research Institute, Moncton, Canada; 2Dr. Georges-L.-Dumont
University Hospital Centre, Moncton, Canada
Introduction: Prostate cancer (PCa) remains the most commonly
diagnosed cancer in men. Elevated blood PSA levels have led to
unnecessary biopsies due to low specificity. Growing evidence
suggests that EVs, and EV markers, are ideal candidates for liquid
biopsy. Using our fast and easy Vn96 peptide EV isolation method, we
are able to efficiently capture urinary EV markers that have clinical
value for PCa. Methods: Patients scheduled for prostate biopsy agreed,
per ethics approval, to provide us with post-DRE urine. Urinary EVs
were isolated either by ultracentrifugation (UC) or using the Vn96
peptide (Vn) protocol. EV protein markers and prostate-specific
protein markers were assessed by western blot (WB). Total and small
RNA was extracted from EVs and urine sediment and analysed by
qRT-PCR for prostate-specific markers. Results: WB revealed the
presence of EV and prostate-specific protein markers. WB also shows
an often greater abundance of these biomarkers with Vn-EVs
compared to UC-EVs. We show improved test specificity for PCA3
when used with the Vn-EVs compared to urine sediment. Vn-based
isolation increases PCA3/PSA ratio specificity by 14%. Urinary EV
marker investigation led to the discovery of a 5 gene panel (5-bio) and
a 10 biomarker panel (10-bio) with predictive PCa diagnosis, based on
biopsy outcome. 5-bio used with Vn isolation showed better accuracy
than with the UC isolation. 10-bio increased the specificity to 90%
and the sensitivity to 75%. Where high-grade PCa (Gleason =7) was
identified on the biopsy sample, the PCa assay using the Vn-EVs was
able to predict the outcome with a sensitivity of 100%. Summary/
conclusion: Here we have identified a Vn-isolated EV biomarker panel
with strong predictive value for PCa. We have also shown that even
better predictive value can be achieved as the cancer aggressiveness
increases. We demonstrate here a novel urinary EV-based prostate cancer
assay that is able to predict cancer grade using clinically viable tools.
PW8.06
Exosomal proteins as prostate cancer biomarkers in urine: from mass
spectrometry discovery to antibody-based validation
Alicia Llorente, Ling Wang, Tore Skotlande, Viktor Berge and Kirsten Sandvig
Oslo University Hospital, Oslo, Norway
Introduction: Exosomes have recently appeared as a novel source of
non-invasive cancer biomarkers since tumour-specific molecules can
be found in exosomes isolated from biological fluids. In terms of
prostate cancer, urinary exosomes may be a valuable source for
biomarkers since urine is easily collected and reflects changes in the
genitourinary system. We have analysed the proteome of urinary
exosomes by mass spectrometry to identify proteins differentially
expressed in prostate cancer patients compared to healthy male
controls. Validation of potential biomarkers by methods more often
used in the clinic, such as antibody-based methods, is ongoing.
Methods: Exosomes were isolated by ultracentrifugation and sub-
jected to several analyses to determine their concentration and
quality. The proteome of urinary exosomes from 15 healthy control
and 16 prostate cancer samples of urinary exosomes was analysed
by mass spectrometry. Western blot and ELISA were used to validate
the results of the mass spectrometry analysis. Results: Mass spectro-
metry analysis showed that 246 proteins were significantly changed
in urinary exosomes from healthy controls compared to prostate
cancer patients. At 100% specificity, 17 of these proteins displayed
individual sensitivities above 60%. The highest sensitivity, 94%,
was observed for transmembrane protein 256. In order to validate
the proteins identified by mass spectrometry as prostate cancer
biomarkers, antibody-based methods have been used. We have
validated several proteins by western blot and ELISA, but the
validation of some proteins is challenging due to their low amounts
and/or lack of good antibodies. Summary/conclusion: This study
clearly shows the potential of using urinary exosomal proteins as
prostate cancer biomarkers. Mass spectrometry is an excellent
method for the biomarker discovery phase. However, since mass
spectrometry is not widely used in the clinic, antibody-based
methods based on the proteomic studies should also be developed.
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Identifying extracellular vesicles-derived miRNAs in advanced prostate
cancer
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The proliferation and survival of prostate cancer cells are regulated
by the presence of steroid hormone androgens. We recently
described the role of androgen in influencing the secretion of
extracellular vesicles (EVs) in advanced prostate cancer. Here, we
further investigate whether androgens also affect the secretion of
small RNAs, such as micro RNAs (miRNAs), through EVs. The LNCaP
prostate cancer cells were grown in the presence of foetal bovine
serum or in androgen-depleted charcoal-stripped serum (CSS). Cells
grown in CSS were treated with 10 nM physiological androgen
dihydrotestosterone (DHT) or 10 mM anti-androgen enzalutamide. EVs
were isolated from conditioned medium by differential ultracentrifu-
gation and confirmed by EM. miRNAs were extracted by miRNeasy
Mini Kit and analysed with Agilent Bioanalyzer 2100, followed by
next-generation high-throughput Solexa sequencing (BGI). Data were
analysed by an integrated in house tool miRDeeP*. We found that
growing cells in the presence and absence of androgens does not
significantly alter the yield of total RNA found in isolated EVs. A total
of 288 miRNAs were identified across EV samples, with 141 miRNAs
(49%) are commonly found in all samples. We compared our result
with miRNAs found in the corresponding parental cells (401 miRNAs),
where 53.1% (213 miRNAs) were found in all cell samples. Quantita-
tive analysis has led to the discovery of 34 candidate miRNAs which
secretion in EVs was increased by 1.5-fold upon DHT treatment, in
comparison with cells grown in androgen-deprived condition.
Among these, miR-454 was previously reported to regulate prostate
cancer proliferation. Validation of longitudinal patient samples is
ongoing. We conclude that in prostate cancer, androgens such as
DHT can influence the secretion of small RNAs, including miRNAs,
through EVs. Our work will help to validate EV-derived small RNAs as
biomarker(s) in advanced prostate cancer.
PW8.08
Prostate cancer exosomes as molecular predictors of response to
abiraterone acetate
Pedro Fonseca1, Seda Sabah O¨zcan1, Dorothea Rutishauser1,
George Baltatzis2, Lena Lenartsson1, Anders Ulle´n1, Sten Nilsson1,
Jeffrey Yachnin1 and Theocharis Panaretakis1
1Karolinska Institutet, Solna, Sweden; 2University of Athens, Athens, Greece
Prostate cancer is the second most common cancer in men world-
wide. Organ-defined prostate cancer is a curable disease, but once it
develops into metastatic castration-resistant prostate cancer, it is
usually a matter of time until the patient develops resistance to
chemotherapy, namely, abiraterone acetate, becoming an incurable
disease. This evokes the need for biomarkers that can predict disease
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progression and response to therapy. Cancer cell-derived exosomes,
with their molecular cargo that represents the tumour cells, have been
demonstrated to be a good source of such prognostic and predictive
biomarkers. In this study, we have developed prostate cancer cell lines
that show increased resistance to abiraterone acetate, which were
then used to isolate exosomes through differential ultracentrifuga-
tion. We then characterized these exosomes by western blot,
nanoparticle tracking analysis, transmission electron microscopy
and linear sucrose gradient ultracentrifugation. It was followed by a
molecular profiling of the exosomes based on a proteomics approach,
where we compared the protein profile of these exosomes with
exosomes from the parental, drug-sensitive cell lines, in order to find a
predictive signature of response to therapy. This signature was then
validated in exosomes isolated from human plasma samples derived
from patients that were non-responsive to abiraterone acetate. One
interesting finding is that cells that are resistant to abiraterone acetate
secrete more exosomes than their sensitive counterparts. We have
also identified a number of putative markers that may constitute a
predictive signature of response to therapy. This molecular data may
provide valuable information in finding predictive signatures for
response to therapy, providing a more personalized medical care and
stratified course of treatment, leading to improved overall survival.
PW8.09
Identifying components that regulate the secretion of
stroma-activating exosomes in prostate cancer
Vincent Yeung1, Zsuzsanna Tabi1, Rachel Howard-Jones1, Rachel Errington1,
Marie Wiltshire1, Malcolm Mason1, Jason Webber1 and Aled Clayton2
1Cardiff University, Cardiff, United Kingdom; 2Division of Cancer & Genetics,
School of Medicine, Cardiff University, Cardiff, United Kingdom
Introduction: Exosomes originate in multivesicular endosomes (MVEs)
and are expelled into the extracellular space to mediate important
effects. In cancer, local interaction of exosomes with stromal cells
(fibroblasts) and angiogenic precursors serves to promote tumour
growth and progression. Secreted exosomes are known to be
heterogeneous, in terms of biophysical and molecular properties,
and it is unclear how this heterogeneity is generated by a given
homogeneous cell source. Blockade of some proteins regulating MVE
trafficking (such as Rab27a) may not fully attenuate exosome secretion
or may exhibit cell-type-dependent effects. Perhaps there are co-
existing, parallel pathways for generating and trafficking distinct MVEs
and hence provide exosome heterogeneity. To better understand this,
we have investigated the roles of 6 proteins: CD9, Rab5a, Rab11b,
Rab35, VAMP7 and VPS25, putatively implicated in exosome biogen-
esis/secretion, and their subsequent functional impact on stromal
cells. Methods: A lentiviral-based delivery of shRNAs was used to
selectively knockdown targets of interest in Du145 cells. Exosomes
present in cell-conditioned media (CCM) were quantified and char-
acterized, by nanoparticle tracking analysis and ELISA, respectively.
Fibroblast activation, in response to CCM, was evaluated microscopi-
cally based on organization of alpha-smooth muscle actin fibers.
Results: Successful stable knockdown of all targets, by at least 80%, was
demonstrated at both mRNA and protein levels. Knockdown of Rab35
or VPS25 resulted in greatest attenuation of exosome secretion, with a
corresponding failure to induce stromal activation compared to
functionally competent control Du145 cells. Conclusion: These results
suggest that both Rab35 and VPS25 are relevant factors for modulat-
ing exosome secretion by Du145 prostate cancer cells. Targeting these
proteins may be sufficient to attenuate exosome-mediated stromal
cell activation and slow tumour growth.
PW8.10
Immunosuppressive effects of tumour exosomes on dendritic cells
cross-presenting tumour antigens
Josephine Salimu, Jason Webber, Mark Gurney, Malcolm Mason,
Aled Clayton and Zsuzsanna Tabi
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Cardiff, UK
Introduction: Exosomes are a distinct population of extracellular
vesicles of endocytic origin, which express a protein repertoire similar
to the cell of origin. Tumour-derived exosomes harbour the immu-
nosuppressive characteristics of tumour cells. However, as tumour-
derived exosomes carry tumour antigens, they may contribute to
cross-presentation of antigen by DC to initiate antitumour immune
responses. The aim for this study was to examine how exosomes
secreted by prostate cancer cells influence tumour antigen cross-
presentation. Methods and results: In order to investigate the effects
of exosome secretion, DU145 cells were transduced with either
shRNA lentiviral particles to knockdown Rab27a (DU145KD) or an
irrelevant control (DU145C). Rab27a deficiency was characterized for
attenuation of exosome secretion. Cross-presentation of the tumour-
associated antigen 5T4 from DU145KD cells generated significantly
stronger anti-5T4 T-cell responses compared to that from DU145C
cells. This enhanced T-cell response was reduced when purified
exogenous DU145 exosomes were added back to the cross-presenta-
tion model incorporating DU145KD cells. This suggests that knock-
down of exosome secretion alleviates tumour-associated immuno-
suppression in this model. While exosomes did not directly inhibit
CD8+ T-cell function, they exerted a negative effect on DC function.
DC exposed to exosomes had an elevated expression of CD73, an
ecto-5-nucleotidase responsible for AMP to adenosine hydrolysis. DC
constitutively express CD39 (ectonucleotidase responsible for ATP-
to-AMP hydrolysis) which, when co-expressed with CD73, resulted
in ATP-dependent inhibition of TNFa and IL-12 release. Inhibition
of PGE2 receptors inhibited exosome-dependent CD73 expression
on DC, pointing towards a possible mechanism. Conclusion: Taken
together, the results reveal a hitherto unknown effect of tumour
exosomes on the suppression of DC function via exosomal PGE2
adding a new element to tumour-immune cell crosstalk.
PW8.11
Exosome DNA: a new promising liquid biopsy-based diagnostic tool for
personalized management of aggressive prostate cancer (PCa) patients
Chiara Foroni1, Simona Bernardi2, Natasa Zarovni3, Domenico Russo4,
Francesca Valcamonico5, Alfredo Berruti5 and Davide Zocco3
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Development of a biomarker-based extracellular vesicle assay for
prostate cancer prognosis
Desmond Pink1, Robert Paproski1, John Lewis1,
Deborah Sosnowski1, Lian Willetts1, Andries Zijlstra2 and
Eric Hyndman3
1University of Alberta, Edmonton, Canada; 2Vanderbilt University, Nashville,
Tennessee, USA; 3University of Calgary, Prostate Cancer Centre, Rockyview
General Hospital, Calgary, Canada
New, more specific biomarkers for prostate cancer (PCa) are needed
to prevent unnecessary surgical biopsies. Analysis of extracellular
vesicles (EVs) in biofluids is an exciting new area of investigation. A
diagnostic test must differentiate EVs originating from PCa cells
versus non-cancerous origins, and also define a biomarker enriched in
PCa EVs. Five prostate-specific membrane antigen (PSMA) antibodies
were tested. Plasma, serum, urine and semen were collected from
healthy men and PCa patients. Assay conditions were optimized
including sequential centrifugation of each biofluid to identify the
optimal fraction for analysis. EV and biomarker levels were deter-
mined using the NanoSight LM10 and micro-flow cytometry using
the Apogee A50, western blotting and TEM during optimization
studies. A cohort of 500 plasma and urine samples were prospectively
collected from men prior to prostate biopsy and are currently being
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analysed for PSMA and other PCa biomarkers. Detection of PSMA+
EVs in biofluids and cell culture media was shown to be optimal using
the J591 antibody, which detects an extracellular domain of PSMA.
Detection of PSMA+ EVs was shown to be linear with concentration
and assay volume. The specificity of the PSMA antibody was shown
using LNCaP cells with immunofluorescence as well as standard flow
cytometry. The specificity of our micro flow cytometry assay was
confirmed using antibody challenge experiments. To date, we have
examined 35% of our pre-diagnosis cohort (plasma) in a blinded
manner. Preliminary analysis of EVs from platelet-depleted plasma
collected pre-biopsy revealed that men testing positive for PCa
(+Gleason) had significantly more extracellular vesicles than men
testing negative (1.6-fold increase). PSA levels in these samples
were significantly (p=0.0021) but weakly (r20.06) correlated with
extracellular vesicles staining positive for PSMA. Our assay holds great
promise for detection of novel biomarkers in PCa.
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Can exosome-associated heparan sulphate proteoglycans
serve as potential new markers for the detection of prostate
cancer?
Alexandra Shephard1, Joanne Welton2, Malcolm Mason1, Zsuzsanna Tabi1,
Aled Clayton1 and Jason Webber1
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Introduction: Current diagnostic tests for prostate cancer lack
sensitivity and specificity, resulting in underdiagnosis of men with
aggressive disease. Improved means of detecting the disease are
therefore urgently needed. We have previously demonstrated a role
of heparan sulphate proteoglycans (HSPGs), present on the surface
of exosomes, in stromal cell activation and subsequent enhancement
of tumour growth. Here we explore the potential of exosomal-
HSPGs, isolated from serum using size-exclusion chromatography
columns, as potential biomarkers for disease. Methods: Exosomes
were isolated from cell-conditioned media, from prostate cancer cells
cultured in bioreactor flasks, using the sucrose cushion method.
To aid assay development, donor serum was spiked with exosomes
prior to size-exclusion chromatography-based exosome isolation.
Exosome-associated and soluble proteins were identified by im-
munofluorescent analysis of eluted fractions. Exosome concentration
was determined by nanoparticle tracking analysis, and total protein
content measured by BCA-assay. The particle:protein ratio was used
as a measure of exosome purity. Results: Our data reveal detection
of several HSPGs (including glypican 1, glypican 6 and syndecan 4)
on exosomes from multiple prostate cancer cell lines. Size-exclusion
chromatography proved a successful method for isolation of
exosomes from serum, enabling detection of HSPGs present on
prostate cancer exosomes. Furthermore, we report increased levels
of heparan sulphate on serum-derived exosomes from prostate
cancer patients compared to healthy individuals. Conclusion: Defined
HSPGs are present on the surface of prostate cancer exosomes. We
have developed an assay capable of detecting these HSPGs on
exosomes isolated from serum. Future work will explore whether
expression of specific HSPGs correlates with disease progression
in prostate cancer patients and will evaluate their potential as
biomarkers for aggressive disease.
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CRIPTO 1 is associated with tumour aggressiveness in prostate
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Introduction: Prostate cancer (PCa) is the most common malignancy
and a prevalent source of cancer-related morbidity and mortality in
men. Identification of tumour biomarkers may help distinguish
significant from indolent PCa and select patients at high risk of
relapse for aggressive treatment. CRIPTO (CR-1), the founding member
of EGF-CFC protein superfamily, plays crucial roles in embryonic
development. In humans, CR-1 is expressed in a wide spectrum of
tumours, but its implication in PCa has remained unexplored. Here, we
investigated the expression pattern of CR-1 and the consequences of
its expression in PCa setting in order to assess its potential impact on
prostate malignancy. Methods: Prostate normal and cancerous tissue
specimens were examined by immunohistochemistry. PCa cell lines
were engaged in experimental studies and analysed using techniques
used in biochemistry, cellular and molecular biology. Results: We found
significant CR-1 expression in 37.9% of PCas, while being absent or
marginally detected in benign conditions. Our studies demonstrated
that CR-1 overexpression plays a functional role in PCa cells by
promoting an epithelial-mesenchymal transition (EMT) associated
with enhanced migration capacity and survival under stress conditions
due to propensity to stimulate PI3K/AKT and FGFR1/ERK signalling
pathways. More interestingly, cells overexpressing CR-1 excessively
secreted vesicles. Among preliminary results obtained and upon
treating different cell line models, CR-1-rich vesicles stimulate the
aggressiveness in prostate cancer. Summary/conclusion: Our results
highlight a new potential function of CR-1 in PCa and identify a new
exosomal form of this protein. All these findings suggest CR-1 as a new
promising target for PCa treatment.
PW8.15
Innovative approach of prostate cancer by the way of tumour
cell-derived extracellular vesicles
Irene Tatischeff
RevInterCell, a Scientific Consulting Service about EVs, Orsay, France
Introduction: Prostate cancer represents the second most important
cancer in men in the USA, with a great inconvenience but a rather
low mortality. As for other cancers, an early diagnostic greatly
enhances the efficiency of a subsequent therapy. Since 1986, the
prostate-specific antigen (PSA) blood test brought a new tool, which,
together with prostate palpation, helps the medical diagnostic. For
prognosis, the agressivity of the tumoural process is measured with
both the Gleason Score and PSA. However, the specificity of PSA is
now seriously questioned, as it diagnoses many false-positive patients,
who may be submitted to inappropriate therapy. The need for other
more reliable diagnostic tools of prostate cancer is therefore a
current challenge. The aim of this study is to gather the main results
obtained about ‘‘Prostate Cancer and EVs’’, in the 4 previous yearly
ISEV International Meetings from 2012 to 2015, in order to get a
leading thread for future research. Methods: Altogether, 107 abstracts
(44 oral communications and 63 posters) dealing with ‘‘Prostate’’
were presented in 60 different sessions. Here, these abstracts have
been classified as a function of their main respective goal: char-
acterization of the various prostate cancer-derived EVs, search for
biomarkers at the proteomics or RNAs levels, influence of prostate
cancer-derived EVs from various cell lines upon normal cells, EVs
clinical measurements in different human biofluids and in vivo models.
New set-ups for sensitive exosome measurements, having a clinical
potential for diagnostics, are also reported. Summary/conclusion: The
main results of this scientific monitoring will be presented. Many in-
teresting observations have already been collected about the charac-
terization and functional properties of prostate cancer cells-derived
EVs. However, a better research coordination about EVs potentials
for theranostics of prostate cancer would be worth seeking.
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OT10.1
Non-enveloped Leishmania RNA virus 1 (LRV1) is released by
Leishmania parasites within exosome-like vesicles
Vanessa Diniz Atayde and Martin Olivier
McGill University, Montreal, Que´bec, Canada
Leishmania are ancient eukaryotes that have retained the exosome
pathway through evolution. Our work focuses on Leishmania RNA
virus 1 (LRV1)-infected Leishmania species, which are associated
with a particularly aggressive mucocutaneous form of leishmaniasis
triggered by a TLR3-dependent response to the viral dsRNA. Thus far,
how LRV1 is exposed to the host cell is unravelled. Some viruses
are known to utilize the host exosome pathway for their formation
and cell-to-cell spread. As a result, exosomes derived from infected
cells contain viral proteins and RNAs. Herein, we propose that LRV1
exploits the Leishmania exosome pathway in order to reach the
extracellular environment. To test this, exosomes derived from LRV1-
infected Leishmania were characterized by biochemical approaches.
Sucrose gradients revealed that most of LRV1 dsRNA co-fractionated
with exosomes. Interestingly, when fractions were observed by
TEM, a portion of the LRV1 particles was found surrounded by these
vesicles. Exosome-trapped particles were protected from RNAseIII
degradation, further confirming our findings. Mass spectrometry
showed that exosome derived from infected parasites had a differed
overall content compared to non-infected ones. To understand the
biological potential of LRV1-containing exosomes, preparations were
used in transfer assays where, remarkably, a significant amount of
non-infected parasites presented an early and transient assimilation
of LRV1, mechanism that may be involved in viral maintenance.
Our work is one of the first reports describing exosomes as viral
envelopes, which may represent an important step in the evolution
of some non-enveloped virus into enveloped ones. Moreover, it
revealed that Leishmania secretes LRV1 possibly to present viral
material to the host as well as to transmit the virus to other parasites,
significantly impacting the fate of cutaneous leishmaniasis.
OT10.2
Extracellular vesicles from milk accelerate osteoblastogenesis but
impair bone matrix formation
Marina C. Oliveira1, Adaliene V. M. Ferreira1, Fons A. J. Van De Loo2 and
Onno J. Arntz2
1Department of Nutrition, Nursing School, Universidade Federal de Minas
Gerais, Belo Horizonte, Brazil; 2Department of Rheumatology, Radboud
University Medical Center, Nijmegen, The Netherlands
Introduction: Recently extracellular vesicles (EVs) that contain proteins
and RNA were discovered in milk but their effect on bone formation
has not yet been determined. We demonstrated previously that
bovine milk-derived EVs (BMEVs) have immunoregulatory properties.
Our aim was to evaluate the effect of bovine milk-derived EVs
(BMEVs) on osteogenesis by mice and human mesenchymal stem
cells (hMSCs). Methods: BMEVs were isolated from commercial cow
milk by ultracentrifugation. Female 1012-week-old DBA/1J mice
received BMEVs (4.7106 particles/mL or 14.3106/mL) in their
drinking water for 7 weeks. Thereafter, trabecular bone area (lamellar/
woven) and density of osteocytes per trabecular bone area were
determined by histomorphometry. Human MSCs were cultured
in osteogenic differentiating medium and BMEVs were added. Cell
proliferation was determined by a crystal violet staining and the
XTT assay. Osteoblast differentiation was evaluated by Alizarin red
staining (mineralization), Sirius red (collagen), alkaline phosphatase
activity and by qRT-PCR. Results: Oral delivery of BMEVs to female
DBA1/J mice during 7 weeks did not alter the tibia trabecular bone
area, however increased osteocyte numbers were found. In addition,
the highest dose of BMEVs markedly increased the woven bone
tissue. Exposure of hMSCs to BMEVs for 21 days resulted in less
mineralization but higher cell proliferation. Interestingly, BMEVs
reduced the collagen production, but enhanced the expression
of characteristic genes for immature osteoblasts. A kinetic study
showed that BMEVs upregulated many osteogenic genes within the
first 4 days. However, the production of type I collagen and its genes
(COL1A1 and COL1A2) were markedly reduced at days 21 and 28. At
day 28, BMEVs enhanced the expression of sclerostin, an osteocyte
marker. Conclusion: Our study adds BMEVs to the list of milk com-
ponents that can affect bone formation and may shed new light on
the contradictory claims of milk on bone formation.
OT10.3
Assessment of the transcriptional response of human bladder cells to
uropathogenic Escherichia coli membrane vesicles
Cherie Blenkiron, Denis Simonov, Priscilla Dauros Singorenko,
Cristin Print, Anthony Phillips and Simon Swift
University of Auckland, Auckland, New Zealand
Introduction: Uropathogenic Escherichia coli (UPEC) have been re-
ported to use secreted membrane vesicles (MVs) to deliver toxins into
human cells. While phenotypic effects of individual MV-associated
toxins on human cells have been described, no study to date has
evaluated the human cell transcriptional response to UPEC MVs as a
whole. Methods: The total MV population was isolated from UPEC
strain 536 cultures by filtration and ultracentrifugation. MV uptake
into bladder cells was investigated with confocal microscopy by
labelling vesicle membranes with a fluorescent dye PKH67. Effects of
MVs on bladder cell viability were measured using the multi-table
tournament (MTT) assay. The transcriptional response of bladder cells
to UPEC 536 vesicles was investigated using Affymetrix GeneChip(r)
PrimeView(tm) Human Gene Expression Arrays. Quantitative real-
time PCR was used to validate changes in expression of bladder cells
genes identified from the microarray analysis. Results: MVs were
delivered into cultured human bladder cells and caused reduced
cellular viability. Analysis of gene expression in treated cells found
that there was a rapid response after just 4 h that triggered the
expression of genes responsible for an early response to infection
and pathways responsible for xenobiotic metabolism. These findings
will be presented and discussed. Ongoing work: Based on the initial
data generated using a total MV preparation, we are now in the
process of using density gradient based purification techniques to
elucidate the component MV fraction(s) that trigger the xenobiotic
metabolism pathway and associated reduction of human bladder
cell viability. Conclusions: Our study programme has provided
insights into the complex events underlying uropathogenesis by
identifying pathways involved in the host bladder cell response to
cytotoxic MVs produced by UPEC.
OT10.4
Investigation of extracellular small RNAs of Heligmosomoides
polygyrus: scope for RNAi mediated cross-species communication
Franklin Wang-Ngai Chow1, Cesare Ovando-Vazquez2, Georgios
Koutsovoulos3, Tuhin Maity4, Mark Blaxter3, Julie Claycomb4,
Cei Abreu-Goodger2 and Amy Buck1
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Edinburgh, UK; 2Langebio, Cinvestav, Irapuato, Mexico; 3Institute of
Evolutionary Biology, The University of Edinburgh; 4Department of Molecular
Genetics, The University of Toronto, Canada
Introduction: Extracellular small RNA has been proposed as a means
of cell-to-cell communication within an organism and a mechanism
of cross-species communication. We previously showed that an
argonaute protein (HpWAGO) and small RNAs including miRNAs
and Y-RNAs are secreted in exosome-like vesicles produced by
Heligomosomoides polygyrus, a gastrointestinal nematode that infects
mice. Intranasal administration of the H. polygyrus vesicles to mice
suppressed a Type 2 innate response in an airway allergy model and
our work suggests that some of the nematodes-derived miRNAs can
suppress host gene expression based on in vitro reporter assays. We
implicated miRNAs as one of the functionally important classes of
exRNAs. Here we examine the other classes of exRNAs that could be
important for hostpathogen interactions, many of which are more
abundant than miRNAs and could operate by distinct RNAi path-
ways. We further characterize the secreted argonaute protein and
aim to identify additional protein binding partners of exRNA. Results
and discussion: H. polygyrus excretory and secretory products (HES)
were purified by size exclusion chromatography to examine co-
fractionation of proteins with small RNAs. Small RNA NGS libraries
revealed that large amounts of 5’-triphosphate 22G small RNAs are
present in exosomes. Many 22G small RNAs were mapped to the
same loci within the genome, suggesting they are originated from
‘‘22G siRNA cluster,’’ which could be features of RdRp amplified 22G
siRNAs. Differential expression levels of Y-RNA, miRNAs and frag-
ments of tRNA were also found inside and outside exosomes and
several appear to co-fractionate with HpWAGO, suggesting potential
RNA-protein complexes. Conclusion: Together these results suggest
further diversity in the exRNA that is secreted by parasitic nematodes
and lays a foundation for further interrogation of the role of exRNA
protein complexes in cross-species communication.
OT10.5
Gut bacteria generated extracellular vesicles mediate cross-kingdom
dialog in the gut
Regis Stentz, Isabelle Hautefort and Simon Carding
Institute of Food Research, Norwich, England
The adult human gastrointestinal (GI-) tract accommodates a bac-
terial community comprising trillions of cells that is dominated
by two bacterial phyla, Firmicutes and Bacteroidetes. It is becoming
increasingly evident that maintaining communication between
those microbial populations and the host is essential for establishing
and maintaining a healthy GI-tract. Considerable effort is now being
made to determine the precise nature of this dialog with much of
the past work focusing on the contributions made by diffusible,
small-molecule hormones and nutrients. However, more recently,
we have uncovered a role for extracellular outer membrane vesicles
(OMVs) produced by Gram-negative bacteria in communicating
with host cells in the lower GI-tract. The OMVs produced by the
prominent commensal gut bacterium Bacteroides thetaiotaomicron
(Bt) contain an inositol polyphosphate phosphatase (BtMinpp) that is
structurally similar to mammalian Minpp1 and interacts with cultured
intestinal epithelial cells to promote intracellular Ca2 signalling.
We have also shown that OMVs from Bt parental cells are normally
produced in vivo in the GI-tract and associate with the intestinal
epithelium. This finding identifies a novel pathway of microbehost
interaction in the GI-tract and challenges the paradigm that OMVs
are associated with bacterial pathogens and the delivery of virulence
factors and toxins.
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Optimization of imaging flow cytometry for exosome analysis using a
biological calibrator
Andre´ Go¨rgens1, Michel Bremer1, Florian Murke1, Coralie L. Guerin2,
Sebastian Seth3, Chantal M. Boulanger4, Peter A. Horn1 and Bernd Giebel1
1Institute for Transfusion Medicine, University Hospital Essen, Germany;
2Luxembourg Institute of Health, Department of Infection and Immunity,
Luxembourg; 3Merck Chemicals Gmbh, Merck KGaA, Darmstadt, Germany;
4Cardiovascular Research Center at HEGP, Institut National de la Sante´ et de la
Recherce Me´dicale, Paris, France
Extracellular vesicles (EVs) such as exosomes (70160 nm) and micro-
vesicles (1001000 nm) can be harvested from cell culture super-
natants and from all body fluids. Current standard techniques to
visualize, quantify and characterize EVs are electron microscopy,
nanoparticle tracking analysis (NTA) and dynamic light scattering. To
further characterize and discriminate EVs, more exact high-throughput
technologies to analyse the surface of EVs are highly desired. While
conventional flow cytometry is limited to measure particles down
to approx. 300500 nm, a new flow cytometric method called
imaging flow cytometry potentially allows for the analysis of EVs
smaller than 300 nm. Here, we prepared eGFP-positive EVs from cell
lines expressing CD63-eGFP fusion proteins. Using these biological
calibrators, which can be clearly separated from background due
to their fluorescence, we optimized different machine/acquisition
parameters and the analysis protocol on the Amnis ImageStreamX
MkII imaging flow cytometry platform. Obtained samples were also
analysed by NTA. The main advantages of imaging flow cytometry
over conventional flow cytometry is the low signal-to-noise ratio,
the automatic simultaneous triggering on all channels and an
improved sensitivity to detect low fluorescence signals. Using the
optimized protocol, we were able to visualize and enumerate
different types of individual EVs (i.e. apoptotic bodies, microvesicles
and exosomes) simultaneously in unprocessed cell culture super-
natants and samples enriched for exosomes. We currently compare
EVs derived from different cell types and use the optimized platform
to evaluate and optimize protocols used for exosome isolation.
Furthermore, we compare different protocols using antibodies or
membrane dyes for EV labelling. We propose that imaging flow
cytometry provides an improved and sensitive high-resolution method
for the field of EV research to perform high-throughput, multipara-
metric EV surface analyses.
OT11.2
Optimization of bulk extracellular vesicle labels for nanoFACS
Aizea Morales-Kastresana, Katherine McKinnon, Jennifer Jones,
Jay Berzofsky, Masaki Terabe, Thomas Musich and Thorsten Demberg
Vaccine Branch, NCI, NIH, Bethesda, MD, USA
Introduction: The source and characteristics of extracellular vesicles
(EVs) are associated with distinct functional roles, suggesting the
existence of different EV subsets with relevance in immunity and
cancer. Most high-resolution flow cytometry methods use a fluor-
escent threshold, but this approach does not detect EVs that are too
dimly labelled to be detected above the threshold of the instrument.
To circumvent this problem, we used a high-resolution SSC light
scattering-based threshold to quantitate the proportion of the EV
population that is labelled and to examine the presence of non-
specific by-products of certain labelling methods. EVs isolated from
DC2.4 cell line culture supernatants by ultracentrifugation were
characterized by NanoSight. NanoFACS was performed with an
AstriosEQ flow cytometer, triggered with a high sensitivity SSC
detector for EV analyses based on light scattering, in addition to
standard FSC and fluorescent parameters. We tested several widely
used lipid (PKH26, CMDiI), RNA (SYTO RNA select) and protein-
binding (CFSE, CellTrace Violet, CellTrace FarRed) dyes. Incorporation
of CFSE/fluorescein was quantitated relative to MESF standards.
Results: We found that lipid and RNA dyes form aggregates that
confound EV flow cytometric analysis. On the other hand, protein-
binding CFSE and CellTrace dyes did not produce these artefacts,
and unbound dye was readily removed with size exclusion chroma-
tography. We refined the staining protocol for protein-binding
dyes to maximize EV staining efficiency and identified optimal
timing, temperature and wash conditions for bulk vesicle labelling.
Conclusions: This optimized protocol provides a robust means of
labelling purified EV populations for single vesicle, high-resolution
flow cytometric analysis. Our data also demonstrate the limitations
of lipid- and RNA-based dyes for individual vesicular cytometric
analysis and demonstrate the importance of robust controls and
parallel methods of analysis for EV subset studies.
OT11.3
Diversity of extracellular vesicles in biofluids measured by vesicle flow
cytometry
John Nolan1, Erika Duggan1, Julie Saugstad2, Ji Phillips2, Jf Quinn2,
Kendall Van Keuren-Jensen3, R. Reiman3, Matthew Huentelman3,
Doug Galasko4, Bob Carter4 and Fred Hochberg4
1Scintillon Institute, San Diego, California, USA; 2Oregon Health & Science
University, Portland, Oregon, USA; 3Translational Genomics Research Institute,
Phoenix, Arizona, USA; 4University of California, San Diego, San Diego,
California, USA
Background: Plasma and cerebrospinal fluid (CSF) offer potential
biomarkers originating from cell-free nucleic acids and extracellular
vesicles (EVs). Analysis of the heterogeneity of these biofluids informs
our understanding of their cellular source, physiological role and
clinical significance. We use a novel high sensitivity flow cytometry
approach to count individual EVs in these biofluids, estimate their size
and measure their molecular composition. Methods: Cell-free plasma
was prepared from normal human blood (San Diego Blood Bank) and
cell-free CSF was from patients and normals under informed consent.
Cell-free biofluids were diluted and analysed (NTA) to estimate total
nanoparticle concentration and size distribution and diluted and
stained for analysis of membrane vesicle concentration, size distribu-
tion and surface marker abundance by vesicle flow cytometry (VFC).
Results: Nanoparticle concentrations in normal plasma measured by
NTA ranged from 1.9 to 2.4109/uL, and sizes ranged from 50 to300
nm in diameter (mean 122 nm). EV concentrations in normal plasma
measured by VFC ranged from 0.9 to 1.8108/uL, and sizes ranged
from 70 to 300 nm. VFC of plasma EVs stained positive for annexin
V, CD41, CD235, CD14, CD11b and CD86. Nanoparticle concentrations
in normal CSF measured by NTA ranged from 2.6 to 31106/uL,
and sizes ranged from 50 to 300 nm in diameter (mean 122 nm).
EV concentrations in normal CSF measured by VFC ranged from 1.1 to
2.2 106/uL, and sizes ranged from 70 to 300 nm. VFC revealed EVs
staining for annexin V, CD41 and CD235. VFC of CSF pools from
patients with 6 neurological disorders had EV concentrations ranging
from 2.22 to 14106/uL. Conclusions: Quantitative analysis of the
diversity of individual EVs in plasma, CSF and other biofluids using
VFC provides a new window into the cellular origins, physiological
roles and clinical biomarker utility of these cell-derived nanoparticles.
Funded by NIH EB003824, TR000931, TR000891, and TR000903.
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OT11.4
Towards EV-based biomarker detection using high-resolution flow
cytometric analysis of rare events
Sten Libregts1, Ger Arkesteijn1, Andrea Ne´meth2, Esther Nolte-‘t Hoen1
and Marca Wauben1
1Department of Biochemistry & Cell Biology, Faculty of Veterinary Medicine,
Utrecht University, Utrecht, The Netherlands; 2Department of Genetics,
Cell- and Immunobiology, Faculty of Medicine, Semmelweis University,
Budapest, Hungary
Introduction: Extracellular vesicles (EVs) are promising biomarkers,
since their molecular content may contain important information
regarding disease state and efficiency of medical intervention. Isolation,
detection and characterization of EVs are, however, hampered by
their size and heterogeneity, and the complexity of body fluids.
Moreover, disease-related EV may appear as rare events and could
be obscured by the bulk of EVs and other nano-sized particles
present in body fluids. Methods: We have recently developed a high-
resolution flow cytometry-based method (Hi-Res FCM) that allows
multi-parameter analysis of EVs. To see whether Hi-Res FCM also
allows for detection of rare populations of nano-sized particles, we
performed spike-in experiments using fluosphere beads or EVs
stained with PKH67 and fluorochrome-conjugated antibodies. Parti-
cles were spiked into either PKH67-stained EV samples or body fluids
that were subsequently run over a SEC-column. Samples were then
analysed using Hi-Res FCM. Results: Events that occur at a frequency
of 1:1000 (0.1%) or less are considered rare events. Based on
fluorescence and light scattering, spiked 200 nm fluospheres could
readily be detected in PKH67-stained EV samples up until a
frequency of 0.03%. Spiked multi-parameter-stained EVs, however,
could not be distinguished from other PKH67-positive EVs at low
percentages due to a low signal-to-noise ratio of fluorescence.
Notably, scatters of spiked EVs changed significantly when spiked
into unstained body fluids, indicating that the matrix of body fluids
can affect detection of EVs using Hi-Res FCM. Conclusion: Hi-Res FCM
technically allows for the detection of rare populations of nano-sized
particles. However, for EVs to serve as biomarkers for the detection
of early-stage disease, residual disease or therapy response, isolation
and fluorescent antibody-labelling strategies for rare-event analysis
need further optimization due to low signal-to-noise ratios and the
complexity of body fluids.
OT11.5
Surface plasmon resonance imaging detects lower antigen densities
than flow cytometry
Elmar Gool1, Edwin Van Der Pol1, Rienk Nieuwland2,
Leon Wmm Terstappen3, Auguste Sturk2, T. G. Van Leeuwen1,
Anita Bo¨ing2, Richard Schasfoort3, Frank Coumans1 and Ivan Stojanovic3
1Department of Biomedical Engineering and Physics, Academic Medical
Center, University of Amsterdam, The Netherlands; 2Department of Clinical
Chemistry, Academic Medical Centre, University of Amsterdam,
The Netherlands; 3Department of Medical Cell Biophysics, Mira Institute,
University of Twente, Enschede, The Netherlands
Introduction: The flow cytometry (FCM) mean fluorescence intensity
(MFI) is proportional to the mean number of fluorochrome-antigen
conjugates. However, the MFI of such conjugates on extracellular
vesicles (EVs) is often undistinguishable from background due to low
antigen quantities. Surface plasmon resonance imaging (SPRi) is an
alternative for analysing antigen exposure, which captures EVs on a
surface with an antibody array. The captured EVs cause an increase in
refractive index (RI) at the surface. This RI is directly proportional to
the SPRi signal, which was shown to correlate with antigen exposure
on cells. Here we compare antigen exposure on EVs measured with
FCM and SPRi. Methods: To compare cell surface antigen exposure
measured by FCM and SPRi, human breast cancer cell lines HS578T,
MCF7 and SK-BR-3 were used. The MFI was compared with the SPRi
signal for 11 antibodies on intact cells and EVs derived from each
cell line. The antibodies for CD9, CD44, CD49e, CD63, CD71, CD221,
CD227, EGFR, EpCAM, Her2 and Her3 recognize cell surface antigens
that are expressed on these cell lines. Results: On intact cells, the MFI
and SPRi signals obtained with the eleven antibodies correlate for
HS578T (R20.66), MCF7 (R20.82) and SK-BR-3 (R20.96). Due to
the limited number of antigens with MFI above background for EVs,
correlation between FCM and SPRi could only be determined for
HS578T derived EVs (R20.65). These EVs had 5 antigens with MFI
above background, while MCF7 and SK-BR-3 derived EVs only had
1 and 2, respectively. Interestingly, SPRi signals were above back-
ground for not only these 8 antigens, but for in total, respectively,
7 (HS578T), 7 (MCF7) and 6 (SKBR3) antigens. The remaining 4, 4 and 5
antigens, respectively, had signals below background for both
techniques. These undetectable antigens also had signals below
background for intact cells, except for CD227 on SK-BR-3 cells.
Conclusion: SPRi detects lower antigen densities on EVs than FCM.
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OT12.1
An extracellular vesicle protein signature as a new diagnostic
biomarker for stable coronary artery disease
Ingrid Bank1, Dominique De Kleijn2, Leo Timmers1, Vince De Hoog1,
Crystel Gijsberts2, Gerard Pasterkamp2 and Arend Mosterd3
1Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands;
2Experimental Cardiology, University Medical Center Utrecht, Utrecht,
The Netherlands; 3Cardiology, Meander Medical Center, Amersfoort,
The Netherlands
Introduction: The diagnostic workup for stable coronary artery dis-
ease (SCAD) is inefficient and expensive. Exercise ECG and non-
invasive imaging techniques such as cardiac CT, MRI and nuclear
perfusion imaging are frequently used, but invasive coronary
angiography is often needed to diagnose (or rule out) significant
coronary artery stenosis. Diagnostic blood-based biomarkers do
not exist. We hypothesized that a plasma extracellular vesicle (EV)
protein signature can be used as diagnostic biomarker for SCAD.
Methods: Five extracellular vesicle proteins (SerpinF2, SerpinG1,
SerpinC1, CD14, and Cystatin C) were measured in the LDL, HDL,
remaining (REX) and total (TEX) plasma fractions of n30 patients
with stable coronary artery disease and n30 sex-, age-, history-,
cardiovascular risk factor-, and medication-matched controls, using
sequential precipitation and an immune-bead assay. Patients were
selected from the MYOMARKER cohort, containing patients under-
going myocardial perfusion imaging (Rubidium-82 PET-CT) in the
diagnostic workup for suspected stable angina in the cardiology out-
patient clinic. The MYOMARKER study complies with the Declaration
of Helsinki and was approved by a recognized medical ethics com-
mittee (VCMO). Informed consent was obtained from all patients.
Results: EV levels of SerpinC1 most accurately discriminated between
patients with stable coronary artery disease and matched controls.
SerpinC1 with the ratio HDL/TEX and an AUC of 0.842 (95% CI 0.741
0.944); SerpinC1 with the ratio HDL/REX and an AUC of 0.828 (95% CI
0.7180.938) and SerpinC1 in the HDL fraction with an AUC of 0.812
(95% CI 0.7000.924) were the three best individual markers. The
best combination of markers consisted of SerpinC1-HDL, SerpinG1-
TEX and SerpinC1-REX, and showed an AUC of 0.861 (95% CI 0.758
0.965). Results are being validated in the MYOMARKER cohort of 850
patients. Summary/conclusion: These data show that an EV protein
signature can be used as diagnostic biomarker for SCAD.
OT12.2
Coronary artery calcification associates with specific cell-derived
blood-borne microvesicles in middle-aged women with and without
history of preeclampsia
Muthuvel Jayachandran1,2, Vesna D. Garovic3, Brian Lahr4, Kent R. Bailey4,
Michelle M. Mielke5, Wendy M. White6 and Virginia M. Miller1,2
1Departments of Surgery, Mayo Clinic, Rochester, USA; 2Physiology and
Biomedical Engineering, Mayo Clinic, Rochester, USA; 3Division of Biomedical
Statistics and Informatics, Mayo Clinic, Rochester, USA; 4Division of Nephrology
and Hypertension, Mayo Clinic, Rochester, USA; 5Departments of Health
Science Research and Neurology, Mayo Clinic, Rochester, USA; 6Division of
Maternal Fetal Medicine, Mayo Clinic, Rochester, USA
Background: Coronary arterial calcification (CAC), a risk factor for
myocardial infarction and stroke, occurs in about 14% of women who
are classified as low risk by conventional cardiovascular (CV) risk
factors. This study aimed to determine if a panel of specific cell-derived
blood microvesicles (MV) would associate with CAC in middle-aged
women. Methods: This study was approved by the Institutional Review
Board at Mayo Clinic. Included in the study was a stratified sample of
age-matched women (median60 years) free of CV events: n40
with and n40 without a history of pre-eclampsia (PE). The MV
positive for phosphatidylserine, tissue factor (TF), ICAM-1, VCAM-1,
CD45 (leukocytes), CD42a (platelets), CD62E (endothelium), SM22a
(smooth muscle cells), CD117 (stem/progenitor cells), Pref-1 (adipo-
cytes) and p16set (senescent cells) were evaluated by digital flow
cytometry. CAC was determined by computed tomography. MV
variables (both individually and combined as principal components
[PC]) were analysed for an association with CAC within each strata
using Spearman’s correlation, and across both strata using an ordinal
logistic model that adjusted for history of PE. Results: Of the MV tested,
only those derived from smooth muscle cell correlated (p0.008)
with CAC in women without a history PE, whereas MV positive for
ICAM-1 correlated (p0.042) with CAC in women with history of PE.
Using PC analysis performed on MV data, none of the retained PC
scores correlated with CAC within the two groups. However, the first
PC, which consisted of TF positive MV, MV positive for VCAM-1 and
MV derived from adipocytes, was associated with CAC (p0.034) in a
multivariable model fit on the combined group after adjustment
for history of PE. Conclusions: A specific group of MV was identified
in this study of asymptomatic but at CV risk women that warrants
confirmation in other populations, to identify those who might benefit
from further testing for clinically significant calcification.
OT12.3
Exosomes induce and reverse monocrotaline-induced pulmonary
hypertension in mice
Jason Aliotta, Mandy Pereira, Sicheng Wen, Mark Dooner, Michael Deltatto,
Elaine Papa, Laura Goldberg, Grayson Baird, Corey Ventetuolo,
Peter Quesenberry and James Klinger
Department of Medicine, Rhode Island Hospital, Providence, USA
Aims: Extracellular vesicles (EVs) from mice with monocrotaline (MCT)-
induced pulmonary hypertension (PH) induce PH in healthy mice,
and the exosomes (EXO) fraction of EVs from mesenchymal stem
cells (MSCs) can blunt the development of hypoxic PH. We sought to
determine if the EXO fraction of EVs is responsible for modulating
pulmonary vascular responses and if differences in EXO-miR content
explain the differential effects of EXOs from MSCs and mice with
MCT-PH. Methods and results: Plasma, lung EVs from MCT-PH and
control mice were divided into EXO (exosome), microvesicle (MV)
fractions and injected into healthy mice. EVs from MSCs were divided
into EXO, MV fractions and injected into MCT-treated mice. PH was
assessed by right ventricle-to-left ventricleseptum (RV/LVS) ratio
and pulmonary arterial wall thickness-to-diameter (WT/D) ratio. miR
microarray analyses were also performed on all EXO populations.
EXOs but not MVs from MCT-injured mice increased RV/LVS and
WT/D ratios in healthy mice. MSC-EXOs prevented any increase
in RV/LVS and WT/D ratios when given at the time of MCT
injection and reversed the increase in these ratios when given
after MCT administration. EXOs from MCT-injured mice and patients
with idiopathic pulmonary arterial hypertension (IPAH) contained
increased levels of miRs-19b,-20a,-20b and -145, whereas miRs
isolated from MSC-EXOs had increased levels of anti-inflammatory,
anti-proliferative miRs including miRs-34a,-122,-124 and -127.
Conclusions: These findings suggest that circulating or MSC-EXOs
may modulate pulmonary hypertensive effects based on their
miR cargo. The ability of MSC-EXOs to reverse MCT-PH offers a
promising potential target for new pulmonary arterial hypertension
therapies.
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OT12.4
Trafficking of STAT5 via endothelial cell-derived extracellular vesicles
regulates IL-3 paracrine action
Maria Felice Brizzi, Giovanni Camussi, Patrizia Dentelli, Giusy Lombardo,
Gabriele Togliatto, Arturo Rosso, Maddalena Gili, Sara Gallo and
Maria Chiara Deregibus
Department of Medical Sciences, University of Turin, Italy
Soluble factors and cell-derived extracellular vesicles (EVs) control
vascular cell fate during inflammation. The present study investi-
gates the impact of Interleukin 3 (IL-3) on EV release by endothelial
cells (ECs), the mechanisms involved in EV release and paracrine
actions. We found that IL-3 increases EV release, which is prevented
by IL-3Ralpha blockade. EVs released upon IL-3 stimulation were able
to induce pro-angiogenic signals as shown by chromatin immuno-
precipitation (ChIP) assay performed on the promoter region of
cyclin D1 and tridimensional tube-like structure formation. We herein
demonstrate that these effects rely on the transfer of miR-126 and,
more importantly, of activated signal transduction and activator
of transcription 5 (pSTAT5) from IL-3-EV cargo into recipient ECs.
We show, using the dominant negative form (DN)STAT5 and an
activated STAT5 (1*6STAT5) constructs, that STAT5 drives IL-3-
mediated EV release, miR-126 and pSTAT5 content. Finally, using
EVs recovered from DNSTAT5 expressing ECs, we provide evidence
that miR-126 and pSTAT5 trafficking is relevant for IL-3-mediated
paracrine pro-angiogenic signals. These results indicate that IL-3
regulates EC-EV release, cargo and IL-3 angiogenic paracrine action
via STAT5. Furthermore, these results provide evidence that EC-
derived IL-3-EVs can serve as pro-angiogenic clinical delivery wound
healing devices.
OT12.5
Human endothelial microvesicle shedding in response to simulated
blast trauma
Anna Sharrock1,2, Sara Rankin1, Rory Rickard2, Harsh Amin1 and
Paul Harrison3
1Royal British legion Centre for Blast injury Studies, and National Heart and
Lung Institute, Imperial College, London, UK; 2Academic Department of
Military Surgery and Trauma, Royal Centre for Defence Medicine, Birmingham,
UK; 3Institute of Inflammation and Aging, University of Birmingham,
Birmingham, UK
Introduction: Procoagulant microvesicles have been shown to rise in
clinical studies following blunt and penetrating trauma compared to
healthy controls. It has been established that blast injury mechan-
isms are associated with an increased risk of sepsis, multi-organ
failure and coagulopathy, compared to those with injury severity
matched blunt mechanisms. However, the generation and role of
microvesicles following blast trauma has yet to be elucidated. Aims:
We wished to develop a human endothelial model for studying the
effects of blast waves on cell viability and microvesicle generation
and function. Methods: Confluent human umbilical vein endothelial
cells (HUVECs) were exposed to a 6-bar blast (N6), or control
conditions. Cell viability (calcein, ethidium homodimer-1) and micro-
vesicle formation (annexin V) were assessed by confocal micro-
scopy. Pre-filtered supernatants were removed and assessed at 1, 3, 6
and 24 h by 0.21.1-mm-gated flow cytometry (using annexin V,
CD31, CD51, CD54, CD62E, CD141 and CD142) and calibrated
automated thrombography (CAT) (N2). Results: HUVEC viability
was not diminished by blast wave exposure, and microscopy showed
formation of microvesicular structures. Flow cytometric analysis
demonstrated a trend (NS) increase in annexin V microvesicles at
all time-points. While no significant increase in microvesicles with
any marker was seen, there was a 4.92-fold (p0.087) and 4.63-fold
(p0.085) increase of CD142 and CD141 events, respectively,
at 24 h in the blast group compared with the control group.
Microvesicles were shown to be thrombogenic in two CAT experi-
ments. Conclusions: A model has been developed to establish the
effects of blast waves on human endothelial cells. The application of
6-bar blast in the model has not convincingly shown an increase in
microvesicle formation. Thombography, CD141 and CD142 shifts are
yet to achieve statistical significance. The methodology is estab-
lished to explore the model with a range of blast exposures.
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OT13.1
Hepatocyte-derived extracellular vesicles enzymatic activity modify
serum metabolome
Felix Royo, Sebastiaan Van-Liempd, Diana Cabrera, Esperanza Gonzalez
and Juan Manuel Falcon Perez
Cic BioGUNE, Bizkaia, Spain
Introduction: Hepatocytes release extracellular vesicles (EVs) to
the blood stream, loaded with a varied cargo. Although the most
studied role of EVs is related to cell-to-cell communication, it has been
proven that they could also harbour enzymatic activity. In the pre-
sent work, we evaluate the impact of EVs in the serum composition.
Methods: We had performed a metabolomic profiling of serum
samples after incubation with hepatocyte-secreted EVs that were
isolated by differential ultracentrifugation. The metabolic profile
was performed by using ultra-performance liquid chromatography
coupled to mass spectrometry (UPLC-MS). Results: The results ob-
tained revealed significant changes in various metabolites related to
amino acid metabolism. Importantly, the conversion of arginine into
ornithine was observed after incubation, which was consistent
with the presence of arginase enzyme (ARG1) in the EVs. By sucrose
density gradient, we confirmed that arginase activity was present in
the exosomes-enriched fraction. More importantly, the arginase
activity was found in vivo in the ultracentrifugation pellet obtained
from serum of animals treated with hepatotoxicans. Summary/
conclusion: Hepatocytes-derived EVs carry active enzymes that had a
significant impact in the serum metabolome what could have
important consequences for different pathophysiological processes
including drug-induced liver injury and regeneration.
OT13.2
Controlled enhancement of EV vascularization bioactivity by ethanol
conditioning
Steven Jay, Tek Lamichhane and Christopher Leung
University of Maryland, College Park, Maryland, USA
Introduction: Peripheral vascular disease (PVD) is a leading cause
of mortality, and new strategies for therapeutic vascularization
are needed. Extracellular vesicles (EVs) from many cell types have
vascularization bioactivity and thus represent a potential new class
of PVD therapeutics. Engineering EVs with enhanced vascularization
bioactivity would further promote this approach, thus we examined
numerous chemical conditioning approaches to induce angiogenic
cellular responses, eventually focusing on ethanol conditioning
of endothelial cells (ECs). Methods: EVs were isolated from human
umbilical vein ECs (HUVEC) cultured with or without ethanol
(0200 mM) by differential centrifugation and characterized via
nanotracking analysis, TEM and immunoblotting. Vascularization
bioactivity was assessed via an EC migration assay and a human
angiogenesis PCR array. EV microRNA content was evaluated by a
PCR-based whole miRNome array. Results: Ethanol conditioning of
HUVEC enhanced EV vascularization bioactivity in a dose-dependent
manner; a minimum of 50 mM ethanol was required to achieve
significant increases in EC migration compared to 0 mM control
(migrated area of 0.18/0.032 sq. mm vs. 0.243/0.018), while
concentrations up to 200 mM concentration induced further en-
hancement (0.308/0.016). PCR analysis revealed that ECs
stimulated by EVs isolated from 50 mM ethanol-conditioned HUVEC
had 6-fold increase in CD34 levels compared to control cell EVs.
Analysis of EV miRNA content showed significant decreases in key
anti-angiogenic miRNAs (miR-137, miR-100, miR-24, miR-573, miR-
320), suggesting enhanced pro-vascularization bioactivity. Summary/
conclusion: Ethanol conditioning downregulates several anti-angio-
genic miRNAs in HUVEC EVs. This promotes enhanced vascularization
bioactivity of these EVs, leading to CD34 upregulation in target ECs.
Ethanol conditioning may be a scalable strategy to enhance
vascularization bioactivity of EVs from ECs and other cell types.
OT13.3
Human mesenchymal stem cell-derived extracellular vesicles
ameliorate eye disease by reducing inflammation and
neovascularisation in a corneal alkali burn rat model after topical
administration
Thomas Ritter1, Cerine Lal2, Oliver Treacy1, Grace A. O’ Malley1, Maura
Naughton1, Serika Naicker1, Paul Lohan1, Hrebesh Subash2, Aideen E.
Ryan3, Gerry Fahy4, Martin J. Leahy2, Matthew D. Griffin1 and Sweta Rani1,5
1Regenerative Medicine Institute (REMEDI), College of Medicine, Nursing and
Health Sciences, National University of Ireland, Galway, Ireland; 2School of
Physics, College of Natural Sciences, National University of Ireland, Galway,
Ireland; 3Discipline of Pharmacology and Therapeutics, College of Medicine,
Nursing and Health Sciences, National University of Ireland, Galway, Ireland;
4Department of Ophthalmology, University Hospital Galway, National
University of Ireland, Galway, Ireland; 5Waterford Institute of Technology,
Waterford, Ireland
Introduction: To investigate if topically applied mesenchymal stem
cell (MSC)-derived extracellular vesicles (EVs) promote corneal
wound repair in a rat alkali burn model. Methods: EVs were isolated
from media conditioned by human bone marrow-derived MSCs
(n4) using a series of centrifugation, filtration and ultracentrifuga-
tion steps followed by transmission electron microscopy (TEM) and
nanoparticle tracking analysis (NTA; NanoSight) quality control. Pro-
healing effects of hMSC-derived EVs (hMSC-EV) were examined in
vitro by cell migration and scratch wound healing assays using
human corneal epithelial (HCE) and endothelial (HCEC) cell lines. Rat
corneal alkali burn injury was induced and injury was treated with or
without 30 mg of hMSC-EVs. Efficacy of treatment was monitored by
biomicroscopy and optical coherence tomography (OCT) followed
by extensive tissue analysis. Results: Successful isolation of EVs was
confirmed by immune-gold TEM showing expression of CD63 and
TSG101. NTA showed the average size of EVs ranged between
50130 nm. Significant increases in HCE and HCEC cell migration in
the presence of MSC-EVs were observed compared to PBS control
and EV-depleted media. Moreover, a significant increase in scratch
wound closure of cells treated with hMSC-EVs was observed. In vivo,
analysis of images taken at days 0, 1, 3 and 7 of fluorescein stained
corneal injury showed significantly enhanced healing of the corneal
surface at days 1 and 3 when treated with hMSC-EVs compared to
PBS control. OCT analysis revealed that hMSC-EVs reduced inflam-
mation and maintained the physiological structure of the eye.
Importantly, a reduction in corneal damage and inflammatory infil-
trating cells and an increase in proliferating epithelial cells (Ki67-
positive) was observed following hMSC-EV treatment. Conclusion:
Our results show that topical hMSC-EV application is a novel
promising cell-free therapy with high potential for translation in
ocular surface disease treatment.
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OT13.4
Treatment with extracellular vesicles from adipose tissue
derived mesenchymal stromal cells in a murine model of
silicosis
Elga Bandeira1, Helena Oliveira1, Johnatas Silva1, Rubem Mena-Barreto3,
Christina Takiya1, Jung Soo Suk2, Kenneth Witwer2, Justin Hanes2, Michael
Paulaitis2, Patricia Rocco1 and Marcelo Morales1
1Federal University of Rio De Janeiro, Brazil; 2Johns Hopkins University,
Baltimore, Maryland; 3Fiocruz, Rio de Janeiro, Brazil
Mesenchymal stromal cells (MSC) have been shown to exert bene-
ficial effects in a variety of lung diseases. Recently, it has been
suggested that similar effects can be achieved by the therapeutic
use of extracellular vesicles (EVs) obtained from the conditioned
media of these cells. The aim of this study was to investigate the
therapeutic effects of adipose tissuederived MSC (AD-MSCs) and
EVs produced by them in a model of chronic silicosis. Forty C57BL/6
female mice received saline or silica (20 mg) intratracheally (IT). At
day 15, silica animals received an IT instillation of saline, AD-MSCs
(E05 cells), or EVs in two different doses: equivalent to E05 cells (EV5)
or E06 cells (EV6). EVs were obtained through ultracentrifugation of
conditioned media. Electron microscopy, flow cytometry and nano-
particle tracking analysis were used to characterize the EV samples.
Their stability in various conditions, including aerosolization of the
EV suspension using a microsprayer syringe was assessed through
NTA. Labelled EVs were used to observe uptake in vitro and distri-
bution in the lungs. The RNA content of the EVs was characterized
through electrophoresis, and Nanostring analysis indicated the
presence of miRNA such as miR-494, miR-302d, miR-122 and let-7a.
At day 30, AD-MSCs and EVs led to a reduction in collagen fibre
content. AD-MSCs and the higher dose of EVs also reduced the size
of granuloma and the number of macrophages inside the granuloma
and in the alveolar septa. Additionally, expression of IL-1ß and TGFß
was decreased in the lung of these groups. EV6 group also presented
improved lung elastance when compared to untreated silicosis group.
In conclusion, EVs derived from AD-MSC presented a heterogenous
EV population, capable of sustaining aerosolization without size and
number alterations, and both AD-MSCs and EVs, locally delivered,
ameliorated fibrosis and inflammation, but dose-optimized EVs
yielded better therapeutic outcomes in this model of silicosis.
OT13.5
Mesenchymal stromal cell-derived extracellular vesicles as vehicle of
therapeutic mRNA: evidences for WalkerWarburg muscular dystrophy
treatment
Enrico Ragni1, Federica Banfi1, Valentina Parazzi1, Cristiana Lavazza1,
Mario Barilani1, Vincenza Dolo2, Valentina Bollati3 and Lorenza Lazzari1
1Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy;
2University of L’Aquila, Italy; 3Molecular Epidemiology and Environmental
Epigenetics Laboratory, Department of Clinical Sciences and Community
Health, Universita´ Degli Studi Di Milan, Italy
Introduction: In vitro animal models suggested that mesenchymal
stem cell (MSC)-extracellular vesicles (EVs) are able to transfer pro-
teins, lipids and nucleic acids, thereby influencing various functions
of recipient cells. Notably, increase in proliferation and apoptosis
inhibition were reported upon MSC-EV treatment of injured cells
in various models. Therefore, we investigated EV communication
mechanisms in bone marrow (BM)- and umbilical cord blood (CB)-
MSC at mRNA level, with particular attention to an O-mannoyslation
deficiency-associated congenital muscular dystrophy model (Walker
Warburg syndrome, WWS). Methods: Human MSCs were obtained
from bone marrow and umbilical cord blood after informed consent.
EVs were isolated by differential centrifugation and their integrity
verified by CSFE staining. RNA was extracted and a panel of selected
genes assayed by qRT-PCR. Ability of MSC-EV to fuse with myoblasts
was tested by FACS and confocal microscopy. Recovery of O-
mannosylation in a WWS patient myoblast line after EV administra-
tion was checked by FACS. Results: Transcripts involved in MSC
functions (IL4, IL10, FGF7, CNTF, KDR) were preferentially EV-
accumulated with respect to a random internalization. Their 3’UTR
analysis showed potential binding to 71 miRNA in recipient cells.
These miRNAs, and alteration in their cytosolic levels, were predicted
in silico to modulate transcription/translation and anti-apoptotic
processes. MSC-EV also contained mRNA of O-mannosylation genes
directly involved in WWS pathology and were able to efficiently fuse
with myoblasts. In a patient myoblast line, EV partially reverted O-
mannosylation deficiency, suggesting the translation of wild-type
mRNA into a functional enzyme and contributed to a morphology
recovery. Conclusions: These results proposes a proof of concept
for the use of MSC-EV as a novel therapeutic approach to reduce
apoptotic processes and restore a proper glycosylation profile in
WWS muscular dystrophy myoblasts.
OT13.6
Characterization of exosomes from human amnion epithelial cells
Rebecca Lim1, Jean Tan1, Sinnee Lau1, Siow Chan1, Euan Wallace2 and
Joanne Mockler1
1Hudson Institute of Medical Research, Clayton, Australia; 2Monash University,
Melbourne, Australia
Background and Aims: The efficacy of stem cell therapy is largely
unrelated to functional engraftment. Studies using stem cell
conditioned media indicate that this is attributed to released soluble
factors and/or extracellular vesicles. Our work to date has focused on
stem-like cells from gestational tissues  human amnion epithelial
cells (hAECs). We have reported on the pro-reparative effects of
hAECs in small and large animal models of acute and chronic lung
injury. While there is now growing literature on MSC-derived
exosomes, there has been no information on hAEC-derived exo-
somes. Here, we aimed to characterize hAEC-derived exosomes and
assess their efficacy in bleomycin-induced lung injury. Methods:
hAEC-derived exosomes were characterized by a combination of
electron microscopy, FACS and western blotting. Proteomic analysis
was performed using label-free LC-MS. We assessed the ability of the
exosomes to suppress T-cell proliferation and increase macrophage
phagocytosis. We also assess their biological effects in vivo by
administering amniotic exosomes intranasally to 68 months old
C57Bl6 mice, 7 days following bleomycin challenge (10 ug or 50 ug).
Results: hAEC-derived exosomes inhibited CD3/CD28-induced T-cell
proliferation and increased macrophage phagocytosis in a dose-
dependent manner. Both doses of amniotic exosomes reduced lung
fibrosis to a similar extent (pB0.05) and this coincided with the
reduction of activated myofibroblasts in lung tissues (pB0.05).
Exosome administration also increased activation of endogenous
lung stem/progenitor cells. These outcomes may be associated with
some specific and relatively abundant exosomal cargo including
Wnt5a and HLA-G. Conclusions: hAEC-derived exosomes have pro-
perties similar to MSC-derived exosomes. Future studies should
include comparative analyses of their biological properties and
exosomal content in order to determine which common cargo is
responsible for exerting these beneficial effects.
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Genetically engineered bacterial protoplast-derived nanovesicles that
mimic extracellular vesicles as targeted drug delivery system
Oh Youn Kim, Nhung Dinh, Seng Jin Choi, Hyun Taek Park and
Yong Song Gho
Life Sciences, POSTECH (Pohang University of Science and Technology),
Pohang, Republic of Korea
Introduction: Over the past years, massive improvements have
been made on delivery technologies to help patients undergoing
chemotherapy. However, despite the advancement, the challenge
to specifically deliver the chemotherapeutics to the tumour site to
reduce the undesired adverse effects still remains. Therefore, in this
study, we newly developed bioinspired extracellular vesicle-mimetic
nanovesicles derived from genetically engineered bacterial protoplast
having removed bacterial outer membrane components as targeted
delivery system for chemotherapeutics. Material and Methods:
Bacterial protoplasts expressing human epidermal growth factor
(EGF) as tumour-targeting ligand on the surface were extruded serially
through membrane filters of 10, 5, 1 and 0.5 mm pores to form
nanovesicles. The tumour-targeting efficacy and delivery of drug were
examined on EGF receptor expressing human lung carcinoma A549
cells in vitro and A549 xenografted mice in vivo. Results: Electron
microscopy images revealed that the protoplast nanovesicles had
intact vesicular structures of about 80 nm in diameter. Western
blotting analyses showed that the nanovesicles did not contain toxic
bacterial outer membrane components and expressed EGF on the
surface. Moreover, anti-cancer drug-loaded nanovesicles effectively
targeted to tumour cells in vitro and in vivo via receptor-mediated
endocytosis and induced dose-dependent cytotoxicity. Furthermore,
significant prevention of tumour growth was observed after the
treatment of drug-loaded nanovesicles to tumour xenograft mice
without adverse effects. Summary/conclusion: Together, the results
obtained from this study strongly suggest the potential of extracellular
vesicle-mimetic bacterial protoplast nanovesicles as future advanced
targeted drug delivery vehicle that is both effective and safe.
OT14.2
High-affinity single-chain fragment variables (scFvs) are novel specific
targeting motifs for extracellular vesicles
Christina Schindler, Andrea Longatti, Laura Fitzpatrick, Carl Matthews,
Lesley Jenkinson, Tristan Vaughan and Natalie Tigue
MedImmune, Cambridge, UK
Introduction: Extracellular vesicle targeting to specific cells or tissues
using peptide motifs displayed on their surface has previously been
described. So far, this approach has taken advantage of a small
number of endogenous peptide ligands that target a known binding
partner/receptor and therefore is limited to a small set of applications.
The use of antibody-derived scFv (single-chain fragment variable)
motifs, which can be engineered to bind to any cell surface receptor,
with a defined affinity could be considered as a promising alternative
targeting strategy. Methods: Herein, we describe the generation of
cell linederived exosomes equipped with scFv of different affinities
to the receptor Her2 on their surface. ScFv were anchored to the cell
surface by fusion to the C1C2 domain of lactadherin (MFGE8) and
proteinaceous exosomal content was labelled with the dye CFSE.
Exosome uptake assays were performed in HEK293 lines over-
expressing different amounts of Her2 on their cell surface and CFSE
content in recipient cells was analysed by FACS and confocal
microscopy. Results: We were able to show that exosomes bearing
high and intermediate affinity scFv to Her2 were efficiently taken up
into cells with high surface expression of Her2 whereas a low
affinity or non-targeting scFv resulted in a lower cellular uptake of
exosomes. Exosome uptake relies on high surface levels of Her2 as
cells expressing intermediate levels of Her2 did not take up more
exosomes compared to the parental cell line. Summary/Conclusion:
Here, we present a novel strategy to specifically target exosomes to
cells based on high affinity interactions of scFv with an abundant
surface protein using Her2 as a model receptor. This broadens
the spectrum of interactions that can be used for specific EV
targeting and high uptake into recipient cells as scFv can be readily
engineered to exhibit the desired properties. Our findings may have
a broader application in the design of exosome-based therapeutics.
OT14.3
Effective cellular uptake of biofunctional peptide-modified exosomes
Ikuhiko Nakase
Osaka Prefecture University, Osaka, Japan
Introduction: Exosomes (100 nm in diameter) are small secretory
vesicles released from various cell types, and they represent
potential next-generation biological tools for delivering therapeutic
molecules. In this presentation, I will discuss novel techniques to
effectively target receptors via artificial leucine-zipper peptides and
enhance cytosolic release via a pH-sensitive fusogenic peptide (1).
Additionally, I will provide insights into macropinocytotic-based
cellular uptake of exosomes (2) modified with arginine-rich peptides.
Methods: Secreted CD63-GFP-containing exosomes from HeLa cells
were isolated by ultracentrifugation. All peptides were chemically
synthesized by Fmoc solid-phase peptide synthesis. Results and
conclusion: A 30-residue amphipathic peptide GALA was designed to
mimic viral fusion protein sequences. In our system, cationic lipids
were employed to bind peptides onto the surfaces of exosomes (1).
Enhanced cytosolic release of the cargo from exosomes was suc-
cessfully achieved by using the GALA peptide, resulting in effective
biological activity of originally encapsulated cargo in exosomes (1).
On the other hand, modification of the exosomal surface with
artificial leucine-zipper K4 peptides allowed for recognition of E3-
fused receptors on the cell membrane, leading to efficient cellular
targeting. My research group recently found that induction of
macropinocytosis following the stimulated cancer-related receptors
(e.g. EGFR) or expression of oncogenic K-Ras significantly enhanced
cellular exosome uptake (2). In addition, arginine-rich peptides can
induce macropinocytosis and result in more efficient cellular
uptake. Thus, we studied the effects of exosomal membrane modifica-
tion with arginine-rich peptides (e.g. octaarginine) on cellular uptake
of exosome and found that uptake efficacy was significantly
increased.
References
1. Nakase, I., et al., Sci. Rep. 5, 10112 (2015).
2. Nakase, I., et al., Sci. Rep. 5, 10300 (2015).
OT14.4
Efficient and rapid cellular delivery of bioactive proteins using EXPLOR:
exosomes engineered for protein loading via optically reversible
proteinprotein interaction
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Introduction: Many intracellular proteins with great potential as bio-
pharmaceutical drugs have been identified; however, many of the
challenges associated with intracellular protein delivery have yet to
be solved. Cell-derived exosomes have recently been highlighted as
new therapeutic strategies for the in vivo delivery of nucleotides and
chemical drugs; however, these methods were based on the passive
loading of siRNAs or miRNAs into isolated exosomes by electrophor-
esis, a method poorly suited for the intracellular delivery of cellular
proteins. Methods: We developed an opto-genetically engineered
exosome system, named ‘exosomes for protein loading via optically
reversible proteinprotein interaction’ (EXPLOR) that can deliver
soluble proteins into the cytosol via controlled, reversible protein
protein interactions (PPI). Results: By integrating a reversible PPI
module controlled by blue light with the endogenous process
of exosome biogenesis, we were able to successfully load cargo
proteins into newly generated exosomes. Treatment with protein-
loaded EXPLORs was shown to significantly increase intracellular
levels of cargo proteins and their function in recipient cells in both a
time- and dose-dependent manner. In the present study, we have
demonstrated the intracellular delivery of mCherry, Cre enzyme, Bax,
and Super repressor IkB proteins as functional proteins in the target
cells and in vivo. Summary: These results clearly indicate the
potential of EXPLORs as a mechanism for the efficient intracellular
transfer of protein-based drugs into recipient cells and tissues both
in vitro and in vivo.
OT14.5
Exosome-mediated delivery of hydrophobically modified siRNA for
Huntingtin mRNA silencing
Marie Didiot1, Lauren Hall1, Andrew Coles1, Reka Haraszti1,
Bruno Godinho1, Kathryn Chase1, Ellen Sapp2, Socheata Ly1,
Julia Alterman1, Matthew Hassler1, Lakshni Raj3, David Morrissey3,
Marian Difiglia2, Neil Aronin1 and Anastasia Khvorova1
1RNA Therapeutics, University of Massachusetts Medical, Worcester, MA, USA;
2Institute for Neurodegenerative Disease, Massachusetts General Hospital,
Charlestown, MA, USA; 3Novartis Institutes for Biomedical Research Inc.,
Cambridge, MA, USA
Introduction: Delivery represents a significant barrier to the clinical
advancement of oligonucleotide therapeutics for the treatment
of neurological disorders such as Huntington’s disease (HD). HD
is caused by the autosomal dominant inheritance of the mutant
Huntingtin (HTT) allele and represents an excellent monogenic
disease target for oligonucleotide therapeutics. Small endogeneous
vesicles known as exosomes have the potential to act as oligonu-
cleotide delivery vehicles, but robust and scalable methods for
loading therapeutic cargo into exosomes are lacking. Method: Here
we developed a novel and simple method enabling the efficient
loading of hydrophobically modified siRNAs (hsiRNAs) upon co-
incubation. Results: Loading of hsiRNAs does not alter vesicle size
distribution or integrity. Exosomes loaded with hsiRNAs targeting
Huntingtin mRNA are efficiently taken up by mouse primary cortical
neurons and promote dose-dependent silencing of Huntingtin
mRNA and protein. Unilateral infusion of hsiRNA-loaded exosomes
into mouse striatum results in wide distribution of hsiRNA promoting
the silencing of Huntingtin mRNA in both treated and non-treated
sides of the brain. Summary/conclusion: Thus, the packaging of
hydrophobically modified oligonucleotides into exosomes repre-
sents a key advance in the delivery of therapeutic oligonucleotides.
The broad distribution and efficacy of hsiRNA-loaded exosomes
delivered to brain is expected to improve the development of
advanced therapies for treatment of Huntington’s disease and other
neurodegenerative disorders.
OT14.6
Customizing extracellular vesicles for therapy and imaging
Amanda Silva, Nathalie Luciani, Florence Gazeau and Claire Wilhelm
Physics department, Universite´ Paris 7/CNRS, Paris, France
Introduction: Extracellular vesicles (EVs) are multifaceted subcellular
entities that may represent a new generation of bio-camouflaged
drug/ nanoparticle delivery system. Methods: In a top-down proce-
dure, our group has engineered nanoparticle/drug-loaded EVs from
precursor cells previously loaded with this cargo. For this purpose,
parent HUVEC cells or THP1 macrophages were first incubated with
the desired payload and allowed to internalize it. Starvation stress
was employed to induce the release of vesicles highjacking the
cargo from their precursor cell. Results: By this method, EVs could
encapsulate a set of nanoparticles regardless their chemistry or
shape, such as iron oxide nanoparticles, iron oxide nanocubes, gold/
iron oxide nanodimers, gold nanoparticles, and quantum dot. These
hybrid vesicles were able to generate heat when submitted to an
alternating magnetic field and could be monitored by fluorescence
imaging or MRI. Dual drug/nanoparticle EV loading was also feasible
by this method. We demonstrated that vesicles from THP-1 cells
could be loaded with iron oxide nanoparticles and different
therapeutic agents regardless their molecular weight, hydrophobic,
hydrophilic and amphiphilic character. Thereby, magnetic vesicles
were loaded with a chemotherapeutic drug (doxorubicin), antic-
oagulant protein (tissue-plasminogen activator (t-PA)), or two
photosensitizer (disulfonated tetraphenylchlorin (TPCS2a) or meta-
tetra (hydroxyphenyl)chlorin (mTHPC). The theranostic potential of
mTHPC-loaded magnetic EVs was tested in vivo in a murine tumour
model. EVs could be tracked in vivo by dual-mode imaging
(fluorescence and MRI). The engineered EVs were found to induce
an efficient photodynamic action, as evidenced by tumour growth
curves and histological analysis. Summary/conclusion: In brief, we
succeeded in customizing EV by engineering them to display several
nanoparticle/drug cargoes featuring therapeutic and imaging prop-
erties both in vitro and in vivo.
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OT15.1
Exosomes from non-metastatic melanoma recruit patrolling monocytes
for immune clearance of metastasis
Olga Volpert, Stephen D. Miller, Nicholas L. Angeloni, Michael Plebanek
and C. Shad Thaxton
Northwestern University, Evanston, Illinois, USA
Introduction: Exosomes are critical in shaping tumour microenviron-
ment, especially pre-metastatic niche, which fosters colonization,
survival and proliferation of the vagrant cancer cells. Exosomes
facilitate homing of the tumour cells and determine their organ
tropism through integrins on their surface; they also recruit hyper-
inflammatory macrophages which provide growth advantage for
cancer cells. Finally, in patients/animals with immunogenic tumours,
exosomes enable the escape of metastasizing cancer cells from
immune surveillance. Here, we show that the opposite is also true:
exosomes from non-metastatic melanoma cells potently inhibit
metastasis to the lung by stimulation of immune surveillance.
Methods: We have used ‘non-metastatic’ and control ‘metastatic’
exosomes, in two in vivo models of melanoma metastasis, lung
colonization and extravasation assays. We also performed functional
analysis and molecular characterization of immune cell populations
ex vivo and and in vitro, using knockdown analyses, time-lapse
microscopy, western blotting and flow cytometry. Results: ‘Non-
metastatic’ exosomes stimulated immune surveillance and clearance
(lustration) by the Ly6Clow, Ly6Glow population of monocytes, which
are closely related to patrolling monocytes (PMo). The exosome-
dependent PMo recruitment and subsequent phagocytosis of
melanoma cells at the pre-metastatic niche required the induction
of NR4A1 orphan nuclear receptor and subsequent differentiation
to dendritic-like cells and TRAIL-dependent killing/ phagocytosis
of melanoma cells. The NR4A1 induction and downstream events
were due to the display of pigment epithelium-derived factor (PEDF),
on exosome surface. Summary/conclusion: Our studies imply that
pre-metastatic tumours express triggers of immune lustration (e.g.
PEDF), which are released and delivered to the cells of immune
system via exosomes and that the loss of lustration triggers con-
tributes to metastasis.
OT15.2
Exploitation of exosomes as delivery system of functional pro-
apoptotic membrane TNF-related apoptosis-inducing ligand
Veronica Huber1, Claudia Chiodoni1, Paola Squarcina1, Monica Tortoreto1,
Laura Botti1, Barbara Vergani2, Elisabetta Vergani1, Antonello Villa2, Mario
Paolo Colombo1, Nadia Zaffaroni1, Alessandro Massimo Gianni3 and Licia
Rivoltini1
1Department of Experimental Oncology and Molecular Medicine, Fondazione
IRCCS Istituto Nazionale dei Tumori, Milan, Italy; 2Microscopy and Image
Analysis, Universita´ degli Studi di Milano-Bicocca, Milan, Italy; 3Department of
Clinical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
Introduction: The exploitation of exosomes as novel therapeutic tool
relies on their natural function in intercellular communication and
signal delivery to target cells. We here investigated the ability of
membrane TNF-related apoptosis-inducing ligand (TRAIL)-expressing
exosomes to deliver pro-apoptotic signals to cancer cells and
mediate growth inhibition in different tumour models. Methods:
Exosomes produced by K562 TRAIL cells were characterized by
NanoSight, cytofluorimetry, immunoelectronmicroscopy, western
blot and ELISA. TRAIL-death receptors (DR4, DR5) and apoptosis of
SUDHL4 lymphoma, INT12 melanoma and KMS11 multiple myeloma
cells were detected by flow cytometry. Anti-tumour activity was
tested in local and systemic treatment approaches of SUDHL4, INT12
and KMS11 bearing SCID mice. Homing of TRAIL exosomes was
evaluated by confocal microscopy and near-infrared imaging. Results:
TRAIL exosomes activated the apoptotic cascade primarily in DR5
SUDHL4 and INT12, with respect to DR4 KMS11 cells and intra-
tumour treatments led to growth inhibition and necrosis in SUDHL4
(68%), INT12 (51%) and KMS11-bearing animals. Systemically admi-
nistered TRAIL exosomes mainly accumulated in the liver but also
reached tumour site leading to a significant reduction of tumour
growth (58%) in the SUDHL4 tumour model. A non-statistically
significant reduction of tumour volume was detectable in INT12-
bearing mice accompanied by pronounced tumour necrosis. In
contrast, KMS11 lesions displayed only perivascular necrosis upon i.v.
injection of TRAIL exosomes. Summary/conclusion: TRAIL exosomes
can contribute to tumour growth control, especially in intra-tumour
setting. The efficacy of systemically administered TRAIL exosomes,
significant only in highly TRAIL-sensitive SUDHL4 tumours, could be
potentiated by ameliorating the targeting of TRAIL exosomes to
tumour site. As a natural and tailorable delivery system, exosomes
represent a promising therapeutic tool in cancer.
OT15.3
In vitro and in vivo evaluation of EpsteinBarr virus latency II-derived
peptides as tumour vaccine for immunotherapy of nasopharyngeal
carcinoma
Dhafer Mrizak1, Rami Mustapha1, Sarah Renaud1, Nathalie Martin1,
Hayet Rafa2, Pedro Roman-Puche1, Liu Fei Fei3, Niki Toshiro4,
Lo Kwok-Wai5, Ve´ronique Pancre´1, Pierre Busson6, Nadira Delhem1
and Olivier Morales1
1Centre national de la recherche scientifique, Lille, France; 2University of
Science and Technology Houari Boumediene, Bab Ezzouar, Algeria; 3Ontario
Cancer Institute, Ontario, Canada; 4Galpharma, El Aı¨n, Tunisia; 5Faculty of
Medicine, Chinese University of Hong-Kong, China; 6CNRS-UMR and Institut de
cance´rologie Gustave Roussy, Universite´ Paris, France
EpsteinBarr virus (EBV) is present in undifferentiated nasopharyn-
geal carcinoma (NPC). Thus, tumour-associated viral antigens are
potential targets for immunotherapy. We favoured an approach of
immunotherapy based on the stimulation of CD4 T cell specifics
of EBV antigens, while taking into account that NPC cells secrete
large amounts of immunosuppressives exosomes. Both CD4and
EBV-specific CD4 T cell lines, were generated and cultured with
increasing doses of NPC exosomes, isolated from xenotransplanted
NPC in severe combined immunodeficiency (SCID) mice. We per-
formed (i) proliferation assays, (ii) cytotoxicity tests by measuring the
NPC cells lysis and (iii) cytokine secretion. The efficacy of peptides
vaccination was assessed in an immunodeficient SCID mice model
xenotransplanted with NPC cell lines (C666.1 -Luc), and reconstituted
with human PBMC. The evolution of the tumour has been appreciated,
both by measuring the tumour volume and the bioluminescence
emitted by NPC-Luc cells. We have previously selected 6 peptides
derived from the 3 EBV latency II antigens. We show here that all
these peptides used in cocktail are recognized by human PBMC, after
pre-incubation with NPC cell lines, inducing a broad IFN? cytokine
secretion. Furthermore, peptide-specific CD4 T cell lines generated,
and their cytotoxic potential assessed by lysing different NPC cell
lines, even in the presence of autologous exosomes. We also report
for the first time the ability of the cocktail to restrain tumour growth
in an original NPC xenotransplanted humanized SCID mice model.
Finally, this peptide cocktail had been recognized by all NPC patients
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tested whatever their disease’ stage and treatment status, eliciting a
strong Th1 memory response. Our data clearly suggest that EBV
latency II-derived peptides could be used as tumour vaccine for
immunotherapy of NPC, mainly in refractory patients or to combat
residual disease and prevent relapse in high risk patients after
classical treatments.
OT15.4
The shuttle of extracellular vesicles between cancer and bystander cells
allows dual targeting of malignant and supporter cells of the tumour
microenvironment by antibody drug conjugates
Hinrich Hansen, Maria Dams, Elke Pogge Von Strandmann and
Maximilian Tator
Internal Medicine I, University Cologne, Cologne, Germany
The aim of targeted immunotherapy in cancer is to damage both
malignant and tumour-supporting cells of the tumour microenviron-
ment but spare unaffected tissue. Several hematopoietic malignan-
cies such as Hodgkin lymphoma selectively express the TNF receptor
family member CD30 and the CD30 antibody drug conjugates (ADC)
SGN-35 shows an impressive clinical response in CD30-expressing
malignancies. Here, we investigated how cancer cell-derived extra-
cellular vesicles (EVs) influence the SGN-35 efficacy using in vitro-
models of classical Hodgkin lymphoma (cHL). The malignant Hodgkin
and ReedSternberg (HRS) cells selectively express CD30 and release
this receptor on EVs for the tumour-supporting communication with
CD30 ligand (CD30L)-positive bystander cells. Both, the malignant
cells and the EVs express active sheddases, which cleave CD30 and
release the soluble ectodomain (sCD30) into the environment. In a
3D semi-solid model to simulate the matrix of the tumour micro-
environment, EVs were retained but the cleaved ectodomain pene-
trated readily. This resulted in an enrichment of EV-associated CD30
inside and sCD30 outside the matrix. A low percentage of EV-
associated CD30 was also detected in the plasma of cHL patients,
confirming the relevance of the model. The interaction of EVs with
CD30-/CD30L mast cells and eosinophils allowed the indirect
binding of SGN-35. As a consequence, SGN-35 also damaged CD30-
negative cells, provided they were loaded with CD30-expressing EVs.
Loading with sCD30 was not effective. The fact that EVs loose CD30
when diffusing towards the circulation might explain the powerful
local SGN-35 efficacy against cancer and bystander cells within the
tumour tissue and the minute side effects in the circulation. These
data provide a novel mechanistic insight into the functionality
of ADCs.
OT15.5
Large oncosomes reprogramme prostate fibroblasts towards an
angiogenic phenotype
Valentina R. Minciacchi1, Cristiana Spinelli2, Lorenzo Cavallini2,
Mariana Reis-Sobreiro2, Mandana Zandian1, Rosalyn M. Adam3,
Edwin M. Posadas2, Michael R. Freeman4, Emanuele Cocucci5,
Neil A. Bhowmick2 and Dolores Di Vizio1
1Department of Surgery, Cedars Sinai Medical Center, Los Angeles, USA;
2Cedars-Sinai Medical Center, Los Angeles, CA, USA; 3Urological Diseases
Research Center, Boston Children’s Hospital and Harvard Medical School,
Boston, MA, USA; 4Department of Surgery and Department of Biomedical
Sciences, Cedars-Sinai Medical Center, University of California, Los Angeles;
5Boston Children’s Hospital, Boston, MA, USA
Introduction: Cancer cells communicate with different cells in the
microenvironment, establishing a supportive stroma that sustains
tumour development and facilitates the first steps of metastasis.
Extracellular vesicles (EVs) have emerged as key functional mediators
of this process. Aim: To determine the mechanism of intercellular
communication mediated by the atypically large EVs produced by
highly migratory and metastatic tumour cells, referred to as large
oncosomes (LO), and prostate fibroblasts (NAF). Methods: Filtration,
differential and iodixanol gradient centrifugation; flow cytometry;
confocal imaging; western blotting; kinase assay; TF array; luciferase
assay; tube formation; siRNA; RT-qPCR. Results: Active AKT1 is
significantly more expressed and functional in LO than in exosomes
(Exo). Patients with metastatic disease express abundant active AKT1
in plasma LO. Uptake of LO harbouring active AKT1 by NAF results in
AKT1 and c-MYC activation. Conditioned media from LO-treated
NAF, but not from Exo-treated NAF, promoted endothelial morpho-
genesis. The dynamin (DNM) inhibitor dynasore (Dyn)-inhibited LO-
uptake, as well as MYC activation and tube formation. Transient
silencing of DNM2 significantly reduced LO uptake, suggesting that
uptake occurs by phagocytosis. LO treatment increased levels of
MYC targets in NAF, suggesting that MYC is involved in LO-induced
reprogramming of NAF. Accordingly, MYC expression was higher in
activated fibroblasts than NAF, and MYC overexpression in NAF
induced hyperplasia in normal prostate epithelium in mice, suggest-
ing MYC activation is an early event in cancer development.
Conclusion: Our results indicate that tumour-derived LO induce a
novel, c-MYC mediated, pro-tumorigenic reprogramming of fibro-
blasts that can be reverted by selectively inhibiting LO uptake.
Support: National Institutes of Health NCI NIH R00 CA131472; NIH
UCLA SPORE in Prostate Cancer award P50 CA092131; Avon
Foundation Fund 02-2013-043 (to DDV).
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OT16.1
A nanofluidic device to study of extracellular vesicles on a single vesicle
basis
Marta Bally1, Stephan Block2, Fredrik Westerlund3,
Mohammadreza Alizadehheidari3, Elin Esebjo¨rner3 and Remo Friedrich1
1Department of Physics, Chalmers University of Technology, Go¨teborg,
Sweden; 2Chalmers University of Technology, Go¨teborg, Sweden;
3Department of Biology and Biological Engineering, Chalmers University of
Technology, Go¨teborg, Sweden
Introduction: Extracellular vesicle samples are characterized by an
enormous degree of heterogeneity both in vesicle biomolecular
composition and physical properties. This complexity calls for the
development of methods allowing for the characterization of small
biological vesicles on a single vesicle level allowing for the accurate
description of vesicle subpopulations including the identification
of rare but relevant subfractions. Methods: We present a nanofluidic
device allowing for the fluorescence-based detection of small lipid
vesicles with high-throughput and on a single particle basis. The
device consists of 300 nm300 nm parallel nanochannels fabricated
in fused silica. Results: In pin proof-of-principle experiments carried
out with liposomes, we show that the device can be used to quantify
the fluorescence intensity of individual fluorescent vesicles; vesicles
carrying a few tens of fluorophores could successfully be detected.
We further demonstrate that the device accurately determines the
number of vesicles found in solution; vesicle quantification was
reliable over more than three orders of magnitude and down to a
couple of hundred femtomolar. Finally, our setup is compatible
with dual-colour detection as demonstrated using liposomes carry-
ing both fluorescent lipids and a fluorescent membrane-binding
peptide. For all experiments, samples consumption was low: less
than 20 microliters were required for full analysis. The nanofluidic
device was shown to be well-suited to analyze biological samples.
Extracellular vesicles isolated from a human mast cell line could
be visualized after staining with a membrane dye and their
concentration was determined. Summary/conclusion: These results
illustrate the high potential of our nanofluidic device in the
characterization and quantification of exosomes and other extra-
cellular vesicles without ensemble averaging. It is likely to find
applications in a variety of fields, ranging from diagnostics to
fundamental biology.
OT16.2
Size and refractive index determination of extracellular vesicles smaller
than 70 nm in a nano-fluidic optical fibre
Edwin Van Der Pol1, Sanli Faez2,3, Yoav Lahini4, Markus A. Schmidt5,
Stefan Weidlich5,6, Frank Coumans1, Rienk Nieuwland7,
T.G. Van Leeuwen1 and Auguste Sturk7
1Department of Biomedical Engineering and Physics, Academic Medical
Centre, University of Amsterdam; 2Department of Physics & Debye Institute
for Nanomaterials Science, Utrecht University; 3Huygens-Kamerlingh Onnes
Laboratory, Leiden University, Leiden, The Netherlands; 4Department of
Physics, Massachusetts Institute of Technology, Harvard University, Cambridge,
MA, USA; 5Fiber sensors, Leibniz Institute of Photonic Technology,
Jena, Germany; 6Heraeus Quarzglas GmbH & Co. KG, Hanau, Germany;
7Laboratory of Clinical Chemistry, Academic Medical Centre, University of
Amsterdam, The Netherlands
Introduction: State-of-the-art detection methods show that typically
70% of the extracellular vesicles (EV) have a diameterB70 nm. Thus
far, EV B70 nm have only been studied in frozen state or with
methods requiring EV to be adhered to a surface. Thus, the majority of
EV have never been studied in their physiological environment. Here
we present a novel label-free optical method to track single EV B70
nm in suspension. We use the method to determine the diameter and
refractive index (RI) of EV. Methods: EV from human cell-free urine
(n5) were contained within a single-mode light-guiding silica fibre
with a 450 nm or 660 nm nano-fluidic channel. Laser light (660 nm
wavelength) was coupled to the fibre, resulting in a confined optical
mode in the nano-fluidic channel, which continuously illuminated the
freely diffusing EV inside the channel. Elastic light scattering from the
EV, in the direction orthogonal to the fibre axis, was collected using a
microscope objective (NA0.95) and imaged with a home-built
microscope. Light scattering was calibrated with 35 nm and 50 nm
polystyrene beads. To derive the diameter and RI of EV, we described
the measured thermal diffusion by the StokesEinstein equation and
light scattering by the Rayleigh approximation. Results: Using a nano-
fluidic optical fibre, we could track single EV as small as 50 nm for
60 seconds by elastic light scattering. Furthermore, by combining
data on thermal diffusion and light scattering, we confirmed that most
EV have an RIB1.4. Summary/conclusion: For the first time, we have
tracked single EV B70 nm freely diffusing in suspension to determine
their diameter and RI. Knowledge on the diameter and RI of EV is
essential to data interpretation and standardization. Potential applica-
tions of the nano-fluidic optical fibre are dimensional characterization,
zeta potential analyses and particleparticle interaction analyses of
the smallest EV present.
OT16.3
A biosensor study of extracellular vesicles derived from inflammation-
triggered endothelial cells
Baharak Hosseinkhani1, So¨ren Kuypers1, Jan D’Haen2,
Nynke Van den Akker3, Daniel G. M. Molin3, Inge Nelissen4,
Jef Hooyberghs4 and Luc Michiels1
1Hasselt University, BIOMED, B-3590 Diepenbeek, Belgium; 2Hasselt University,
Institute for Materials Research, B-3590 Diepenbeek, Belgium; 3Maastricht
University, dept. Of Physiology, Cardiovascular Research Institute Maastricht
(CARIM), Universiteitssingel 50, 6200 MD Maastricht, The Netherlands; 4Flemish
Institute for Technological Research (VITO), Boeretang 200, 2400 Mol, Belgium
One of the major challenges using extracellular vesicles (EV) as
diagnostic biomarkers is the assessment of translational methodol-
ogies to profile EV in relation to their physiological perturbations.
Surface plasmon resonance (SPR) offers a promising real-time, label-
free and highly versatile sensor platform with high potential for
EV biomarker detection. Therefore, we aim to develop a uniform SPR
methodology to detect specific protein surface markers on EV. EV
were purified from the culture supernatant of HUVEC, either untreated
or treated with TNF-a to induce an inflammatory stress response by
using different isolation procedure. Different analysis tools such
as TEM and NTA were used to study the size distribution and con-
centration of EV. Thereafter, biomarker profiling EV was carried out
using Immuno-EM, western blot, ELISA and SPR techniques. EV
having a size range of approximately 100200 nm were isolated. The
mean size of EV derived from TNF-a treated cells was relatively
bigger EV from untreated HUVEC. Overall, higher concentrations of
EV were detected in TNF-a treated HUVEC when compared to non-
stressed cells. Semi-quantitative screening of biomarkers present on
EV-surface was carried out using immunogold-conjugated antibo-
dies against ICAM-1, VCAM-1, PECAM-1, CD9, CD81, CD63 and TNF-a
receptor. Collectively, ratios of ICAM-1 and CD63 biomarkers allowed
to discriminate between EV derived from untreated and inflamed
cells. In order to assess the specificity of antibodies towards EV
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detection on SPR, the surface of a C1 chip was first functionalized
with antibodies and then exposed to EV. Results showed that both
anti-ICAM1 and CD63 tended to bind more EV produced by TNF-a
treated cells than others. Our current findings open up novel
opportunities for in-depth and label-free investigation of EV related
biomarkers in a high-end SPR platform. This work was co-financed by
the Interreg IVV Flandersthe Netherlands project VaRiA and TTD.
OT16.4
EVQuant: a novel extracellular vesicle quantification and
characterization assay for scientific and diagnostic use
Thomas Hartjes1, Diederick Duijvesz1, Roy Van Der Meel2,
Mirella Vredenbregt1, Matthijs Bekkers1, Adriaan Houtsmuller1,
Raymond Schiffelers2, Guido Jenster1 and Martin Van Royen1
1Erasmus MC, Rotterdam, The Netherlands; 2University Medical Center Utrecht,
The Netherlands
Introduction: Extracellular vesicles (EVs) are an important source for
biomarker discovery in cancer. As EVs in body fluids (i.e. urine) can be
obtained without invasive biopsies, EVs could be ideal for detection
or monitoring disease. Although various methods exist for quantify-
ing EVs, these methods are often time-consuming and detection
in clinical samples remains challenging. Current methods are also
unable to perform immunofluorescent imaging to detect multiple
biomarkers on single vesicles. Here we provide a rapid and easy to
use fluorescence-based assay (EVQuant) to quantify and characterize
single EVs in research and clinical samples without the need for EV
purification. Methods: In short, membranes of vesicles are fluores-
cently labelled using dyes for general cell membrane labelling (i.e.
rhodamine, PKH26/67) and/or immunofluorescent antibodies. To
detect low intensity signals, EVs are immobilized in a transparent
medium and visualized using confocal microscopy. Fluorescent EV
signals are quantified using a customized protocol. Results: Medium
from a panel of cell lines, isolated EVs and urine samples were
quantified using EVQuant, nanoparticle tracking analysis (Nanosight
NS300) and a CD9/CD63 time-resolved fluorescence immunoassay
(TR-FIA). We found a good correlation between EVQuant and
NanoSight but observed cell line specific differences when compar-
ing EVQuant and TR-FIA. When combining Rhodamine with fluor-
escent antibodies against CD9 and CD63, we were able to identify
subpopulations of EVs with specific phenotypes. Conclusion: EV-
Quant is a rapid, robust, low-cost, widely accessible assay which can
be of great value in research and clinical settings. As only a small
sample is needed without the need for EV purification, but mainly
the opportunity to perform multi-colour labelling of EVs (combina-
tion of biomarkers) makes this technique a suitable candidate for
implementation in a clinical setting.
Prostate Cancer UK (G2012-36) funds this project.
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OT17.1
EV-mediated procoagulant activity in multiple myeloma and
its precursor monoclonal gammopathy of undetermined
significance
Thøger Nielsen1, Søren Kristensen1, Shona Pedersen1, Henrik Gregersen1,
Elena Manuela Theodorescu1 and Gunna Christiansen2
1Aalborg University Hospital, Aalborg, Denmark; 2Aarhus University, Aarhus,
Denmark
Multiple myeloma (MM) and its precursor monoclonal gammopathy
of undetermined significance (MGUS) have a high risk of developing
thromboembolic events. Many factors are believed to contribute to
this hematological imbalance. Possible contributors may be extra-
cellular vesicles (EVs) circulating in the blood exerting procoagulant
behaviour linked to tissue factor (TF) and phosphatidyl serine. Here,
we investigated hypercoagulability in relation to EVs in blood from
MM and MGUS patients. Platelet free plasma was collected from
15 MM and 14 MGUS patients and 10 age-related control persons. All
test subjects gave written consent and the local ethics committee
approved the study. EVs were visualized using transmission electron
microscopy (TEM) and size and concentration were examined by
nanoparticle tracking analysis (NTA). Furthermore, calibrated auto-
mated thrombogram (CAT) and procoagulant phospholipids (PPL)
analyses were executed. To examine the procoagulant effect of EVs
exposing TF, fibrin generation test (FGT) and commercial antigenic
and activity assays for TF were conducted. By means of NTA we
observe a markedly higher particle count in patient plasma with
the most distinct difference in MM. Both patient groups exhibited
both shorter lag time and time-to-peak and a slightly elevated peak
thrombin in the CAT analysis. Faster clotting times in the PPL assay
were found in both MGUS and MM patients compared to controls,
thus indicating more procoagulant phospholipid activity. In addition,
the levels of circulating EV-associated TF in the age-related controls
differ from the patients, towards a more diseased profile. Our results
indicate that there is a link between EV-phenotypes and hypercoa-
gulability in patients with MM and demonstrates a similar premalig-
nant pattern of hypercoagulability present in the precursor stage,
MGUS. These findings may prove useful in identifying individual
patients at risk of developing thrombosis and allow for an early
intervention.
OT17.2
Extracellular vesicles mediate a hypercoagulable profile in small cell
lung carcinoma patients
Anne Flou Kristensen1, Gezelius Emelie2, Shona Pedersen3,
Søren Risom Kristensen1 and Mattias Belting2
1Department of clinical biochemistry/Deaprtment of clinical medicine, Aalborg
University Hospital, Aalborg, Denmark; 2Department of Clinical Sciences, Skane
University Hospital, Lund, Sweden; 3Department of Clinical Biochemistry,
Aalborg University Hospital, Aalborg, Denmark
Introduction: Small cell lung cancer (SCLC) is an aggressive subtype
of lung cancer and patients have an increased risk of developing
venous thromboembolisms (VTE). Chemotherapy administration is
associated with increased shedding of extracellular vesicles (EVs) that
are involved in thrombosis and metastasis. Recently, EVs have been
proposed to mediate a hypercoagulable profile in cancer patients,
therefore the aim of this project is to investigate the hypercoagul-
ability mediated by EVs in SCLC patients during disease progres-
sion and treatment. Methods: In a randomized phase III study
(NCT00717938) with 245 SCLC patients (105 with limited disease
(LD) and 140 with extensive disease (ED) receiving chemotherapy),
blood samples were collected at baseline, during treatment and at
follow-up 2 months after the end of chemotherapy. The hypercoa-
gulability was determined using calibrated automated thrombogra-
phy (CAT) and measuring the procoagulant phospholipids of EVs, i.e.
the PPL assay. To enumerate EV concentration and size, nanoparticle
tracking analysis (NTA) was used. Controls were 60 age-matched
healthy donors collected at Aalborg university hospital (N-20140055).
Results: At baseline, we observed a 40% increase in the thrombin
generated (CAT) and a 50% increase in PPL activity in patients with
SCLC compared to healthy controls. There was no difference in the
coagulation profile of patients with LD and ED. Moreover, we find
that the peak thrombin increased approx. 25% during treatment
and the same at follow-up compared with baseline. In addition, PPL
activity increased approx. 10% at follow-up. We find an increased
mean particle concentration with a reduced particle size during
treatment and follow up compared to baseline. Conclusion: Our
results demonstrate that SCLC-derived EVs possess a procoagulant
potency compared to controls and this may even be augmented
during and after therapy.
OT17.3
Cerebrospinal fluid microRNA (CSF miRNA) signature as a biomarker for
glioblastoma detection
Johnny Akers1, Valya Ramakrishnan1, Ying Mao2, Wei Hua2, Bob S. Carter1
and Clark C. Chen1
1Center for Theoretical and Applied Neuro-Oncology, University of California,
San Diego, San Diego, California, USA; 2Department of Neurosurgery, Huashan
Hospital, Fudan University, Shanghai, China
Introduction: Glioblastoma (GBM) is the most common form of
primary brain neoplasm and remains one of the deadliest of human
cancers. Clinical care for GBM patients is largely limited by the
absence of biomarker for assessment of tumour burden or ther-
apeutic response. Methods: Clinical GBM specimens and extracellular
vesicles (EV) of cerebrospinal fluids (CSF) from the same patient were
profiled using the TaqMan OpenArray miRNA platform. CSFs from
non-oncology patients were also profiled. A miRNA signature that
discriminated GBM CSF from non-oncology patients was identified
and validated in independent cohorts. Secretion of miRNAs compris-
ing this signature by GBM was studied using in vitro cell line models.
Results: In miRNA profiles of 24 matched clinical GBM specimens
and CSF, 10% of the GBM miRNAs can be reliably detected in the
matched clinical CSF. Good correlation was noted between the
abundance of the miRNAs in the clinical specimens and cerebrosp-
inal fluid. Profiling of additional GBM CSF (n164) and non-
oncology CSF (n111) revealed a molecular signature that reliably
discriminated GBM CSF from non-oncology CSF. For CSF derived
from the cerebral ventricle (cisternal), the sensitivity and specificity
for GBM detection were 80% and 67%, respectively. For CSF derived
from lumbar puncture, the sensitivity and specificity for GBM detec-
tion were 28% and 95%, respectively. These results were confirmed
in two additional patient cohorts (30 GBM CSFs and 30 non-oncology
CSFs). In GBM cell lines, secretion of signature miRNAs was highly
stimulated by co-culture with cell components that comprise the in
vivo GBM microenvironment (including bone marrow stromal cells).
Conclusion: The study represents the largest profiling effort of clinical
GBM CSF specimens to date and provides compelling results sup-
porting CSF miRNA signature as a biomarker platform for GBM
detection. Source of CSF (cisternal vs. lumbar) significantly influences
the sensitivity and specificity of this platform.
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OT17.4
Identification of individual exosome like vesicles by surface enhanced
Raman spectroscopy
Stephan Stremersch1, Monica Marro2, Bat-El Pinchasik3, Pieter Baatsen4,
An Hendrix5, Stefaan C. De Smedt1, Pablo Loza-Alvarez2,
Andre G. Skirtach3,6, Koen Raemdonck1 and Kevin Braeckmans1
1Department of pharmaceutics, Laboratory of General Biochemistry and
Physical Pharmacy, Ghent University, Ghent, Belgium; 2Super-resolution Light
Microscopy & Nanoscopy Lab, ICFO-Institut de Ciencies Fotoniques, Barcelona,
Spain; 3Department of Interfaces, Department of Biomaterials, Max Planck
Institute of Colloids and Interfaces, Potsdam, Germany; 4EM-facility EMoNe,
VIB-KULeuven Bio Imaging Core and Center for Human Genetics, KULeuven,
Leuven, Belgium; 5Department of Radiation Oncology and Experimental
Cancer Research, Laboratory of Experimental Cancer Research, Ghent
University, Ghent, Belgium; 6Department of Molecular Biotechnology, Ghent
University, Ghent, Belgium
Introduction: Exosome like vesicles (ELVs) are increasingly studied in a
diagnostic context. The fact that they contain many molecules
derived directly from the parent cell in combination with their
easy accessibility makes them interesting biomarker candidates. To
date, most approaches focus on identifying one specific molecular
component by elaborate ‘omics’ studies on bulk ELV isolates. Here
instead we tried to tackle the pending challenge to discriminate
cancerous ELVs from healthy ELVs on the single vesicle level. In
this respect, we explored gold functionalization of ELVs and sur-
face enhanced Raman spectroscopy (SERS) to obtain a molecular
fingerprint of single vesicles while circumventing the long integra-
tion times of conventional Raman spectroscopy. Methods: ELVs
were purified from B16F10 melanoma cells and RBC by density
gradient UC. Raman spectra of single, gold nanoparticle (AuNP)
coated ELVs were recorded with conventional confocal Raman
microscopes. Spectra were analyzed by multivariate statistical
analysis, i.e. PLS-DA and MCR-ALS. Results: To obtain a SERS signal,
a nanoplasmonic material has to be in close proximity to the ELVs. To
this end, ELVs were coated with a self-assembling AuNP shell, formed
by charge-based interaction, while still maintaining a colloidal stable
suspension of ELVs. Next, Raman spectra were obtained with a short
acquisition time of 500 ms. We found that cancerous B16F10 ELVs
have a different Raman fingerprint from ‘healthy’ RBC-derived ELVs.
By means of PLS-DA analysis we could demonstrate that both types
of ELVs can be discriminated from one another on the single vesicle
level. Finally, we validated this approach in a mixture of ELVs derived
from both cell types and were able to quantify the ratio of both ELV
types. Conclusion: We presented a method to obtain Raman spectra
from individual ELVs with a minimal acquisition time. Based on these
spectra, ELVs from different origin could be identified and quantified
in a mixture.
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OT18.1
Exosomes and microvesicles from ALS CNS tissues contain misfolded
SOD1 and transmit intracellular propagated misfolding
Sarah Fernando, Leslie Grad, Catherine Cowan, Neil Cashman and
Judith Silverman
University of British Columbia, Vancouver, Canada
Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative
disease causing progressive paralysis in affected patients. ALS
pathology begins focally and spreads spatiotemporally throughout
the neuroaxis, reminiscent of the systematic mechanism of prion
propagation. Superoxide dismutase (SOD1) gene mutations cause
20% of inheritable ALS, and misfolded SOD1 protein is found in
both sporadic and familial ALS. We have previously shown that cell-to-
cell transmission of misfolded SOD1 can occur via the uptake
of exosomes. However, the role of exosomes and microvesicles in
protein misfolding and propagation in ALS patients is yet to be
defined. Exosome and microvesicle populations (EVs) isolated from
frozen whole neural tissues of ALS mouse models and human ALS
patients by serial centrifugation and purification on a sucrose
cushion. Misfolded SOD1 protein was identified by ELISA, immuno-
precipitation, and TEM on the surface of both vesicle populations
using conformation-specific antibodies. Detergent lysis of EVs showed
a far greater abundance of misfolded SOD1 in the lumen of the
vesicles than on the surface. Quantitative proteomic analysis suggests
that exosomes from an ALS mouse model display a greater amount of
EV surface Excitatory Amino Acid Transporter 2 (EAAT2) relative to
control. Similarly, analysis by flow cytometry showed more ALS mouse
model-derived vesicles were positive for the astrocyte marker EAAT1
than control vesicles. Finally, preliminary results suggest that applying
ALS mouse model tissue-derived EVs onto fresh HEK cell cultures causes
misfolding of wild-type SOD1 in those cells. In summary, we have
successfully isolated EV populations from ALS patient and murine
neural tissues, and shown these vesicles to carry misfolded SOD1. Our
results suggest that EVs bearing misfolded protein can be detected
with conformation-specific antibodies, intimating their diagnostic and
therapeutic potential in ALS and other protein misfolding diseases.
OT18.2
Influence of Parkinson’s pathology upon exosomal alpha-synuclein
Lydia Alvarez-Erviti1, J. Mark Cooper2 and Michele Di Stefano2
1Molecular Neurobiology, Center for Biomedical Research of La Rioja (CIBIR),
Logrono, Spain and Clinical Neuroscience, University College London, London;
2Clinical Neuroscience, University College London, London, UK
Introduction: Alpha-synuclein aggregation is a central theme in
Parkinson’s disease (PD) pathology and the transmission of the
protein between cells has been suggested to mediate the spread of
the pathology within the brain as the disease progresses. We have
shown that alpha-synuclein can be released from cells in exosomes
which can mediate the generation of aggregates in neighbouring
cells. We have demonstrated that alpha-synuclein enters exosomes
via an hsc70-dependent pathway. Subsequently we have investi-
gated the impact of the pathways implicated in PD upon alpha-
synuclein release and transmission. Methods: Using cell models we
have investigated the pathway of the intracellular transfer of alpha-
synuclein to exosomes to understand how factors associated
with PD pathology may influence the level of alpha-synuclein release
from cells in exosomes. We have modelled chaperone-mediated
autophagy (CMA) dysfunction (LAMP-2A knockdown), and various
important risk factors for developing PD including: alpha-synuclein
A53T, S129D mutations; LRRK2 G2019S mutation and GBA1 knock-
down or inhibition. Results: Our experiments demonstrated that
decreased alpha-synuclein degradation due to CMA and GBA1
dysfunction, or LRKK2 mutation increased exosomal and total
alpha-synuclein release. Moreover we confirmed that alpha-synuclein
mutation increased its release by exosomes. Conclusion: We have
demonstrated that influencing the delivery of alpha-synuclein to
lysosomes for degradation by CMA leads to elevated exosomal
alpha-synuclein levels and subsequent release, highlighting a new
target for therapeutic intervention.
OT18.3
PrPC on exosomes drives fibrillization of amyloid beta and ameliorates
amyloid beta-mediated neurotoxicity
Alexander Hartmann1*, Clemens Falker1*, Inga Guett1, Frank Dohler1,
Hermann Altmeppen1, Christian Betzel2, Robin Schubert2, Pooja Joshi3,
Claudia Verderio3, Markus Glatzel1, Susanne Krasemann1
*These authors contributed equally
1Institute of Neuropathology, University Medical Center Hamburg-Eppendorf,
Hamburg, Germany; 2Institute of Biochemistry and Molecular Biology,
University of Hamburg, Hamburg, Germany; 3Neurodegenerative Diseases,
CNR-Institute of Neuroscience, Milano, Italy
Alzheimer’s disease (AD) is the most common neurodegenerative
disorder. Deposition of amyloid beta into plaques is a key step in AD
pathogenesis. However, small soluble amyloid beta oligomers rather
correlate with neurotoxic effects, disease initiation and progression.
A couple of recent findings identified the cellular prion protein (PrPC)
as receptor for amyloid beta oligomers, eliciting these neurotoxic
effects. The role of exosomes in Alzheimer’s disease is only poorly
understood. Besides serving as disease-biomarkers, they may promote
amyloid beta plaque formation, thereby decreasing amyloid beta-
mediated synaptotoxicity and enhancing amyloid beta-clearance. To
investigate the potential role of exosomal PrPC and its effect on the
protective functions attributed to exosomes in AD, we generated a
mouse neuroblastoma PrPC knockout cell line. Using these, as well as
SH-SY5Y human neuroblastoma cells, we showed that PrPC is highly
enriched on exosomes compared to cells. Moreover, we found that
exosomes bind amyloid beta via PrPC with highest binding affinity
for low molecular weight oligomeric amyloid beta species. Exosomal
PrPC accelerates fibrillization of amyloid beta on exosomes, whereas
exosomes devoid of PrPC did not show this effect. This leads to a
significant reduction of neurotoxic effects imparted by oligomeric
amyloid beta. In conclusion our data leads to further evidence for a
protective role of exosomes in amyloid beta-mediated neurodegen-
eration. Moreover, it highlights the importance of exosomal PrPC in
molecular mechanisms of Alzheimer’s disease.
OT18.4
Glioblastoma extracellular vesicles drive normal astrocytes toward a
tumor-enhancing phenotype
Michael Graner1, Soliman Oushy2, Justin Hellwinkel2, Mary Wang1,
Ger Nguyen1, Tessa Harland2, Dicle Gunaydin1
1University of Colorado Denver Anschutz Medical Campus, Aurora, Colorado,
USA; 2University of Colorado Denver School of Medicine, Aurora, Colorado,
USA
Glioblastomas (GBMs, WHO grade IV astrocytomas) are the worst of the
central nervous system tumors; despite maximum (and damaging)
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therapeutic intervention, median survival time for patients is
B15 months, and overall quality of life becomes quite poor. These
abysmal outcomes have changed little in the past 20 years. Clearly,
our current therapies are inadequate, and we need innovative strides
in understanding GBM biology to rectify this situation. One ‘‘hot’’
research area is that of the impact of tumor extracellular vesicles
(EVs) on normal recipient cells. Tumor cell EVs have extraordinary
abilities to manipulate their microenvironments and recipient cells
both proximally and distally (eg, fibroblast differentiation, endothe-
lial cell tubule formation, stromal cell interactions, immune cell
influence). Tumor EVs prepare the "metastatic niche" for circulating
tumor cells prior to colonization of a target organ. Thus, tumor EVs
can impact recipient cells to support tumor growth and progression,
which undoubtedly holds true for GBMs as well. However, it appears
no one has asked what effects GBM EVs have on normal astrocytes*
do GBM EVs drive astrocyte phenotypic changes, potentially making
the astrocytes into tumor promotors? The answers could re-shape
our paradigms on gliomagenesis, particularly in the recurrent setting.
Here we show that GBM EVs activate cancer-type signaling pathways
in recipient astrocytes, promoting astrocyte migration towards the
EVs, as well as astrocyte anchorage-independent growth in soft agar.
The extracellular release of various factors by astrocytes generates a
tumor-promoting milieu, which results in increased tumor cell
growth. We will discuss the consequences of these phenomena in
the context of our current therapies with a view towards therapeutic
improvement.
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PT1.01
Identification of extracellular vesicles in three parasitic nematodes of
veterinary importance
Eline Palm Hansen, Merete Fredholm, Stig Milan Thamsborg,
Peter Nejsum and Kasper Lind Andersen
University of Copenhagen, Copenhagen, Denmark
Introduction: Parasitism has been denoted the most successful way of
life and their success relates to their ability to evade or modulate
the host immune response. However, the underlying mechanisms
behind this are poorly understood. Parasites from all major parasitic
groups have been shown to release extracellular vesicles (EVs)
containing protein and RNA species and seems to be of importance
in the hostparasite interplay. The aim of this study was to examine
the secretion of EVs for three of the most important parasitic nema-
todes of pigs, Ascaris suum, Trichuris suis and Oesophagostomum
dentatum in order to later functionally test their role in hostparasite
interactions. Methods: Adult worms of A. suum, T. suis and
O. dentatum were incubated in RPMI 1640 containing streptomycin,
penicillin, amphotericin B and gentamycin (Gibco(r)) for 2448 h. EVs
were purified from parasite-depleted RPMI by an initial filtering step
(200 nm) followed by differential centrifugations with two final
ultracentrifugations at 110.000g (Beckman Optima(tm) L-70) for
70 minutes. The final pellet was analyzed with a CM 100 BioTWIN
transmission electron microscope (TEM) and RNA was purified using
a miRCURY(tm) RNA Isolation Kit (Exiqon A/S). The RNA concentra-
tion was measured using a NanoDrop 2000 spectrophotometer.
Results: The TEM analysis revealed that all three species produce EVs
in the size of 100 nm and the NanoDrop measurements show that
the purification products contain RNA. Conclusion: These results
suggest that adult worms of the three porcine parasite species,
A. suum, T. suis and O. dentatum secrete RNA-containing EVs. Future
studies should focus on an in-depth characterization of the EVs and
their contents through RNA sequencing and proteomic analysis.
With this, we may unravel important aspects of the complex inter-
play between parasites and their hosts and potentially discover
novel targets for diagnostics and therapy.
PT1.02
Examining the exosome cargo of Theileria annulatainfected cells
Victoria Gillan, Jane Kinnaird, Brian Sheils and Eileen Devaney
University of Glasgow, Glasgow, UK
The protozoan parasite, Theileria annulata causes Tropical Theiler-
iosis, a disease that is often severe and can be fatal. One of the most
interesting features of the T. annulata infection cycle is its phase of
neoplastic growth. The parasite can transform its host leukocyte
resulting in an immortalized phenotype in vitro. In vivo these cells
become highly metastatic, forming tumours in multiple organs of
the host with subsequent destruction and disorganisation of the
lymphoid system. As evidence from cancer biology has shown,
metastasis is a highly complex process and although the pathogenic
events have been defined, the mechanisms that initiate and drive
metastasis are still largely unresolved. The field of microvesicle biology
has significantly expanded to reveal that intercellular communication
is critical for metastatic progression, and that the release of
exosomes from tumour-infected cells into the micro-environment
induces pre-metastatic niche formation. It is intriguing to consider
that exosomes derived from T. annulatainfected cells may transfer
proteins, soluble factors and nucleic acids to recipient cells and
therefore may be involved in altering adaptive immune responses
of the host or have a role in migration/invasion of infected cells. To
investigate the role of exosomes in this system we carried out
proteomics on exosome samples from a bovine lymphosarcoma cell
line (BL20) and the same cells infected with T. annulata (TBL20).
Differentially regulated proteins were analysed using Ingenuity
Pathway Analysis, revealing that infection associated proteins and
molecules essential to migration and extracellular matrix digestion
are up-regulated in TBL20 exosome samples compared with controls.
miRNA sequencing of these samples is also underway. Exosome
transfer experiments will be carried out to observe if exosomes from
TBL20 cells can increase the migratory or invasive potential of
control cells, or disrupt the cellular immune response.
PT1.03
Mechanics of extracellular vesicles derived from malaria parasite-
infected Red Blood Cells
Raya Sorkin1, Daan Vorselen1, Yifat Ofir-Birin2, Wouter H. Roos1,
Fred C. MacKintosh1, Neta Regev-Rudzki2 and Gijs J. L. Wuite1
1Department of Physics and Astronomy and LaserLab, VU University,
Amsterdam, The Netherlands; 2Department of Biomolecular Sciences, Faculty
of biochemistry, Weizmann Institute of Science, Rehovot, Israel
Malaria is a life-threatening disease caused by parasites that are trans-
mitted through the bites of infected mosquitoes, with Plasmodium
falciparum (Pf) causing the most severe form of malaria (1). Very
recently it was discovered that Pf infected red blood cells (iRBC)
directly transfer information between parasites within a population
using exosome like-vesicles that are capable of delivering genes (2).
This communication promotes parasite differentiation to sexual
forms and is critical for its survival in the host and transmission to
mosquitoes. Efficient DNA transfer via extracellular vesicles (EVs)
occurs mainly at the early ring stage within the blood-stage
asexual cycle, and it can be inhibited by the addition of actin
polymerization inhibitors. This suggests that actin polymerization is
required for cellcell communication (2). We expect, therefore,
that mechanical properties of vesicles at different stages of the life
cycle will be optimized for their gene-delivery function. With the aim
to understand how mechanical properties of EVs effect their
efficiency of cargo delivery, we use Atomic Force Microscopy for
mechanical characterization of extracellular vesicles secreted from P-f
infected RBCs. We compare bending modulus values of these
vesicles and those secreted from healthy RBCs, as well as compare
their size, morphology and surface charge. We also prepare and
characterize synthetic vesicles (SVs) with varying mechanical
strength to determine how stiffness of SVs affects their adhesion
to cells and cellular uptake rate, to gain a broader understanding
of the link between mechanical properties and efficient cellular
uptake.
References
1. WHO. http://www.who.int/mediacentre/factsheets/fs094/en/.
2. N. Regev-Rudzki et al., Cell 153, 1120 (May 23, 2013).
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PT1.04
The immunomodulatory role of human macrophages exosomes during
Trypanosoma cruzi infection
Andre´ Cronemberger Andrade1, Patrı´cia Xander1, Rodrigo Pedro Soares2,
Marcos Vinicios Salles Dias3, Kleber Ribeiro1, Vilma R. Martins3 and
Ana Claudia Torrecilhas1
1Federal University of Sa˜o Paulo, Sa˜o Paulo, Brazil; 2Oswaldo Cruz Foundation,
Rio de Janeiro, Brazil; 3A.C. Camargo Cancer Center, Sa˜o Paulo, Brazil
Introduction: EVs isolated from Trypanosoma cruzi, the etiologic
agent of Chagas disease, modulate innate immune response via
TLR2 and inflammatory responses in host cells and during in vitro
and in vivo infection. Macrophages are major targets of T. cruzi
infection however, whether infected macrophages also release
specific EVs that could modulate the inflammatory response is
completely unknown. Therefore, we aimed to characterize EVs from
human macrophage (THP-1) infected with trypomastigote from
T. cruzi. Methods and Results: THP-1 cells were differentiated into
macrophages by using phorbol 12-myristate 13-acetate and incu-
bated with LPS, parasite antigens, T. cruzi EVs, or infected with the
trypomastigotes. The macrophage culture supernatants were cen-
trifuged several times (twice at 1,500xg for 10 minutes and once at
8,000xg for 5 minutes) to remove residual cells and debris, and EVs
were collected in the pellets of 1 h centrifugation at 100,000xg. EVs
were resuspended in saline buffer and analyzed by NTA, scanning
electronic microscopy and western blotting to CD63, CD9, MHC class
II, TLR2, TLR4 receptors, and anti-T. cruzi antigens. We found that
24-h treatments with LPS, T. cruzi EV or infection with trypomasti-
gotes induced the secretion of larger amounts of EVs by the
macrophages than control untreated macrophages. The EVs ranged
from 20 to 100 nm in size and they contained CD63, CD9, MHC class
II which are known markers from macrophages-derived exosomes,
but they lack parasite antigens. Remarkable, trypomastigotes EVs or
trypomastigote infection also increased TLR2 and TLR4 expression by
THP-1 macrophages. Conclusion: As T. cruzi EVs have a regulatory role
through macrophage cells, we propose that macrophage-derived
exosomes could transmit signals to alert the immune system during
T. cruzi infection.
PT1.05
Characterization of extracellular vesicles from stressed pathogenic
fungal cells
Natanael Leitao1, Rosana Puccia1, Alexis Melo1, Renato Mortara1 and
Alexandre K. Tashima2
1Microbiology, Immunology and Parasitology Department, Federal University
of Sa˜o Paulo, Sa˜o Paulo, Brazil; 2Biochemistry, Federal University of Sa˜o Paulo,
Sa˜o Paulo, Brazil
In pathogenic fungi, extracellular vesicles (EVs) carry molecules po-
tentially relevant for pathogenicity and host interaction, as suggested
by the protein, lipid, carbohydrate, and RNA contents described in
some species. Interestingly, a high percentage of EV proteins have
been described in the fungal cell wall, suggesting that EV transpor-
tation is responsible for the finding of cytosolic proteins there. Little
is known about modulation of fungal EV production or fungal cell
signalling by EVs. We aimed to characterize EVs from pathogenic
Paracoccidioides brasiliensis and Candida albicans submitted to
oxidative, nitrosative, farnesol, and tyrosol stimuli; we also evaluated
the fungal cells ability to uptake EVs. EVs were isolated from cell-free
culture supernatants by standard concentration/centrifugation pro-
cedures. EV proteins were precipitated and analyzed by liquid
chromatography coupled to mass spectrometry (Synapt G2 HDMS).
EVs morphology/concentration were measured by NanoSight (Malvern).
We identified 153 P. brasiliensis EV proteins in the control, versus
about 280 at oxidative or nitrosative stresses. In both conditions, the
amount of EVs isolated was two-fold larger than in controls. In
C. albicans, we identified 233 proteins in control EVs, versus 222250
in EVs from stimulated cultures. The amount of EVs increased eight
times under farnesol stimulus, but decreased under tyrosol and
oxidative stress. P. brasiliensis showed 40 exclusive proteins to each
stress condition, but not C. albicans EVs. Differences in EV protein
amounts were observed in both species. Cell uptake was observed
for EVs stained with PKh67 or PKh26 dye (Sigma) co-incubated for
14 h with C. albicans and analyzed by fluorescence and confocal
microscopy. We observed interaction after the first hour of incuba-
tion, with apparent uptake. Our results suggest that EVs production/
contents can be modulated by stress conditions and that EVs can
potentially play a role in fungal cell communication.
PT1.06
Characterisation of extracellular vesicles secreted by HPV and HPV-
oropharyngeal carcinoma cells
Ben Peacock, Daniel Lambert, Keith Hunter and Stuart Hunt
Unit of Oral and Maxillofacial Pathology, The School of Clinical Dentistry,
The University of Sheffield, Sheffield, UK
Introduction: Viruses are capable of manipulating host endosomal
exosomal pathways which can aid in tumourigenesis. Studies have
shown that human papilloma virus (HPV) encoded proteins can alter
the production and contents of extracellular vesicles (EVs) secreted
by cervical cancer cells. However, the extent of HPV’s oncogenic
properties relating to EV release in oropharyngeal carcinoma (OPC) is
not well understood. This study aims to evaluate differences in size,
quantity, and molecular contents of EVs released by two HPV
and two HPV- OPC cell lines. Methods: EVs were purified from the
conditioned medium of OPC cell lines by size exclusion chromato-
graphy (SEC). EV size and concentration was measured by Tuneable
Resistive Pulse Sensing (TRPS). Transmission electron microscopy
was used to validate size measurements made by TRPS. Vesicular
protein and RNA were extracted and measured by BCA and Agilent
Bioanalyzer, respectively, for subsequent iTRAQ proteomics and next
generation sequencing. Vesicular impact on fibroblast and endothe-
lial cell phenotype was assessed by MTT assay and/or tubule for-
mation assay. Results: The number of EVs released per cell did not
vary significantly between cell lines. The modal diameter of vesicles
from HPV cell lines was noticeably smaller than that of HPV- lines,
although this was not statistically significant. The yield of EVs
purified by SEC that were deemed pure enough for downstream
analysis was approximately 30%. Vesicular RNA isolated from 50
million cells over a 72 h incubation period ranged between 500
and 1500 ng across the cell lines, with approximately 50% of RNA
being miRNA, and vesicular protein ranged between 25 and 50 mg.
Conclusion: TRPS analysis detected size differences between EVs
produced by HPV and HPV- OPC cell lines. SEC appears to be a
valid technique for purification of EVs suitable for further down-
stream analysis by iTRAQ and RNA-seq.
PT1.07
Functional analysis of packaged viral RNAs from EpsteinBarr virus
(EBV) by using recombinant exosomes
Corinna Hu¨ls and Reinhard Zeidler
Department of Gene Vectors, Helmholtz Center Munich, Oberschleißheim,
Germany
Introduction: EBV is a widespread human herpesvirus that persists
in an infected host lifelong by establishing latent infection in B cells.
Viral particles do not only contain the DNA-genome, but additional
viral RNAs. These RNAs are transduced to target cells during infec-
tion, where they can be translated immediately. By using recombi-
nant exosomes, carrying selected viral transcripts, we are aiming
to investigate the function of these RNAs. We are focussing on
transcripts which are important for the initiation of pre-latent phase
of the viral transcription (e.g. BZLF1) and for latent establishment of
the genome. Methods: Exosomes were generated by transfecting
producer cells with plasmids encoding for the viral transactivator
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BZLF1, and the glycoprotein gp350. Purification was done via dif-
ferential centrifugation, including a filtration step and exosomes
were characterized using dot blot and flow cytometry, followed
by RNA isolation to control successful packaging of BZLF1-RNA.
Next, primary B cells were incubated with BZLF1-containing and
non-containing exosomes and performed a subsequent RNA-isola-
tion. RNA-sequencing was used, to see if the transduced BZLF1-RNA
has an impact on the expression pattern of the target cells compared
to the control. Results: We were successful in generating exosomes
which carry gp350 (which mediates the binding to B cells), and
mRNA encoding BZLF1, which is an important trigger in the early
phase of infection. The purified exosomes were positive for CD63
and gp350 in dot blot and flow cytometry. Moreover, we were able
to determine the concentration of our preparation by nano particle
tracking analysis (NTA). Successful packaging of BZLF1-RNA into
exosomes could be shown by RNA isolation and subsequent qRT-
PCR. Summary: Recombinant exosomes containing viral transcripts
could be a suitable tool for studying the impact of individual
transduced viral RNAs on the early phase of infection and establish-
ment of latency and thus for the biology of EBV.
PT1.08
Cellular survival and response to HIV infection in the absence of
extracellular vesicles
Zhaohao Liao, Meghan Travers, Dillon Muth, Bonita Powell
and Kenneth Witwer
Johns Hopkins University, Baltimore, Maryland, USA
Introduction: Extracellular vesicles (EVs) are involved in intercellular
communication and affect disease processes, e.g. by promoting
tumour progression or by shuttling messenger molecules between
cells. Furthermore, EVs are important in immune and antiviral
responses. Given that cells are normally exposed to high concentra-
tions of Evs, cultured cells may be affected by surrounding concen-
tration of EVs from serum. These effects may include response to
viral infection. We examined the effects of varying EV levels in
different media on viral production and cell viability. Methods: T-cell
and myeloid-lineage cell lines and primary cells were grown in 10%
serum medium depleted of EVs using ultracentrifugation or a
proprietary method (Life Technologies/Gibco) and in 10% FBS serum
medium with no depletion of EVs. Cells were subsequently infected
with HIV-1. Cell counts, viability and activity (MTT and WST assays)
and HIV production (p24) were assessed. Results: In both T-cell and
macrophage cell cultures, significant increases in HIV-1 viral produc-
tion (p24 assay) were noted when EVs were depleted from cell
culture medium. Changes in cell morphology and viability/activity
were also observed in EV-depleted media. In contrast, primary CD4
T-cells showed no significant changes in viability post infection,
although a slight increase in viral production was observed.
Increased infectivity of virus released under depleted EV culture
conditions was also observed, correlating with increased expression
of several cell surface receptors. Conclusions: The concentration
of EVs around HIV-1 susceptible cells affects viral production and
infectivity, as well as cell viability. These effects appear to be espe-
cially pronounced for cell lines. EV dependence of cell cultures
should be tested carefully prior to including additional experimental
variables, particularly in infection experiments.
PT1.09
The role of exosomes in the development of Chlamydia-induced upper
genital tract pathology
Raedeen Russell1, Joseph Igietseme2 and Francis Eko1
1Morehouse School of Medicine, Atlanta, Georgia; 2Centers for Disease Control
and Prevention, Atlanta, Georgia, USA
It is estimated that 70% of chlamydial infections in women are
asymptomatic and, if left untreated, can lead to severe irreversible
complications including ectopic pregnancy and pelvic inflammatory
disease. Chlamydia trachomatis infects cells in the cervix of the
female genital tract and ascends to the upper genital tract (UGT)
where it can cause diverse pathologies. It has been shown that
Chlamydia-induced UGT pathology occurs even in the absence
of live Chlamydia in the lower genital tract. The mechanism of
ascending infection and disease is largely unknown. We hypothesize
that the ascending infection that leads to UGT pathology is mediated
by exosomes. Exosomes are vesicles that can package intracellular
molecules from donor cells and release their cargo into recipient
cells thereby manipulating gene expression and cellular activity.
To test our hypothesis, HeLa cells were infected with C. trachomatis
serovar D and exosomes isolated from culture supernatants were
characterized. Cytokines and chemokines from exosomes were
assessed by a multiplex cytokine ELISA assay. Furthermore, purified
exosomes were co-cultured with uninfected cells and the protein
content of the lysed cells was examined. The results showed infected
cells released higher concentrations of exosomes during early
infection compared to uninfected cells and significantly higher levels
of inflammatory cytokines were associated with these exosomes.
Moreover, exosome recipient cells were found to contain chlamydial
proteins. These results suggest exosomes could transport patho-
genic chlamydial proteins from infected to uninfected cells with
potential to stimulate inflammation in recipient cells and suggest a
possible mechanism for development of UGT pathology.
PT1.10
Identification of outer membrane vesicles derived from Orientia
tsutsugamushi
Hea Yoon Kwon, Sun-Myoung Lee, Jin-Soo Lee, Ji Hyeon Baek and
Jae-Hyong Im
Inha University School of Medicine, Incheon, South Korea
Orientia tsutsugamushi, a causative pathogen of Scrub typhus, is
a gram-negative intracellular bacterium. Outer membrane vesicles
(OMVs) are produced from the membrane of bacteria and play many
roles related to the survival of the pathogen. However, there have
been no reports confirming whether O. tsutsugamushi indeed pro-
duce OMVs. O. tsutsugamushi boryong was cultured in ECV-304 cells
for the purification of OMVs. Western blot analysis and immunoen-
richment using anti-O. tsutsugamushi monoclonal antibody and
electron microscopy were employed for identification and character-
ization of OMVs. We confirm the presence of OMVs derived from
O. tsutsugamushi, and also found that those OMVs contain a major
surface antigen of 56-kDa protein and variant immunogenic antigens.
PT1.11
Cytotoxicity of host cells induced by Staphylococcus aureus membrane
vesicles is dependent on proteomes of membrane vesicles
Je Chul Lee, So Hyun Jun, Hyejin Jeon, Yoo Jeong Kim, Hyo Il Kwon and
Seok Hyun Na
Kyungpook National University School of Medicine, Daegu, South Korea
Staphylococcus aureus secretes membrane-derived vesicles (MVs),
which can deliver virulence factors to host cells and induce
cytopathology. However, cytopathology of host cells induced by
MVs derived from different S. aureus strains has not been character-
ized yet. The present study compared the cytotoxic activity of MVs
from different clinical S. aureus isolates on host cells and analyzed
the proteomes of S. aureus MVs. MVs purified from S. aureus M060
showed a high cytotoxic activity towards host cells, compared with
MVs from three other clinical S. aureus isolates. S. aureus M060 MVs
induced apoptosis of HEp-2 cells in a dose-dependent manner, but
cytotoxic activity of MVs was completely abolished by treatment
with proteinase K. Proteomic analysis revealed that a total of 153 and
143 proteins were identified in the MVs from S. aureus M060 and
03ST17, respectively. Comparative proteomic analysis showed that
S. aureus MVs contained 60 strain-specific proteins. d-hemolysin
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(Hld), g-hemolysin, lukocidin D, and exfoliative toxin C were
commonly identified in S. aureus MVs, but exfoliative toxin A (ETA)
was specifically identified in S. aureus M060 MVs. ETA was delivered
to HEp-2 cells via S. aureus MVs. MVs from clinical S. aureus isolates
have different cytotoxic activity in host cells, which may result from
difference in proteomes of MVs. Further proteogenomic analysis can
be useful for identification of virulence factors in MVs from clinical
S. aureus isolates.
PT1.12
Extracellular vesicles from gram-positive bacteria Staphylococcus
aureus and Staphylococcus epidermidis induce a strong inflammatory
response and cell death in vitro
Forugh Vazirisani, Margarita Trobos, Magdalena Zaborowska,
Xiaoqin Wang, Omar Omar, Karin Ekstro¨m and Peter Thomsen
Department of Biomaterials, Sahlgrenska Academy University of Gothenburg,
Gothenburg, Sweden; Biomatcell Vinn Excellence Center of Biomaterials and
Cell Therapy, Gothenburg, Sweden
Introduction: The majority of biomaterial-associated infections (BAI)
are caused by S. aureus and S. epidermidis. Bacterial extracellular
vesicles (EVs) are involved in the delivery of toxins and bacterial
components to host cells. It is therefore of relevance to investigate if
the EVs from these bacterial species have a role in BAI. The aim of the
present study was: i) to investigate whether clinical strains from
S. aureus and S. epidermidis, isolated from osteomyelitis associated
with bone-anchored amputation prosthesis, release EVs, ii) to study
the biological effects of these EVs on monocytes and iii) to evaluate
the effect of these EVs on the secretion of pro-inflammatory
substances by monocytes. Material and methods: EVs were isolated
from S. aureus 64516 and S. epidermidis 64518 cultures. The collected
EVs were characterized by western blot. Human primary monocytes
were stimulated by different concentrations of EVs (0, 5, 10 and 50
mg/ml). After 24 h, cell death was evaluated using propidium iodide
in a nucleocounter and further, levels of IL-8, IL-6, TNF-a, MCP-1 and
MMP-9 were determined by ELISA. Results: The two staphylococcal
strains secreted EVs in vitro. Both types of EVs contained d-toxin
whereas protein A and SCP-A were only detected in S. aureus EVs.
The monocyte viability was reduced in a dose-dependent manner
after incubation with EVs. More than 50% of monocytes died with
5 mg S. aureus EVs. The S. epidermidis EVs had relatively less toxic
effects. Stimulation of monocytes with S. aureus and S. epidermidis
EVs significantly increased the release of IL-8, IL-6, TNF-a, MCP-1 and
MMP-9. Conclusion: The results from this study show that clinical
pathogens causing BAI have the ability to secrete EVs in vitro.
The EVs promote pro-inflammatory cytokine release from human
monocytes and subsequent cell death. It is suggested that EVs con-
tribute to the inflammation and injury associated with biomaterials-
associated infection.
PT1.13
Membrane vesicles released during macrophage-infection with airway
pathogens modulate innate immune responses
Charlotte Volgers1, Birke Benedikter2, Paul H. M. Savelkoul2,3 and
Frank R. M. Stassen1
1Department of Medical Microbiology, Maastricht University Medical Center,
Maastricht, The Netherlands; 2Department of Medical Microbiology and
Respiratory Medicine, Maastricht University Medical Center, Maastricht,
The Netherlands; 3Department of Medical Microbiology and Infection Control,
VU University Medical Center, Amsterdam, The Netherlands
Introduction: During infection a plethora of messenger molecules
are released by both host and bacterial cells. These molecules serve
to confer information and can be released in a soluble form as well
as in association with membrane vesicles (MVs). In this respect it has
been demonstrated that host-cell vesicles are involved in the im-
mune response to bacteria. Moreover, bacteria also shed membrane
vesicles which are able to affect immunity by serving as transport
vehicles of several virulence factors. Hence, the objective of this
study was to assess side by side vesicles released following infection
of macrophages by the airway pathogens Pseudomonas aeruginosa,
non-typeable Haemophilus influenzae, Moraxella catarrhalis and
Streptococcus pneumoniae. Methods: MV-release kinetics were deter-
mined by flow cytometry following infection of Thp1 macrophages
(MFs). Thereafter MVs released by infected MFs or by bacteria
only were isolated by ultrafiltration and purified by size exclusion
chromatography to assess their functional activity. Results: Flow
cytometric analyses confirmed the release of MVs during macrophage
infection. Functional experiments showed that MVs released upon
infection as well as bacterial MVs, induced the release of TNF-a from
naive MFs. The amount of TNF-a released varied markedly in response
to MVs from different bacterial species. Moreover, pre-incubation of
MFs with MVs dampened the TNF-a release in response to several
TLR-agonists (LPS and PAM3CSK4). Finally, pre-incubation of MFs with
MVs led to an enhanced bacterial adhesion and invasion. Summary:
Overall, we found that the activity of MVs was highly species dependent
with a high resemblance in the activity between vesicles released
by infected MFs to vesicles released by bacteria only. Furthermore,
our findings indicate that MVs released during infection may be
beneficial to some bacteria by their ability to suppress pro-inflammatory
responses and to enhance bacterial adhesion and invasion.
PT1.14
Bacterial membrane vesicle RNA in hostpathogen interactions: on the
road towards specific functional studies
Denis Simonov, Cristin Print, Anthony Phillips, Simon Swift and
Cherie Blenkiron
University of Auckland, Auckland, New Zealand
Introduction: We have previously reported that MVs from Uropatho-
genic Escherichia coli (UPEC) can deliver bacterial RNA into human
cells. This observation raises questions about the function of bac-
terial MV RNA in cross-species and cross-kingdom communication.
However, the isolation of bacterial MV RNA and demonstration of its
effects on target cells poses a number of unique challenges. This
includes the presence of bacterial toxins in MVs and co-isolation of
some of them with MV RNA. Here we report on our study inves-
tigating the effects of RNA from UPEC MVs on human bladder cells.
Methods: MVs were isolated from UPEC strain 536 cultures by filtra-
tion and ultracentrifugation followed by density gradient centrifuga-
tion. RNA from each fraction was extracted with a mirVana RNA
kit. RNA purification was performed with Norgen CleanAll DNA/RNA
kit. Fractions and extracted MV RNA were analysed for protein
and endotoxin levels. Bladder cell viability was quantified using MTT
reagent. Results: Culture growth conditions and MV isolation
methods determined levels of contaminants present in both MV
and MV RNA preparations. Density gradient centrifugation of MV
preparations allowed for isolation of distinct fractions characterised
by differences in MV particle number, protein, endotoxin, and nucleic
acids levels, as well as human bladder cell toxicity profiles. Endotoxin
was identified as a common contaminant of RNA isolated from UPEC
MVs. The effect of the contaminating endotoxin on bladder cell
viability was found to be dependent on the method of delivery of
isolated MV RNA into human cells. Methods for separating effects
of MV RNA on bladder cell phenotype from those of contaminants
were investigated. Conclusions: Our study addresses the challenges
associated with isolating RNA from membrane vesicles of Gram-
negative bacteria. Methodological and experimental approaches
to studying the role of vesicle-delivered bacterial RNA in host
pathogen interactions are considered.
PT1.15
Extracellular vesicles from milk promote the formation of small
osteoclasts but reduce bone resorption
Marina C. Oliveira1, Peter L. E. M. Van Lent2, Irene Di Ceglie2,
Adaliene V. M. Ferreira1, Onno J. Arntz2 and Fons A. J. Van De Loo2
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Introduction: Recently, extracellular vesicles present in milk have
emerged as biologically active components. In this study we
investigated the effect of bovine-derived milk extracellular-vesicles
(BMEVs) on osteoclast differentiation and bone resorption. Methods:
BMEVs were isolated from commercial cow milk by ultracentrifuga-
tion. Bone marrow cells (100,000 cells/well) isolated from femurs of
male C57BL/6 mice were cultured in a-MEM containing 5% exosome-
free FBS, 2 or 20 ng/ml RANKL and /- BMEVs (200 mg/ml) added at
day 1 or day 4. Osteoclast differentiation was determined by TRAP-
staining and stratified accordingly to their nuclei. Osteoclast resorp-
tion was determined on calcium phosphate-coated plates. After,
710 days of culture with BMEVs added at day 1 or day 4, the cells
were removed and resorption pits were visualized by von Kossa
staining. On bovine cortical bone slices, cells were lysed after 9 days
and resorption pits were stained with Coomassie brilliant blue. Cell
proliferation was assessed by XTT assay, acidification of osteoclasts
by acridine orange staining and gene expression by qRT-PCR. Results:
BMEVs treatment until day 4 increased the number of TRAP-positive
mononuclear cells and small (5 5 nuclei) osteoclasts. The number of
large (] 6 nuclei) osteoclasts remained the same. These alterations
were associated with increased expression of TRAP, NFATc1 and
c-Fos. Cells seeded in a calcium-phosphate coated plate or bone
slices showed reduced resorption area when exposed to BMEVs
during the differentiation phase and even after osteoclast formation.
Interestingly, BMEVs treatment enhanced Cathepsin K expression but
reduced Carbonic Anhydrase 2 gene expression. Moreover, intracel-
lular acid production was also decreased by BMEVs treatment.
Conclusion: We showed for the first time that BMEVs increased the
formation of small osteoclasts but this does not lead to more bone
resorption probably due to reduced acid secretion.
PT1.16
Cross-kingdom uptake and transfer of exosomal watermelon
microRNAs in human intestinal epithelial cells
Kate Timms1, John Mclaughlin1, Anil Day1, Beth Holder3, Melissa Westwood1
and Karen Forbes2
1University of Manchester, Manchester, UK; 2University of Leeds, Leeds, UK;
3Imperial College London, London, UK
Introduction: Recent studies suggest that human consumption of
fruit/vegetable products, e.g. watermelon juice, leads to increased
circulating levels of plant-specific microRNA (miRs). Here we inves-
tigate whether these function-regulating miRs could be transferred
between species via uptake and export of miR-containing exosomes
by the small intestine. Methods: Exosomes were isolated from water-
melon via centrifugation, labelled fluorescently and characterised by
Nanoparticle Tracking Analysis. Human intestinal epithelial cells
(Caco-2) were cultured for 21 days post-confluency in transwells to
allow formation of a small intestine-like enterocyte monolayer.
Exosomes were applied apically to the Caco-2 cell monolayer, incu-
bated for up to 4 h (to mimic the duration of chyme in the small
intestine) then cells were analysed by fluorescence microscopy and
flow cytometry. Plant-specific miR-156a was quantified using qPCR.
Results: qPCR demonstrated that watermelon exosomes are rich in
miR-156a. Microscopy and flow cytometry demonstrated that these
exosomes were internalised by the tight, polarised Caco-2 barrier
(confirmed using Lucifer Yellow and staining for ZO-1 and ß-catenin).
Exosomes were selectively transferred into Ki67 cells, suggesting
uptake into a proliferative subtype. Analysis of uptake kinetics
revealed maximal internalisation at 180 minutes (48.90%, IQR 7.5,
pB0.01). By 240 minutes, miR-156a was detected in the basal
compartment (pB0.05), suggesting export of plant-specific miRs by
intestinal cells. Conclusions: Watermelon-derived exosomes contain-
ing plant-specific miRs are internalised into a proliferative sub-
population of Caco-2 cells, concurring with reports of fruit-derived
exosome uptake into mouse small intestinal stem cells. Plant-specific
miRs were transported from the apicalto basal side of a tight Caco-2
barrier, suggesting cross-kingdom transfer of dietary miRs into
human circulation is likely mediated by exosome uptake by the
intestine.
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PT2.01
Obligatory role of mitochondrial cross-talk with endoplasmic reticulum
in the regulation of oxidative stress leading to endothelial dysfunction
by human microparticles
Ramaroson Andriantsitohaina1, Raffaella Soleti1, Zainab Safiedeen1,
Luisa Vergori1, Isabel Rodriguez-Gomez1, Denis Leiber1, Se´verine Dubois1,
Gilles Simard1, Kazem Zibara2 and M. Carmen Martinez1
1INSERM 1063, Universite´ d’Angers, Angers, France; 2Biology Department,
Faculty of Sciences-I, Lebanese University, Beirut, Lebanon
Elevated levels of circulating microparticles (MPs) are detected in
many diseases including metabolic syndrome (MetS). We have pre-
viously shown that MPs from MetS patients (MetS MPs) and those
generated from apoptotic T cells induce endothelial dysfunction.
Here, we analyzed the mechanisms of this endothelial dysfunction
with respect to endoplasmic reticulum (ER) stress and the mitochon-
dria in the regulation of reactive oxygen species (ROS) production
in human aortic endothelial cells and mouse aorta. MPs at their
circulating levels from MetS and T lymphocyte MPs increased protein
expression of ER stress such as XBP-1, p-eIF2alpha and CHOP and
nuclear translocation of ATF6. Both types of MPs decreased endo-
thelial NO release and reduced endothelium-dependent relaxation of
mouse aorta. All the above-mentioned effects of MPs are abrogated
by pharmacological inhibition of ER stress. MPs increased expression
of mitofusin-2 and decreased expression of VDAC-1. Interestingly,
MPs evoked sequential increase of cytosolic and mitochondrial ROS
with differential pattern of regulation between MetS MPs and T
lymphocyte MPs. Silencing of neutral sphingomyelinase (SMase)
expression reduced all the effects induced by both types of MPs.
Finally, neutralization of Fas Ligand carried by MPs abolished the
effects of the two types of MPs on ER stress, whereas neutralization
of LDL receptor on endothelial cells prevented the effects of T
lymphocyte MPs only. Collectively, we demonstrate that endothelial
dysfunction triggered by MPs involves temporal cross talk between
ER and mitochondria with respect to spatial regulation of oxidative
stress via the SMase route. These events occur via interaction of MPs
on endothelial cells with Fas and/or LDL receptor. These results
highlight novel potential targets to fight against the pivotal role of
MPs on endothelial dysfunction leading to the increase of cardio-
vascular complications including those associated with MetS.
PT2.02
An imbalance between circulating microparticles and annexin-A5 may
promote vascular injury during sickle cell disease
Sihem Sadoudi1, Dominique Charue2, Chantal Boulanger2,
Sylvain Le Jeune3 and Olivier Blanc-Brude2
1INSERM; 2Institute of Health and Medical Research, Paris, France; 3Assistance
Publique-Hopitaux De Paris, Paris, France
Chronic hemolytic anemia, including sickle cell disease (SCD) is
characterized by painful vaso-occlusive crises (VOC), vascular injury,
red blood cell (RBC) aggregation and vesiculation, and intravascular
hemolysis. At steady state, RBC release haemoglobin, heme and
microparticles (MP) in plasma. This increases again two-fold during
VOC. MP from stressed RBC express phosphatidylserine (PS) at their
surface and contain cytotoxic heme. On the other hand, annexin-
A5 is an intracellular protein released in plasma during cell stress.
Annexin-A5 acts as a PS inhibitor, neutralizing PS-mediated effects in
stressed cells and MP. We collected plasma from cohorts of SCD
patients during steady state, or VOC, and controls. We designed a
novel ELISA-based assay to capture PS MP with an anti-annexin-A5
antibody. It quantified annexin-A5-covered MP in plasma, but also
estimated ligand-free functional annexin-A5. We characterized
plasma MP by FACS with labelling of ligand-free PS with annexin-
A5 and anti-CD235a, and size by NTA (501500 nm). We tested
annexin-A5 to block ROS production induced by SCD MP in
endothelial cells. In controls, FACS and ELISA revealed that MP were
few and covered with endogenous annexin-A5. Some annexin-A5
remained bioavailable in plasma. Conversely, RBC MP levels were
increased in steady state SCD MP, with increased mean fluorescence
intensities (MFI), but similar size vs. controls. SCD MP bore more PS
available to annexin-A5 at their surface and the equilibrium between
PS and annexin-A5 was compromised. In VOC, MP levels were in-
creased even further and bore cytotoxic heme and CD235a. We
still found virtually no ligand-free annexin-A5.This suggested that
endogenous annexin-A5 might be consumed by excess PS externa-
lization in SCD, and insufficient to neutralize the high levels of PS
MP produced by RBC during hemolysis. In SCD, the therapeutic use
of recombinant annexin-A5 may thus help compensate the imbal-
ance between PS MP and annexin-A5.
PT2.03
Exosomes released from sulforaphane-treated fibroblasts protect the
cardiomyocytes from angiotensin II-induced hypertrophy
Gaia Papini1, Marco Matteucci1, Enrica Ciofini1,2, Vincenzo Lionetti1,2
1Scuola Superiore Sant’Anna, Institute of Life Sciences, Pisa, Italy; 2Fondazione
Toscana ‘‘G. Monasterio’’, Pisa, Italy
Introduction: The communication between fibroblasts and cardio-
myocytes underlies the pathological cardiac hypertrophy induced by
angiotensin-II (AngII), which contributes to heart failure. Fibroblast-
derived exosomes (F-Exo) have been implicated in mediating
AngII-induced cardiomyocyte hypertrophy. However, how release of
anti-hypertrophic F-Exo is induced, remains an unanswered issue.
Sulforaphane (SFN), a naturally occurring isothiocyanate extracted
from cruciferous vegetables, attenuates AngII-induced cardiomyo-
cytes hypertrophy. We tested the effects of SFN on the release of
anti-hypertrophic F-Exo in vitro. Methods: Murine embryo fibroblasts
were treated with non-toxic dose of SFN (3 mM/7 days). Intact F-Exo
were isolated from cell culture media by differential centrifugation.
F-Exo were quantified by Western blot using CD63. Hypertrophy of
HL-1 cardiomyocytes was induced by AngII (100 nM/12 h). Cell
viability was assessed by MTT assay. Cell surface area, an indicator of
cell hypertrophy, was measured after 3 or 24 h incubation with 30 mg
exosomes isolated from SFN-treated (SFN-F-Exo) or untreated (F-Exo,
control) fibroblasts. Uptake by HL-1 of DiA-labeled exosomes was
measured under rest or AngII. Exosomal content of Maspin, a
protease inhibitor with function of inhibitor of histone deacetylase
1, was assessed by Western blot. Results: Treatment with F-Exo
significantly increased HL-1 viability by 53% under stress compared
to control. Stressed HL-1 treated for 24 h with SFN-F-Exo displayed
cell surface area similar to resting cells, but not those treated with F-
Exo. Stressed HL-1 exhibited a 3-fold increase in SFN-F-Exo uptake
rather than F-Exo. SFN-F-Exo are enriched in Maspin. Summary/
conclusion: SFN increases the uptake of F-Exo which display the
ability to prevent AngII-induced cardiomyocytes hypertrophy. Higher
content of Maspin in SFN-F-Exo suggests that modulation of
exosomal uptake and hypertrophy in stressed cardiomyocytes may
be epigenetically driven.
PT2.04
Preconditioning with isoflurane and hypoxia: a possible role of
exosomes?
Sandra Kraemer, Sebastian Borosch, Eva Dahmen, Mareike Hob,
Christian Beckers, Christian Stoppe and Andreas Goetzenich
University Hospital RWTH Aachen, Aachen, Germany
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Introduction: A promising technique to protect the heart from
ischemia-reperfusion (IR) injury is preconditioning with brief cycles
of hypoxia or volatile anaesthetics like isoflurane. Lately, exosomes
emerged as possible communication mediators that may be involved
in the exchanges of cardioprotective proteins. Recent publications
indicate general cardioprotective properties of exosomes but it still
remains to be investigated whether specific preconditioning stimuli
trigger the additional release of exosomes and influence cargo
composition. Methods: Rat cardiomyocytes and fibroblasts were
preconditioned with isoflurane (1.5 Vol %) and hypoxia (B1% O2).
Supernatants were collected after 48h and exosomes were isolated
by size-exclusion chromatography or the ExoEasy Kit. Particles were
characterized by tunable resistive pulse sensing (TRPS) and electron
microscopy. Purity was assessed by protein to particle ratio. Exosome
composition was analysed by western blot. To investigate their
cardioprotective role, preconditioned supernatants or isolated exo-
somes were transferred to unstimulated cells for 24 h prior to I/R
damage. Cell viability was analysed by AlamarBlue. Results: Precon-
ditioning triggers the release of exosomes from both cell types but
the specific release is more pronounced in fibroblasts. Interestingly,
protein composition (Alix, CD63, HSC70, Flot-1) differed depending
not only on the cell type and stimulus but also on the isolation
method. Preliminary data from still on-going transfer experiments
indicate a protective role from fibroblast-derived, preconditioned
supernatants and exosomes on cardiomyocytes. Conclusion: Primary
cardiac cells actively secrete exosomes after different preconditi-
oning stimuli. The protein composition of these exosomes differs,
depending on cell type, stimulus and purification method. Current
on-going exosomes-transfer studies will give further insight
whether these differences result in differential roles during cardiac
preconditioning.
PT2.05
Matrix vesicle-like particles are associated with aortic valve calcification
Lin Cui1, Dongxing Zhu2, Daniel Lerman3, Gillian Milne4, Marc Dweck3,
Alex Vesey3, David Newby3, Elspeth Milne5, Miep Helfrich4, Frank Rao6,
Colin Farquharson1 and Vicky Macrae1
1The Roslin Institute, University of Edinburgh Easter Bush Campus, Edinburgh
EH25 9RG, UK; 2Insitute of Cellular Medicine, Newcastle University, Newcastle
upon Tyne NE2 4HH, UK; 3Centre for Cardiovascular Sciences, University of
Edinburgh, Edinburgh EH16 4TJ, UK; 4Institute of Medical Sciences, University
of Aberdeen, Aberdeen AB25 2ZD, UK; 5The Royal (Dick) School of Veterinary
Studies, University of Edinburgh EH25 9RG, UK; 6Dundee Cell Products Ltd,
Dundee DD1 5JJ, UK
Introduction: There is currently no medication to inhibit the progres-
sion of aortic valve calcification (AVC), and the underpinning mech-
anisms are not fully understood. This study determined whether
elevated calcium (Ca) and/or phosphate (Pi) induces calcification of
aortic valve interstitial cells (VICs) via the secretion of mineralisation-
competent matrix vesicles (MVs). Methods: Sv40T rat VIC cells were
treated with elevated Ca and/or Pi, and assessed by qPCR. MVs were
harvested using ultracentrifugation from primary rat VICs, cultured
with control or calcifying medium (2.7 mM Ca and 2.5 mM Pi) for
16 h, and assessed by mass spectrometry. Immunohistochemistry
and transmission electron microscopy were performed on human
valve tissue obtained with appropriate ethical approval and in-
formed consent from patients undergoing valve replacement
surgery (Ethics No: 10/S1402/33). This study was done in conforma-
tion with the declaration of Helsinki. Results: Elevated Ca treatment
(2.7 mM Ca) induced calcium deposition in Sv40T cells (4.5-fold;
PB0.01). Ca treatment (3.6 mM Ca) increased mRNA expression of
the osteogenic markers PiT-1, Runx2 and Msx2 (PB0.05). While no
effect of Pi treatment alone was observed, treatment with 2.7 mM Ca
and 2.5 mM Pi synergistically induced calcium deposition (4.14-fold;
PB0.001). VIC-MVs isolated from calcifying medium shared similar
protein composition with chondrocyte-derived MVs, including the
enrichment of the calcium-binding proteins: annexin (Anx) A2
(4.8-fold), A5 (4.6-fold) and A6 (4.3-fold). Currently, the functional
role of selected Anxs in VIC calcification is being examined. Increased
Anx A6 expression was noted in severely calcified human valve
compared to uncalcified control. MV-like structures were observed in
the extracellular matrix of the calcified valve. Summary/conclusion:
We establish calcium as a novel trigger of VIC calcification and
suggest that AVC is a cell-mediated process regulated by vesicle
release.
Funding: BBSRC, UK.
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Endoplasmic reticulum stress in vascular smooth muscle cells regulates
exosome release and results in calcification
Gosia Furmanik1, Leon Schurgers2, Chris Reutelingsperger1,
Catherine Shanahan3, Rick Van Gorp1 and Kapustin Alexander4
1Maastricht University, Maastricht, The Netherlands; 2Department of
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Introduction: Vascular calcification (VC) is the process of hydroxya-
patite deposition in the blood vessel wall, which leads to vascular
stiffening and heart failure. It is a health problem common in ageing
populations, and in patients with diabetes and chronic kidney
disease. VC is a regulated process mediated by vascular smooth
muscle cells (VSMCs), with similarities to developmental osteogen-
esis. The exact molecular events responsible for triggering VC are
unknown. The endoplasmic reticulum (ER) is involved in folding of
proteins. ER stress occurs as a result of unfolded protein accumula-
tion and has been implicated in osteoblast differentiation and bone
mineralization. Therefore we hypothesized that ER stress signalling
regulates VC. Methods: Human primary VSMCs were treated with
tunicamycin (TM) and thapsigargin (TG) and elevated Ca2 and
PO42-, to induce ER stress and calcification, respectively. Calcification
was quantified with the o-cresolphthalein assay. Exosomes were
captured on beads and detected with FACS. Grp78 and Grp94
expression by western blotting. SMPD3 expression was measured by
qPCR. Results: ER stress was induced in VSMCs by TM and TG and
increased their calcification. Warfarin, an anticoagulant whose known
side effect is inducing calcification, induced ER stress in rat aortas as
well as VSMCs in vitro. Warfarin-induced calcification of VSMCs in
vitro is ER stress dependent, as blocking ER stress with the inhibitor
PBA decreased calcification. Induction of ER stress in VSMCs was
associated with an increase in exosome release regardless of the ER
stress inducer. Increases in exosome release correlated with upre-
gulation of SMDP3 expression. Conclusions: VC is partially regulated
by ER stress-mediated increase of exosome release. This is the first
time that a link between ER stress and exosome release has been
reported. In addition, these findings provide a novel mechanism of
action of warfarin on VSMCs.
PT2.07
Extracellular vesicles isolated from conditioned media from cells
overexpressing osteopontin promote an increase in cardiomyoblast
cell size
Laura Downie1, Delyth Graham1, Stuart Nicklin2, Martin Mcbride1 and
Tamara Martin1
1The Institute of Cardiovascular and Medical Sciences, University of Glasgow,
Glasgow, Scotland; 2The Institute of Cardiovascular and Medical Sciences,
BHF Glasgow Cardiovascular Research Centre College of Medical, Veterinary
and Life Sciences, University of Glasgow, Glasgow, UK
Introduction: The stroke-prone spontaneously hypertensive rat (SHRSP)
develops increased left ventricular mass index (LVMI) prior to the
onset of hypertension. We identified a quantitative trait locus (QTL)
for LVMI on chromosome 14 and by using chromosome 14 congenic
strains and gene profiling have identified positional candidate genes
within the chromosome 14 congenic interval, including osteopontin
(Spp1). Here, we show that Spp1 may cause cardiac remodelling via
extracellular vesicle (EV) signalling. Methods: H9c2 cells were seeded
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(3.4x104 cells per well) 24 hrs prior to transfection with Spp1 cloned
into pcDNA1 (3 ug) for 48 hrs. EVs were isolated from conditioned
media (CM) via ultracentrifugation, verified by NanoSight, re-
suspended in PBS and placed onto fresh H9c2 cells for 48 hrs.
Crystal violet stained H9c2 cells were analysed using ImageJ. Results:
Spp1 expression was significantly increased in H9c2 cells transfected
with Spp1 (Spp1-cDNA) as determined by qRT-PCR (Spp1-cDNA 58-
fold increase*, pcDNA two-fold increase, compared to cell control
*pB0.01). EVs isolated from CM transfected with Spp1-cDNA sig-
nificantly increased H9c2 cell size (cell control 74.290.9 vs. Spp1-
cDNA 126.092.4*, *pB0.001). Inhibition of EV biogenesis using
GW4869 (20 mM) after transfection with Spp1-cDNA prevented
cellular hypertrophy of fresh H9c2 cells after treatment with CM
(cell control 78.391.09 vs. Spp1-cDNA 82.391.22, p0.05) or
isolated EVs (cell control 80.391.3 vs. Spp1-cDNA 80.691.4,
p0.05). Pre-treatment of Spp1-cDNA EVs with Spp1 neutralising
antibody (1 mg) did not prevent cellular hypertrophy (cell control
80.191.6 vs. Spp1-cDNA 118.191.9*, *pB0.001), suggesting that
Spp1 is not present on the surface of the EVs. Summary/conclusions:
Collectively these data suggest that overexpression of Spp1 pro-
motes an increase in cell size via EV signalling. Further studies are
required to characterise the EVs and the downstream mechanisms
leading to hypertrophy.
PT2.08
Neutrophil microvesicles preferentially adhere to endothelium exposed
to disturbed flow
Ben Ward, Ingrid Gomez, Paul Evans and Victoria Ridger
Immunity, Infection and Cardiovascular Disease Department, University of
Sheffield, England
Background: Atherosclerosis is an inflammatory disease of arteries that
develops at areas exposed to disturbed or low oscillatory wall shear
stress (WSS). At these sites, elevated adhesion molecule expression
facilitates inflammatory cell transmigration. Although neutrophil
depletion is associated with reduced lesion progression, neutrophils
are seldom found within developing plaques and their role in
atherosclerosis remains uncertain. Neutrophils release microvesicles
(MVs) that are able to interact with and activate the endothelium. We
hypothesise that neutrophil MVs preferentially adhere to endothelial
cells at sites of low WSS, contributing to atherogenesis. Methods and
Results: The spatial distribution of MVs in vivo was studied by injecting
CFDA-SE labelled MVs into the tail vein of ApoE-/- or C57BL/6 mice.
After 2 h, en face immunohistochemistry revealed more MVs at
atheroprone (low WSS) than atheroprotected (high WSS) regions of
the aortic arch (MVs per field of view; atheroprotected1.390.4,
atheroprone8.192.4, PB0.001). Additionally, human coronary
artery endothelial cells (HCAEC) were pre-conditioned under high
unidirectional WSS (13 dyn/cm2) or low oscillating WSS (4 dyn/cm2,
0.5 Hz) for 72 h, then incubated with PKH-26 labelled MVs for 2 h.
Fluorescence microscopy revealed that low oscillating WSS induced
greater adhesion of MVs to hCAECs compared to high WSS (MVs per
field of view; low WSS20.691.4, high WSS4.791.5, PB0.05).
Enhanced binding of MVs under low WSS conditions correlated with
greater expression of ICAM-1 (2.3-fold greater in hCAECs subject
to low oscillatory compared to high WSS (PB0.01)). Conclusions:
Neutrophil MVs preferentially adhere to endothelial cells at ather-
oprone regions of the arterial tree in hypercholesterolemic mice. The
mechanism involves low WSS which primes cultured HCAEC for
enhanced expression of ICAM-1 and capture of MVs. These data
implicate neutrophil MVs in the focal nature of atherogenesis.
PT2.09
A functional role for extracellular vesicles in heart failure and cellular
electrical remodelling
Danielson Kirsty1, Haisam Ismail1, Ling Xiao2, Fernando M. Contreras-Valdes1,
Olivia Ziegler2, Avash Das1, Vasilis Toxavidis3, Daniel B. Kramer1,
Peter J. Zimetbaum1, Mark E. Josephson1, Kapil Kumar1, David Milan2,
Saumya Das1, Camacho Virginia4 and John Tigges4
1Medicine, Cardiovascular Medicine, Beth Israel Deaconess Medical Center,
Boston, USA; 2Medicine, Cardiology, Massachusetts, General Hospital,
Boston; 3Beth Israel Deaconess Medical Center, Boston, Massachusetts;
4Flow Cytometry Science Center, Center for Extracellular Vesicle Research,
Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA
Introduction: We have previously identified plasma microRNAs that
are associated with heart failure (HF) and are enclosed in extracellular
vesicles (EVs). This study compares the characteristics of EVs in
HF patients compared to healthy controls and investigates their
functional effect on human induced-pluripotent stem cell-derived
cardiomyocytes (iPSC-CMs). Methods: All experiments were con-
ducted with informed consent and in accordance with the IRB of
BIDMC. Coronary sinus blood was collected from patients under-
going electrophysiology study for supraventricular tachycardia
(healthy controls) or implantation of cardiac resynchronization therapy
for HF. Cell-free plasma was analyzed by nano flow cytometry to
determine differences scatter properties of EVs. Plasma EVs were
isolated by iodixanol density gradient and miRNA expression was
assessed by qRT-PCR. The functionality of these EVs was tested by
addition to iPSC-CMs infected with lentiviral vector carrying ArcLight.
Action potentials were obtained through ArcLight fluorescence
imaging and analyzed at 80% repolarization. Results: EV profiles in
HF patients had an increase in the geometric mean value of side
scatter compared to controls (SVT, 1.0290.19 gMFI; HF, 1.3990.064
gMFI). Increases in microRNAs previously associated with HF were
observed in the EV fraction from HF patients compared to controls,
including miR-151a, miR-30d and miR-660. Addition of EVs isolated
from HF patients to iPSC-CMs produced a 34% increase in APD80 at
24 hrs (pB0.0001), with no change observed following the addition
of control patient-derived EVs. Conclusions: EV profiles and microRNA
contents differ between patients with HF and healthy controls, and
EVs in HF patients appear to play a functional role in electrical
remodelling at the cellular level. EVs and their contents may reflect a
novel paracrine signalling mechanism in HF that may be targeted for
therapy.
PT2.10
Exosomal miRNA as liquid biomarker for canine arrhythmogenic right
ventricular cardiomyopathy (ARVC) in Boxer Dogs
Vicky Yang1, Andrew Hoffman2, Dawn Meola1, Suzanne Cunningham2
1Tufts University, North Grafton, MA, USA; 2Tufts University Cummings School
of Veterinary Medicine, North Grafton, MA, USA
Introduction: ARVC is a heritable disease that accounts for 1122% of
sudden cardiac death (SCD) in young athletes and also affects middle
aged Boxer Dogs. In both species, histopathologic changes from ARVC
include fibrofatty replacement of the heart muscle. The disease is often
transmitted with an autosomal dominant pattern with incomplete
penetrance in both people and Boxers. Mutation in desmosomal
proteins have been implicated. Given the presence of phenotypic
variation, epigenetics, including miRNA control, may be involved. We
attempted to find plasma exosomal miRNAs in Boxers that can serve as
biomarkers and as potential therapeutic targets for ARVC. Methods:
Echocardiograph and ECG were used to diagnose normal Boxers
or Boxers with ARVC. Exosomes from 1ml of plasma were isolated
from each dog (normal Boxers, n7, ARVC Boxers, n8) using
ultracentrifugation. The exosomal miRNAs were then isolated and
pre-amplified. miRNA expression was analyzed using commercially
available miRNA RT-qPCR arrays. Results: Eight of the 277 miRNAs
tested showed statistically significant (p0.05) differences between
normal dogs and dogs with ARVC, including miR-125b (fold change,
FC13.1), miR-28 (FC4.1), miR-29c (FC8.7), miR-30b (FC
7.2), miR-497 (FC7.5), miR-93 (FC5.3), miR-98 (FC
88.8), and miR-133b (FC2.0). miR-125b showed the most
significant change (p0.008). miR-125b, miR-29c, and miR-93 have
been shown to modulate cardiomyocyte ion channels and electrical
signaling, and upregulation of miR-125b predisposed mice to
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ventricular tachycardia. In addition, upregulation of miR-125b or
downregulation of miR-29c has been associated with increased
fibrosis. Summary: Plasma exosomal miRNAs may serve as potential
biomarkers and therapeutic targets for Boxer ARVC. Plasma biomar-
kers enable early detection so that necessary monitoring may be
initiated. Prospective validation of the biomarkers is warranted, and
therapeutic potential of these miRNAs requires further study.
PT2.11
Processed small hairpin RNAs are secreted from transduced cells to
surrounding tissue in vivo in mouse myocardial infarction model
Ida-Liisa Kolari1, Mari Va¨a¨na¨nen2, Mikko P. Turunen2,
Seppo Yla¨-Herttuala1,3, Tiia Turunen2 and Pia Laitinen2
1Department of Biotechnology and Molecular Medicine, A.I.Virtanen Institute,
University of Eastern Finland, Kuopio, Finland; 2Department of Biotechnology
and Molecular Medicine, University of Eastern Finland, Kuopio, Finland;
3Science Service Center and Gene Therapy Unit, Kuopio University Hospital,
Kuopio, Finland
We have reported that lentiviral shRNAs targeted to murine VEGF-A
promoter are able to repress or induce VEGF-A expression both in
vitro and in vivo by transcriptional gene regulation. In this study we
focus on clarifying the in vitro and in vivo transfer of small RNAs
mediating transcriptional gene activation of mouse VEGF-A. Our data
demonstrates that mature shRNA-451 sense and antisense strands
are efficiently secreted to cell culture medium. Still, neither C166 nor
MS-1 cells were found to intake secreted shRNA-451 strands in vitro.
However, when cells from transduced infarcted hearts were sorted
for co-expressed GFP (positive and negative fractions), we detected
mature strand of shRNA-451 also in GFP negative population by qRT-
PCR analysis, suggesting that in infarcted mouse heart shRNA-451
transfer from cell to cell occurs, proposing that transfer may be cell
type or tissue dependent. Further studies are required to find out if
epigenetic changes are passed on to recipient cells in vivo. Mature
form of shRNA-451 is also found in serum of MI mice that have
received intra-myocardial injection of lentiviral vector expressing
shRNA-451. Therefore, also tissue to tissue transfer of shRNAs is
possible. This study explains why promoter targeted shRNAs have
surprisingly good in vivo efficiency and also point out that the safety
of traditional RNAi therapeutics should be reconsidered because
possible biodistribution and off-target effects in chromatin.
PT2.12
Valve interstitial cell (VIC) miRNA profile and phenotype are affected
by canine Wharton’s Jelly mesenchymal stem cell conditioned media
(WJ-MSC CM) in canine myxomatous mitral valve disease (MMVD)
Vicky Yang, Dawn Meola and Andrew Hoffman
Cummings School of Veterinary Medicine, Tufts University, Medford,
Massachusetts
Introduction: Histological changes in canine MMVD and its functional
consequences are virtually identical to human mitral valve prolapse.
Changes include disarray of collagen/elastic fibres and greater
prevalence of VICs with myofibroblastic phenotype, growth retarda-
tion, and lower viability. Our previous results showed that canine WJ-
MSC exosomes (EX) improve cell growth and viability, and that these
EXs are internalized by VICs. We further investigated effects of WJ-MSC
CM on VIC miRNA profile and phenotypic expressions. Methods: VICs
were isolated from normal (n3), mildly (n4), severely affected
valves (n3). CM was collected from WJ-MSC cultured in aMEM15%
FBS for 24 hrs. RT-qPCR was used to evaluate mRNA and miRNA
expressions of VICs cultured with or without WJ-MSC CM and of WJ-
MSC and its EXs. Results: VICs from diseased valves have decreased
miR-29b, miR-30a, and increased miR-99a (pB0.05) expressions. With
WJ-MSC CM, increased miR-26a (1.5, SD 0.4), miR-29a (1.5, SD 0.3), miR-
29b (1.4, SD 0.3), and decreased miR-21 (1.4, SD 0.2) expressions for
VICs from mildly diseased valves were seen. For VICs from severely
affected valves, increased miR-29c (3.8, SD 2.6), miR-146a (1.3, SD 0.1),
and decreased miR-133a (1.8, SD 0.2), miR-218 (1.6, SD 0.2)
expressions were seen. With WJ-MSC CM, VICs from severely diseased
valves had decreased aSMA (1.8, SD 0.4), COL4A5 (4.9, SD 3.4),
COL7A1 (5.0, SD 1.9), HAS3 (2.6, SD 1.2), MMP28 (1.8, SD 0.6),
p21 (1.5, SD 0.6), and increased vimentin (1.4, SD 0.6) expression.
WJ-MSC and its EXs both contain miR-29a/b/c, miR-30a/b/c. Summary:
VICs from diseased valves have decreased expressions of miR-29b and
miR-30a that are important in fibrosis control, and both are found in
WJ-MSC and EXs. Co-culturing with WJ-MSC CM decreased expres-
sions of myofibroblast-related genes in VICs from diseased valves
and increased expressions of miR-29a/b/c. Our results suggest that
WJ-MSC and EXs have potential therapeutic benefits for MMVD
treatment.
PT2.13
Tumour necrosis factor-a carried by microparticles from apoptotic RAW
264.7 macrophage cells triggers deleterious effects on cardiomyocytes
from adult mice
Edward Milbank1, M. Carmen Martinez2, Emilie Martinez1,
Badreddine Lahouel1, Gre´gory Hilairet1, Jacques Noireaud1,
Raffaella Soleti1 and Ramaroson Andriantsitohaina2
1Inserm UMR1063 SOPAM, Inserm, Angers, France; 2INSERM U1063, University
of Angers, Angers, France
Introduction: After ischaemic injury and in patients with atherosclerosis,
the pool of inflammatory macrophages is enlarged in the heart and in
atherosclerotic plaques. Monocyte/macrophage-derived microparticles
(MPs) are part of the pathological process of unstable atherosclerotic
plaques. The hypothesis that these MPs could induce deleterious
effects in adult myocardial cells was evaluated. Methods: MPs were
isolated through differential centrifugation from the supernatant of
RAW 264.7 macrophages. MPs were characterized through flow
cytometry and western Blot. Their effects on cardiac cell shortening
were evaluated in presence or absence of specific inhibitors. Interaction
between MPs and cardiomyocytes was detected through confocal
microscopy. MP pro-apoptotic effects were assessed through western
blot. Results: We showed that these MPs contained the soluble form of
tumour necrosis factor alpha (TNF-a). Furthermore, cardiomyocyte
sarcomere shortening amplitudes and kinetics were reduced within
5 min of exposure to MPs without any modifications in Ca2 transients.
The contractile effects of MPs were completely prevented after pre-
treatment with nitric oxide synthase, guanylate cyclase or TNF-a
inhibitors as well as blocking TNF-a receptor 1 with neutralizing
antibody. Moreover, confocal microscopy showed that, after 1 h, MPs
were clearly surrounding rod-shaped cardiomyocytes, and after 2 h
they were internalized into cardiomyocytes undergoing apoptosis.
Indeed, after 4 h of treatment with MPs, cardiomyocytes expressed
increased apoptotic markers expression (caspase-3, caspase-8, Bax and
cytochrome C) as demonstrated by western blot. Summary/conclusion:
The present study showed that these MPs carry functional TNF-a and
activate TNFR1 in isolated adult murine ventricular cardiomyocytes,
inducing a negative inotropic effect via a mechanism sensitive to NO
synthase inhibitor and that the mitochondrial intrinsic pathway was
implicated in their proapoptotic effects.
PT2.14
Bone marrow endothelial progenitor cells are the cellular mediators of
pulmonary hypertension in the murine monocrotaline injury model
Jason Aliotta1, Mandy Pereira1, Sicheng Wen1, Mark Dooner1, Michael
Deltatto1, Elaine Papa1, Yan Cheng1, Laura Goldberg1, James Klinger1 and
Peter Quesenberry2
1Department of Medicine, Rhode Island Hospital, Providence, USA;
2Department of Medicine, The Warren Alpert Medical School of Brown
University, Providence, USA
Aims: We sought to determine if BM-derived endothelial progenitor
cells (BM-EPCs) are responsible for inducing pulmonary hypertension
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(PH) and if their PH-inducing effect could be attenuated by
mesenchymal stem cell (MSC)-derived extracellular vesicles (EVs).
Methods: Three BM populations were studied: 1. BM from vehicle,
monocrotaline (MCT)-treated mice (PH induction); 2. BM from mice
treated as above after MSC-EV infusion into these mice (PH reversal,
in vivo); 3. BM from vehicle-, MCT-treated mice cultured with MSC-
EVs (PH reversal, in vitro). BM was separated into EPCs (sca-1/
cKit/VEGFR2) and non-EPCs (sca-1-/cKit-/VEGFR2-) and trans-
planted into healthy mice. Right ventricular (RV) hypertrophy was
assessed by RV-to-left ventricleseptum (RV/LVS) ratio and
pulmonary vascular remodelling by blood vessel wall thickness-to-
diameter (WT/D) ratio. Results: PH induction: Transplantation of EPCs
from mice with MCT-induced PH (MCT-PH) resulted in similar RV/
LVS, WT/D ratios as treatment with MCT, whereas transplantation
of non-EPCs from MCT-PH mice did not. PH reversal, in vivo:
Compared to EPCs isolated from MCT-PH mice treated with vehicle,
EPCs isolated from MCT-PH mice treated with MSC-EVs did not
impact RV/LVS, WT/D ratios in healthy mice. PH reversal, in vitro:
Treatment of EPCs from MCT-PH mice with MSC-EVs before
transplantation prevented increases in RV/LVS, WT/D ratios.
MCT-PH mice treated with MSC-EVs had more BM-EPCs, decreased
EPC adhesion receptor expression in the lung and increased BMPRII
and PDGFRa expression in the lung compared to MCT-PH mice not
treated with MSC-EVs. Conclusions: Pulmonary hypertensive effects
of BM may be mediated by EPCs and MSC-EVs can attenuate these
effects by down regulating EPC adhesion receptors in the lung.
These findings provide new insights into PH pathogenesis and offer
a potential target for development of novel therapies for this
disease.
PT2.15
Non-canonical WNT signalling is mediated by extracellular vesicles in
pulmonary fibrosis
Aina Martin1, Marion Frankenberger1, Ju¨rgen Behr2, Michaela Aichler3,
Thomas Hofer2, Axel Walch3 and Melanie Ko¨nigshoff1
1Comprehensive Pneumology Center (CPC), Ludwig-Maximilians-Universita¨t,
Universita¨tsklinikum Grosshadern, und Helmholtz Zentrum Mu¨nchen,
Oberschleißheim, Germany; 2Comprehensive Pneumology Center and Eva
Study Center, Helmholtz Zentrum Mu¨nchen, German Research Center For
Environmental Health and Asklepios Kliniks, Oberschleißheim, Germany;
3Helmholtz Zentrum Mu¨nchen Deutsches Forschungszentrum Fu¨r Gesundheit
Und Umwelt (GMBH) Institute of Pathology, Oberschleißheim, Germany
Idiopathic pulmonary fibrosis is a lethal lung disease of yet unknown
etiology characterized by epithelial injury, myofibroblast activation
and increased extracellular matrix deposition. Reactivation of WNT/
ß-catenin pathway is linked to pulmonary fibrosis (PF); however, the
role of non-canonical WNT signalling has not been explored in detail.
Recently, it has been shown that WNT ligands can be secreted on
extracellular vesicles (EVs). We hypothesize that WNTs contribute
via EVs to impaired cellular crosstalk in PF. First, we performed a
comprehensive profiling of EVs in experimental and human PF
(inform consent was obtained and the study was approved by the
ethics committee at the Ludwig-Maximilians Universita¨t Munchen).
EVs were isolated by ultracentrifugation from bronchoalveolar lavage
fluid (BALF) and characterized by transmission electron microscopy,
western blotting and nanoparticle tracking analysis. Notably, we
found increased EV secretion in BALF obtained from fibrotic mice
which are enriched in non-canonical WNT5A. We also detected an
upregulation of WNT5A in lung homogenates of PF patients com-
pared to donors. Moreover, we observed an increase in CD81-
derived EVs in human PF BALF suggesting fibroblasts as a potential
source. Indeed, WNT5A was found upregulated in EVs from TGFß-
treated primary human lung fibroblasts (phLFs). In line with the
profibrotic effects, treatment of phLFs with autocrine EVs enhances
proliferation, and WNT5A-conditioned media potentiates TGFß-
induced Cola1a1 and MCP1 in lung epithelial cells which have been
linked to PF. In conclusion, we report an increase of EVs in PF, which
impacts autocrine profibrotic signalling and we found that WNT5A
increases in phLFB-EVs upon fibrotic stimulus, suggesting a new role
of EVs traffic of WNTs in the disease.
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PT3.01
Neutrophil-derived-microvesicles could play a role in the early stages
of atherosclerosis
Ingrid Gomez1, Ben Ward1, Paul Hellewell2, Paul Evans1 and
Victoria Ridger1
1Immunity, Infection and Cardiovascular Disease Department,
University of Sheffield, Sheffield, UK; 2Life Sciences, College of Brunel,
Brunel, UK
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PT3.02
Endogenous cardiac extracellular vesicles are transiently
released during experimental myocardial infarction
in mice
Xavier Loyer1, Min Yin1, Coralie L. Gue´rin1, Jose Vilar1, Clotilde The´ry2,
Jean-Se´bastien Silvestre1 and Chantal M. Boulanger1
1Inserm U970 Paris Cardiovascular Research Center (PARCC), Paris France;
2Institut Curie -Inserm U932 Paris France
Introduction: Different subsets of monocytes and macrophages have
been shown to coordinate cardiac remodelling after myocardial
infarction (MI), at least in part through their ability to release anti-
fibrotic and pro-angiogenic factors as VEGF. Extracellular vesicles (EVs),
including exosomes (Exos) and microvesicles (MVs), may play a
seminal role during cardiac remodelling by transferring biological
information to recipients cells. So far, no data exist on the endo-
genous release of EVs following MI. We hypothesized that EVs are
locally released in response to MI and synchronize the monocyte-
induced left ventricle remodelling. Methods: MI was induced by
permanent left anterior descending artery ligation in C57BL/6 mice.
Sham-operated mice were used as controls. Sham and MI mice
were sacrificed between 0 and 14 days after the onset of ischemia. EVs
from ischemic and sham left ventricles were isolated by sequential
centrifugations, analyzed by Nanoparticle tracking analysis (NTA), and
MVs cellular origin as well as phosphatidylserine exposure (annexinV
AV labelling) by flow cytometry. Bone marrow-derived monocytes
were also stimulated for 24 h with EVs isolated from sham and MI
hearts 15 h post ligation and subsequent VEGF release assessed
by ELISA and qPCR. Results: When comparing with Sham, AVMVs
levels rapidly increased between 6 and 24 hrs in the infarcted
myocardium and then returned to basal level after 3 days. NTA
analysis also demonstrated greater release of MVs and Exos in
infarcted myocardium 15 h post-MI, when compared to sham
experiments. Local MVs in ischemic tissue originated mainly from
cardiomyocytes (86% caveolin3MVs). Both MVs and Exos isolated
from ischemic myocardium or cultured cardiomyocytes stimulated the
release of VEGF by bone marrow-derived monocytes. Conclusion:
Endogenous EVs originating from the myocardium accumulate rapidly
and transiently in ischemic heart to stimulate monocyte production
of VEGF.
PT3.03
Role of extracellular vesicles in thrombosis in paroxysmal nocturnal
hemoglobinuria patients
Adeline Wannez1, Be´range`re Devalet1, Franc¸ois Mullier1,
Bernard Chatelain1, Christian Chatelain2, Jean-Michel Dogne´2 and
Celine Bouvy2
1Chu Dinant Godinne, Ucl Namur, Namur, Belgium; 2University of Namur,
Namur, Belgium
Introduction: Paroxysmal nocturnal hemoglobinuria (PNH) is a
complement-mediated hemolysis caused by the lack of complement
regulator GPI-anchored proteins (CD55-CD59) at cell surface. 40% of
PNH patients will undergo thromboembolic events. The release of
procoagulant extracellular vesicles (EV) by the cells could explain the
patient’s thrombosis sensitivity. Eculizumab, used in the treatment of
PNH, interacts with C5 leading to an inhibition of the membrane
attack complex (MAC) formation. The aim of the study is to set-up an
in vitro model of PNH in order to assess the production of EV during
a hemolytic crisis. The second objective is to study the procoagulant
profile of PNH patient during the treatment with eculizumab.
Method: The in vitro model is based on several cell types (endothelial
cell line, leucocytes and red blood cell) from which we remove GPI-
anchored proteins with an enzyme. Besides, we collect plasma of
PNH patients before, after 4 and 11 weeks of Eculizumab (clinical
study was approved by a recognized ethics committee and informed
consent was obtained). We assess the effect of treatment on the EV
procoagulant activity by thrombin generation assay. Results: For the
in vitro model, the enzyme performance varies between cell types. It
seems to be less effective on red blood cells. For the ex-vivo part, we
observe a trend showing a decrease of the procoagulant properties
of EV during the treatment. Conclusion: We succeeded in obtaining
PNH-like cells for all cell types with more or less efficacy. The next
step is to study the complement attack with serum and to check if
procoagulant EV will be released. For the ex vivo part, we observed
some trends suggesting a decrease of the EV procoagulant proper-
ties with the treatment. We found no significant difference in terms
of coagulation profile for patients before and after several weeks of
treatment, however, the number of studied patients was low and
significant results could be reached with a wider cohort.
PT3.04
Platelet-derived extracellular vesicles exposing fibrinogen may be a
potential marker for ongoing thrombus formation
Anita Bo¨ing1, Sami Valkonen2, Augueste Sturk1, Najat Hajji1, Chi Hau1 and
Rienk Nieuwland3
1Department of Biosciences, Division of Biochemistry and Biotechnology;
Division of Pharmaceutical Biosciences, University of Helsinki; Finnish Red
Cross Blood, Helsinki, Finland; 2Laboratory of Experimental Clinical Chemistry,
Academic Medical Center, University of Amsterdam, Amsterdam, The
Netherlands; 3Academic Medical Centre, Amsterdam, The Netherlands
Background: Arterial thrombosis is a major cause of human death.
Patients at risk of, e.g. an acute myocardial infarction (AMI) are in a
pre-thrombotic state, with increased activation of platelets and
coagulation. In patients with AMI, thrombi of 10 days old can be pre-
sent, indicating that thrombus growth can occur silently before
becoming clinically evident. However, no biomarkers are available to
identify such pre-symptomatic patients. We investigated whether in
vitro generated human thrombi release extracellular vesicles (EVs)
exposing unique epitopes that may be useful as biomarkers to iden-
tify patients with on-going thrombus formation. Methods: Citrate-
anti-coagulated blood was collected from healthy subjects (n2)
and platelet-rich plasma (PRP) was prepared by centrifugation. PRP
was incubated with ADP (10 mmol/L, CaCl2 2.5 mmol/L) under stirring
conditions (378C; Multiplate analyzer) in the absence or presence of
Abciximab as glycoprotein (GP)IIb/IIIa receptor antagonist. Samples
were collected at t0, 1 and 24 h. Samples were analyzed for EVs
exposing glycoprotein IIIa (CD61), P-selectin, fibrinogen (FG), or
phosphatidylserine (PS) by flow cytometry (Apogee A50) and their
morphology was studied by transmission electron microscopy (TEM).
Results: The number of EVs exposing CD61, P-selectin, FG and PS
increased 155-, 38-, 3- and 6- fold at 1 h after thrombus formation.
After 24 h, only minor changes were observed in the numbers of
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CD61-, P-selectin and PS-exposing EV compared to t1, but the
number of FG-exposing EVs increased 64-fold compared to t1. All
increases in EV numbers were completely abolished by Abciximab,
indicating that both platelet activation and binding of FG to GPIIb/
IIIa are necessary for EV release. With TEM mostly EVs were present
at t1 h, whereas at t24 h not only EVs but also larger non-EV
structures were present. Conclusions: The release of FG-exposing EVs
may offer a biomarker for on-going thrombus formation.
PT3.05
Flow cytometric measurement of CD41/CD61 and CD42b major platelet
receptors of infusible platelet membrane as a platelet substitute
Saleh Nasiri
Blood Transfusion Research Centre, Higher Institute for Research and
Education in Transfusion Medicine, Tehran, Iran
Introduction: Blood transfusion centres are under considerable pres-
sure to produce platelet concentrates with a shelf life limited to 35
days. Many approaches have been investigated experimentally
to produce new hemostatically active platelet products that are
capable of long-term storage. Recent studies have shown that
infusible platelet membrane may have a hemostatic effect. We
investigated both major adhesion and aggregation receptors of IPM
in comparison with fresh platelet concentrate by flow cytometric
method. Methods: Infusible platelet membrane was prepared from
outdated platelet concentrates. Platelet concentrates were pooled,
disrupted by freezethaw procedure, washing steps were per-
formed, formulated with sucrose and human serum albumin and
lyophilized. Flow cytometric assay was performed to identify CD41/
CD61 and CD42b for IPM after reconstitution with distilled water for
injection and also for pooled fresh platelet concentrate. Results: Flow
cytometric analysis of CD41, CD61 and CD42b showed that IPM
express these receptors with 66.27%, 66.92% and 44.47% and pooled
fresh platelet concentrate with 81.5%, 87.5% and 81.1% respectively.
Conclusion: We concluded that IPM still works with major adhesion
and aggregation receptors that confirms potential hemostatic effect
and finally may support its clinical potential utility as a transfusion
substitute for platelets.
PT3.06
Exploring the phenotypic assessment of antithrombin deficiency by
means of exosomes
Annalisa Radeghieri1, Francesca Todaro1, Giuseppe Di Noto1,
Giuliana Martini2, Sara Pontoglio2, Massimiliano Viti2, Francesca Maffina2,
Vanessa Cancelli2, Luigi Caimi1,2, Paolo Bergese1 and Doris Ricotta1,2
1Department of Molecular and Translational Medicine and Instm, University of
Brescia, Brescia, Italy; 2Spedali Civili of Brescia, Clinical Chemistry Laboratory,
Brescia, Italy
Antithrombin (AT) is the most important plasma inhibitor for the
activated coagulation factors. Its primary target is thrombin followed
by Factor Xa, IXa and VIIa. AT deficiency is associated with an
increased risk of deep vein thrombosis and pulmonary embolism,
major causes of morbidity and death. When reduced activity levels
are identified it is important to measure the AT antigen levels to
differentiate type I (quantitative) from type II (qualitative) disorders,
as type II defects have varying thrombotic risk. No functional routine
diagnostic assay, however, can be assumed to detect all forms of
deficiency, due to lack of specificity. In our study we first show by
a nanoplasmonic assay that the exosomal molar concentration in
Type I, Type II and healthy individuals is the same. Exosomal
concentration normalization allowed to reveal for the first time that
AT is physiologically present in plasma exosomes and Type II defect-
derived vesicles harbour a higher copy number of AT compared
to controls. Furthermore Type II deficient exosomal AT shows a
unique pattern in 2D electrophoresis, probably related to differential
glycosylation. These findings suggest plasma exosomes could
complement routine diagnostic tools to unravel qualitative defects
in AT deficient patients.
PT3.07
A novel thrombo-inflammatory pathway for monocyte recruitment
mediated by platelet-derived microvesicles
Aigli Evryviadou1, Clare Box2, Myriam Chimen1, Matthew Harrison1,
Sahithi Kuravi1, Steve Thomas1, Steve Watson1, Paul Harrison3, Gerard
Nash1 and Ed Rainger1
1Institute of Cardiovascular Sciences, College of Medical and Dental Sciences,
University of Birmingham, Birmingham, UK; 2Institute of Cancer and Genomics
Sciences, College of Medical and Dental Sciences, University of Birmingham,
Birmingham, UK; 3Institute of Inflammation and Aging, University of
Brimingham, Brimingham, UK
We have recently described a novel paradigm where platelets sup-
port monocyte recruitment to the vessel wall in a model of in-
flammation by acting as adhesive bridges between monocytes and
endothelial cells. Given this observation, we wondered whether
formation of platelet-monocyte aggregates in whole blood might
also support the thrombo-inflammatory recruitment of monocytes
to the vessel wall. After addition of platelet agonists to whole blood,
we assessed binding of platelets to monocytes by measuring accu-
mulation of GPIb on CD14 and CD16 labelled monocytes using flow
cytometry. Platelet activation in blood resulted in monocytes
acquiring GPIb in small quanta that were significantly smaller than
the amount of GPIb present on a single platelet. This suggested that
monocytes acquired GPIb from platelet-derived vesicles. Heterotypic
aggregate formation was time-dependent and largely monocyte-
specific. Provision of pre-labelled platelet-derived vesicles in whole
blood also resulted in rapid accumulation of GPIb on monocytes
with similar dynamics. Super-resolution microscopy demonstrated
numerous GPIb positive, sub-micron particles, on the surface of
monocytes. Monocyte borne GPIb was also functional. Thus, we
could observe high levels of adhesion of heterotypic aggregates
flowed across immobilised recombinant vWF or TGF-ß-stimulated
endothelial cells, which present vWF on their surface. Thus we des-
cribe a new functional consequence of platelet-derived vesicle
accumulation by monocytes. This thrombo-inflammatory pathway
of monocyte recruitment may be important in vascular disease, as
it is likely to bypass the usual regulatory pathways that control
monocyte recruitment during inflammation.
PT3.08
Citrate concentration influences platelet activation and microvesicle
generation during lipid apheresis
Rene´ Weiss1, Michael Bernhard Fischer2 and Viktoria Weber1
1Christian Doppler Laboratory For Innovative Therapy Approaches In Sepsis,
Krems an der Donau, Austria; 2Center For Biomedical Technology, Krems an
der Donau, Austria
Introduction: We aimed to assess the influence of citrate antic-
oagulation on platelet activation, microvesicle (MV) generation and
cell adhesion to acrylamide-polyacrylate adsorbents for low density
lipoprotein (LDL) apheresis. Methods: Blood was drawn from healthy
volunteer donors and anticoagulated with citrate (2, 4 and 13 mM
final concentration). Aliquots of 50 mL were recirculated over
columns (3.51.8 cm) containing adsorbents for LDL apheresis at a
flow rate 1.2 mL per min for 4 h. Samples were taken every hour, and
blood cells in the flow-through were quantified using a blood cell
counter. MVs were determined with a Gallios Flow Cytometer
(Beckman Coulter) after calibration with fluorescent beads to cover
the MV (0.3 and 0.9 mm) and the cell size (0.9 and 3 mm) ranges.
Lactadherin staining was used to identify MVs of cellular origin. The
following markers were used to differentiate cell-derived MVs:
CD45, CD14 (monocytes); CD45, CD41 (platelets); CD45,
CD235a (red blood cells). Platelet activation was monitored by
expression of CD62p (p-selectin), platelet factor-4 (PF4) and PAC-1
(activated GPIIb/IIIa). Results: Platelet activation markers CD62p, PF4
and PAC-1 were significantly elevated for citrate anticoagulation below
4 mM, which was accompanied by significantly higher adhesion of
platelets and white blood cells to the adsorbents, as demonstrated by
cell counting and electron microscopy. Likewise, the release of MVs
Scientific Program ISEV 2016 meeting
Citation: Journal of Extracellular Vesicles 2016, 5: 31552 - http://dx.doi.org/10.3402/jev.v5.31552 97
was dependent on citrate concentration and higher amounts of MVs
(red blood cell-and platelet-derived MVs) were released at lower
citrate concentration. After 4 h more than 70% of all monocytes were
lactadherin, indicating their association with MVs. We analysed the
cellular origin of MVs adhering to monocytes and found that nearly
80% were derived from platelets. Conclusion: Our data show that
citrate suppresses cellular activation and generation of MVs during
contact of whole blood with adsorbents for lipid apheresis.
PT3.09
Extracellular vesicles characterization and possible pathogenic role in
ß-thalassemia major
Carina Levin1,2,3, Annie Rebibo-Sabbah3, Benjamin Brenner2,3 and
Anat Aharon2,3
1Pediatric Hematology Unit, Emek Medical Center, Afula Israel; 2Thrombosis
and Hemostasis Unit and Department of Hematology, Rambam Health Care
Campus, Haifa, Israel; 3The Bruce Rappaport Faculty of Medicine, Technion,
Haifa, Israel
Background: Patients with ß-thalassemia major (TM) require blood
transfusion for life and develop severe dysfunctions in major organs
and systems; however not all complications can be explained by iron
overload. Aims: Characterization of extracellular vesicles (EV) in TM
and evaluation of their role in the pathogenesis of TM complications.
Methods: 30 transfusion dependent ß-thalassemia (TDT) patients and
30 controls were included after signing the informed consent. TDT
patients were divided into 3 groups: 1) non-splenectomized, 2)
splenectomized (SP) and 3) hypersplenic (HS). EV characteristics
(cellular origin, cytokine and microRNA content, thrombogenicity)
were assessed by FACS, protein array and RT-PCR. Apoptotic effects
of patients’ EVs on endothelial and liver cells were evaluated
(TUNNEL assay). Results: EV count /mL was lower in HS (178996)
compared to C (4109167, p0.02) and SP (181291937, p0.001).
The % of RBC-EVs was lower in HS vs. controls (p 0.03) and SP
(p0.06) and it correlated with the hematocrit in HS and SP groups.
The % of annexin-V labelled EVs were lower in patients vs. controls
(p0.01). Substantial differences in cytokines and angiogenic
proteins and in microRNA profile were found between the controls
and patients EVs. The amount of 11 proteins in SP-EVs was twice
as high compared to that of controls. Patient EVs induced higher
in vitro apoptotic rate on endothelial and liver cells (16.5%910;
20.9%96.6) compared to control EVs (7.6%95, p0.007; 14.8%95,
p0.09), respectively. Conclusions: Important differences in EV
properties (EV number, exposure of negatively charged phospholipids,
cell origin and cytokine, protein and miRNA content) were found
between patient and control EVs. Patient EVs increased apoptosis in
cultured cells, suggesting a novel mechanism of organ damage in TM.
PT3.10
Pro-coagulant activity of platelet-derived extracellular vesicles
Carla Tripisciano1, Rene´ Weiss1, Tanja Eichhorn1 and Viktoria Weber1,2
1Christian Doppler Laboratory for Innovative Therapy Approaches in Sepsis,
Danube University Krems, Krems, Austria; 2Center for Biomedical Technology,
Danube University Krems, Krems, Austria
Please see OPW1.8
PT3.11
Impact of leukocyte-derived procoagulant extracellular vesicles on
endothelial cells: significance in blood-mediated pancreatic islets graft
reaction
Ali El Habhab1, Malak Abbas2, Guillaume Kreutter1, Mohamad Kassem1,
Fatiha Zobairi1, Valerie Schini-Kerth2, Laurence Kessler1 and Florence Toti2
1EA 7293, Fe´de´ration de Medecine Translationnelle, Faculty of Pharmacy,
University of Strasbourg, Illkirch, France; 2UMR 7213, CNRS, Faculty of
Pharmacy, University of Strasbourg, Illkirch, France
Please see OPW2.4
PT3.12
Microvesicles and Microvescicles associated miRNA as biomarker of
acute kidney injury in a paediatric population following cardiac surgery
Nikol Sullo, Silvia Mariani, Maria T. Jn Tala, William Dott, Marcin J. Wozniak,
Danny Chan, Tracy Kumar, Attilio A. Lotto and Gavin J. Murphy
Department of Cardiovascular Sciences, University of Leicester, Leicester, UK
AKI is very common in paediatric cardiac surgery patients. The
diagnosis relies on changes in serum creatinine and urine output,
which lack specificity and sensitivity especially in new-borns and
premature infants. Microvesicles have been shown to be altered in
animal models of AKI where they regulate injury responses. MV and
associated miRNA could provide specific and early-detection markers
for AKI and a tool to investigate AKI pathogenesis. Study subjects
were 24 children (17 yrs), undergoing cardiac surgery with
cardiopulmonary bypass (CPB) without pre-existing inflammatory
state, AKI or extracorporeal life support. AKI was diagnosed following
the KDIGO definition. Blood and urine samples were collected pre-
operatively and at 6 and 24 hours. Cytokines were measured on a
MAGPIX platform. Leukocyte and platelets activation, and MV
derivation was assessed by flow cytometry and NanoSight device.
miRNAs were isolated from MV preps and analyzed by RTPCR using
Applied Biosystems kits. AKI was diagnosed in 14 patients and was
confirmed by urinary NGAL increase at 6 hours after the operation
(2593.45 ng/ml vs 10.4492.9 ng/ml; p 0.006). Patients with AKI
were younger, underwent longer CPB, received higher volumes of
red blood cells, and required higher inotrope support. AKI subjects
had increased levels of monocyte and ß1-integrin MV. That
correlated well with IL-8 and MCP-3 levels and monocyte activation.
These changes were also reflected in miRNA profile. In fact we
observed a different expression of several miRNA in the two groups
only at 612 hrs and associated with an inflammatory response and
renal ischemia/reperfusion injury. Our data indicate that miRNA
could potentially serve as early AKI markers in children and their
analysis reveals mechanistic parallels with adults.
PT3.13
Decrease of concentration of extracellular vesicles in blood isolates of
27 athletes one day after long distance running
Mitja Drab1, Mojca Pusnik2, Roman Stukelj1, Ljubisa Paden1,
Apolonija Bedina-Zavec3, Judita Lea Krek1, Bostjan Simunic4, Rado Jansa5,
Veronika Kralj-Iglic1, Mojca Bencina3, Barbara Drasler2, Neza Rugelj6,
Damjana Drobne2 and Manca Pajnic1
1Faculty of Health Sciences, University of Ljubljana, Ljubljana, Slovenia;
2Biotechnical Faculty, University of Ljubljana, Ljubljana, Slovenia; 3National
Institute of Chemistry, Ljubljana, Slovenia; 4Science and Research Centre,
Institute for Kinesiology Research, University of Primorska, Koper, Slovenia;
5Clinical Department of Gastroenterology, University Medical Centre Ljubljana,
Ljubljana, Slovenia; 6Department of Biology Biotechnical Faculty, University of
Ljubljana, Ljubljana, Slovenia
Objectives: In order to study the effect of physical effort on mech-
anisms of blood cell membrane vesiculation we measured concen-
tration of extracellular vesicles (EVs) in blood isolates, inflammation
markers TNF alpha and IL6 in plasma, and activity of glutathione
S-transferases (GST) and cholinesterases (ChE) in blood and in
plasma, two days before and one day after long distance running
(10 km, 21 km, 42 km). We also measured blood cell counts and
biochemical parameters of blood the day after running. Methods: The
study was approved by the National Medical Ethics Committee (82/
07/14). After 12 h fasting, blood was sampled and eythrocytes were
separated from plasma by centrifugation. EVs were isolated from
plasma by repetitive centrifugation (at 17570 g) and washing, and
counted by flow cytometry. Inflammation markers were measured
by ELISA. GST and ChE activities were measured by elution and
colorimetry. Standard blood parameters were assessed in a clinical
laboratory. Results: We found on the average a considerable (59%)
and statistically significant decrease of the concentration of EVs in
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isolates from blood (probability pB0.01), of IL6 (92%, p0.04), of
GST activity in erythrocytes (17%, PB0.01), of ChE activity in
erythrocytes (75%, pB0.01), in blood plasma (41%, pB0.01) and
in whole blood (62%, pB0.01). We found a positive and statistically
significant correlation between the concentration of EVs after the
effort and the mean platelet volume after the effort (p0.04).
Concentration of C reactive protein in serum was on the average
slightly elevated after running (7.3 mg/l; ref. value 5 mg/ml) and
statistically significantly correlated with the running distance
(pB0.01). Conclusions: Vesiculability of blood cells a day after
physical effort on the average decreased concomittantly with a de-
crease of some markers of inflammation and oxidative stress in
blood and plasma, presumably due to adaptation mechanisms and
prandial state of the participants.
PT3.14
Altered distribution of HDL- and extracellular vesicle associated
circulating microRNAs in diabetic nephropathy and systemic
microvascular damage
Barend W. Florijn1, Jacques M. G. J. Duijs1, Johannes H. Levels2,
Geesje M. Dallinga-Thie2, Anita Bo¨ing4, Yuana Yuana4,
Rienk Nieuwland4, Ton J. Rabelink1, Marlies J. Reinders3, Roel Bijkerk1
and Anton Jan Van Zonneveld1
1Department of Internal Medicine (Nephrology) and Einthoven Laboratory for
Experimental Vascular Research, Leiden University Medical Center, Leiden,
The Netherlands; 2Department of Experimental Vascular Medicine, Amsterdam
Medical Center, Amsterdam, The Netherlands; 3Department of Internal
Medicine (Nephrology), Leiden University Medical Center, Leiden,
The Netherlands; 4Laboratory of Experimental Clinical Chemistry, Academic
Medical Center, University of Amsterdam, The Netherlands
Introduction: We previously demonstrated circulating miRNAs can
serve as biomarkers for microvascular injury in diabetic nephropathy
(DN) patients. Recent studies revealed that circulating microRNAs
also play a causal role in the pathogenesis of microvascular injury
which depends on their association with a specific plasma carrier.
To assess the plasma carrier distribution of microvascular injury-
associated microRNAs in DN compared to diabetic control subjects
we developed a method to isolate HDL and extracellular vesicles
(EVs) from plasma of these patients and profiled the miRNA content
of plasma and isolated fractions. Methods: EVs were isolated from
EDTA-plasma (125 mL) of DB (n20) and DN control patients (n20)
using Sepharose CL-2B size-exclusion chromatography (SEC). EVs in
fractions were validated by western blot and electron microscopy
and quantified by tunable resistive pulse sensing. HDL was isolated
from plasma using KBr density gradient ultracentrifugation and
further purified with Sepharose CL-2B to deprive HDL from EVs with
the same density. EV- and HDL-miRNA expression profiles were
determined using a custom TaqMan(r) MicroRNA Array Card contain-
ing 48 selected miRNAs and controls. Results: Our method allowed
isolation of non-contaminated HDL (45% recovery) and EVs from
900 mL plasma samples. Differential circulating levels of microvas-
cular injury associated miRNAs were confirmed in total plasma
samples in the DN group compared to DB controls. Interestingly,
preliminary data suggests for some miRNAs the carrier distribution
was selectively altered in HDL or EVs (e.g. miR-331 in EVs, 4.7-fold
difference), suggesting a different pathophysiological origin. Conclusion:
Sub-fractionation of miRNA-carrier fractions improves the selectivity
and sensitivity of biomarkers for microvascular injury in DN and
enables in vitro studies to assess the impact of transfer of HDL-
and EV-derived post-transcriptional regulators on microvascular
integrity.
PT3.15
Quick screening for microparticle content in platelet-rich plasma of
cardiovascular patients
Elisabeth Maurer-Spurej1 and Audrey Labrie2
1University of British Columbia, Department of Pathology and Laboratory
Medicine, Vancouver, BC, Canada; 2LightIntegra Technology Inc., Vancouver,
BC, Canada
Please see OPW1.5
PT3.16
Levels of circulating microvesicles are associated with plasma lipids
and ectopic fat accumulation in type 2 diabetic men with low
testosterone and are unchanged after testosterone replacement
therapy
Jaco Botha1, Line Velling Magnussen2, Morten Hjuler Nielsen1,
Tine Bo Nielsen1, Kurt Højlund2, Marianne Skovsager Andersen2 and
Aase Handberg1
1Department of Clinical Biochemistry, Aalborg University Hospital, Aalborg,
Denmark; 2Department of Endocrinology, Odense University Hospital, Odense,
Denmark
Low testosterone in men has been associated with the metabolic
syndrome (MetSy) and type 2 diabetes (T2D), and testosterone
replacement therapy (TRT) shown to improve several components
associated with higher T2D risk. The multifunctional receptor CD36
may be involved in dyslipidaemia, insulin resistance and ectopic
fat storage in MetSy. We aimed to investigate the hypothesis that
effects elicited by TRT are reflected in levels of circulating micro-
vesicles (MVs), and investigated how MV phenotypes are associated
with insulin sensitivity, body composition, plasma lipids and ectopic
fat accumulation in the liver. Thirty-nine Caucasian males with T2D
and low testosterone levels were assigned to either TRT or placebo
(CTRL) groups, subjected to a 24-week treatment regime, and
evaluated at baseline and after 24 weeks. MVs were analysed by
flow cytometry and defined as lactadherin binding particles within
the 0.11.0 mm gate. MVs of platelet (PMV), monocyte (MMV) and
endothelial cell (EMV) origin were identified by cell-specific markers
and their expression of CD36 was investigated. Data were analysed
by Wilcoxon’s signed rank test and Spearman’s ranked correlation
analysis. No differences in any MV levels were identified between TRT
and CTRL at the end of the trial period. Triglycerides correlated with
PMVs, CD36PMVs, EMVs, CD36EMVs, MMVs and CD36MMVs
(rS0.370.58, pB0.05). Furthermore, indicators of ectopic liver fat,
alanine aminotransferase (ALT) and gamma glutamyltransferase
(GGT) correlated with PMVs, EMVs, CD36PMVs and CD36MMVs
(rS0.330.49, pB0.05). Body composition measures were asso-
ciated with CD36MMV (rS0.330.35, pB0.05), while insulin
sensitivity was not correlated with any of the studied MV pheno-
types. Although TRT improved body composition measures, levels
of MV phenotypes were unaffected, thus refuting our hypothesis.
MetSy components were associated with MV phenotypes, in parti-
cular CD36MVs, which may support the involvement of CD36 in
MetSy pathogenesis.
Scientific Program ISEV 2016 meeting
Citation: Journal of Extracellular Vesicles 2016, 5: 31552 - http://dx.doi.org/10.3402/jev.v5.31552 99
Poster Session 4 - EVs in stem cells
Chairs: Ewa Stepien and Steven Jay 5:00-8:00 p.m.
PT4.01
Extracellular vesicles produced by the microenvironment of low-grade
gliomas at different risk of anaplastic progression differ in terms of
miRNA content
Daniela Cesselli1, Elisabetta Ruaro1, Damiano Mangoni2, Ivana Manini1,
Giacinto Scoles2, Tamara Ius2, Miran Skrap2 and Antonio Paolo Beltrami1
1Department of Medical and Biological Sciences, University of Udine, Udine,
Italy; 2Department of Neurosurgery, University Hospital of Udine, Udine, Italy
Introduction: Although considered benign, 70% of low-grade gliomas
(LGG) undergo anaplastic transformation. Up to now, adjuvant
chemo and/or radiotherapy are not indicated, since they can cause
chronic neurocognitive impairment not justifiable in patients that
may be at low risk of progression. Therefore, new drugs specifically
designed to act on LGG are requested. Researchers have identified in
the tumour microenvironment (TME) a new therapeutic target. In
this regard, we isolated from human gliomas a population of glioma-
associated stem cells (GASC), representing an in vitro model of
the glioma microenvironment. GASC, through the release of extra-
cellular vesicles (EV), support the glioma growth. Aim of the present
study was to study, by means of gene sequencing analysis and
bioinformatics, the miRNA content of GASC isolated from LGG at
high- (LGG-BAD) and low- (LGG-GOOD) risk of progression and their
respective EV. Methods: We selected 3 LGG-GOOD and 3 LGG-BAD.
EVs were collected through precipitation and microRNA extracted.
GASC- and exosomes- miRNAs were sequenced by Illumina platform
(HiSeq2000). Data were verified and count of reads for individual
miRNAs in the individual samples were normalized to obtain a matrix
of expression for the subsequent analysis of comparison between
categories (edgeR package). Functional analysis was performed
using the IPA program. Results: The content in miRNAs of
GASC and their respective EV differs significantly, stressing that the
EV production is a finely tuned process. In addition, the miRNA
profile of GASC and EV differs for LGG-GOOD and LGG-BAD. For
example, in LGG-GOOD GASC, miR-1-3p and miR-1304-3p were,
respectively, up and down regulated. While in LGG-GOOD exo-
somes, miR-6087 and miR-374a were, respectively, up- and down-
regulated. Functional analyses will be presented. Conclusions: The
analysis of exosomal miRNA can open the way to possible new
strategies aimed at blunting the tumour-supporting function of
the TME.
PT4.02
Extracellular vesicles released by Glioma Stem Cells activate astrocytes
and induce the acquisition of neural stem-like potential by astrocytes
Damiano Mangoni1, Emilio Agostinelli1, Miran Skrap2, Tamara Ius2,
Antonio Paolo Beltrami1 and Daniela Cesselli1
1Department of Medical and Biological Sciences, University of Udine, Udine,
Italy; 2Department of Neurosurgery, University Hospital of Udine, Udine, Italy
Introduction: Cellular heterogeneity and plasticity is a hallmark of
glioblastoma multiforme (GBM) and the role played by its micro-
environment (TME) is crucial for tumour progression. Findings sug-
gest that GBM TME is populated by glial cells that undergo a process
of activation resembling reactive gliosis, along with the acquisition
of stem cell potential. We evaluated if exosomes produced by
glioblastoma stem-like cells (GSC) could induce in normal astrocytes
an activated phenotype and stem-like features. Methods: GSC and
glioblastoma primary cells (GC) were isolated from human GBM
(n3). EV were obtained as in Bourkoula et al., 2014. Human
astrocytes (CellScience) were cultured in a medium conditioned or
not by EV derived from GSC, GC, U87 and Wi38 fibroblasts and
subsequently evaluated in terms of growth kinetics, acquisition of a
reactive phenotype (anchorage-independent growth, specific pro-
tein expression) and stem-like features (neurosphere assay). The
miRNA content of GSC-derived EV was evaluated by next-generation
sequencing and validated by qRT-PCR. The role played by miR-181a
and miR-92b in activating in astrocytes a stem-cell program was
evaluated taking advantage of miRNA mimic and antagomir. Results:
EV, both from U87, GC and GSC, but not Wi38, were able to induce in
astrocytes morphology and function of ‘‘reactive’’ cells. However,
only exosomes derived from GSC promoted the de-differentiation of
human astrocytes, increasing their ability to form neurospheres. It
was then identified in the exosomal miRNA-181a and miRNA-92b
the responsible for this activation. The two miRNAs acted reducing
the levels of the protein Nemo-like kinase, activating the ß-catenin
pathway thus inducing the expression of a set of genes respon-
sible for de-differentiation of astrocytes. Conclusions: Glioma
cells utilize EV in order to modify the biological behaviour of
normal glia inducing an activated phenotype and increasing its
plasticity.
PT4.03
Extracellular vesicles released by stem cells isolated from the
glioma microenvironment enhance the in vivo aggressiveness of
glioblastoma cells
Ivana Manini1, Andea Zanello1, Antonio Paolo Beltrami1, Tamara Ius2,
Miran Skrap2 and Daniela Cesselli1
1Department of Medical and Biological Sciences, University of Udine,
Udine, Italy; 2Department of Neurosurgery, University Hospital of Udine,
Udine, Italy
Introduction: Studies highlight the importance of tumour-supporting
cells in cancer progression and the role played by extracellular
vesicles (EV) in tumour-stroma interactions. Recently, we optimized
a method to grow in culture a population of human Glioma-
Associated Stem Cells (GASC) that, although devoid of genetic
alterations, are characterized by stem cell properties and are able,
through the release of exosomes, to modify the biological properties
of glioma stem cells. We wanted to verify whether GASC and GASC-
derived exosomes exert a pro-tumourigenic effect in an orthotopic
murine model of human glioma. Methods: EVs were isolated from
GASC culture supernatants by ExoQuick-TC and their presence
verified by FACS and NanoSight. 1.5x105 U87 were xenotransplanted
into the striatum of SCID/Beige mice alone (5), in combination with
GASC (5) or with GASC-derived EVs (5). After 3 weeks, animals were
sacrificed and tumour size as well as histology was evaluated. Human
origin, proliferation and expression of genes related to angiogenesis,
invasiveness and epithelial to mesenchymal transition (EMT) were
evaluated. GASC-derived miRNAs were sequenced. Results: Tumours
developed in the animals injected with U87GASC or U87GASC-
derived EVs presented, with respect to those receiving U87 only, a
twofold increase in the diameter. Immunofluorescence showed that
a tumour derived by the co-injection of U87 and GASC and U87 and
GASC-derived EVs are characterized by an increased number of
vessels, nestin and CD44 expression, as well al an increased expres-
sion of gene related to EMT. EV-derived miRNAs possible responsible
of the tumour supporting function were identified. Conclusion: GASC
enhance the aggressiveness of glioma cells through an exosome-
mediated mechanism. Studying the molecular cargo of exosomes
could be important to understand the tumour biology, opening the
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way to new therapeutic approaches aimed at interfering with the
tumour-stroma interplay.
PT4.04
The contribution of the cancer initiating cell markers EpCAM and
claudin7 to metastatic progression
Sarah Heiler, Margot Zoeller and Florian Thuma
Tumor Cell Biology, Heidelberg University Hospital, Heidelberg, Germany
Functional activity of EpCAM (EpC) in colorectal and pancreatic
cancer progression depends on its association with palmitoylated
claudin7 (cld7) which is excluded from tight junctions and is
recruited to glycolipid-enriched membrane microdomains (GEM)
cooperating with EpC, additional transmembrane and cytosolic
molecules. We now explored how palmitoylated cld7 contributes
establishing a metastatic phenotype. The loss of metastatic capacity
of a rat pancreatic adenocarcinoma by a knockdown (kd) of EpC or
cld7 is waved by the rescue of wt EpC, but not EpC with a mutation
in the cld7 binding site (EpCmAG) or cld7 with a mutation in the
palmitoylation site (cld7mPalm). Cld7mPalm also does not rescue
anchorage-independent growth, motility, invasiveness and apopto-
sis resistance. This is due to cld7, but not cld7mPalm associating with
a3, b4, ezrin, uPAR and MMP14, which support motility and invasion.
Palmitoylated cld7 additionally is engaged in Pten repression, which
allows Akt phosphorylation accounting for apoptosis resistance. Cld7
supports EMT gene expression and nuclear translocation of Snail,
Sox2 and Notch. These activities of GEM-located palmitoylated cld7
are transferred into TEX, cld7kd TEX failing to modulated the host
surrounding or to induce EMT in non cancer-initiating cells. Finally,
several components of the vesicle transport machinery required for
exosome biogenesis and exosome release preferentially commu-
noprecipitate with palmitoylated cld7 such that TEX release by
cld7kd cells is strongly reduced and uptake by host cells and non-
cancer-initiating cells is severely impaired. GEM-located palmitoy-
lated cld7 acts as a cancer-initiating cell marker by associating with
signalling molecules and EMT genes, which are transferred together
with cld7 into TEX and account for the crosstalk with host and
tumour cells. Furthermore, by the association with the vesicle
transporter machinery GEM-located, palmitoylated cld7 actively
contributes to TEX biogenesis.
PT4.05
Paediatric brain cancer stem cells and their exosomal miRNA content
A´gota Tuzesi, Anna Danielsson and Helena Care´n
Sahlgrenska Cancer Center, University of Gothenburg, Sweden
Introduction: Brain tumours are the leading cause of cancer-related
mortality and morbidity in children. A major problem is the re-
currence of cancer, which is thought to be dependent on cancer
stem cells. In order to increase survival of patients with brain
tumours a proper understanding of the cancer stem cell mechanisms
are required. The generation and maintenance of cancer stem cells
seems to be orchestrated by different epigenetic changes. One
important epigenetic change that can contribute to the cancer stem
cell features in tumour progression is driven by miRNAs. These short
non-coding RNAs are enriched in exosomes and based on the
current knowledge it is reasonable to consider a role of exosomes in
cancer stem cells mechanisms. Methods: Extracellular vesicles re-
leased from paediatric brain cancer stem cells were isolated with
differential centrifugation. Exosomes were characterised by size deter-
mination with Nanoparticle Tracking Analysis (NTA) and Transmis-
sion Electron Microscopy (TEM), characteristic exosomal protein
markers were detected with western blot. Exosomal miRNA content
was studied with 3D-Gene(tm) Human miRNA array chips from Toray
Industries. Results: We identified several deregulated miRNAs in
paediatric cancer stem cells and exosomes. Pathway analysis revealed
the role of these miRNAs in Glioma, ErbB signalling pathway, p53
signalling pathway and several other cancer related pathways.
Conclusions: Our investigation on the altered expression patterns
of miRNA expression in paediatric brain cancer stem cells and their
exosomes revealed a possible role of exosomal miRNAs in brain
tumour biology.
PT4.06
The regenerative potential of the amniotic fluid stem cell
microvesicles
Carolina Balbi1, Martina Piccoli2, Lucio Barile3, Valentina Ulivi1, Pamela
Becherini4, Daniele Reverberi5, Luisa Pascucci6, MariaCarla Bosco4,
Luigi Varesio4, Massimo Mogni7, Domenico Coviello7, Michela Pozzobon2,
Ranieri Cancedda1* and Sveva Bollini1*
*Equal contribution
1Regenerative Medicine Lab, Department of Experimental Medicine (DIMES),
University of Genova, Genova, Italy; 2Stem Cells and Regenerative Medicine
Lab, Fondazione Istituto di Ricerca Pediatrica Citta´ della Speranza, Department
of Women and Children Health, University of Padova, Padova, Italy;
3Laboratory of Molecular and Cellular Cardiology, CardioCentro Ticino
Foundation_CCT, Switzerland; 4Molecular Biology Laboratory, IRCCS Istituto
Giannina Gaslini, Genova, Italy; 5Molecular Pathology Unit, IRCCS AOU San
Martino - IST National Institute for Cancer Research, Genova, Italy; 6Veterinary
Medicine Department, University of Perugia, Perugia, Italy; 7Human Genetics
Laboratory, Galliera Hospital, Genova, Italy
Introduction: Human amniotic fluid stem cells (hAFS) have been
described as endowed with a distinct secretory profile and sig-
nificant regenerative potential. Here we aim at characterising the
hAFS-derived EV (hAFS-EV) as biological mediators of therapeutic
paracrine effect within the hAFS secretome. Method: hAFS were
isolated upon expression of c-kit from left over samples of amniotic
fluid collected for prenatal diagnosis, following informed consent.
hAFS were cultured under normoxia (20% O2) versus hypoxia (1% O2)
preconditioning for 24 h to improve the secretion of EV. EV were
obtained by ultracentrifugation of the hAFS-conditioned medium
and characterised by transmission electron microscope, NanoSight
analysis, western blot and flow cytometry. Their microRNA content
was evaluated by Agilent technology and qRT-PCR. The hAFS-EV
proliferative and pro-survival capacity was assessed on human
dermal fibroblast and myoblast C2C12 cells. The regenerative
potential of the hAFS-EV was also tested in a mouse preclinical
model of spinal muscular atrophy, (HSA-Cre, SmnF7/F7 mice) with
clinical features of human muscular atrophies, in which transplanta-
tion of hAFS previously enhanced muscle strength and survival.
Results: hAFS showed to secrete 1001000 nm sized EV, with hypoxic
preconditioning leading to CD81 exosomal marker enrichment.
hAFS-EV isolated under hypoxic conditions showed up-regulation
of specific microRNA involved in regeneration and repair. In vitro
analysis suggested a role for the hAFS-EV as biologically mediators of
cell proliferation and survival following oxidative stress. Preliminary
results on atrophic mice advised a modulatory role of the hAFS-EV in
decreasing skeletal muscle inflammation. Conclusion: This is the first
study showing that hAFS can actively secrete EV with hypoxic
preconditioning improving their isolation efficiency. These promising
findings suggest a novel translational approach based on exploiting
hAFS-EV for future paracrine therapy.
PT4.07
Hedgehog associated to microparticles inhibits adipocyte
differentiation via a non-canonical pathway
Soazig Le Lay1, Ramaroson Andriantsitohaina1, Caroline Jacques1,
Jerome Larghero2, Audrey Fleury1 and M. Carmen Martinez1
1Oxidative stress and metabolic pathologies, INSERM U1063, University
d’Angers, Angers, France; 2Cellular Therapy Unit, CIC Biothe´rapies, Assistance
Publique  Hoˆpitaux de Paris, Hoˆpital Saint-Louis, INSERM UMR1160, University
of Paris Diderot, Paris, France
Hedgehog (Hh) is a critical regulator of adipogenesis. Extracellular
vesicles are natural Hh carriers, as illustrated by activated/apoptotic
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lymphocytes specifically shedding microparticles (MP) bearing the
morphogen (MPHh). We show that MPHh inhibit adipocyte
differentiation and orientate mesenchymal stem cells towards a pro-
osteogenic program. Despite a Smoothened (Smo)-dependency,
MPHh anti-adipogenic effects do not activate a canonical Hh
signalling pathway in contrast to those elicited either by the Smo
agonist SAG or recombinant Sonic Hedgehog. The effects of MPHh
on adipogenesis are abrogated by pharmacological inhibition of Smo
with LDE225. We further underscore the activation of a Smo/Lkb1/
Ampk axis as the non-canonical Hh pathway elicited by MPHh to
inhibit adipocyte differentiation. Our results highlight for the first time
the ability of Hh-enriched MP to signal via a non-canonical pathway
opening new perspectives to modulate fat development.
This project was funded by a French research national grant
(ANR MilkChEST n8ANR-12-BSV6-0013-04) and by a grant from ‘‘Re´gion
Pays de la Loire’’. AF received a PhD fellowship from ‘‘Re´gion Pays de la
Loire’’.
PT4.08
Augmented production of mesenchymal stem cell-derived therapeutic
extracellular vesicles via 3D-bioprocess
Jae Min Cha1, Eun Kyoung Shin2, Eun Hee Kim3, Ji Hee Sung2,
Oh Young Bang4 and Gyeong Joon Moon2
1Medical Device Research Center, Samsung Medical Center, Seoul, Republic of
Korea; 2Stem Cell and Regenerative Medicine Institute, Samsung Medical
Center, Seoul, Republic of Korea; 3Medical Research Institute, Sungkyunkwan
University School of Medicine, Seoul; 4Department of Neurology, Samsung
Medical Center, Seoul, Republic of Korea
Introduction: Recent studies have drawn attention to extracellular
vesicles (EVs) secreted from mesenchymal stem cells (MSCs), as an
ideal therapeutic candidate. However, the intrinsic ability of MSCs is
significantly deteriorated by conventional 2D culture, so that the
clinical scale production of EVs is problematic requiring countless
batches with significant impact on costs. In this study, we employed
effectual 3D-bioprocessing techniques to enhance MSCs’ biological
properties for a large-scale production of clinically applicable MSC-
derived EVs. Methods: MSCs were seeded onto the array composed of
1,225 poly-ethylene glycol microwells with 200 mm of diameter at a
density of 5105 cells/array. After spontaneously formed in the
microwells, MSC-aggregates were subsequently moved to suspension
culture under 35 rpm of an orbital-shaking condition. On 3, 5, 7 days of
culture, microvesicles (MVs) secreted from MSCs were quantitatively
measured in terms of production rates and inclusions of cytokines and
micro-RNAs. Therapeutic efficacy of the MVs was also evaluated in
neurogenesis and angiogenesis models in vitro. Results: MSC-
aggregates were spontaneously formed with a homogeneously regu-
lated size in 12 h after cell inoculation in the microwells. Live and Dead
assay displayed that most cells were highly viable in the
3D cellular constructs during culture. The highly augmented rate of
MV production from MSC-aggregates was quantitatively shown
about 100-fold greater than those from the 2D control. Those MVs
were enriched with various angiogenic/immunomodulatory and neu-
rotrophic factors. Summary and conclusion: A set of 3D-bioprocessing
techniques employed in this study enabled the large-scale production
of MSC-derived EVs and will possibly possess custom-engineered
therapeutic properties in our future study. Consequently, our research
could contribute to extended benefits of powerful therapeutic capacity
of stem cells with an economic consideration.
PT4.09
Exosomes from placental MSCs as vehicles for the Na/I symporter
(hNIS): a new antitumoural therapy
Alejandra Crespo-Barreda1, Maite Iglesias1, Miguel Quintanilla2,
Antonio de la Vieja3 and Pilar Martin-Duque1,4,5
1Biotechnology Department, Universidad Francisco de Vitoria., Madrid Spain;
2Instituto De Investigaciones Biomedicas Alberto Sols, Madrid, Spain;
3Instituto de Salud Carlos III, Madrid, Spain; 4IACS-IIS Aragon, Zaragoza, Spain;
5Fundacion Araid, Zaragoza, Spain
The Na/I symporter gene (hNIS) is expressed in the thyroid and
allows the accumulation of iodine from the diet, to form T3 and T4
hormomes. Moreover, it is used (i) as a reporter gene for molecular
imaging (when the positron emitter isotope is I124 for PET or Tc99
for SPECT) or (ii) as a therapeutic gene for cancer therapy, mediated
by the accumulation of I131. An unresolved challenge is how to
direct this gene specifically to the tumoural area. Previously, our
group demonstrated the migratory capacity of placental mesench-
ymal stem cells (MSCs) to tumours, carrying adenovirus expressing
hNIS. However as hNIS is expressed at the placental tissue (because
it transfers iodine to the foetus from the maternal blood) we
also observed that placental MSCs expressed hNIS endogenously.
Here, we studied whether exosomes derived from those MSCs (1)
expressed hNIS endogenously (2) reached the tumoural areas when
they were intratumourally injected. Here we present the therapeutic
capacity of the exosomes isolated from those of placenta for cancer
therapy and imaging.
Funding: This work has been funded by Universidad Francisco de
Vitoria.
PT4.10
Effect of ageing on pro-inflammatory micro-RNAs contained in
MSC-derived extracellular vesicles
Juan Antonio Fafian Labora1, Fons A. J. Van De Loo2, Onno J. Arntz2,
Pablo Ferna´ndez Pernas1, Miranda Bennink3 and Marı´a C. Arufe1
1Grupo De Terapia Celular Y Medicina Regenerativa (TCMR-CHUAC). Ciber-
BBN/ISCIII. Departamento de Medicina., University of A Corun˜a, A Corun˜a,
Spain; 2Department of Rheumatology, Radboud University Medical Center,
Nijmegen, The Netherlands; 3Experimental Rheumatology, Radboud University
Medical Center, Nijmegen, The Netherlands
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PT4.11
Cancer stem cell markers and exosomes
Ulrike Erb and Margot Zoeller
Department of Tumor Cell Biology, Heidelberg University Hospital, Heidelberg,
Germany
It is unknown whether there is link between cancer stem cell (CSC)
markers and metastasis/EMT promoting activities of CSC TEX. The
question was explored by a knockdown (kd) of the CSC markers
CD44v6, Tspan8, EpCAM and cld7 in gastrointestinal cancer. Each kd
was accompanied by loss of EMT and metastases formation, wt TEX
repairing the defects. As a kd of one CSC marker suffices for a CSC
breakdown we performed proteome and miRNA analyses of wt and
kd TEX searching for joint features. The CSC makers are located in
internalization prone microdomains (GEM). GEM-located Tspan8
recruits a6b4, the cMET-CD44v6 complex is recruited upon ligand
binding. Internalized cld7 becomes palmitoylated, which fosters GEM
location and EpCAM association.Tspan8 and cld7 are engaged in TEX
biogenesis. Tspan8 associates with molecular complexes promoting
GEM internalization and scission. Tspan8 and palmitoylated cld7
associate with intracellular vesicle transporters. Proteome analysis
and immunoprecipitation also confirmed GEM-located complex
internalization including cytoskeletal linker and signalling molecules
at the inner membrane. By regulating cMET and Tspan8 transcrip-
tion, CD44v6 favours a second level of connectivity and due to CSC
marker recruitment via Tspan8, TEX biogenesis. There is a strong
overlap in missing miRNA recruitment in CSC marker kd TEX arguing
for a contribution in miRNA recruitment. CD44 also is involved in
miRNA processing. In TEX targeting Tspan8 and CD44v6 play a major
role, joint features relying on Tspan8 and CD44v6 associating with
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integrins and proteases, cytoskeletal components and signalling
molecules. The intracellular domain of EpCAM and CD44v6 promote
EMT gene transcription. CSC protein markers are recovered in TEX
and are engaged in biogenesis including loading. Joint target
modulation is promoted by associations between CSC markers and
additional TEX components. Thus, TEX-based diagnosis and therapy
should appreciate the central role of CSC markers.
PT4.12
Human iPSC-derived extracellular vesicles: unique properties and
biological activities in vitro and in vivo
Vasiliki Machairaki, Hao Bai, Yongxing Gao, Samarjit Das, Kenneth Witwer
and Linzhao Cheng
Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
Human induced pluripotent stem cells (iPSCs) derived from somatic
cells of patients provide an unprecedented source of cells for
research into future cell therapies. Unlike many adult human stem
cells, human iPSCs can be expanded in culture indefinitely and
efficiently (1012-fold every 3 days), while maintaining their devel-
opmental potential to generate nearly any cell type. We and others
recently developed a highly defined culture system to expand
human iPSCs under either adherent or suspension condition. This
system includes the E8 culture medium that is free of any serum or
animal proteins, and human recombinant vitronectin as a culture
substrate. We analyzed extracellular vesicles (EVs) made by iPSCs by
using transmission electron microscopy and NanoSight, following
standard methods recommended by ISEV. We observed a concen-
tration of 2xE9 particles per millilitre of conditioned medium, with
diameters of 100 and 200 nm as dominant peaks. The purified EVs
contain RNAs, but not genomic DNA. Proteomic and flow cytometric
analyses confirm that they express CD9, CD63 and CD81, as well as
many membrane and cytoplasmic proteins of human iPSCs. EVs from
human iPSCs stimulated endothelial cell growth in culture. We also
investigated iPSC-derived EVs that stably express the firefly luciferase
(fluc) gene as a marker. We confirmed that EVs express fluc,
indicating the EVs are membrane-enclosed and metabolic active.
We further investigated the EV uptake and activities in vitro (cell
cultures) and in vivo (in NSG immune-deficient mice), by monitoring
horizontal transfer of the fluc activity in live cells once a cell-
permeable substrate, D-luciferin, is provided. One day after deliver-
ing fluc-labelled EVs into the retro-orbital vein of NSG mouse eyes,
we detected luciferase signal in the injected eye. We envision that
human iPSC-derived EVs, especially those with genetic enhance-
ment, may provide a novel and safer cell-free modality of ‘‘cellular’’
therapies.
PT4.13
Extracellular vesicles released by renal cancer stem cells inhibit
immune response
Giovanni Camussi1, Stefania Tritta1, Marta Tapparo2, Cristina Grange1,
Maria Felice Brizzi1 and Maria Chiara Deregibus1
1Department of Medical Sciences, University of Turin, Italy; 2University of Turin,
Italy
Tumour immune-escape has been related to the ability of cancer
cells to inhibit T cell activation and dendritic cell (DC) differentiation.
A CD105 population of renal clear cell cancer that fulfil the char-
acteristic of tumour stem cells (CSCs) was shown to release
extracellular vesicles (EVs) that favour angiogenesis and metastasis.
In the present study we compare the ability of EVs derived from CSCs
and from non-tumour initiating population CD105- (TCs) to inhibit
dendritic cell differentiation and T cell activation. The results ob-
tained demonstrate that EVs from both CSCs and TCs impaired the
differentiation process of DCs from monocytes and the activation of
T cells. After monocyte incubation with cancer cell-derived EVs an
impaired expression of HLA-DR, and of CD83 and CD40 differentia-
tion and activation markers was observed by FACS analysis. More-
over, EVs maintained CD14 expression and reduced the acquisition
of the specific dendritic marker CD1a and down regulated the
expression of costimulatory molecules (CD80 and CD86) and of
adhesion molecules (a4 and a5 integrin and CD54). The ability of DCs
to induce T lymphocytes proliferation detected by BrdU incorpora-
tion was also inhibited. However, these immunomodulatory effects
were significantly higher in the presence of EVs derived from CSCs in
respect to those derived from TCs. IL10 release was significantly
increased in the supernatant of DCs stimulated with cancer cell-
derived EVs. In addition, EVs carried HLA-G which has been
previously involved in cancer immune escape. HLA-G blockade on
EVs significantly decreased the ability of EVs to suppress T cell
activation and DC differentiation. In conclusion, these results suggest
that EVs released by renal cancer cells and in particular those
derived from CSCs inhibited activation of T cells by preventing DC
differentiation. This immunomodulatory effect of EVs was at least in
part ascribed to the presence of HLA-G in the EV cargo.
PT4.14
Role of argonaute 2-Alix interaction in miRNA enrichment in
extracellular vesicle released by human liver stem cells
Giovanni Camussi1, Chiara Gai1, Alessandra Iavello1, Valeska Frech1,
Maria Chiara Deregibus1 and Peter Quesenberry2
1Department of Medical Science, University of Turin, Italy; 2Department of
Medicine, Hematology/Oncology, The Warren Alpert Medical School of Brown
University, Providence, Rhode Island, USA
Several evidence reports that the biogenesis of extracellular vesicles
(EV) involves the endosomal sorting complex required for transport
(ESCRT). Alix is an accessory protein of ESCRT with several domains
exhibiting multiple protein-binding sites and activities. In addiction,
EV contain argonaute 2 (Ago 2) ribonucleoprotein which is involved
in binding and processing of miRNA. The aim of this study was to
better understand the mechanism of miRNA enrichment in EV. We
evaluated whether an interaction between Alix and Ago2 occurs
during packaging of miRNA within EV released by human liver stem
cells (HLSC). We observed that EV isolated from HLSC supernatants
expressed different ESCRT proteins, such as Hrs, Tsg101, CHMP4a,b,c,
and Alix, which was one of the most abundant. In addiction EV
contained several RNA-binding proteins, such as TIA-1, TIAR, HuR,
Stau-1, 2 and Ago 2, and were enriched in several miRNA (miR24,
miR31, miR125b, miR99b, miR221, miR16 and miR21) involved in in
tissue regeneration and anti-tumoural activities. Experiments of co-
immunoprecipitation (co-IP) showed the interaction between Ago2
and Alix. By qRT-PCR we showed the association of miRNA with the
Ago2-Alix co-IP. Moreover, EV derived from Alix knock down-HLSC
showed a significant decreased expression of Ago2 and of miRNA,
even if the number of released EV was not affected. In conclusion,
these results suggest that Alix by binding to Ago2 is instrumental in
the accumulation of miRNA within EV during their biogenesis.
PT4.15
Regulation of macrophage polarization by mesenchymal stem cell
derived-exosomes
Gareth Willis, Alex Mitsialis, Angeles Fernandez-Gonzalez and
Stella Kourembanas
Division of Newborn Medicine, Boston Children’s Hospital, Harvard University,
Boston, USA
Background: Mesenchymal stem cells (MSCs) have been used to
successfully treat a variety of inflammatory diseases in preclinical
models. Recent evidence has implicated MSC exosome (MEX)
secretion as the predominant mechanism of MSC therapeutic
activity. Macrophage polarization plays an important role in regulat-
ing the immune response and inflammation. However, it remains
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unclear as to whether MEX harnesses the MSCs therapeutic
immunomodulatory capacity. We aim to investigate the ability of
MEX to modulate macrophage polarization states in vitro. Methods:
MEX were isolated by gradient density and size exclusion chromato-
graphy (SEC). MEX were characterized by electron microscopy,
nanoparticle tracking analysis, fluorescence microscopy and western
blot. The immunomodulatory capacity of MEX was assessed in vitro
where alveolar macrophages (MH-S cell line) were polarized to M1
(classical - LPS, IFN?), M2 (alternative - IL4, IL13) and M2r (anti-
inflammatory - IL4, IL10, TGF-b) phenotypes in the presence (0.050.5
10^6 MSC cell equivalents) or absence of MEX. Macrophage mRNA
levels were assessed by RT-qPCR. Results: MEX immunoblots were
positive for CD9, TSG101, and Alix. Macrophage-MEX interaction was
confirmed by fluorescence microscopy. The addition of MEX to
alveolar macrophages significantly reduced the mRNA induction of
classically-activated macrophage markers such as TNFa and CCL5,
pB0.05. MEX treatment super-induced ARG-1 mRNA in the M2 state
(pB0.05) but did not affect ARG-1 levels in the M2r phenotype
p0.05. Separating vesicle populations via SEC demonstrated that
the immunomodulatory capacity of MSC-vesicles is attributed solely
to MEX, microvesicles had little effect on macrophage polarity.
Conclusion: We demonstrate a novel mechanism where MEX may
modulate the lung macrophage polarity, suppressing the pro-
inflammatory M1 and shifting the alternatively-activated M2 pheno-
type, to favor the anti-inflammatory (M2r-like) phenotype.
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Extensive phenotyping of plasma EVs from small cell lung cancer
patients undergoing treatment
Rikke Baek1, Emelie Gezelius2, Kim Varming1, Malene Moeller Joergensen1
and Mattias Belting2
1Department of Clinical Immunology, Aalborg University Hospital, Denmark;
2Department of Clinical Sciences, Section of Oncology-Pathology, Lund
University Cancer Center, Sweden
Introduction: With increasing incidence, lung cancer is a leading
cause of cancer death worldwide. Small cell lung cancer (SCLC)
accounts for app. 13% of the total Lung Cancer diagnoses, and it is
related with early metastasis as well as poor prognosis with 5-year
survival rates of app. 10% and 5% in limited and extensive disease
(ED), respectively. Thus, it is crucial to identify new biomarkers of
diagnostic and prognostic value to target SCLC. Here, we use an
internationally unique study-based SCLC cohort (RASTEN: a rando-
mized phase III study of standard treatment9enoxaparin) featuring
baseline samples, samples taken after two cycles of treatment, and
follow-up samples, to clarify the potential role of EVs as prognostic
predictors. Methods: Plasma from 245 SCLC patients (108 with limited
and 137 with ED) were subjected to analysis by the extracellular
vesicle array (EV Array). The array was composed of 29 capturing
antibodies targeting well known EV-associated as well as hypoxia
and lung cancer-related proteins. The binding of EVs was visualized
and recorded using a cocktail of biotin-conjugated CD9, CD63 and
CD81 antibodies combined with fluorescently-labelled streptavidin.
Results: We were able to detect and phenotype EVs in all samples
from only 10 mL of plasma. The array was composed of general EV-
related markers (e.g. CD9, CD63, CD81, TSG101, and CD82), selected
relevant cancer biomarkers (e.g. CD151, c-MET, and VEGFR2), and
markers of hypoxia (CAIX and CAXII). On the basis of this analysis the
potential predictive role of EVs in prognostics has been clarified.
Summary/conclusion: Compared to healthy controls, SCLC patients
have a specific protein signature regarding EVs in plasma. The
EV Array technique states itself as a relatively simple, non-invasive
tool with potential to provide prognostic information on SCLC
patients.
PT5.02
Potentials of plasma EVs in relation to diagnostics and prognostics in
lung cancers
Malene Moeller Jørgensen1, Rikke Baek1, Kristine Raaby Jakobsen2,3,
Birgitte Sandfeld Paulsen2,4, Mattias Belting5, Emelie Gezelius5,
Boe Sorensen2 and Kim Varming1
1Department of Clinical Immunology, Aalborg University Hospital, Denmark;
2Department of Clinical Biochemistry, Aarhus University Hospital, Denmark;
3Department of Biomedicine, Aarhus University, Denmark; 4Department of
Oncology, Aarhus University Hospital, Denmark; 5Department of Clinical
Sciences, Section of Oncology-Pathology, Lund University Cancer Center,
Sweden
Introduction: The majority of lung cancer patients present advanced
stage disease at the time of diagnosis and the outcome is often fatal.
Hence, new clinical tools are needed to secure a better and earlier
diagnosis. Studies have identified plasma EVs as useful markers in
several diseases including late stages of non-small cell lung cancer
(NSCLC, Jakobsen et al., 2015, JEV). In this study, we focused on
identifying the potential of plasma EVs for detection of early stages
of NSCLC. Small-cell lung cancer (SCLC) is associated with a poor
prognosis and survival. A cohort of SCLC patients treated with
enoxaparin or standard treatment was included in the current study
to follow the changes in plasma EVs as a response to treatment.
Methods: Plasma samples from cohorts of patients with non-
cancerous lung diseases, patients with SCLC, and NSCLC were
analyzed for their content of EVs. The cohort of NSCLC patients
included all stages of adenocarcinoma (stage I  IV). The cohort of
SCLC patients are included in the international study ‘‘RASTEN’’
(a randomized phase III study of standard treatment9enoxaparin).
The EVs were extensively phenotyped with the use of the EV Array
technology (Joergensen et al., 2013, JEV). Results: Analysis of more
than 30 different EV markers in the plasma samples made it possible
to generate EV profile signatures for the various cohorts. Multivariate
data analysis was performed and revealed that smoking tended to
have great influence on the EV protein profiles of non-cancerous
lung disease patients and NSCLC patients implying that smoking
influences the protein profiles of plasma EVs. The predictive use of
plasma EVs was investigated with the cohort of enoxaparin treated
SCLC patients. Each of the 245 patients revealed a personal plasma
EV profile and a time line data analysis was performed. Summary/
conclusions: Using the EV Array technology, we demonstrate how
plasma EVs serves as a potential diagnostic and predictive tool in
different types of lung cancer.
PT5.03
miR126 is mainly delivered through exosomes in early-stage NSCLC
patients
Franco Grimolizzi1, Francesca Leoni1, Sara Staffolani2, Marco Tomasetti2
and Franca Saccucci1
1Dip. Scienze Cliniche Specialistiche ed Odontostomatologiche, Universita`
Politecnica delle Marche, Ancona, Italy; 2Dip. Scienze Cliniche e Molecolari,
Universita` Politecnica delle Marche, Ancona, Italy
Introduction: Lung cancer is one of the leading causes of cancer-
related death. The major issue of this disease is that diagnosis occurs
mostly at locally advanced or metastatic stage. Therefore, new
diagnostic approaches based on early detection of cancer biomar-
kers are needed. Recently, increasing attention has being paid to the
role of exosomal microRNAs (exo-miRNAs) in tumour metastasis and
angiogenesis. Such discoveries open the possibility of using exo-
miRNAs as cancer biomarkers and treatmentresponse predictors. In
this study, we evaluated expression levels of miRNA-126 (miR126) in
serum and exosomes of non-small cell lung cancer (NSCLC) patients.
Methods: Stem-loop RT-PCR was performed for expression analysis
of miR126. Exosomes were purified by ultracentrifugation over a
sucrose cushion and quantified using Nanoparticle tracking analysis
(NTA) technology. Results: The miR126 expression in serum showed
no significant difference among NSCLC patients at early stage and
healthy controls, but much higher in the exosome fraction of patients
with NSCLC. In cancer patients there is a shift in miR126 distribution in
exosomes of about 30% of all miR126 present in the serum. In the
healthy control group, the exosomal miR126 was of 10%. Summary/
conclusion: Our results showed that in lung cancer patients, miR126 is
preferably transported by exosomes, which might suggest that this
mechanism plays an important role in the lung cancer development.
PT5.04
Tissue-compatible EGFR genotyping in tumour-derived extracellular
vesicles from malignant pleural effusions
Jae Young Hur
ASAN Medical Center, Seoul, Republic of Korea
Background: Tumour cells shed extracellular vesicles (TEV) into body
fluids. These TEV are a potential source for biomarkers that could
be used for non-invasive molecular diagnosis. We investigated
whether TEV contain cell-specific mutant EGFR DNA using PC9 cells
harbouring an exon 19 deletion (E19 del) and PC9/GR cells harbouring
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a T790M mutation. In addition, we investigated whether the TEV from
malignant pleural effusions can be used for EGFR mutation testing.
Materials and methods: TEV were isolated from the culture medium
of PC9 and PC9/GR cells or pleural effusions by serial centrifugations.
Isolated TEV were inspected by DLS to determine their size. EGFR
mutation testing was performed using PNA-mediated clamping PCR.
Results: EGFR genotyping of TEV DNA revealed exactly the same
EGFR mutations with cellular DNA in the PC9 and PC9/GR cells. These
findings suggest that TEV contain cell-specific mutant DNA that may
contain an oncogenic molecular signature such as mutations in
EGFR. Testing of the TEV from malignant effusions in 23 NSCLC
patients yielded the same genotyping results as from tissue samples.
We observed T790M mutation in addition to the initial E19 del and
L858R mutations from seven patients who developed acquired
gefitinib-resistance. Conclusions: In this study, we demonstrated that
TEV contain cell-specific oncogenic DNA, including EGFR mutants in
the cell lines and malignant pleural effusions.
PT5.05
Circulating RNAs as biomarkers in Epstein Barr virus-associated
nasopharyngeal carcinoma
Octavia Ramayanti1, Sandra A.W.M. Verkuijlen1, Lisa Beckers1,
Jordy Meijer1, Debora Martorelli2, Chantal Scheepbouwer3,
Michael Hackenberg4, Ruud H. Brakenhoff5, Marlinda Adham6,
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VU University Medical Center, Amsterdam, The Netherlands; 4Genetics
Department, University of Granada, Granada, Spain; 5Tumour biology section,
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Mangunkusumo Hospital, University of Indonesia, Jakarta, Indonesia
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Molecular profiling of metastatic versus non-metastatic breast cancer
cell-derived exosomes
Ioulia Vardaki1, George Baltatzis2, Theodoros Foukakis1 and
Theocharis Panaretakis1
1University of Athens, Greece; 2Karolinska Institutet, Solna, Sweden
Introduction: Breast cancer (BrCa) is the most frequent cancer type in
women and a leading cause of cancer related deaths in the world.
Despite the decrease in mortality due to better diagnostics and
palliative care, there is a lack of prognostic biomarkers for metastasis.
Early detection of metastasis is crucial for the survival of the
BrCa patients. Recently, the examination of liquid biopsies and in
particular of the enriched extracellular vesicles has shown promise in
the identification of such predictive biomarkers. Methods: In this study
we compared the proteomic content of exosomes derived from the
syngeneic, non-metastatic 67NR and highly metastatic 4T1 mouse
BrCa model. We demonstrate that concentration and protein content
of the 67NR and 4T1 exosomes differ significantly. We validated our
findings in human cell lines (MCF7 and MDA-MB-231) and in a small
cohort of patient samples with early disease or lymph node (LN)
metastasis. Results: We found that the exosomes isolated from the
mouse cell lines, human cell lines and plasma of BrCa patients with LN
metastasis were enriched in N-cadherin and periostin. Moreover
exosomes from mouse cell lines and plasma of BrCa patients with LN
metastasis had higher number of larger exosomes. Furthermore, we
identified differences in the uptake of exosomes, with the ones
derived from 4T1 cells being taken up more readily and having a
bigger effect in the migration of the non-metastatic 67NR recipient
cells. Summary/conclusion: Exosomes from non-metastatic versus
metastatic breast cancer cell lines have both molecular and functional
differences. Moreover, these differences are present in samples from
patients with non-metastatic disease versus LN metastatic patients.
PT5.07
Development of blood exosome-based immunoassays and PCR tests
for active surveillance of neurofiboromatosis patients and early
detection of malignant peripheral nerve sheet tumours (MPNST)
Natasa Zarovni1, Davide Zocco1, Antonietta Corrado1, Elisa Lari1, Giorgia
Radano1, Judy Longo2, Steven Carroll2, Paolo Guazzi3 and Antonio Chiesi3
1Exosomics Siena SpA, Siena, Italy; 2Medical University of South Carolina,
Charleston, South Carolina; 3HansaBioMed, Tallinn, Estonia
Background: Our project was directed towards the identification of
MPNST specific exosome associated markers, with the ultimate aim of
developing a non-invasive, sensitive and specific multimarker assay
for identification of neurofibromatosis (NF1) patients with the risk of
MPNST development and early detection. NF1 is a hereditary
syndrome characterized by growth of multiple benign tumours that
impose high risk of malignant transformation, representing thus a
paradigm for surveillance of high risk individuals, likely to benefit from
employing circulating exosomes as early sentinels of cancer onset and
progression. Methods: Exosome associated MPNST proteins and RNAs
were revealed via screening of exosomes purified from patient-
derived MPNST and plexiform NF lines. Selected markers related to
tumour metabolism, adhesion and growth factor signalling were used
as targets for exosome-based sandwich immunoassays validated in
spiked-in plasma and serum samples, and subsequently for monitor-
ing of tumour growth in a biouminescent MPNST xenograft murine
model, and comparison of MPNST and NF patient serum samples.
miRNA (8) and mRNA molecules (1024) were analysed in a semi-
quantitative RT-PCR and in Taqman miRNA array. NTA analysis was
performed for sample normalization. Results: ELISA assays employing
some proprietary and commercial antibodies (i.e. Flotillin1, NEK2,
HIF1) and a restricted RNA panel (5 mRNAs5 miRNAs) displayed high
sensitivity for monitoring of MPNST in a mouse model in terms of early
post-graft signals and overall correlation with tumour size. These data
partially matched the observations in human serum samples, with
behaviour of several candidate markers (two proteins, four mRNAs
and three miRNAs) that warrant further validation complemented
with identification of additional markers. Conclusions: Exosome
MPNST markers identified in ex vivo blood samples pave the way to
fine assay validation in longitudinal samples from NF patients as well
as in other solid tumours.
PT5.08
Characterization of microRNAs and proteomic cargo in exosomes
secreted by neuroblastoma
Luigi Tomao1, Andrea Petretto2, Andrea Masotti3, Alessandro Paolini3,
Marta Colletti1, Ana Amor-Lo´pez4, Aurora Castellano1, Nadia Starc1, David
Lyden5, He´ctor Peinado4, Franco Locatelli1 and Angela Di Giannatale1
1Department of Oncohematology, Bambino Gesu` Children’s Hospital, IRCCS,
Roma, Italy; 2Core Facility, Istituto G. Gaslini, Genova, Italy; 3Gene Expression -
Microarrays Laboratory, Bambino Gesu` Children’s Hospital, IRCCS, Roma, Italy;
4Microenvironment and Metastasis Laboratory, Department of Molecular
Oncology, Spanish National Cancer Research Center (Cnio), Madrid, Spain;
5Department of Pediatrics, Weill Cornell Medical College, New York City,
New York, USA
Introduction: Neuroblastoma (NB) is the most common extracranial
paediatric solid tumour. At diagnosis, about 70% of patients with
metastatic disease present bone-marrow (BM) infiltration. However,
the mechanism underlying the BM tropism remains incompletely
elucidated. It has been demonstrated that tumour-derived exosomes
can support metastatic progression. Here, we characterize NB exo-
somes cargo setting the stage for future functional investigations.
Methods: We characterized exosomes from five NB cell lines: one
derived from primary tumour (IMR32) and four from BM metastasis
(SKNSH, SHSY5Y, SKNBe2c and LAN1). We isolated exosomes using
standard ultracentrifugation and confirmed their number/size by
NanoSight and TEM. We analyzed protein content by BCA and
proteomic approach. We further characterized exosomal microRNAs
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(miRs) of SHSY5Y and IMR32 by microarray profiling. Results: TEM on
SHSY5Y confirmed a population of exosome-like vesicles (30100 nm).
The protein content of SKNSH and SHSY5Y exosomes was signifi-
cantly increased compared to IMR32. Exosomal miR profiling showed
153 miRs expressed both in SHSY5Y and IMR32, whereas nine and
12 miRs were found exclusively in SHSY5Y and IMR32, respectively. We
found 30 miRs more than two-fold up-regulated in IMR32 exosomes
and 28 down-regulated compared to SHSY5Y. The proteomic analysis
of exosomes showed 666 common proteins among all NB lines and 18
proteins exclusively present in exosomes from BM metastasis. Classifi-
cation of exosomal proteins by biological process showed proteins
mainly involved in cell growth, proliferation, death and protein
synthesis. Furthermore, we found proteins involved in RNA post-
transcriptional modification and invasion/metastasis. Summary/
conclusion: our data suggest that NB-derived exosomes contain a
specific signature. Further studies are needed to determine the
functional role of NB-derived exosomes in tumour progression and their
potential use as prognostic biomarkers of metastasis and BM infiltration.
PT5.09
Circulating cancer-associated extracellular vesicles as early detection
biomarkers for pancreatic ductal adenocarcinoma
Yusuke Yoshioka1, Hiroko Tadokoro1 and Takahiro Ochiya2
1Division of Molecular and Cellular Medicine, National Cancer Center Institute,
Tokyo, Japan; 2Division of Molecular and Cellular Medicine, National Cancer
Center Research Institute, Tokyo, Japan
Introduction: Pancreatic ductal adenocarcinoma (PDAC) is usually
found at an advanced stage, although diagnosis at an early stage is
unequivocally associated with better long-term survival. Therefore,
there is an urgent need to develop early detection methods to
improve these outcomes. Extracellular vesicles (EVs) attract much
attention as potential biomarker because tumour cells have been
shown to release EVs into circulation, which mirror their cellular
origin. Detection of cancer-associated EVs in body fluids from the
patients could serve as a non-invasive liquid biopsy for diagnosis and
monitoring of cancer. The main objective of this study is identification
and detection of PDAC-specific EVs in serum from the patients.
Methods: To identify the protein profile of EVs in serum from PDAC
patients and healthy donors, major serum proteins in blood were
removed using ultracentrifugation and affinity spin column for 14
highly abundant serum proteins, and then total EV proteins were
purified from 3 different stages of PDAC (stage II, III and IV, each
group: 6 patient sera pooled) and healthy donor. Mass spectrometry
was performed with purified EV proteins, and the biomarker
candidates were validated by immunoblotting in PDAC patient blood
samples. Results: Proteomics analysis individually identified over 500
proteins in each pooled samples, and we identified 9 membrane
proteins, which were detected in only PDAC patients, not in healthy
donors. We focused on 2 proteins and performed immunoblotting for
the validation of potential biomarkers in 3 stages of PDAC blood
samples. As a result, these proteins were detected exclusively in EVs
of PDAC patient sera including stage II. Summary/conclusion: We
identified 2 potential EV-associated proteins as PDAC biomarkers.
Further validation of the candidate markers is still needed on large
patient cohorts including early stage of pancreatic cancer patients.
PT5.10
Plasma-derived exosomes as a reservoir of biomarkers for leukaemia
patients stratification
Maddalena Arigoni1, Federica Riccardo1, Massimo Delledonne2, Laura
Bettinetti2, Vladimir Benes3, Jesus Herna´ndez-Rivas4, Ana Rodriguez-
Vicente4, Antonella Padella5, Giovanni Martinelli5 and Raffaele Calogero1
1University of Torino, Turin, Italy; 2University of Verona, Verona, Italy;
3European Molecular Biology Laboratory, Heidelberg Germany; 4Hospital
Universitario De Salamanca, Spain; 5University of Bologna, Bologna, Italy
We have analysed the transcriptome content of blood circulating
exosomes isolated from lymphoid and myeloid malignancies. We
evaluated for each disease (ALL, CLL, MBL, AML, MDS, MPN) and for
the healthy donors (HD) the overall composition of the various RNA
species that can be detected using the sequencing methodology
designed to detect mature miRNA, that is, small RNA sequencing
(miRNA-seq), and whole transcriptome, that is, non-polyA selected
stranded total RNA sequencing (WT-seq). Specifically, we detected
both coding and non-coding RNAs (mRNAs, miRNAs, snRNAs,
snoRNAs, lincRNAs, circRNAs) transported by the exosomes. We
have analysed by miRNAs-seq 256 samples and 123 samples by WT-
seq. From the comparison between AML, ALL, CLL and HD speci-
mens, we identified subsets of coding and non-coding RNAs that
were disease specific. Specifically, we detected a subset of AML-
specific miRNAs and subsets of CLL-specific miRNAs/mRNAs/
lincRNAs. Using the miRNA AML-specific signature, we managed
to stratify MPN and MDS, diseases that in some cases can pro-
gress in AML, AML-like, HD-like and MPN/MDS-only subgroups. Using
the mRNA and lincRNAs CLL-specific signatures, we managed to
discriminate efficiently MBL from CLL. Interestingly, our data
suggest that exosomes transcriptome provides extra features for
the discrimination of MBL from CLL, which cannot be grasped
in case miRNAs from the intracellular compartment are analysed.
Preliminary observations suggest that the signature allows the
prediction of the evolution of MBL in CLL. Taken together, our
results indicate that exosome transcriptome represents a powerful
new instrument for the discovery of new biomarkers for disease
stratification.
PT5.11
Exosomes secreted by apoptosis-resistant AML blasts harbour
regulatory network proteins potentially involved in antagonism of
apoptosis
Anna Wojtuszkiewicz1, Connie Jimenez2, Jaco C. Knol1, Yehuda G. Assaraf3,
Floortje L. Kessler1, Thang V. Pham1, Sonja Zweegman1, Jacqueline Cloos1,
Gertjan Jl. Kaspers1, Gerrit-Jan Schuurhuis1, Gerrit Jansen1, Rene Jp Musters1,
Johan Van Meerloo1 and Sander R. Piersma1
1VU University Medical Center, Amsterdam, The Netherlands; 2VU University
Medical Center-Cancer Center Amsterdam, The Netherlands; 3Technion - Israel
Institute of Technology, Haifa, Israel
Introduction: Expression levels of proteins promoting apoptosis-
resistance in acute myeloid leukaemia (AML) bone marrow (BM)
blasts at diagnosis are associated with shorter disease-free survival.
We have previously measured, by flow cytometry, expression of
anti-apoptotic and pro-apoptotic proteins in leukaemic combining
them to define the anti-apoptosis index (AAI). The AAI of normal
lymphocytes in the AML patients paralleled that of AML blasts of the
same patient. This points to a role of microenvironment in regulation
of apoptosis in AML BM cells. The aim of this study was to char-
acterize the microenvironment generated in the BM with apoptosis-
resistant AML cells, in terms of its protein composition. Methods:
To characterize the AML microenvironment, conditioned media (18 h)
from patient samples displaying either high AAI (n5) or low AAI
(n6) were analysed using mass spectrometry-based proteomics.
We further investigated protein profiles of purified extracellular
vesicles (EVs) of 2 high AAI patients and 1 low AAI patient combined
with confocal imaging of the EV transfer between cells. Results: The
total secretome data set consisted of 1492 proteins. Our comparative
proteomics analysis showed that the major functional protein
clusters upregulated in secretomes of the high-AAI AML were
involved in mRNA splicing, protein translation and chromatin
remodelling. EV proteomics indicated that these functional protein
networks are cargo of EVs that are enriched for exosome markers.
Finally, confocal microscopy-based co-localization studies suggest
that EVs, containing splicing factors and secreted by high AAI cells,
are taken up by low AAI cells. Conclusion: Transfer of functional
proteins between cells by EVs is a well-documented phenomenon.
Therefore, it is conceivable that the regulatory proteins detected in
EVs excreted by AML blasts are involved in regulation of apoptosis in
recipient bone marrow cells, whereby apoptosis resistance in AML
blasts contributes to therapy resistance.
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PT5.12
Plasma extracellular vesicles as a liquid biopsy source for RNAseq-
based detection of cancer-associated microRNAs
Monique Aj Van Eijndhoven1, Serena Rubina Baglio1, Nils Groenewegen1,
Stuart Van Niele1, Ruben Prins1, H. van der Voorn2, Sten Libregts3, Renee
X. De Menezes4, Marca Wauben3, A. Diepstra5, Anke Jhm Van Den Berg5,
Daphne De Jong6, Josee M. Zijlstra7 and Dirk Michiel Pegtel1
1Department of Pathology, Exosomes Research Group, VU University
Medical Center, Amsterdam, The Netherlands; 2iZON Science, Oxford, UK;
3Department of Biochemistry and Cell Biology, Faculty of Veterinary
Medicine, Utrecht University, Utrecht, The Netherlands; 4Department of
Epidemiology and Biostatistics, VU University Medical Center, Amsterdam,
The Netherlands; 5Department of Pathology and Medical Biology, University
of Groningen, University Medical Center Groningen, Groningen,
The Netherlands; 6Department of Pathology, VU University Medical
Center, Amsterdam, The Netherlands; 7Department of Hematology,
VU University Medical Center, Amsterdam, The Netherlands
Current treatment strategies for cancer patients aim towards per-
sonalized therapy by early identification of the effectiveness of
treatment and detection of relapse during follow-up. Non-invasive,
sensitive diagnostic tools are highly desirable. Extracellular vesicles
(EVs) that encapsulate miRNAs with biomarker potential are actively
secreted into circulation. We used SEC to separate plasma EVs and
protein/HDL from Hodgkin lymphoma (cHL) patients and healthy
donors and prepared libraries for RNAseq analysis. The distribution
of different small RNA species is similar in cHL compared to healthy
plasma EVs. Libraries from cHL EVs yielded a larger amount of
miRNAs than EVs from healthy donors and the proportion of miRNAs
in EVs outnumber miRNAs identified in protein/HDL. Importantly, the
number of different miRNAs does not correlate with the total
amount of reads and is therefore not merely caused by sequence
depth but seems related to pathological conditions. We examined
the potential role of non-templated nucleotide additions (NTAs) in
miRNA secretion. Circulating miRNAs in the EVs from cHL patients
but not healthy individuals have a high percentage of NTA(U)
compared to NTA(A), suggesting disease-associated alterations in
EV-mediated isomiR secretion. In a direct comparison of individual
miRNAs, several potential biomarkers were identified in plasma EVs.
MiR21-5p, let7a-5p, miR24-3p, miR155-5p and miR127-3p were
significantly increased in plasma EVs of cHL patients. qRT-PCR
analysis confirmed these RNAseq results and allowed us to monitor
patient response during and after treatment. We show that several
candidate miRNA biomarkers in plasma EVs decrease significantly in
clinical responders, as determined by FDG/PET scan. Moreover,
a perfect correlation was found with serum TARC, a chemokine
secreted by Hodgkin tumour cells. Altogether these data show that
plasma EVs can be used for biomarker discovery by RNAseq and
that these biomarkers directly reflect the presence of vital tumour
cells.
PT5.13
Depletion of normal blood cell-derived exosomes from plasma to
enhance a tumour-associated exosomal mRNA signature
Christine Coticchia1, Vincent O’Neill2, Graham Brock1, Shauna Blackmon3,
Ryan Sullivan4, Keith Flaherty5, James Hurley1, Lan Hu1 and Johan Skog1
1Research and Development, Exosome Diagnostics, Cambridge, MA, USA;
2Medical/Clinical, Exosome Diagnostics, Cambridge, MA, USA; 3Cancer Center
Protocol Office, Massachusetts General Hospital Cancer Center, Boston,
Massachusetts, USA; 4Hematology/Oncology and Medicine, Massachusetts
General Hospital and Harvard Medical School, Boston, Massachusetts, USA;
5Hematology/Oncology and Medicine, Massachusetts General Hospital,
Boston, Massachusetts, USA
Introduction: Exosomes are released from cells, including tumour
cells, into biofluids and carry nucleic acids and proteins from the cell
of origin. Exosome-based liquid biopsies enable non-invasive
monitoring of a patient’s tumour status in real time, an advantage
over invasive tissue-based tests. However, the tumour signature
must be identified against a background of exosomes originating
from non-malignant cells. To reduce this background, we developed
a platform to deplete exosomes from normal blood cells. We can
remove (a) reticulocyte-derived exosomes, (b) platelet cell exosomes
and (c) leukocyte-derived exosomes. We hypothesize that removal of
normal blood cell-derived exosomes will enrich tumour-derived
exosomes. Methods: Plasma exosomal mRNA (exoRNA) was extracted
from 40 plasma samples (36 metastatic melanoma, 4 normal) using
two extraction methods, total exosome isolation using exoRNeasy
and reticulocyte-depleted exosomes using ExosomeDx Depletion/
Enrichment (EDDE) Platform. Analysis of exoRNA utilized the Open-
Array Human Inflammation Panel. The impact of removing reticulo-
cyte exosomes was examined by comparing genes from EDDE
Platform versus total exosomes. Results: For each sample, 607 genes
were ranked based on their Ct value. A systematic assessment of the
delta rank was performed to determine the utility of the EDDE
Platform. This assessment revealed that the EDDE Platform enriched
13 genes and reduced 4 genes on average, significantly more
compared to total exosomes with 0 genes under the same selection
criteria. When comparing plasma exoRNA signatures of metastatic
melanoma immunotherapy patients who responded to treatment
compared to non-responders, only the EDDE platform revealed gene
changes consistent with response. The removal of targeted exo-
somes was validated using western blot and ELISA. Conclusions: We
have developed a customizable platform to deplete normal exo-
somes from plasma which increases the power to discriminate
tumour-associated exoRNA.
PT5.14
Exosomes from hypoxic colorectal cancer cells  miRNA cargo as
indicator of adverse CRC biology?
Tonje Bjørnetrø1,2, Anne Hansen Ree1,2, Kathrine Røe Redalen1 and
Karianne Risberg1
1Department of Oncology, Akershus University Hospital, Lørenskog, Norway;
2Institute of Clinical Medicine, University of Oslo, Oslo, Norway
Introduction: Tumour hypoxia (oxygenation deficiency) contributes
significantly to treatment resistance and metastatic progression in
colorectal cancer (CRC), and evidence supports a central role of
exosomes in the aggravated biology caused by tumour hypoxia. We
therefore aimed to characterize exosomes released by normoxic and
hypoxic CRC cells and study their miRNA cargo. Methods: The CRC
cell line HCT 116 was cultured in RPMI-1640 supplemented with 1%
bovine serum albumin under normoxia (21% O2) or hypoxia (0.2%
O2) for 24 h. Vesicles were isolated from conditioned media by
differential ultracentrifugation and characterized by western blot and
flow cytometry. Particle size was measured by nanoparticle tracking
analysis (NTA) using NanoSight (Malvern), and vesicle integrity and
size were determined by cryo-electron microscopy (cryoEM). Expres-
sion profiling of exosomal miRNA was conducted using the miRCURY
LNA Universal RT microRNA PCR Human panel I (Exiqon). Results:
Normoxic and hypoxic HCT 116 cells released vesicles that expressed
proteins known to be present in exosomes (CD9, CD63, CD81, Alix)
and with the absence of contamination markers (the endoplasmic
reticulum markers GRP78 and calnexin and the Golgi marker GM130).
Vesicles isolated by using CD81-antibody-coated beads counter-
stained with anti-CD9, anti-CD63 and anti-CD81 in flow cytometry
analysis. Vesicle size ranged from 30 to 130 nm, confirmed by cryoEM
and NTA, and supported the presence of exosomes. Preliminary data
confirmed the presence of miRNA in exosomes and an altered
miRNA profile in response to hypoxia. Summary/conclusion: Using
differential centrifugation, vesicles released from both normoxic
and hypoxic CRC cells were isolated and further characterized and
defined as exosomes. We are currently investigating the miRNA
cargo in exosomes from CRC cells and will further analyse plasma
samples from patients with locally advanced rectal cancer, and
whether exosomal miRNA could serve as a novel biomarker of
tumour hypoxia.
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PT5.15
Targeting tumour-associated exosomes with novel integrin-binding
peptides
Randy Carney, Sidhartha Hazari, Alisha Knudson and Kit Lam
University of California, Davis, California, USA
Introduction: The lag in exploiting the potential of extracellular
vesicles (EVs) as tumour biomarkers is largely due to the inability of
easily distinguishing tumour-associated vesicles from healthy ones.
Here, we report our recent development of a set of novel peptide
ligands capable of binding exosomes derived from specific tumour
cells. Methods: Via a combinatorial-based screening method of
tumour cells against libraries containing millions of solid-phase
bound peptides, some were found to specifically bind either ovarian
(SKOV-3) or leukaemia (Jurkat) tumour cells through their integrin
surface proteins. By mass spectrometry proteomics measurement,
we found that exosomes produced from these cells (isolated both by
differential and density gradient ultracentrifugation methodologies)
similarly overexpress these integrins. Those exosomes were then pre-
mixed with a dye-labelled analogue of the respective integrin-
binding peptide ligand and subsequently bound to latex beads for
flow cytometry analysis. Additionally, the ligands were functionalized
with a Raman tag and mixed with the target exosomes before
Raman laser trapping measurement for the presence of the ligand on
a single exosome. Results: Both flow cytometry and Raman laser
trapping experiments confirmed the specificity of binding for the
peptide ligands to their respective tumour cell-isolated exosomes
and furthermore showed little affinity to other types of normal cell-
derived exosomes. Finally, scrambled analogues of the peptides did
not exhibit binding to the tumour-associated exosomes. Summary:
Given the overexpression of certain integrins present at the surface
of EVs released from a variety of tumour types, we believe this
technology will be useful in separating circulating EVs according to
their tissue of origin or state of disease. Therefore, we are further
investigating these ligands for use as exosome markers for a variety
of clinical applications.
PT5.16
High-throughput, purification-free, multiplexed profiling of circulating
miRNA for discovery, validation and diagnostics
Juan Hidalgo De Quintana
Abcam, Cambridge, UK
We have developed the multiplexed circulating microRNA assay that
allows the detection of up to 68 microRNA targets per sample. The
assay combines particle-based multiplexing, using patented firefly
hydrogel particles, with single-step RT-PCR signal. Thus, the circulat-
ing microRNA assay leverages PCR sensitivity while eliminating the
need for separate reverse transcription reactions and mitigating
amplification biases introduced by target-specific qPCR. Furthermore,
the ability to multiplex targets in each well eliminates the need
to split valuable samples into multiple reactions. Results from the
circulating microRNA assay are interpreted using Firefly Analysis
Workbench, which allows visualization, normalization and export of
experimental data. To aid discovery and validation of biomarkers, we
have generated fixed panels for oncology, cardiology, neurology,
immunology and liver toxicology. Here we present the data from
several studies investigating circulating and tumour microRNA,
showcasing the ability of the technology to sensitively and specifi-
cally detect microRNA biomarker signatures from fluid specimens.
PT5.17
Metabolomics of urinary EVs: main pathways, normalization and
potential for biomarker studies
Maija Puhka1, Maria-Elisa Nordberg1, Vidya Velagapudi1, Maria Aatonen2,
Kimmo Pitka¨nen1, Tuomas Mirtti1, Pia Siljander2, Antti Rannikko1,3,
Olli Kallioniemi1 and Taija Af Ha¨llstro¨m1
1Institute For Molecular Medicine Finland (FIMM), University of Helsinki,
Finland; 2Division of Pharmaceutical Biosciences, Faculty of Pharmacy and
Department of Biosciences, Division of Biochemistry and Biotechnology,
University of Helsinki, Finland; 3Helsinki University Central Hospital,
Department of Urology, Helsinki, Finland
Introduction: Extracellular vesicles (EVs) are promising sources of
biomarkers. Metabolomics of EVs is an unexplored field, although it
holds the potential to reveal dynamic changes in the metabolism
downstream of genetic and proteomic regulation. Here we sought
to clarify, what metabolites are found within urinary EVs, could
EV metabolites act as biomarkers in prostate cancer and how to
normalize the data. Methods: We purified EVs from urine samples of
three consented prostate cancer patients before and after radical
prostatectomy and 3 controls, and subjected them together with
their source urine samples to UPLC-MS-MS analysis of 102 metabo-
lites. For normalization, EV-derived (CD9, particle number and
volume) or urine-derived parameters (volume and creatinine) and
calculation of metabolite proportions were tested. Results: We were
able to quantify 3255% of the screened metabolites in EV samples
containing as little as 6 x 109 EVs or EVs from 10 mL of urine. The
EV metabolome differed clearly from the urine. While most of
the metabolites were more abundant in urine, some were better
detected in the EVs. All EV samples contained nucleotide, amino
acid, vitamin B, carnitine, amine or related metabolites representing
mainly urea cycle, purine nucleotide, glutathione and carnitine
shuttle pathways. Normalization of the data with EV-derived factors
or metabolite proportions together revealed reduction of glucur-
onate, ribose-5-phosphate and isobutyrylcarnitine in cancer samples
compared to control or post-prostatectomy samples. No changes
were observed by normalization to urine-derived parameters.
Conclusion: Relatively small number of EVs is sufficient for detection
of EV metabolites. Normalization to EV-derived parameters or
metabolite proportions reveals differences between samples better
than urine-derived parameters. The observed changes in the cancer
samples relate to cancer metabolism and suggest that EV metabo-
lites could act as prostate cancer biomarkers.
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PT6.01
Autophagy activation prevents alpha-synuclein secretion in exosomes
Rita Perfeito1, Vanessa Anjos1, Rui Nobre1, Manuel Garrido1,2 and
Luı´s Pereira De Almeida1
1Center for Neuroscience and Cell Biology, Coimbra, Portugal; 2Genibet
Biopharmaceuticals, Lisbon, Portugal
Parkinson’s disease (PD) is a neurodegenerative disorder character-
ized by the accumulation of misfolded protein aggregates of alpha-
synuclein (a-syn). a-syn has been described to be transmitted from
neuron to neuron through exosomes, propagating aggregate
pathology to different brain areas and contributing to PD progres-
sion. a-Syn accumulation in neurons has also been linked to an
ineffective clearance of this protein by autophagy. The main goal of
this work was to investigate whether the transport of a-syn occurred
via exosomes using an in vitro model of mouse neuroblastoma cells
(N2a) expressing human WT a-syn. We aimed to clarify a possible
interaction between a-syn exosome secretion and autophagy by
investigating whether pharmacological activation of autophagy
would prevent secretion of a-syn in exosomes. Results show that
upon incubation of exosomes isolated from N2a cells expressing
human a-syn with non-transfected N2a cells, a-syn was detected in
the latter, suggesting that it was transferred from cell-to-cell via
exosomes. Pharmacological activation of autophagy in N2a cells
overexpressing human WT a-syn effectively reduced the levels of this
protein. A decrease in the number of aggregates positive for a-syn
was also observed. Importantly, we found that in exosomes isolated
from transfected N2a cells treated with an autophagy activator
during 12 h, a-syn levels were significantly decreased, suggesting
that this strategy of autophagy activation prevented the secretion of
a-syn via exosomes. Our data strengthen previous evidence that the
autophagy pathway plays an important role in the clearance of a-syn
levels and provides new information on a possible interaction
between the autophagic process and the spreading of a-syn via
exosomes. We propose that inhibiting a-syn release in exosomes and
inducing degradation of a-syn and/or aggregates by autophagy may
constitute a novel pharmacological approach for treatment of
synucleinopathies such as PD.
PT6.02
Investigation of the role exosomes play in the propagation of tau
pathology
Aaron Bradshaw1, Danning Li1, Rohan De Silva2, J. Mark Cooper3 and
Lydia Alvarez-Erviti4
1University College London, England; 2University College London, Institute of
Neurology, London, England; 3Department of Clinical Neurosciences,
University College London, England; 4Centro De Investigacion Biomedica De La
Rioja, Spain
Introduction: Microtubule-associated protein tau exists in neurons as
6 alternatively spliced isoforms. The misfolding and intracellular
aggregation of tau is a pathological hallmark of Alzheimer’s disease
(AD) brains and correlates with neuronal loss. In AD tau, pathology
follows a typical spatial progression through the brain suggesting
active propagation of the pathological protein, a common feature
in several neurodegenerative diseases. One potential mechanism
underlying this spread is via release in exosomes. Tau protein has
been observed in exosomes although the factors underlying its
exosomal targeting are unknown. Previous work with alpha synu-
clein suggests the presence of a chaperone-mediated autophagy
pentapeptide motif (of which tau has two) may play a key role in
targeting specific proteins to exosomes. Defects in protein degrada-
tion also increase the release of misfolded proteins via this pathway.
We aim to understand the factors influencing exosomal tau release
and if this plays a key role in the spread of tau pathology. Methods:
We have used SH-SY5Y neuroblastoma clones stably expressing
different tau isoforms. Exosomes were purified from conditioned
medium using ultracentrifugation. Genetic and pharmacological
techniques were used to study the degradation pathways of tau
and the effects upon exosomal tau release and transmission to naı¨ve
cells. Results: We have confirmed the full length tau isoform (2N4R)
and alternatively spliced isoforms (2N3R, 0N3R, 0N4R) are present in
the exosomal fraction isolated from conditioned medium. We will
present data regarding the intracellular degradation pathways of tau
protein and how genetic and pharmacological manipulation affects
exosomal tau release and transmission. Summary: We have con-
firmed different tau isoforms are released from neuronal cultures
in exosomes and are beginning to understand the factors that
influence the propagation of tau aggregation, which will be
important targets for therapeutic intervention.
PT6.03
Microvesicles in amyotrophic lateral sclerosis: potential biomarkers for
disease propagation and therapeutic targets
Daisy Sproviero1, Sabrina La Salvia1,2, Federico Colombo3, Marta
Giannini2, Luca Diamanti4, Paola Bini4, Orietta Pansarasa1, Laura Porretti3
and Cristina Cereda1
1Laboratory of Experimental Neurobiology, ‘‘C. Mondino’’ National
Neurological Institute, Pavia, Italy; 2Department of Brain and Behavioral
Sciences, University of Pavia Pavia, Italy; 3Clinical Chemistry and Microbiology
Laboratory, Flow Cytometry and Experimental Hepatology Service, Fondazione
IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy; 4Neurology
Department, IRCCS National Neurological Institute C. Mondino, University
of Pavia, Pavia, Italy
Introduction: The lack of biomarkers in neurodegenerative diseases
makes impossible to determine the stage of illness in patients
delaying therapeutic trials. Blood contains microvesicles (MVs), pro-
inflammatory vesicles that transfer mRNA, non-coding RNA or
transcription factors among different cell types. This facilitates the
spreading of the disease through the delivery of genetic material
and pathogenic proteins. A new hypothesis about disease transmis-
sion merges several neurological diseases associated with protein
misfolding and aggregation, in the statement of ‘‘prion-like dis-
eases.’’ MVs can initiate prion propagation from prion-infected
neuronal cells to uninfected cells. The aim of our study is to inves-
tigate MVs in plasma of amyotrophic lateral sclerosis (ALS) patients,
in order to support the ‘‘prion-like theory’’ and discover a new
mechanism in disease progression. Methods: Peripheral blood (5 mL
in sodium citrate tubes) from 20 ALS, 20 Alzheimer’s disease (AD)
patients and 20 healthy volunteers was centrifuged in two steps:
1000xg for 10 min and 1600xg for 20 min. The plasma obtained was
then centrifuged at 20,000xg for 1 h and the MVs pellet was
immunostained with anti-annexin V and anti-CD45 (pan-leucocyte
antigen) antibodies and then analysed by flow cytometry. Misfolded
protein level was detected by western blot. Results: The number of
annexin-VCD45 MVs and annexin-V-CD45 were increased in
the plasma of ALS patients, respectively, of 2- and 4-fold compared
to healthy controls and AD patients (ANOVA test, pB0.05). Different
misfolded protein levels (SOD1, FUS, TDP43 and Aß) were found in
plasma-derived MVs of ALS patients compared to healthy controls
and AD patients. Summary and conclusion: Leukocyte-derived
MVs are overexpressed in ALS patients, and this could have a
relevant role in the disease propagation of ALS. Moreover, they
might be the ‘‘carriers’’ of misfolded proteins, main cause of disease
progression.
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PT6.04
Exosomes as a source of new biomarkers and candidate therapeutic
targets in Parkinson’s disease
Anna Gharibyan1, Shaochun Zhu1, Sandra Gouveia-Figueira2,
Lars Forsgren1 and Miles Trupp1
1Department of Pharmacology and Clinical Neurosciences, Division of Clinical
Neurosciences, Umea University, Umea, Sweden; 2Department of Chemistry,
Umea University, Umea, Sweden
Parkinson’s disease is characterized by multi-focal, progressive
neurodegeneration that often begins in olfactory and vagal neurons,
clinically presenting as a movement disorder only when substantia
nigra neurons are severely compromised. Efforts to restore or replace
neuronal populations post-presentation are likely to suffer from the
existing and progressive load of misfolded and aggregated alpha-
synuclein. We suggest that the development of disease altering
medications must focus upon identification of early markers of
disease spread between neurons and characterization of these
molecular mechanisms as candidate therapeutic targets. We are
investigating the potential of exosomes to mediate transfer of
different alpha-synuclein variants between multiple cell-types and
attempting to identify molecular markers of toxic vesicles as candidate
therapeutic targets. We have isolated exosomes from various cellular
models and biological fluids and characterized their physical proper-
ties by using electron and atomic force microscopy, analysed their
chemical compositions by LC-MS proteomics and lipidomics, as well
as performed cell-based assays for functional studies. Our results
show that pathological conditions such as mitochondrial stress can
affect both physical properties and chemical composition of
exosomes. In particular, stress-induced exosomes appeared to be
smaller and more homogeneous in size than those produced by the
cells growing in normal conditions. Using targeted and untargeted
LC-MS methods, we have identified a number of proteins and
bioactive lipids that are significantly altered in stress-induced
exosomes. Together these results indicate that altered surface and
cargo molecules could change exosomal targeting, signalling or
enzymatic properties and suggest that these models have a strong
potential to identify candidate therapeutic targets to reduce the
progressive spread of protein aggregation diseases.
PT6.05
Salivary vesicles expression in traumatic brain injury
Mandy Pereira1, Mark Dooner1, John Reagan2, Yan Cheng1,
W. Curt Lafrance2, Joseph Crisco1, Bethany Wilcox1, Jeffery Rogg2, Jason
Machan2, Matt Quesenberry1, Neha Raukar2 and Peter Quesenberry1
1Rhode Island Hospital, Providence, Rhode Island, USA; 2Rhode Island Hospital/
Alpert Medical School of Brown University, Providence, Rhode Island, USA
Background: Studies have been conducted to determine if biomar-
kers in body fluids such as cerebral spinal fluid and blood are
predictive of degenerative brain disease in patients post-traumatic
brain injury (TBI). Aberrant levels of neurofilaments, cleaved tau,
microtubule-associated protein 2, myelin basic protein, neuron-
specific enolase, S100ß, glial fibrillary acidic protein, ubiquitin
carboxyl terminal hydrolase L1 and alpha-II spectrin breakdown
products can be detected post-TBI (Dash, 2010; Yokobori, 2013;
Zetterberg, 2013). Increased levels of beta amyloid, tau and TDP-43
have been shown to be associated with Alzheimer’s disease (AD) in
patients post-TBI (Blennhow, 2010). In addition, increased levels of
caspase-3, S100Bm, Gfap and TrkB have been found in the brains of
patients that died due to TBI and other cerebral traumas (Staffa,
2012). We wished to determine if aberrant levels of similar genes
could be found in salivary extracellular vesicles (EVs) of subjects after
TBI. Methods: Saliva was collected from current athletes who either
had a confirmed head impact or no recorded impact, and emergency
room (ER) patients to isolate EVs. Athletes had samples collected
prior to and after their game. ER patients that suffered head trauma
had saliva samples collected post event. EVs were isolated via
differential centrifugation and analysed for mRNA content. Results:
Salivary EVs derived from athletes were different in number and size
and had different gene expression profiles (pre- vs. post-game).
ER patients admitted due to head trauma had elevated salivary
EV expression of genes associated with TBI and AD (vs. subjects
with no known head trauma). One ER patient with a confirmed
concussion had the highest expression of AD genes. Conclusion:
Salivary EV profiling could be developed as a non-invasive test that
might predict the development of degenerative brain disease post-
TBI.
PT6.06
MicroRNAs in human cerebrospinal fluid as biomarkers for Alzheimer’s
disease
Julie Saugstad1, Jay Phillips1, Theresa Lusardi2, Joseph Quinn1,
Jodi Lapidus1, Betty Lind1, Chris Harrington1 and Jack Wiedrick1
1Oregon Health & Science University, Portland, Oregon; 2Legacy Research
Institute, Portland, Oregon, USA
Alzheimer’s disease (AD) is the most common form of dementia;
nearly 44 million people worldwide are affected today. There are
currently no biomarkers to confirm the onset of AD, but a preclinical
tool that can diagnose AD earlier in stage, allowing treatments to be
initiated earlier in the disease, would be a great asset to patients,
family and caregivers. We examined miRNA expression in 49 controls
and 50 moderate AD patients. Cerebrospinal fluid samples from
living donors were obtained from the Oregon Alzheimer’s Disease
Center. Total RNA was isolated using the mirVana PARIS kit, and RNA
expression was quantified using TaqMan Human MicroRNA Arrays.
Cycle threshold (Ct) values for each miRNA were determined using
QuantStudio(tm) software (v1.2.2), using automated baseline and
threshold values. Starting with a set of 151 miRNAs meeting quality
and attestation criteria, we performed 5 phases of inferential analysis
on the Ct values, normalized to U6 snRNA. The first 2 phases
assessed per-target associations with AD using log-rank testing of
KaplanMeier curves and predictions from logistic regression models
while accounting for censoring of the Ct values. The next 2 phases
used different random forest classifiers to gauge the predictive
importance of miRNA targets while accounting for cross-miRNA
interactions. Thirty-six miRNAs were flagged in more than one phase
and carried forward for the final phase, where we used best-subsets
logistic regression to rank multimarker classification performance.
Top-performing 3- and 4-marker models have AUC of 0.790.83,
increasing to 0.840.86 when combined with ApoE4 gene status, a
current biomarker. We identified a panel of miRNAs that can dis-
criminate AD patients from control subjects. Multiple miRNAs show
better biomarker performance than ApoE4 alone, and combining
ApoE4 and miRNA together provides a powerful AD biomarker tool.
Funded by NIH NCATS TR000903 (JAS & JFQ), and NIA AG08017
(JFQ).
PT6.07
Serum exosomal RNA as a biomarker in multiple sclerosis
Michael Buckland1, Saeideh Ebrahimkhani2, Michael Barnett2,
Jennifer Cropley3, Paul Young3 and Catherine Suter3
1Neuropathology, RPA Hospital AND Brain & Mind Centre, University of
Sydney, Sydney, Australia; 2Brain and Mind Centre, University of Sydney,
Sydney, Australia and Victor Chang Cardiac Research Institute, University of
New South Wales, Sydney, Australia; 3Victor Chang Cardiac Research Institute,
University of New South Wales, Sydney, Australia
Multiple sclerosis (MS) is an idiopathic chronic inflammatory
demyelinating disease of the central nervous system, which leads
to progressive motor and cognitive disability. There is currently no
blood-based assay to detect the disease, to monitor its progression
or to judge therapeutic response. We are studying small non-coding
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RNAs derived from exosomes in patient serum to assess their
potential as biomarkers in MS using unbiased deep sequencing
assays and quantitative RT-PCR. We have collected serum from over
160 MS patients at different stages of disease (first demyelinating
event, relapsing-remitting MS, secondary- and primary-progressive
MS) with extensive clinical annotations. Our initial results based on
a small discovery set have identified several microRNAs (miRNAs)
dysregulated in disease compared to healthy age and gender-
matched controls. Some of these miRNAs have been previously
reported as dysregulated in whole blood or plasma analysis of MS
patients; however, we have also identified novel dysregulated
miRNAs that have predicted effects on endothelial cell maturation
and/or TGF-beta signalling. We are currently completing additional
discovery set investigations as well as exploring our initial findings in
larger validation sets.
PT6.08
ApoE-containing particles excreted by astrocytes and neurons:
Exosomes or lipoproteins?
Sandra Den Hoedt, Frank Leijten, Darcos Wattimena, Jeroen Van De Peppel,
Marijke Schreuders-Koedam, Theo Luider, Adrie Verhoeven, Eric Sijbrands
and Monique Mulder
Erasmus MC, Rotterdam, The Netherlands
Introduction: The e4 allele of the APOE gene is the strongest genetic
risk factor for the development of late-onset Alzheimer’s disease.
Apolipoprotein (Apo) E synthesized by the liver is best known for its
role in cholesterol trafficking in circulatory lipoproteins. Notably,
ApoE is also highly synthesized in the brain, predominantly by
astrocytes and likely to be involved in the lipid trafficking. The brain
produces most of its cholesterol endogenously and does not rely on
cholesterol from the circulation. Astrocytes secrete ApoE-containing
lipoprotein-like particles, which are thought to best resemble high-
density lipoproteins (HDL). However, these ApoE-carrying particles
also share features with exosomes, and ApoE has recently been
detected on exosomes excreted in vitro by osteoblasts, platelets and
pigment cells. Our aim is to better characterize the kind of ApoE-
carrying particles that are secreted by astrocytes. Materials and
methods: Particles derived from the human astrocytoma cell line
CCF-STTG1 are isolated from conditioned media by ultracentrifuga-
tion and immunoprecipitation using magnetic beads. The isolated
particles are characterized using cryo-electron microscopy, mass
spectrometry, western blotting, size distribution, mRNA and proteo-
mics. Results: Western blot analysis showed the presence of both
CD9 and ApoE in particle preparations isolated from CCF-STTG1
conditioned media. Furthermore, we found no expression of ApoAI,
an essential protein of HDL. Results of other analyses are pending.
Conclusions: Our preliminary results suggest that the ApoE-containing
particles secreted by astrocytes may represent exosomes rather than
HDL-like lipoproteins. This could potentially lead to the identification
of novel mechanisms by which ApoE4 contributes to the develop-
ment of Alzheimer’s disease.
PT6.09
Proteomics characterization and functional assays of leech microglia
extracellular vesicles
Tanina Arab1, Francesco Drago1, Ilaria Prada2, Christelle Camp1,
Franc¸oise Le Marrec-Croq1, Julien Franck1, Maxence Wisztorski1,
Jean-Pascal Gimeno1, Michel Salzet1, Christophe Lefebvre1,
Claudia Verderio2, Jacopo Vizioli1 and Pierre-Eric Sautiere1
1Laboratoire PRISM, Institut national de la sante´ et de la recherche
me´dicale U1192, Paris, France; 2Consiglio Nazionale Delle Ricerche-Cnr,
Rome, Italy
The medicinal leech (Hirudo medicinalis) is a well-known model in
neurobiology due to its ability to naturally repair the central nervous
system (CNS) after injury. The present study is focused on the
involvement of resident microglial cells in this repair mechanism. In
particular, we investigated the crosstalk between microglial cells and
damaged neurons mediated by extracellular vesicles (EVs) inducing
neuroprotection. In mammals, microglial cells are considered as the
resident immune cells in CNS. Many studies demonstrated that, after
injury, these cells were activated and recruited at the site of lesion.
Leech microglia present a similar pattern of activation and migration
upon experimental lesion of CNS. In addition, we observed that this
activation is linked to the release of a large amount of EVs. In order
to identify in the leech the functional properties of microglial cells
leading to a nerve repair, EVs released by naı¨ve or ATP-stimulated
microglia were collected. Then, their protein content was analysed
using mass spectrometry approaches. Results showed the presence
of specific proteins in differentially stimulated samples. Interestingly,
an important amount of proteins found in leech microglia EVs were
previously described in mammalians. On the other hand, EVs issued
from ATP-stimulated microglial cells were assessed for their neuritic
outgrowth potential on leech neurons and mammal cell lines. The
measurement showed an increase in neurite size compared to
the controls. These results suggest a conservation of pathways
involved in neuroprotection. The present study will permit to
determine the molecular signature of microglial EVs exerting a
neurotrophic effects and would lead to target-specific proteins
promoting CNS repair.
PT6.11
Microvesicles derived from specific cells of the neurovascular unit
associate with white matter hyperintensities in brains of middle aged
women with and without history of preeclampsia
Muthuvel Jayachandran1,2, Kejal Kantarci3, Vesna D. Garovic4,
Brian Lahr5, Kent R. Bailey5, Michelle M. Mielke6 and
Virginia M. Miller1,2
1Departments of Surgery; 2Physiology and Biomedical Engineering;
3Center for Advanced Imaging Research; 4Division of Nephrology and
Hypertension; 5Division of Biomedical Statistics and Informatics;
6Departments of Health Science Research and Neurology, Mayo Clinic,
Rochester, MN, USA
Background: A history of preeclampsia (PE) has been associated with
cerebral white matter lesions, which may be associated with small
vessel ischemic disease. Our objective was to quantify circulating
microvesicles (MVs) derived from cells of neurovascular unit and to
determine their association with small vessel ischemic disease
markers, white matter hyperintensities (WMH) in middle-age women
with and without a history of PE. Methods: This study was approved
by the Institutional Review Board at Mayo Clinic. Age-matched
women (median, 60 years) free of cerebrovascular events: n40
with and n40 without a history of PE participated in this study.
The MV positive for low-density lipoprotein receptor-related receptor
(bloodbrain barrier endothelium), glial fibrillar acidic protein
(astrocytes), Iba1 (ionized calcium adaptor molecule 1, microglia),
Tuj-1 (neuron specific class III beta-tubulin) and Tau or amyloid ß1-42
(Alzheimer’s disease) were quantified by digital flow cytometer.
Volume of WMH was quantified by FLAIR MRI of the brain. MV
variables were analysed for an association with WMH volume on the
combined group of women (n80), after adjustment for history of
PE, BMI and HOMA-IR in multivariable linear regression. Results:
Numbers of MVs derived from the cells of neurovascular unit were
not statistically different between women with and without a PE
history. Multivariable linear regression analysis showed a negative
correlation between astrocyte-derived MVs and WMH volume
(p0.025). Conclusions: MVs derived from cells of neurovascular
unit can be detected in peripheral blood of asymptomatic women.
Astrocyte-derived MVs were found to be associated with WMH
suggesting that reactive astrocytes may contribute in the pathophy-
siology of WMH. Further validation of these results in different
cohorts may identify novel cellular processes that are associated with
WMH, cerebrovascular disease and cognitive impairment.
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PT6.13
Extracellular vesicles as mediators of periphery to brain
communication: relevance for stress-induced behavioural disorders
Giorgio Bergamini1, Hannes Sigrist1, Tobias Suter1, Tobias Hildebrandt2,
Boris Ferger2, Erich Seifritz1 and Christopher Pryce1
1University of Zurich, Zurich, Switzerland; 2Boehringer Ingelheim Pharma
GmbH & Co. KG., Biberach, Germany
Introduction: Understanding the aetio-pathophysiology of depres-
sion is the route to identification of efficacious therapies. A major
theory is that stress-induced inflammation is aetiological in depression
and that one of its effects is to alter dopamine signalling leading to
depressive symptoms. Extracellular vesicles (EVs) comprise a group
of secreted vesicles that are able to transfer biomolecules between
cells and organs. EVs derived from hematopoietic cells deliver
miRNAs to CNS cells during inflammatory conditions. The objective
of this study is to (a) investigate the effect of psychosocial stress on
the peripheral immune system and on dopamine (DA) neurons and
(b) assess the role of EVs in the communication between activated
peripheral immune cells and DA neurons. Methods: Mice are exposed
to chronic social defeat (CSD) stress and the effects of CSD on
immune cells are studied using flow cytometry. To investigate the
effect of CSD on EVs, plasma EVs are isolated and miRNA content is
analysed. Using Vav1-iCre x Rosa26-GFP mice, neurons receiving EVs
cargo from (Vav1) hematopoietic cells are identified by Cre-
mediated GFP expression, and their gene expression pattern is
examined. Results: Mice exposed to CSD exhibit peripheral inflam-
mation: increased splenic granulocytes, inflammatory monocytes
and T helper 17 cells. The immune response co-occurs with
attenuation of dopamine signalling. Future experiments will inves-
tigate (1) CSD effects on miRNA content of EVs secreted by
peripheral immune cells, (2) CSD effects on EVs shuttling to the
brain and cargo delivery to brain cells and (3) influence of EVs cargo
on target dopamine neurons function. Conclusion: Analysis of EVs-
associated miRNA that are transferred to neurons and modulate their
function will be important for the identification of pathophysiologi-
cal pathways for stress-induced behavioural disorders and will serve
as the basis for the discovery of peripheral biomarkers and the
development of targeted therapies.
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Extracellular vesicles from oral squamous cell carcinoma cells in culture:
isolation and characterization
Eduarda Guerreiro1, Beate Vestad2, Reidun Øvstebø2, Hilde Galtung1 and
Tine Søland1
1Department of Oral Biology, Faculty of Dentistry, University of Oslo, Norway;
2The Blood Cell Research Group, Department of Medical Biochemistry, Oslo
University Hospital, Ulleva˚l, Oslo, Norway
Oral squamous cell carcinoma (OSCC) incidence is increasing and is the
most common oral malignant tumour. Tumour-derived extracellular
vesicles (EVs) have been described to be involved in tumour develop-
ment and progression but their role in the processes is unclear.
Traditionally, EVs isolation has been achieved by ultracentrifugation.
This requires specialized equipment, is time consuming and may cause
vesicle damage. Here we aimed to establish a fast and effective protocol
for isolation of EVs from OSCC cells by ultrafiltration followed by size
exclusion chromatography (SEC). PE/CA-PJ49 (OSCC) cells were cultured
in advanced DMEM (Gibco) with L-glutamine, PSA and exosome-
depleted FBS (1% V/V, Thermo Fisher Scientific) until 80 and 100%
confluence. Conditioned culture media were concentrated by ultrafil-
tration (Amicon Ultra Centrifugal Filters, Ultracel 50K and 100K  50 and
100 KDa cut-off, respectively) followed by SEC (Sepharose CL-2B, GE
Healthcare). Fractions were quantified for protein amount by spectro-
photometry (A280 nm). Particle number determined by nanoparticle
tracking analysis (NTA) using NanoSight NS500, followed by detection of
magnetic bead-bound CD9 positive EVs by flow cytometry (median
fluorescence intensity (MFI), BD Accuri C6). Preliminary results from NTA
showed no variation from cell culture at 80% confluence between both
ultrafiltration devices. Still, a slight decrease (approx. 15%) was observed
in 100% confluence culture run in Ultracel 100K compared to 50K. Flow
detection of CD9 positive EVs revealed10% reduction in MFI for both
culture conditions when concentrated with Ultracel 100K. Our findings
entail a successful isolation of EVs from cultured OSCC cells using both
Ultracel (100K and 50K) devices. However, our data imply that loss of EVs
may occur when supernatants are concentrated with Ultracel 100K.
More details on the impact of the different ultrafiltration devices on EVs
are to be elucidated by western blot and electron microscopy.
PT7.02
Role of extracellular vesicles in epithelialendothelial communication
during thyroid development
Jonathan Degosserie, Patrick Van Der Smissen, Didier Vertommen,
Donatienne Tyteca, Pierre J. Courtoy and Christophe E. Pierreux
De Duve Institute, Brussels, Belgium
Intercellular communications are important for organ development and
homeostasis, as well as for pathological and repair processes. Our lab is
interested in epithelialendothelial communications during thyroid
gland development. We have shown that epithelial production of VEGFa
first allows endothelial cell recruitment and invasion around and in the
developing thyroid lobes. In turn, endothelial cells instruct epithelial
cells to organize in polarized spheres, thereby forming angio-follicular
unit. Indeed, Vegfa cKO mice display reduced endothelial cell density
and impaired follicle formation. Using an ex vivo culture system of
thyroid lobes, we demonstrated that medium conditioned (CM) by
endothelial progenitor cells (EPC) promote follicle formation and that
partial activity was present in the high-speed pellet (H-SP) isolated from
this CM. We postulated that the H-SP contains extracellular vesicles
(EVs). Using classical differential centrifugation protocol, we character-
ized the H-SP by western blotting, floatation density gradient and
electron microscopy. The H-SP was positive for CD63 and Flot-1, but
negative for cellular marker calnexin, had a density of 1.09 g/mL and an
average particle size of 100 nm. Altogether, these data indicate that H-
SP contains EVs. We then confirmed that EVs from EPCs can stimulate
follicle formation in thyroid lobes. To identify potential folliculogenic
factors carried by EVs, we resorted to mass spectrometry. Candidate
molecules potentially involved in this process are currently under
study. In parallel, we developed a protocol to isolate EVs from
embryonic thyroid lobes and demonstrated that an H-SP isolated from
embryonic thyroid tissue was positive for CD63 and Flot-1, while it was
negative for calnexin. Our future aims will be to test candidate
folliculogenic factors, identify which cell type of the explants is
targeted by the EVs produced by EPCs and continue the characteriza-
tion of the H-SP isolated from embryonic thyroid.
PT7.03
Concomitant evaluation of a panel of exosome proteins and miRs for
qualification of cultured human corneal endothelial cells
Junji Hamuro
Kyoto Prefectural University of Medicine, Kyoto, Japan
Purpose: Cultured human corneal endothelial cells (cHCECs) serve
as an alternative to donor corneas for the medication of corneal
endothelial dysfunction. However, predisposition of cHCECs into a
senescence phenotype, epithelial-mesenchymal transition has been
hampering the practice in clinical settings. The aim of this study was to
find the way to utilize secreted miRNA (miR) profiles to qualify cHCECs
adaptable for cell injection therapy. Methods: The variations of cHCECs in
their composites of heterogeneous subpopulations (SPs) were certified
in the context of their surface CD markers. The integrated analysis of
miRNA profiles in culture supernatants were investigated by 3D-gene
(Toray). To validate 3D gene results, qRT-PCR was carried out for a vast
number of cultures, distinct in their morphology and the composites of
SPs. The exosomes and miRNAs in culture supernatants (CS) were also
analysed. Results: Secreted miRNA profiles among morphologically
diverse cHCEC SPs proved to be useful for their distinction each other.
The candidate miRs to discriminate CD44-SPs from those with
CD44 phenotypes were miRs 221-3p, 1246, 1915-3p and 4732-
5p. The levels of the latter 3 miRs decreased dramatically in CS of cHCECs
without CST, whereas those from cHCECS with senescence-like CST
showed the increase. Of note, miR184 only decreased inversely in
parallel with the upregulation of CD44 on cHCECs. CD9 exosomes
were far elevated in CS of cHCECs with senescence-like CST than those
without CST, indicating the possible import of these extracellular
vesicles (EVs) into cHCECs without CST. Conclusions: The cHCECs sharing
a CD44-phenotype may be discriminated by measuring the amount of
miRs or exosome in CS. Thus, miRs in CS may serve as the tool to qualify
cultured cHCECs. The future extended analysis of cell-to-cell commu-
nication through these EVs might open the new aspect for the better
understanding of cell state transition of cultured cells.
PT7.04
Visualization and characterization of extracellular vesicles derived from
human bone marrow mesenchymal stem cells using different staining
analysis
Sylwia Koniusz1, Malgorzata Frontczak-Baniewicz2 and Barbara Lukomska1
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Introduction: Mesenchymal stem/stromal cells (MSCs) are of great
interest in regenerative therapies. The predominant mechanism
by which MSCs participate in tissue repair is mainly related to
their paracrine activity. In parallel to soluble factors, MSCs release
microvesicles that contribute to the reparative processes. The aim of the
study was to optimize the method of staining for EVs derived from MSCs
in term of their visualization after transplantation. Methods: The
experiments were performed on human bone marrow mesenchymal
stem cells (hBM-MSCs) (Lonza). hBM-MSCs were labelled with two
different dyes: lipophilic stain PKH26 and iron nanoparticles conjugated
with rhodamine (Molday) and co-stained with anti-CD9, anti-CD63 and
anti-CD81 (tetraspanins) antibodies. Then, EVs were isolated from the
culture media of previously labelled hBM-MSCs by centrifugation at
1800 x g for 30 min at 48C followed by two times ultracentrifugation at
100,000 x g for 60 min at 48C. To observe the transfer of EVs to hBM-MSCs
in vitro, isolated EVs were co-cultured with hBM-MSC during 24 or 48 h.
The results were analysed by confocal microscopy and transmission
electron microscopy. Results: Our results depicted the presence of
intracellular structures positively stained with PKH26 or iron nanopar-
ticles visible inside hBM-MSCs, which co-expressed CD9, CD63 and CD81
markers specific for EVs. The isolated EVs represent heterogeneous
population differed with size and content as confirmed by electron
microscopy analysis. Co-culture of EVs with hBM-MSCs revealed their
uptake by cells during short time of observation. Conclusions: PKH26 and
Molday proved to be efficient stains, biocompatible with EVs and the
labelling did not interfere with the capability of EVs to re-enter hBM-
MSCs during in vitro co-culture studies.
This work was supported by KNOW 06 project: ‘‘The role of bone
marrow mesenchymal stem cells and microvesicles derived from
these cells in CNS repair of brain ischemia disorders.’’
PT7.05
Analysis of extracellular vesicles obtained from clear cell renal cell
carcinoma tissue
Kentaro Jingushi1, Nakata Wataru2, Ueda Koji3, Uemura Motohide2,
Fujita Kazutoshi2, Nonomura Norio2 and Tsujikawa Kazutake1
1Laboratory of Molecular and Cellular Physiology, Graduate School of
Pharmaceutical Sciences, Osaka University; 2Department of Urology,
Graduate School of Medicine, Osaka University; 3Project for Personalized
Cancer Medicine, Genome Center, Japanese Foundation for Cancer
Research
Introduction: In the last decade, extracellular vesicles (EVs) have
emerged as a novel mediator of tumorigenesis. Many reports sug-
gest that EVs are inseparable part of cancer microenvironment from
the experiments using cell lines and body fluids. However, these
observations have not yet been experimentally proven in vivo.
Methods: We attempted to obtain EVs directly from fresh clear cell
renal cell carcinoma (ccRCC) clinical specimens by an ultracentrifuge
method. Obtained tissue-derived EVs (TEVs) were analysed by western
blot, transmission electron microscopy (TEM) and LC/MS/MS analysis.
Furthermore, obtained TEVs were used for the functional analysis on
HUVEC cells. Results: EVs obtained from ccRCC clinical specimens
expressed CD9, CD63 and CD81. To identify the ccRCC-TEVs-specific
cargo, we focused on protein signatures by LC/MS/MS analysis. The
expression signature revealed that several proteins were enriched in
ccRCC-TEVs but not in EVs obtained from adjacent normal kidney
tissue (Normal-TEVs). Moreover, ccRCC-TEVs-specific protein ‘‘protein
X’’ was only detectable in the serum of ccRCC patients and not in the
serum of healthy control. Functional analysis revealed that angiogen-
esis and endothelial permeability were upregulated by ccRCC-TEVs
treatment but not by the Normal-TEVs. Summary/conclusion: In this
study, we successfully obtained EVs directly from the clinical speci-
mens and found that those TEVs have biological activities against
endothelial cells. Moreover, those biological functions were different
between Normal- and ccRCC-TEVs. Taken together, TEVs might be a
powerful tool for researching the in vivo EVs.
PT7.06
Characterization of retinal progenitor cell microvesicle content
Jing Zhou1,2, Jason Mighty1,2, Shima Ghorighi1, Alberto Benito-Martin3,
Hector Peinado Selgas4 and Stephen Redenti1,2
1Lehman College, City University of New York, Bronx, USA; 2Department of
Biological Sciences, City University of New York, Bronx, USA; 3Department
of Pediatrics, Hematology-Oncology Division, Weill Medical College of
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Microvesicles (MVs) are membrane-covered cell fragments released
from the plasma membrane of a range of cell types including central
nervous system microglia, astrocytes and neurons. MVs engulf
cytoplasm through membrane blebbing leading to encapsulation
of unique combinations of microRNA, mRNA and proteins similar
to those present in the cells from which they originate. MVs carry
functional molecules, transfer genetic information between cells and
mediate physiologic and pathologic processes. Here we describe MV
release, content and transfer from mouse retinal progenitor cells
(mRPCs). MV release rate and ultrastructure were described using
SEM and NanoSight analysis. Under standard culture conditions,
mRPCs were shown to release 4800 MVs per cell/48 h, with an
average size of 100 nm. Using immunogold TEM and immuno-
histochemical techniques, we established that mRPC-derived MV
structure incorporated the tetraspanin protein, CD63. Following
genetic content analysis, mRPC-derived MVs were shown to contain
mRNA, miRNA and proteins that reflect the cell’s expression state.
MVs transferred GFP mRNA to non-GFP recipient cells in a transwell
assay. These findings demonstrate that mRPC-derived MVs contain
genetic material with reflective of the expression states of the cells of
origin. Our established release rates and the MV-mediated transfer of
GFP to recipient cells suggest that MV-mediated genetic transfer
may play a role in communication between mRPCs in vitro.
PT7.07
Differential characterization of microvesicles and exosomes from
activated and apoptotic human lymphocytes
Christine Tucher, Hanns-Martin Lorenz, Martin Schiller, Susanne Neu,
Stefan Krienke and Petra Schiller
Department of Internal Medicine V, Division of Rheumatology, University of
Heidelberg, Heidelberg, Germany
Introduction: Extracellular vesicles (EVs), microvesicles (MVs) and
exosomes (Exos) are released from activated and apoptotic lympho-
cytes and may have an influence in the pathogenesis of autoimmune
diseases. MVs are shed from the plasma membrane, while Exos are
released from an intracellular compartment, the multivesicular bodies.
Since MVs and Exos are released either after cellular activation or
apoptosis induction, we wanted to systematically characterize EVs
released after different stimuli. Further, we have been interested in the
interactions between EVs and dendritic cells (DC). Methods: MVs and
Exos from activated and apoptotic human lymphocytes were isolated
by filtration and ultracentrifugation (MV: 10,000g; Exos: 100,000g).
Isolated vesicles were analysed by transmission electron microscopy
(TEM) and NanoSight and were used to stimulate monocyte-derived
DC. EV protein-profile was analysed by western blot analysis and 2D
gel electrophoresis. Results: Western blot analysis presented a distinct
protein expression pattern in activated and apoptotic EV. We found
proteins of the T-cell receptor signalling complex (LAT, LCK) exclu-
sively in MVs. Actin, a cytoskeletal protein, and ERK1 were concen-
trated especially in MVs released from apoptotic cells. From around
8000 2D gel spots, we picked 60 and analysed them by mass spec-
trometry. Some proteins (n30) had a distinct regulation between
activation and apoptosis (e.g. LAP3; DDB1), whereas others were
differentially regulated in MVs when compared to Exos (e.g. YWHAQ;
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HSPD1). Finally, DC-stimulated MV/Exos had higher expression of
CD83, CD80, CD86 and CD274, compared to untreated DC, while
MHCII was significantly less expressed on MV-treated DC. Conclusions:
We observed a distinct protein expression in MVs and Exos with a
differential regulation, depending on distinct stimuli, Implicating
possibly new markers for vesicle identification. Moreover, we show
that MVs and Exos cause a distinct regulation of DC maturation.
PT7.08
Characterization of mycobacterial membrane vesicles
James Dalton, Priscila Dauros Singorenko, Cherie Blenkiron,
Anthony Phillips, Siouxsie Wiles and Simon Swift
University of Auckland, New Zealand
Please see OPW2.8
PT7.09
Diversity of extracellular vesicles addressed by immunoaffinity beads
Stefan Wild, Andreas Bosio, Yvonne Wiencek, Ute Heider and Nina Koliha
Miltenyi Biotec, Bergisch Gladbach, Germany
Introduction: Extracellular vesicles (EVs) are loaded with specific sets of
proteins, lipids and nucleic acids, depending on the originating cell.
EVs can be distinguished by surface marker profiling and markers can
be used to separate EV populations. Methods: Defined blood cell
populations were separated and cultivated. EVs were isolated by
serial centrifugation, filtration and ultracentrifugation. A multiplex
bead assay was used to analyse EV markers: EVs were incubated with
a mix of 39 distinct labelled antibody beads. Beads were discrimi-
nated by flow cytometry and bound EVs were detected by labelled
antibodies. For immunomagnetic isolation, EVs were incubated with
microbeads, separated on a magnetic column, washed and eluted.
Eluted EVs were analysed by western blot or the multiplex assay.
Results: We investigated surface proteins of EVs from NK cells,
platelets and activated B cells. The multiplex analysis showed that
CD9 was low on NK cell EVs and platelet EVs hardly carry CD81. Using
a mixture of NK cell/platelet EVs, we proved that EV populations can
be separated by immunomagnetic microbeads. EVs of activated B
cells comprised also EVs due to contaminating platelets in the B cell
culture. To purify the EVs, we depleted platelet EVs using anti-CD61
microbeads. Low signals for platelet markers (CD41b, CD42a, CD62P)
in the flow through fraction confirmed the depletion of platelet EVs.
As the CD9 signal also disappeared and was recovered in the eluted
CD61 fraction, we conclude that B-cell EVs are CD9. Positive
signals on CD80 and CD86 beads indicate the transfer of activation
markers from B cells to EVs. A subpopulation of CD80 andCD86 EVs
likely derive from cells before activation. In addition, we found a
subpopulation of B-cell EVs that carry high levels of CD20. Summary:
We demonstrate that EVs differ in surface protein composition.
Marker profiles can reveal subpopulations. Cells secreting diverse EVs
might address different target cells or instruct distinct EV tasks.
PT7.10
Fractionation of discrete MDA-MB-231-derived extracellular vesicle
sub-populations reveals distinct protein and RNA profiles
Morayma M. Temoche-Diaz1, Matthew J. Shurtleff1, Ryan Nottingham2,
Jun Yao2, Alan Lambowitz2 and Randy Schekman1,3
1Howard Hughes Medical Institute, Department of Plant and Microbial
Biology, University of California at Berkeley, California USA; 2Institute for
Cellular and Molecular Biology, The University of Texas at Austin, Texas,
USA; 3Department of Molecular and Cellular Biology, University of California
at Berkeley, California, USA
Cells release an array of extracellular vesicles (EVs) consisting of a lipid
bilayer and transmembrane proteins enclosing soluble cellular content
and encompassing a broad size range (30 to 1000 nm). One of the
most common methods to isolate EVs is by differential velocity
ultracentrifugation culminating with a 100,000g spin. Unfortunately,
downstream analyses from vesicles isolated by this method suffer from
the co-isolation of multiple EV subpopulations and protein aggregates.
To resolve this issue, we developed a fractionation method combining
differential velocity centrifugation and buoyant density flotation into a
525% linear iodixanol gradient. Using this method, we separated at
least 2 different EV subpopulations in HEK 293T cells and resolved
vesicles from protein aggregates. The linear gradient showed differ-
ential distribution of soluble (HSC70, Alix, TSG101) and membrane
protein (CD63, CD9, MFGE8 and flotillin-2) EV markers. Immunoisolation
experiments showed different co-purification patterns for EV markers,
confirming our previous observations. We next probed the RNA content
of the distinct vesicle populations. The RNA amount across the gradient
varied by an order of ten. The highest RNA levels were found in the very
dense fractions, likely associated with ribonucleoprotein complexes
rather than vesicles. The EV fractions were enriched in small RNA species,
while the higher density fractions displayed longer RNAs. Interestingly, a
miRNA (miR-223) that is highly enriched in exosomes from HEK 293T
cells was clearly associated with the EV fraction and depleted from
the other fractions. We used the same approach to isolate EV-
subpopulations from MDA-MB-231 cells and are evaluating differences
in their RNA content through RNA seq. In conclusion, purification of
EVs from debris and other vesicle subpopulations can dramatically
influence the downstream protein and RNA analysis and is essential for a
detailed examination of EV cargo and function.
PT7.11
MSC secretes at least three EV types each with a unique permutation of
membrane lipid, protein and RNA
Ronne Yeo2, Soon Sim Tan2, Reunn Chai Lai2, Agnes Reiner1,
Kok Hian Tan3 and Sai Kiang Lim2,4
1Bio Sensor Technologies, Ait-Austrian Institute of Technology Gmbh,
Seibersdorf, Austria; 2A*STAR Institute of Medical Biology, Singapore;
3KK Women’s and Children’s Hospital, Singapore; 4Department of Surgery, YLL
School of Medicine, NUS, Singapore
Mesenchymal stem cell (MSC), a widely used adult stem cell candi-
date for regenerative medicine, has been shown to exert some of its
therapeutic effects through the secretion of extracellular vesicles
(EVs). These homogenously sized EVs of 100150 nm exhibited many
exosome-like biophysical and biochemical properties and carry both
proteins and RNAs. Recently, exosome-associated proteins in this
MSC EV preparation were found to segregate primarily to those EVs
that bind cholera toxin B chain (CTB), a GM1 ganglioside-specific
ligand, and pulse-chase experiments demonstrated that these EVs
have endosomal origin and carried many of the exosome-associated
markers. Here we report that only a fraction of the MSC EV proteome
was found in CTB-bound EVs. Using annexin V (AV) and Shiga toxin
B subunit (ST) with affinities for phosphatidylserine and globo-
triaosylceramide, respectively, an AV- and an ST-binding EV were
identified. CTB-, AV- and ST-binding EVs all carried actin. However,
the AV-binding EVs carry low or no detectable levels of the exosome-
associated proteins. Only the ST-binding EVs carry RNA and EDA-
containing fibronectin. Proteins in AV-binding EVs are also different
from those released by apoptotic MSCs. CTB- and AV-binding
activities are localized to the plasma membrane and cytoplasm of
MSCs, while ST-binding activity is localized to the nucleus. Together,
this study demonstrates that cells secrete many types of EVs,
specifically MSCs secrete at least 3 types. They can be differentially
isolated based on their affinities for membrane lipid-binding ligands.
As the subcellular sites of the binding activities of these ligands and
cargo load were different for each EV type, they are likely to have a
different biogenesis pathway and possibly different functions.
PT7.12
Presence of DNA in subsets of exosome-like extracellular vesicles
Elisa Lazaro-Iban˜ez1,2, Rossella Crescitelli1, Anaı´s Garcı´a1, Ganesh Shelke1,
Pia Siljander2, Cecilia La¨sser1 and Jan Lo¨tvall1
1Krefting Research Centre, Institute of Medicine, The Sahlgrenska Academy,
University of Gothenburg, Gothenburg, Sweden; 2Division of Pharmaceutical
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Helsinki, Helsinki, Finland
Introduction: The RNA cargo of extracellular vesicles (EVs) is relatively
well investigated, but less is known about the presence of DNA in EVs.
Currently, it has been confirmed that EVs carry mitochondrial DNA,
single-stranded and double-stranded DNA, as well as oncogene
amplifications within their cargo. The DNA content associated with
EVs has a great potential to be used as a biomarker for several diseases,
but needs to be better characterized among vesicle subsets. The aim of
this study was to determine the DNA content of different exosome-like
EV subsets to achieve a better understanding of their nucleic acid
content. Methods: EVs were isolated from human HMC1 mast cells and
erythroleukaemic TF1 cells by differential centrifugation at 120,000 x g
for 2.5 h, after removal of debris and larger vesicles. The vesicles were
further separated by iodixanol density gradient, resulting in two main
subsets: low-density EVs and high-density EVs. Both subpopulations
were characterized with western blot and particle concentration with
ZetaView analyser. Isolation of DNA and RNA was performed using
QIAamp DNA and miRCURY RNA kits, respectively, and the nucleic acid
profiles were analysed with Bioanalyzer. Furthermore, the association of
the DNA in or outside the EVs was evaluated using DNAse I treatment
comparing DNA concentrations and profiles of treated/untreated
vesicles. Results: Low-density EVs contained low quantities of DNA
and exhibited RNA profiles with 18S and 28S ribosomal RNA peaks. In
comparison, high-density EVs contained greater quantities of DNA, and
the RNA profiles consisted mainly in small RNAs without ribosomal RNA
peaks. Most of the DNA protected from DNase degradation, suggesting
it was intravesicular. Summary/conclusion: The DNA content varies in
different subsets of exosome-like EVs. Further characterization of the
EV-DNA cargo can help to clarify its physiological significance, as well as
its possible utilization in biomarker discovery studies.
PT7.13
Transcriptome of different types of human blood circulating
complexes
Anna Savelyeva1, Elena Kuligina1, Vladimir Richter1, Vadim Kozlov2,
Elena Chikova3 and Dmitry Semenov1
1Institute of Chemical Biology and Fundamental Medicine, Novosibirsk, Russia;
2Novosibirsk Regional Oncology Center, Novosibirsk, Russia; 3Center of New
Medical Technologies, Novosibirsk, Russia
RNAs of extracellular circulating complexes  exosomes, microve-
sicles and ribonucleoproteins  are an important component, which
mediates functions of circulating complexes after their internaliza-
tion by recipient cells. Each type of circulating complexes is seemed
to be enriched with the specific array of RNA species different from
the RNA content of donor cells. In order to characterize transcrip-
tome of human blood plasma microvesicles, exosomes and extra-
cellular ribonucleoproteins, we processed blood of healthy donors,
patients with squamous cell lung cancer or lung adenocarcinoma
by sequential centrifugation steps at 1200g, 16,000g and 160,000g
and used each pellet and final supernatant for RNA extraction
and sequencing with high-throughput SOLiD 5500xl platform. On
average, 14 millions of reads per cDNA library were obtained. High-
throughput RNA sequencing data were analysed using Bowtie/
Cufflinks pipeline via step-by-step mapping to mitochondrial tran-
scripts, transcribed human repeats, human RefSeq RNAs and human
genome reference sequences. Differential expression analysis
showed that main distinctive feature of 160,000g pellet transcrip-
tome in comparison with other examined blood plasma subfractions
and blood cells is an enrichment with fragments of mRNAs (such as
KRTAP10-5, TSHB, IK, PMP22, HOXB8, OR9Q2, UCHL3) and non-
coding RNAs (RNU11, set of microRNAs). The RNA content of blood
plasma 16,000g pellets was enriched with microRNAs, snoRNAs and
vault RNA. We suppose that explored differences related to
biogenesis of human blood extracellular circulating complexes, and
thus, this study will promote to a better understanding of their
underlying biological functions.
The work was supported by the RFBR 16-04-01457.
PT7.14
Comparative transcriptomic analysis of human and Drosophila
extracellular vesicles reveals extensive conservation
Fabio Alexis Lefebvre, Louis Philip Benoit Bouvrette, Lilyanne Perras and
E´ric Le´cuyer
RNA Biology, IRCM (Institut de Recherches Cliniques de Montreal), Montreal,
Canada
Extracellular vesicles (EVs) are membrane-enclosed nanoparticles
containing specific repertoires of genetic material. In mammals, EVs
can mediate the horizontal transfer of various cargos and signalling
molecules, notably miRNA and mRNA species. Whether this form of
intercellular communication prevails in other metazoans remains
unclear. Here, we report the first parallel comparative morphologic
and transcriptomic characterization of EVs from Drosophila and
human cellular models. Electronic microscopy revealed that human
and Drosophila cells release similar exosome-like EVs with diameters
ranging from 30 to 200 nm, which contain complex populations of
transcripts. RNA-seq identified abundant ribosomal RNA pseudo-
genes and retrotransposons in human and Drosophila EVs. Vault
RNAs and Y RNAs abounded in human samples, whereas small
nucleolar RNAs involved in pseudouridylation were most prevalent
in Drosophila EVs. Numerous mRNAs were identified, largely con-
sisting of exonic sequences displaying full-length read coverage and
enriched for translation and electronic transport chain functions. By
analogy with human systems, these extensive similarities suggest
that EVs could potentially enable RNA-mediated intercellular com-
munication in Drosophila.
PT7.15
Membrane proteomics of extracellular vesicles
Su Chul Jang1,2 and Jan Lo¨tvall2
1Department of Life Sciences, Pohang University of Science and Technology,
Pohang, Republic of Korea; 2Krefting Research Centre, Department of Internal
Medicine and Clinical Nutrition, University of Gothenburg, Gothenburg,
Sweden
Introduction: Plasma membrane proteins play diverse roles in
intercellular communication by accepting or releasing signalling.
Extracellular vesicles (EVs) are intercellular communicators, which
contain multiple plasma membrane proteins and bioactive surface
molecules. Identification of those highly bioactive surface molecules
is important to understand the role of EVs in intercellular commu-
nication. However, it is difficult to identify these molecules by
standard LC-MS/MS, because of their low abundance. Here, we
present a method for identifying low abundant membrane proteins
on EVs. Methods: EVs were isolated from the human mast cell line
HMC-1 by differential centrifugation and density gradient. Then, EVs
were treated with high pH solution to open the membrane and to
eliminate cytosolic proteins. Non-treated and high pH treated EVs
were subjected to LC-MS/MS. Relative protein abundance was
obtained by label free quantification. Results: In total, 1658 and
1492 proteins were identified from non-treated and high pH treated
EVs, respectively. The relative abundance of cytosolic proteins was
greatly reduced after high pH treatment. By contrast, low abundant
receptors (e.g. VEGFR1 and IL9R) and growth factors were identified
after high pH treatment. Conclusions: Our results show that high pH
treatment increases the identification of bioactive, but low abun-
dant, surface molecules by LC-MS/MS. This study can contribute to
EV research fields by providing a new method for identifying surface
molecules of EVs.
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Surface markers profiling of prostate cancer exosomes
Elena Khomyakova1, Elena Sharova2, Dmitry Bagrov3, Elena Kostryukova2,
Maxim Peshkov2, Eduard Generozov1 and Vadim Govorun4
1Laboratory of molecular and human genetics, Federal Research and Clinical
Center of Physical Chemical Medicine, Moscow, Russia; 2Laboratory of post-
genomic research, Federal Research and Clinical Center of Physical Chemical
Medicine, Moscow, Russia; 3Department of bioengineering, Faculty of Biology,
Lomonosov Moscow State University, Moscow, Russia; 4Laboratory of
proteomics, head of Federal Research and Clinical Center of Physical Chemical
Medicine, Moscow, Russia
Introduction: Prostate cancer is one of the most common types of
cancer in men. The markers capable to better distinguish cancerous
from benign conditions and slow-growing cancers from aggressive
ones are required. This study is aimed to analysis of expression of
CD9, CD81, CD147, CD117 CD29 and EGF markers on the exosomes
isolated from the urine of patients with hystologically confirmed
prostate cancer and age matched patients without cancer. Materials &
Methods: Urine samples from men with or without PC were collected
after digital rectal exam (DRE). Urine exosomes were isolated either by
differential centrifugation or using Exosome Precipitation solution
(Machery-Nagel). The purity of exosome population was analysed
using TEM. Pre-purified exosomes (5 ml of urine per sample) were
incubatred with CD9 exosomes dynabeadsd for 36 hrs at 4 C followed
by antibody staining and flow analysis. Results & Discussion: In the test
experiments exosomes from four urine samples were purified by
differential centrifugation and with Exosome Precipitation solution.
In our hands the higest CD81 fluorescence signal was observed
for exosomes purified by differential centrifugation. This method
was further used for exosomes purification. Our Initial data showed
essential difference between the patients in expression of CD9/CD81
markers and markers associated with PC progression. A further larger-
scale study is required to confirm our observations. This work was
supported by Ministry of Education and Science of the Russian
Federation (grant No. 14.607.21.0068, Sep 23, 2014).
PT8.02
Detection and characterization of extracellular vesicles in pancreatic
juice and blood of patients with pancreatic cancer
Xabier Osteikoetxea1, Ka´roly Ve´key2, A´kos Szucs1, Lilla Turia´k2,
Ma´rton Benke1, La´szlo´ Harsa´nyi1, Krisztina V. Vukman3, Krisztina Pa´lo´czi1,
Katalin Szabo´-Taylor1, Barbara So´dar1, A´gnes Kittel1, E´va Pa´llinger1,
Andrea Ne´meth1, Marta Rodrı´guez1 and Edit Buzas1
1Semmelweis University, Budapest, Hungary; 2Hungarian Academy of Sciences,
Budapest, Hungary; 3Semmelweis University Department of Genetics, Cell- and
Immunobiology, Budapest, Hungary
Introduction: In recent past, the prognosis of patients with pancreatic
adenocarcinoma has remained virtually unchanged with a 95%
mortality rate over 5 years. An earlier detection would provide a time
window of opportunity for treatment and prevention of deaths. In
recent past, many reports have been published on the potential of
extracellular vesicles (EVs) to carry biomarkers for different diseases
including pancreatic cancer. In the present study we attempted to
extend the list of EV biomarkers for pancreatic cancer by directly
assessing EVs secreted into the pancreatic juice of patients. Methods:
We obtained pancreatic juice by intraoperative puncture and blood
from 36 patients, 13 with pancreatic head tumor, 12 with Vater
ampulla tumor, and 11 with chronic pancreatitis. These EVs were
characterized by flow cytometry using fluorochrome conjugated anti-
CD9, -CD63, as well as Annexin V followed by lysis with Triton X-100.
The EV concentration and size distribution was measured using
tunable resistive pulse sensing (qNano, Izon Science). Morphology of
EVs was assessed by transmission electron microscopy. Protein com-
position of EVs was analyzed by mass spectrometry (MS). Results: Here
we show for the first time the presence of EVs directly in human
pancreatic juice samples. These EVs could be isolated for MS
characterization of their cargo and were surprisingly stable despite
their presence within a lipase and protease rich body fluid. The mean
EV size in pancreatic juice was 149.93935.37nm (n = 18) and did not
differ between disease groups. Transmission electron microscopy
showed typical EV morphology. Importantly, we found that certain
pancreatic juice and blood EV proteins distinguished patients with
pancreatic carcinoma from those with chronic pancreas inflammation.
Conclusions: These data suggest that detection of EVs directly in
pancreatic juice may provide new hints regarding pancreatic cancer
biomarkers.
PT8.03
Breast cancer cell-derived exosome secretion is regulated by
intracellular calcium concentration
Ye-Rin Ko1, Moon-Chang Baek2 and Eun Ju Im2
1Department of Molecular Medicine, School of Medicine, Kyungpook National
University, Daegu, Republic of Korea; 2School of Medicine, Kyungpook National
University, Daegu, Republic of Korea
Introduction: In exosome biogenesis, many factors are related to
exosome secretion pathway such as ESCRT, ceramide, Rab-GTPase
proteins, calcium and so on. It has been reported that intracellular
calcium concentration is the one of the important factors to regulate
exosome secretion in K562 cell. Here, we show that breast cancer
cell-derived exosomes are regulated by intracellular calcium con-
centration. Methods: To understand the effect of intracellular calcium
on exosome secretion in breast cancer cell lines, we used chemical A
that regulates intracellular calcium concentration. After treatment of
chemical A to breast cancer cell lines, secreted exosomes were
collected and concentration of secreted exosomes were measured
by NTA system. To confirm the effect of chemical A on exosome
secretion, we measured the intracellular calcium concentration and
performed RT-PCR and western blot to check the Rab11 RNA and
protein expression. Results: Our results indicate that breast cancer
cell-derived exosome secretion is inhibited by chemical A. The effect
of chemical A on exosome release is caused via a decrease of
intracellular calcium concentrations. Rab11 protein and RNA expres-
sion levels are decreased by treatment of chemical A to breast cancer
cell lines in calcium-dependent manner. Summary/Conclusion: Taken
together, exosome secretion is regulated by intracellular calcium
concentration in breast cancer cell lines. Decrease of intracellular
calcium concentrations influence exosome secretion. Chemical A
might act as exosome secretion inhibitor by regulating intracellular
calcium concentration and Rab11 expression.
PT8.04
Tumor-education of platelets by pre-mRNA splicing and alternative
RNA processing enables blood-based detection of cancer
Myron Best1,2, Sjors in ’t Veld1, Nik Sol3 and Thomas Wu¨rdinger1
1Department of Neurosurgery, VU University medical center, Amsterdam,
The Netherlands; 2Department of Pathology, VU University medical center,
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medical center, Amsterdam, The Netherlands
Introduction: Tumor-educated platelets (TEPs) are a new blood-based
biosource for the detection of cancer. TEPs respond to local and
systemic stimuli during tumor progression by altering their RNA
profile. Platelets are anucleated, but contain an RNA processing and
translation machinery and a functional spliceosome. Methods: Blood
platelet samples of 283 patients with cancer covering six tumor types
(60 non-small cell lung cancer, 41 colorectal cancer, 39 glioblastoma,
35 pancreatic cancer, 14 hepatobiliary cancer, and 39 breast cancer)
and of 55 healthy donors were isolated from whole blood by
differential centrifugation. Total platelet RNA was isolated, subjected
to SMARTer mRNA amplification and subjected to mRNA sequencing
on the HiSeq 2500 platform. RNA-seq data was mapped to the human
reference genome, and subjected to MISO, Samtools- and R-based
bioinformatic algorithms. Results: The 283 platelet samples were
successfully sequenced (Best et al. Cancer Cell 2015), and the RNA-seq
read coverage analysis demonstrated an increased abundance of
spliced RNAs in patients with cancer (n = 228) compared to healthy
controls (n = 55). Deduction of RNA isoforms enabled generation of
isoform-based TEP signatures for cancer classification. Finally, several
alternative RNA processing events, such as exon skipping and intron
retention, were identified in TEP RNA. Conclusion: Molecular inter-
rogation of TEP-based liquid biopsies allows for cancer detection. The
TEP RNA signatures are characterized by alternative RNA splicing
events, indicating complex regulation of the RNAs in TEPs. Additional
biological insight into the altered RNA signatures is necessary for
understanding the mechanism of platelet-education and further
optimization of TEP-based diagnostics.
PT8.05
Metabolomic profiling of breast cancer-derived extracellular vesicles
Hiroko Tadokoro1, Ryuhei Kudo2, Akiyochi Hirayama2, Yusuke Yoshioka1,
Masahiro Sugimoto2 and Takahiro Ochiya1
1Division of Molecular and Cellular Medicine, National Cancer Center Research
Institute, Tokyo, Japan; 2Institute of Advanced Biosciences Keio University,
Yamagata, Japan
Introduction: Cancer cells secrete a lot of extracellular vesicles (EVs),
and these cancer cell-derived EVs are known to mediate cell-cell
communication in order to modulate cancer microenvironment. EVs
contain various molecular constituents such as proteins, mRNAs, and
micro RNA (miRNAs) to act on around cell. On the one hand, the
metabolisms of cancer cells are different from normal cells, and these
the cancer metabolites were reported of suppress immune response.
However, the existence of metabolites in EVs and their functions
remain largely unknown. Therefore, this study aimed to perform a
metabolomic analysis of breast cancer cells and breast cancer cell-
derived EVs. Methods: Metabolomic analysis of cell and EVs were
performed on two breast cancer cell lines, MDA-MB-231-D3H1
(D3H1) and MDA-MB-231-D3H2LN (D3H2LN). D3H1 is low-metastatic
cell line and D3H2LN is high-metastatic cell line. EVs were purified
from cell supernatant by ultracentrifugation. EV samples were then
washed with 5% mannitol for metabolomics analysis. Next, ethanol
solution or methanol containing internal standard was added to the
sample. The metabolomic analysis were performed by LC-TOFMS
and CE-TOFMS. Results: Based on the analysis by LC-TOFMS, we
found that cells contain the 149 metabolites (Positive ionization
mode (Pos): 117, Negative ionization mode (Neg): 32) and EVs
contain the 99 metabolites (Pos: 76, Neg: 23). The 46 metabolites
(Pos: 39, Neg: 7) were detected to be a higher amount in D3H2LN
cell-drived EVs than D3H1 cell-derived EVs, and the 15 metabolites
(Pos: 12, Neg: 3) were significantly a higher amount in D3H2LN cells.
Summary/Conclusion: The breast cancer cell-derived EVs contain a lot
of metabolites, and some metabolites are characteristic in D3H2LN
cell-derived EVs which compared with D3H1-derived EVs.
Disclosure of interest: None Declared.
PT8.06
EXO-DNA applications: a novel EV-based method for detection of
actionable mutations from the blood of cancer patients
Paolo Guazzi1, Davide Zocco2, Elisa Lari2, Elena Brini3, Anna Moles3,
Armando Felsani3, Mauro Novelli4, Chiara Foroni5, Natasa Zarovni2 and
Antonio Chiesi2
1HansaBioMed LLC, Tallinn, Estonia; 2Exosomics Siena SpA, Siena, Italy;
3Genomnia srl, Milan, Italy; 4Medical Science, University of Turin, Turin, Italy;
5Medical Oncology, AIL Research Lab, Hospital of Brescia, Brescia, Italy
Introduction: Circulating DNA is emerging as a novel non-invasive
tool for patient’s stratification and disease monitoring. While most
of the research has focused on circulating cell-free (cfDNA) or
circulating-tumor-cell-(CTC)-derived DNA, extracellular vesicle-(EVs)-
associated DNA (EV-DNA) is emerging as a third valuable ‘‘liquid
biopsy’’ platform. We developed a novel protocol, using EXO-DNA
kit, for the isolation of cfDNA and EV-DNA from blood and
subsequent detection of actionable mutations by PCR and next-
generation-sequencing (NGS). We assessed BRAF WT and BRAFV600E
levels in patients with metastatic melanoma and compared our
protocol with the current gold-standard kit for circulating nucleic
acids extraction. Methods: Immuno-affinity and chemical precipita-
tion were evaluated for enrichment of tumor-derived EVs from
healthy donor samples spiked-in with melanoma-cell-derived EVs
and ‘‘real’’ melanoma samples. DNA was extracted with EXO-DNA kit
(HansaBioMed) and amplified by allele-specific-locked-nucleic-acid-
(LNA)-qPCR. DNAse protection assay and electropherogram analysis
were performed to assess the source and integrity of the isolated
DNA. Advantages over benchmark methods (Qiagen kit for circulat-
ing nucleic acids) were also assessed by digital PCR and NGS. Results:
Affinity isolation method yielded the highest BRAFV600E copy
number/ml and BRAFV600E/BRAFWT ratio, suggesting a significant
enrichment of tumor-derived DNA versus background circulating
DNA. LNA-PCR detected BRAFV600E in the serum of 6 out of 7
patients previously stratified as BRAFV600E-positive from tissue
biopsy. Only 1020% of DNA was found to be protected from
DNAse digestion but its quality was sufficient for amplification. The
enrichment of actionable mutations over a generic kit was confirmed
by digital PCR and NGS analyses. Conclusions: The novel EXO-DNA
protocol enriches for cfDNA and a significant fraction of EV-DNA
conferring a competitive advantage to ‘‘liquid biopsy’’ applications.
PT8.07
Energy-requiring uptake of prostasomes and PC3 cell-derived
exosomes into non-malignant and malignant cells
Theocharis Panaretakis, K. G. Ronquist, C. Shanchez, L. Dubois,
D. Chioureas, P. Fonseca, A. Larsson, A. Ulle´n, J. Yachnin and G. Ronquist
Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden
Epithelial cells lining the prostate acini release, in a regulated manner
(exocytosis), nanosized vesicles called prostasomes that belong to
the exosome family. Prostate cancer cells have preserved this ability
to generate and export exosomes to the extracellular space. We
previously demonstrated that human prostasomes have an ATP-
forming capacity. In this study, we compared the capacity of
extracellular vesicles (EVs) to generate ATP between normal seminal
prostasomes and exosomes secreted by PC3 cells (PC3 exosomes), a
prostate cancer cell line. Proteomic analyses identified enzymes of
the glycolytic chain in both prostasomes and PC3 exosomes, and we
found that both of them were capable of generating ATP when
supplied with substrates. Notably, the net production of extracellular
ATP was low for prostasomes due to a high ATPase activity contrary
to an elevated net ATP level for PC3 exosomes because of their low
ATPase activity. The uptake of the 2 types of EVs by normal prostate
epithelial cells (CRL2221) and prostate cancer cells (PC3) was
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visualized and measured, demonstrating differential kinetics. Inter-
estingly, this uptake was dependent upon an ongoing glycolytic flux
involving extracellular ATP formation by EVs and/or intracellular ATP
produced from the recipient cells. We conclude that the internaliza-
tion of EVs into recipient cells is an energy-requiring process also
demanding an active V-ATPase and the capacity of EVs to generate
extracellular ATP may play a role in this process.
PT8.08
Exosomes and microparticles: extracellular vesicles with functionally
different roles in colorectal cancer progression
Rahul Bhome1, Rebecca Goh2, Hajir Al Saihati3, Emre Sayan3 and
Alex Mirnezami3
1University of Southampton, Southampton, UK; 2Southampton Medical School,
Southampton, UK; 3Somers Cancer Research Building, Southampton, UK
Introduction: Activated stroma promotes tumour progression. Fibro-
blasts are the most populous stromal cell. Paracrine signalling
between fibroblasts and cancer cells occurs in part through shuttling
of extracellular vesicles (EVs). We aimed to investigate the effect of
fibroblast EVs on colorectal cancer cells and vice versa. We consider
exosomes as sub-100 nm vesicles with a specific structural signature
and microparticles (MPs) as all EVs larger than this. Methods: MPs and
exosomes were isolated from DLD-1 colorectal cancer cells and MRC5
fibroblasts by selective centrifugation, labelled with a lipophilic dye
and validated by transmission electron microscopy, flow cytometry
and western blotting. 4 mg of MPs or exosomes (by protein) were
reciprocally co-cultured with 1106 DLD-1 or MRC5 cells for 24 h.
Uptake of EVs was confirmed by fluorescence microscopy. Protein
expression was analysed by western blotting, proliferation by cell
counting and chemoresistance by mitochondrial depolarisation (after
24 h 300 mM oxaliplatin treatment). Results: Cancer exosomes
induced phosphorylation of AKT and its downstream target Bad in
fibroblasts, corresponding with increased resistance to oxaliplatin;
there was no effect on ERK activity. Cancer MPs had no effect on ERK
or AKT signalling in fibroblasts. In contrast, fibroblast exosomes
strongly induced ERK phosphorylation in cancer cells, corresponding
with increased proliferation on days 14; AKT/Bad signalling was
concomitantly induced with associated oxaliplatin resistance. Inter-
estingly, fibroblast MPs did induce AKT signalling in cancer cells
without Bad activation or chemoresistance and had no effect on ERK
activity. Conclusion: Exosomes are reciprocally shuttled between
fibroblasts and cancer cells in the tumour microenvironment (TME),
making both more resistant to chemotherapy. Fibroblast exosomes
increase proliferation of cancer cells, another hallmark of cancer.
Exosomes and MPs have distinct cellular and functional effects.
PT8.09
‘‘Artificial neoepitope’’- bearing exosomes derived from tumor cells
being genetically modified to express Mycobacterium tuberculosis
antigen: a novel vaccine for cancer therapy
Yoshiyuki Koyama1, Tomoko Ito1, Aya Hasegawa2, Masazumi Eriguchi1,
Kikuya Sugiura2 and Toshio Inaba2
1Japan Anti-tuberculosis Association Shin-Yamanote Hospital, Tokyo, Japan;
2Osaka PrefectureUniversity, Osaka, Japan
Introduction: Tumor-derived exosomes can be regarded as miniatures
of the originating tumor cells containing same antigens, and were
expected as cancer vaccines. However, treatment with those
exosomes often failed to elicit efficient antitumour T-cell responses
in in vivo experiments or clinical studies. Moreover, recent evidences
suggest that tumor-derived exosomes possess rather immunosup-
pressive properties, and facilitate immune evasion of the tumor cells.
To overcome these problems, we prepared the exosomes bearing
highly immunogenic bacterial epitopes as ‘‘artificial neoepitopes’’ by
gene transfection of the parent tumor cells. Ability of these exosomes
to evoke the cellular immunity against tumor cells, and their potential
as a cancer vaccine was examined. Methods: B16 melanoma cells were
transfected with a plasmid encoding the Mycobacterium tuberculosis
antigen, early secretory antigenic target-6 (ESAT-6), and the secreted
exosomes were isolated. They were injected into mice to examine
their ability to evoke the cellular immunity against ESAT-6, and to the
tumor cells. Antitumor therapeutic efficacy of the ‘‘artificial neoepi-
tope’’-bearing exosomes was also explored in mice with B16 tumors.
Results: Exosomes bearing ESAT-6 epitopes effectively evoked high
cellular immunity against both ESAT-6, and B16 tumor cells.
Intratumoral injection of the exosomes demonstrated significant
tumor growth suppression in mice with syngeneic tumor transplants,
while those derived from the non-transfected B16 cells showed no
effect on the tumor growth. Conclusions: The tumor-derived exo-
somes bearing Mycobacterium tuberculosis antigen epitopes as
‘‘artificial neoepitopes’’ were shown to have a high potential as a
candidate for cancer vaccine to overcome the low immunogenicity of
the tumor cells.Acknowledgments: This work was supported by JSPS
KAKENHI Grant Number 25350555, and The Cosmetology Research
Foundation.
PT8.10
Extracellular vesicles are involved in MAPC† promotion of
oligodendrocyte differentiation in vitro
Cutrone Rochelle1, Sarah Busch1, Bradley Lang1, Nicholas Lehman1,
Robert Miller2 and Robert Mays (Athersys)1
1Athersys, Cleveland, USA; 2George Washington University, Washington DC,
USA
Multiple sclerosis (MS) is a chronic inflammatory demyelinating
disease of the central nervous system. While the exact cause of MS
is unknown, considerable research has targeted a hyperactive
immune system as a mediator of disease progression. Infiltration by
a heterogeneous population of immune cells including T cells, B cells
and macrophages, along with increased levels of pro inflammatory
cytokines and chemokines contribute to disease progression. Current
standard of care focuses on diminishing the inflammatory response
as opposed to promoting remyelination to improve quality of life.
Multipotent adult progenitor cells (MAPC) are a well characterized
population of bone marrow-derived cells that exhibit immunomo-
dulatory effects in central nervous system injury models such
traumatic brain injury, stroke and spinal cord injury. Further, MAPC
cell therapy has been previously shown to reduce deficits in mouse
models of EAE. However, whether MAPC cells promote recovery by
decreasing inflammation, promoting repair, or both is unknown.
Here, we show that MAPC cells and MAPC cell-secreted factors
promote the differentiation of oligodendrocytes from C57BL/6
mouse postnatal neural stem cells in vitro. We observed a significant
increase in the number of MBP and O1 positive oligodendrocytes in
the presence of MAPC cells or MAPC cell-conditioned media when
compared to control. Depletion of extracellular vesicles from MAPC
cell-conditioned media diminished the increase of MBP and O1
positive cells. Our results suggest that MAPC cell-secreted soluble
factor(s) and/or extracellular vesicles are capable of driving oligoden-
drocyte differentiation. We are currently investigating the role of
MAPC cell therapy in the regulation of human oligodendrocyte
maturation.
PT8.11
Dendritic cell exosomes are rich in chemotactic mediators and recruit
mesenchymal stem/stromal cells
Andreia Silva1,2, Maria Ines Almeida1, Jose´ Teixeira1,2, George A. Calin3,
Ma´rio Barbosa1,2 and Susana Santos1
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1INEB-Instituto de Engenharia Biome´dica, Instituto de Investigac¸a˜o e Inovac¸a˜o
em Sau´de, Porto, Portugal; 2Instituto de Cieˆncias Biome´dicas Abel Salazar,
Porto, Portugal; 3The University of Texas MD Anderson Cancer Center,
Houston, TX, USA
Introduction: Orchestration of cell-cell communication is crucial for
tissue repair, and reported to be influenced by Extracellular Vesicles
(EV), namely exosomes. Immune cells, including dendritic cells (DC),
are present at initial stages of tissue repair, secrete many mediators
and high amounts of EV. Mesenchymal stem/stromal cells (MSC)
migrate to injury locations and contribute to repair. Thus, herein we
investigate the content and functional impact of EV secreted by
human DC on human MSC. Methods: Primary human bone marrow
MSC and monocyte-derived DC were used. EV were isolated from DC
cultures (DC-EV) by differential centrifugation (final ultracentrifuga-
tion 100000g), and characterized by standard techniques. Content
of DC-EV was evaluated using an antibody array, combined with
Western Blot, imaging flow cytometry and gelatin zymography. EV
effect on MSC was tested by transwell cell migration assay, Ki67
immunostainning and gene expression. Results: DC-EV were highly
enriched in exosomes, and contained several chemotactic factors,
such MCP-1 and osteonpontin. MMP9 was also enriched inside EV.
DC-EV were internalized by MSC, and were able to recruit MSC in a
dose-dependent manner. On the other hand, DC-EV decreased the
number of proliferating cells and did not impact significantly MSC
differentiation. Conclusion: Taken together our results show that DC-
EV are packed with chemoattractants and able to recruit MSC,
suggesting a functional role for these vesicles in linking inflammation
and tissue repair.Acknowledgments: We thank Centro Hospitalar
S.Joa˜o (Porto, Portugal) for sample donation. Work funded by FEDER,
through COMPETE 2020-Operacional Programme for Competitive-
ness and Internationalisation (POCI), Portugal 2020; and Portuguese
funds via FCT/Ministe´rio da Cieˆncia, Tecnologia e Inovac¸a˜o, Project
‘‘Institute for Research and Innovation in Health Sciences’’-POCI-01-
0145-FEDER-007274, and fellowships SFRH/BD/85968/2012; SFRH/
BPD/91011/2012; SFRH/BD/112832/2015.
PT8.12
Female patients with suspected adverse effects of vaccination against
human papilloma virus, have a different composition of extracellular
vesicles in plasma compared with a healthy female control group
Kim Varming1, Rikke Baek1, Malene Moeller Joergensen2, Louise Brinth3
and Jesper Mehlse3
1Aalborg University Hospital, Aalborg, Denmark; 2Department of Immunology,
Aalborg University Hospital, Aalborg, Denmark; 3Frederiksberg Hospital,
Frederiksberg, Denmark
Introduction: In Denmark around 2000 patients with suspected
adverse effects of vaccination against human papilloma virus have
been referred to 5 hospital centers. In one center 177 patients have
been investigated for possible biomarkers. Most of these patients
were diagnosed with the chronic fatigue syndrome, a syndrome
which most clinicians perceive as a functional disease. The aim of this
study is to explore the potential of using surface proteins from
extracellular vesicles as biomarkers for this illness. Methods: Plasma
from 177 female patients and 96 healthy female controls were
subjected to analysis by the extracellular vesicle array (EV Array)
(Joergensen et al., 2013, JEV). The array was composed of 29
capturing antibodies targeting well-known EV-associated proteins.
The binding of EVs was visualized and recorded using a cocktail of
biotin conjugated CD9, CD63 and CD81 antibodies combined with
fluorescently-labeled streptavidin. Results: The protein profiles of the
plasma EV?s were analyzed in a multivariate manner with a random
forests prediction model. The best obtained model using all 29
markers, resulted in a sensitivity of 0.72 and a specificity of 0.65 (AUC:
0.70). Conclusion: Female patients with suspected adverse effects of
vaccination against human papilloma virus, have a different compo-
sition of extracellular vesicles in plasma compared with a healthy
female control group, which indicate that we are facing a biological
state instead of functional disease.
PT8.13
Canine Wharton’s Jelly mesenchymal stem cell suppression of T helper
cell division is mediated by exosomes
Sarah Crain, Kristen E. Thane, Airiel M. Davis and Andrew M. Hoffman
Veterinary Clinical Sciences, Cummings School of Veterinary Medicine at Tufts
Univeristy, North Grafton, Massachusetts, USA
Introduction: Mesenchymal stem cells (MSC) are known to suppress
activation and proliferation of T helper (TH) cells, but the specific
contribution of extracellular vesicles (EV) remains unclear. Knowl-
edge of signaling roles for EV may lead to novel EV-based therapies
for chronic inflammatory diseases. We hypothesized that MSC EV
suppress TH cell division. Methods: EV blockade was tested by
incubating canine Wharton’s Jelly MSC (WJ-MSC; CD44+ CD90+
CD34- CD45- MHCII-) with GW4869 (2.510 uM) for 48 hr and EV
output assessed using nanoparticle tracking analysis (NTA; NS300,
NanoSight NTA3.0 software). For lymphocyte suppression assays, WJ-
MSC cell lines (n = 5) were exposed to 6 uM GW4869 or vehicle.
Peripheral blood mononuclear cells from healthy beagle donors
(n = 2) were stained with CFSE and co-cultured (10:1) with WJ-MSC
across transwell membranes (0.4 um pore size) for 72 hours. Analysis
of CFSE fluorescence using FlowJo yielded percent CD4+ divided and
mean number of cell divisions in dividing CD4+ cells. Results: EV from
WJ-MSC conditioned medium were mainly (87.2%) in the exosome
size range (30200 nm) based on NTA. Concentrations of 2.5, 5, and
10 uM GW4859 reduced exosome counts by 36%, 55%, and 73%,
respectively. The percentage of CD4+ T cells that divided in response
to ConA alone, ConA + WJ-MSC, or ConA + WJ-MSC + GW4869 (6 uM)
was 74.4 + 10.6%, 52.5 + 12.4% (PB0.01 vs ConA), and 64.8 + 10.7%
(PB0.01 vs. ConA + WJ-MSC), respectively. Therefore exosomes
contributed to 56% of the effect of WJ-MSC to reduce the
percentage of dividing CD4+ cells. No significant effect was noted
on the number of cell divisions in dividing CD4+ cells (P = 0.14).
Summary/Conclusions: These data support a significant role for
exosomes to alter CD4+ cell kinetics in response to ConA, specifically
to suppress entry into the cell cycle. Further exploration is needed to
identify the specific contents of exosomes (e.g. miRNA, proteins) and
exosome-CD4+ T cell interactions responsible for this effect.
PT8.14
Extracellular vesicle miRNA 371-5p is a biomarker candidate in isolated
hepatic perfusion from patients with metastatic uveal melanoma
Rossella Crescitelli1, Taral Lunavat1, Valerio Belgrano2,
Roger Olofsson Bagge2, Hideo Akiyama3, Cecilia La¨sser1 and
Jan Lo¨tvall1
1Krefting Research Centre, The Sahlgrenska Academy, University of Go¨teborg,
Go¨teborg, Sweden; 2Department of Surgery, Institute of Clinical Sciences,
Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University
Hospital, Gothenburg, Go¨teborg, Sweden; 3New Projects Development
Division, Toray Industries, Inc., Kamakura, Japan
Introduction: Uveal melanoma arises from the eye and 30% of
patients develop liver metastases that can be treated by isolation of
the liver circulation for local chemotherapy. We have previously
shown that liver perfusates contains miRNA-containing extracellular
vesicles (EVs), and the aim was now to compare the extracellular
miRNAs in liver circulation EVs with that of tumor tissue and liver
tissue. Method: One superficial liver melanoma metastasis and a small
piece of normal liver tissue from each patient were extracted during
surgery. EVs were isolated from perfusates by multiple centrifugations.
Presence of miRNAs was analyzed with Toray 3D-Gene platform.
Results: miRNAs expressed in melanoma and liver tissues were com-
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pared with miRNAs from perfusate EVs. Melanoma and liver tissues
expressed similar miRNAs (80% overlap). Comparison between
miRNAs in perfusate plasma and melanoma tissue showed the
presence of 11 and 16 miRNAs overlapping uniquely between
melanoma tissue and perfusate EVs for each patient respectively.
The melanoma specific miR-371b-5p was commonly express in EVs
between the two patients, and was found in the peripheral
circulation of one of these patients. The miR-371b-5p found primarily
in larger EVs (classically called microvesicles). Conclusions: miRNAs
from melanoma tissue can be detected in larger vesicles in the liver
circulation and in peripheral plasma of uveal melanoma patients. It is
possible that microRNAs in larger EVs can be a source of uveal
melanoma biomarkers and miR-371b-5p is one possible candidate.
Room: Jurriaanse
Satellite Event - ISEV-ISAC-ISTH Workshop
Chairs: Joanne Lannigan and Marca Wauben 6:30-8:30 p.m.
Satellite meeting ISEV-ISAC-ISTH EV flow cytometry work group
This satellite event will provide insight into the scientific interaction of
three big international societies, and will also give opportunity for
young researchers to present the first results of this collaboration
6:30-6:35: Marca Wauben - Introduction of the ISEV-ISAC-ISTH EV flow
cytometry work group
6:35-6:45: Leonie de Rond - Size and refractive index determination to
standardize vesicle flow cytometry
6:45-6:55: Sten Libregts - Interference of non-fluorescent particles in
fluorescence EV measurements
6:55-7:10: Rienk Nieuwland - Update on ISTH EV flow cytometry
workgroup studies (scatter-based measurements)
7:10-7:35: John Nolan - Standards and calibration in flow cytometry &
workgroup Spring 2016 activities
7:35-7:45: Joanne Lannigan - Update on the ISAC MV IDG workshop
7:45-8:30: Discussion about next steps
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Room: Jurriaanse
Symposium Session 19 - EVs in the immune system
Chairs: Jan Lo¨tvall and Esther Nolte-‘t Hoen 9:00-10:15 a.m.
OF19.1
Macrophages preferentially package TNF within microvesicles in
response to ATP
Soni Sanooj, Ying Ying Tan, Kahori Cho, Michael wilson, Kieran O’Dea,
Masao Takata
Imperial College London, England
Introduction: Tumour necrosis factor (TNF) is a potent pro-inflammatory
cytokine, playing a crucial role in various inflammatory diseases.
Microvesicles (MVs), carrying a variety of mediators including
cytokines, provide a vital alternative pathway for inflammatory
signalling, yet there is a paucity of literature examining MV-associated
TNF transfer. Here we investigate the effect of ATP, a typical danger
signal that also stimulates MV production, on the manner of TNF
release by macrophages. Methods: RAW 264.7 cells were stimulated
with 1 mg/mL LPS for 1 h and then treated with an additional ‘‘second
hit’’ of ATP 6 mM/ecto-ATPase inhibitor 1 mM for 1 h to produce MVs.
Cells were analysed by flow cytometry for TNF expression. Cell-free
supernatant underwent high speed centrifugation to separate MV
pellet and MV-free supernatant, and TNF/IL-6 content of both
fractions were quantified by ELISA/western blotting. Controls in-
cluded cells stimulated with LPS alone for 2 h. Results: Compared to
LPS alone, surface TNF expression on RAW cells was lower with the
second hit of ATP (2093 vs. 292, mean fluorescent intensity,
pB0.01, N3). ATP treatment almost abolished soluble TNF release
into the media (4719127 vs. 32914 pg, pB0.05, N3) but
substantively upregulated TNF content within MVs (1.190.2 vs.
2397 pg, pB0.05, N3), as measured by ELISA. Western blotting
confirmed the presence of TNF within MVs. The profile of IL-6 release
between the soluble vs. MV-associated fractions were not altered by
ATP, suggesting this ‘‘switch’’ phenomenon may be specific to TNF.
Conclusion: These data show, for the first time, that ATP preferentially
packages TNF within MVs, while concurrently inhibiting soluble TNF
release. Our results indicate that danger signals superimposed onto
pro-inflammatory signals can switch macrophage TNF release from
the ordinary soluble from to the MV-associated form, suggesting a
novel mechanism of long-range MV-associated TNF transfer in case of
significant tissue injury.
OF19.2
Extracellular vesicles rapidly and massively released from
degranulating mast cells are enriched in distinct phospholipid
species and contain active carboxypeptidase
Tom Groot Kormelink1, Willie J. C. Geerts2, Ger J. A. Arkesteijn1,3, Maarten
Altelaar4, Frank A. Redegeld5, Esther N. M. Nolte-’t Hoen1, Marca H. M.
Wauben1
1Department of Biochemistry and Cell Biology, Faculty of Veterinary Medicine,
Utrecht University, Utrecht, The Netherlands; 2Biomolecular Imaging, Bijvoet
Center, Utrecht University, The Netherlands; 3Department of Infectious
Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University,
Utrecht, The Netherlands. 4Biomolecular Mass Spectrometry and Proteomics
Group, Bijvoet Center for Biomolecular Research, Utrecht University, Utrecht,
The Netherlands; 5Division of Pharmacology, Department of Pharmaceutical
Sciences, Faculty of Science, Utrecht University, Utrecht, The Netherlands
Degranulating mast cells, found in tissues during allergic reactions
and chronic inflammation, release a plethora of soluble mediators.
Previously, we showed that degranulation also resulted in the instant
release of large numbers of extracellular vesicles (EVs). We here
analysed the morphology, phospholipid and protein composition of
EVs to define their putative biogenesis and functional properties.
Unstimulated murine serosal mast cells were cultured for 24 h, or
degranulation was induced for 1.5 h. EVs were isolated by differential
centrifugation and floatation into iodixanol density gradients. EV
sizes were determined by Cryo-EM. Phospholipids were isolated by
Bligh and Dyer extraction followed by LC-MS analysis, and proteins
were identified using LC-MS/MS proteomics and western blotting.
Carboxypeptidase (CPA) activity was determined by measuring
hydrolysis of N-(4-methoxyphenylazoformyl)-Phe-OH.EVs released
after degranulation were between 40 and 80 nm, whereas those
released from unstimulated cells were more heterogeneous in size
(70300 nm). These EV types differed in phospholipid composition,
with a particular enrichment of phosphatidylinositol in EVs released
after degranulation. These latter EVs contained mast cell-specific
proteases as identified by proteomics and confirmed by western
blotting for CPA. EV-associated CPA showed significant functional
activity. C-Kit and Fc receptor gamma chain, both associated with
mast cells, and proteins with immune-modulating capacities were
also identified. Although exclusively considered as soluble mediators,
mast cell-specific proteases also associate with a subset of relatively
small EVs. Whether the distinct phospholipids present in these EVs
imply differences in function or biogenesis is subject of current
research. The EV-associated transfer may enhance relocation of
locally high concentrations of active proteases, ensuring a function-
ally significant activity at sites distant from the degranulating mast
cells.
OF19.3
Apoptotic cell-derived extracellular vesicles (ACdEV)  a matter of life
and death
Andrew Devitt1, Allan Cameron1, Roberta Liccardo1, Khaled Alghareeb1,
Parbata Chauhan1 and Ivana Milic1
1Aston Research Centre for Healthy Ageing and School of Life & Health
Sciences, Birmingham, England
Introduction: Damaged, aged or unwanted cells are removed from
the body by apoptosis. This highly orchestrated programme results
in the exposure of ‘‘flags’’ at the dying cell surface and the release of
attractive signals to recruit phagocytes. Together these changes
ensure efficient phagocytic removal of dying cells, which is central to
the control of inflammation. We have shown that dying lymphocytes
release apoptotic cell-derived extracellular vesicles (ACdEV) and
these are strongly attractive to phagocytes in vitro. Our work seeks
to characterize ACdEV, their release, physical characteristics and their
molecular structure-to-function relationships. Methods: ACdEV were
enumerated using qNano to identify kinetics of EV release. Monocyte
migration to ACdEV was assayed using horizontal Dunn chemotaxis
chambers, Cell-IQ live cell imaging and an in vivo mouse tumour
model. The involvement of specific molecules was assessed using
mAbs or reduced antigen expression. Additionally, the molecular
profile of ACdEV was assessed using mass spectrometry. Results:
ACdEV released early in apoptosis promote strong directional
migration of phagocytes but the molecular mechanisms mediating
this attraction vary between dying cells. Monoclonal antibody
blockade of ICAM-3 on ACdEV can reduce phagocyte migration
towards apoptotic foam cells, while CX3CL1 mAbs reduce migration
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to apoptotic macrophages. Using transwell studies, we further
demonstrate that THP-phagocytes are attracted across endothelial
cell barriers to dying cells, also in an ICAM-3-dependent manner.
Finally, our in vivo studies indicate that macrophages migrate
towards dying cells in a manner that is ACdEV-ICAM-3 dependent.
Summary: Our data suggest ICAM-3 may play an important role in
monocyte recruitment to sites of cell death, for example, tumours
and atherosclerotic plaques. Furthermore, the inhibition of mono-
cyte migration in the presence of anti-ICAM-3 mAbs suggests ICAM-3
may be a useful target for modulation of monocyte recruitment for
therapeutic gain.
OF19.4
Vitamin D3-tolerized dendritic cells release extracellular vesicles that
suppress pro-inflammatory cytokine production
Susanne van der Grein, Tom Driedonks, Tom Groot Kormelink, Henrike
Jekel, Marca Wauben and Esther Nolte-’t Hoen
Department of Biochemistry and Cell Biology, Faculty of Veterinary Medicine,
Utrecht University, The Netherlands
Introduction: Antigen presenting dendritic cells (DC) are key regulators
of the adaptive immune system that collect and interpret information
on the local immune status of peripheral tissues. Vitamin D3 is an
immune suppressive environmental signal that induces tolerogenic
DC (tol-DC), which have been implicated in repression of Th17-driven
immune responses. Th17 cells are pro-inflammatory CD4 T cells that
produce interleukin 17 (IL-17) and play an important role in the
clearance of extracellular bacteria, but are also strongly associated
with autoimmune disorders. DC-derived extracellular vesicles (EVs) are
thought to play an important role in the communication between DC
and T cells and the control of immune responses. We therefore aimed
to study the immune regulatory function of EVs released by tol-DC.
Methods: Tol-DC were generated by treating murine bone marrow-
derived DC with 1a,25-dihydroxyvitamin D3. EVs released by tol-DC or
control DC were isolated by density gradient ultracentrifugation and
added to in vitro DC-CD4 T co-cultures using various stimulation
and differentiation regimes. Modulation of the T-cell response was
assessed by flow cytometry and cytokine profile analysis. Results:
Tol-DC-derived EVs were able to modulate T cells during DC-CD4
T-cell co-cultures. The modulated T cells displayed largely reduced
secretion of Th17-related pro-inflammatory cytokines upon T-cell
re-stimulation under Th17-skewing conditions. This repression of
Th17 responses by tol-DC-derived EV was apparent under suboptimal
T-cell stimulating conditions and could be overcome by strong
T-cell stimulation. Initial data indicate that the modulating effect of
tol-DC-derived EVs on T cells is not antigen specific and requires
T-cell interaction with a DC. Conclusion: This study suggests a role for
tol-DC EVs in creating a local immune suppressive milieu in which
tolerogenic DC inhibit potentially harmful Th17 responses until a
strong danger signal is perceived.
OF19.5
Polyclonal T-cell proliferation is inhibited by umbilical cord
MSC-derived EVs but not by MSC conditioned media
Marta Monguio´-Tortajada, Santiago Roura, Anna Oliveira-Tercero,
Marcel La Franquesa, Antoni Bayes-Genis and Francesc E. Borra`s
Germans Trias i Pujol Health Sciences Research Institute (IGTP), Can Ruti
Campus, Badalona, Spain
Introduction: Mesenchymal stem cells (MSC) have been proposed as
powerful inhibitors of unwanted immune responses. MSC’s condi-
tioned medium (CM) partially mediate MSC’s immune suppressive
paracrine activity but is often less effective than the MSC themselves.
Our aim is to isolate EVs from umbilical cord MSC-CM, compare their
suppressive effect to the MSC and derived CM and investigate their
mechanism of action. Methods: MSC 48 h-CM was concentrated by
ultrafiltration. MSC-EVs were isolated by size-exclusion chromatogra-
phy (SEC) and characterized by NTA and Cryo-TEM and checked for EV
markers by bead-based flow cytometry. CM or purified MSC-EV were
co-cultured with allogenic T cells stimulated with anti-CD2/CD3/CD28
loaded beads and proliferation was assessed by CFSE. Cytokines
produced were analysed by multiplex ELISA. Results: SEC-purified EVs
were enriched in CD9 and CD63, and bulk proteins were eliminated
from EV fractions. Importantly, the MSC markers CD73 and CD90 were
found in EV-containing SEC fractions. Also, the immune suppressive
molecule CD73 seemed to be specifically sorted to MSC-EV with IFN?
conditioning, while levels in MSCs and EV production remained
unaltered. Functionally, purified MSC-EVs suppressed polyclonal
proliferation in a dose-dependent manner, to the same extent as
the MSC, whereas neither the CM nor the concentrated CM was able
to affect T-cell proliferation. While CD73 did have an important role in
MSC-mediated reduction of T-cell proliferation, inhibition of CD73 did
not modify MSC-EV immune suppressive functions. Conclusions: Our
results demonstrate the higher potential of purified MSC-EV over CM
to suppress T-cell proliferation. While CD73 is an important immune
suppressive molecule used by MSC, it seemed to have a marginal role
in EV-mediated suppression of T-cell proliferation.
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Room: Willem Burger
Symposium Session 20 - EVs in cancer metastasis I
Chairs: Dolores Di Vizio and Suresh Mathivanan 9:00-10:15 a.m.
OF20.1
Positive effects of vitamin D in bone metastases: role for extracellular
vesicles?
Marjolein Van Driel1, Resti Rudjito1, Iris Robbesom1, Hideki Chiba2 and
Johannes Van Leeuwen1
1Department of Internal Medicine, Erasmus MC, Rotterdam, The Netherlands;
2Fukushima Medical University, Fukushima, Japan
The bone microenvironment provides a fertile soil for cancer cells
to metastasize to. These cells de-arrange bone metabolism that
stimulates cancer cell growth. Compounds that restore bone integrity
are promising therapies, such as vitamin D (1a,25-OH2D3), a bone
stimulatory and anti-cancer agent. Novel routes of metastatic
communication have been shown via extracellular vesicles (EVs).
Here, we aim to investigate the potential of vitamin D as a novel
bone-targeted therapy for bone metastatic cancer and study under-
lying mechanisms involving EVs. We used a human co-culture model
of differentiating osteoblasts (SV-HFO) and bone metastatic prostate
cancer cells (PC-3). EVs released by PC-3 cells were isolated via
ultracentrifugation (20,000 g and 100,000 g). EVs were quantified on a
NanoSight NS300. The effect of 1a,25-OH2D3 (10-7 M) was studied on
(1) osteoblast differentiation (alkaline phosphatase (ALP) activity) and
mineralization (calcium) and PC-3 growth (FACS), (2) EV production
by PC-3 cells (NanoSight) and (3) PC-3 EV interaction with osteoblasts
(ALP activity). 1a,25-OH2D3 treatment recovered the negative effects
of PC-3 cells on osteoblast differentiation and mineralization and
significantly reduced cancer cell growth by 80%. Interestingly, the
number of EVs produced by PC-3 cells is increased by 1a,25-OH2D3
(20,000 g fraction 10-fold, 100,000 g fraction 2-fold). These EVs
significantly increased the ALP activity of human osteoblasts with
20%. This is in contrast to EVs from PC-3 cells that were not treated
with 1a,25-OH2D3; these EVs significantly decreased ALP activity of
human osteoblasts with 20%. These are the first observations that
vitamin D may act as a therapeutic agent in bone metastases, with an
involvement of EVs. EVs from bone metastatic prostate cancer cells
negatively affect osteoblast differentiation. After vitamin D treatment,
EV production by these cancer cells is strongly increased and these
EVs positively affect osteoblast differentiation.
OF20.2
Role of bone marrow-mesenchymal stromal cell-derived extracellular
vesicles on chronic lymphocytic leukaemia B cells defined by functional
studies and microarray analysis
Emerence Crompot1, Dominique Bron2, Philippe Mineur3,
Laurence Lagneaux1, Basile Stamatopoulos1, Nathalie Meuleman2,
Michael Van Damme1 and Karlien Pieters1
1LTCC, Jules Bordet Institute - ULB, Brussels, Belgium; 2Hematology, Jules
Bordet Institute, Brussels, Belgium; 3Hematology, Grand Hopital de Charleroi,
Charleroi, Belgium
Introduction: The interactions between chronic lymphocytic leukae-
mia B cells (CLL-B-cells) and the bone marrow microenvironment (BM-
ME) (notably composed by mesenchymal stromal cells-MSC) play an
important role in promoting the increased survival of CLL-B-cells.
Extracellular vesicles (EVs) produced by CLL-B-cells and the ME may be
implicated in this crosstalk. Methods: Ultracentrifugation (150,000g)
was applied to isolate EVs from supernatant of BM-MSC. Different
concentrations of EVs were added to CLL-B-cells to evaluate their
impact on cell survival, migration and chemoresistance. The gene
expression change induced by EVs in CLL cells was also defined by
microarray analysis (Affymetrix) after their incubation (24 h) with BM-
MSC-EVs. Some genes identified as differentially expressed were
validated by real-time PCR. Results: We demonstrated that BM-MSC
EVs are able to enter in CLL-B-cells (PKH67 labelling): after 24 h,95%
of CLL cells had integrated EVs. Apoptosis was assessed by flow
cytometry: addition of increasing concentrations of EVs showed a
protective effect on CLL-B-cells from spontaneous cell death (n21/
p-valueB0.0001). CLL-B-cells pre-incubated with EVs (4 h) displayed
an increased spontaneous migration index and also in response to
SDF1a (n10/p-value 0.002). We also observed that EVs rescue
CLL-B-cells from drug-induced apoptosis. Microarray analysis reveals a
significant effect on the expression of 987 genes after the integration
of EVs in CLL-B-cells, notably implicated in apoptosis, epigenetic,
adhesion, migration, cell activation, actin cytoskeleton regulation and
immune pathways. Conclusion: Here we show for the first time that
BM-MSC-EVs protect CLL cells from spontaneous apoptosis and
influence their migration and chemoresistance capacities. The
implication of EVs in several cell functions was observed by microarray
analyses. This study provides evidence of the critical role of EVs in the
interactions between leukaemic cells and their ME.
OF20.3
Pancreatic cancer initiating cell and exosome CD44v6 affects additional
stem cell marker expression and cancer stem cell activities
Zhe Wang, Anja Von Au and Margot Zoeller
Tumor Cell Biology, Heidelberg University Hospital, Heidelberg, Germany
CD44 variant isoform v6 (CD44v6) is a metastasis-promoting mole-
cule, upregulated in pancreatic cancer initiating cells (CIC). We
explored by a CD44v6 knockdown (v6kd) and by CIC enrichment of
human pancreatic adenocarcinoma (PaCa) the impact of exosomal
CD44v6 on stem cell features and metastases. A CD44v6kd was
accompanied by a striking loss in anchorage independent growth,
sphere/holoclone-forming capacity and apoptosis resistance.
CD44v6kd cells poorly migrated and lost invasive capacity. Exosomes
(TEX) from wild-type cells and CIC rescued migratory and invasive
capacity. Loss of migratory capacity was accompanied by reduced
integrin recovery in cells and TEX and mitigated activation of
joint CD44v6-integrin signalling. Loss of invasion was promoted by
reduced recovery of CD44v6-associated proteases in cells and TEX.
The impact of the TEX CD44v6 - protease liaison on metastasis was
verified in vivo, Matrigel embedded CD44v6kd cells not invading
the surrounding, but progressing, when supported by CD44v6-
competent CIC-TEX. Importantly, beyond affecting integrin and
protease expression, CD44v6 exerted a striking effect on CIC markers,
including c-Met, the a6b4 integrin, CXCR4 and strongly Tspan8.
Tetraspanins playing a central role in TEX generation and delivery, we
hypothesized that reduced Tspan8 transcription in CD44v6kd cells
might account for the overall collapse of CIC activities. The assump-
tion was supported by the finding that Tspan8-competent TEX
promoted upregulation of mesenchymal genes in CD44v6kd cells
and in vivo metastatic settlement. On the other hand, an excess of
CD44v6kd TEX sufficed to outsmart CIC TEX such that CIC largely lost
the capacity to metastasize. CD44v6 affects metastasizing tumour cell
motility and invasion by cooperating/associating with integrins and
proteases and by regulating expression of additional TEX-enriched
CIC markers. Thereby, the deficit of CD44v6 suffices for a collapse of
the exosome CIC crosstalk with non-CIC and host cells.
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OF20.4
Exosomes mediate intra-tumour communication in pancreatic cancer
Carolina F. Ruvio1,2, Agustin F. Fernandez3, Mario Frraga3,
Jose Luis Costa1,2,4, Jose Carlos Machado1,2,4 and Sonia A. Melo1,2,4
1i3S-Instituto de Investigac¸a˜o e Inovac¸a˜o em Sau´de, Universidade de Porto,
Portugal; 2IPATIMUP Institute of Pathology and Molecular Immunology of the
University of Porto, Portugal; 3Cancer Epigenetics Laboratory, Insitute of
Oncology of Asturias (IUOPA), HUCA, Universidad de Oviedo, Spain;
4Department of Pathology Medical Faculty of Porto, Portugal
Tumours are characterized by a great diversity of cancer cells, and
this substantial intra-tumour heterogeneity reflects different cell
phenotypes and tumorigenic capacity. Pancreatic cancers are known
for their heterogeneity and for the presence of hierarchical cancer
cell subpopulations. Subpopulations of cancer cells cooperate to
drive and maintain tumour progression. Exosomes contribute to
horizontal reprogramming and phenotypic re-education of recipient
cells. The role that exosomes play in intra-tumour heterogeneity is
still unclear. We have identified 5 pancreatic cancer cell subpopula-
tions. Exosomes from each subpopulation were characterized by
nanoparticle tracking analysis (NTA), transmission electron micro-
scopy (TEM) and by western blot for common exosomes markers.
In order to study the exosomes flow between these 5 different
subpopulations of cancer cells, we developed stable clones combin-
ing known exosomes markers with a fluorescent reporter protein.
Subpopulations of cancer cells that secrete color-coded exosomes
were co-cultured and the flow of exosomes analysed by confocal
microscopy and flow cytometry. Exosomes from different subpopu-
lations of cancer cells present a different proteome. Additionally,
co-cultures demonstrated the presence of multicolour positive cells,
which indicates that exosomes are exchanged between different
tumour subpopulations. The communication network mediated by
exosomes among phenotypically different cancer cells might be
involved in tumour progression and metastatic disease.
OF20.5
Hypoxic cancer-derived EVs contain specific miRNA cargo and mediate
intercellular communication among hypoxic cancer cells
Aija Line1, Artu¯rs A¯bols1, Elı¯na Zandberga1, Rasita Toleikiene1, Cristina
Bajo1, Da¯rta Pu¯pola1, Lilite Sadovska1, Pavel Zayakin1, Una Riekstin¸a2
1Latvian Biomedical Research and Study Centre, Riga, Latvia; 2Faculty of
Medicine, University of Latvia, Riga, Latvia
Introduction: Hypoxia is a common feature of the vast majority of
solid cancers, which has been shown to promote cancer cell survival,
chemoresistance, motility and self-renewal capacity of cancer stem
cells. We hypothesized that hypoxic cancer-derived EVs may transfer
these features among cancer cells and the presence of hypoxic
EVs in biofluids of cancer patients may serve as a biomarker for
aggressive phenotype and reveal hypoxia status in the tumour.
Methods: Exosome-enriched EVs were isolated from colorectal
(SW480 and SW620) and breast cancer (MCF7) cell cultures exposed
to hypoxic or normoxic conditions by using sequential centrifuga-
tion, filtration and size-exclusion chromatography steps. The EVs
were visualized by electron microscopy, quantified by NanoSight and
Zetasizer Nano and characterized by western blot analysis. EVs were
stained using Exo-APC stain and their uptake by SW480, SW620 and
MCF7 cells was analysed by FACS. Small RNA libraries were
constructed from hypoxic and normoxic SW480 and SW620 cells
and EVs and sequenced using Ion Proton Platform. Results: The
obtained EV subpopulations ranged in size from 30 to 180 nm and
were positive for CD9, CD63, CD81 and Alix and negative for GM130.
Importantly, EVs expressed hypoxia-inducible CAIX that potentially
might allow isolation of hypoxic EVs from biofluids. Under normoxic
conditions, the cells preferentially internalized normoxic EVs, while
hypoxic conditions enhanced the uptake of hypoxic EVs. Preliminary
RNASeq data analysis revealed a set of miRNAs that were induced by
hypoxia in the cells. However, only a few of these miRNAs were also
found to be upregulated in hypoxic EVs, while a subset of miRNAs
that were not significantly upregulated in the cells were found to be
upregulated in the EVs. Conclusions: These data suggest that EVs
mediate intercellular communication between cancer cells under
hypoxic conditions and hypoxia may serve as a signal for sorting
specific miRNA cargo into EVs.
Scientific Program ISEV 2016 meeting
Citation: Journal of Extracellular Vesicles 2016, 5: 31552 - http://dx.doi.org/10.3402/jev.v5.31552 127
Room: van Weelde
Symposium Session 21 - EVs in reproduction and pregnancy
Chairs: Chris Gardiner and Paul Harrison 9:00-10:15 a.m.
OF21.1
Extracellular vesicles  the next small thing in epigenetic inheritance
Navind Jayasooriah1,2, Paul Young1, Sally Eaton1,2, Jennifer Cropley1,2 and
Catherine Suter1,2
1Victor Chang Cardiac Research Institute, Darlinghurst, NSW, Australia;
2University of New South Wales, Kensington, NSW, Australia
Introduction: Epigenetics is the study of heritable changes in gene
expression that are not caused by changes in DNA sequence.
Environmental effects such as diet and stress are able to affect an
individual’s epigenotype and phenotype. These effects can persist
beyond the initial exposed generation, suggesting that a signal is
passed through the germline. However, it is not known what the
signal is or the mechanism of transmission. We propose that the
signal is somatic-derived non-coding RNA that is packaged inside
extracellular vesicles (EVs). We have started to test this hypothesis in
vitro using Sertoli cells, a germline-associated somatic cell. We aimed
to determine if Sertoli EVs interact with germ cells and investigate
whether Sertoli EV cargo is altered by environmental stress. Methods:
Sertoli cells were exposed to bisphenol A (BPA), a known reproduc-
tive toxin for 12 days. EVs were isolated from conditioned culture
media by filtration and differential centrifugation. Sertoli EVs were
labelled with PKH26 and CFSE dyes and co-cultured with sperma-
togonial stem cells. EV RNA was extracted with Trizol LS. Small RNA
libraries were constructed using a NEBNext Small RNA Library Kit
and sequenced on an Illumina HiSeq 2500. Differential expression
analysis was performed in R using the edgeR package. Results: Sertoli
EVs are able to bind and fuse with spermatogonial stem cells in vitro.
BPA exposure increases the ratio of EVs released per cell. BPA
exposure also alters the selective packaging of small RNA inside
Sertoli EVs, with altered miRNAs implicated in defective spermato-
gonial stem cell renewal and maintenance. Summary/conclusion: We
show that somatic EVs are able to interact with germ cells. We also
show that somatic EV cargo is susceptible to the environment. Taken
together, this suggests that environmental effects may be trans-
mitted from the soma to the germline via EVs  that EVs are a vector
for transgenerational epigenetic inheritance.
OF21.2
Extracellular vesicles contents alter RNA profile after in vitro treatment
of bovine cumulus-oocyte complex
Juliano Da Silveira1, Luiz Coutinho2, Aline Cesar2, Felipe Perecin1,
Fla´vio Meirelles2, Marcelo Nogueira3, Gabriella Andrade2, Marcelo Ce´zar2
and Maite Del Collado2
1Faculty of Animal Science and Food Engineering, Department of Veterinary
Medicine, University of Sa˜o Paulo, Pirassununga, Sa˜o Paulo, Brazil; 2Faculty of
Animal Sciences, Department of Animal Science, ‘‘Luiz de Queiroz’’ College of
Agriculture, University of Sa˜o Paulo, Piracicaba, Sa˜o Paulo, Brazil; 3Faculty of
Sciences and Letters, Department of Biological Science, University of Sa˜o Paulo
State, Assis, Sa˜o Paulo, Brazil
Intercellular communication is crucial to induce cell proliferation and
differentiation during cumulus-oocyte complex (COC) maturation.
RNA molecules accumulated within the oocyte and are important
during early embryo development. Extracellular vesicles (EVs) were
identified in follicular fluid and can mediate cell communication. Our
hypothesis is that extracellular vesicles from bovine follicular fluid
can modulate changes on mRNA levels during early bovine embryo
development. To test this hypothesis, extracellular vesicles isolated
from 3 to 6 mm and pre-ovulatory ovarian follicles were supple-
mented during oocyte maturation. Follicular fluid was submitted to
differential centrifugation for removal of cellular components and
debris before freezing at 808C. COCs were in vitro matured in
control media or media supplemented with EVs for 24 h and then
fertilized. After 7 days in culture, embryos were collected for RNA
analysis. EVs RNA-seq analysis demonstrated a variety of coding and
non-coding RNA molecules including epigenetic-modifying enzymes
(DNMT1 and DNMT3a) and mRNA-binding proteins (EIF4b and
EIF4e). Functional annotation analysis of EVs RNA contents demon-
strated to be involved in the regulation of chromatin remodelling
or transcription activation. We identified 280 EVs miRNAs involved
in regulation of important follicle developmental pathways. EVs
supplementation increased levels of DNMT3a, an enzyme involved in
de novo methylation of DNA, in embryos treated with exosomes
from 3 to 6 mm follicles compared to control embryos. Thus, our
results demonstrated that EVs carry RNA molecules involved in
chromatin regulation capable of modulating transcript levels. Further
experiments are necessary to explore if changes in RNA levels are
mediated by extracellular vesicles delivery or gene activation.
Supported by FAPESP GIFT-2012/50533-2; CEPID-CTC-2013/08135-2;
BPD-2013/10473-3, JP-2014/22887-0.
OF21.3
Functional impact of delivery of oviductosomal PMCA4 to Pmca4 null
sperm in vitro
Amal Al-Dossary1, Pradeepthi Bathala2 and Patricia Martin-Deleon2
1Biological Sciences, University of Dammam, Dammam, Saudi Arabia;
2Biological Sciences, Newark, Delaware, USA
Introduction: Reproductive extracellular vesicles (EVs) in the male
(epididymosomes and prostasomes) and those in the uterine
secretion (uterosomes) play a role in the maturation of sperm and
in their functional competency. We hypothesize that the recently
identified EVs in the oviductal secretion, oviductosomes (OVS), play a
pivotal role in capacitation, the final sperm maturation process. OVS
carry an essential fertility-modulating protein, plasma membrane
Ca(2)-ATPase 4 (PMCA4), which is the major Ca(2) efflux pump in
murine sperm where its absence leads to male infertility due to loss
of sperm motility. Following co-incubation of OVS and sperm,
oviductosomal PMCA4 can be delivered to sperm by a fusogenic
mechanism. To test our hypothesis of a functional role of oviducto-
somal PMCA4 in capacitation, we evaluated the impact of PMCA4
delivery in vitro to Pmca4 KO sperm. Methods: We examined the
effect of fusion of WT and Pmca4 KO OVS and sperm after in vitro co-
incubation on (a) Ca(2)-ATPase activity, (b) Ca(2) loading and (c)
motility. The basis of fertility of Pmca4 KO females was assessed by
investigating the presence of PMCA1 in OVS, via western analysis.
Results: After co-incubation, Ca(2)-ATPase activity significantly
increased (pB0.01) for WT sperm and OVS and for Pmca4 KO sperm
and WT OVS (pB0.003). Here, Ca(2) levels significantly decreased
(p0.015) and motility rates increased (p0.007). Fertility of Pmca4
KO females is associated with a significant upregulation of PMCA1 in
Pmca4 KO OVS, compensating for PMCA4’s loss. Conclusion: Our
results show that oviductal PMCA4 transferred to sperm via OVS is
functional and contributes to proper Ca(2) handling, impacting
sperm phenotype. Knowledge of OVS transfer of fertility-modulating
proteins to sperm provides new insights into molecular interactions
at the fertilization site. This has important implications for increas-
ing the fertilizing competence of sperm in the in vitro fertilization
clinic.
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Exosome trafficking from immune cells to the placenta: a novel mode
of maternal-placental messaging
Thomas Rice1, Tessa Jones1, Lynda Harris2, Karen Forbes3, Beverly
Donaldson1, Marielle Bouqueau1, Beate Kampmann1 and Beth Holder1
1Paediatrics, Department of Medicine, Imperial College London, London, UK;
2School of Pharmacy, The University of Manchester, Manchester, UK; 3Division
of Reproduction and Early Development, University of Leeds, Leeds, UK
Introduction: The placenta forms the interface between the maternal
and foetal circulations and sheds extracellular vesicles, including
exosomes, into the maternal circulation. These interact with maternal
immune cells and alter their activation status. We have recently
published the first demonstration that this trafficking is bi-
directional. We propose that exosomes released by maternal
immune cells interact with the foeto-placental unit and impact on
placental immune response. Methods: Exosomes were isolated from
macrophage supernatants and from serum, by ultracentrifugation or
by size exclusion chromatography. Exosome membranes were
labelled with PKH-26, and RNA and protein cargoes labelled with
fluorescent SYTO RNASelect and CFSE, respectively. Uptake by the
BeWo trophoblast cell line, human placental explants and the mouse
placenta in vivo was measured by flow cytometry and confocal
microscopy. Inhibitors of endocytosis were used to determine route
of exosome uptake. Functional impact of exosomes on the placenta
was measured by cytokine ELISA. Results: Uptake of exosomes
was observed in the human and mouse placentas. Exosome uptake
by trophoblast cells was mediated via clathrin-mediated endocytosis.
This interaction has functional impact, as macrophage exosomes
induced release of cytokines from the human placenta, with
altered responses depending on the macrophage activation status.
Summary/conclusion: We have demonstrated the trafficking of
exosomes from immune cells to the placenta. We are also the first
to demonstrate uptake of heterologous exosomes by the placenta.
Importantly, we also show functional impact on placental cytokine
release, presenting a novel mode of communication between the
mother’s immune system and the placenta during pregnancy. This
has important impact for understanding placental responses to
maternal infection, inflammation and vaccination, which could
impact on the health of both mother and baby during pregnancy,
and beyond.
OF21.5
Extracellular vesicles produced by group B streptococcus disrupts
foeto-placental barrier and leads to preterm birth
Anirban Banerjee1, Manalee Surve1, Anjali Anil1, Kshama Kamath1,
Smita Bhutda1, Lakshmi Kavitha Sthanam1, Shamik Sen1, Deepak Modi2
and Bhakti Basu3
1Indian Institute of Technology - Bombay, Powai, Mumbai, India; 2National
Institute For Research In Reproductive Health, Parel East, Mumbai, India;
3Bhabha Atomic Research Centre, Trombay, Mumbai, India
Introduction: Preterm rupture of the foetal membranes is a direct
consequence loss of amniotic barrier integrity leading to preterm
birth. Intrauterine infections and lower genital tract infections are
major causes of preterm birth. However, 5080% women with
chorioamnionitis do not have bacteria in their amniotic fluid or in the
decidual tissue. This implies the presence of unidentified mechanism
of amniotic barrier integrity perturbance and subsequent preterm
birth induction by distant infections. Colonization of vagina and
cervix of pregnant women with Group B Streptococcus (GBS)
significantly increases the probability of preterm birth. In this report,
we demonstrate for the first time that GBS produces extracellular
membrane vesicles, which lead to preterm birth. Methods: We have
isolated the MVs from GBS culture supernatant and characterized
them both physically and biochemically. We also examined how GBS
MVs interacted with host cells in vitro as well as mice amniotic
membrane ex vivo. Finally, we performed in vivo studies in pregnant
mice to analyse the effects of these vesicles on preterm birth.
Results: Our results demonstrate that MVs produced by GBS is a
strain independent trait, and these are loaded with different
virulence factors including proteases and pore-forming toxins. GBS
MVs were cytotoxic and led to apoptosis in HeLa cells. Mice amniotic
membranes challenged with MVs ex vivo resulted in extensive
membrane damage because of connective tissue degradation. This
led to loss of mechanical strength, making the membrane prone to
rupture. Finally, intra-amniotic injections of GBS MVs in pregnant
mice led to chorioamnionitis and resulted in premature delivery and
foetal demise. Conclusions: Our findings provide a novel insight into
how GBS while colonizing in the lower genital tract can orchestrate
events at the foetal membrane by secreting extracellular vesicles
that lead to premature rupture of amniotic membrane and
subsequent preterm birth.
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OF22.1
Circulating EBV-modified exosomes in SLE patients target the renal
tubular epithelium delivering inflammatory EBER1 and EBV-microRNAs
N. Masoumi1, M. Tsang A Sjoe2, M. A. J. van Eijndhoven1, K. M. Heutinck3,
M. Middeldorp1, A. E. Voskuyl2 and D. M. Pegtel1
1Department of Pathology, VU University Medical Center, Amsterdam,
The Netherlands; 2Department of Rheumatology, VU University Medical
Center, Amsterdam, The Netherlands; 3Experimental Immunology Department,
University of Amsterdam, The Netherlands
A possible pathogenic role of EpsteinBarr virus (EBV) in autoimmune
diseases such as systemic lupus erythematosus (SLE) is long
suspected, but its exact role remains unknown. Recently, we have
shown that EpsteinBarr virus-encoded small RNA 1 (EBER1) and
some EBV-related microRNAs (miRNA) are selectively released from
infected B cells via exosomes and are internalized by human
plasmacytoid DCs (pDC’s) expressing TIM1 phosphatidylserine recep-
tor, which is a known viral and exosomal target molecule. We
found evidence that EBV-modified exosomes target the skin in SLE
patients that may involve EBER1-activated pDCs. In this study, we first
analysed lupus nephritis (LN) and other kidney disease control
biopsies by in situ hybridization, which revealed a defined EBER1
presence in tubular epithelial cells (TEC) of LN. High levels of EBER1
and EBV-miRNAs were detected in LN biopsies by RT-PCRs, while EBV
DNA was absent. TIM1 is expressed by TEC cells, especially in higher
levels after kidney damage. We confirmed in primary TEC cultures
that EBV-modified exosomes are internalized in a PtdSer-dependent
manner, delivering inflammatory RNAs into endosomes. To verify
whether circulating EBV-modified exosomes may target the kidneys in
SLE patients, we isolated exosomes from blood and urine of SLE and
LN patients and detected EBV-miRNAs and EBER1. We next analysed
the possible inflammatory effects of EBV-modified exosomes in TEC
cells, by isolation of exosomes from EBV-infected and non-infected B
cells. The addition of EBV-modified exosomes, as well as infection of
RNA-isolated from the same exosomes into TEC cells caused an
increased level of cytokine production such as IL6 and interferon-
stimulated genes. This effect was significantly lower upon addition of
non-EBV-modified exosomes, supporting the hypothesis that EBV-
modified exosomes might play a significant role in promoting inflam-
matory responses in autoimmune diseases including SLE and LN.
OF22.2
Molecular pathology of circulating extracellular vesicles in systemic
lupus erythematosus (luposomes) provides novel insight into disease
mechanisms
Heegaard Niels H. H.1,2, Ole Østergaard1, Christoffer Nielsen3,
Julia Tanassi1, Line Iversen4 and Søren Jacobsen5
1Department of Autoimmunology and Biomarkers, Statens Serum Institute,
Copenhagen, Denmark; 2Department of Clinical Biochemistry and
Pharmacology, Odense University Hospital, Odense, Denmark; 3Department of
Rheumatology, Gentofte University Hospital, Copenhagen, Denmark;
4Department of Dermatology, Bispebjerg University Hospital, Copenhagen,
Denmark; 5Department of Rheumatology, Rigshospitalet University Hospital,
Copenhagen, Denmark
Introduction: Systemic lupus erythematosus (SLE) is a chronic, auto-
immune disease of unknown aetiology. The sustained autoimmunity
and the systemic type I interferon response in SLE may be due to
clearance defects. It is unknown, however, where such defects reside
and if the disease is aggravated or triggered by increased subcellular
material, such as cell fragments and vesicles that are normally cleared
by non-pro-inflammatory mechanisms. We therefore profiled circulat-
ing EVs from SLE patients and controls using tandem mass spectro-
metry. Methods: EVs were isolated from platelet-poor plasma from
patients (n45 SLE; n38 Systemic sclerosis (SSc)) and healthy
controls (HC, n50) by repeated 18,900xg centrifugations. Samples
were processed into peptide fragments and analysed by tandem mass
spectrometry. Proteins were annotated and quantitated based on
their intensity values and compared between the groups using
nonparametrical statistics and corrections for multiple comparisons.
Results: More than 1000 individual proteins were identified in the
SLE/HC (1139 proteins) and the SSc/HC (1032 proteins) cohorts.
The circulating EV proteomes were distinctly different between SLE/
SSc patients and HC and differences between EVs in the SLE and SSc
groups allowed a complete differentiation between these two
autoimmune diseases. The data suggest a markedly increased
production of circulating abnormal EVs in SLE characterized by
profound metabolic, cytoskeletal and mitochondrial alterations.
Summary/conclusion: The primary pathology in SLE is an increased
production of abnormal EVs that are released to the circulation and
become immunogenic because the amount or nature of these SLE-
specific EVs  that we call luposomes  cannot be appropriately
handled by normal non-inflammatory clearance mechanisms. Our
findings pave way for new candidate biomarkers, support particle
clearance disturbances as a central disease mechanism and give
insight into new treatment modalities in SLE.
OF22.3
Suppression of autophagy by extracellular vesicles promotes
myofibroblast differentiation in COPD pathogenesis
Tsukasa Kadota1,2, Kuwano Kazuyoshi1, Kenji Kobayashi1, Hiromichi Hara1,
Jun Araya1, Saburo Ito3, Yu Fujita4, Yusuke Yoshioka5 and Takahiro
Ochiya5
1Division of Respiratory Diseases, Department of Internal Medicine, The Jikei
University School of Medicine; 2Department of Internal Medicine, Division of
Respiratory Diseases, Department of Internal Medicine, The Jikei University
School of Medicine, Tokyo, Japan; 3David Cheresh Laboratory University of
California, San Diego, Sanford Consortium for Regenerative Medicine; 4Division
of Molecular and Cellular Medicine, National Cancer Center Institute, Tokyo,
Japan
Introduction: Chronic obstructive pulmonary disease (COPD) is a
chronic inflammatory lung disease that causes obstructed airflow
from the lungs. Cigarette smoke is the main causes of COPD and
cigarette smoke-stimulated bronchial epithelial cells produce various
paracrine factors that affect neighbouring lung fibroblasts (LFs),
resulting in airway fibrosis in COPD. Here, we investigated an
extracellular vesicle (EV)-mediated intercellular communication me-
chanism between primary human bronchial epithelial cells (HBEC)
and LFs. Methods: EV from cigarette smoke extract (CSE)-exposed
HBEC were isolated by ultracentrifugation and characterized by
electron microscopy, western blot and nanoparticle tracking analysis.
The profiles of EV microRNA (miRNA) were examined by microarray.
The in situ hybridization was used to detect miRNA expression in
non-smokers, non-COPD smokers and COPD lungs. Results: Evalua-
tions of the modified EV and COPD lung samples indicated
that cigarette smoke induced relative upregulation of cellular and
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EV miR-210 expression of bronchial epithelial cells. In co-culture
assays, we showed that HBEC-derived EV miR-210 promotes
myofibroblast differentiation in LFs. We found that miR-210 directly
regulates autophagy processes via targeting ATG7, and expression
levels of miR-210 are inversely correlated with ATG7 expression in
LFs. Importantly, autophagy induction was significantly decreased in
LFs from COPD patients, and silencing ATG7 in LFs led to
myofibroblast differentiation. These findings demonstrate that CSE
triggers the modification of EV components and identify bronchial
epithelial cell-derived miR-210 as a paracrine autophagy mediator of
myofibroblast differentiation. Summary/conclusion: Our findings
show that stressor exposure changes EV compositions as emerging
factors, potentially controlling pathological disorders such as airway
remodelling in COPD.
OF22.4
Extracellular vesicles and their microRNA cargoes are novel biomarkers
and intercellular communicators in alcoholic liver disease
Gyongyi Szabo, Banishree Saha, Fatemeh Momen-Heravi, Karen Kodys
and Shashi Bala
Department of Medicine, University of Massachusetts Medical School,
Worcester, USA
Introduction: Alcohol induces hepatocyte damage and inflammation
in the liver. miR-122 is abundant in hepatocytes and circulating miR-
122 was found in liver injury. We hypothesized that extracellular
vesicle (EV)-associated miRs can serve as biomarkers and provide
communication between hepatocytes and immune cells in alcoholic
hepatitis. Methods: EVs isolated from sera of chronic alcohol-fed
(5 weeks Lieber DeCarli diet) or pair-fed mice and patients with
alcoholic hepatitis were characterized by western blot, nanoparticle
tracking analysis system and miRNA analysis. Results: The number of
circulating EVs was significantly increased in alcohol-fed mice
compared to controls. Exosomes represented most of the EVs
(80%). MicroRNA array of EVs revealed a significant increase of
7 inflammatory miRs (miR-192, 122, 30a, 744, 1246, 30b and miR-
130a) in alcohol-fed mice compared to controls and of those miR-
192, 122 and 30a excellent diagnostic value by receiver operating
characteristic (ROC) curve analyses. In patients with acute alcoholic
hepatitis, we found a significant increase in the number of circulating
EVs compared to controls with an increase in miR-192 and miR-30a in
their cargo. Serum miR-122 was increased after alcohol binge
drinking. In vitro, exosomes derived from ethanol-treated human
hepatocytes were taken up by monocytes and transferred mature
miR-122 into monocytes. This horizontally transferred miR-122
inhibited hemeoxygenase-1 expression, a target of miR-122 and
sensitized monocytes to LPS stimulation to increase production of
pro-inflammatory cytokines, TNF-a and IL-1ß; these effects were
inhibited by exosome-mediated delivery of a miR-122 inhibitor in
monocytes. Summary/conclusions: Elevated levels of EVs and their
miR signature could serve as biomarkers of alcoholic hepatitis. We
found a novel EV-mediated mechanism of alcohol-induced commu-
nication between hepatocytes and monocytes by transferring
hepatocyte-derived miR-122 that reprograms monocytes promoting
inflammation in alcoholic hepatitis.
OF22.5
Subtypes of extracellular vesicles released by dendritic cells promote
differential CD4 T-cell responses
Mercedes Tkach, Joanna Kowal and Clotilde Thery
Institut Curie, PSL Research University, INSERM U932, 75005, Paris, France
Introduction: Cells secrete into their environment different types of
extracellular vesicles (EVs) that have distinct structural and biochem-
ical properties depending on their intracellular site of origin. We have
recently shown that different subtypes of EVs secreted by human
dendritic cells can be recovered during the steps of the differential
ultracentrifugation protocol (1). Large EVs are pelleted at 2000xg
(2005000 nm diameter), intermediate size EVs at 10,000g (100
800 nm) and small EVs (50150 nm), as the exosomes, at 100,000g.
Whether these EVs have similar or different effects on target cells, as
CD4T cells, has never been addressed. Methods: EVs released by
human monocyte-derived DCs were recovered at all steps of the
differential centrifugation purification protocol. Activation of CD4T
lymphocytes by EV-borne MHC class II was measured by culturing
EVs with allogeneic T cells and analysing cell proliferation and
cytokine secretion. Results: All the pellets were able to induce, to a
similar extent, primary CD4T-cell proliferation. The EVs recovered
at 2000g induced Th2 cytokines secretion (IL-13, IL-5 and IL-4),
while the EVs recovered at medium/high centrifugation speed
induced the secretion of both Th1 and Th17 cytokines (IFN-g and
IL-17A). To study the role of different molecules present on EVs
involved in this CD4T-cell differential polarization, we added
blocking antibodies for MHC class II, LFA-1, CD40 and DC-SIGN to
the EV-CD4T cells co-cultures. MHC class II and LFA-1 were
involved in the responses induced by all the pellets, while DC-SIGN
and CD40 blockade affected only the response induced by the
100,000g. Conclusion: We observed that all the EVs assayed in this
work are able to induce CD4T-cell activation and proliferation.
Interestingly, EVs subtypes promote differential CD4T-cell polar-
ization, suggesting that cells can spread different responses though
the secretion of several types of EVs (1).
Reference
1. Kowal J, et al. 2016. PNAS (113: E968-977).
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OF23.1
Osteosarcoma exosomes establish a prometastatic inflammatory loop
by engaging mesenchymal stem cells
Serena Rubina Baglio1, Tonny Lagerweij2, Maria Pe´rez Lanzo´n1,
Roberta Bonafede3, Ekaterina S. Jordanova4, Nicolas Le´veille´5,
Koos Rooijers6, Monique A. J. Van Eijndhoven1, Gloria Bonuccelli7,
Laura Roncuzzi8, Sonia A. Melo9, Anne-Marie Cleton-Jansen10,
Thomas Wurdinger2, Nicola Baldini8 and D. Michiel Pegtel1
1Department of Pathology, VU University Medical Center, Amsterdam,
The Netherlands; 2Department of Neurosurgery, VU University Medical Center,
Amsterdam, The Netherlands; 3Department of Neurological, Biomedical and
Movement Sciences, University of Verona, Verona, Italy; 4Department of
Obstetrics and Gynecology, VU University Medical Center, Amsterdam, The
Netherlands; 5Center for Experimental Molecular Medicine, Academic Medical
Center, Amsterdam, The Netherlands; 6Department of Biological Stress
Response, Netherlands Cancer Institute, Amsterdam, The Netherlands;
7Institute of Cancer Sciences, University of Manchester, Manchester, UK; 8Lab
Orthopaedic Pathophysiology and Regenerative Medicine, Rizzoli Orthopaedic
Institue, Bologna, Italy; 9Institute of Pathology and Molecular Immunology of
the University of Porto (IPATIMUP), Porto, Portugal; 10Department of
Pathology, Leiden University Medical Center, Leiden, The Netherlands
Introduction: Metastasis formation and resistance to therapy, for
example via STAT3 activation in tumour cells, could be a conse-
quence of driver-mutations in cancerous ‘‘stem’’ cells or of cancer-
stroma interactions, but a role for mesenchymal stem cells (MSCs) is
poorly understood. Here we explored in an in vivo osteosarcoma (OS)
model of how tumour exosomes may engage MSCs to facilitate
tumour progression. Methods: To study the effect of OS exosomes on
MSC behaviour, we injected OS exosome-educated MSCs in a
bioluminescent orthotopic OS xenograft model. The effects of OS
exosomes on MSC cytokine expression were assessed by FACS and
ELISA. TGFß1 was identified as the exosomal component responsible
for IL-6 induction by using a combination of assays including ELISA,
and exosome uptake and ALK5 inhibition. STAT3 activation in OS
tissues was assessed by IHC staining of tissue microarrays. Circulating
levels of exosomal TGFß1 were assessed by size exclusion chromato-
graphy followed by TGFß1 ELISA. The R2 Genomics Analysis Platform
was used to correlate our findings with clinical data. Results: We found
that while OS tumours have elevated pSTAT3 levels, local IL-6
expression is low. We confirmed this in primary OS cells and OS cell
lines suggesting that STAT3 activation may be a consequence of an
exogenous source. We demonstrated that OS tumour exosomes
decorated with TGFß1 educate MSCs to secrete IL-6 leading to
elevated STAT3 activation and malignant progression in vivo. TGFß1
expression in OS tumours correlates with poor outcome, and
circulating levels of exosome-associated TGFß1 is increased in OS
patients compared to controls. Breaking this pro-malignant EV-
mediated inflammatory loop by administering the MoAb Tocilizumab
to OS-bearing mice reduced tumour growth and metastasis forma-
tion. Conclusion: Our studies indicate exosomes as powerful messen-
gers in OS progression and provide a rationale for the clinical use of
IL-6R blocking agents to stop OS progression.
OF23.2
Role of tumour-secreted exosomes in reprogramming the lymph node
microenvironment during metastasis
Hector Peinado1, Alberto Benito-Martin2, Ana Amor-Lopez1,
Susana Garcia-Silva1, Irina Matei2, Raghu Kataru3, Babak Mehrara3,
David Lyden2, Laura Nogues-Vera2, Marta Hergueta-Redondo1,
Carolina Villarroya-Beltri4 and Lucı´a Robado De Lope1
1Microenvironment and Metastasis Group, Molecular Oncology Program,
Spanish National Cancer Research Center (CNIO), Spain; 2Department of
Pediatrics, Hematology-Oncology Division, Weill Medical College of Cornell
University, NY, USA; 3Department of Surgery, Memorial Sloan-Kettering Cancer
Center, New York, USA; 4Intercellular Communication in the Inflammatory
Response Group, Spanish National Cardiovascular Research Centre (CNIC),
Madrid, Spain
Metastasis is the most devastating phase of tumour progression.
Recent research has demonstrated that microvesicle-based informa-
tion transfer by exosomes plays a key role in tumour progression.
Melanoma-secreted exosomes have been demonstrated to home
to the lymph nodes (LNs). Exosomes derived from highly
metastatic models (B16-F10) have a faster and wider distribution in
the lymphatic system as compared to exosomes derived from low
(B16-F1) or non-metastatic model (melan-a) whose distribution is
restricted to the sentinel lymph node. Our data demonstrate that
exosomes secreted by highly metastatic models promote vascular
leakiness in the sentinel lymph node in a short time range. Another
main consequence of in vivo exposure of B16-F10-derived exosomes
is the promotion of new lymphoangiogenesis in sentinel and distal
LNs. In order to identify primary cell targets of melanoma-secreted
exosomes, we have performed confocal imaging and flow cytometry
analysis. Our findings indicate that there exists a primary uptake of
exosomes by lymphatic endothelial cells (LECs) from the lymph
nodes. RNAseq and RT-PCR analysis of human LECs incubated
with melanoma-derived exosomes confirm upregulation of lym-
phoangiogenesis-related genes together with the positive enrich-
ment of molecular adhesion-, autoimmune- and cytokine-related
signatures among others. Our results support a role of tumour-
secreted exosomes in promoting cellular and molecular alterations in
the lymph node microenvironment fostering metastasis. In addition,
analysis of exosome content in human lymphatic fluid suggests that
proteomic cargo and particles are increased in melanoma patients
opening the possibility of the use of circulating vesicles in lymphatic
fluid as biomarkers and as a source of novel markers in pre-
metastatic sentinel lymph nodes that predict relapse and metastatic
potential.
OF23.3
Metastatic colon cancer extracellular vesicles spread malignant
properties in tumour microenvironment affecting the behaviour
of both tumour and endothelial cells
Odessa Schillaci1, Riccardo Alessandro1, Franccesca Monteleone1,
Simona Taverna1, Valentina R. Minciacchi2, Dolores Di Vizio2 and
Simona Fontana1
1Dipartimento di Biopatologia e Biotecnologie Mediche, Sezione di Biologia e
Genetica, Universita´ degli Studi di Palermo, Palermo, Italy; 2Department of
Surgery, Biomedical Sciences and Pathology and Laboratory Medicine, Samuel
Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center,
Los Angeles, USA
Introduction: Intratumoural heterogeneity makes the development of
new anticancer treatments difficult. Several studies suggest that
exosomes may be an important microenvironmental factor affecting
tumour heterogeneity. In this context, our goal was to understand
if exosomes derived from highly metastatic cell lines may affect
the behaviour of less aggressive cells and the properties of the
endothelium, thus promoting metastatic dissemination of cancer
cells. Methods: Isogenic SW480 and SW620 colon carcinoma lines
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derived from primary and secondary tumours resected from the same
patient were our model system. We used (1) differential centrifuga-
tion and iodixanol gradients to purify EVs; (2) transwell migration,
dextran permeability and tube formation assays to test the functional
role of EVs; and (3) high-throughput, label-free mass spectrometry
SWATH to profile exosome proteins. Results: We found that
EVs released by metastatic SW620 cells are able to induce a
mesenchymal-amoeboid transition in SW480 non-metastatic cells.
Treatment of SW480 cells with exosomes from SW620 cells induced
non-apoptotic membrane blebbing, associated with higher migra-
tory and invasive capabilities. Moreover, SW620 exosomes, in
comparison with SW480 exosomes, induced a stronger permeability
of endothelial monolayers, which appeared to be due to destabiliza-
tion of endothelial junctional systems. RacGap1, which is a well-
known activator of RhoA, emerged as enriched in SW620 exosomes
by quantitative proteomic analysis. Further experiments demon-
strated that the effects of SW620 exosome treatment, both on SW480
and endothelial cells, are mediated by RhoA, responsible of cytoske-
letal remodelling. Conclusions: We demonstrated that, through
exosomes, highly metastatic cells spread their malignant behaviour
to less aggressive cells and affect tumour microenvironment.
OF23.4
Exosome-mediated delivery of miR-26a suppresses liver cancer growth
in vitro and in vivo
Jie Hu, Zhou Jian and Liu Wei-Feng
1Liver Cancer Institution Zhongshan Hospital, Fudan University, Shanghai,
China
Background: Accumulating evidence indicates that miRNAs in exo-
somes function as a communicator to modulate tumour biogenesis
and development. Delivery of miR-26a by adeno-associated virus
(AAV) potently results in dramatic suppression of liver tumour
progression in vivo and in vitro. However, safety consideration limited
the clinical application of AAV. In this study, we tried to establish a
novel miRNA delivery system based on exosomes. Methods: The
expression of exosomes miR-26a in healthy, cirrhosis and hepatocel-
lular carcinoma (HCC) patients was investigated. Purified exosomes
were loaded with synthetic miR-26a by chemical transduction and
then cultured with SMMC7721. The expression of miR-26a and its
targeted genes was determined by RT-PCR and validated by luciferase
reporter assays (LRA). The proliferation was evaluated by CCK8 assay
and Edu dye array. MHCCLM3-luciferase and BALB/c nude mice were
adopted to establish orthotopic HCC models. Tumour growth and
DiR-labelled exosome distribution were monitored dynamically by
IVIS Spectrum. Results: Exosomes miR-26a was significantly lower in
HCC patient versus healthy and cirrhosis. Patients with metastatic HCC
showed lower miR-26a compared with that of non-metastatic HCC
(pB0.01). LEF1 level in HCC tissue was inversely correlated with
exosomes miR-26a (r0.5478, pB0.001). KaplanMeier analysis
showed that tissue LEF1 and exosomes miR-26a were correlated with
OS and DFS. LRA demonstrated that exosome-mediated delivery of
miR-26a into HCC cells inhibits their proliferation by directly targeting
CCND1, CCND2 and CCNE2. In vivo imaging systems demonstrated
that xenografts exosomes distributed mostly in liver even 3 days
after intravenously injected. MiR-26a loaded exosomes showed
dramatic suppression of tumour size and lung metastasis in mice
model. Conclusions: HCC patients with low miR-26a level in exosomes
showed shorter DFS and OS. Delivery miR-26a by exosomes inhibits
HCC proliferation and metastasis through Wnt pathway in vitro
and in vivo.
OF23.5
CD8 T cells interrupt tumour progression including invasion and
metastasis by exosome-mediated depletion of mesenchymal tumour
stromal cells
Naohiro Seo1,2, Kazunari Akiyoshi1,3, Yoshitaka Shirakura4;
Tahara Yoshiro1,2, Hiroshi Shiku1,2 and Naozumi Harada1,2
1ERATO Bio-nanotransporter Project, Japan Science and Technology Agency,
(JST), Tokyo, Japan; 2Gradurate School of Engineering, Kyoto University, Kyoto,
Japan; 3Department of Polymer Chemistry, Graduate School of Engineering,
Kyoto University, Kyoto, Japan; 4Department of Immuno-Gene Therapy, Mie
University, Graduate School of Medicine, Mie, Japan
Introduction: Fibroblastic mesenchymal tumour stromal cells promote
strongly tumour progression in part an exosome-mediated manner.
On the other hand, there is no report about the role of CD8 T-cell-
released exosomes on the regulation of tumour progression. In this
study, we investigated in murine models whether or not exosomes
from CD8 T cells including CTLs affect the tumour progression
focusing on the modification of tumour stromal cells. Methods:
Supernatants obtained by the cultivation of CD8 T cells or control
cells were collected and subjected to exosome purification by the
filtration and ultracentrifugation (25,000 g, 2 h). The purified exosomes
were injected into d-10 subcutaneous CMS5a, B16 and B16F10
tumours (1.01.5 cm diameter) to investigate growth and CD140a
expression of tumours, and subsequent tumour invasion and metas-
tasis. CMS5a-specific CD8 T cells treated with/without GW4869 were
transferred i.v. of CMS5a tumour-bearing mice to examine exosome-
dependent depletion of fibroblastic tumour stromal cells. Results:
CD8 T-cell-released exosomes from the culture supernatant of
CD8 splenocytes of normal or CMS5a-specific TCR gene-transgenic
mice, but not tumour-bearing mice, attenuated CMS5a and B16
growth in correlation with the downregulation of CD140a expression.
The detailed studies using SYTO RNASelect-stained exosomes, MSC
chimeric mice and the cultured bone-derived MSCs demonstrated that
the reduced growth and CD140a expression in CD8 T-cell-released
exosome-treated tumours caused by interrupting tumour progression
after apoptotic death of exosome-engulfed fibroblastic mesenchymal
tumour stromal cells rather than the direct attenuation of tumour cells.
Furthermore, subcutaneous B16F10 tumour lost invasive and lung
metastatic properties by i.t. treatment of CD8 T-cell-released
exosomes. Conclusion: Our findings provide crucial insights that
CD8 T cells play as an anti-stromal effector in addition to the
conventional cytolysis of tumour cells and have a possibility to
develop effective treatment of patients with advanced cancer.
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OF24.1
Spleen-dependent immune protection elicited by reticulocyte-derived
exosomes from malaria infection revealed by T-cell population changes
Lorena Martin-Jaular1*, Armando De Menezes-Neto1,
Marta Monguio-Tortajada2, Aleix Elizalde-Torrent1,
Carmen Fernandez-Becerra1, Francesc E. Borras2, Maria Montoya3
and Hernando A. Del Portillo1
1Barcelona Institute for Global Health, Barcelona, Spain; 2Germans Trias I Pujol
Health Science Research Institute, Badalona, Spain; 3Centre De Recerca En Sanitat
Animal, Institut De Recerca I Tecnologia Agroalimenta´ries, Barcelona, Spain
*Present address: Institut Curie, INSERM U932, Paris, France.
Introduction: Reticulocyte-derived exosomes (rex) are released
during the maturation of reticulocytes. We previously found that the
immunization of mice with rex from Balb/c infected with the
reticulocyte-prone non-lethal P.yoelii17X strain (rexPy) in combination
with CpG-ODN promoted survival and long lasting protection of mice
subsequently challenged with a lethal strain. Methods: Exosomes were
isolated from P. yoelii-infected reticulocytes culture and used to
immunize Balb/c mice in combination of CpG-ODN 1826. Importance
of the spleen in the protection elicited by rexPy was assessed by
immunization of splenectomized mice and by transfer of splenocytes.
T-cell responses in the spleen after immunization were analysed by
flow cytometry. Analysis of the protein content of rexPy was done by
mass spectrometry. In order to translate these results to humans, in
vitro experiments with splenocytes from transplantation donors were
performed to analyse exosomes uptake and stimulation of spleno-
cytes by these vesicles. Results: We show that rexPy-mediated
protection is completely lost in splenectomized animals and such
protection is 100% achieved after passive transfer of splenocytes
obtained from animals immunized with rexPy. Notably, rexPy im-
munization of mice induced non-exhausted memory T cell expansion
with effector phenotype. Proteomics analysis of rexPy confirmed their
reticulocyte origin and demonstrated the presence of parasite
antigens. Moreover, human splenocytes were able to actively capture
plasma-derived exosomes from patients infected with P. vivax (exPv)
and stimulation of spleen cells with exPv for 72 h lead to an increase in
the number of T cells. Summary/conclusions: Our studies prove, for
what we believe is the first time, that rex from reticulocyte-prone
malarial infections are able to induce non-exhausted splenic long-
lasting memory responses. All together, these data further support the
value of rex as a novel vaccine and platform against malaria.
OF24.2
Malaria parasites regulate secretion of exosomes carrying distinct
cargo
Neta Regev-Rudzki
Weizmann Institute of Science, Rehovot, Israel
Cells use extracellular vesicles to communicate, to coordinate social
activities and, in the case of pathogens, to export virulence effectors
into host target cells. Previously, we showed that the lethal malaria
parasites directly communicate within a population using exosome-
like vesicles that are capable of delivering episomal plasmids and
these are produced at the ring-stage of the asexual life cycle.
Here, we identify these nanovesicles as exosomes and determine
their molecular content. By establishing advanced nano-resolution
techniques for analysing exosome content, we discovered that the
exosomes deliver endogenous nuclear genes, parasite apicoplast
and mitochondrial genomic DNA. Moreover, we show that the
nucleotide cargo is packaged into released exosomes only at specific
stage of parasite development in host (infected red blood cells),
highlighting the selectivity of this process. Our work identifies
previously unknown molecular players in signalling pathway of
malaria parasite and provides a new insight into our understanding
of how malaria parasites can manipulate their host environment.
OF24.3
Immunomodulation of anti-parasitic responses via Heligmosomoides
polygyrus secreted exosomes
Gillian Coakley1, Marissa Lear1, Rick Maizels2, Henry Mcsorley1,
Fabio Simbari1 and Amy Buck1
1Institute of Immunology and Infection Research, Ashworth Laboratories,
University of Edinburgh, Scotland; 2The Queen’s Medical Research Institute,
Centre for Inflammation Research, University of Edinburgh, Scotland
Helminth secretomes have been shown to play a central role in both
pathogenicity and the regulation of host defense. Through previous
studies, we have demonstrated that secreted vesicles from the
murine gastrointestinal nematode Heligmosomoides polygyrus ex-
hibit a range of regulatory properties in the murine host. To
investigate the fundamental interactions between helminth-derived
exosomes and host cells, we have performed comparative studies
between mammalian and H. polygyrus-derived exosomes. Using the
PKH67-labelling system, we were able to track exosome uptake in
cells (such as intestinal epithelial cells and primary macrophages)
over the course of 24 h. This illustrated a number of factors required
for optimal uptake and potential exosome function, including; time
of incubation, cell type and exosome origin. Microarray of
H. polygyrus exosome-treated small intestinal epithelial cells reveals
significant host gene changes, including those involved in the anti-
parasite response, such as IL1RL1 (the receptor for IL-33). We have
shown that H. polygyrus-derived exosomes can suppress the onset of
alternative activation and reduce expression of the IL33R in
macrophages. In addition, we have shown that a prophylactic dose
of exosomes can suppress IL33R expression in the ILC2 population
during an allergic asthma response in vivo. Immunization of mice
using an exosome/alum conjugate elicits significant immune protec-
tion from a subsequent H. polygyrus infection, as seen through a
reduction in egg counts and worm burden, whereby exosomes
can induce specific antibody responses. Complementary studies are
now under way to determine whether exosome-induced immunity
is intact in IL33R/ST2 knockout mice. Taken together, these studies
suggest that exosomes secreted by nematodes can mediate the
transfer of parasitic products into host cells, establishing cross-
species communication to modulate the host response, and that we
can block this process through vaccination.
OF24.4
Worsening of atopic dermatitis by Staphylococcus aureus-derived
membrane vesicles
Je Chul Lee, Hyejin Jeon, Hyo Il Kwon, Seok Hyun Na, Yoo Jeong Kim and
So Hyun Jun
1Kyungpook National University School of Medicine, Daegu, Republic of Korea
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Skin colonization or infection with Staphylococcus aureus is known
to trigger aggravation of atopic dermatitis (AD). We investigated
whether and how S. aureus-derived membrane vesicles (MVs)
contribute to worsening of AD. HaCaT cells were treated with
S. aureus MVs and analysed for the expression of pro-inflammatory
cytokine genes. Immunopathology and cytokine gene profiles were
analysed in the AD-like skin lesions of mice after topical application
of S. aureus MVs. Intact S. aureus MVs delivered their components to
keratinocytes and stimulated pro-inflammatory cytokine gene ex-
pression. However, MVs with a disrupted membrane did not sti-
mulate cytokine gene expression. A knockdown of TLR2 or NOD2 by
using siRNAs suppressed IL-8 gene expression. Topical application of
S. aureus MVs to AD-like skin lesions in the mouse model induced
infiltration of inflammatory cells and the resulting eczematous
dermatitis. This inflammatory reaction was associated with a mixed
Th1/Th2 immune response and enhanced expression of chemokine
genes in AD-like skin lesions. Our study provides evidence that
S. aureus MVs trigger an inflammatory response in AD-like skin
lesions. MVs produced by S. aureus colonizing or infecting AD skin
lesions may be responsible for worsening of AD.
OF24.5
Legionella pneumophila outer membrane vesicles are potent
pro-inflammatory stimulators for macrophages
Anna Lena Jung1, Cornelia Stoiber2, Christina Herkt1, Christine Schulz1,
Wilhelm Bertrams1 and Bernd Schmeck1
1Institute for Lung Research, Philipps-University Marburg, Marburg, Germany;
2Institute for Virology, Philipps-University Marburg, Marburg, Germany
The formation and release of outer membrane vesicles (OMVs) is a
phenomenon of Gram-negative bacteria. This includes Legionella
pneumophila (L. pneumophila), a causative agent of severe pneumo-
nia. Upon its transmission into the lung, Legionella primarily infects
and replicates within macrophages. Here, we analysed the influence
of L. pneumophila OMVs on macrophages. To this end, differentiated
THP-1 cells were incubated with increasing doses of Legionella
OMVs, leading to a TLR2-dependent classical activation of macro-
phages with the release of pro-inflammatory cytokines. Inhibition of
NF-kB signalling reduced the induction pro-inflammatory cytokines.
Furthermore, treatment of THP-1 cells with OMVs prior to infection
reduced replication of L. pneumophila in THP-1 cells. Blocking of
TLR2 activation or heat denaturation of OMVs restored bacterial
replication in the first 24 h of infection. With prolonged infection-
time, OMV pre-treated macrophages became more permissive for
bacterial replication than untreated cells, dependent on NF-kB
signalling, and showed increased numbers of Legionella-containing
vacuoles and reduced pro-inflammatory cytokine induction.
Additionally, miRNA-146a was found to be transcriptionally induced
by OMVs and to facilitate bacterial replication. Accordingly, IRAK-1,
one of miRNA-146a’s targets, showed prolonged activation-
dependent degradation, which rendered THP-1 cells more permis-
sive for Legionella replication. In conclusion, L. pneumophila OMVs
are initially potent pro-inflammatory stimulators of macrophages,
acting via TLRs, IRAK-1 and NF-kB, while at later time points,
OMVs facilitate L. pneumophila replication by miR-146a-dependent
IRAK-1 suppression. OMVs might thereby promote spreading of
L. pneumophila in the host.
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Adaptive Dynamic Artificial Poly-ligand Targeting (ADAPT) of Plasma
Exosomes: a Highly Multiplexed Non-Invasive Diagnostic Discovery
Platform
Mark R. Miglarese1, Valeriy Domenyuk1, Zhenyu Zhong1, Jie Wang1,
Adam Stark1, Xixi Wei1, Patrick Kennedy1, Brandon Toussaint1,
Radhika Santhanam1, Symon Levenberg1, Nianqing Xiao1, David Halbert1,
George Poste2, Michael Famulok3,4, Gu¨nter Mayer4 and David B. Spetzler1
1Caris Life Sciences, Phoenix, AZ, USA; 2Complex Adaptive Systems Initiative,
Arizona State University, Scottsdale, AZ, USA; 3Chemical Biology Max-Planck-
Fellowship Group, Center of Advanced European Studies and Research, Bonn,
Germany; 4LIMES Program Unit Chemical Biology & Medicinal Chemistry,
University of Bonn, Bonn, Germany
Introduction: Understanding individual biomarkers and multi-mole-
cular complexes in their native states represents a major hurdle in the
development of systems biology platforms and requires multiplexing
capabilities many orders of magnitude greater than what is currently
available. This knowledge is especially important in diseases like
cancer, where perturbations in signalling pathways lead to the
initiation and propagation of a vast range of molecularly hetero-
geneous phenotypes. Ideally, this information would be gathered
non-invasively from peripheral compartments. We report ADAPT as an
unbiased discovery method to identify native proteins and multi-
molecular complexes in plasma exosomes. Methods: ssDNA libraries of
2x1011 unique sequences were enriched towards association with
exosomes of plasma pools from breast cancer patients (n60) or
from a control cohort of women without breast cancer (n60). Two
thousand ODNs were selected from the enriched library and used to
profile 500 plasma samples: 206 breast cancer biopsy positive (BC),
177 biopsy negative (BCi) and 117 self-declared healthy (H)
samples. Results: Random Forest Modelling (RFM) was used to build
classifiers for BC versus both BC and H, BC versus BC and
BC versus H, with AUC values of 0.64, 0.64 and 0.73, respectively.
Out-of-bag validation was used for this analysis. Notably, 10-fold
cross-validation, repeated 20 times, resulted in ROC AUC values of
0.58 for BC versus both controls, 0.59 for BC versus BC, 0.62
for BC versus H. This difference between the out-of-bag and
cross-validation results suggest that the study is underpowered to
define an algorithm capable of handling the heterogeneity found in
this set of breast cancer patients. Conclusions: The ADAPT platform
uses ultra-high complexity libraries to improve the probability of
identifying ODNs which recognise biomolecules in their native state.
This unbiased approach quantifies differences between plasma from
women with breast cancer and women without breast cancer, likely
due to perturbations in molecular pathways. An ADAPT-derived
breast cancer test may find utility as a diagnostic tool in clinical
practice.
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OF25.1
MiR-9-mediated synaptodendritic alterations in HAND: role of
extracellular vesicles
Guoku Hu, Yu Cai, Lu Yang, Yeonhee Kook and Shilpa Buch
Department of Pharmacology & Experimental Neuroscience, University of
Nebraska Medical Center, Omaha, NE, USA
Introduction: Synaptodendritic injury (SDI) has emerged as an
important phenotype and correlate of HIV-associated neurocognitive
disorders (HAND). Furthermore, persistent inflammation has been
implicated as a major underlying factor in the progression and
pathology of HAND. Intriguingly, similar to HIV subjects on
antiretroviral therapy, SIV-infected rhesus macaques also demon-
strate SDI, increased glial activation and dysregulation of various
signature miRNAs (miRs) including miR-9. The goal of the present
study was to understand how HIV protein Tat mediates SDI via the
release of miR-9 in EVs. Methods: Using qPCR we demonstrated
increased expression of miR-9 in the frontal cortex of HIV/SIV-infected
humans/macaques. Transmission electron microscopy and western
blots were used to characterize EVs. The functional end point of SDI
was assessed by spine density assays. Results: HIV Tat exposure
resulted in increased release of miR-9 in the EVs isolated from
astrocytes. MiR-9-enriched EVs, in turn, were taken up by the neurons
resulting in SDI. This correlated with downregulated expression of
PDGF-CC, NLGN2 and MCPIP1, key players regulating normal synaptic
function in neurons, in SIV/HIV brains compared to uninfected
controls. This was validated by infection of rat primary cortical
neurons with lentivirus-miR-9, which resulted in decreased expression
of each of these proteins. Interestingly, neurons exposed to EVs
isolated from conditioned media of Tat-treated astrocytes also
demonstrated decreased expression of miR-9 target proteins.
Summary: HIV Tat-exposed astrocytes upregulate the expression
and release of miR-9 in EVs, which upon uptake by the neurons, leads
to SDI via downregulation of its target genes. Therapeutic strategies
aimed at maintaining the levels of miR-9 in the neurons, could be
developed for treatment of SDI in HAND.
OF25.2
Sensing of latent EBV infection through exosomal transfer of 5’pppRNA
Dirk Michiel Pegtel1, Monique Aj Van Eijndhoven1, Serena Rubina Baglio1
and Danijela Koppers-Lalic2
1VUmc, Department of Pathology, Exosomes Research Group; 2Vu University
Medical Center, Department of Pathology, Exosomes Research Group,
The Netherlands
Complex interactions between large DNA herpes viruses and host
factors determine the establishment of a life-long asymptomatic
latent infection. The lymphotropic EpsteinBarr virus (EBV) seems to
avoid recognition by innate sensors despite massive transcription of
immunostimulatory small RNAs (EBV-EBERs). Here, we demonstrate
that in latently infected B cells EBER1 transcripts interact with the La
ribonucleoprotein, avoiding cytoplasmic RNA sensors. However, in
co-culture experiments we observed that latent-infected cells trigger
antiviral immunity in dendritic cells through selectively release and
transfer via exosomes. In ex vivo tonsillar cultures, we observed that
EBER-loaded exosomes are preferentially captured and internalized
by human plasmacytoid dendritic cells (pDCs) that express the TIM1
phosphatidylserine receptor, a known viral- and exosomal target.
Using an EBER-deficient EBV strain, enzymatic removal of 5’ppp, in
vitro transcripts and co-culture experiments, we established that
5’pppEBER1 transfer via exosomes drives antiviral immunity in non-
permissive DCs. Lupus erythematosus patients suffer from elevated
EBV load and activated antiviral immunity in particular in skin lesions
that are heavily infiltrated with pDCs. We detected very high levels of
EBER1 RNA in such skin lesions as well as EBV-microRNAs but no
intact EBV-DNA, linking non-cell autonomous EBER1 presence to skin
inflammation in predisposed individuals. Collectively our studies
support the idea that virus-modified exosomes have a physiological
role in the host-pathogen stand-off and may promote inflammatory
disease.
OF25.3
Exosomal incorporation but not interaction with major
histocompatibility class II molecules is a conserved feature of alpha
herpes virus glycoprotein B
Andrea D. Lipinska, Kinga Grabowska, Magda Wachalska, Vasil B.
Krapchev, Paula Mazurek, Michal Rychlowski and Krystyna Bienkowska-
Szewczyk
Department of Virus Molecular Biology, Intercollegiate Faculty of
Biotechnology, University of Gdan´sk, Gdan´sk, Poland
Herpes viruses represent one of the most widespread pathogens.
Recent studies indicate intersections between exosome biogenesis
pathway and herpes virus assembly during infection and the role of
exosomes in the formation of antiviral immunity. Glycoprotein B (gB)
is a conserved in all herpes viruses entry mediator. Human herpes
simplex 1 (HSV-1)-encoded gB can additionally divert the major
histocompatibility (MHC) II molecules to exosomes, thus here we
aimed at assessing whether exosomal incorporation of gB and its
interaction with MHC II are conserved in other alpha herpes viruses.
gB homologs from HSV-1, bovine herpes virus 1 or pseudorabies virus
was introduced to human melanoma MJS as well as species-specific
cells (bovine MDBK, swine SK6, ST) using retroviruses. Extracellular
vesicles (EVs) were isolated from cell culture supernatants by
size-exclusion chromatography or ultracentrifugation followed by
discontinuous iodixanol or Ficoll density gradients. EVs were char-
acterized by TEM or NTA and their content by immunoblotting.
Subcellular localization of gB and exosomal markers was analysed by
confocal microscopy and gB-MHC II interactions were also deter-
mined by immunoprecipitation. N-glycosylation was analysed with
endoglycosidases, surface MHC II by FACS. EVs isolated from all stable
cell lines were enriched in gB. We could detect in EVs only the mature,
fully glycosylated form of gB. gB co-localized with exosomal marker
CD63 and mature MHC II, but only HSV-1 and BHV-1 homologs co-
precipitated MHC II. Their expression resulted in downregulation of
surface MHC II levels. This feature was not shared by PRV-encoded
gB which had no significant influence on MHC II. Our data show
that utilization of exosome biogenesis pathway by gB seems to
be conserved in alpha herpes viruses. gB released in EVs could
potentially act as a decoy for virus-neutralizing antibodies. MHC class
II-modulatory property is shared by HSV-1 and BHV-1 gB, but it may
differ in other alpha herpes viruses.
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OF26.1
Osteogenic differentiation of human mesenchymal stem cells using
exosomes derived from mesenchymal stem cells undergoing
osteogenic differentiation
Xiaoqin Wang, Omar Omar, Forugh Vazirisani, Karin Ekstro¨m and
Peter Thomsen
Department of Biomaterials, Sahlgrenska Academy, University of Gothenburg,
and BIOMATCELL VINN Excellence Center of Biomaterials and Cell Therapy,
Gothenburg, Sweden
Introduction: In a bone trauma, human mesenchymal stem cells
(hMSCs) migrate and home to injury sites and further contribute to
bone regeneration. However, the mechanism how hMSCs commu-
nicate with each other to promote osteogenic differentiation is still not
clear. In this study, we aimed to explore whether exosomes derived
from hMSCs undergoing osteogenic differentiation induced hMSCs to
differentiate and further investigated the possible underlying me-
chanism. Materials and methods: hMSCs were cultured with osteo-
genic additives in exosome-free media for 21 days (D). Conditioned
media (CM) were collected every 3 days. Exosomes (Exo) were isolated
from CM by ultracentrifugation and added to undifferentiated MSCs.
The osteogenic differentiation of Exo-treated MSCs was evaluated by
ALP assay after 14D, calcium/phosphate assay and Alizarin red staining
after 21D. Exosomal RNA was extracted and microRNA expression
profile was detected on Exiqon miRCURY LNATM Universal RT micro-
RNA PCR Human panel I. Results: ALP level was significantly increased in
all groups of Exo-treated MSCs compared with untreated group. In
contrast only D15-, D18- and D21-Exo induced significant increase of
calcium and phosphate, which indicates mineralization, in Exo-treated
MSCs. Exosomes from expansion (Exo-Exp), early differentiation (Exo-
D3) and late differentiation (Exo-D21) showed altered microRNA
expression profiles. There were 10 and 11 microRNAs having significant
change when comparing Exo-D21 with Exo-Exp and Exo-D3, respec-
tively. Interestingly, microRNAs related to osteogenic differentiation,
such as miR-31 and miR-10b, were found among these microRNAs.
Conclusions: The present observations indicate that exosomes derived
from hMSCs undergoing osteogenic differentiation promote a variable
degree of osteogenic differentiation and mineralization of MSCs.
Moreover, the delivery of osteogenic specific microRNAs from the
exosomes is a possible mechanism for the observed differentiation.
OF26.2
Human iPS-derived cardiac progenitors secrete cardioprotective
extracellular vesicles
Nisa Renault1, Anaı¨s Kervadec1, Vale´rie Bellamy1, Nadia el Harane1,
Hany Nematalla1,2, Mathilde Lemitre1, Florent Dumont3, Alexandre Colas4,
Marie Mercier1, Albert Hage`ge1,2, Mark Mercola3, Jean-Se´bastien Silvestre1
and Philippe Menasche´1,2
1Institut national de la sante´ et de la recherche me´dicale, Paris, France;
2Assistance PubliqueHoˆpitaux de Paris, France; 3Institut Cochin, Paris, France;
4Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California
Introduction: Extracellular vesicles (EV) have been reported to mediate
the cardioprotective effects of cell therapy for the treatment of
chronic heart failure (CHF). However, a direct comparison of their
effects with those of their parent cells has not been reported. We
explored whether human induced pluripotent stem-cell derived
cardiac progenitors (hiPS-Pg) and their EV were effective in the
treatment of CHF, and whether these effects were mediated by
microRNA (miR). Methods: hiPS-Pg were cultured in serum-free media
and total EV were collected by ultracentrifugation. EV number and size
distribution were determined by dynamic light scattering. iPS-Pg and
EV miR contents were determined by chip. EV pro-survival and pro-
proliferation potential on cultured cardiomyocytes (CM) were deter-
mined in vitro. In parallel, the therapeutic effects of hiPS-Pg and their
EV were examined by injection of cells (n=17 mice), EV (n=19) or PBS
(vehicle control; n=17) into the infarct border zone of nude mice with
CHF. Six-weeks later, blinded echocardiographic assessment of heart
function was performed. Results: A large number of EV were isolated
(732 EV/iPS-Pg; mode: 184 nm). EV increased CM viability in serum-
free media by 3.3 times and CM proliferation in a dose-dependent
manner, with a 2.5 fold average maximum increase. More than 100
miR, whose main targets are currently under investigation, were
identified that were highly enriched in EV as compared to hiPS-Pg. EV
significantly improved cardiac function in CHF mice, with decreased
left ventricular (LV) volumes (LVESV: 11%, pB0.001; LVEDV: 4%,
p=0.002) and increased LV ejection fraction (+14%, pB0.0001)
compared to baseline values. Surprisingly, EV out-performed the
iPS-Pg cells which showed no significant improvement in LV volumes.
Summary/Conclusion: hiPS-Pg secrete EV which are effective in the
treatment of CHF, possibly, in part, by promoting the survival and
proliferation of host CM through the transfer of specific miR.
OF26.3
Breast milk-derived extracellular vesicles influence the development
of the epithelial and immunological gastrointestinal barrier
Marijke I. Zonneveld1,2, Martijn J. C. van Herwijnen2, Marije Kleinjan2,
Marit de Groot3, Marcela Fernandez-Gutierrez4, Alice Sijts3, Michiel
Kleerebezem4, Leonie S. Taams5, Johan Garssen1,6, Esther N. M. ‘t-Hoen2,
Frank A. Redegeld1 and Marca H. M. Wauben2
1Division of Pharmacology, Department of Pharmaceutical Sciences, Faculty
of Science, Utrecht University, Utrecht, The Netherlands; 2Department of
Biochemistry & Cell Biology, Faculty of Veterinary Medicine, Utrecht University,
Utrecht, The Netherlands; 3Department of Immunology, Faculty of Veterinary
Medicine, Utrecht University, Utrecht, The Netherlands; 4Host Microbe
Interactomics Group, Department of Animal Sciences, Wageningen University,
Wageningen, The Netherlands; 5Centre for Molecular and Cellular Biology of
Inflammation, Division of Immunology, Infection and Inflammatory Disease,
King’s College London, London, UK; 6Nutricia Research Centre
for Specialized Nutrition, Utrecht, The Netherlands
Introduction: The gastrointestinal barrier is both a physical barrier and
an immunological site, which needs to mature in neonates. Breast milk
reduces intestinal permeability and supports neonatal immunity and
oral tolerance. However, the specific contribution of the different milk
components in these processes is not fully understood. Here, we
investigated the potential role of breast milk-derived extracellular
vesicles (EV) on components of the innate and adaptive immune
system, as well as on the epithelial barrier. Methods: We developed a
density gradient-based (optiprep) protocol for isolation of naturally
occurring EV from breast milk. The function of breast milk EV was
assessed in vitro by determining their effects on activation and cytokine
production of adult and neonatal CD4 T cells, on activation of Toll-
like receptor (TLR) reporter cell lines and downstream signalling,
and on migration/proliferation of epithelial cells in a wound-healing
assay. Results: Breast milk EV strongly inhibited aCD3/aCD28-induced T
cell activation and proliferation and resulted in an overall reduced
cytokine production. In this assay, high levels of CD45RA were
maintained on T cells, indicating a more naı¨ve and unresponsive state,
while no increase of FoxP3 regulatory T cells was observed. EV also
inhibited triggering of intracellular TLR while activation of extracellular
TLR2 and TLR4 was not inhibited. Finally, epithelial cells showed a
substantially increased wound-healing capacity in the presence of
breast milk EV. Summary/conclusion: Breast milk EV reduces immune
activation by inhibiting both T-cell responses and endosomal TLR
activation, while stimulating epithelial cell proliferation and migration.
Taken together, our data suggest a role for breast milk EV in both the
development of the intestinal barrier and the immune system.
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OF27.1
KRAS signalling regulates Argonaute 2 sorting into exosomes
Alissa Weaver1, Andrew Mckenzie2, Daisuke Hoshino3, Diana Cha4, Robert
Coffey5,6,7, James Patton4 and Jeff Franklin8
1Departments of Cancer Biology, Cell and Developmental Biology, and
Pathology, Microbiology and Immunology, Vanderbilt University, Nashville, TN,
USA; 2Department of Cancer Biology, Vanderbilt University School of Medicine,
TN, USA; 3Department of Cancer Cell Research, Kanagawa Cancer Center,
Yokohama, Japan; 4Department of Biological Sciences, Vanderbilt University,
Nashville, TN, USA; 5Departments of Medicine, Cell and Developmental
Biology, Vanderbilt University, Nashville, TN, USA; 6Department of Cell and
Developmental Biology, Vanderbilt University School of Medicine, Nashville;
7Veterans Affairs Medical Center, Nashville, TN, USA; 8Epithelial Biology Center,
Department of Cell and Developmental Biology, Vanderbilt University,
Nashville, TN, USA
Introduction: Secretion of miRNAs in extracellular vesicles (EVs) is a
novel form of intercellular communication. However, the mechanisms
governing miRNA and miRNA-binding protein secretion into exo-
somes remain largely unknown. Recently, mutant KRAS was shown to
regulate the content of RNA-binding proteins in exosomes. Based on
these data, we hypothesized that KRAS may control the secretion of
key RNA-binding proteins into exosomes. Methods: We performed
biochemical and confocal imaging experiments in isogenic cell line
models to investigate whether KRAS signalling controls the secretion
of Argonaute 2 (Ago2) in extracellular vesicles. Results: We find that
Ago2 is present in exosomes but not microvesicles purified from our
cell lines. Furthermore, KRAS signalling controls the secretion of
Argonaute 2 (Ago2) into exosomes. Ago2 phosphorylation down-
stream of KRAS leads to decreased association of Ago2 with multi-
vesicular endosomes (MVE) and a concomitant decrease in Ago2
secretion in exosomes. Mechanistically, inhibition of MEKI/II reverses
the KRAS-dependent phosphorylation of Ago2 and leads to increased
Ago2-MVE association and Ago2 secretion into exosomes. Moreover,
inhibition of Ago2 phosphorylation rescues the secretion of KRAS-
dependent miRNAs in exosomes. Summary/conclusion: These data
demonstrate regulation by KRAS signalling of Ago2 secretion into
exosomes. Furthermore, they suggest a potential mechanism for
regulating miRNA secretion into exosomes downstream of KRAS.
Funded by NIH grant U19 CA179514.
OF27.2
Syntenin exosomes mediate SRC function in cell-cell communication
Naga Sailaja Imjeti1,2, Frederique Lembo1, Antonio Egea-Jimenez2, Celine
Lecointre3, Rania Ghossoub1, Guido David1,2, Habib Bouguenina1, Ali
Badache1, Serge Roche3 and Pascale Zimmermann1,2
1Centre de Recherche en Cance´rologie de Marseille, 13009 Marseille, France;
2Department of Human Genetics, KULeuven, 3000 Leuven, Belgium; 3CRBM,
34000 Montpellier, France
We previously showed that the small PDZ-adaptor protein syntenin
supports the biogenesis of exosomes and the loading of these
vesicles with cargo. We showed that this syntenin function depends
on its direct interaction with the ESCRT accessory component ALIX,
and on mechanisms involving syndecans and heparanase, on the
luminal side, and the small GTPase ARF6 and its effector PLD2, on
the cytosolic side (reviewed in Friand et al., 2015). Interestingly, in a
model of SRC dependent colon carcinogenesis, SRC was shown to
increase the tyrosine phosphorylation of syntenin and ALIX (Sirvent
et al., 2012). Here, we investigated the role of SRC in the syntenin
exosomal pathway. By gain and loss of function studies, we
established that SRC and SRC kinase activity strongly regulate the
exosomal levels of syntenin, ALIX, syndecans and CD63 but not that
of CD9 or flotillin-1. We provided evidence that SRC impacts on
syntenin exosomes by controlling endosomal budding and endocy-
tic events upstream of ARF6. We showed that SRC requires syntenin
to work in trans, via exosomes, to control the migration of
endothelial cells. Our study highlights that SRC functions in cell
cell communication by controlling syntenin-dependent exosome
biogenesis, and reveals a mechanism most probably supporting
tumour-host transcellular signalling.
This work was supported by the Concerted Actions Program of
the KU Leuven (GOA/12/016), the Institut National du Cancer (INCa,
subvention 2013-105) and the Fund for Scientific Research 
Flanders (FWO, G.0846.15).
OF27.3
Exosomes surf on filopodia to enter cells at endocytic hot spots, and
shuttle with endosomes to scan the endoplasmic reticulum  a
highway to the cell
Nicole Meisner-Kober1, Wolf Heusermann1, Justin Hean2, Emmanuelle
Steib3, Dominic Trojer3, Stefan Vonbueren3, Alexandra Graff-Meyer4,
Christel Genoud4, Katrin Martin1, Hans Voshol3, David Morrissey5, Samir El
Andaloussi6 and Matthew Wood2
1Novartis Institutes for Biomedical Research, Cambridge, Massachusetts;
2University of Basel, Basel, Switzerland; 3Oxford University, Oxford, England;
4Friedrich Miescher Institute, Basel, Switzerland; 5Intellia Therapeutics;
6Karolinska University Hospital, Solna, Sweden
Exosomes are nanovesicles released by virtually all cells which
can act as intercellular messengers by transfer of protein, lipid and
RNA cargo. Their quantitative efficiency, routes of cell uptake and
subcellular fate within recipient cells remain elusive. Here, we will
describe a quantitative characterization of exosome cell uptake
at the single cell  single vesicle level using an automated high
content screening assay, single particle tracking in live cells as well as
transmission electron microscopy. We reveal that exosomes are
recruited as single vesicles to the cell body by surfing on filopodia, as
well as filopodia grabbing and pulling motions to reach endocytic
hot spots at the filopodial base  highly reminiscent of viruses and
pathogenic bacteria. Following internalization, exosomes shuttle as
intact vesicles within endocytic vesicles to scan the endoplasmic
reticulum before being sorted into the lysosome as their final
intracellular destination. Our data quantify and explain the efficiency
of exosome internalization by recipient cells, establish a new parallel
between exosome and virushost cell interaction, and suggest
unanticipated routes of subcellular cargo delivery.
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PF1.01
Urinary extracellular vesicles number and diameter as biomarkers of
renal disease in diabetic patients
Agnieszka Kaminska1, Mark Platt2, Beata Kusnierz-Cabala3,
Marek Kuzniewski4 and Ewa Stepien1
1Department of Medical Physics, Faculty of Physics, Astronomy and Applied
Computer Science, Jagiellonian University, Krakow, Poland; 2Department of
Chemistry, Loughborough University, Loughborough, UK; 3Department of
Diagnostics, Chair of Clinical Biochemistry, Jagiellonian University Medical
College, Krakow, Poland; 4Department of Nephrology, Jagiellonian University
Medical College, Krakow, Poland
Background: About 3040% of diabetic patients develop renal disease,
although not all of these will progress to renal failure. Extracellular
vesicles (EVs) reside in various body fluids, including urine. Their
amount or molecular content are specific with disease progression
and tissue damage. Aim: Finding the relationship between the
urinary EVs number and size distribution and the progress of renal
disease in type 2 diabetic patients (T2DM). Patients and methods:
T2DM patients were enrolled to this study: UD  poorly controlled;
CD  properly controlled diabetes. HbA1C below 7% was a threshold
for diabetes treatment. Patients were further divided on two groups:
NRF  without renal failure and RF with renal failure, according to the
estimated GFR below 60 mL/min/1.73 m2. First morning urine
specimens were collected for analysis. Number and diameter of EVs
were determined by Tunable Resistive Pulse Sensing technology,
which was used in qNano system. Results: RF patients had reduced
number of EVs compared with NRF ones (2.57*E10 vs. 8.73*E10 count/
mL; pB0.05). We observed a positive correlation between the number
of EVs and level of serum glucose in controls (R0.6; pB0.05) and a
negative correlation in UD (R0.38; pB0.05) and RF (R0.66,
pB0.05) patients. In RF, we found also a negative correlation between
EVs number and creatinine concentration (R0.73; pB0.05). The
size distribution study showed that CD patients had larger EVs (mode)
then UD patients (114.5 vs. 108.67 nm; pB0.05), nevertheless the mean
MV diameter was smaller in controls than in the CD group (123.28 vs.
133.86 nm; pB0.05). Summary: Our results indicate that number and
size of urinary EVs can be considered as renal failure biomarkers. The
lower amount of EVs corresponds with deteriorating and worsening
renal function in diabetes in routine biochemical parameters.
Funding: This study was funded by the NCN grant (2012/07B/NZ5/
02510).
PF1.02
Discovery of a Urinary exosome mRNA signature for the diagnosis
of human kidney transplant rejection
Lan Hu1, Johan Skog1, James Hurley2, Graham Brock2, Jamil Azzi3,
Anand Srivastava4, Esilida Karecci4, Albana B. Mihali4 and Daniel Gauvin4
1Research and Development, Exosome Diagnostics, Cambridge, MA, USA;
2Exosome Diagnostics, New York, NY, USA; 3Brigham and Women’s Hospital
and Children’s Hospital, Boston, Massachusetts, USA; 4Transplantation
Research Center, Renal Division, Brigham and Women’s Hospital and Children’s
Hospital, Boston, Massachusetts, USA
Introduction: Patients with end-stage renal disease usually undergo
transplantation, but acute rejection carries a risk of 1015%. Methods
for monitoring clinical rejection including increases in serum creati-
nine and urinary protein excretion may not reflect subclinical rejection.
Similarly, repeat biopsy may result in increased complications and
cost. An accurate non-invasive method would allow for earlier
diagnosis and minimize the amount of immunosuppression needed.
Nucleic acids and proteins extracted from urinary pellets are currently
the main source for such biomarker studies. Extracellular vesicles such
as exosomes are released by cells and carry the parent cells’ surface
proteins and nucleic acids. Exosomes can be isolated and their nucleic
acid profile interrogated. In the transplanted kidney, exosomes will
originate from glomerular podocytes, renal tubular cells and from
immune cells, generated during rejection. Methods: Urine samples
were collected from patients undergoing a transplant kidney biopsy
for clinical indications. A total of 28 urine samples (14 rejections, 14
non-rejections) were collected from 24 patients. RNA from both the
urinary cell pellets and exosomes were isolated for expression
profiling. We characterized 586 mRNAs associated with inflammation
and 21 endogenous controls on the OpenArray(r) system. Results:
Two samples were excluded from analysis due to low RNA yield.
We detected the expression of 207 (34%) to 521 (86%) genes. Seven
control genes with robust detection were used for normalization.
Analysis of mRNA expression in urinary pellets and exosomes
identified genes that were differentially regulated. The exosome
samples identified 23 significantly differentially expressed genes.
The genes identified from exosomal RNA performed significantly
better in correctly differentiating between rejection and non-
rejection compared to the cell pellet RNA. We are now validating
these markers from exosomes in an independent patient cohort.
PF1.03
The content of microRNA is modulated in plasma extracellular vesicles
in patients with end-stage chronic kidney disease
Ciro Tetta
Fresenius Medical Care
Background: On-line haemodialtration(OL-HDF) was shown to im-
proveintra-dialytic haemodynamics and cardiovascular outcome in
randomized clinical trials. Despite potential explanations for such
benefit, the biological mechanism/s is still unclear. In this study,
we evaluated whether an evolved form of ON-HDF, the so-called
mixed OL-HDF (mOL-HDF), may modulate the release and the
phenotype of plasma extracellular vesicles(EVs), as known mediators
of cell-to-cell-communication. Methods: A total of 30 bicarbonate
haemodialysis (BHD) patients were randomized to continue BHD
(n15) or to switch to mOL-HDF (n15). Plasma concentration,
size, cellular origin and miRNA content of EVs was evaluated for
9 consecutive months and compared with EVs from healthy controls
(n10). EV-induced angiogenesis and apoptosis of endothelial cells
(HUVEC) and osteoblast mineralization of vascular smooth muscle
cells (VSMC) were evaluated. Results: Endothelial cell-derived EVs
were highest in BHD patients with no difference in number or size.
However, anti-angiogenic miR-223 was increased in BHD in respect
to healthy subjects and mOL-HDF. In vitro EVs from BHD reduced
angiogenesis and increased endothelial cell apoptosis and VSMC
calcification in respect to EVs from health subjects. Of note, EVs
from mOL-HDF significantly increased angiogenesis and reduced
endothelial apoptosis and VSMC calcification. The involvement of
mRNA-223 was evidenced in vitro by cell transfection with mRNA-
223 or antagomiR. Conclusions: mOL-HDF significantly reduced
miRNA-223 expression in plasma-EVs, increased angiogenesis and
decreased VSMC calcification. These data may give a biological
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rationale to the clinical benefit of OL-HDF treatments. Further studies
are needed to confirm these observations on large cohorts of
patients and to draw a relationship with clinical end points.
PF1.04
RNA profiles in exosomes from kidney transplantation preservation
fluid are associated with post-transplantation kidney function
Bas Van Balkom1, Hendrik Gremmels1, Raechel Toorop1,
Gert Jan De Borst1, Yu-Xuan Chen1, Liselotte Ooms2, Frank Dor2,
Olivier De Jong1, Laura Michielsen1, Alexander Vlassov3,
Arjan Van Zuilen1 and Marianne Verhaar1
1UMC Utrecht, Utrecht, The Netherlands; 2Erasmus Medical Center, Rotterdam,
Netherlands; 3Thermofisher, Waltham, Massachusetts
Introduction: Kidney transplantation is the preferred option for end-
stage kidney disease patients, but shortage of donor kidneys is an
increasing problem. Zero-hour biopsies analysis can assess kidney
quality and have predictive value for short- and long-term transplan-
tation outcome but require an invasive procedure and may not reflect
the entire organ. Alternatively, non-invasive and more representative
methods to assess graft quality are required. We hypothesized that
kidney preservation fluid contains exosomes which harbour biomar-
kers associated with graft quality, allowing prediction of kidney
function and risk for complications after transplantation. Methods: We
developed a protocol to collect preservation fluid. Preservation fluid
from kidneys from different donor types (living, donation after brain
dead [DBD] or after circulatory death [DCD]) each associated with
different risks for post-transplantation adverse kidney function, was
analysed for the presence of exosomes by ultracentrifugation or
commercial reagents followed by nanoparticle tracking, electron
microscopy and density gradient analyses. Small RNA content was
analysed by next-generation sequencing and qPCR array analysis.
Results: Exosomes of around 132 nm with a density of 1.11 g/ml were
isolated from the donor kidney preservation fluid. RNA was isolated
and sequenced, identifying 2000 small RNAs, including miRNAs
and tRNAs. Comparing exosomal small RNAs from different donor
types identified 83 small RNAs that distinguish between donor types.
Analysis of the most abundant small RNAs by qPCR array, comparing
RNA profiles from DCD donor kidneys with delayed or immediate graft
function, identified 4 small RNAs that are significantly associated with
post-transplantation kidney function. Summary/conclusion: We present
a novel exosome-based approach to assess donor kidney quality and
post-transplantation function. This approach is non-invasive, easy to
implement and can be easily translated to other donor organs.
PF1.05
Detection of Plasmodium vivax, Trypanosoma cruzi and Fasciola
hepatica proteins by extensive proteomic analysis in plasma-derived
exosomes
Joan Segui1, Antonio Osuna2, Antonio Marcilla3 and
Hernando A. Del Portillo4
1ISGlobal - Institute for Global Health, Hospital Clı´nic - Universitat de Barcelona;
2Institute of Biotechnology, Biochemistry and Molecular Parasitology, University
of Granada, Granada, Spain; 3Area De Parasitologia, Department De Biologia Cel.
Lular I Parasit, Universitat De Vale`ncia - Research Unit on Endocrinology,
Nutrition and Clinical Dietetic - La Fe, Valencia, Spain; 4ICREA at Isglobal -
Institute for Global Health, Hospital Clı´nic - Universitat De Barcelona and Institut
D’Investigacio´ Germans Trias I Pujol (IGTP), Barcelona, Spain
Introduction: Malaria is caused by Plasmodium vivax, fasciolosis
and Chagas diseases. These are three neglected tropical diseases
responsible each year for millions of infections worldwide, including
disease and death. Our present research effort is focused on the
molecular characterization of plasma-derived exosomes from these
diseases. Exosomes are nanovesicles of endocytic origin recently
shown to be involved in inter-cellular communication and whose
selective-cargo is being explored as novel therapeutic agents and
diagnostic markers in parasitic diseases (Marcilla et al., J Extracell
Vesicles 3: 25040, 2014). Methods: Exosomes were obtained from
plasma of infected patients (malaria and Chagas) and infected cows
(Fasciola hepatica), as well as from healthy volunteers and animals
as negative controls. Vesicle isolation was performed using size
exclusion chromatography (SEC) using sepharose CL-2B, commercially
available qEV columns (iZONTM). Profiling of individual fractions
eluted from SEC was conducted by use of latex beads coated with
antibodies against the tetraspanins CD9 and CD81, cryo-transmission
electron microscopy (cryo-TEM) and Nanoparticle Tracking Analysis
(NTA) to confirm their presence, size and concentration. An extensive
LC-MS/MS proteomic analysis was performed in these samples
comparing different pre-treatments, digestions, and mass spectro-
meters. Results: After defining the best protocol, several parasite
proteins were identified in plasma-derived exosomes. Summary/
conclusion: Plasma-derived exosomes from samples of these ne-
glected tropical diseases contain parasite-specific proteins which
could facilitate studies on mechanistic insights of pathology, antigen
discovery for vaccination and disease biomarker identification.
Funded by Fundacio´n Ramo´n Areces, Madrid, Spain.
PF1.06
A plasma extracellular vesicle protein signature as a biomarker for
diagnosis of unstable angina
Ingrid Bank1, Arend Mosterd2, Crystel Gijsberts1, Gerard Pasterkamp1,
Leo Timmers3, Vince De Hoog3, Sui Kwan Sze4 and Dominique De Kleijn1
1Experimental Cardiology, University Medical Center Utrecht, Utrecht, The
Netherlands; 2Cardiology, Meander Medical Center, Amersfoort, The
Netherlands; 3Cardiology, University Medical Center Utrecht, Utrecht,
The Netherlands; 4School of Biological Science, Nanyang Technological
University, Singapore, Singapore
Introduction: Annually, millions of patients enter the emergency
department with chest pain suggestive of myocardial infarction (MI)
or unstable angina (UA). MI can quickly be diagnosed based
on elevated high-sensitive troponin. In contrast, for the diagnosis
of UA (by definition troponin-negative) no diagnostic blood-based
biomarkers are available. We hypothesized that a plasma extracel-
lular vesicle (EV) protein signature can be used as a diagnostic
biomarker for unstable angina. Methods: From the MINERVA acute
chest pain cohort, 27 patients with UA and 31 with matched controls
(i.e. matched for sex, age, history, risk factors and medication) were
selected. LDL, HDL, remaining (REX) and total (TEX) plasma fractions
were isolated using sequential precipitation and EV proteins were
measured in these plasma fractions. SerpinF2, SerpinG1, SerpinC1,
CD14 and Cystatin C were identified as potentially associated with
UA by a mass spectrometry-based proteomics and were measured in
all plasma fractions of the individual patients with an immunobead
assay. Univariable and multivariable logistic regressions, as well
as ROC-curves and AUCs, were used to evaluate the diagnostic
performance of individual and combined biomarkers. This study
complies with the declaration of Helsinki, informed consents were
obtained and ethical approval was waived by the medical ethics
committee. Results: The best individual markers to discriminate
between UA and matched controls were SerpinC1 with the ratio
HDL/REX and an AUC of 0.855 (95% CI 0.7530.957); CD14 with the
ratio HDL/REX and an AUC of 0.847 (95% CI 0.7460.948) and
SerpinC1 in the HDL fraction with an AUC of 0.844 (95% CI 0.741
0.947). The best combination of markers was SerpinC1-HDLCD14-
TEXSerpinC1-LDL and showed an AUC of 0.933 (95% CI 0.865
1.000) and is being validated in the large MINERVA cohort of 2000
patients. Summary/conclusion: This study shows that EV proteins can
be used as diagnostic biomarkers for unstable angina.
PF1.07
Impact of Age on Plasma Extracellular Vesicle Concentration and
Protein Content in Humans
Erez Eitan1, Kenneth Witwer2, Jamal Green1, Monica Bodogai1, Nicole
Noren Hooten1, Michele Evans1 and Mark Mattson3,4
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The concentration and molecular composition of extracellular
vesicles (EVs) in the plasma have been reported to vary in association
with various disease states, and such alterations provide opportu-
nities for the development of novel biomarkers. However, it is not
known if plasma EV concentration and molecular composition might
change during ageing in healthy individuals. Here, we report the
results of measurements of plasma EV concentration and levels
of several proteins of interest. EVs were isolated by ExoQuick from
75 males and females (2 samples/subject 3070 years old) in the
Healthy Aging in Neighborhoods of Diversity across the Life Span
study. The EV concentration was measured by nanoparticle tracking
and levels of selected proteins were measured by EV-array and ELISA.
The uptake of flourescently labelled EVs by leucocyte was evaluated
by FACS analysis. The concentration of EVs in the plasma was
negatively correlated with age and was independent of body weight,
glucose levels and smoking status (pB0.01 repeated measure
multiple regression model). Body weight was positively correlated
with EV concentration independently of age (pB0.01). EV size was
not affected by age. Analyses of 37 EV surface proteins revealed age-
related increases in neuronal and oncogenic proteins (pB0.05).
Moreover, LC3, JnK, HSP70 and pTau-181 levels in EVs increased with
advancing age. EVs were internalized by monocytes and B cells, but
not T cells in a dosetime-dependent manner. Interestingly, EVs from
old individuals were internalized by B cells significantly more than
EVs from young individuals, but similar internalization was observed
by monocytes. The plasma concentration of EVs declines during
ageing and is positively associated with body weight. EVs from
old subjects are more readily internalized by B cells, suggesting
enhanced antigenicity of EVs during ageing. Our data provide insight
into the role of plasma-derived EV role in ageing, and circulating
immune cells.
PF1.08
Combined use of exosome miRNA, TREC and thymulin values as
circulating biomarkers of immune senescence
Krisztian Kvell1, David Ernszt1, Dorottya Kardos1, Sarra Baehl2,
Tamas Fulop2 and Judit Pongracz1
1University of Pecs, Pe´cs, Hungary; 2University of Sherbrooke, Que´bec
Introduction: The thymus is a central immune organ that shows rapid
senescence with approximately 90% decline by the age of 50 years in
human. However, significant individual variations exist and immuno-
logical age may diverge from chronological age. Historically, thymulin
serum levels have been suggested to characterize thymic function.
Currently, TREC numbers of circulating T-cells are gold-standards for
evaluating thymic function. However, selective enrichment of thymic
epithelial exosomes and characteristic miRNA profiling may provide
further insight into age-related thymic decline. Methods: For the
current pilot study, 5 verified healthy young (1825 years old) and
5 verified healthy senior (5565 years old) individuals provided
peripheral blood samples following informed consent. Serum and
cellular components were separated by Ficoll-gradient centrifuga-
tion. Serum thymulin values were measured by competitive ELISA
using recombinant human thymulin. TREC values were obtained by
TaqMan 3D PCR using PBMC genomic DNA. CD63-negative thymic
exosomes were enriched then assayed for transcription levels of miR-
27, miR-154, miR-200, miR-382, miR-431 and miR-465. Results and
discussion: As expected, if single parameters of thymic age or function
(like thymulin, TREC or miRNA levels) are compared between young
and senior individuals, data show significant overlap, and differences
lack statistical power. However, the combined use of multiple
parameters may increase statistical power despite relatively low
number of samples and relatively high level of individual differences.
We plan to expand our research using further samples and
biomarkers to increase the statistical power of immune age profiling
from peripheral blood samples.
PF1.09
Exosomal isoforms of microRNAs as a novel group of tissue-specific
biomarkers
Benedikt Kirchner1, Dominik Buschmann1, Vijay Paul2 and
Michael W. Pfaffl1
1Division of Animal Physiology and Immunology, School of Life Sciences
Weihenstephan, Technical University Munich, Germany; 2National Research
Centre On Yak (Icar), Arunachal Pradesh, India
The high resolution down to single nucleotide changes afforded by
small RNA-seq has revealed a new dimension of heterogeneity
during miRNA biogenesis, resulting in multiple sequence and length
isoforms (isomirs) besides canonical miRNAs. Isomirs have been
shown to associate with RISC and the translational machinery and
can be functional by regulating miRNA targets. Similar to strand
switching between -5p and -3p as the dominant miRNAs, recent
studies have shown differential expression of isomirs across tissues
and developmental stages. As exosomes (Exo) are key mediators of
intercellular communication, we assessed holistic isomir expression
profile specificity in Exo of 2 major biofluids, bovine blood and milk.
Exo were isolated from calf plasma and additionally from milk by
differential ultracentrifugation and purified on a sucrose density
gradient. Total RNA including miRNA was isolated from Exo as well as
whole milk and blood samples. Isomir variants were generated from
canonical miRNA sequences obtained from mirbase and differential
expression profiles were analysed via small RNA Seq and an in-house
developed data analysis workflow. Breakdown of miRNA expression
into isoform transcripts revealed a substantial amount of isomirs
in blood and milk samples. Isomirs accounted for 4564% of all
mapped reads and, consistent with the prevailing view, showed
a clear preference for miRNA alterations at the 3? end (93.8%) and
not the 5? end (6.2%). Expression of isomir variants was not evenly
distributed between miRNAs in both tissues with some miRNAs
being almost exclusively expressed as isomirs (e.g. bta-mir-144 in
milk). Significantly different isomir profiles could be detected be-
tween both biofluids (blood and milk) and between exosomes and
cells of the same tissue. In summary, our findings highlight the still
unexploited potential of miRNA isoforms as tissue-specific biomar-
kers especially in heterogeneous biofluids.
PF1.10
Comparison of circulating exosomal miRNAs during the process of liver
fibrosis by chronic hepatitis B and C infections
Joeri Lambrecht, Pieter Jan Poortmans, Hendrik Reynaert and Leonardus
Adrianus Van Grunsven
Vrije Universiteit Brussel, Brussels, Belgium
Introduction: Chronic hepatitis B (HBV) and chronic hepatitis C (HCV)
infections are associated with activation of the hepatic stellate cells
(HSCs) towards a myofibroblastic phenotype, resulting in excessive
scar formation, and the development of liver fibrosis and its
progression towards a cirrhotic state. Till date, the golden standard
for liver fibrosis remains liver biopsy, which is however associated
with pain, bleeding and sometimes even death. Other non-invasive
scoring systems evade these drawbacks, but lack inter-stage
specificity and are unable to detect early stages of the fibrosis
process. Circulating exosomal miRNAs derived from the affected liver
could be a potential stage-specific biomarker for this pathology.
Research concerning the analysis of exosomal miRNAs in hepatitis B
and C patients has already been conducted by some research groups
but lacks significant comparison of the results of both groups, and
their relationship with the stage of fibrosis progression. We aimed to
verify the dynamic expression of various exosomal miRNAs in the
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circulation of HBV and HCV patients and associate them with fibrosis
staging. Methods: Blood samples were obtained from healthy
individuals and HBV- and HCV-infected patients who underwent
transient elastography (Fibroscan). Exosomes were purified from the
plasma by Exoquick precipitation and their miRNA content was
analysed by qRT-PCR. Results/conclusion: Obtained miRNA expression
profiles were correlated with the calculated Fibroscan liver fibrosis
staging. Analysed miRNAs were selected from literature based on
correlation in expression patterns during HBV- and HCV-induced
fibrosis, and include amongst others miR-122, miR-21 and miR-92a.
Results will be discussed during ISEV 2016.
PF1.11
The utility of exosomes as a biomarker of N-methyl-D-aspartate
receptor encephalitis
James Bowness1, Deborah Forbes1, Julia Sawatzky2, Sharon King1,
Simon Powis2 and Tim Hales1
1University of Dundee, Scotland; 2University of St Andrews, Scotland
Introduction: N-methyl-D-aspartate (NMDA) receptor encephalitis
presents insidiously, with changes in behaviour, but subsequently
develops psychotic features and disordered movement. Hypoventila-
tion and coma can necessitate critical care support. IgG autoanti-
bodies to NMDA receptor NR1 subunits are believed to stimulate an
autoimmune neuroinflammatory state. A growing body of evidence
implies a role of exosomes in immune modulation and as biomarkers
of disease. This study aims to explore the potential of exosomes as a
biomarker of NMDA receptor encephalitis. Methods: Serum from a
patient with NMDA receptor encephalitis was compared with normal
serum. The concentration and size of the microvesicles was deter-
mined by NanoSight tracking analysis (NTA). They were assessed for
the presence of characteristic exosome markers (ALIX, TSG101,
GAPDH) and NMDA receptor using western blotting. Mouse fibro-
blasts (LtK-)-expressing NMDA receptors were cultured with patho-
logical (containing NMDA receptor antibody) and normal serum.
Media from these cultures were assessed using NTA and western
blots. Results: The size of microvesicles in pathological and normal
serum differed: peak diameter 2632 versus 143169 nm, respec-
tively. Pathological serum contained 6.3 times as many particles of
50150 nm diameter (805 vs. 128 x 108/mL). Western blotting of
exosome pellets confirmed the presence of exosome markers and the
NMDA receptor. Media from fibroblasts, cultured in the presence of
NMDA receptor antibody, contained 3.7 times as many exosome-
sized particles (4.78 vs. 1.28 x 108/mL). Exosome markers and the
NMDA receptor were again present. Summary: This exploratory study
shows a differing microvesicle population in NMDA receptor en-
cephalitis and normal sera. They contain recognized exosome
markers and NMDA receptor. The exosome population produced
by mouse fibroblasts containing the NMDA receptor altered by
exposing them to NMDA receptor antibody, potentially replicating
the state found in disease.
PF1.12
Skeletal muscle-derived microvesicles expressing fatty acid
transporters are increased by acute exercise
Morten Hjuler Nielsen1, Andreas Pedersen2, Kurt Højlund2 and
Aase Handberg1,
1Department of Clinical Biochemistry, Aalborg University Hospital, Aalborg,
Denmark; 2Department of Endocrinology, Odense University Hospital, Odense,
Denmark
Introduction: Skeletal muscle is a secretory organ important for
intercellular metabolic communication. We propose that microve-
sicles (MVs) shed from skeletal muscle (SMMVs) may be involved.
Furthermore, acute exercise (AE) induces release of SMMVs, in
particular SMMVs expressing fatty acid transporter protein 4 (FATP4)
and CD36. The aim of this study was to investigate the presence
of circulating SMMVs and to study the impact of AE on SMMVs and
SMMVs expressing FATP4 and CD36 in particular. In addition, the
influence of T2DM was explored because fatty acid uptake is
increased in T2DM. Methods: Obese males with (N13) and without
(N14) T2DM underwent a 60-min bicycle exercise test. Blood
samples were collected before and immediately after AE. SMMVs
were identified by flow cytometry as particles positive for phospha-
tidylserine and muscle-specific Sarcoglycan and either FATP4 or
CD36. Study groups were compared by MannWhitney U test and
AE-induced MV release by Wilcoxon signed-rank test. The study was
approved by the local ethical committee and informed consent was
obtained before inclusion. Results: At baseline, total MV numbers
were increased by 10% in T2DM compared to controls (pB0.05) and
SMMVs tended to be increased, whereas SMMVs expressing FATP4
or CD36 were unaltered. In T2DM, AE increased total SMMVs by 42%
(pB0.05), whereas SMMVs carrying FATP4 or CD36 were increased
by 130% (pB0.01) and 120% (pB0.02), respectively. In controls,
total SMMVs and SMMVs carrying FATP4 were unaltered after AE,
whereas CD36-positive SMMVs were increased by 15% (pB0.02).
Conclusion: This study presents novel data demonstrating the
presence of circulating SMMVs. AE triggers release of SMMVs into
the circulation, and their fatty acid transporter expression is
dependent on the presence of T2DM. We hypothesize that SMMVs
shed upon muscle contraction may be involved in intercellular
communication and provide novel insight to the metabolic condi-
tion of their parental skeletal muscle cells.
PF1.13
Extracellular vesicles from lung epithelial cells as early indicator
of paraquat exposure
Gesiele Verissimo1, Birke Benedikter2, Charlotte Volgers2,
Frank R. M. Stassen2, Aalt Bast1 and Antje R. Weseler1
1Department of Pharmacology and Toxicology, Maastricht University,
Maastricht, The Netherlands; 2Department of Medical Microbiology,
Maastricht University, Maastricht, The Netherlands
Introduction: Despite its high toxicity, the herbicide paraquat (PQ) is
still widely used in many countries worldwide. Exposure of humans
to PQ causes fatal lung damage due to PQ accumulation in airway
cells and extensive intracellular redox cycling. Early detection and
treatment initiation of PQ poisoning is yet impossible due to a lack of
sensitive markers. Since extracellular vesicles (EVs) are released upon
cell stress, we hypothesized that the release of EVs may indicate PQ
exposure before cytotoxic effects are detectable. Methods: After 24
and 48 h exposure of bronchial epithelial (BEAS-2B) cells to various
PQ concentrations (12.51000 mM), cell viability was assessed. EVs in
the cell supernatant and after isolation were quantified by flow
cytometry. EVs were further characterized by tunable resistive pulse
sensing (TRPS) and transmission electron microscopy (TEM). Results:
While 24-h exposure of BEAS-2B cells to 12.5200 mM PQ exerted
minor cytotoxicity, viability was significantly reduced by 1000 mM PQ
compared with unexposed cells. After 48 h, a clear concentration-
dependent reduction in cell viability was found. EV release in the
supernatant did not change upon PQ exposure for 24 h compared
with unexposed cells. However, 12.5200 mM PQ for 48 h increased
EVs in the culture medium by 1.2- to 1.6-fold compared with
unexposed cells. After isolation, TEM confirmed the presence of
membrane surrounded by round-shaped vesicles; flow cytometry
revealed the presence of the exosomal proteins CD63 and CD81.
PQ-induced EVs’ diameter (83502 nm; mode size: 116 nm) did not
significantly differ from the diameter of EVs from control cells (77578
nm; mode size: 115 nm). Summary/conclusion: Our data suggest
that EVs indicate PQ exposure of lung epithelial cells before
substantial cell damage occurs. These findings encourage to further
explore the characteristics and cellular functions of PQ-induced
EVs and to determine their levels in body fluids of humans exposed
to PQ.
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PF2.01
Induced cell damage altered proteome and miRNA profile of melanoma
exosomes and interactions with tumor stroma cells
Maria Harmati1, Laszlo Janovak2, Krisztina Buzas3, Imre Dekany4, Eva
Hunyadi-Gulyas1, Peter Horvath1, Bea Botyanszki1, Gabriella Dobra1,
Istvan Nagy1, Okay Saydam5 and Edina Gyukity-Sebestyen6
1Institute of Biochemistry, Biological Research Centre of The Hungarian
Academy of Sciences, Budapest, Hungary; 2Department of Physical Chemistry
and Materials Sciences, University of Szeged, Szeged Hungary; 3Laboratory of
Tumor Immunology and Pharmacology, Institute of Biochemistry, Biological
Research Centre of the Hungarian Academy of Sciences, Szeged, Hungary
Department of Oral Biology and Experimental Dental Research, Faculty of
Dentistry, University of Szeged, Szeged, Hungary; 4MTA-SZTE Supramolecular
and Nanostructured Materials Research Group, University of Szeged, Szeged,
Hungary; 5Molecular Neuro-Oncology Research Uni, Medical University of
Vienna, Vienna, Austria; 6Biological Research Centre, Hungarian Academy of
Science, Budapest, Hungary
Introduction: Increasing evidences suggest that tumor-derived exo-
somes have a role in promoting cancer development and metastasis
formation. Recently it was also described that these exosomes may
contribute to the adaptive response of the tumor cells to microenviron-
mental stress. The aim of this study was to investigate the effect of
suboptimal conditions on melanoma cell-derived exosomes. Methods:
Quantitative and qualitative analyzes were performed to compare
exosome samples produced by the B16F1 mouse melanoma cell line
under normal or suboptimal conditions (cytostatic, oxidative or heat
stress). Number of the exosomes were measured by NanoSight NS500
device, their miRNA content and whole proteome were analyzed by
SOLiD 5500xl technology and mass spectrometry (LC-MSMS on LTQ
Orbitrap Elite [Thermo] mass spectrometer), respectively. Since me-
senchymal stem cells (MSCs) are important players of the tumor stroma,
uptake of stress-exposed cell-derived exosomes by MSCs was also
investigated by high throughput microscopy. Results: Under stress
conditions, significant changes were observed in the number and
content of exosomes. Diversity of exosomal miRNAs increased under
oxidative stress, but decreased in the two other cases. All type of stress
conditions caused significant changes in qualitative and quantitative
properties of exosomal proteome and miRNA profile. Kinetics of the
exosome uptake by MSCs was also different in each case. Conclusion:
Based on our results, we hypothesize that the microenvironmental
stresses affect the intercellular communication between the tumor cells
and the stromal cells via altered exosome profile. Induced alterations
could have influence for metastatic potential of tumor cells and might
predict the efficiency of different type cytostatic effects, e.g. che-
motherapy, oxidative stress or heat induced cell damage.
This research was funded by OTKA PD 84064, OTKA K 112493, TAMOP-
4.2.2-A-11/1/KONV-2012-0025 and IPA HUSRB/1203/214/230.
PF2.02
Extracellular vesicles from mesenchymal stromal/stem cells transfer
miRNAs 205 and 31 and inhibit breast cancer metastasis by regulating
UBE2N/Ubc13
Krishna Vallbhaneni and Radhika Pochampally
Biochemistry/Cancer Institute, University of Mississippi Medical Center,
Jackson, Mississippi
Extracellular vesicles (EVs) derived from mesenchymal stem/stromal
cells (hMSCs) have recently gained attention for their tumour-
supportive characteristics. Based on our previous studies characterizing
EVs from stressed hMSCs (hMSC-EVs) and their role in primary tumours,
we investigated the role of hMSC-EVs in breast cancer metastasis using
metastaticMDA-MB-231 (231) and organotropic sub-lines (231BrM-2a,
231LM-4175, 231BoM- 1833). We show that hMSC-EVs significantly
suppressed the metastatic potential of parental cell lines (MDA-MB-231)
when compared with their organotropic sublines that colonize bone
(231BoM- 1833), brain (231BrM-2a) and lungs (231LM-4175) in vivo.
miRNA expression assays revealed that the parental MDA-MB-231 cell
line expressed significantly lower levels of miR-205 and miR-31
compared with their organotropic sublines. When MDA-MB-231 cells
were incubated with hMSC-EVs, the expression levels of miRNAs 205
and 31 were increased. Further bioinformatic assays demonstrated that
miRNAs 205 and 31 were capable of modulating UBE2N/Ubc13  a
known metastasis regulating gene. Silencing UBE2N/Ubc13 expression
significantly suppressed migration, invasion and proliferation of MDA-
MB-231 cells demonstrating its role in tumour metastasis. Studies
described here suggest that hMSC-EVs support primary breast tumour
progression in both non-organ-committed and organotropic cells.
However, hMSC-EVs suppress the metastasis of breast cancer cells that
are not organ-committed through the UBE2N/Ubc13 pathway.
PF2.03
Exosomes from human colorectal cancer induce a tumour-like
behaviour in colonic mesenchymal stromal cells
Luana Lugini, Cristina Federici, Mauro Valtieri, Serena Cecchetti,
Elisabetta Iessi, Stefania Meschini, Maria Condello, Michele Signore and
Stefano Fais
Istituto Superiore Di Sanita`, Rome, Italy
Introduction: Cancers release high levels of nanovesicles called exo-
somes, acting as vehicles for biochemical messages towards neigh-
bour or far cells. Mesenchymal stromal cells (MSCs), as ubiquitary
architects of the microenvironment, play a key and contradicting role
in tumour progression. Colorectal cancer cellderived (CRC) exosomes
may affect both neighbour and distant cells because they freely
circulate in the bloodstream. We thus investigated the effect of human
CRC exosomes on tissue-specific colonic (c) MSCs that we recently
isolated. Methods: cMSCs, obtained from colonic mucosa, were
exposed to primary or metastatic CRC exosomes and we analysed
them by light and electron microscopy, proliferation assays in 2D
and 3D cultures, migration and invasion assays, and Western blot and
confocal analysis for carcinoembryonic antigen (CEA) and vacuolar
H-ATPase. Results: CRC exosomes express high levels of CEA and
induce in cMSCs: i) atypical morphology (i.e. microvilli, pseudopods,
vesicles) and functions (i.e. higher proliferation, migration, invasion)
usually present in highly activated or transformed cells; ii) production
of large 3D spheroids; iii) an acidic extracellular environment asso-
ciated with iv) increased expression of CEA and a plasma membrane
redistribution of vacuolar H-ATPase. Colon cancerderived MSCs
recapitulate the changes observed in colonic MSCs exposed to CRC
exosomes, forming peculiar umbilicated spheroids and therefore
mimicking in vitro the events occurring in vivo upon exposure to
native exosomes in the cancer cell mass. Summary/conclusion: CRC
exosomes are able to induce morphological and functional changes in
colonic MSCs, which may in turn favour tumour formation and the
malignant progression, recapitulating the in vivo exposure to native
exosomes inside the cancer cell mass. Our results suggest that local
and/or systemic control of CRC exosomes release could represent a
novel approach and a major improvement in cancer management.
PF2.04
EV transfer of the proinflammatory signal from cells carrying
lymphoma-associated MyD88 mutation
Mateja Mancek Keber and Roman Jerala
National Institute of Chemistry, Ljubljana, Slovenia
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Introduction: Innate immune system protects organisms against
pathogens and endogenous damage. This is however a double-edged
sword as unregulated inflammation may lead to pathology, including
autoimmune disease and even cancer. Toll-like receptors, interleukin-1
receptor and inflammasomes are pivotal in these processes. Another
discovery in oncology is the realization of the role of extracellular
vesicles (EVs) in cancer development and dissemination of their
signals to the surrounding tissue. The level of EVs in peripheral blood
is elevated in patients with cancer and their role in cancer has up to
now been focused mainly on the miRNAs; however, proteins of the
signalling pathways might also strongly affect the cellular phenotype.
Materials and methods: EVs were isolated from overexpressed HEK293
cells and lymphoma cell line by ultracentrifugation. Confocal micro-
scopy was used for detection of signalling complexes. Dual luciferase
test was used for detection of cell activation. Results: Activated
lymphoma cells affect other non-transformed cells within the organ-
ism through secretion of inflammatory cytokines. We investigated an
alternative mechanism via EVs. We showed that signalling molecules
per se can be transferred from overexpressed HEK293 cells and
activated lymphoma cells via EVs to other cells. Signalling molecules
formed active complexes and triggered activation of the inflammatory
pathway in recipient cells thus propagating the inflammation.
Conclusions: This mechanism should be most relevant for the
lymphomas harbouring mutated constitutively active MyD88, where
the cancer cells could spread inflammatory signal and might provide
the necessary survival signal needed for the development of cancer
systemically to the non-cancer cells.
PF2.05
The role of extracellular vesicles in the intercellular response to stress
Dave Carter, Ryan Pink, Findlay Bewicke-Copley and Laura Jacobs
Biological and Medical Sciences, Oxford Brookes University, Oxford, UK
Introduction: When cancer cells are treated with ionizing radiation, the
resulting DNA damage can also be observed in neighbouring, non-
irradiated cells. We have previously shown that this spread of
deleterious effects from irradiated to non-irradiated cells, which is
known as the bystander effect, is mediated by extracellular vesicles
(EVs). We also showed that uptake of EVs released by irradiated cells
leads to a long-term genomic instability that also appears to involve the
activity of specific non-coding RNAs. However, it is unclear whether this
EV-mediated phenomenon is a peculiar phenomenon restricted to the
effects of ionizing radiation or whether it is a more general response to
stressful situations. We therefore tested whether other stressors
including heat shock and cytotoxic drugs can also induce an EV-
mediated bystander effect. Methods: Human MCF-7 breast carcinoma
cells were exposed to elevated heat levels or treated with the cytotoxic
drug cisplatin. Following treatment, the cells were allowed to condition
the media for 24 h and EVs were extracted by differential centrifugation
before being placed onto fresh MCF-7 cells. Levels of DNA damage and
apoptosis were measured using comet assays and nuclear staining with
DAPI, respectively. Results: Our preliminary data reveal that heat stress
and cisplatin treatment caused the release of vesicles capable of
inducing bystander effect. Further analysis of the bystander cells reveals
changes in activity of a number of signalling pathways and alterations in
gene expression patterns. Conclusion: The results of these experiments
suggest that the bystander effect mediated by EVs is not limited to the
consequences of ionizing radiation but may represent a fundamental
mechanism by which cells respond to many forms of stressful stimuli.
This work offers insight into the processes of cells during normal
homeostasis and the response to supraphysiological conditions.
PF2.06
The volatile anaesthetic agent sevoflurane influences cancer-related
miRNAs in circulating extracellular nanovesicles
Dominik Buschmann1, Marlene Eggert2, Benedict Kirchner1,
Melanie Ma¨rte3, Martina Pfob2, Alexander Chouker3, Michael Pfaffl1 and
Gustav Schelling3
1Division of Animal Physiology and Immunology, School of Life Sciences
Weihenstephan, Technical University Munich, Germany; 2Institute of
Human Genetics, University Hospital, Ludwig-Maximilians-University,
Munich, Germany; 3Department of Anesthesiology, University Hospital,
Ludwig-Maximilians-University, Munich, Germany
Introduction: There is evidence that volatile anaesthetic gases (VAGs)
administered during surgical resection of solid tumours may
enhance cancer cell growth and the risk for metastasis. Extracellular
nanovesicles (EVs) may be released from the tumour during surgery.
Their nucleic acid cargo is known to mediate tumour progression
and could be influenced by VAGs. Methods: We assessed the impact
of the VAG sevoflurane on EV miRNA in patients undergoing non-
cancer surgery (n6). Informed consent was obtained and the study
was approved by the local IRB. miRNAs were isolated from serum
EVs and from blood cells at the awake state and after 40 min of
anaesthesia. The presence of EVs was confirmed by transmission
electron microscopy and nanoparticle tracking analysis. Unbiased
profiling of miRNAs from EVs and blood cells was performed by small
RNA-Seq. For data analysis and miRNA target scanning, a commer-
cially available gene expression and pathway analysis software
was used. Only miRNAs meeting predefined cut-off values (base
mean50, log2foldchangeI1I and PadjB0.05) were analysed and
only experimentally confirmed relationships were considered.
Results: The VAG influenced only EV-encapsulated miRNAs but had
no significant effect on miRNA expression in blood cells. Among the
EV-derived miRNAs, the software identified cancer, cellular develop-
ment and cellular growth/proliferation as top regulated networks.
Four miRNAs were identified as primarily cancer-related (miR-26a-5p,
miR-409-3p, mirR-493-5p, miR-205-5p, p-value range: 4.01E-02
8.27E-05). In addition, miR-26a-5p and miR-205-5p (p-value range:
6.29E-039.69E-04) were associated with cell cycle/cellular develop-
ment and miR-493-5p (p2.92E-05) with cell death and survival.
Conclusion: Given the important function of circulating EVs in cell
cell communication and cancer, our data suggest that VAG-induced
changes in the nucleic acid cargo of EVs could be a mediator of this
anaesthetic technique’s effects on long-term survival of cancer
patients.
PF2.07
Transfer of multidrug resistance between leukaemia cells via
extracellular vesicles
Celine Bouvy1, Christian Chatelain1, Adeline Wannez1, Franc¸ois Mullier2
and Jean-Michel Dogne´1
1Department of Pharmacy, University of Namur, Namur, Belgium; 2Department
of Hematology Laboratory, CHU UCL Namur, Yvoir, Belgium
Introduction: Chemoresistance of tumour cells is a major issue for
the treatment of acute myeloid leukaemia (AML). This chemo-
therapeutic resistance is established by clonal selection of resistant
leukaemic cells. However, a horizontal transfer of chemoresistance
has recently been discovered between tumour cells via extracellular
vesicles (EVs). Several researches demonstrated a transfer of multi-
drug resistance proteins, miRNA and mRNA, from multiresistant cells
to sensitive ones via EVs. The aim of this research is to investigate
the role of EVs in chemoresistance in AML. For this purpose, two
strains of the promyelocytic leukaemia HL60 cell line have been
analysed: the sensitive one (HL60) and a multiresistant one (HL60/AR).
The latter overexpresses multidrug resistance  associated protein 1
(MRP1) conferring resistance to daunorubicin among others. Methods:
The production of EVs by HL60/AR (EVs/AR) was first investigated
by transmission electron microscopy. The chemoresistance transfer
via EVs/AR was then analysed by treating HL60 with EVs/AR isolated
by ultracentrifugation. The interaction between HL60 and EVs/AR
was measured by flow cytometry. The viability of HL60 treated
with EVs/AR after daunorubicin treatment was assessed by a MTT
cytotoxicity assay. The daunorubicin retention and the expression
of MRP1 were finally evaluated by a flow cytometry drug reten-
tion assay. Results: HL60/AR spontaneously produces EVs/AR that
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can interact with HL60. This binding or incorporation of EVs/
AR confers an advantage in terms of survival to HL60 after a
daunorubicin treatment. EVs/AR-treated cells also begin to express
MRP1. Conclusion: This study demonstrates a real benefit of EVs
from resistant cells on sensitive cell viability. This resistance transfer
could be due to a direct transfer of MRP1 by EVs/AR or to a trans-
mission of nucleic acids (microRNA or messenger RNA) modifying
target cells’ phenotype. These hypotheses will be tested in the
future experiments.
PF2.08
Detection, characterization and function of extracellular vesicles in
resistant melanoma
Giulia Cesi1, Francois Bernardin2, Yeoun Jin Kim2 and Stephanie Kreis1
1Life Science Research Unit (LSRU), University of Luxembourg, Belvaux,
Luxembourg; 2Department of Oncology, Luxembourg Institute of Heath (LIH),
Strassen, Luxembourg
Extracellular vesicles are nano-sized structures that are released by all
cell types under both physiological and pathological conditions.
It has been shown that different diseases can induce specific changes
in the levels of extracellular vesicles secretion so that different
amounts and/or different content profiles can be studied and
potentially used as biomarkers. As extracellular vesicles can be
released by ‘‘donor’’ cells and taken up by ‘‘recipient’’ cells, it has
been hypothesized that they are important players in influencing key
biological functions by delivering and transporting cytokines, growth
factors, proteins, mRNAs and microRNAs. Recently, extracellular
vesicles have also been identified as new messengers in transferring
drug resistance to still sensitive or ‘‘drug-naı¨ve’’ cells. In melanoma
patients, drug resistance is a pressing clinical problem. Despite the
promising initial results obtained with vemurafenib and dabrafenib
(BRAF kinase inhibitors) in the clinic, it soon became evident that
these molecules were not able to provide durable responses, as
resistance to treatment soon develops within months in almost
all patients. The aim of my project is to understand the potential
involvement of extracellular vesicles in the ‘‘spreading’’ of drug
resistance. The content of the extracellular vesicles released by
melanoma cells and their corresponding cells that have been made
drug resistant will be analysed. Preliminary results show that sensitive
melanoma cells acquire the drug resistant phenotype if co-cultured
with extracellular vesicles released by resistant cells. This suggests
an involvement of extracellular vesicles in propagating important
tumourigenic properties.
PF2.09
D-type CpG oligonucleotide encapsulating and antigen harbouring
exosomes improve therapy of tumours
Gozde Gucluler, Tamer Kahraman1, Muzaffer Yildirim2 and Ihsan Gursel1
1Bilkent University, Ankara, Turkey; 2Council of Forensic Medicine, Department
of Histopathology, Istanbul, Turkey
Please see OPW3.3
PF2.10
Oral delivery of the chemotherapeutic drug paclitaxel via bovine milk
exosomes
Farrukh Aqil1, Ashishkumar Agrawal1, Jeyaprakash Jeyabalan1, Radha
Munagala1, Subbarao Bondada2, Beth Gachuki2, Lynn Parker1, Wendy
Spencer3 and Ramesh Gupta1
1University of Louisville, Kentucky, USA; 2University of Kentucky, Lexington,
Kentucky, USA; 33P Biotechnologies, Louisville, Kentucky, USA
Introduction: Chemotherapeutics, given intravenously, result in spikes
in blood level and toxicities. We recently showed that bovine milk
derived exosomes can be delivered orally as nano-carriers for
therapeutic applications. Here, we show that a widely used che-
motherapeutic drug paclitaxel (PAC) can be given orally in exosomal
(Exo) formulation to enhance its efficacy, and that it lacks toxicities.
Methods: PAC was incubated with the exosomes in the presence of
ethanol: acetonitrile (1:1) for drug loading. Anti-proliferative activities
against human lung (A549) and ovarian (A2780) cancer cells were
assessed by MTT assay, and antitumour activity was determined
against lung and ovarian cancer xenografts in nude mice. Exo-PAC
was administered by oral gavage and compared with the free drug
given i.p.  three doses weekly each at 2.7 mg/kg against ovarian and
4 mg/kg against lung cancer; control animals received vehicle alone.
Potential toxicities of Exo and Exo-PAC were determined in wild-type
mice. Results: PAC was loaded at levels of 1020%. Exo-PAC exhibited
significantly improved anti-proliferative activity against the A549 cells
compared with the free drug; higher efficacy of Exo-PAC was also
observed against the ovarian cancer cells. Oral administration of Exo-
PAC showed enhanced growth inhibition of lung tumour and the
response was dose dependent. Higher efficacy of Exo-PAC was also
observed against the ovarian tumour growth; the efficacy of Exo-PAC
functionalized with folic acid (68%) was higher than Exo-PAC (41%).
Finally, daily oral dosing of mice for 15 days with Exo and Exo-PAC
showed no systemic toxicity and also reduced PAC-associated toxicity
based on analysis of cytokines and inflammatory markers. Conclusion:
This is the first demonstration of effective oral delivery of the
chemotherapeutic drug, PAC, as an Exo formulation against lung
and ovarian cancers.
Financial support: USPHS grant R41-CA-189517, Agnes Brown
Duggan Endowment, and Helmsley Trust Fund.
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PF3.01
Immunogenic and tolerogenic dendritic cells release extracellular
vesicles that differ in small non-coding RNA content
Tom Driedonks, Susanne Van Der Grein, Henrike Jekel, Tom Groot
Kormelink, Marca Wauben and Esther Nolte-’t Hoen
Department of Biochemistry and Cell Biology, Faculty of Veterinary Medicine,
Utrecht University, The Netherlands
Please see OPW2.2
PF3.02
Exosomes released by regulatory T cells modulates T cell
polarization
Sim Tung, Akansha Agarwal, Marilena Letizia, Giorgia Fanelli, Robert
Lechler, Giovanna Lombardi and Lesley Smyth
Division of Transplantation Immunology and Mucosal Biology, MRC Centre for
Transplantation, King’s College London, London, England, UK
Please see OPW2.3
PF3.03
An antigen-specific exosome cascade leads to final antigen presenting
cell-derived peptide-MHC-specific exosomes that suppress the effector
T cells
Phil Askenase
Yale University, New Haven, Connecticut
Introduction: T suppressor cell antigen (Ag)specific suppressive
exosomes in ovalbumin (OVA) protein-induced delayed-type hypersen-
sitivity (DTH) are coated with antibody (Ab) light chains that we bind
Ag-peptides in MHC on the antigen-presenting cell (APC) surface. Here
we examined the mechanism of subsequent APC suppression of the
DTH-effector T cells. Methods: APC pulsed with T suppressor exosomes
carrying inhibitory miRNA-150 were cultured for release of secondary
suppressive exosomes we characterized. Results: A 100,000g pellet from
the supernatant released in culture in vitro by the T suppressor
exosome-pulsed APC itself suppressed the effector T cells. These were
characterized as secondary suppressive exosomes acting directly on the
DTH-effector T cells. This secondary exosome suppression was blocked
by treating these exosomes with monoclonal Ab to MHC Class II and to
Ag peptides. Similarly obtained APC-derived secondary suppressive
exosomes from a system of tolerized miRNA150-/- mice were not
suppressive, unless the APC were pre-treated instead with wild-type
mouse T cellderived suppressor exosomes delivering miRNA-150.
Conclusions: We concluded that Ag-specific suppressor exosomes
bound peptides in MHC on APC to transfer inhibitory miRN-150 that
induced these Ts exosome pulsed APC to release secondary suppres-
sive exosomes with MHC-peptide specificity. These directly suppress
the effector T cells likely via interaction with their TCR to then deliver
regulatory miRNA to the DTH-effector T cells. We theorize that multiple
cell and exosome cascades may underlie other immune and possibly
non-immune functional cell interactions in vivo.
PF3.04
Immunomodulatory effect of mast cellderived extracellular vesicles
Krisztina V. Vukman, Barbara So´dar, Andrea Ne´meth, Xabier Osteikoetxea,
Krisztina Pa´lo´czi, Kata Szabo´-Taylor, Zolta´n Wiener, E´va Pa´llinger and
Edit I. Buza´s
Department of Genetics, Cell and Immunobiology, Semmelweis University,
Budapest, Hungary
Introduction: Mast cells are associated with many Th1-/Th2-mediated
inflammatory disorders such as autoimmune diseases and allergy.
In these diseases, mast cellderived extracellular vesicles (EVs) may
be involved in the pathomechanism. The aim of this study was to
carry out systemic characterization of mast cellderived EVs and to
investigate their role in the development of immune responses.
Methods: The MC/9 murine mast cell line and bone marrowderived
mast cells were stimulated by LPS (100 ng/ml) or Ionomycin (0.5 mM),
and the secreted EVs were isolated with differential centrifugation
and hydrostatic filtration and were investigated with tunable
resistive pulse sensing, flow cytometry and Western blotting. Mast
cells and splenocytes were cultured with the conditioned media
or isolated EVs of stimulated and non-stimulated mast cells. Cell
activation was monitored by proliferation assays and cytokine
secretion (ELISA). Results: Ten minutes after Ionomycin treatment,
a significant increase (466.8%9101.1; p0.05) was found in the
number of secreted EVs. The released vesicles were positive for CD63
but not for annexin V or CD9, suggesting that they were extracellular
granules rather than ordinary EVs. Surprisingly, 6 h after LPS
treatment, mast cells produced significantly less EVs (73.9%96.2,
p0.01) in the size ranges of 150200 nm and 300350 nm than
unstimulated cells. In contrast, after Ionomycin stimulation, the
number of EVs was still increased (255.5%926.3; p0.01). We also
found that both the conditioned medium of mast cells and the
isolated mast cellderived EVs could activate mast cells and
splenocytes, respectively. This activation was further enhanced after
LPS treatment. Summary: We showed that mast cellderived EVs
differ after different types of stimulation (LPS or Ionomycin), and the
induced EVs are involved in cell-to-cell communication between
mast cells and other immune cells.
Funding: OTKA PD 112085; Janos Bolyai Research Fellowship (MTA).
PF3.05
Evaluation of the CD73 transfer into NK cells by exosomes derived from
endothelial cells and its immunomodulatory effect
Gabriel Dostert, Vale´rie Jouan-Hureaux, Huguette Louis, Iouri Motorine,
Patrick Menu, Ve´ronique Decot and Emilie Velot
Universite´ De Lorraine, Nancy, France
Introduction: The multipotency and immunomodulatory properties
of mesenchymal stem cells (MSCs) make them good candidates to
be used in an allogeneic context. One of the MSCs’ immunosup-
pressive mechanisms is mediated via an adenosinergic pathway by
ectonucleotidases such as CD73. In a previous study, we have shown
that NK cells, which are negative for CD73, acquired this one after
an exposure to MSCs before and after their differentiation into
endothelial cells (ECs). As ECs express CD73 and are closely in
contact with NK cells into blood, we wanted to explore whether the
transfer of CD73 could occur after a co-culture between mature ECs
and NK cells and whether exosomes (EXs) could play a role in this
transfer. Methods: EXs from human umbilical vascular endothelial
cells (HUVECs) were isolated by ultracentrifugation and filtration
(0.22 mm), then characterized by NanoSight and flow cytometry
(CD9, CD63, CD81). Peripheral blood NK cells were next cultured with
either HUVECs or EXs alone. Immunological activation of NK cells
was evaluated by flow cytometry via the expression of CD3, CD56,
NK-activating receptor natural-killer group 2, member D (NKG2D)
and CD73. The staining of EXs followed by incubation with NK cells
allowed the observation of their internalization. Results: The samples
analysed by NanoSight after isolation showed a high concentration
of nanoparticles (30100 nm) with over 90% of particles in the
exosomal scale. The flow cytometry dot plots of EXs showed a
positive staining for the exosomal markers CD9, CD63, CD81 and also
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for CD73. Co-cultured NK cells with HUVECs or EXs alone showed
similar results. CD73, which is negative on inactive NK cells, was
observed after a co-culture with EXs alone. Furthermore, a diminu-
tion of NK cell cytotoxicity was observed after a co-culture with EXs.
Summary/conclusion: Our results showed that CD73 acquisition on
NK cells after contact with EXs carrying this nucleotidase could have
an immunosuppressive effect on these cells.
PF3.06
Contact-dependent and -independent co-cultures of allogeneic human
immune cells yield heterogeneous vesicle phenotype but conserved
cellular phenotype
Anne Louise Schacht Revenfeld1, Anne Elbaek1, Allan Stensballe2,
Rikke Baek1, Malene Moeller Joergensen2 and Kim Varming1
1Department of Clinical Immunology, Aalborg University Hospital, Aalborg,
Denmark; 2Department of Health Science and Technology, Aalborg University,
Aalborg, Denmark
Introduction: Extracellular vesicles (EVs) can be employed by the
immune system to orchestrate immune responses. A new functional
phenotype can be induced in the EV-recipient cell, which is linked to
the molecular content of the EVs. Hence, a molecular profile of EVs is
interesting for functional indications. Here, an extensive phenotyp-
ing of a membrane sub-proteome of EVs from an in vitroinduced
immune response was performed, comparing any effects of the
presence/absence of physical contact between the two interacting
cell populations. Methods: Human peripheral blood mononuclear
cells (PBMCs) were isolated from two individuals with mismatched
tissue types. One PBMC population was irradiated. A 6-day co-culture
of the allogeneic PBMCs was created with or without physical
contact between the two cell populations. EVs from the cell culture
media were captured on the EV Array containing antibodies against
24 different markers, including general EV and immune markers. EV
detection was performed with a cocktail of antibodies against CD9,
CD63 and CD81. The cellular phenotype of activated CD4 T cells
was determined by flow cytometry, focusing on regulatory markers.
Results: Comparable levels of general vesicle-associated markers
were observed for EVs from all culture combinations and across
individuals (n3; biological). However, a prominent heterogeneity
was found for the remaining investigated markers. In contrast, the
cellular phenotype of the activated CD4 T cells was conserved and
reproducible, showing marker enrichment, when physical contact
was present between the two cell populations. Summary/conclusion:
Primary immune cells produce EVs during in vitro culturing and
activation. The detected phenotype of these EVs was very hetero-
geneous, while the investigated cellular phenotype was conserved.
This could suggest a more adaptable role for EVs in immune
responses, while the requirements for the cellular phenotype are
less flexible.
PF3.07
Immune-stimulatory properties of serum exosomes from (pre-) diabetic
mice
Steffi Bosch1, Jean-Marie Bach1, Laurence De Beaurepaire1, Marie Allard1,
Gioia Mingozzi1, Laurence Dubreil2 and Dominique Jegou1
1Physiopathology, Lunam Universite, Oniris, USC 1383 INRA, EA 4644 IECM,
Nantes, France; 2Physiopathology, Lunam Universite, Oniris, INRA, UMR_A0703
PanTHER
Introduction: Type 1 diabetes (T1D) is a chronic autoimmune disease
that results from the destruction of insulin-producing pancreatic
ß-cells by autoreactive T-lymphocytes. Serum exosomes (EXO) are
more abundant in non-obese diabetic mice (NOD) with spontaneous
diabetes raising the question of their contribution to the immune
deregulation leading to the disease. Here we studied the influence of
serum exosomes on immune cell activation ex vivo. Methods: EXOs
were isolated from serum drawn from pre-diabetic versus sponta-
neously diabetic NOD mice through size exclusion chromatography.
Phenotypical changes of EXOs were analysed by nanoparticle
tracking analysis, automated electrophoresis and detection of
surface markers by cytometric bead assays. Biological activity of
(pre-) diabetic serum EXOs on murine spleen cells was assessed in
vitro using flow cytometry, confocal microscopy and ELISA analysis.
Results: Serum EXOs from both pre-diabetic and diabetic (T1D-EXOs)
mice expressed CD63 CD9 tetraspanins and were approximately
100 nm in size. Spleen cells readily internalized serum EXOs that
co-localized with the early endosomal antigen 1 marker. T1D-EXOs
reduced TNFa and IL-10 cytokine secretion in comparison with pre-
diabetic EXOs. Flow cytometry data on surface and activation
markers of T1D-EXO target cells will be presented. Summary/
conclusion: In this study, we thought to elucidate the role of
serum EXOs in T1D immune imbalance. We demonstrate that T1D
serum EXOs modulate cytokine secretion and phenotype of murine
immune cells. This evidence suggests that serum EXOs may fuel
activation of diabetogenic effectors and might be a useful target in
the development of T1D therapeutics.
PF3.08
Phenotyping of leukocytes and leukocyte-derived extracellular vesicles
Lotte H. Pugholm, Rikke Bæk, Evo K. L. Søndergaard,
Anne Louise S. Revenfeld, Malene M. Jørgensen and Kim Varming
Clinical Immunology, Aalborg University Hospital, Aalborg, Denmark
Introduction: Extracellular vesicles (EVs) have demonstrated an invol-
vement in modulating the immune system. It has been proposed
that EVs could be used as biomarkers for detection of inflammatory
and immunological disorders. Consequently, it is of great interest to
investigate EVs in more detail with focus on immunological markers.
Methods: Five major leukocyte subpopulations were isolated from
peripheral blood mononuclear cells from healthy donors and
cultured separately for 2 days. Subsequently, the leukocyte-derived
EVs were phenotyped for a panel of 34 immunological and vesicle-
related markers using the EV Array. For comparison, the phenotype
of EVs present in plasma from healthy donors was also investigated.
For the leukocyte monocultures, the cellular expressions of CD9,
CD63 and CD81 were determined by flow cytometry and compared
with the expression pattern observed for leukocytes present in
whole blood. Results: The majority of the lineage-specific markers,
used for identification of the parent cell types, could not be detected
on EVs released from monocultures of the associated cell type.
In contrast, the vesicular presentation of CD9, CD63 and CD81
correlated to the cell surface expression of these markers, however,
with few exceptions. In addition, the leukocyte-derived EVs displayed
phenotypic differences in the 34 markers investigated. Regarding
the cellular expression of CD9, CD63 and CD81, a variation in the
expression of these markers were observed between the leukocytes
present in whole blood and the cultured leukocytes. Summary/
conclusion: The current data demonstrate that the cellular and
vesicular presentation of selected lineage-specific and vesicle-related
markers may differ, supporting the accumulating observations that
sorting of molecular cargo into EVs are tightly controlled and might
not represent a mirror image of the parent cell.
PF3.09
Impact of pre-eclampsiaassociated extracellular vesicles on the
monocytemacrophage system: an in vitro analysis
A´rpa´d Ferenc Kova´cs1, Orsolya La´ng1, La´szlo´ Ko´´hidai1, Ja´nos Rigo´2,
No´ra Fekete1, Edit Buza´s1 and E´va Pa´llinger1
1Department of Genetics, Cell- and Immunobiology, Semmelweis University,
Budapest, Hungary; 2Department of Obstetrics and Gynaecology, Semmelweis
University, Budapest, Hungary
Introduction: Pre-eclampsia is a serious, pregnancy-specific multi-
system disorder. Both maternal and foeto-placental factors are
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involved in its pathogenesis, including immunologic intolerance
between the foetus and mother and the imbalanced activity of the
maternal monocytemacrophage (Mo-Mph) system. The aim of our
study was the characterization of the effects of pre-eclampsia
associated circulating EVs (P-EV) on the monocytes. Methods: THP-1
cell line was used as a monocyte model system. The EV-binding
capacity of THP-1 cells as well as the EV-induced migratory and
adhesive properties and phagocytic activity were monitored. Adhe-
siveness of THP1 cells was characterized by both multicolour
immunophenotyping of cell surface adhesion proteins (CD44, integrin
a2, integrin b1, integrin b7) and also by an impedance-based real-time
method. The effects of P-EVs on the migratory activity of THP-1 cells
were documented by holographic microscopy. The uptake of PKH-
labelled P-EVs by phagocytosis was evaluated by flow cytometry. EVs
isolated from the plasma of healthy pregnant women (HP-EV) were
used as biological controls. Results: Although P-EVs and HP-EVs bound
to THP-1 cells equivalently, THP-1 cells phagocytosed significantly
lower amounts of P-EVs. This may be explicable by the significantly
higher expression levels of CD47 ‘‘don’t eat me’’ signal and the
significantly lower externalization of the phosphatidylserine, an ‘‘eat
me’’ signal on P-EVs. Furthermore, by reduced exofacial CD44 and
integrin a2, P-EVs may have a significant impact on adhesiveness and
change the migration activity of the THP-1 cells. Summary: Circulating
P-EVs induce a different functional pattern of cellular responses in
THP-1 cells, which is reflected by i) a differential cell surface adhesion
protein distribution, ii) a reduced cell motility and iii) decreased
phagocytosis. Consequently, circulating pre-eclampsiaassociated
EVs may have a pathogenic role by modifying the MoMph system.
PF3.10
Placenta-derived extracellular vesicles induce differentiation of
monocyte into decidual macrophage-like phenotype
Cheuk-Lun Lee, William S. B. Yeung and Philip C. N. Chiu
Department of Obstetrics and Gynaecology, The University of Hong Kong,
Hong Kong, Hong Kong SAR
Introduction: Macrophages comprise 2030% of the leukocytes in the
pregnant uterus and their cell number remains constant throughout
pregnancy. The monocytes migrate into the decidualized endome-
trium in the pre-implantation period and differentiate into decidua-
specific macrophages upon exposure to the local microenvironment.
Decidual macrophages are located close to the invaded extravillous
trophoblasts and contribute to placental development. The placenta
produces large quantities of extracellular vesicles during pregnancy
which are involved in foetomaternal communication. In this study,
we hypothesize that placenta-derived extracellular vesicles polarize
the differentiation of human monocytes into decidual macrophages.
This action in turn regulates placental remodelling at the foetoma-
ternal interface. Methods: First trimester human placentas were
obtained with informed consent from patients who had undergone
termination of pregnancy. Placenta-derived extracellular vesicles
were isolated from the conditioned medium of the placental villous
tissue explants culture using ultracentrifugation. Human peripheral
blood monocytes were differentiated into macrophages by treat-
ment with macrophage colony-stimulating factor in the presence or
absence of placenta-derived extracellular vesicles during the differ-
entiation process. The phenotypes and biological activities of the
differentiated macrophages were compared. Results and Summary:
Placenta-derived extracellular vesicles drove the differentiation of
macrophages with a higher expression of decidual macrophages
phenotypic markers. These macrophages also had an altered
cytokine secretion profile, which induce trophoblast invasion. In
sum, placenta-derived extracellular vesicles polarize the differentia-
tion of macrophages towards a decidual macrophage-like pheno-
type, which could regulate placental development.
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PF4.01
Gastric cancer cellderived extracellular vesicles modulate E-cadherin
expression, invasion and migration of normal cells from the tumour
microenvironment
Joana Carvalho1,2*, Sara Rocha1,2*, Patrı´cia Oliveira1,2 and Carla Oliveira1,2,3
1Expression Regulation in Cancer, Institute of Molecular Pathology and
Immunology, University of Porto (IPATIMUP), Portugal; 2Instituto de
Investigac¸a˜o e Inovac¸a˜o em Sau´de (i3S), Universidade do Porto, Portugal;
3Department Pathology and Oncology, Faculty of Medicine, University of
Porto, Portugal
*These authors equally contributed to this work. Please see OPW3.2
PF4.02
Functional analysis of extracellular vesicles in scirrhous type gastric
cancer microenvironment
Yutaka Naito1, Wataru Yasui2, Kosei Hirakawa3, Masakazu Yashiro4 and
Takahiro Ochiya1
1Division of Molecular and Cellular Medicine, National Cancer Center Research
Institute, Tokyo, Japan; 2Department of Molecular Pathology, Hiroshima
University Institute of Biomedical and Health Sciences, Hiroshima, Japan;
3Osaka City University Graduate School of Medicine, Osaka, Japan;
4Department of Surgical Oncology, Osaka City University Graduate School of
Medicine, Osaka, Japan
Introduction: Scirrhous type gastric cancer (GC) is highly metastatic
and is characterized clinically by rapid disease progression and poor
prognosis. Therefore, better understanding of the pathological and
biological basis of scirrhous type GC is necessary to improve the
diagnosis and the treatment. Extracellular vesicles (EVs) are small
membrane vesicles that are secreted by various cell types including
cancer cells and surrounding stromal cells. Several lines of evidence
support that some components of EVs derived from cancer stroma,
including microRNAs (miRNAs), function to promote the progression,
growth and spread of cancer. However, the precise mechanisms
controlling cancer stromal interaction are not fully understood. In
this study, we aimed to investigate the difference of miRNA
expression in EVs between cancer stromal fibroblasts (CaFs) and
normal fibroblasts (NFs) and identify the specific miRNAs of CaF-
derived EVs. Methods: To check the differences of EV number between
NFs and CaFs, we performed nanoparticle tracking analysis (NTA). To
confirm the presence of EVs obtained by ultracentrifugation, western
blot analyses were performed. Furthermore, we also investigated
the effect of EV derived from NF and CaF on the invasive activity of
HSC-44PE scirrhous type GC cell line by invasion assay. To identify
specific miRNAs in CaF-derived EVs, miRNA microarray analysis
was performed. Results: EV numbers did not differ between NF and
CaF. CD9 and CD63 proteins, as markers of EVs, were detected on
each fibroblast-derived EVs. There is no difference in these marker
expressions between NF-derived EVs and CaF-derived EVs. However,
CaF-derived EVs could impact on GC cell invasion but not NF-derived
EVs. Microarray analysis identified several miRNAs that were upregu-
lated in CaF-derived EVs as compared with those derived from
NF-derived EVs. Conclusion: These data suggested that CaF-derived
EVs contribute to the invasion activity of scirrhous type GC.
PF4.03
The role of anaplastic large cell lymphomaderived exosomes in the
tumour microenvironment
Dimitrios Chioureas, Georgios Rassidakis and Theocharis Panaretakis
Oncology-Pathology, Karolinska Institutet and University Hospital, Stockholm,
Sweden
Introduction: Lymphoma, one of the most common types of blood
cancer, manifests itself mainly as Hodgkin lymphoma or non-
Hodgkin lymphoma (NHL). Anaplastic large cell lymphoma (ALCL)
is an aggressive type of T-cell NHL and represents the most frequent
large cell lymphoma in childhood. The current WHO classification
recognizes two distinct types of systemic ALCL based on the
presence of the anaplastic lymphoma kinase (ALK), the ALK-positive
and the ALK-negative ALCLs. In the former type, expression and
activation of ALK is the result of chromosomal translocations
involving the alk gene locus, the most frequent being the t(2;5)
leading to the chimeric NPM. ALK oncogenic kinase. The disease
disseminates in the lymph nodes, spleen, bone marrow, skin as well
as other extranodal sites. Although, there have been many studies
on the mechanisms of ALCL lymphomagenesis, as well as therapeu-
tic strategies, very little is known about the bidirectional crosstalk
between the microenvironment (TME) and ALCL. Methods: Exosomes
derived from various ALCL cell lines have been isolated and
characterized by nanoparticle tracking analysis, transmission electron
microscopy and western blotting for their size, shape and protein
composition. Stroma cells have been co-cultured with the lymphoma
cells or have been educated with exosomes and the effects have
been investigated. Results: We have studied the role of the ALCL
exosomes in activating the tumour stroma (fibroblasts and me-
senchymal stem cells) as well as being responsible for the horizontal
transfer of oncogenes and growth promoting signalling molecules.
We have also tested the ability of the TME to either protect or
sensitize the lymphoma cells upon treatment. Conclusions: Better
understanding of the interactions between the ALCL cells and their
microenvironment will shed light on the mechanisms of resistance to
targeted therapy that would lead to more efficient therapeutic
approaches for the ALCL patients.
PF4.04
Stress response signalling in leukaemia cells modifies composition
of proteases in extracellular vesicles what supports invasion
Paulina Podszywalow-Bartnicka, Anna Cmoch, Agnieszka Wesolowska,
Lukasz Bugajski and Katarzyna Piwocka
Nencki Institute of Experimental Biology, Warsaw, Poland
Introduction: Secretome, which bypasses regulatory signals via
secreted proteins, lipids and nucleic acids, plays an essential role in
crosstalk between leukaemia and bone marrow stromal cells support-
ing growth, self-renewal and drug resistance of leukaemic cells.
Previously, we proved that BCR-ABL1 oncogene in CML cells leads to
activation of unfolded protein response [Kusio-Kobialka Cell Cycle
2012]. As a consequence, enhanced phosphorylation of eukaryotic
initiation factor 2 alpha subunit (eIF2a) allows adaptation of translated
mRNA to stress conditions. The aim of the current study was to verify if
eIF2a phosphorylation has an impact on the composition of extra-
cellular vesicles (EVs) secreted by CML cells and how it influences
vesicles properties supporting cells invasiveness. Methods: EVs
were obtained by ultracentrifugation of conditioned media of bone
marrow stromal fibroblasts (HS-5) or CML cells (K562) of wild type
expressing eIF2a non-phosphorylable protein. The influence of EVs on
proliferation/apoptosis was assessed using flow cytometry. Cells
motility and invasiveness were verified in matrigel invasion assay.
Antibody arrays and zymography were used to compare proteases
profile and their digestive activity in vesicular fraction. Results:
Direct interaction of fibroblasts with CML EVs facilitated motility
and invasiveness in the matrigel invasion assay, accompanied by
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stimulation of matrix gelatin digestion by CML vesicles. This attribute
of EVs was dependent on eIF2a-P level in CML cells. We found that
eIF2a-P in CML cells modified the efficacy of synthesis and release of
proteases in the vesicular fraction. Conclusion: Altogether, our results
indicated that enhanced activation of UPR pathway in CML cells that
accompanies the cancer progression has an impact on extracellular
vesicles and so the intercellular communication.
Grants: IP2011043071 from the Polish Ministry of Science and
Higher Education and 2013/10/E/NZ3/00673 from National Science
Centre.
PF4.05
Role of Extracellular Vesicles in Acute Myeloid Leukaemia evolvement
Inna Tzoran
Department of Hematology and Bone Marrow Transplantation, Rambam
Health Care Campus, Haifa, Israel
Introduction: Acute myeloid leukaemia (AML) is characterized by
rapid growth of leukaemic blast cells. Extracellular vesicles (EVs),
shedding from various cells, express antigens, reflecting their cellular
origin. Aim: The current study was aimed to explore the role of
circulating EVs as potential biomarkers of AML activity and predictors
of thrombogenicity in these patients Method: Blood samples were
collected from healthy controls and patients with newly diagnosed
AML at three time points: diagnosis, nadir and remission. EV
concentration, cell origin and expression of coagulation proteins
were characterized by fluorescence-activated cell sorting (FACS). EV
cytokine contents were evaluated by protein array. Procoagulant
activity was assessed using Factor Xa chromogenic assay. MicroRNA
EVs profile was screened by Nano string technology and validated by
RT-PCR. Results: Forty-two AML patients were enrolled in the study.
Total EV numbers were higher in patients in first remission compared
with controls, while blast EV counts were higher in patients at
diagnosis compared with controls and patients in remission. Blast EV
levels were found to be significantly lower in patients who achieved
remission and were alive at 3 years of follow-up compared with their
succumbed counterparts. Percentage of endothelial EVs was higher
in patients compared with controls at all three time points. EV
procoagulant activity was elevated at diagnosis and in remission,
and unlike controls’ EVs, patients’ EVs increased endothelial cell
thrombogenicity. We found significant changes in several micro
RNA in EVs obtained at diagnosis compared with remission which
are involved in myeloid differentiation. Conclusion: AML patients’ EVs
express membrane proteins of blast cells and might serve as
biomarkers of leukaemia dynamics and for minimal residual disease.
Increased levels of endothelial EVs and their procoagulant activity
may indicate a vascular injury associated with a hypercoagulable
state in AML.
PF4.06
The role of microvesicles in multiple myeloma progression
Anat Aharon1, Moran Zarfati2, Tami Katz1, Irit Avivi1 and Benjamin Brenner1,2
1Rambam Health Care Campus, Haifa, Israel; 2Bruce Rappaport Faculty of
Medicine, Technion, Haifa, Israel
Introduction: Multiple myeloma (MM) is an incurable, genetically
heterogeneous malignancy of plasma cells. MM is characterized by
bone marrow infiltration, cytopenia and increased rate of thrombotic
events. Microvesicles (MVs) are involved in thrombosis and cancer.
However, the effect of MM-MVs on disease progression is unclear.
Aim: To characterize MM-MVs and investigate their effects on the
bone marrow (BM) microenvironment cells model. Method: MVs were
isolated from MM cell line, untreated or treated with bortezomib and
from peripheral blood (PB) and BM of MM patients (n13) and
healthy controls (n14). MM-MV size, concentration and cell origin
were measured by Nanosite and FACS. Protein content was
evaluated by protein array. Coagulation and proteasome activity
were assessed by chromogenic assays. Effects of MVs on migration,
proliferation and cell-signalling on BM-mesenchymal and endothelial
cells (ECs) were analysed. Results: MM cells exhibited high MV
shedding rate, which further increased with exposure to bortezomib
in MM patients. MM-MVs expressed membrane MM markers,
coagulation and growth factors and displayed procoagulant and
proteasome activity. MM-MVs penetrated cells and affected their
function. MVs of untreated cells and patient MVs increased EC
and mesenchymal cell migration and EC proliferation, while MVs
obtained from bortezomib-treated cells decreased these effects.
MVs of untreated cells increased ERK1/2 and c-Jun phosphorylation
while bortezomib-treated cells reduced c-Jun phosphorylation in
ECs. Summary: MM cells are characterized by high shedding rate of
MVs. They are pro-coagulants and increase EC thrombogenicity,
suggesting their involvement in MM-related thrombosis. MVs con-
tain high levels of angiogenic factors that affect mesenchymal and
EC. MVs exposed to bortezomib display lower levels of angiogenic
factors, which limit proliferation and migration. MVs reflect the
efficacy of therapy and involved in MM dynamics.
PF4.07
The role of lung cancerderived extracellular vesicles in tumour
progression
Wei-Lun Huang1, Shang-Rung Wu2, Wu-Chou Su1 and Chien-Chung Lin3
1Cancer Center, Department of Internal Medicine, and Institute of Clinical
Medicine, National Cheng Kung University College of Medicine and Hospital,
Tainan, Taiwan; 2Institute of Oral Medicine, National Cheng Kung University
College of Medicine and Hospital, Tainan, Taiwan; 3Department of Internal
Medicine and Institute of Clinical Medicine, National Cheng Kung University
College of Medicine and Hospital, Tainan, Taiwan
Introduction: Extracellular vesicles (EVs) have been shown to play
important roles in many diseases including tumour. However, the
role of EVs in lung cancer is still not fully understood. In this study,
we tried to find out the biological functions of EVs in lung cancer.
Methods: EVs were isolated from culture supernatants, serum and
malignant pleural effusion (MPE) using ultra-centrifugation and ultra-
filtration and then evaluated by TEM, cryo-EM and NanoSight. The
biological functions of EVs were analysed in both in vitro cell line
model and in vivo animal model. Results: EVs could be isolated from
culture supernatants, serum and MPE samples using these two
methods with different capacity revealed by EM and NanoSight.
Specific EV markers including Alix, CD63 and Tsg101 were detected
in the isolated EVs which carried various RNA species that small RNAs
were enriched in EV portion compared with the cytosolic portion.
Furthermore, the EVs could be uptaken by lung cancer cells and
trigger oncogenic signals such as Stat3 and Akt in an autocrine/
paracrine fashion. Previously, we have shown that IL-6/Stat3/tissue
factor (TF)/vascular endothelial growth factor (VEGF) pathway plays
an important role in lung cancer angiogenesis and metastasis as well
as in the formation of MPE. Here, we showed that EVs from lung
cancer samples carried high level of VEGF and TF and triggered
vascular permeability changes in both in vitro and in vivo models.
Summary/Conclusions: Using these methods, we isolated EVs not
only from culture supernatants but also from various lung cancer
associated clinical samples and showed that the EVs triggered
oncogenic signals and increased vascular permeability in an auto-
crine/paracrine fashion. These results may help the understanding of
the biological functions of EVs in lung cancer and also the discovery
of novel biomarkers and potential drug targets.
PF4.08
Stressors alter intercellular communication and exosome profile in
nasopharyngeal carcinoma cells
Gabriella Dobra1, Istvan Nagy2, Maria Harmati2, Sandor Kormondi3,
Zsolt Szegletes4, Zsofia Tarnai5, Imre Dekany6, Laszlo Janovak7, Katalin
Nagy5, Krisztina Buzas1,5, Gabor Decsi5, Edina Gyukity-Sebestyen8 and
Okay Saydam9
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Introduction: Head and neck cancers comprise the sixth most
common type of cancer worldwide. One of the most remarkable
malignancies of the head and neck is the cancer of the nasopharynx,
with a strong metastatic tendency already in the early stage. Beside
the conventional pathways of metastasis formation, the information
content of exosomes produced by the cancer cells may play a key
role in metastatic transformation. The aim of this study was to
investigate how stressors (cytostatic therapy or oxidative stress)
alter the characteristic of tumour-derived exosomes. Materials and
Methods: In our experimental model, we compared the quantity
and content of exosomes produced by a nasopharyngeal carcinoma
cell line (5-8F) under conventional (chemotherapy) and alternative
(AgTiO2-catalyzed reactive oxygen species generation) cytostatic
treatments. After isolation, exosomes were identified by atomic force
microscopy and quantified with NanoSight NS500 device. Their
microRNA content was analysed using SOLiD 5500xl technology. The
sequences were annotated in CLC Genomics Workbench version
5.5.1. Results: Beyond the classic chemotherapeutic agent (doxor-
ubicin), AgTiO2 in a photo-catalytic process also showed cytostatic
activity. Tumour cell damage induced by the cytostatic treatments
significantly altered the quantity of exosomes and their miRNA
content. Conclusion: The increased quantity of exosomes and
diversity of miRNAs stimulated by stressors may potentiate the
information transfer from tumour cells to the surrounding stroma
cells. A high rate of tumour suppressor miRNAs can lead to an
important second-line anti-proliferative and a metastasis inhibitory
effect of cytostatic treatments.
This research was funded by OTKA PD 84064, OTKA K 112493,
TAMOP-4.2.2-A-11/1/KONV-2012-0025 and IPA HUSRB/1203/214/230.
PF4.09
EVs from human ovarian cancer drive the normal fibroblasts shift to
‘‘cancer associated fibroblasts’’-like phenotype
Marianna Di Francesco, Ilaria Giusti, Sandra D’Ascenzo and
Vincenza Dolo
University of L’Aquila, L’Aquila, Italy
Introduction: It is well known that cancer cells release extracellular
vesicles (EVs) able to modulate the tumour microenvironment. Thus,
our study considered how human ovarian cancer derivedEVs affect
normal fibroblasts, in order to evaluate if they are induced to acquire
the properties of cancer-associated fibroblasts (CAFs). Methods:
EVs were isolated from conditioned culture media of human ovarian
cancer cell lines, CABA I and SKOV-3 (the latter being more
aggressive than the former), through differential ultracentrifugation.
Normal human fibroblasts were then cultured with EVs according to
the scheme: i) Single treatment (150 mg/ml). After 72 h, fibroblast
proliferation rate was evaluated through XTT colorimetric assay,
while after 24 h their motility was estimated using the Boyden
chamber. ii) Daily treatment, up to 5 days (1 mg/ml). Proliferation was
evaluated 48 h after the end of the treatment. Meanwhile, FBS-free
supernatants were assessed for gelatinases (MMP-2 and -9) and
plasminogen activators (PA) expression by means of zymography
assays with appropriate substrates. Results: EVs do not encourage
fibroblast proliferation but increase their migration. The expressions
of pro-MMP-2 and of high molecular weight urokinase-type plasmi-
nogen activator (HMW-uPA) were up-regulated in EVs-treated
fibroblasts; SKOV-3 EVs induced a more marked effect than CABA I
EVs. In turn, the conditioned media of stimulated fibroblasts
promoted the migration capacity of ovarian cancer cells. Summary/
conclusion: EVs were able to affect fibroblasts’ behaviour, stating
their importance in the intercellular crosstalk between ovarian
cancer cells and normal fibroblasts in order to establish a tumour
microenvironment favourable to cancer progression. The present
results highlighted that EVs, even if not able to induce fibroblast
proliferation, can promote their migration and an increased expres-
sion of proteolytic enzymes needed for tumour microenvironment
invasion.
PF4.10
GBM extracellular vesicles: mediators of invasion and brain stromal
modulation
Christian Brøgger Stolberg1, Gunna Christiansen2,
Johann Mar Gudbergsson1, Nichlas Karred1 and Meg Duroux1
1Laboratory of Cancer Biology, Biomedicine, Department of Health Science and
Technology, Aalborg University, Frederik Bajers Vej, Aalborg Ø, Denmark;
2Institute for Biomedicine, Aarhus University, Vennelyst Boulevard, Aarhus C,
Denmark
The tumour milieu in Glioblastoma Multiforme (GBM) plays an
important role in therapeutic resistance and facilitates tumour
progression through cell-to-cell communication mediated by extra-
cellular signalling. Extracellular vesicles (EVs) are cell-derived nano-
vesicles which have been shown to contribute to cancer hallmarks,
such as invasion and angiogenesis, through autocrine and paracrine
signalling. We hypothesized that GBM EVs facilitate cancer stem
celllike invasion in a spheroid migration assay and that GBM
conditioned media (CM) can facilitate an angiogenic response
through stromal modifications that drive pericyte expression of
alpha smooth muscle actin (aSMA). EVs were isolated from mono-
layer cell culture supernatant of a primary GBM cell line by
ultracentrifugation. Characterization of EV size was done with NTA
and protein quantification with BCA; vesicle morphology was
examined with immuno-TEM. To investigate the invasive potential
of GBM EVs (derived from monolayer culture), cells were grown as
spheres, added to Geltrex matrix and treated with EVs in two
concentrations (low and high). Total area of invasion was measured
by brightfield microscopy for 5 days along with appropriate controls.
The angiogenic potential of the EVs was examined using primary rat
pericytes as a stromal model. Pericytes cultured as a monolayer were
treated with CM and analysed for the expression of aSMA. EV size
distribution was in accordance with the literature and appeared to
be round in shape as observed with TEM. In the spheroid invasion
assay, GBM EVs increased the rate of cell invasion into the matrix and
the sphere core was dispersed compared with controls. The CM from
primary GBM cells elicited an expression of aSMA in the pericytes
mirroring the activity of TGF-ß regulation of aSMA. The results of this
study provide evidence that the EVs alone can facilitate cell
migratory and invasive properties of GBM and that CM stimulates
primary pericytes to induce the expression of aSMA.
PF4.11
Exosomal miRNAs play an important role in cellcell
communication between bladder cancer cells and tumour
microenvironment
Sophie Baumgart1, Joana Heinzelmann1, Michael Stoeckle1, Marie Stampe
Ostenfeld2 and Kerstin Junker1
1University Hospital of Saarland, Department of Urology, Homburg, Germany;
2University Hospital Aarhus, Department of Molecular Medicine, Aarhus,
Denmark
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Introduction: Interaction of tumour cells and the tumour microenvir-
onment (TME) plays an important role in tumour development and
progression. miRNAs, packed in exosomes (EV), can affect cellcell
communication at the site of origin as well as the TME. Our aims are
the identification of a specific exosomal miRNA expression pattern
from EV of urinary bladder cancer (UBC) cell lines depending on the
invasiveness of parental cells and characterization of their functional
role in reprogramming fibroblasts. Methods: EV were isolated from
invasive (T24,253J-BV,J82) and non-invasive (RT112,5637) UBC cells
and characterized by Western Blot, NTA and electron microscopy.
miRNA-expression analysis in UBC cells and their EV was performed
by microarray and qPCR. Uptake of labelled UBC-EV by naive
fibroblasts was shown by laser scanning microscopy. EV-mediated
miRNA transfer between UBC cells and fibroblasts was shown by
transfection of UBC cells with cel-miR-39, EV isolation, transfer to
fibroblasts and qPCR analysis of recipient fibroblasts. After treatment
of fibroblasts with UBC-EV, proliferation, invasion and migration
assays are performed. Results: Isolated EVs exhibited a size between
6181 nm and typical EV markers. EVs of invasive UBC cells are
characterized by a specific miRNA signature of 15 miRNAs. Six
significantly differently expressed miRNAs clearly separate both
invasive and non-invasive UBC cells and their EV. Labelled EV of
UBC cells and exosomal miRNA were taken up by naive fibroblasts.
After co-cultivation of EV and naive fibroblasts, high proliferation
rates were detected in fibroblasts. Conclusion: EV secreted by UBC
cells exhibit a specific miRNA signature depending on the invasive-
ness of parental cells. For the first time we demonstrated that
EV-mediated transfer of miRNAs between UBC cells and naive
fibroblasts leads to an increase of fibroblast proliferation. These
results emphasize the role of exosomal miRNAs for the interaction
between tumour cells and the TME.
PF4.12
Differential expression of ligands for NKG2D and DNAM-1 receptors
by epithelial ovarian cancer-derived exosomes and their influence on
NK cell cytotoxicity
Alireza Labani Motlagh, Pernilla Israelsson, Ulrika Ottander, Eva Lundin,
Ivan Nagaev, Olga Nagaeva, Eva Dehlin, Vladimir Baranov and
Lucia Mincheva-Nilsson
Department of Clinical Microbiology/Division of Clinical Immunology,
Umea University, Sweden
Tumour-derived exosomes down-regulate the immune response
of cancer patients to gain an immune privilege for the primary
tumour and its metastases. Epithelial ovarian cancer (EOC) is a highly
malignant gynaecological tumour and a great exosome producer.
We studied the immunosuppressive ability of EOC exosomes in two
cytotoxic mechanisms  the NKG2D receptor-ligand pathway, known
to be a major cytotoxic mechanism in anti-tumour defence, and the
accessory DNAM-1-PVR/nectin-2 mediated pathway. EOC exosomes
were isolated from the EOC cell lines, OVCAR-3, SKOV-3, and from
tumour explant cultures and ascitic fluids from EOC patients after
ethical permission and informed consent. The expression of NKG2D-
and DNAM-1 ligands on/in EOC exosomes and their effect on in vitro
cytotoxicity was studied. We show that NKG2D- and DNAM-1 ligands
are carried by EOC exosomes in a differential way  while NKG2D
ligands were constitutively expressed on the exosomal surface, the
DNAM-1 ligands were less frequently expressed and present only
inside the exosomes. The EOC exosomes significantly down-modu-
lated the expression of the NKG2D receptors on NK and cytotoxic
T cells whereas the exosomal DNAM-1 ligands had no influence on
the DNAM-1 receptors. The down-regulation of NKG2D receptor
expression led to inhibition of NKG2D receptormediated degranu-
lation and cytotoxicity as measured in vitro with OVCAR-3 and K562
cells as targets. Acting as a decoy, the EOC exosomes impaired the
NKG2D-mediated cytotoxicity while the DNAM-1 receptor pathway
was not affected. We conclude that in EOC, NK cells kill tumour cells
mainly through the DNAM-1 signalling pathway and that the NKG2D
receptor-ligand pathway probably only plays a complementary role.
Our results contribute to dissect and understand the complex
tumour exosome-associated network of immunosuppressive me-
chanisms to be able to prevent facilitation of tumour escape, booster
patients’ anti-tumour defence and find novel therapies to combat
cancer.
PF4.13
The role of extracellular vesiclemediated signalling in the oral cancer
microenvironment
Mark Ofield, Daniel Lambert and Stuart Hunt
University of Sheffield, England
Introduction: Oral cancer mortality rates have increased by 10% in
the past decade. Efforts to reverse this are hampered by a limited
understanding of the underlying molecular complexity of the
disease. Recently, interest has grown in the contribution of extra-
cellular vesicles (EVs) to cancer pathogenesis. Since the discovery of
mRNA and miRNA in EVs, they have been considered a signalling
system capable of exerting behaviour-changing effects on local or
distant cells. Developing tumours exist as a complex milieu
comprising multiple cell types, each capable of producing a range
of different EVs with pleiotropic functions. The aim of this work is to
explore the role of EVs, and their cargoes, in oral cancer progression.
Methods: EVs were extracted from the culture media of oral cancer
cell lines by ultracentrifugation or size-exclusion chromatography
and characterized by transmission electron microscopy (TEM),
tunable resistive pulse sensing (TRPS) and western blotting. Next
generation sequencing and iTRAQ mass spectrometry were used to
identify the molecular contents. Fluorescence assays were used to
examine the ability of EVs to transfer between cell types. Prolifera-
tion and viability assays determined the impact of this transfer on
the recipient cell behaviour. Results: EVs were isolated from cell lines
representative of the stages of oral cancer development (dysplastic,
carcinoma and metastatic) and their presence confirmed by western
blot, TEM and TRPS showing them to be between 50200 nm
in diameter and bearing common markers including CD63. EV
production increased with oral cancer stage. Fluorescent labelling
visualized the transfer of EVs derived from cancer cell lines to other
cell types. Conclusion: EVs were readily isolated from dysplastic,
carcinoma and metastatic cell lines, suggesting a role for EVs in oral
cancer progression. We demonstrate here that these EVs are able
to transfer their molecular contents to cells of the oral cancer
microenvironment.
PF4.14
Modulation of exosomes secretion during NaBu induced differentiation
of HT29 colon cancer cells, and effects of exosomes administration on
normal and cancer cells
Federica Calapa`1, Fanali Caterina1, Carbone Federica1, Valentina Palmieri2,
Alma Boninsegna1, Marco De Spirito2 and Alessandro Sgambato1
1Institute of General Pathology, Catholic University, Rome Italy; 2Institute of
Physics, Catholic University, Rome Italy
Introduction: Exosomes are involved in inter-cellular communication.
Sodium butyrate (NaBu) has been shown to stimulate differentiation
of colon cancer cells. We previously reported that NaBu-induced
differentiation of HT29 colon cancer cells is associated with a
reduced expression of CD133. Aims: To analyse the effects of NaBu
administration on the release of exosomes and to study the effects
of the administration of exosomes to both normal and cancer cells.
Methods: Exosomes were prepared using differential centrifugations.
MicroRNA and mRNA expression levels were evaluated by RT-PCR.
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Cell proliferation rate was assessed by MTT assay and confirmed with
the Electric Cell-substrate Impedance Sensing while cell motility was
assessed using the scratch test and confirmed by Confocal Micro-
scopy. Results: NaBu-induced differentiation of HT29 colon cancer
cells increased the levels of exosomes, and their expression of CD133
when compared to untreated cells. HT29 cells differentiation and the
decrease of cellular CD133 expression levels were prevented by
blocking multivesicular body maturation with NH4Cl. The exosomes
isolated from differentiated cells carried specific microRNAs at levels
higher than those isolated by untreated cells. Incubation with
exosomes isolated from differentiating HT29 cells increased the
proliferation and the motility rate of both colon cancer cells and
normal fibroblasts, increased the colony-forming efficiency of cancer
cells and reduced the NaBu-induced differentiation of HT29 cells.
Such effects were associated with an increased phosphorylation level
of both Src and Erk proteins and with an increased expression of
genes involved in EMT. Conclusions: These findings confirm the role
of CD133 in the maintenance of stem cells properties; exosomes are
used by differentiating cells to get rid of cellular components that
are no longer necessary for the cells which might continue to exert
their effects in tumour micro-environment.
PF4.15
HAS3 overexpression induces secretion of diverse EVs by tumour cells
Kai Ha¨rko¨nen1, Uma Arasu1, Arto Koistinen2 and Kirsi Rilla1
1Institute of Biomedicine, University of Eastern Finland, Kuopio, Finland;
2SIB Labs, University of Eastern Finland, Kuopio, Finland
Hyaluronan (HA) is essential for maintenance of normal tissues, but it
also promotes cancer progression by creating a favourable micro-
environment for growth of tumour cells. Hyaluronan is produced by
HA synthases (HAS) on the plasma membrane. Overexpression of
HAS3 is known to induce formation of different plasma membrane
protrusions, disturb normal epithelization and enhance shedding of
EVs. This work shows that HAS3 overexpression induces formation of
EVs of diverse shape and size (505000 nm) by MCF-7 breast cancer
cells. High-resolution imaging techniques like airyscan confocal
microscopy, scanning and transmission microscopy, and correlative
microscopy were used to characterize the EVs secreted by HAS3
overexpressing cells in monolayer and organotypic breast cancer cell
cultures. Especially EVs originating from protrusions interacting with
neighbouring cells were increased upon HAS3 overexpression,
suggesting EV-mediated contact-dependent interactions between
cells. Interestingly, HAS3 overexpression was associated with enhan-
ced spheroid formation in organotypic breast cancer cell cultures.
The effects of HAS3-induced vesicles on target cell behaviour like
invasion potential were also studied. This study shows that in
addition to previously described vesicle shedding mechanism from
tips of thin protrusions, activity of HAS3 induces formation of
vesicles of variable size originating from membrane blebs, retraction
fibres and other actin-dependent protrusions. It can be assumed that
active synthesis of HA on the plasma membrane creates hydrostatic
forces that promote disruption of the cortical actin cytoskeleton. This
creates membrane bulges that give rise to different protrusions and
blebbing of the plasma membrane, resulting in enhanced shedding
of EVs. Additionally, HA carried on the surface of EVs modifies the
extracellular niche of tumour cells and modulates the surface
properties of EVs, regulating the interactions of EVs with target cells.
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Biological effects of different extracellular vesicles (EVs) population on
reversal of marrow cells radiation damage
Sicheng Wen1, Elaine Papa1, Laura Goldberg1, Michael Del Tatto1,
Yan Cheng2, Mandy Pereira3, Connor Stewart2, Pamela Egan1,
Jason Aliotta1, Peter Quesenberry1, Giovanni Camussi4 and
Mark Dooner1
1Hematology/Oncology, Brown University, Rhode Island Hospital, Providence,
RI, USA; 2Department of Medicine, Rhode Island Hospital, Providence, USA;
3Rhode Island Hospital Hematology/Oncology, Providence, Rhode Island;
4Department of Medical Sciences, Translational Center of Regenerative
Medicine and HUGEF University of Torino, Torino, Italy
Three different fractions (10k pellet, 100-10k pellet and 100k pellet) of
murine/human mesenchymal stem cell (MSC)-derived vesicles were
isolated by differential centrifugation. FDC-P1 cells were exposed at
500cGy irradiation and cultured with 3 different preparations of MSC-
derived vesicles for 7 days. A significant increase in cell proliferation
was observed after 3 different vesicle fractions treatments. However,
exosomes were clearly inferior, microvesicles and the combined
exosomes and microvesicles population were superior. The capacity
of human MSC-derived vesicles of different fractions on reversal of
murine bone marrow damage was also evaluated in vivo. The
combined fractions shown a significant increase donor chimerism
in bone marrow at 6 months post-transplant with 5x’s the level of
engraftment compared to irradiation control. The 10k and 10010k
fractions showed intermediate healing. Exposure to vesicles in
irradiated FDC-P1 cells downregulated phosphorylated H2AX, the
DNA damage marker and decreased apoptosis marker, PARP
cleavage. The effect of murine marrow MSC-derived vesicles on the
gene expression in peripheral blood cells from radiation damaged
mice was investigated. 28 genes were altered by irradiation; 22
showed partial or complete reversal of these alterations. The char-
acterization of three different fractions of vesicles derived from
murine bone marrow cells and human MSC were evaluated by miRNA
real-time PCR array (total 750 miRNA). Several MSCEV-associated
miRNAs responsible for the reversal of radiation damage were
evaluated. Our preliminary data shown that miR-221, miR654-3p
and miR210-5p could partially reverse radiation damage in FDC-P1
cells. There are different biological effects in different EV populations.
For reversal of radiation toxicity, the most effective vesicle population
would include both smaller (exosomes) and larger vesicles (micro-
vesicles).
Acknowledgements: This work was supported by the NIH grant
5UH2TR00080.
PF5.02
Mesenchymal stromal/stem cell-derived extracellular vesicles- towards
a novel therapy for osteoarthritis
Lucienne Vonk, Sanne Van Dooremalen, Paul Coffer, Danie¨l Saris and
Magdalena Lorenowicz
Center for Molecular Medicine & Regenerative Medicine Center University
Medical Center Utrecht, Utrecht, The Netherlands
Introduction: Osteoarthritis (OA) is a rheumatic disease leading to
chronic pain and disability with no effective treatment available.
Recently, allogeneic human mesenchymal stromal/stem cells (MSCs)
entered clinical trials as a novel therapy for OA. Increasing evidence
suggests that therapeutic efficacy of MSC depends on paracrine
signalling. Here, we investigated the role of MSC-derived extracellular
vesicles (EVs) in cartilage repair. Methods: MSC-EVs were added to
regeneration cultures of OA chondrocytes in fibrin glue and to
monolayers of OA chondrocytes treated with TNF-a. MSC-derived
conditioned medium (CM) and EV-depleted CM were used as
controls. COX2 gene expression and PGE2 protein levels were
measured in the monolayer cultures and culture supernatant,
respectively after 48 h. The regeneration cultures were analysed after
4 weeks for glycosaminoglycan content by DMMB and paraffin
sections of the regenerated tissue were immunostained for proteo-
glycans and type II collagen. Results: We show that MSC-EVs promote
cartilage regeneration in vitro, as addition of MSC-EVs to the cultures
of OA chondrocytes-induced production of proteoglycans and
collagen type II by these cells. MSC-EVs also inhibit the adverse
effects of inflammatory mediators on cartilage homeostasis. When co-
cultured with OA chondrocytes treated with TNF-alpha, MSC-EVs
inhibit the expression of COX2, the pro-inflammatory enzyme
important for production of prostaglandins and known to inhibit
proteoglycan and collagen synthesis. To understand the mechanism,
by which MSC-EVs perform these beneficial effects we analysed their
RNA content. We found 206 mRNAs and lncRNAs enriched in MSC-EVs.
Importantly, among the genes enriched in MSC-EVs were putative
regulators of cartilage regeneration, factors important for immuno-
modulation, cell growth and differentiation. Conclusions: Our data
indicate that MSC-EVs are important regulators of cartilage repair and
hold a great promise as a novel therapy for OA.
PF5.03
Immunomodulatory impact of mesenchymal stem cell-derived
extracellular vesicles on peripheral blood cells in vitro
Kyra De Miroschedji, Andre´ Go¨rgens, Michel Bremer, Verena Boerger and
Bernd Giebel
Institute for Transfusion Medicine, University Hospital Essen, Essen, Germany
Human mesenchymal stem cells (MSCs) have been administered in
more than 500 NIH-registered clinical trials to patients suffering from
various diseases including myocardial infarction, stroke and graft-
versus-host disease (GvHD). Initially, MSCs were thought to replace
lost cells in damaged tissues. Despite controversial reports regarding
the efficacy of MSC-treatments, MSCs seem to exert their beneficial
effects rather by secretion of immunosuppressive factors than by cell
replacement. In this context, extracellular vesicles (EVs), such as
exosomes and microvesicles, were identified to execute the MSCs’
therapeutic effects. Our recent successful treatment of a steroid-
refractory GvHD patient and the demonstration of pro-regenerative
effects in a murine stroke model confirmed the MSC-EVs’ therapeutic
potential. Due to the fact that MSCs provide a heterogeneous cell
entity, we compared the MSC-EV fractions obtained from MSCs of 20
healthy donors in immune modulatory in vitro assays. Our ongoing
results confirm quantitative and qualitative differences within these
MSC-EV fractions. A critical step in comparing and interpreting the
obtained data is the normalization procedure. Initially, we used cell
equivalents for normalization. However, upon learning that a huge
proportion of EVs get lost during ultracentrifugation, which we use
as a final step to concentrate PEG precipitated MSC-EVs, cell
equivalents and processed media volumes, were found as inap-
propriate parameters for normalization. For EVs prepared with the
PEG method  in contrast to EVs prepared with the differential cen-
trifugation method  normalization to the protein amount of applied
MSC-EVs revealed reliable data. Critical issues in the normalization
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process and challenges of the applied purification method, especially
the ultracentrifugation step, will be discussed.
PF5.04
Hyaluronan-coated extracellular vesicles are secreted by human
mesenchymal stem cells
Kirsi Rilla1, Uma Arasu1, Mikko Lammi2, Chengjuan Qu2, Arto Koistinen3,
Kai Ha¨rko¨nen1 and Riikka Ka¨rna¨
1Institute of Biomedicine, University of Eastern Finland, Kuopio, Finland;
2Department of Integrative Medical Biology, University of Umea˚, Umea˚,
Sweden; 3SIB Labs, University of Eastern Finland, Kuopio, Finland
Hyaluronan (HA) is the most abundant polysaccharide of the
extracellular matrix (ECM), promoting growth and healing of tissues.
HA is synthesized by specific plasma membrane-bound enzymes, HA
synthases (HASs) that induce shedding of HA-coated EVs (HA-EVs).
EVs can transfer information between bone marrow stem cells and
damaged tissue, suggesting that stem cells can repair tissue injuries
without directly replacing parenchymal cells. Human mesenchymal
stem cells (MSCs) secrete high levels of HA, which may associate
with the EV secretion of the MSCs. To confirm this hypothesis, we
characterized the EVs secreted by the bone marrow-derived MSCs
and their relationship with HA synthesis. The EVs secreted by the
MSCs were characterized by NTA, immunoblotting and qPCR. Their
HA content, morphology and budding mechanisms were inspected
by live cell confocal microscopy. LPS and RNA interference were
utilized to study the mechanisms regulating the EV secretion and
their association with HA. It was found that the MSCs have extremely
long HA-coated plasma membrane protrusions typical for cells with
an active HA secretion. Additionally, they secreted high numbers of
HA-EVs, which carried also mRNAs for CD44 and all HAS isoforms.
HAS silencing inhibited and LPS increased the HA-EV secretion,
suggesting that their secretion is associated with the activity of HA
synthesis. The EVs that carry HA on their surface are potential
vehicles in preparing suitable niches for tissue regeneration. The HA-
EVs and signals within them may participate in ECM remodelling
directly or indirectly by interacting with ECM-producing cells.
Moreover, HA coating may facilitate EV binding to target cells via
HA-CD44 interactions. These features make the HA-EVs potential
therapeutic tools to heal the damaged ECM in the injured tissues.
The results of this study suggest that secretion of the HA-EVs is a
general process, which explains many unsolved questions on the
mechanisms of HA-mediated tissue regeneration.
PF5.05
Paracrine effect of membrane vesicles released by mouse
mesoangioblast stem cells
Fabiana Geraci1,2, Maria Magdalena Barreca3, Emanuele Aliotta4,
Chiara Petruzzelli3, Linda Sansiverino3, Juan Falcon-Perez4, Felix Royo4
and Walter Spinello3
1STEBICEF, University of Palermo, Palermo, Italy; 2Stress, Epigenetic, Health and
Sport Biology, Euro-Mediterranean Institute of Science and Technology,
Palermo, Italy; 3Stebicef University of Palermo, Italy; 4Food Chemistry,
Sperimental Zooprophylactic Institute of Sicily, Palermo, Itlay; 5Exosomes Lab.
& Metabolomics Platform. Cic Biogune, Ciberehd, Ikerbasque, Bizkaia, Spain
Introduction: Mouse mesoangioblasts are vessel-associated multi-
potent progenitor stem cells, which are able to differentiate into
different mesodermal cell types. In our previous paper, we have
demonstrated that mesoangioblasts are able to shed in the extra-
cellular environment membrane vesicles (EVs), which contain both
structural proteins and biological factors such as FGF2 and the two
gelatinases MMP2/9. We investigated whether these EV interact in a
paracrine way with other cell types different from mesoangioblasts,
and eventually the effects of this interaction. Methods: Mesoangio-
blast EVs were collected from conditioned media by ultracentrifuga-
tion. Total mRNAs from mesoangioblasts and from two preparations
of EVs were used to perform microarray. Different concentrations of
mesoangioblast EV were used to evaluate in vitro migration modula-
tion on human ECV304 cells by wound healing assay or study their
influence on capillary-like structures formation. Murine RAW 264.7
macrophages were cultured with or without mesoangioblast-derived
EVs to investigate their effect on cytokines secretion profile and RTK
phosphorylation levels by array. Results: We observed that mesoan-
gioblast EV contained a huge amount of mRNA; most of the
transcripts are co-expressed in EV and cells, whereas 20 mRNA were
accumulated within EV and absent in the cells. Gene ontology
analysis showed that the common mRNA could be involved in cell
survival and differentiation. We demonstrated that mesoangioblast
EV interact with endothelial ECV304 cells by positively influencing
their migration capability. Moreover, they induce in vitro the ECV304
differentiation versus capillary-like structures depending on their
concentration. Mesoangioblast EVs are also able to interact with RAW
264.7 cells inducing dramatic changes in cytokines secretion and in
RTK phosphorylation levels. Conclusions: We demonstrated that
mesoangioblast EV interact with endothelial cells and macrophages
and influence on their behaviour.
PF5.06
CD47 regulates the reprogramming of endothelial cells by breast
cancer stem cell-derived extracellular vesicles
Sukhbir Kaur1, David D. Roberts2 and Elkahloun Abdel2
1National Cancer Institute, Bethesda, Maryland, USA; 2National Human Genome
Research Institute/National Institutes of Health, Bethesda, Maryland, USA
CD47 is a ubiquitously expressed signalling receptor in human cells
that is also present in extracellular vesicles. CD47 is often highly
expressed in tumour cells and is associated with a poorer prognosis.
A microarray analysis of human umbilical vein endothelial cells
(HUVEC) treated with MDA-MB-231-derived extracellular vesicles
showed global changes in mRNA expression. To examine whether
extracellular vesicles derived from breast cancer stem cells (bCSCs)
mediate these changes in mRNA expression we isolated MDA-MB-
231 and MCF7 bCSCs. Quantitative PCR and ELISA analyses revealed
that the expression of vascular endothelial growth factor (VEGF)
and its receptor (VEGFR2) phosphorylation were downregulated in
the presence of MDA-MB-231-derived extracellular vesicles but not
MCF7-derived extracellular vesicles. VEGF expression and VEGFR2
phosphorylation in HUVEC were also inhibited by thrombospondin-1
(TSP1) or the CD47 blocking antibody B6H12 in presence or absence
of bCSCs. The downregulation and inhibition of VEGF signalling
we observed might be part of the mechanism by which cancer cell
extracellular vesicles co-opt healthy cells and perturb normal
endothelial cell signalling. Endothelial-to-mesenchymal transition is
often categorized as a specialized form of epithelial-to-mesenchymal
transition (EMT). MDA-MB-231-derived extracellular vesicles altered
ß-Catenin, Slug and LYVE1 markers as compared to normal HUVEC.
This indicates that extracellular vesicles may reprogramme HUVEC
into mesenchymal cells. MDA-MB-231 breast cancer cells are more
metastatic and more aggressive than MCF7, and extracellular vesicles
from MBA-MB-231 bCSCs preferentially impart these phenotypes
into endothelial cells. Future studies will reveal how TSP1 and CD47
play a role in EndMT and their potential as candidates to inhibit
the crosstalk between cancer-derived extracellular vesicles and
healthy cells.
PF5.07
Extracellular vesicles released by induced pluripotent stem cells
modulate cellular function of recipient cardiac endothelial cells
Marta Adamiak1, Sylwia Bobis-Wozowicz1, Sylwia Kedracka-Krok2,
Slawomir Lasota1, Elzbieta Karnas1, Michal Sarna3, Zbigniew Madeja1 and
Ewa Zuba-Surma1
1Department of Cell Biology, Faculty of Biochemistry, Biophysics and
Biotechnology, Jagiellonian University, Krakow, Poland; 2Department of
Physical Biochemistry, Faculty of Biochemistry, Biophysics and Biotechnology;
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PF5.08
Extracellular vesicle-delivered bone morphogenetic protein (BMP): a
novel paracrine mechanism during heart development
Thomas Draebing, Hugo A. Katus and David Hassel
Innere Medizin III, Universita¨tsklinikum Heidelberg, Heidelberg, Germany
Introduction: The closely related morphogens BMP2 and BMP4
(BMP2/4), secreted by endodermal and ectodermal cells, respec-
tively, have a dominant role in early cardiac progenitor cell induction
and later heart formation. Recently, it has been shown that the
morphogens Wnt3a and Hedgehog are transported by extracellular
vesicles (EVs). We hypothesized that EVs might also be involved in
transporting BMPs and thereby regulate cardiogenesis. Methods: A
new method to isolate EVs in vivo from zebrafish embryos based on
differential ultracentrifugation was established and used to purify
zebrafish EVs at the onset of cardiac progenitor cell induction (bud
stage, 10 h post-fertilization). Using western blotting and OptiPrep-
based gradient preparation, we verified the presence of BMP2/4 in
zebrafish EVs. BMP signalling activity was measured applying a dual
luciferase assay of ‘BMP-Responsive Element’-Luciferase reporter
transfected HEK293 cells treated with EVs. Results: Using our own
zebrafish EV isolation protocol, we can show that EVs released at the
onset of cardiac progenitor cell induction in vivo contain mature and
various premature forms of BMP2/4 peptide. To narrow down the
origin of EV-delivered BMP2/4, we examined the endoderm as a
possible source. Strikingly, using the endodermal cell line End2, we
can show that endoderm-derived EVs contain BMP2/4, establishing
the endoderm as a natural source for EV-delivered BMP. Additionally,
besides BMP peptides, we demonstrate the presence of BMP Type
II receptors being co-transported in EVs derived from zebrafish
embryos. Importantly, EVs isolated from zebrafish embryos and
from End2 cells are able to significantly activate a BMP-dependent
transcriptional response, indicating biological activity. Summary/
conclusion: EV-delivered BMP2/4 and BMP Type II receptors secreted
partly by the endoderm represent a new paracrine signalling
mechanism possibly involved in cardiogenesis.
PF5.09
Depleting extracellular vesicles from fetal bovine serum affects muscle
cell proliferation and differentiation
Sophie Rome, Hala Aswad and Audrey Jalabert
INRA Human Nutrition, CarMeN laboratory (INSERM 1060, INRA 1362, INSA),
University of Lyon, Oullins, France
Introduction: We have tested the role of fetal bovine serum (FBS)
extracellular vesicles (EVs) on myoblast proliferation and differentia-
tion using the murine cell line C2C12 and confirmed the data with
rat L6 myoblasts and human primary muscle cells. Methods: EVs
were removed from sera by ultracentrifugation (18h). Myoblasts
were grown either in classical DMEM or EV depleted-DMEM (EDDM).
Differentiation was induced by replacing the culture medium with
either normal media or EV-depleted media. qRT-PCR of relevant
genes and miRNAs for myogenesis, energy metabolism and EVs
secretion were performed. Results: Removal EVs from serum delays
C2C12 and human myoblast proliferation and committed cells to
differentiate precociously. In addition, the expressions of important
myomiRs for myogenesis were significantly decreased (i.e. miR-1,
miR-206 and miR-133a). When constantly grown in EDDM during
proliferation and differentiation, myoblasts formed less myotubes
than cells grown in classical serum. Conversely, L6 myoblasts were
positively affected and formed more and larger myotubes when
grown in EDDM compared to normal growth condition. In fact,
EDDM induced myostatin in C2C12 and human myotubes, a
negative regulator of muscle cell size. As L6 does not expressed
myostatin, induction of early differentiation markers during prolif-
eration by EDDM medium resulted in large hypertrophic myotubes.
Conclusions: We can recapitulate the crosstalk between myoblasts
and myotubes during myogenesis (Forterre 2013, PlosOne) by using
bovine serum-EVs. This result implies that bovine-EVs can transfer
specific signals to cells from unrelated species and thus that part of
serum EVs composition is evolutionarily conserved (e.g. miR-133a
and miR-1 are detected in FBS-EVs). Generally speaking, these results
suggest that EVs in body fluids could have an unsuspected function
during embryogenesis and in regulation of cellular processes that
lead to hypertrophy and hyperplasia.
PF5.10
Extracellular vesicles (EVs) from human cardiac-derived adherent
proliferating cells (CardAPs)  a comparative characterization
Christien Beez1, Meaghan Stolk1, Marion R. Haag2, Anita N. Bo¨ing3, Sophie
Van Linthout1 and Martina Seifert1
1Berlin-Brandenburg Center For Regenerative Therapies (BCRT) & Institute
of Medical Immunology, Charite´-Universita¨tsmedizin Berlin, Germany;
2Tissue Engineering Laboratory, Charite´-Universita¨tsmedizin Berlin, Germany;
3Department of Clinical Chemistry, Academic Medical Center of The University
of Amsterdam, The Netherlands
Introduction: Human cardiac-derived adherent proliferating cells
(CardAPs) isolated from endomyocardial biopsies own an extraordin-
ary phenotype and a proven cardiomyocyte protective potential with
substantial pro-angiogenic and anti-inflammatory effects in vitro and
in vivo. In this study, we phenotypically characterized EVs from
CardAPs in comparison with CardAP cells and further investigated the
ability of EVs to interact with either murine cardiomyocytes (HL-1) or
human endothelial cells (HUVECs). Methods: EVs were isolated from
CardAP conditioned medium via ultracentrifugation following removal
of apoptotic bodies. BCA assays and Nanoparticle Tracking Analysis
detected protein concentration, particle size and concentration. EVs
were coupled to 4 mm aldehyde/sulphate beads and analysed by flow
cytometry to evaluate surface markers. Interaction with target cells
was visualized by microscopy and flow cytometry of co-cultured
PKH26-labelled EVs with DiD-labelled HL-1 or HUVECs. Results: Our
data indicate that CardAP EVs (n6, 3 donors) have a modal particle
peak size of 95.7 (9 4.7) nm with a mean particle concentration of
8.05 (9 1.81) *108 mL1 and a mean protein concentration of 147.4
(9 18.6) mg/mL. No significant differences in particle peak size or
particle and protein concentrations were measured between different
passages of CardAPs. EVs possessed CD73, HLA-ABC, CD29 and the
tetraspanins CD9, CD81 and CD63 on their surface. In contrast to the
originating CardAP cells, CD90, CD54, CD144 and CD105 could not be
detected on EVs. Labelled isolated EVs are co-stained with DiD
target cells already 30 min after co-culture and further accumulate
over time. Summary/conclusion: Based on the tetraspanins detected
and the modal peak size of particles, we can conclude that CardAP-
derived EVs are composed of exosomes and microvesicles. Further-
more, EVs show similar but not identical surface protein expression as
CardAP cells and are able to interact with relevant target cells.
PF5.11
Hematopoietic differentiation of embryonic stem cells by stromal
cell-derived nanovesicles
Junho Kim1 and Chungmin Han2
1School of Interdisciplinary Bioscience and Bioengineering, POSTECH, Pohang,
South Korea; 2Mechanical engineering, POSTECH, Pohang, South Korea
Introduction: Culturing embryonic stem cells (ESCs) on a stromal cells
has long been used for differentiating ES cells to haematopoietic
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lineage cells. ES/stromal co-culture system induces differentiation of
ES cells through physical contact and soluble factor. However, the
co-culture system results in low differentiation yield and requires
separation of the differentiated cells from the mixed cell population.
We generated nanovesicles using stromal cells. These stromal cell-
derived nanovesicles had similar membrane and cytosolic compo-
nents of stromal cells, thus ESCs treated with the stromal cell-derived
nanovesicles (ESC/nanovesicle) would imitate the co-culture system.
The ESC/nanovesicle culture method showed increased efficiency
of differentiation when higher concentration of nanovesicles was
treated. This new method is free from active stromal cells and,
therefore, the differentiated cells can be used for further analysis
without an additional separation process. Materials and methods: To
make nanovesicles, OP9 stromal cells were extruded through two
different micro-sized filters which were enclosed in a mini-extruder.
OP9 nanovesicles (1200mg/ml) were treated to B6 ESCs every 3 days
for 3 weeks. Expression of differentiation markers was analysed using
a flow cytometry. Results: The size of OP9 nanovesicles was 100
nm and they enclosed mRNAs and proteins of stromal cells with
intact membrane proteins. When the ESCs were treated with
nanovesicles, they formed haematopoietic colonies with cobble-
stone-like appearance and expressed haematopoietic stem cell
markers. The treatment of high-dose nanovesicles showed 58
times increased haematopoietic marker (CD45, c-Kit, SCA-1) com-
pared to stromal cell co-culture samples. Conclusion: ESCs/nanove-
sicle culture method shows increased efficiency of differentiation
and did not require additional separation steps, thus nanovesicles
are expected to substitute co-cultures in various cellcell interaction
studies.
PF5.12
The Effect of Exosome-Mimetic-Nanovesicles on Mesenchymal Stem
Cell Proliferation.
Wonju Jo2, Junho Kim2, Sehong Kang1, Dayeong Jeong2 and
Jaesung Park1
1School of Interdisciplinary Bioscience and Bioengineering., Pohang University
of Science and Technology, Pohang, South Korea; 2Department of Mechanical
Engineering, POSTECH, Pohang, Republic of Korea
Introduction: Mesenchymal stem cells (MSCs) are widely used in
regenerative medicine, but low proliferation rate and loss of multi-
potency were limitations of MSCs. Exosomes may become good
materials for the cell proliferation because they can stimulate the
signal transduction and deliver the genetic materials. However,
low yield and complex isolation have made it difficult to obtain the
enough amount of exosome for exosome-related research. We
fabricated the exosome-mimetic nanovesicles (NVs) from living cells
to substitute the exosome. The NVs were generated from ruptured
cell membrane which can form NV due to self-assembly ability. The
NVs were applied to mouse MSC (mMSC), and enhancement of
proliferation was verified. Methods: Murine embryonic stem cells (ES)
were used for source of NVs, and large-scale generation system was
used to generate the NVs. To confirm the effect of NVs on
proliferation, NVs were applied to mMSCs after 24 h of serum-
starving. After 24 h treatment, the cell number was counted by
haemocytometers. BrdU were shown by fluorescence microscropy
image, and proliferation-related proteins (PCNA and MAPK) were
shown by western blotting. To identify the characteristic of mMSCs
after treatment, immunophenotyping and differentiation were
performed. Results: The ES NVs were 100 nm in diameter and
contained cellular contents like natural exosomes. The treatment of
ES NVs induced the enhancement of mMSCs proliferation (1.52
times) and phosphorylation of MAPK regulating proliferation. The
repeated NV treatments with proper dose (50 mg/ml) enhance
mMSC proliferation steadily without detrimental damage. Also, the
NV-treated mMSC showed well osteogenic and adipogenic differ-
entiation. Conclusion: The ES NVs had similar characteristic of
natural ES exosome and enhanced the proliferation of mMSCs. The
treatment of NVs did not influence to characteristics and multi-
potency of mMSC. Thus, the NVs generated from living cells are
expected to contribute to regenerative medicine.
PF5.13
RNA profiling of naive and differentiated MSC-derived EV: towards
miRNA-based release criteria for future therapeutic application of
EV in clinical trials
Karin Pachler1, Thomas Lener2, Doris Streif1, Zsuszanna A. Dunai1,
Alexandre Desgeorges1, Ravi Kalathur1, Sandra Laner-Plamberger2,
Katharina Schallmoser2, Gerhard Weidler1, Dirk Strunk1, Eva Rohde2 and
Mario Gimona2
1Paracelsus Medical University, Sci-Trecs, Salzburg, Austria; 2Paracelsus Medical
University, University Clinic for Blood Group Serology and Transfusion
Medicine & Sci-Trecs, Salzburg, Austria
Introduction: Mesenchymal stromal cells (MSCs) of various tissue
origin display differential therapeutic effects despite their overall
similar surface marker expression. Similarly, extracellular vesicles (EVs)
that largely mediate the paracrine effects of MSC differ with respect
to their protein and RNA content. Here, we analysed the EV of MSC
from three different sources [bone marrow (BM), adipose tissue (AT)
and umbilical cord (UC)] as well as from naive and differentiated BM-
MSC-derived EV to evaluate whether miRNA profiling may serve as a
release criterion for future EV-based therapies. Methods: EV were
purified from either naive or osteogenically differentiated MSC by
differential ultracentrifugation and characterized by NTA and western
blotting. Agilent Bioanalyzer-based total RNA profiling and miRNA
next-generation sequencing were employed to identify differences
in the EV RNA content. Results: RNA profiling revealed that EV from
UC-MSC contained significantly larger amounts of total RNA and
miRNAs than EV from the other two MSC tissue sources. Comparison
of naive and osteogenically differentiated MSC EV showed a
significant shift towards larger RNA species in the latter. miRNA
sequencing results confirmed the increased content of miRNAs found
in UC-MSC-derived EV. However, the most abundant miRNA in EV
from all three naive tissue sources was miR-146a, which is involved in
immunosuppressive processes. This miRNA was strongly reduced in
EVs from osteogenically differentiated BM-MSCs, which were en-
riched in miRNAs involved in promoting osteogenic differentiation.
Conclusions: Immunosuppressive miRNAs packaged into EV from
naive MSC may reflect their immunomodulatory potential. In con-
trast, EVs released by differentiated MSC contain miRNAs as potent
transducers of differentiation signals. miRNA profiling may thus be
employed to define the targeted therapeutic activity in MSC-derived
EV to promote future preclinical and clinical trials.
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Characterization of extracellular vesicles by flow cytometry
John Tigges, Camacho Virginia and Toxavidis Vasilis
1Flow Cytometry Science Center, Center for Extracellular Vesicle Research,
Beth Israel Deaconess Medical Center, Boston, USA
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PF6.02
Optimized staining protocol for extracellular vesicle characterization by
dedicated flow cytometry
Elmar Gool1, Frank Coumans2, Chi Hau3, Edwin Van Der Pol2, Rienk
Nieuwland4, Anita Bo¨ing4, Auguste Sturk1 and T. G. Van Leeuwen1
1Academic Medical Center, University of Amsterdam, The Netherlands;
2Department of Biomedical Engineering and Physics, Academic Medical
Center, University of Amsterdam, The Netherlands; 3Laboratory of
Experimental Clinical Chemistry, Academic Medical Center, University of
Amsterdam; 4Department of Clinical Chemistry, Academic Medical Center,
University of Amsterdam, The Netherlands
Background: Flow cytometry is commonly used to detect and
characterize single extracellular vesicles (EVs). However, conventional
staining protocols were developed for flow cytometers with an EV
detection limit around 500 nm. Dedicated flow cytometers detect
smaller EVs, but these EVs have lower numbers of antigens and their
labelling has not been optimized. Therefore, we developed a new
labelling protocol to increase the number of fluorochromes per EV
and improve antigen detection of smaller EVs. In addition, we
determined the minimal detectable number of fluorochromes per
EV. Methods: Platelet-derived EVs, obtained from platelet-depleted
supernatant of outdated platelet concentrates, were diluted 10-fold
in PBS/citrate. Samples (22.5 mL) were labelled with the conventional
staining protocol, that is, 62.5 ng/mL CD61-PE or 90 ng/mL CD9-PE
and incubation for 15 min. In addition, the sample was labelled with
higher concentrations (ranges of CD61-PE: 62.5-625 ng/mL or CD9-
PE: 90-900 ng/mL) and incubated for 15 or 60 min. IgG1-PE isotype
control was used in identical conditions. PBS/citrate (200 mL) was
added after incubation. Samples were analysed on a dedicated flow
cytometer (Apogee A50). Quantibrite beads (BD Biosciences) were
used to extrapolate the minimal detectable number of fluoro-
chromes per EV. Results: With the conventional staining protocol,
5.7x108 CD61 and 8.8x107 CD9 EVs/mL were detected, whereas
incubation of EVs with the highest antibody concentrations during
60 min resulted in a 5- and 18-fold increase in CD61 and CD9
EVs, respectively. Extrapolation of the fluorescence signal of
Quantibrite beads showed that approximately 100 PE molecules
are required to score a single EV as CD61 or CD9. Conclusion:
A 10-fold increase in antigen concentration and a 4-fold longer in-
cubation time resulted in a 5- to 18-fold increase in detected CD61
or CD9 EV. This increase is likely due to more EV exceeding the
detection threshold of approximately 100 PE molecules/EV.
PF6.03
Flow cytometry for determining size distribution of microvesicles and
variation in the lipid composition of individual liposomes
Jens B. Simonsen
University of Copenhagen, Copenhagen, Denmark
Recently, the need for a standard to determine the sizes of
extracellular vesicles, including microvesicles, by flow cytometry has
been emphasized. We suggest using artificial vesicles as calibrators
to estimate the size of microvesicles from the side scattering
(SSC) measured by flow cytometry. We prepared fluorescently
labelled liposomes with different maximum sizes defined by the
pore size (200, 400, 800 and 1000 nm) of the membrane used for the
extrusion. The fluorescence strengths from the largest liposomes
pertaining to each pore size enabled us to verify the correlation
between the SSC from a liposome and the corresponding size.
We propose that artificial vesicles are more accurate size
calibrators compared with the commonly used polystyrene calibrator
beads illustrated by the SSC from 110 nm polystyrene beads
corresponds to the scattering from 400-nm-sized vesicle-like
particles. We also evaluated the size resolution of this technique. In
addition, we used flow cytometry to reveal the variation in the
lipid composition of individual liposomes based on the ratio of the
fluorescence intensity of two different fluorophore-labelled lipids. We
show for the first time that the degree of variation in the lipid
composition of the liposomes is about 20-fold larger than predicted
by a binomial distribution and show in a quantitative way that
this variation decreases as the size of the liposome increases. The
size-dependent variation in lipid or in principal protein com-
position of microvesicles could potentially be used as new disease
biomarkers.
PF6.04
Development of a bead-assisted flow cytometry method for the
semi-quantitative analysis of EVs
Henar Suarez1, Ana Ga´mez-Valero2, Soraya Lo´pez-Martı´n1,
Ana Oliveira-Tercero2, Francesc Enric Borra´s2 and
Marı´a Ya´n˜ez-Mo´1
1Unidad de Investigacio´n Hospital Santa Cristina and Departamento de
Biologı´a Molecular, UAM/CBM- SO/IIS-IP, Madrid, Spain; 2REMAR-IVECAT Group
and Nephrology Service, Fundacio´ Institut d’Investigacio´ en Cie`ncies de la
Salut Germans Trias i Pujol (IGTP), Barcelona, Spain
Because of the under resolution size of extracellular vesicles (EVs),
most experimental approaches commonly employed for the char-
acterization and quantitation are time consuming, require expensive
instrumentation or are rather inaccurate. Our main aim for this
project was to assess whether we can circumvent all these caveats
by the use of general and specific markers in bead assisted flow
cytometry, to provide a semi-quantitative measure of EV content
in a given sample. EVs were isolated from cells in in vitro culture
(both tumoural cell lines and primary T-lymphoblasts) and from
biological samples such as urine. Isolation was performed by clas-
sical ultracentrifugation and size exclusion chromatography. EVs
were coupled to aldehyde/sulphate latex beads to provide the
sample with an appropriate size to be detected by standard flow
cytometers. We performed serial dilutions of the samples and
we quantified their EV content using BCA, NanoDrop and NanoSight.
By comparing these results with Mean Fluorescence Intensity
values using flow cytometry, we demonstrated that differences
in EV concentration using flow cytometry, we demonstrated
that differences in EV concentration linearly correlated with MFI
values. Linearity and detection limits of this technique were
determined using a panel of EV-general markers. EV classical markers
such as CD81, CD63 and the complement regulatory molecule
CD59 gave a higher sensitivity in EV detection, when mean
fluorescence intensity was plotted against sample dilution. Thus,
we provide evidence that this bead assisted flow cytometry method
is a fast, accurate and reliable method for the semiquantitative bulk
analyses of EVs, which could be easily implemented in a laboratory
routine.
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Label-free detection of extracellular vesicles in human breast milk
compared to infant formula
L. De Rond1,2, Edwin Van Der Pol1,2, Auguste Sturk2, Rienk Nieuwland2,
Frank Coumans1,2 and T. G. Van Leeuwen1
1Department of Biomedical Engineering and Physics; Academic Medical
Centre, Amsterdam, The Netherlands; 2Department of Clinical Chemistry,
Academic Medical Centre, Amsterdam, The Netherlands
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PF6.06
Using F-NTA for characterizing exosomes
Pauline Carnell-Morris
Malvern, Wiltshire, UK
Introduction: NTA is a valuable technology within the field of
exosomes research providing both high-resolution-sized data and
number concentration of exosomes. It is often extended to fluores-
cence labelling for better insight into the samples (F-NTA). However
the procedures for carrying out such measurements can be found to
be challenging because several variables need to be investigated
and optimized. Here, we show data for membrane labelling of
exosomes populations and for labelling specific surface markers with
antibodies, sharing our insight into the factors that influence the
chance of labelling success. Methods: Commercially available mem-
brane labelling dyes were used to label human exosomes. Dye:
exosomes concentration, incubation times, volumes, temperature,
etc., were investigated in order optimize labelling conditions. Using
a similar approach, QDots were used to label exosomes’ surface
markers via commercially available antibodies. Instrument configura-
tions and settings were investigated to ensure optimum sample
measurement. In addition, appropriate controls were taken to
measure size distribution and concentration with NTA. Results: Both
membrane dyes and antibody labelling successfully labelled a
population of exosomes in the samples. Various issues were identified
during the optimization process, such as disturbing the stability
of the sample by the addition of dye formulation buffer, impact of
labelling kit preparation, understanding about the risk of labelling
contaminants that may co-purify with exosomes and the impact
of excess reagents. Conclusions: F-NTA has been shown to be an
effective and rapid way to characterize and identify the presence of
membrane containing particles, while the use of antibodies and
quantum dots allowed exosomes exhibiting specific epitopes to
be measured. Using this approach, we were able to characterize
exosomes of interest from the total population while membrane
labelling provided confidence as to the purity of the sample.
PF6.07
Simulation study of optical trapping of vesicles with a
dual-waveguide trap
Gyllion Loozen and Jacob Caro
Delft University of Technology, Delft, The Netherlands
There is increasing interest in extracellular vesicles (EVs) as biomar-
kers for diseases such as cancer. As a result, efforts direct towards
developing techniques to characterize EVs. We develop a dual-
waveguide trap for optical trapping and Raman of single and
multiple vesicles, to obtain the composition of the trapped vesicle(s).
In this device, two opposing waveguides emit counter-propagating
beams into a microfluidic channel that supplies the EVs. The beams
create a strong light concentration for trapping and Raman. In this
contribution, we report on the capability of the device to stably trap
spherical particles with a homogeneous refractive index mimicking
EVs. We perform FDTD simulations of the optical field between the
waveguide facets, which have a separation of 5 mm. The simulated
field is inclusive the EV. Water is the fluid surrounding the EV, with
a refractive index n(H2O)1.33. The wavelength of the light is
785 nm, a common Raman wavelength. The waveguides have a
composite structure which is very suitable to generate confined
beams. The waveguide cross section is 11 mm2. The refractive
index is n(EV)1.37. Diameters are d1000, 500 and 200 nm. The
forces are calculated using the Maxwell stress-tensor method,
inputting the simulated field. The forces are calculated on the axes
perpendicular to the waveguide direction. Trapping potentials follow
from integrating force curves. For an optical power of 20 mW we get
normalized trap stiffnesses of 140, 22 and 0.05 pN/nm/W for
d1000, 500 and 200 nm, respectively. The corresponding normal-
ized potential well depths U/kT are 205, 28 and 3, respectively. Using
the criterion U/kT10, the diameters 1000 and 500 nm are stably
trapped, while 200 is not. Raising the power to 75 mW, the d200
nm EV is stably trapped as well. The powers we find suffice for
Raman spectroscopy. In conclusion, our simulations indicate that a
TripleX dual-waveguide device can stably trap EVs with diameters
down to at least 200 nm.
PF6.08
Optimal EV measurement in complex biological samples using
nanoparticle tracking analysis
Martin E.M. Parsons1, Fionnuala Ni Ainle1, Damien Mcparland2, Paulina B.
Szklanna1, Patricia B. Maguire1, Karen O’Connell3, Christopher Mcguigan3
and Hugh O’Connor4
1University College Dublin Conway Institute, Dublin, Ireland; 2University
College Dublin, Ireland; 3St Vincent’s University Hospital, Dublin, Ireland;
4Rotunda Hospital, Dublin, Ireland
Introduction: Nanoparticle tracking analysis (NTA) allows a quantita-
tive estimation of extracellular vesicle (EV) size, size distribution and
concentration. For routine NTA analysis of biological samples,
containing polydispersed EVs, it is essential to capture sufficient
data to facilitate more accurate quantification. Currently, NTA
analysis is performed by capturing consecutive recordings over a
15 min period. We sought to determine if an increase in total
recording time would increase the reproducibility of EV quantifica-
tion from plasma and from the supernatant of activated purified
platelets, the platelet releasate (PR). Methods: Consecutive 1-min NTA
recordings were captured for 5, 10, 15, 20, 25 and 30 min for three
technical replicates of both plasma and PR isolated from three
healthy donors. Statistical analysis was performed in R Studio 3.2.3.
Following this, 5 and 15 min of NTA recordings of the plasma and PR
isolated from a larger cohort of 32 healthy donors were then
compared. Results: When comparing technical replicates of both
plasma and PR, we found increased correlation between donor
samples with increasing NTA capture time, concomitant with a
reduction in relative standard error (RSE). We propose 15 min to be
the optimal recording time, with average correlation coefficients
between technical replicates found to be 0.93 and 0.95 and a de-
crease in RSE by 42 and 41% for plasma and PR, respectively.
Decreased %RSE was also observed when directly comparing 5 and
15 min NTA capture time across 32 healthy donors, with differences
between individual donor measurements falling outside the 95%
confidence interval especially in the exosomal size range. Summary/
conclusion: Increasing NTA capture time thereby enables a more
accurate and reproducible characterization of EVs in complex
biological samples, especially in the exosomal size range, and
will facilitate future clinical diagnostic studies investigating
circulating EVs.
PF6.09
Physical characterization of extracellular vesicles using surface-based
sensing
Deborah L. M. Rupert1, Ganesh Shelke2, Mokhtar Mapar1, Cecilia La¨sser3,
Stephan Block4, Virginia Claudio1, Gustav Emilsson1, Andreas Dahlin1,
Bjo¨rn Agnarsson1, Marta Bally5, Jan Lotvall3 and Fredrik Ho¨o¨k1
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The enquiry to unravel different modes of biological action of
extracellular vesicles (EVs) is limited by the availability of methods
able to characterize EV multifaceted profiles which include their
biomolecular composition, their physicochemical properties and their
concentration in biological fluids. In this work, we explore the
potential of two surface-based sensor methods, namely surface-
plasmon resonance (SPR) and optical waveguide scattering and
fluorescence microscopy (OWSFM) for physical characterization of EV
suspensions. Here, EVs isolated from culture media of HMC-1.2 cell line
through density gradient were characterized. SPR operated in mass
transport regime was used to determine the bulk concentration of EVs
carrying CD63 exosomal marker. For this approach to yield reliable
quantification, both the size of EVs and the average thickness of the
film they form on the sensor surface must be known. The latter
parameter was determined by operating SPR in dual-wavelength
mode and the average size of CD63-positive HMC-1.2 EVs was
obtained using fluorescence-based nanoparticle tracking analysis.
The analysis demonstrated that this particular sub-population of EVs
corresponds to 10% of the entire EV content and that its mean
diameter (5080 nm) is significantly lower than that of the average
entire EV suspension (140 nm).O WSFM was utilized to compare
refractive index and lipid content of two sub-populations of HMC-1.2
EVs of different buoyant densities at the single EV level using
combination of scattering and fluorescence observations. This study
revealed a higher lipid content for low density EVs while the
analysis of the scattering intensity suggested a low average optical
density for both low and high density EVs. In summary, this work
highlights new surface-based sensing tools for the characterization
of physicochemical properties of different EVs at the single particle
level and improves concentration determination of subpopulations
of EVs.
PF6.10
Use of surface plasmon resonance and Raman spectroscopy for the
detection and characterization of exosomes
Silvia Picciolini1, Renzo Vanna1, Massimo Masserini2, Marzia Bedoni1,
Furio Gramatica1, Carlo Morasso1 and Alice Gualerzi1
1Laboratory of Nanomedicine and Clinical Biophotonics (LABION), Fondazione
Don Carlo Gnocchi, Milan, Italy; 2School of Medicine and Surgery,
Nanomedicine Lab, University of Milano-Bicocca, Monza, Italy
Introduction: Exosomes have been proposed as potential biomarkers
of multiple diseases. The quantity of exosomes released from cells and
their composition changes according to the physio-pathological
condition of the tissue of origin, mirroring their direct involvement
in specific pathogenic mechanisms, including neurodegenerative
processes like those of Alzheimer’s disease. In order to better
understand their biological function, an effective method of detection
and characterization of exosomes is still needed. We propose herein
two label-free approaches: surface plasmon resonance imaging (SPRi)
that allows the study of the interactions of exosomes with biomole-
cules, and Raman spectroscopy (RS), suitable for exosomes character-
ization. Methods: Commercial exosomes from plasma of healthy
donors were injected with a low flow on a SPRi chip conveniently
treated: the chip was coated with a self-assembled monolayer, used to
perform the conjugation of antibodies and to reduce unspecific
binding. SPRi signals were collected to evaluate the interaction of
antigens on exosome membranes with the antibodies. RS was used
for the chemical characterization of exosomes extracted by ultracen-
trifugation from different human cell cultures, such as mesenchymal
stem cells and SH-SY5Y neuroblastoma cells. Results: Taking advan-
tage of the multiplexing capability of SPRi technology, different
biomarkers have been analysed simultaneously, revealing the pre-
sence of selected antigens on the surface of exosomes. The collected
Raman spectra showed the chemical composition of exosomes, with
Raman peaks related to cholesterol, phospholipids, proteins and
nucleic acids. Conclusion: Our preliminary results suggest that the SPRi
technology has the potential to detect exosomes and to provide
information about the interaction with biomolecules, paving the way
for a better understanding of their biochemical role. Moreover, SPRi
coupled with RS represents a valid and fast approach for exosomes
characterization.
PF6.11
Combined lipid and protein analysis of extracellular vesicles with
surface plasmon-enhanced fluorescence spectroscopy
Agnes T. Reiner1,2,3, Dietmar Pils4, Alain Brisson5, Sai-Kiang Lim3,
Wolfgang Knoll1,2 and Jakub Dostalek1
1BioSensor Technologies, AIT-Austrian Institute of Technology GmbH, Vienna,
Austria; 2Centre for Biomimetic Sensor Science, School of Materials Science and
Engineering, Nanyang Technological University, Singapore, Singapore;
3Institute of Medical Biology, A*STAR, Singapore, Singapore; 4Department
of Obstetrics and Gynecology, Molecular Oncology Group, Medical University
of Vienna, Vienna, Austria; 5Molecular Imaging and NanoBioTechnology,
University of Bordeaux CNRS-UMR-CBMN, Pessac, France
Extracellular vesicles (EVs) emerged as a new class of biomarkers,
but simple and reliable methods for their analysis are still lacking.
In 2014, plasmonic biosensors appeared as EV analysis tools using
surface plasmon resonance for detection of EVs captured by specific
antibodies to sensor surfaces. Surface plasmons can also be employed
to enhance fluorescence emission of fluorophores in their proximity,
which is used in surface plasmon-enhanced fluorescence spectroscopy
(SPFS). Furthermore, such sensors are capable of detecting exosomes
which are typically hard to detect due to their small size. We developed
an SPFS biosensor for EV analysis based on combined lipid and protein
binding. For EV isolation, cell culture supernatant of the cell lines CaOV3,
HCT8 and BJ-1 biological samples, that is, ascites and plasma of ovarian
cancer patients, was filtered and ultracentrifuged. The purified vesicles
were analysed with flow cytometry examining the surface markers
CD63, CD9 and PS as general EV makers and EpCAM and CD24 as
markers for ovarian cancer cellderived EVs. A biosensor employing
SPFS for EV analysis was built, where Annexin-V was used as capturing
molecule on the sensor surface and fluorescently labelled Annexin-V or
specific antibodies were used for detection. EVs purified by ultracen-
trifugation were characterized by flow cytometry and the general EV
markers were present on EVs of all sources. The ovarian cancerspecific
markers were only present on EVs from CaOV3 cell culture supernatant
and ascites, but not from plasma of ovarian cancer patients, indicating
that the concentration of cancer-derived EVs in plasma might be below
the detection limit. The SPFS model system could detect standard
vesicles with a size of about 50 nm down to fM concentrations.
Combining the specificity of molecular binding, the sensitivity of
SPFS and the simplicity of plasmonic sensors, SPFS can provide a
cheap and simple platform for EV analysis for scientific and clinical
application.
PF6.12
A microfluidic chip system for profiling individual extracellular
vesicles
Takanori Ichiki, Satoshi Oniyanagi and Takanori Akagi
University of Tokyo, Tokyo, Japan
Introduction: To accelerate the application technologies of extracel-
lular vesicles (EVs), their accurate characterization is important.
Multi-parameter single-EV profiling using diameter, zeta potential
and surface protein levels can provide reliable information of EVs.
However, it is difficult for conventional equipment to measure several
parameters of individual EVs simultaneously. We have been devel-
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oping a microfluidic chip system for profiling individual EVs within 10
minute. In this study, we present the simultaneous measurement of
individual EVs of breast cancer cells using the prototype. Methods:
The system for profiling EVs comprises a microcapillary electrophor-
esis (mCE) chip and a laser dark-field microscope with a CMOS
camera. Individual EVs with a diameter of 50 nm or smaller can be
visualized. EV samples were extracted from supernatant of human
breast cancer MDA-MB-231 and Sk-Br-3 cell lines after cultivation with
a serum-free MEM medium for 48 h. After the differential centrifuga-
tion, a final pellet was suspended in phosphate-buffered saline (PBS).
Results: Firstly, to examine a detection range of concentration of our
prototype, dilution series of standard silica beads of 100 nm were
introduced into microchannels, and area density of bright spot was
evaluated. A liner relationship between the area density of
bright spot and concentration was observed between 108 and 1010
particle/ml. For obtaining detection ranges of concentration of
EVs, the measurement is now studying. Secondly, to examine the
applicability of our system to EV analysis, EVs of breast cancer cells
were evaluated. Mean diameter and zeta potential of EVs were 229
nm and -2.1 mV (MDA-MB-231) and 170 nm and -1.5 mV (Sk-Br-3),
respectively. Since surface protein expression level of EVs can be
evaluated by immunoelectrophoresis, protein expression level of
each EV can be obtained.
PF6.13
Cloud-hosted tools for the analysis of extracellular RNA and the
construction of the exRNA Atlas
Rocco Lucero1, Sai Lakshmi Subramanian1, Robert Kitchen2,
Rozowsky Joel2, Matthew Roth1, Aleksandar Milosavljevic1,
Fabio Navarro2, William Thistlethwaite1, Alexander Pico3,
Roger Alexander4, David Galas4 and Mark Gerstein2
1Molecular and Human Genetics, Baylor College of Medicine, Houston, USA;
2Yale University, New Haven, Connecticut; 3Gladstone Institutes,
San Francisco, California; 4Pacific Northwest Diabetes Research Institute,
Seattle, Washington
As part of the Extracellular RNA Communication Consortium,
we developed tools for the analysis of extracellular RNAs and are
employing them to construct a comprehensive atlas of exRNA
species found in human body fluids. The tools were deployed using
the Genboree framework and include Data Analysis and Data
Submission Pipelines, and exRNA Metadata Tracking tools. Data
analysis tools such as the exceRpt small RNA-seq pipeline, RSEQtools
long RNA-seq pipeline, Pathway Finder and Target Interaction Finder
are available in the Genboree Workbench. The exceRpt pipeline
generates a variety of sample-level quality control metrics, produces
abundance estimates for various small RNA species and makes
available detailed alignment information for visualization and
validation. The FTP data submission pipeline has been implemented
for submitting small exRNA-seq datasets (with associated metadata)
for processing through exceRpt, sharing via the exRNA Atlas and
deposition into dbGaP, GEO and SRA archives. The GenboreeKB-
hosted exRNA Metadata Tracking System allows for submission,
tracking and editing of associated exRNA metadata for biosamples,
donors, experiments, runs, studies and analyses. The public exRNA
Atlas is available via the ExRNA Atlas link in the quick links section
of the exRNA Portal. As of 15 January 2016, it includes 519 small
exRNA profiles derived from about 6.4 billion reads uniformly
processed using the exceRpt pipeline. Faceted filtering and data
navigation tools are enabled by rich metadata standards developed
by the consortium and metadata annotations contributed by the
data producers. Uniform data quality metrics agreed by the ERCC
were applied to all datasets. Users can browse, select, filter and
download processed results and raw data files of open access
datasets available in the exRNA Atlas. All links to data analysis tools,
the exRNA Atlas and learning materials can be found in the exRNA
Portal.
PF6.14
Developing quality control metrics for Extracellular RNA
Communications Consortium data
Joel Rozowsky1, Mark Gerstein2, Kitchen Robert1, Kendall Van
Keuren-Jensen3, Sai Lakshmi Subramanian2 and Aleksandar Milosavljevic2
1Yale University, New Haven, Connecticut; 2Molecular Biophysics &
Biochemistry, Yale University of Medicine, New Haven, Connecticut;
3Neurogenomics, Translational Genomics Research Institute, Phoenix,
AR, USA
We present the current progress towards developing quality control
(QC) standards for data being generated by the Extracellular RNA
Communications Consortium (ERCC). In particular, we will focus on
the QC metrics for small exRNA-Seq data which form the majority of
the data that is currently being produced by members of the
consortium. Metrics such as, for example, mapped read counts and
fraction of reads mapping to categories, such as annotated miRNAs
or potential laboratory contaminants. The metrics presented here
were developed using data from seven different ERCC labs that were
shared with the DMRR for the purposes of this analysis. Many of the
sample-level QC metrics discussed here are already built in to the
exceRpt small-RNA pipeline, which automatically reports detailed
QC information for each sample. However, there is a clear desire
amongst the international exRNA community to understand and
interpret the quality of their RNA-seq samples. We therefore intend
to include automatic QC evaluation of any sample submitted by any
user based on the current set of ‘gold-standard’ exRNA samples
provided by ERCC members. We discuss the various QC metrics, and
acceptable tolerances, for what we define as ‘high-quality’ RNA-seq
data from an extracellular preparation.
PF6.15
Size and refractive index determination by flow cytometry to
discriminate between extracellular vesicles and lipoprotein particles in
human plasma
Edwin Van Der Pol1, Rienk Nieuwland2, Frank Coumans3, Leonie De
Rond1, Auguste Sturk4, T. G. Van Leeuwen4, Elmar Gool3 and Anita Bo¨ing5
1Biomedical Engineering & Physics, Laboratory Experimental Clinical Chemistry,
Academic Medical Center, University of Amsterdam, The Netherlands;
2Depertment of Clinical Chemistry, Academic Medical Center, University of
Amsterdam, The Netherland; 3Department of Biomedical Engineering and
Physics, Academic Medical Center, University of Amsterdam, The Netherland;
4Academic Medical Center, University of Amsterdam, The Netherlands;
5Laboratory of Experimental Clinical Chemistry, Academic Medical Center,
University of Amsterdam, The Netherlands
Introduction: Flow cytometry is the most widely used method to
study single extracellular vesicles (EV). However, flow cytometry data
have arbitrary units, which hamper data interpretation and compar-
ison. Moreover, identification of EV requires fluorescent labelling,
which is expensive, laborious and prone to artefacts. Here we
present a label-free method to obtain the diameter and refractive
index (RI) from the light scattering signals of a flow cytometer.
Besides the obvious advantage of relating scattering signals in
arbitrary units to comparable measurement units, we hypothesized
that RI detection can discriminate between EV (RI 1.36-1.42) and
lipoprotein particles (RI 1.45-1.60). Methods: Mie theory and reference
beads were used to obtain the relation between the measured
forward and side scattering of a flow cytometer (A50-Micro; Apogee,
UK) and diameter and RI of a particle. We validated this approach by
determining diameter and RI of (1) a mixture with 5 populations of
silica and polystyrene beads B500 nm, and (2) EV and lipoproteins
from the platelet-depleted supernatant of outdated platelet con-
centrates (centrifuged 3-fold, 1,550 g, 20 min). Results: For each
population in the beads mixture, d and RI were determined with
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measurement errors on the mean B8% and B2%, respectively.
For the platelet-depleted supernatant, two populations with different
RI were clearly discernable. Using fluorescent labelling, we confirmed
that the population with RI 1.42 contains EV and the population
with RI 1.42 contains lipoproteins. Summary/conclusion: We have
developed the first method that converts the scattering signals of
a commercial flow cytometer to the comparable measurement units
of dimension and refractive index. We have demonstrated that
this method is accurate and that it allows label-free discrimination
between EV and lipoprotein particles in plasma.
PF6.16
Biological reference materials to standardize measurements of
extracellular vesicles
Sami Valkonen1,2,3, Anita E Grootemaat4, Yuana Yuana4, Anita N Bo¨ing4,
Edwin Van Der Pol4,5, Marjo Yliperttula2,6, Saara Laitinen3,
Rienk Nieuwland4 and Pia RM Siljander1,2
1Department of Biosciences, Division of Biochemistry and Biotechnology,
University of Helsinki, Helsinki, Finland; 2Division of Pharmaceutical
Biosciences, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland;
3Research and Development, Medical Services, Finnish Red Cross Blood
Service, Helsinki, Finland; 4Department of Clinical Chemistry, Academic
Medical Center, University of Amsterdam, Amsterdam, The Netherlands;
5Department of Biomedical Engineering & Physics, Academic Medical
Center, University of Amsterdam, Amsterdam, The Netherlands;
6Department of Pharmaceutical and Pharmacological Sciences,
University of Padova, Padova, Italy
Most current studies on extracellular vesicles (EVs) use synthetic
reference materials (SRM) to increase the comparability of EV
measurement results between instruments, institutes and over time.
As the physical properties of SRM, such as silica and polystyrene
beads, differ from EV, the use of SRM as size references for EV may lead
to erroneous inclusion of EV subpopulations and/or non-EV particles.
Here, we present an overview of: 1) the optimal physical properties
of biological reference materials (BRMs) as surveyed from people
working with EV, 2) choices for such BRMs based on a literature search
and 3) characterization of the physical properties of a promising
potential erythrocyte-derived BRM, nanoerythrosomes (NEs). To dis-
cover the user preferences of the physical properties of BRM, a
questionnaire was sent to 46 laboratories working with EVs (44% reply
rate). According to the survey response, the most used method to
measure EV is flow cytometry (90%), and biochemical resemblance to
EV was considered to be the most important property of BRM. The
results of literature search of BRM could be divided to three
categories: 1) naturally occurring BRM (e.g. isolated EV populations,
marine bacteria), 2) BRM from purified biochemical components or
membranes (e.g. liposomes and oil droplets) and 3) miscellaneous
biological particles (e.g. lipoparticles). Taking into consideration the
desired properties for BRM and the feasibility for a large scale
production, NEs, particles created by (mechanical) disruption of
erythrocytes, were chosen for further studies. Large-scale production
of NEs was tested by three different methods. Two important physical
properties, that is, the size distribution and refractive index, of the
produced NEs were comparable to EVs satisfying some of the key
aspects of an optimal BRM. Further investigation of the BRM choices,
novel and those reported in the overview, will be needed to find
BRMs which match multiple standardization properties of the EV.
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On-chip biodetection, analysis and nanometrology of platelet-derived
vesicles
Sameh Obeid1, Belliot Gae¨l2, Benoit Le Roy de Boiseaumarie´1,
Adam Ceroi3, Guillaume Mourey3, Philippe Saas3, Wilfrid Boireau1,
Ce´line Elie-Caille1 and Ksenia Maximova1
1FEMTO-ST Institute, Besanc¸on, France; 2National Reference Center for Enteric
Viruses, Dijon, France; 3INSERM U1098, Besanc¸on, France
Introduction: Extracellular vesicles (EV) are small vesicles released
from different type of cells upon their activation or apoptosis. They
play an important role in multiple biological processes and can
serve as biomarkers of various health disorders. Thus the detection
and characterization of EV in the large spectrum of size are of
primary importance. Flow cytometry is conventionally used for the
EV analysis, however due to its detection limit a large fraction of
smaller particles (B300 nm) remains uncovered. Our work aims
to use the potential of Surface Plasmon Resonance (SPR) technique
to detect and qualify EVs specifically and without labeling and per-
form their nanometrology by using Atomic Force Microscopy (AFM).
Methods: The on-chip EVs characterization is based of the SPR
method. EVs are immunocaptured on the biochip surface using
specific ligands. For the quantification of EV component we use two
calibration standards of known size and concentrations: virus-like
particles (VLP  diameter 50 nm) and modified melamine resin beads
(diameter 920 nm). EVs captured on the biochip are further sub-
jected to AFM investigation in order to identify their subpopulations
in size and shape. Results: We have demonstrated that capture level
of calibration standards is linearly related to their concentration in
the sample. Dynamic concentration ranges vary from 81010 to
21012 particles/mL for the VLPs and from 3.25107 to 2108
particles/mL for melamine beads. We have adjusted this analytical
platform to qualify microparticles released from resting platelets
(PMP). We demonstrate that MPs with diameter below 300 nm
represent up to 90% of the PMPs samples. Moreover differential
analysis of MPs released from resting and activated platelets have
been performed leading to significant size variation profiling that we
aim to correlate with proteomic profiling. Summary: Our strategy
enables simultaneous determination of EVs cell origin and size
subpopulation in the large ranges.
PF7.02
Surface protein profiling on exosomes by proximity barcoding
assay
Junhong Yan1, Di Wu2 and Masood Kamali-Moghaddam3
1Biomedical Engineering, TUe, Eindhoven, The Netherlands;
2SciLifeLab, Stockholm University, Stockholm, Sweden; 3IGP, Uppsala
University, Uppsala, Sweden
Proteomic profiling of exosomes provides valuable knowledge about
their species and functions. Previous studies have shown structural
and proteomic heterogeneity among exosomes secreted from a
certain organ or isolated from a specific cell type. However, most
of the current methods only measure the total protein content of
a mixture of exosomes, thus fail to characterize proteomic hetero-
geneity on individual exosome level. Here we propose a novel
method, proximity barcoding assay (PBA), to analyze the surface
proteins on individual exosomes in the same sample. In PBA, distinct
oligonucleotides with different Protein-SpecificTags (ST) were con-
jugated to each of 24 different antibodies, directed against 24 dif-
ferent potential proteins targets, expressed on the surface of exosomes.
Clusters of antibody-conjugated oligonucleotides are brought in
proximity when the antibodies bind proteins on the surface of the
same exosome and will hybridize and extend on part of a DNA
concatemer of identical copies of a DNA strand carrying a unique
Complex-ST, generated by rolling circle amplification (RCA). Thus
clusters of oligonucleitdes on the same exosome will incorporate
the same Complex-ST. Through next-generation sequencing, we will
be able to identify the protein composition on individual exosome
by analyzing the Protein-ST and Complex-ST from each sequencing
read. We applied PBA to analyze surface proteins expressed on
individual exosomes purified either from seminal fluid (prostasomes)
or isolated from different cell lines (Colo1, HCT116, MMK7, KatoIII).
Among the complexes identified by PBA, we are able to find a series
of surface protein combinations specific for each type of exosomes
isolated from different body fluid or cell lines (specificity95%). This
method can be potentially used to identify exosomes from a mixture
sample, e.g. human serum as biomarkers for diagnostics.
PF7.03
Search for the optimal dye for EV characterization
Andre´ Go¨rgens1, Thu Le2, Alexander Klibanov3, Bernd Giebel1,
Joanne Lannigan4 and Uta Erdbruegger2
1University Hospital Essen, Institute for Transfusion Medicine, Essen,
Germany; 2Department of Medicine, University of Virginia Health System,
Charlottesville, VA, USA; 3Department of Biomedical Engineering, University
of Virginia, Charlottesville, VA, USA; 4Department of Microbiology,
Immunology and Cancer Biology, University of Virginia, Charlottesville,
VA, USA
Extracellular vesicles (EVs) are currently explored as biomarkers, cell
communicators and therapeutic tools. A rigorous characterization is
needed to understand their correct biology. AnnexinV (AnV) binding
is commonly used as a general membrane marker for detecting EVs,
however, electron microscopy studies have shown that the majority
of vesicles, e.g. B500 nm, do not bind AnV. The purpose of this study
was to find a membrane dye that would label the majority of EVs,
not form micelles and help to distinguish EVs from cells and other
particles. In addition, we investigated the possibility to use these
dyes for labeling liposomes and nanoparticles for use as reference
particles for standardization of EV measurement. We studied different
lipophilic dyes and carboxyfluorescein succinimidyl ester (CFSE). The
lipophilic dyes are water soluble, non-toxic, and show fluorescence
only after membrane incorporation. CFSE is a membrane-permeable
fluorescent dye that binds to intracellular/intravesicle amines as a
way to fluorescently label cells and vesicles. All dyes were titrated
for labeling of EVs generated from PPP, liposomes and polystyrene
beads (PS). Dyes were also added to buffer as control. Fluorescent
signals of particles were detected with imaging flow cytometry
(ImagestreamX MKII, Amnis). As expected, CFSE did label EVs but
not liposomes or beads. The lipophilic dyes labeled all particle types:
EVs, liposomes and PS, the latter believed to be through charge
interactions. Use of CFSE in comparison to the other lipophilic dyes
resulted in a good separation of larger and smaller EVs. Of note, not
all CFSE positive EVs were positive for AnV. CFSE and lipophilic dyes
can be used to label the membrane of EVs and might offer a more
complete analysis of EVs than it is possible with use of AnV. The
lipophilic dyes also label liposomes and PS, which may be useful as
standards/calibrators. A comprehensive analysis of these dyes is
crucial to improve characterization of EVs.
PF7.04
Rapid isolation of intact exosomes and extracellular vesicles
Casey A. Maguire1, Constanze Kindler2, Martin Schlumpberger2,
Karolin Spitzer2, Bence Gyorgy3, Sybren L. N. Maas1, Valentina Zappulii1,
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Introduction: We previously demonstrated the use of a new mem-
brane affinity-based procedure in spin column format for fast and
efficient isolation of vesicular RNA from exosomes and other extra-
cellular vesicles (EVs) in serum and plasma [1]. Here, we demonstrate
a new protocol, using the same principle for isolation of intact EVs
from different biological fluids. Methods: Morphology and integrity
of isolated vesicles were assessed using cryo-electron microscopy.
Protein content of isolated vesicles was examined using SDS-PAGE.
Physical characterization of EVs was performed by Nanoparticle
Tracking Analysis (NTA). RNA content was analyzed quantitatively
using real-time RT-PCR on selected mRNA and miRNA targets.
Uptake of isolated EVs into different target cells, including primary
mouse fibroblasts was examined using fluorescent labeling (bodipy-
ceramide). Performance was compared to alternative methods, in-
cluding ultracentrifugation and precipitation reagents. Results and
Conclusions: EVs isolated using the new method are within expected
size range and morphologically intact when viewed by cryo-electron
microscopy. By analyzing total protein content of the isolated EVs,
we also demonstrate efficient separation of EVs from highly abundant
plasma proteins, compared to alternative methods. Consistent with
this observation, particle counts determined using NTA in precipi-
tated material appear to be inflated due to the presence of
particulates other than vesicles, whereas counts obtained using
the new method are more representative of EVs. Finally, we show
efficient uptake of isolated EVs into target cells, further confirming
recovery of intact, biologically functional vesicles.
Reference
1. Enderle D, Spiel A, Coticchia CM, Berghoff E, Mueller R,
Schlumpberger M, et al. (2015) Characterization of RNA from
Exosomes and Other Extracellular Vesicles Isolated by a Novel Spin
Column-Based Method. PLoS ONE 10(8): e0136133.
PF7.05
Comparative analyses of differential miRNA expression profiles
between extracellular and intracellular components of SCN2.2 cells
Yuhua Farnell, Dan Zhao, Chuan-Yu Hsu and Tony Arick
Mississippi State University, Mississippi State, MS, USA
Suprachasmatic nuclei cells (SCN2.2) are crucial in mammalian
clock pacemaker, and secret soluble factors that drive oscillation of
peripheral tissues or cells. The mechanisms of the synchronization
are not fully understand, however, extracellular vesicle-mediated
communication has been implicated in the intercellular transferring
of miRNAs in circadian clock. Thus, this study explored the miRNA
expression profile between extracellular matrix, including SCN2.2
cell-derived exosome and exosome-depleted conditioned media (EDCM),
and intracellular components of SCN2.2 cells. We have assembled a
quantitative miRNA expression profiles between intracellular (SCN2.2
cells) and extracellular (SCN-derived exosomes and EDCM through
the use of small RNA deep sequencing. The profiling data shows that
expression profiles of extracellular miRNAs in both exosomes and
EDCM are significantly different from their parental cells. We have
identified 71 unique exosomal miRNAs and 270 unique miRNAs in
EDCM by differential expression (DE) analyses. In particular, miR-34c-
5p, miR494-5p, miR142, and let-7 in exosomes have been reported to
be involved in circadian gene regulation. Additionally, Several DE
miRNAs in EDCM including miR-122, miR-155, miR-219, miR-200 and
miR-375 were reported to target circadian clock genes such as Per2,
Bmal1&2, Clock, and Cry1&2. Interestingly, both miR-155 and miR-29,
which were significantly higher in exosomes and EDCM than in
SCN2.2 cells, have been reported to directly involve in circadian clock
system. Through the comparison of the miRNA DE profiles in
extracellular fluids, including exosomes and EDCM, and intracellular
part of SCN2.2 cells, we have identified several candidate miRNA
which are associated with in the regulation of circadian clock system.
More work need to be done to explore the pathway and functional
role of extracellular miRNAs, which regulate circadian rhythmicity in
peripheral tissues by facilitating cell to cell communication.
PF7.06
Increased recovery of CD44+ extracellular vesicles from synovial fluid
of healthy joints by incubation with hyaluronidase prior to isolation
Janneke Boere1,2,3, Chris van de Lest1,2, Sten Libregts2, Ger Arkesteijn4,
Willie Geerts5, Esther Nolte-‘t Hoen2, Jos Malda3, Rene´ van Weeren1 and
Marca Wauben2
1Utrecht University, Department Equine Sciences, Utrecht, The Netherlands;
2Department Biochemistry & Cell Biology, Utrecht, The Netherlands; 3University
Medical Center Utrecht, Department Orthopaedics, Utrecht, The Netherlands;
4Utrecht University, Department Infectious Diseases & Immunology, Utrecht,
The Netherlands; 5Bijvoet Center for Biomolecular Research, Utrecht, The
Netherlands
Introduction: Synovial fluid (SF) extracellular vesicles (EVs) are in-
vestigated for their role in joint disease and articular tissue repair.
To understand EV-driven (patho)physiological processes in joints,
knowledge about EVs in healthy joints is of utmost importance. EV
sedimentation from SF is challenging due to the high and differential
viscosity of the fluid in normal and diseased states of the joint. Since
hyaluronic acid (HA) in SF causes this viscosity, it was hypothesized
that EV-recovery could be optimized by enzymatic degradation
of HA by incubation of SF with hyaluronidase (HYase). We here
analyzed the EV-recovery from healthy SF in the presence and
absence of HYase. Since CD44 is a marker for synovial cells and it is
the HA-receptor, we focused on the effect of HYase-treatment on the
recovery of CD44+ EVs. Methods: SF from healthy equine joints was
incubated with or without HYase. EVs were isolated by differential
centrifugation at 1,000g, 10,000g, 100,000g and 200,000g. EVs were
labeled with PKH-67 and anti-CD44 antibody, floated in density
gradients and quantified by high-resolution flow cytometry. Char-
acterization was performed with western blotting (EV markers) and
cryo-TEM (morphology and size distribution). Results: The majority of
EVs from healthy SF could be recovered at 100,000g, however, in the
absence of HYase a substantial amount of EVs was only recovered
after 200,000g. Healthy SF-derived EVs contain CD9, Annexin-1 and
CD90/Thy1.1, and most EVs are spherical with a diameter of 20-200
nm. Importantly, an increased yield of CD44+ EVs was achieved by
pre-incubation of SF with HYase. Summary: For body fluids which
contain relatively high amounts of HA, such as SF, HYase treatment
could facilitate recovery and detection of CD44+ EVs from the HA-
rich extracellular matrix. Furthermore, it is recommended, especially
if HYase treatment is omitted, to use a high-speed centrifugation
step of 200,000g for efficient sedimentation of EVs from SF.
PF7.07
Biological properties of extracellular vesicles in bovine milk
Maria Stenum Hansen1, Kristine Blans2, Lene Niemann Nejsum3,
Eva Christensen Arnspang3 and Jan Trige Rasmussen2
1Aarhus University, Aarhus, Denmark; 2Department of Molecular Biology and
Genetics, Aarhus University, Aarhus, Denmark; 3Department of Clinical
Medicine, Aarhus University, Aarhus, Denmark
Introduction: Milk extracellular vesicles (MEVs) are a novel class of
milk bioactives which most likely support infant development by
transferring molecular messages to the infant’s cells. Bovine milk is
also a rich source of MEVs. As bovine milk represents a significant
food source world-wide, it is of our interest to investigate the bio-
logical potential in bovine MEVs. We have investigated the cellular
uptake and fate of bovine MEVs in a human intestinal cell line.
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Method: MEVs from untreated bovine milk was purified using a
gentle protocol developed to avoid MEV pelleting. Isolated MEVs
were labeled with Alexa Fluor tagged lactadherin, which binds tightly
to phosphatidylserine in membrane bilayers. Moreover, lactadherin
is an abundant protein naturally associated with MEVs. A human
intestinal epithelial cell line, Caco-2, was used to investigate cellular
internalization of MEVs. Fluorescence microscopy and plate reader
measurements were used to evaluate the qualitative and quantita-
tive cellular uptake, respectively. Additionally, fluorescent constructs
of early, late and recycling endosomal markers (Rab5, Rab7, and
Rab11 respectively) will be used to evaluate localization of MEVs
taken up in Caco-2 cells. Results: Bovine MEVs were successfully
labelled with fluorescent lactadherin. Caco-2 cells incubated with
labeled MEVs reveal a linear increase in total cell fluorescence over
24 hours compared to controls when measured on a plate read-
er.Consistently, fluorescence microscopy confirmed uptake of MEVs
in Caco-2 cells. Colocalization between MEVs and Rab5, Rab7, and Rab11,
which indicate internalization via endocytotic pathways, are to be
performed. Summary/Conclusion: A successful and specific fluorescent
labeling method was developed to investigate bovine MEV uptake in
the human intestinal cell line, Caco-2. Cell studies indicate increased
uptake over time and fluorescence microscopy is being applied to
investigate uptake mechanisms and faith of MEVs in the cells.
PF7.08
First proteomic profiling of exosomes in rodent intestinal lymph
Jiwon Hong1,2, Shorena Nachkebia2, Soe Min Tun2, Rakesh Premkumar2,
Cherie Blenkiron3, John Windsor2 and Anthony Phillips1,2
1School of Biological Sciences, University of Auckland, Auckland, New Zealand;
2Department of Surgery, University of Auckland, Auckland, New Zealand;
3Department of Molecular Medicine and Pathology, University of Auckland,
Auckland, New Zealand
Introduction: Exosomes are released by many cell types and can be
taken up by other cells. They may play an important role in cell-to-cell
communication and disease pathogenesis. Exosomes derived from
plasma or urine have been extensively studied, but that of intestinal
lymph has not been reported due to the difficulty in obtaining these
samples. Intestinal lymph is continuously draining from the intestine
and enters the veins just before the heart and lungs. These organs
may therefore be directly influenced by intestinal exosomes. Methods:
Intestinal lymph was collected from a rodent experimental model of
critical illness. Exosomes were isolated from the intestinal lymph using
a commercially available exosome isolation kit. Particle size and
concentration were determined by Nanosight. Proteomic profiling of
lymph exosomes and its changes in critical illness were analysed by
LC-MS. Results: The size and concentration of ‘‘exosomes’’ isolated
from the intestinal lymph did not change significantly in the critical
illness. The exosome preparation contained proteins previously
identified in microparticles or exosomes (e.g. inter-alpha trypsin
inhibitor), but also the highly abundant plasma proteins (e.g.
complement C3, albumin). Common exosomal markers (e.g. TSG101,
CD63) were not detected. Instead, substantial amounts of Apo B and
A-I were found, indicating presumed co-isolation of chylomirons.
Lymph chylomicrons are similar to size of ‘‘exosomes’’, and produced
in high concentration from the intestine. Our study indicates the
unexpected difficulty in isolating pure exosomes using a commercial
kit in this unique fluid. Conclusion: This present study provides the first
attempt at a proteomic profile of an exosome preparation from
intestinal lymph. Collectively, multiple proteins were identified, but
found to have come from both exosomes and chylomicrons. New
purification methods will be needed to study pure isolates of each
particle type in this unique fluid.
PF7.09
Non-phagocytic epithelial cells take up microvesicles by
macropinocytosis
Uchini Kosgodage1, Jameel Inal1 and Sigrun Lange2
1Cellular and Molecular Immunology Research Centre, School of Human
Sciences, London Metropolitan University, London, UK; 2Biomedical Science,
University of Westminster, London, UK
Introduction: As intercellular communicative vectors, able to deliver
or present a range of surface and intravesicular molecules, many of
the findings in the Exosomes and Microvesicles (EMV) field depend
on an initial EMV interaction with recipient/acceptor cells. The nature
of EMV-cell interaction, however, remains a poorly defined area
requiring further investigation. Methods: Microvesicles (MVs) were
isolated by removing cells (HeLa/HCvEpC) and cell debris (160 g/5
min; 2x 4,000 g/60 min) and spinning the resulting supernatant
(11,000g /90 min). To assay MV uptake by macropinocytosis, PKH67-
labelled MVs and Dextran-FITC (as control) uptake was monitored by
flow cytometry. The fate of endocytosed MVs together with that of
lysotracker red DND-99, was monitored by confocal microscopy. MV-
cell interaction was monitored by R18 dequenching (lipid mixing)
and time lapse fluorescence microscopy. Results: It was possible
to inhibit macropinocytosis with the Na + /H+ ion exchange pump
inhibitor, amiloride and a range of other inhibitors including methyl-
ß-cyclodextrin, dynasore, bisindolylmaleimide, cytochalisin D and
nocodazole. Using dextran-FITC as positive control, MV-PKH67 were
found to co-locate to late endosomes. In addition, MVs were found
to undergo a degree of fusion with the recipient cell plasma membrane
using a lipid mixing assay. Summary: This study showed microvesicles to
stimulate their uptake in non-phagocytic epithelial cells by macro-
pinocytosis. Upon uptake by macropinocytosis, MVs located to late
endosomes/lysosomes. MVs were also found to fuse with the plasma
membrane of acceptor epithelial cells by lipid mixing. Conclusion: In
short, this work reveals macropinocytosis as an important route by
which MVs are taken up by epithelial cells. These findings are of
paramount importance, from the point of view of understanding MV
involvement in disease pathology and progression, but also with the
longer term aim of their use in drug delivery and therapy.
PF7.10
Characterization of RNA contained in extracellular vesicles released by
primary astrocyte cultures
Silvia Chiera1, Laura Pasetto2, Valentina Bonetto2 and Manuela Basso1
1Laboratory of Transcriptional Neurobiology, Centre for Integrative Biology
(CIBIO), University of Trento, Italy; 2Laboratory of Translational Proteomics,
IRCSS-Istituto di Ricerche Farmacologiche ‘‘Mario Negri’’, Milan, Italy
In numerous neurodegenerative diseases the interplay between
neurons and glia modulates the outcome and progression of the
pathology. A particularly intriguing way of interaction between
neurons, astrocytes and microglia is characterized by the release of
microvesicles able to transport proteins, lipids and nucleotides from
one cell to the other. We have previously reported that astrocytes
carrying a pathogenic mutation for Amyotrophic Lateral Sclerosis can
selectively induce neuronal death through microvesicles and their
content. In particular, we showed that exosomes derived from mutant
SOD1-primary astrocyte cultures are sufficient to induce selective
motoneuronal death (Basso et al., J Biol Chemistry 2013). Considering
the growing evidence of a role for RNA pathology in ALS, we are
interested in analyzing the RNA profile of EVs derived from several
models of ALS and investigate the possibility that an alteration in RNA
cargos into the EVs contributes to the spreading of motoneuronal
death. In order to reach our goal, we are comparing numbers of
astrocytes, plating, purification protocols and RNA extraction methods
to reach a consistent method to analyze the nucleotide EV content.
PF7.11
Proteomics and miRNA Analysis of Exosomes Derived from
Differentiating Neuronal Cells
Xuewei Zhao, Yuji Takeda and Qiaobing Xu
Tufts University, Medford, MA, USA
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Exosomes deliver their endogenous proteins, lipids and RNAs to
their neighboring cells to cause functional and physiological effects.
They are known to promote tissue regeneration by the delivery of
various biologics, including microRNA, mRNA and proteins. However,
the mechanism of exosome-promoted tissue regeneration is still
not well understood. In our previous study, we showed exosomes
derived from differentiating neuronal progenitor cells (PC12), drives
the differentiation of mesenchymal stem cells (MSCs) into neuron.
We have isolated exosomes from different differentiating stage of
these cells to identify the functional contents for neuronal differ-
entiation. Here, we discuss our results on microRNA profiling and
proteomics analysis with an aim to elucidate the mechanism of
exosome-assisted cell reprograming.
PF7.12
Cytotoxic miRNAs against the cultured mesenchymal stem cells are
included in human T cell-derived exosomes
Momose Fumiyasu1,3, Seo Naohiro1,3, Harada Naozumi1,3,
Sawada Shin-ichi2,3, Akiyoshi Kazunari2,3 and Shiku Hiroshi1,3
1Mie University Graduate School of Medicine, Department of Immuno-Gene
Therapy, Tsu, Japan; 2ERATO Akiyoshi Bio-nanotransporter Project, Japan
Science and Technology Agency (JST), Tokyo, Japan; 3Kyoto University
Graduate School of Engineering, Department of Polymer Chemistry, Kyoto,
Japan
Introduction: Our group has found in murine models that CD8+
T cell-released exosomes play as an inhibitor for tumor progression
including invasion and metastasis by destructing mesenchymal
tumor stromal cells in part micro (mi) RNA-mediated manner. In this
study, we tried to identify cytotoxic miRNAs in human T cell-released
exosome-dominant miRNAs against mesenchymal stem cells (MSCs)
in vitro. Methods: Exosomes were purified from the culture super-
natants of CD3- and RetroNectin-stimulated PBMCs by the ultracen-
trifugation after removing cells and debris. Exosome-dominant
miRNAs were selected by comparative analysis of microarray data
of the exosomal miRNAs with the donor T cell miRNAs, and then
synthesized to examine cytotoxicity against MSCs. Cytotoxicity of
each synthesized miRNA against adipose tissue-derived MSCs cells
was examined after transfection by a real-time cell analyzer. Results:
CD8+ T cells enriched in the culture process of PBMCs produced
exosomes of approximately 150 nm size. The CD8+ T cell-released
exosomes showed the expression of not only tetraspanins but also
CD8 and HLA-I molecules. miRNAs from CD8+ T cell-released exo-
somes showed different distribution pattern from donor T cell
miRNAs, indicating the active translocation of endogenous cellular
miRNAs into exosome cargos when multivesicular bodies were
generated in donor T cells. By the real-time cell analysis, we iden-
tified two exosomal miRNAs (miR-6089, miR-6090) capable of ex-
hibiting cytotoxicity and the attenuation of growth of MSCs. The
total mRNA array of cytotoxic miRNA-introduced MSCs revealed the
correlation between MSC cytolysis and interferon (IFN)-related gene
expressions. Conclusion: We demonstrated that anti-MSC miRNAs
existed into human T cell-released exosomes consistent with the
study of murine CD8+ T cell-released exosomes. Our study may
propose pivotal insights for clinical application of exosomal miRNAs
in patients with invasive and metastatic cancer.
PF7.13
Automated extracellular vesicle production and concentration from
bone marrow-derived mesenchymal stem cells
Boah Vang, Brian Nankervis and Kim Nguyen
Cell Processing, Terumo BCT, Lakewood, CO, USA
Introduction: The Quantum cell expansion system has been shown to
successfully expand a variety of adherent and suspension cells in
vitro all the while being functionally-closed and automated. The
properties of the semi-permeable hollow fibers along with the ability
to command the system to automatically perform various tasks via
the graphical user interface make the Quantum an efficient system
for producing extracellular vesicles (EVs). When cells shed EVs into
the fluid, EVs can be concentrated on the intracapillary (IC) side of
the hollow fibers while the semi-permeable membranes allow
essential nutrients to reach the cells via continuous perfusion and
waste is actively removed. Methods: Bone marrow derived mesench-
ymal stem cells (bmMSC) were expanded on the Quantum with
serum-containing media until confluent. The serum was completely
washed out from the system and replaced with base media. EVs
were concentrated on the IC side for 48 hours and then harvested.
Results: The total protein concentration of isolated EVs from the
Quantum was five-fold higher than EVs isolated from cells cultured
in tissue culture flasks. The ratio of cells harvested to CD63+ EVs
was nearly 1:10,000. Summary: EV production in the Quantum
required less manual intervention due to the automation of the sys-
tem and EV particles were able to concentrate on the IC side before
harvesting. The number of EV particles compared to the number of
cells harvested from the Quantum was exponential.
PF7.14
Extracellular vesicles in the regulation of host-pathogen interactions
during malaria
Pierre-Yves Mantel1,2, Michael Walch1, Luis Filgueira1,
Solange Kharoubi-Hess1, Ionita Ghiran2 and Mathias Marti2
1University of Fribourg, Fribourg, Switzerland; 2Harvard University, Boston, USA
Extracellular vesicles (EVs), including exosomes and microvesicles,
are small membrane vesicles derived from multivesicular bodies or
from the plasma membrane. Most cell types release EVs, which then
enter the bodily fluids. These vesicles contain a subset of proteins,
lipids and nucleic acids that are derived from the parent cell. Recent
works demonstrated that EVs play important roles in intercellular
communication, both locally and systemically, as they transfer their
contents, including proteins, lipids and RNAs, between cells. EVs
are involved in numerous physiological processes, and vesicles
from both non-immune and immune cells have important roles in
immune regulation. Therefore EVs contribute significantly to pathol-
ogy during infections. We have showed that Plasmodium falciparum
infected red blood cells (iRBCs) release vesicles, which not only
regulate parasite development but also mediate the host-pathogen
interactions. EVs contain RBC-derived miRNAs that regulate gene
expression in the recipient cells including endothelial cells and
neutrophils. We are investigating the contribution of EVs in the
regulation of the pathogenesis during malaria. Our data suggest that
miR451a contained in EVs is an important regulator of the immune
response to the malaria parasites.
PF7.15
The role of extracellular vesicles in pathogenesis of the human
pathogen Cryptococcus gattii
Ewa Bielska, Marta Arch Sisquella and Robin C. May
School of Biosciences, Institute of Microbiology and Infection/School of
Biosciences, University of Birmingham, UK
Cryptococcus gattii is a fungal pathogen of humans and other
animals. Although typically a disease of immunocompromised
patients, since 1999 an unusual lineage of this organism has been
responsible for a large and ongoing cluster of infections in otherwise
healthy people living in the Pacific Northwest area of North America.
We recently demonstrated that the hypervirulence of this lineage
results from an unusual ‘Division of labour’ mechanism in which a
virulent strain of C. gattii enables a non-virulent strain to survive and
proliferate inside the hostile environment of host macrophages. To
achieve this, individual fungal cells must communicate in order to
act as a ‘‘team’’, but how they do this remains unknown. Our data
suggests that this communication may be mediated via extracellular
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vesicles (EVs), which are known to be secreted by many organisms
including bacteria, fungi and mammalian cells. EVs isolated from a
virulent strain of C. gattii increased survival (but not phagocytosis)
of a non-virulent strain inside macrophages. This effect relies on
proteins within the vesicles but not on capsular polysaccharide,
which is a major EV cargo. Thus our data suggest a novel mechanism
of fungal virulence in C. gattii that involves communication via EVs
and potentially represents a new avenue for therapeutic intervention.
PF7.16
Profiling and characterization of embryo and seminal fluid extracellular
vesicle-associated microRNAs in Sus scrofa: a possible role in
differentiation and developmental communication processes
Muhammad Nawaz1, Tina Rødgaard Højbøge2, Marco Maugeri1,
Matin Mehryar1, Klaus Villemoes3, Peter M. H. Heegaard2, Henrik Callesen3
and Hadi Valadi1
1Department of Rheumatology and Inflammation Research, Sahlgrenska
Academy at University of Gothenburg, Gothenburg, Sweden; 2Section for
Immunology and Vaccinology at National Veterinary Institute, Technical
University of Denmark, Frederiksberg, Copenhagen, Denmark; 3Department of
Animal Science - Reproductive Biology, Aarhus University, Aarhus, Denmark
Introduction: Extracellular vesicles (EVs) are nano-sized vesicles
secreted by variety of cell types, contain RNAs, proteins, lipids and
serve as newly described mediators of cell-to-cell communication.
Hitherto, embryonic cells and seminal fluid have been reported to
contain EVs, nevertheless, their miRNA content have not been
characterized. We performed a systematic evaluation of miRNAs from
pig embryonic cell-derived EVs and semen EVs to identify putative
miRNAs and their possible role in differentiation and development.
Methods: EVs (exosomes and microvesicles) were isolated from
embryo cells, seminal fluid and PZM-3 medium and were character-
ized by Zetasizer-nano, Nanosight Tracking Analysis (NTA) and Atomic
Force Microscopy (AFM-Bio). Total RNA was extracted from embryo
cells, embryonic EVs, seminal EVs and PZM medium by 3D-GeneTM
miRNA extraction reagent (Toray, Japan) and miRNA identification
was performed using microarray platforms. From microarray data,
some potential EV-miRNAs were validated by high-throughput qPCR
system (Fluidigm) and used for in vivo uptake to witness their effects
on embryo growth. Results: The size of characterized EVs ranged
between 40350 nm which include both exosomes and microvesicles.
In total, 79 miRNAs were identified in embryonic cells, 16 miRNAs
were unique to EVs from embryonic cells and 11 unique to EVs from
semen. In comparison, 10 miRNAs were common between embryonic
cells and embryonic EVs and 4 common between embryonic cells and
semen EVs. However, no common miRNA species were detected in
embryonic EVs and semen EVs. MiRNA target analysis, gene ontology
and networking analysis revealed that embryonic and semen
EV-miRNAs are enriched in RNA biosynthetic regulation process,
reproduction, cellular differentiation and embryonic development.
Summary/conclusion: These data for the first time provide an insight
into the role of EV-miRNAs in pig embryonic cell communication and
differentiation during developmental process.
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LBO1.1
Cancer-ID: strategies to identify rare extracellular vesicles in human
body fluids
Linda Rikkert1, Frank Coumans1, Rienk Nieuwland1 and Leon W.M.M.
Terstappen2
1Academic Medical Center, Amsterdam, The Netherlands; 2Department of
Medical Cell BioPhysics, MIRA institute, University of Twente, Enschede, The
Netherlands
Introduction: Extracellular Vesicles (EV) have a great potential as
biomarker in cancer diagnostics. In the Dutch Cancer-ID program 8
universities and 23 companies work together to develop a platform
capable of reliable identification and characterization of tumor
vesicles in human body fluids. Methods: Methods involved are
atomic force microscopy, Coherent anti-Stokes Raman spectroscopy,
flow cytometry, scanning electron microscopy-Raman microspectro-
scopy, RNA sequencing, smart microsieves, and surface plasmon
resonance imaging. To compare measurement results, EV-containing
samples from prostate cancer cell lines (PC3 and LNCaP) and blood
products (platelets, red blood cells, and plasma) were distributed to
obtain a first assessment of specificity and sensitivity of all methods.
Results: Of before mentioned methods, both flow cytometry and
Raman microspectroscopy are operational, whereas other methods
are currently being optimized for EV detection. Raman microspec-
troscopy is capable of capturing and measuring single EV, but a
molecular fingerprint to reliable identify tumor EV will require
additional experiments. Flow cytometry was able to identify tumor
EV (CD63+, EpCAM + ) in PC3-EV and LNCaP-EV spiked plasma
samples at a ratio of 1:80,000. The spike in dilution and the lowest
detectable tumor EV concentration can be used to compare
sensitivity and specificity between techniques. Conclusion: The
heterogeneity of EV in morphology, size and refractive index
comprises a major challenge to develop a single platform capable
of reliable identification and characterization of tumor EV in ‘‘liquid
biopsies’’. By combining complementary detection methods, we will
be able to explore the full potential of EV in cancer diagnostics.
Further, a detection limit of 1 tumor EV in 80,000 EV means that the
sample will need to be enriched prior to analysis of clinical samples.
LBO1.2
Chemokine receptor targeting inhibits EV uptake and EV-induced
phenotype
Jordi Berenguer1, Tonny Lagerweij1, Xi Wen Zhao1, Marloes Zoetemelk1,
Sophie Dusoswa2, Mark C. de Gooijer3, Jacco Van Rheenen4, Olaf Van
Tellingen3, Michiel Pegtel5 and Thomas Wurdinger1
1Neuro-oncology Research Group, Cancer Center Amsterdam, VUMC,
Amsterdam, The Netherlands; 2Molecular Cell Biology and Immunology,
Cancer Center Amsterdam, VUMC, Amsterdam, The Netherlands; 3Preclinical
Pharmacology and Clinical Chemistry, Netherlands Cancer Institute,
Amsterdam, The Netherlands; 4Cancer Biophysics, Hubrecht Institute, Utrecht,
The Netherlands; 5Pathology, Cancer Center Amsterdam, VUMC, Amsterdam,
The Netherlands
Introduction: Extracellular vesicles (EVs) are important mediators of
tumor communication. Tumor EVs have been shown to support
tumor growth and induce therapy resistance. Therefore, targeting EV
uptake is a promising therapeuthic strategy. Methods: In order to
identify EV receptors, we performed a siRNA screen against a library
of G protein-coupled receptors combined with PKH-67-labelled EV
uptake analysis. We performed validation studies by genetic and
functional inhibition. We used a Cre recombinase-based model for
EV transfer studies in vivo and in vitro. In vivo tumor growth analysis
was performed using bioluminescent GBM xenografts. Results: We
have observed physiologically relevant transfer of GBM EVs within
the tumor. We identified and validated a chemokine receptor
responsible for glioblastoma (GBM) EV uptake, in a mechanism
involving bridging by the chemokine ligand. GBM EVs induced
phenotypical changes in GBM EV recipient cells such as increased
proliferation rates and enhanced resistance to the chemotherapeutic
agent temozolomide. Pharmacological inhibition of the newly
identified EV receptor counteracted the phenotypical changes
observed in GBM EV recipient cells. Conclusion/Summary: GBM EVs
stimulate both tumor growth and therapy resistance. We have
identified a chemokine receptor which can be pharmacologically
targeted for inhibiting EV uptake and counteracting EV-induced
effects.
LBO1.3
The role of cancer cell-derived exosomes in monocyte
survival
Yanping Ding, Xiao Song, Gang Liu, Xiao Yang and Guangjun Nie
National Center for Nanoscience and Technology, Beijing, China
Introduction: Tumor-associated macrophages (TAM), an essential
tumor stromal cell type, are mainly derived from recruited mono-
cytes. In physiological environment, monocytes undergo sponta-
neous apoptosis to maintain the homeostasis of the immune system.
However, they can survive in the inflammatory tumor microenviron-
ment for continuous generation of sufficient TAMs. The mechanism
underlying how monocytes escape apoptosis within tumor is largely
unknown. Methods: We imitated a pro-inflammatory environment by
treatment of human primary monocytes with a combination of
lipopolysaccharide and interferon-g, and a conflicting environment
with lipopolysaccharide, interferon-g and interleukin-4. Cancer cell-
derived exosomes were isolated from the culture medium of various
human cancer cell lines by ultracentrifugation. After treatment of
exosomes in above inflammatory niche for different days, viable
monocytes stained by trypan blue were counted. Key signaling
molecules of the survival machinery in monocytes were analyzed by
western blot. Functional molecules in cancer cell-derived exosomes
were evaluated after construction of knockout clones using CRISPR-
Cas9 system or treating cells with specific inhibitors. Results: Cancer
cell-derived exosomes significantly elevated monocyte survival rate
and prevented caspase cleavage in the inflammatory niche through
activation of Ras and extracellular signal-regulated kinases in the
mitogen-activated protein kinase pathway. Activated receptor tyr-
osine kinases in cancer cell-derived exosomes, such as phosphory-
lated epidermal growth factor receptor and human epidermal
growth factor receptor 2, were indispensable for improving mono-
cyte survival. Conclusion: This study demonstrated the role of cancer
cell-derived exosomes in promoting monocyte survival and explored
the underlying molecular mechanism, which provided evidences for
the alteration of monocyte status before differentiation into tumor-
associated macrophages.
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LBO1.4
GABARAPL1 is required for hypoxia-induced extracellular vesicle
secretion
Tom Keulers1, Sten Libregts2, Marco Schaaf1, Hanneke Peeters1, Kim
Savelkouls1, Hans Duimel3, Johan Bussink4, Barry Jutten1, Marc Vooijs1,
Marca Wauben2 and Kasper Rouschop1
1Department Radiotherapy/ Maastro Lab, Maastricht University, Maastricht,
The Netherlands; 2Utrecht University, Faculty of Veterinary Sciences,
Department of Biochemistry & Cell Biology, Utrecht, The Netherlands;
3M4I Division of Nanoscopy, Maastricht University, Maastricht,
The Netherlands; 4Department of Radiation Oncology, Radboud
University medical center, Nijmegen, The Netherlands
Hypoxia is a hallmark of solid tumors and triggers secretion of pro-
angiogenic factors to stimulate blood vessel formation. In part,
Extracellular Vesicles (EVs) mediate the intercellular communication
between tumors and endothelial cells. Here we describe the role of
GABARAPL1 in the secretion of EVs that contribute to angiogenesis
and tumor progression. GABARAPL1 production is increased during
hypoxia. GABARAPL1 associates with vesicles and colocalizes with
CD63, CD81 and CD9. Its knock-down results in reduced EV secretion
as assessed by immunoblot analysis and quantitative single vesicle-
based high-resolution flow cytometry. EV analysis by Resistive pulse
sensing (qNANO) revealed GABARAPL1 requirement for a subset EVs
that is uniquely secreted during hypoxia. Mass spectrometry on
conditioned medium of GABARAPL1 knockdown cells show a
decrease of angiogenic factors like VEGF and PDGF-AA. In line, the
angiogenic capacity of GABARAPL1-deficient vesicles compared to
control EVs, as assessed by endothelial tube formation, is abrogated.
Furthermore, cryo immuno-electron microscopy showed that
GABARAPL1 is expressed on the outer leaflet of EVs, indicating that
GABARAPL1 is accessible for targeting. Interestingly, anti-GABARAPL1
antibodies blocked the angiogenic capacity of GABARAPL1 EVs.
Together, these data suggest that EV secretion is mediated by
GABARAPL1 and that GABARAPL1+ EVs have angiogenic potential. In
vivo, GABARAPL1 knockdown reduced tumor growth and is asso-
ciated with decreased vessel density. Interestingly, implantation of a
control tumor in the same animal resulted in growth and vessel
density normalization, emphasizing the importance of circulating
factors. Moreover, GABARAPL1 targeting after a single dose of
irradiation (10Gy) increased tumor regrowth delay. Also these tumors
displayed a decreased vessel density. In conclusion, we provide
evidence that GABARAPL1 is involved in the secretion of hypoxia
associated EVs that act as mediators of angiogenesis.
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LBO2.1
EV-TRAQ: Tracking transparent reporting and quality to boost
standardized extracellular vesicle research
Jan Van Deun1, Pieter Mestdagh2, Jasper Anckaert2, Jo Vandesompele2,
Olivier De Wever1 and An Hendrix1
1Laboratory of Experimental Cancer Research, Department of Radiation
Oncology and Experimental Cancer Research; 2Center for Medical Genetics,
Ghent University, Ghent, Belgium
Introduction: While a small, dedicated part of the scientific commu-
nity is struggling to determine the characteristics of all extracellular
vesicle (EV) subtypes, their putative functions are featured in an
increasing number of publications. This dangerous hiatus between
our limited basic knowledge and extensive functions that are being
attributed to EVs is emphasized by the fact that most studies do not
properly report their isolation and characterization. Methods: We
performed a PubMed search for research articles with keywords
‘‘exosomes’’ or ‘‘extracellular vesicles’’ published in 20102015. After
manual inspection, 1256 articles were withheld for inclusion. Articles
were analysed based on a matrix querying article content, aim, and
EV isolation and characterization procedures. Results: After evaluat-
ing the quality of all study entries (n = 1785) using the ISEV minimal
experimental requirements, only 1 study was fully compliant. For all
sample types, less than 10% of studies have a compliancy of 50% or
more. Isolation methods increasingly comprise commercial kits (15%
in 2014) at the expense of density gradients (10% in 2014).
Differential ultracentrifugation is by far the most used method
(50%), but the heterogeneity in applied centrifugation steps
reveals an estimated 250 potentially different vesicle populations
that were isolated. Quality controls are often omitted, with more
than 2 protein markers being checked maximally in 25% and non-EV
enriched proteins in only 20% of studies (dependent on sample
type). We established EV-TRAQ, a database tracking EV research
evolution as online resource to identify trends in methods and
quality allowing for timely update of the minimal experimental
requirements. Summary: We are confident that this meta-analysis will
contribute to the maturation of EV research by pinpointing existing
gaps in isolation and characterization procedures as well as allowing
comprehensive evaluation of EV research methods and quality
through our online repository.
LBO2.2
A combination of size-exclusion chromatography with density gradient
centrifugation to purify EVs from plasma
Glenn Vergauwen1,2, Joeri Tulkens1, Pieter Mestdagh3, Jo Vandesompele3,
Raija Sormunen4, Esther Nolte-‘t-Hoen5, Marca Wauben5, Kris Gevaert6,
Hannelore Denys7, Geert Braems2, Rudy Van den Broecke2,
Olivier De Wever1 and An Hendrix1
1Laboratory of Experimental Cancer Research, Ghent University, Ghent,
Belgium; 2Gynaecology-Obstetrics Department Ghent University Hospital,
Ghent, Belgium; 3Medical Genetics Department Ghent University, Ghent,
Belgium; 4Biocenter Oulu, Oulu, Finland; 5University of Utrecht, Utrecht,
The Netherlands; 6Biochemistry Department Ghent University, Ghent, BE;
7Medical Oncology Department Ghent University Hospital, Ghent, Belgium
Introduction: The exponential increase of EV-related research in the
last decade has given rise to multiple described protocols for
isolation of EVs in several sample types, including plasma. Despite
these efforts, the ‘golden standard’ has not yet been established for
plasma. The quantity-purity trade-off is crucial and mandatory for
biomarker discovery. Here we provide a protocol for high-purity
isolation of EVs in plasma. Methods: Plasma EVs were isolated in a
two-step protocol consisting of size-exclusion chromatography (SEC)
followed by iodixanol density gradient ultracentrifugation (ODG).
Nanoparticle tracking analysis (NTA), Western blot (WB), high
resolution flow cytometry and ELISA were implemented to assess
the purity of isolated EV samples. Results were validated by
proteomic analysis. Results: SEC separates EVs from the bulk of
protein contaminants such as albumin, and Ago2. The EV-rich SEC-
fractions contain 31% of total particles of plasma, while only less
than 1% of protein. Combinations of SEC fractions show therefore a
250-fold enrichment in EV compared to protein but still show
presence of lipoprotein particles. Addition of density gradient
ultracentrifugation further purifies the CD9 and flotilin-1 positive
EVs from lipoproteins and Ago2 protein complexes. Spiking of
plasma with exogenous GFP-positive EVs shows presence of GFP in
similar SEC and ODG fractions as the endogenous EVs. Our protocol
was further validated on plasma from breast, ovarian and prostate
cancer patients. We were able to detect EV-enriched markers (CD9,
flotillin-1) from 6ml plasma of cancer patients on WB, without
contaminating Ago2 and ApoA-1. Conclusion: Combination of SEC
and density gradient ultracentrifugation is mandatory for purification
of EVs from contaminating proteins and lipoproteins in plasma. We
provide hereby a protocol for isolation of high-purity EVs from
plasma, a prerequisite for biomarker discovery.
LBO2.3
Raman tweezers microspectroscopy of extracellular vesicles: a pilot
study on nucleic acids detection and characterization
Sergei G. Kruglik1, Pierre-Yves Turpin1, Felix Royo2, Juan Manuel Falcon
Perez3 and Irene Tatischeff4
1University Pierre & Marie Curie Paris 6, Paris, France; 2CIBERehd- CIC bioGUNE,
Derio, Spain; 3CIC bioGUNE, Derio, Spain; 4RevInterCell, a Scientific Consulting
Service about EVs, Orsay, France
Introduction: Extracellular vesicles (EVs) are involved in intercellular
communication providing a wealth of information on health and
disease. The search for EVs-based biomarkers is an actual challenge
especially for early diagnosis of cancer. In addition to «omics»
techniques deciphering individual molecules, Raman Tweezers
Microspectroscopy (RTM) is arising as a label-free analytic tool,
providing information on global molecular composition of EVs [1].
Inspired by the discovered ability of EVs to transport nucleic acids
(NAs), in this study we tested the RTM potential for NAs detection
and characterization. Methods: RTM was used to study small EVs
obtained from human urine (exosomes) and secreted by primary rat
and mouse hepatocytes, as well as mixed samples of transfection
agents FuGENE and oligofectamine in DNA and siRNA solutions,
respectively. Bioparticles were optically trapped by a 785-nm laser
beam through a microscope objective and their Raman spectra were
analyzed for the presence of NAs. Results: The lower concentration
limit for Raman detection of NAs was of the order of a few mM in
base-pairs, as determined for free calf-thymus DNA in PBS. However,
for optically trapped mixed samples, DNA and siRNA signals were
observed even for initial NAs concentration as low as 1 mM in the
surrounding solution. Exosomes from human urine did not show any
NA signal, while EVs from rat and mouse hepatocytes revealed
random NAs signals of variable intensity. Summary/conclusion:
Although nano- and micromolar concentrations of free NAs are
out of detection range, RTM can effectively detect and quantify high
local concentration of NAs bound or incorporated into bioparticles.
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Raman spectra provide specific structural information about NAs, in
particular the A/B form of the helix. Possible RTM applications
comprise a search for DNA-biomarkers and discrimination between
small EVs and viruses in 50-100 nm size range, among others.
Reference
1. I. Tatischeff et al. JEV, 2012, 1, 19179.
LBO2.4
A Mathematical Approach to Understand the Generation of
Multivesicular Bodies
Barbora Konecna1,2, Robin Long, Johanna Ho¨o¨g3 and Jan Lo¨tvall1
1Krefting Research Centre, University of Gothenburg, Gothenburg, Sweden;
2Institute of Molecular Biomedicine, Comenius University, Bratislava, Slovakia;
3Department of Chemistry and Molecular Biology, University of Gothenburg,
Sweden
Introduction: Current theory suggests that multivesicular bodies
(MVBs) are produced from endosomes through their inward bud-
ding. Thus, the intraluminal vesicles (ILVs) inside the MVBs are
formed by the budding of the membrane of an early endosome (EE).
Here we challenge this hypothesis, first by testing mathematically
whether this dogma can be true, and then applying the mathema-
tical models to published data. Methods: The surface area (SA) of
MVBs and the SA of ILVs were calculated using images produced by
published studies, including electron microscope tomography.
Further, electron microscope sections of MVBs were modeled to
be spherical, and the SA of MVBs and ILVs were estimated based on
the packing density. Mathematical operations were used to establish
credible conclusion. Results: The numbers of ILVs within an MVB,
diameters of both and the packing density varies hugely among
species. One MVB in a eukaryotic cell was apx. 600nm and carried
estimated 500 ILVs. In this example, the SA of the MVB is 1.1mm2 and
the SA of ILVs (60nm diameter) is 5.7mm2. This example would have
suggested that the EE was 1400nm in diameter. Further developing
the mathematical models compared published data with estimated
calculations, which suggested that there should be a negative
correlation between MVB diameter and number of ILVs if the
budding was uniquely inward budding. However, the published
data showed a positive correlation in different cells. This argues that
the EE membrane is insufficient to provide membrane for the ILVs.
Summary/Conclusion: This mathematical modeling of the relationship
between MVB diameter and number of ILVs strongly suggests that
the ILVs are not only produced by inward budding of the EE
membrane. Therefore, ILVs are likely to be produced by addition of
membrane material prior to their release to the extracellular space as
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‘‘exosomes’’. This data can explain why bioinformatics argues the
presence of multiple organelle components in exosome isolates.
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LBO3.1
Assessing the role of extracellular vesicle enclosure as non-lytic egress
route for mengovirus
Kyra A. Y. Defourny1, Susanne G. van der Grein1, Martijn A. Langereis2,
Huib H. Rabouw2, Frank J. M. van Kuppeveld2 and Esther N. M. Nolte-’t
Hoen1
1Department of Biochemistry and Cell Biology, Faculty of Veterinary Medicine,
Utrecht University, Utrecht, The Netherlands; 2Department of Infectious
Diseases and Immunology - Virology, Faculty of Veterinary Medicine, Utrecht
University, Utrecht, The Netherlands
Picornaviridae are a large family of non-enveloped RNA viruses that
are released via induction of cell lysis. However, recent electron
microscopy studies indicate that part of the virions exit the cell
enclosed in extracellular vesicles (EV), thereby blurring the classic
distinction between ‘enveloped’ and ‘non-enveloped’ viruses. En-
closure of virions and viral components in EV may have a large
impact on antiviral immunity, and this phenomenon can thus
influence the pathology of many human and animal diseases caused
by the picornaviridae. Nevertheless, the relative frequency of this
process and the regulating viral and/or host factors involved remain
elusive. We therefore set out to characterize the composition and
release dynamics of the particles excreted upon picornavirus
infection, using mengovirus as model system. The release of
mengovirus particles was analyzed over time using end-point
titration while the onset of the lytic phase of the infection cycle
was monitored via live-dead staining and release of cytoplasmic
luciferase. A strong increase in extracellular virus titers could already
be observed 8 hours post infection. In this time frame, however,
there was no evidence of cell death or lysis, suggesting the presence
of a non-lytic release pathway. Iodixanol density and velocity
gradient centrifugation were used to purify particles released early
in infection. The different iodixanol fractions were analyzed for the
presence of viral RNA, capsid protein, infectious units and EV
markers. This analysis revealed the existence of a previously
undescribed membrane-associated form of mengovirus. Building
upon this approach, EV composition and release kinetics during
mengovirus infection will be assessed quantitatively on a single
particle basis using high-resolution flow cytometry. Knowledge on
the formation and release of EV-virus hybrids will aid our under-
standing of how EV contribute to viral dissemination and antiviral
responses.
LBO3.2
Kaposi’s sarcoma-associated herpesvirus manipulates exosomes
secretion to regulate its microenvironment metabolism
Ohad Yogev1, Matthew John Hayes2, Yifat Ofir-Birin3, Neta Regev-Rudzki3
and Tariq Enver1
1Research Department of Cancer Biology, University College London, London,
United Kingdom; 2Institute of Ophthalmology, University College London,
London, United Kingdom; 3Department of Biological Chemistry, Weizmann
Institute of Science, Rehovot, Israel
Altered tumour metabolism is now generally regarded as a hallmark
of cancer and presents an attractive therapeutic target. Although
most studies focus on the autonomous metabolic regulation in
cancer cells and their role in tumorigenesis recently it was suggested
that cancer cells can induce metabolic alteration also in surrounding
cells. Kaposi’s sarcoma-associated herpesvirus (KSHV) is the etiologi-
cal agent of Kaposi’s sarcoma (KS). KS is the most common neoplasm
in HIV-1-infected individuals and is also induces significant morbidity
in other immunosuppressed individuals and in populations where
KSHV infection is endemic. KS also provides a tractable model for
elucidating to delineate critical pathways involved in oncogenesis,
and an entry point to study aspects of tumour development. We
demonstrate that exosomes secreted from KSHV latently infected
cells can strikingly reprogram metabolism in surrounding non-
infected cells. We found that upon uptake of these exosomes
non-infected cells reduce mitochondria biogenesis and oxidative
phosphorylation, and induce aerobic glycolysis. Moreover our results
suggest that this reprogramming is mediated by the KSHV encoded
microRNAs which are transferred to non-infected cells via exosomes
and down regulate metabolic genes. Finally our data shows that this
exosomes mediated metabolic reprogramming of neighbour cells
supports the growth of infected cells. Taken together our results
reveal a new mechanism used by KSHV to transfer its microRNAs into
non-infected cells. In this way KSHV manipulating and recruiting its
microenvironment during latency without producing new viruses
and exposing itself to the immune system.
LBO3.3
Exosome from Plasma of Plasmodium-infected Host Expressing
MicroRNAs Inhibit Angiogenesis in A Murine Lewis Lung
Cancer Model
Yijun Yang, Limei Qin, Quan Liu, Junnan Lu, Siting Zhao, Li Qin and
Xiaoping Chen
Guangzhou Institutes of Biomedicine and Health, Chinese Academy of
Sciences, Guangzhou, China
Our previous studies demonstrated that malaria infection provided
anti-tumor effects by inducing both anti-angiogenesis and potent
anti-tumor immune responses in a murine Lewis lung cancer model.
Exosomes, which are extracellular vesicles that function in inter-
cellular communication, may play a key role in the dissemination of
pathogen, host-derived molecules and in modulating the immune
response during infection. It is reported that microvesicles isolated
from the plasma of Plasmodium-infected could induce specific
immune response in host, but it is unknown whether the exosomes
derived from Plasmodium-infected hosts effect tumor angiogenesis
or not, therefore we designed a murine Lewis lung cancer model
study to answer this question. Exosomes were isolated from plasma
of Plasmodium-infected mice. We found Intra-tumor injection of the
exosomes signi?cantly inhibit tumor growth in mice. Furthermore,
the exosomes when co-cultured with endothelial cells markedly
suppressed VEGFR-2 expression and decreased endothelial cell
migration, which demonstrated the exosomes contribute to angio-
genesis inhibition in vitro. Interestingly, we detected remarkably
higher expression levels of micro-RNA cluster (miRNA16/322/497) in
the exosomes that secreted from the plasma of Plasmodium-infected
mice, which are predicted to target VEGFR-2 through bioinformatics.
Overexpression of miRNA16/322/497 cluster in endothelial cells was
followed with decreased VEGFR-2 expression and inhibition of
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angiogenesis in vitro, whereas inhibition of miRNA16/322/497 cluster
significantly alleviated these effects. These data suggest exosomes
derived from Plasmodium-infected host play a specific role in anti-
angiogenesis in tumor development, which provided a novel
understanding of the interaction between malaria infection and
lung cancer.
LBO3.4
Spinal Cord Injury Recovery Mediated by Exosomes from Mesenchymal
Stem Cells (MSC)
Phil Askenase1, Karen Lankford2, Jeffery Kocsis2, Krzysztof Bryniarski3 and
Katarzyna Nazimek3
1Section of Allergy and Clinical Immunology, Department of Internal Medicine,
Yale University School of Medicine, New Haven, CT, USA; 2Department of
Neurology, West Haven Veterans Administration Hospital, Yale University
School of Medicine, New Haven, CT, USA; 3Department of Immunology,
Jagiellonian University Medical College, Krakow, Poland
Introduction: Traumatic spinal cord injury (SCI) damages the cord
vascular barrier and allows local accumulation of destructive
inflammatory cells with release of toxic molecules that infiltrate into
the cord, contributing to the neuronal loss, axon severing, and
demyelination that can lead to paralysis. Intravenous infusions of
mesenchymal stem cells (MSCs) can reduce the severity of SCI, but
the involved mechanisms are not fully understood. Methods: Groups
of 8 young adult rats were subjected to a homogeneously delivered
moderate contusive SCI at the T9 level. Then cell treatment was
attempted by i.v. infusion of 1x106 rat bone marrow derived MSCs or
exosomes isolated from MSC-conditioned media, compared to
media alone, at one week post-SCI. Animals then were assessed
for functional recovery and vascular permeability by Evans blue dye
extravasation. Distribution of DiR-labeled MSCs vs MSCexos was
assessed by in vivo and ex vivo imaging of organs and by
fluorescence microscopy monoclonal antibody staining of frozen
sections. Results: SCI resulted in profound weakness and large
vascular leakage that were reduced in MSC transplanted rats
beginning 1 week post-MSC infusion. However, i.v infused MSCs
were not detected within the spinal cord at any time point, but
appeared to traffic just transiently to the lungs. In contrast, MSCexos
produced comparable improvements and were readily detected at
sites of SCI; especially localizing to M2 macrophages (Mf) associated
with healing vs. pro-inflammatory M1 Mf. Summary: Infusion of
MSCexos one week after contusive SCI reduced, like i.v. injection of
MSC increased vascular permeability and improved functional
recovery with strong localization at site of SCI; preferentially to local
M2 Mf of healing and not M1 Mf of inflammation Conclusion: The
data suggest that the therapeutic effect of MSCs on SCI likely is
mediated by their secreted MSCexos that preferentially target
healing M2 and not inflammatory M1 macrophages.
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PRS.1
The first massive open online course on extracellular vesicles
Cecilia La¨sser1, Clotilde The´ry2, Edit Buzas3, Suresh Mathivanan4,
Weian Zhao5, Yong Song Gho6 and Jan Lo¨tvall7
1Krefting Research Centre, Department of Internal Medicine and clinical
nutrition, Sahlgrenska Academy, University of Gothenburg, Gothenburg 405 30,
Sweden; 2Department ‘‘Immunite´ et Cancer’’, INSERM U932, Institut Curie, PSL
Research University Paris, France; 3Department of Genetics, Cell- and
Immunobiology, Semmelweis University, Budapest, Hungary; 4Department of
Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe
University, Melbourne, Australia; 5Department of Pharmaceutical Sciences,
University of California, Irvine, CA; 6Life Sciences Division of Molecular and Life
Sciences, Pohang University of Science and Technology, Pohang, Republic of
Korea; 7Krefting Research Centre, Institute of Medicine and Clinical Nutrition,
Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
Introduction: Massive Open Online Course (MOOC) is an online
course that is open access via the World Wide Web and can be
accessed by an unlimited number of participants. It was first
introduced in 2008 and has emerged as a popular mode of learning,
where filmed lectures and presentations are used. Methods: ISEV has
decided to organize a series of educational MOOCs for students
and beginners in the field of extracellular vesicles. These MOOCs will
be open access, and will be produced via the platform ‘Coursera’
(www.coursera.org/), in collaboration between ISEV, University
of California Irvine (USA), University of Gothenburg (Sweden)
and Pohang University of Science and Technology (South Korea).
Results: The first course, ‘Basics of Extracellular Vesicles’, is divided in
five modules and will be launched during spring 2016 and aims to
provide the basic knowledge about extracellular vesicles. Module 1 is
an introduction to the field and will cover the nomenclature and the
history of EVs. Module 2 will focus on the biogenesis, release and
uptake mechanisms of EVs as well as the different EV cargos (RNA,
protein, lipids). In module 3, we will focus on the collection and
processing of cell culture media and body fluids such as blood,
breast milk, cerebrospinal fluid and urine prior to isolation of EVs.
Modules 4 and 5 will present different isolation methods and
characterization/quantification techniques, respectively. Here, differ-
ential ultracentrifugation, size exclusion chromatography, density
gradient, kit-based precipitation, electron microscopy, cryo-electron
microscopy, flow cytometry, atomic-force microscopy and nanopar-
ticle tracking analysis will be presented. Summary: This first MOOC on
extracellular vesicles will be free of charge and open to everybody. It
will cover the basics of EVs and will be launched in spring 2016.
PRS.3
Tracking exosomal miRNA biomarkers in prion disease
Benjamin Scicluna1,2, Lesley Cheng1, Camelia Quek1,2, Shayne Bellingham2,
Laura Ellett3, Laura Vella4, Kevin Barnham4, Vicki Lawson3 and Andrew Hill1,2
1Department of Biochemistry and Genetics, La Trobe Institute for Molecular
Science, La Trobe University, Victoria, Australia; 2Department of Biochemistry
and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute,
University of Melbourne, Victoria, Australia; 3Department of Pathology,
University of Melbourne, Victoria, Australia; 4The Florey Institute for
Neuroscience & Mental Health, Bio21 Molecular Science and Biotechnology
Institute, University of Melbourne, Victoria, Australia
Introduction: Prion diseases are transmissible, fatal neurodegenerative
disorders in which the misfolded prion protein (PrPSc) drives
transmission and intercellular spread of the disease by inducing
conversion of the normal prion protein (PrPSc) into the misfolded
form. Both normal PrPC and infectious PrPSc are transported by
exosomes, with PrPSc containing exosomes capable of transmitting
the disease. Furthermore, exosomal miRNA cargo is altered in
exosomes isolated from prion-infected cells, suggesting these
changes may provide a source of biomarkers for prion disease.
Methods: Brain tissue and serum (n4) were collected from three-
time points in a prion mouse model, spanning from early in the
infection (weeks 3 and 13 post-inoculation) to terminal disease.
Disease progression was assessed by histology and western blot
detection of PrPSc. Exosomes were isolated from brain tissue and
characterised by electron microscopy and western blot for disease and
exosome markers. Small RNA deep-sequencing was then performed
on whole brain (thalamus) tissue, and brain-derived exosomes and
serum to identify differentially expressed miRNA at each time point of
disease. Results: Expression changes of several prion-associated miRNA
biomarkers were detected in both the brain and serum throughout the
time course of the disease. These serum exosome biomarkers may be
an indicator of early pathological changes in the brain. Additional
miRNAs were also detected upon clinical symptoms and terminal
stage. Conclusion: This study is the first in vivo analysis of exosomal
miRNA deregulation across prion disease progression. The compara-
tive analysis of exosomes from brain tissue and sera allows for the
identification of potential brain derived biomarkers in the sera
furthering our understanding of brain derived in the periphery.
PRS.4
Neutrophil-derived microvesicles enter cartilage and protect the joint
in inflammatory arthritis
Sarah Headland1, Hefin Jones1, Lucy Norling1, Patricia Souza1, Elisa Corsiero1,
Cristiane Gil2, Alessandra Nerviani1, Francesco Dell’Accio1,
Costantino Pitzalis1, Sonia Oliani2, Lily Jan3, Andrew Kim3 and Mauro Perretti1
1William Harvey Research Institute, London, England; 2Sa˜o Paulo State
University, Sao Paulo, Brazil; 3Howard Hughes Medical Institute, Chevy Chase,
Maryland, USA
Introduction: Microvesicles (MVs) are found in high abundance within
RA synovial fluid, and in particular MVs derived from neutrophils. As
there is emerging evidence of pro-resolving and anti-inflammatory
functions of neutrophil MVs, the aim of this study was to ascertain
the role neutrophil MVs play in cartilage remodelling within the RA
synovium. Methods: Healthy human neutrophil MVs were isolated
from TNFa-stimulated neutrophils by ultracentrifugation at 100,000 g
for 60 min at 48C after removing cells and contaminating platelets/
erythrocytes. MVs were immunophenotyped and enumerated using
the Imagestream MKII and standard cytometry. 3D cultures of
primary and immortalized chondrocytes and mouse cartilage
explants were used to quantify changes in cartilage accumulation.
Rat femoral head explants were used to test whether articular
cartilage was penetrable by MVs. The K/BxN murine model of
autoantibody-induced arthritis was used to evaluate the impact of
exogenous MV administration on cartilage integrity. Results:
Neutrophil-derived MVs were increased in concentration in RA
synovial fluid compared to paired plasma and expressed the pro-
resolving protein annexin A1 (AnxA1). Exogenously administered
neutrophil-derived MVs migrated into cartilage and protected
against its degradation during inflammatory arthritis. This was
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dependent on MV-associated AnxA1 interacting with its receptor
FPR2 increasing TGFß production by chondrocytes, ultimately
leading to cartilage protection. Summary/conclusion: The present
study demonstrates that neutrophil-derived MVs can migrate into
cell-impermeable cartilage where they exert anabolic effects on
chondrocytes by delivering AnxA1 signals via chondrocyte FPR2 and
preserve cartilage integrity in models of inflammatory arthritis. We
envisage that MVs, either natively or loaded with therapeutics, can
be harnessed as a unique therapeutic strategy for protection in
diseases associated with cartilage degeneration.
PRS.5
PAD-1 activates TAT-5 to prevent extracellular vesicle release
in Caenorhabditis elegans embryos
Katharina Beer and Ann Wehman
Rudolf-Virchow-Center, University of Wu¨rzburg, Wu¨rzburg, Germany
Background: Despite the pleiotropic functions of extracellular vesicles
(EVs), little is known about the molecular details of EV release,
especially for EVs that form by plasma membrane budding. The
outer membrane of EVs contains lipids such as phosphatidyletha-
nolamine (PE) that are normally restricted to the inner leaflet of the
plasma membrane, suggesting a role for lipid asymmetry in EV
release. Previously, we showed that TAT-5 phospholipid flippase
activity prevents EV release and maintains PE asymmetry in
Caenorhabditis elegans (Wehman et al., Curr Biol 2011). However, it
was unclear how TAT-5 activity is regulated. The yeast homolog of
TAT-5 binds to a protein homologous to the large and novel protein
PAD-1. Therefore, we hypothesized that PAD-1 could regulate TAT-5
activity and EV release. Methods: Using C. elegans as a genetic model
system, we analysed the role of PAD-1 in EV release. We examined
pad-1 mutants using transmission electron microscopy and a
fluorescent membrane reporter that makes EVs visible by light
microscopy. To test whether PAD-1 regulates the lipid flipping
activity of TAT-5, we stained worms with the PE probe duramycin.
Results: We discovered excess membrane labelling in pad-1 mutants
and TEM analysis revealed excessive release of EVs, similar to TAT-5
mutants. Using a GFP-tagged reporter, we found that PAD-1 localizes
to domains on the plasma membrane, where it is likely to interact
with TAT-5. PE was exposed on the plasma membrane of PAD-1
mutants, similar to TAT-5 mutants. Thus, PAD-1 is required for the
lipid flipping activity of TAT-5. We are currently testing how PAD-1
activates TAT-5 to prevent EV release. Conclusion: We identified
PAD-1 as a new regulator for EV release in C. elegans, providing a
better understanding of the molecular details of EV release. Our
study further supports the model that lipid asymmetry regulates
plasma membrane budding.
Room: Willem Burger
Special Achievement Award, Wrap-up Sessions, Oral and Poster Awards
Scientific wrap-up: Alissa Weaver
Clinical wrap-up: Peter Quesenberry 11:50-12:35 p.m.
Saturday May 7, 2016
178 Citation: Journal of Extracellular Vesicles 2016, 5: 31552 - http://dx.doi.org/10.3402/jev.v5.31552
